<?xml version="1.0"?>
<rdf:RDF
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:vocab="file:///home/yin2/Downloads/d2rq-0.8.1/vocab/"
    xmlns:obo="http://purl.obolibrary.org/obo/"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
    xmlns:db="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf"
    xmlns:map="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#"
    xmlns:d2r="http://sites.wiwiss.fu-berlin.de/suhl/bizer/d2r-server/config.rdf#"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:j.0="obo:"
    xmlns:meta="http://www4.wiwiss.fu-berlin.de/bizer/d2r-server/metadata#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
  xml:base="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#" > 
  <rdf:Description rdf:about="http://dikb.org/method/78a2443a-51b6-4e2d-8ded-a286dc6995b1">
    <rdfs:label>desvenlafaxine-midazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/880acbe5-7866-4187-b63d-04dee36c2537">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4268270a-3c2f-4bf2-9d7b-ceec50b5e298">
    <obo:OBI_0001937>19</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b37dcd90-b72e-48b2-8507-109dc2a11e99">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/7b53fa43-f481-491f-b6dd-87a7c79f3f0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b87ddbda-aa59-4b66-8444-304360f88602">
    <obo:OBI_0001937>22.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/63e3e87a-bfaf-4035-a504-2f58d7a7d3e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4d717a00-06d2-4a33-b03f-19a7c460a816">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
    <rdfs:label>zaleplon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/43aa88a4-c2b7-423f-9636-0787577e68c4">
    <obo:OBI_0001937>160</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/1e6c066f-3c31-4e40-9d77-e35ca4d54316"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e832b309-dcf6-4f1d-a8f8-0c9d52ca2ab5">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9b5bcd70-0ea7-4ccf-b343-ef1d74965520"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ab8436ce-ae2c-4830-a774-30bdf392b698">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5330b2f8-d7f3-4c2b-831f-d32c21a4b739"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/9689d1bf-39a0-4750-afc7-d143c76e1995"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2ab62ac3-ba47-4481-82a1-1174dbd3729e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5ad5a3d7-2ebd-4649-b198-2f375576f3d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7209f765-b121-46dc-9522-607177cb3338">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/cd9f7fca-967d-4704-932b-83f2870490fa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/26b1f549-dc6b-4cfa-a769-3b2904a80d11"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/53cca23a-b251-4a98-bc6f-58f0f8ec84ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/b3de6934-e045-4d24-9b08-a5a8e469db34">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c1a33f10-b90a-44d3-abdf-4b6d646060a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/5d58c187-4122-4274-ba06-92f705049c6e">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/5260e851-6ee7-4c8f-a506-263c7e1f302a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2ba37d89-702f-4881-87ae-bf07f548c04b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/26701077-ca48-49e2-ad4b-572bdbcbf75a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/dba52a23-99c3-4332-8983-c74b5c832562"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3ffc8d83-1d0c-42e3-9591-b3c7dcb46b61">
    <rdf:type rdf:resource="obo:RxNorm_593411"/>
    <rdfs:label>sitagliptin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/52181dd1-516a-4539-ab6b-f38182c99352">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ae426c77-969c-46bb-9511-dc5bb0902425"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3a04f565-b18e-4b7f-a554-aeb2d6542ea1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/27fa22e6-cfa4-44c1-adca-5e5e5c6619f6">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d4ad157c-dd43-4409-8c2c-bfa88810de60"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a9f57c38-a6e1-4522-8a68-2d2b86d30d1c">
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dbd78ba9-c955-4383-a02c-17b6bf666d08">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6b8b3b25-b773-4af5-bf33-cbf8db24fba2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/16e8e862-0d77-4f41-b8ca-07df46547a49"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/3bb4660a-3549-45be-8300-cb4777d40686"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/881d70a8-d16d-4c8a-8a86-b6aa609ca7de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a6d093e6-3973-4d19-9289-1fa2d91fbe89">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/05a3ac72-44f3-498c-a770-606d397c5186"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/39a386c1-8f28-415e-b917-b0c5de8c1174"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/91cdf5f2-e08c-4ab9-87f8-775e1f943a16">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2cf41260-99da-449a-8026-0b73258a70b8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/c95f54de-f3b9-4324-88f5-3336f1c9d5fc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/42958174-7fd8-4959-98e7-d5e7efc2657e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/afa2ba75-71af-4f13-b88f-05d7d0fce615">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6d9d73c1-e26b-4c87-b465-8b2919430840">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/e2c840c8-6d0e-4675-af1e-cfe519bb7583"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/1781377c-d04d-4a9d-8f3c-4ce0fa6dfd17"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/867b58e5-4e31-4f15-bd89-6a02cac55d9b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/86da0515-1f70-4d2f-afad-60b36fd8dc07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/42bb63bc-fcff-4094-92d4-d985dcde9db6">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/4689264b-b056-44ae-956e-113e49525226"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fb1b48c5-d5f0-4105-b4f4-1124d7c580d0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/61964558-267f-45fd-8919-b756ecaed52c"/>
    <rdfs:label>paroxetine-P95 drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/83f3bc9c-5594-4822-a30a-1df0e48fa2eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f437297f-938b-4dbb-8687-ca3035527312">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/07923610-f593-4b77-80e2-e41b8d4e45c5"/>
    <rdfs:label>efavirenz-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3c78c1dc-a57d-45b7-869c-b0408c481480"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9dbfae3e-597a-4f45-9a84-098fac9862db">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/f740e592-19ae-41ad-92a7-29ba8964e05e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/15fa0b4c-afe5-47fc-b81a-870daa013ceb">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/5716c1c5-47da-48de-a9ca-883be3d0e3e2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/17ed1cd5-143e-4285-b41e-d8368a3c1164"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/cb49afc2-0588-4398-b085-b862efbc7dc3">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/71e940c0-0819-45ef-b66e-83d1148842aa"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/667fe52a-3426-4654-af22-f7c43c1be0ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c94f88ef-699f-4f1e-beae-294b873b67f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/f9140a6b-aebe-43ae-adcc-f4d1877e0930">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a0f2013f-c2c8-4c3d-9b0e-d785e2bd6331">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fcd933b1-a91c-4608-855a-8ba5a10dd458">
    <obo:OBI_0001937>54</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ee9e7e3b-c72a-4b8c-a600-252b632e54b3">
    <rdf:type rdf:resource="obo:RxNorm_8183"/>
    <rdfs:label>phenytoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/c85e66cf-a312-4288-94fb-9210051ba9c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/785df0e2-5466-40fc-aef9-aa5e7d8a4c8a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/92fd9fca-8bff-44cc-aafb-b655a55aac8a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f9d2570f-6c18-4236-a7c4-be53dab350ce"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ac0ab53a-4087-49c5-aa7d-5d59f960fa73"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c4147637-26bb-466c-8b30-c05f9fcfc41e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ece881a7-2726-4ab3-ab9d-41cbbe7014ae"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f43cc8ec-4263-4867-b86b-b82fd63ae3be"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/7eff2c69-40f3-4c54-a485-f89d98d2157a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/baa3ec08-4141-4a6b-adc5-5af1a36bee21">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/2972b6de-c015-4de6-82c4-3fec74bbbc4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/fdaba699-1559-4da4-98fe-b1145ff36067">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/65d3361a-1cc8-4658-9bfc-4252e65d98c1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/e2c840c8-6d0e-4675-af1e-cfe519bb7583"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7f6492af-8e5d-4d49-9c53-9480ce2c0f0c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a673dd0a-c468-4fe5-868f-4b2f20c04d1f">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/fff63ee1-d2c3-4cac-a393-d654554dcdfe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9d4e3f42-6f14-4d4c-a345-1068167ad9f1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8dab20fb-2503-4578-a64f-033f15f90e2d"/>
    <rdfs:label>paroxetine-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d7191d58-d97f-4ab0-bd97-d5a66245799b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9d82f13f-7c33-4a73-a0f2-3d0e18f41a13">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/40b4f8f9-1748-4977-a74f-9ee133ba3fc3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/391592a6-1de2-47d4-b362-d43477be151c">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/8a2fa2bf-323b-4e58-817f-af50a172f975"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/675ffc03-a4cb-49ee-9310-4a78f9c2b794">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f1f8f444-f659-41fd-9d1b-ff658f3d545e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/da3cef89-ab21-464a-a6d3-d0786c30240f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bd596230-488b-40ac-aadb-2a45cfd35e77">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f0b46919-6c6d-45e1-baeb-0e3ae96afb0a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/cda145cb-e039-494d-be41-b2a9b09e1a02"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/09666b5c-e33f-4253-95d2-3e382f50fc4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/2fa47551-4178-4fda-9238-82072d917bdd">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f1192df4-04a7-45b9-a020-8884b6ab6b03"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/c13714ae-ec77-4f9f-bae0-d88bff6c81e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ac5cb73f-0dd0-4800-b713-2830ebb91406">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/4482e28b-3da1-42a3-a87c-239aa78a07af"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/62004d4a-e9e8-4a03-ba37-432f15005a86"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d706e397-b856-4704-9174-f74354ea09a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8de37d52-dfb6-4cbb-b2e7-05fbc9f004b8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cd3ca106-e7a7-4ce5-bbf0-c9711eee6529"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2ef91e09-2bd5-4a6b-a8ba-586462aca9e9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1dfa4075-f6ad-47d3-8dec-789ff27f4475"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d6d00280-c79c-410f-9d86-ddddbf989471"/>
    <rdfs:label>Nelfinavir-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/191baf73-ef06-4aba-bc2d-3ae702c51eb0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9bb019f8-06ae-409f-a79c-ea4af15c41f1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/02d3a694-339e-46b8-87e4-bb04403e2b18"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c8a174dc-42fd-440c-ac3f-50a35fdf381c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/127f0240-4b7b-4cbc-b5fc-9ff1f5b2670d">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2f58076b-ddc6-4de7-8a0a-32be4a8493de">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a103e907-33e1-4295-a315-d94af381cf10">
    <obo:OBI_0001937>9.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3db849d1-72f9-4d89-9e35-bfabcae32157">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ab4063aa-71cd-4c0a-a85f-08549322c3d8">
    <rdfs:label>ketoconazole-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/76cdd98d-b4bb-45ca-a2dc-cd3d1de5f2a5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/99c92a07-5b27-4254-ac7c-8b78fcd9001d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0e5f8de1-02d4-4cea-b79f-9c59ddc22392"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/768bd941-0997-4e2e-a29f-dbe63e34178d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c7ca8296-799c-451c-8100-663416c62a2e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/739aeb94-b19c-48a4-aef1-27b632e1d6f0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/066953d8-6b36-44de-b45a-2ac499e64809"/>
    <rdfs:label>rifampin-pitavastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d83f00a0-49d5-4bf2-9855-1f27e65919e7">
    <obo:OBI_0001937>42</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b9415f2c-e07c-4bf5-bb88-b40fc2bc191c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/009169d6-a444-4c17-a92e-2b4559f9e5ed"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/c00e41d5-0788-46b2-b3cf-12b9d48aedeb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e60596b9-1866-4fdc-a33b-e017cf86e668">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/35282cae-2626-4a4a-adf0-72abc32bca4f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fefb5e87-e056-49b9-8027-9de6b71d94ca"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/1ca2060a-70ba-4756-9041-7fe22fd007fb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9b460c73-df93-4fb0-8042-f33a2694c4e8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7071a248-ff3c-45fe-887f-4f684721563c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/44ea4f37-7612-420e-af1c-4fd3967a535a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/57941b20-f33f-4807-8da6-fd65d1ff2c99">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/21528712-6380-47b8-8fe2-9c91029d77e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/621990b0-7575-41a9-b906-85a938fe83e6">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d4d2537c-9934-4c56-bbd9-ee8dad901581">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/9ee94b38-445a-4feb-8ed9-e0cbbfe756ea"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/eefcdc9b-c7c6-461c-8499-a40931acb7dc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/5485ac24-68d6-4350-b055-66d5cd344a7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f3c5bd1c-3f34-4a98-9bdc-23fca26160f7">
    <obo:OBI_0001937>95.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f57e75ee-56de-4379-9755-aa73e46fe8ef">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/43e8cf86-42a1-4497-8d7b-b1825b10db87"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/bc2ffee8-7b96-48c7-9a97-847af57b9746">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/300c02b3-b53b-4577-9986-f258f7d46869">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/701b2f48-ed9d-42d3-b2c0-224153c8f499">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a1f3a9a6-d0a1-4c15-9812-0fd00395a0f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/a400a687-0f27-4037-8c33-edbde920eb64">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2ad9f2da-c9b5-4470-a9a9-444738e19e91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d217418b-e285-4a40-9971-4841cba2cb3a">
    <rdfs:label>fluvoxamine-duloxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cefef994-298e-4394-9532-bdf0d3e32cf0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/12c71d28-07a3-41f5-9920-4b9af671dda7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/98297b6b-3e63-47da-acb1-0f292c64233e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/95ae9689-d2a4-4665-875f-e6e29c2befea"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/89f93d8a-def8-41b9-aa9d-ed265e229373"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/398a7130-d5ad-411e-88b1-5972593900bf">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/bef61128-bf35-441b-8317-bd429e507f41"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/20a29583-4ab2-49c9-9b64-82e3c451766a">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/d8b507ea-5181-4849-9925-6c0f8b3f66d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/29ba2658-fb2a-45bb-9b99-7bf04412b3bd">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/946180a9-fad0-45ec-829e-0fd0f392e9af"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d6ebd500-b680-43dc-ba8f-fa26b4388ee1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/00baf8d6-6fe3-43bf-9482-ba2b103119b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/60cc9ac8-d8b0-420c-87be-4748989633a5">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/912992b9-c53b-4a4f-b797-01db53109e89"/>
    <rdfs:label>mirtazapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/16641bfd-47d7-4c1d-ab70-12d10a756c59">
    <rdfs:label>ketoconazole-citalopram DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5933b615-6c65-4705-ba80-30977fdd084e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7fde6d46-9663-4c34-84a7-85d2e9490772"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/0aac6d77-313a-415b-b08a-8bac6b25f2bf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/4b29e57b-7fbf-4553-820b-e511ed63e824">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/d0b6c183-a466-4b80-aae0-2125221eb92a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/977beebd-f438-4a9f-bfd4-f944cfde44d9">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/87797b0c-422f-4898-a1c7-bda7b8eb68b3"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f9305edf-c9e7-4ebf-84f5-a2b797de6113">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6f924414-429c-41d2-9be3-25240f8b00b4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/51c9493c-3b39-40a9-902b-d4c17eed116f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/f8a75b10-9e6a-4c2c-a606-4b4d43a98adf"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/3830b5de-f2c9-4443-ae73-8dc2182c7825"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6c394544-62e0-4115-9e65-a1bf7fd2cbbb">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/826d6ec6-5b3c-4e1f-b818-98599179e05e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/9d918bcb-21c4-47cd-a96a-c6dde090e9bb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/895e8768-670b-4c5f-b10a-18c3e1acd59e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5643eff3-0029-4681-b555-ff86cdf161fb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5d0937a0-92a6-4826-b311-826d60bdb44e"/>
    <rdfs:label>warfarin-ambrisentan drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ccc047fd-d053-42ce-9d96-51bf039dd526"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7c4525b8-d149-433d-b417-84b92937476a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/cee33a84-bcbd-42a4-8dec-d462f37ca6b7">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/8aa5737b-2e58-4e58-a531-173e832df18d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ecfb6b95-528e-45f4-b72c-87ddff108913"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b093004a-58fe-4a83-bdd4-9f8303c67169">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f7511bbe-e566-4dc3-8991-19d4fd4c59a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f1ca93c6-c5b0-4ac6-8bdc-35882e8c414e">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d12a7e1e-55c7-418d-84fc-8205de63c9b7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/25278d2b-9d93-4651-8c3c-1ca7dc644d3b"/>
    <rdfs:label>paroxetine-duloxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ee54986b-7d04-4bd4-9375-f56dda5a1792"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e099fd12-1525-4aec-aa3e-b544deb10655">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cf5ad0c2-27c1-42dc-ae90-8c5af46ff95c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1140840-bbef-4521-b5c0-cf370a68aec2"/>
    <rdfs:label>telaprevir-atorvastatin drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/293dad75-4a6e-4408-94bf-23bd3512c393"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d5b8b54c-51b4-41cb-9117-919f3270f8c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b38d8c8e-0685-4359-bd86-8cb1088cd1c8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b67bf448-aaa0-4027-bb49-a573b8a8275e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/384ae7ad-7920-4040-b96b-1fd154d1ba13"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1f6a45e2-30f7-4652-a8e5-ba8bd3a66019">
    <obo:OBI_0001937>39</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0cc3dd37-9a7f-4f8c-a298-2dd008facc64">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/7461542f-12fa-4ed9-b599-c6e852436cbb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f6b3bd32-32f1-431c-9126-c21d50feae14">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/506786b7-164f-493f-8ed6-99214686e56c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/53cca23a-b251-4a98-bc6f-58f0f8ec84ff">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/603ff81d-4ae1-43ab-afd3-843c63cf41e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/234a1987-80ca-4c30-9a3f-27dad65fb482">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/f24df5cc-483d-42d8-9c23-1b967302ae5f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/e0a8b3db-a51b-4d0e-89fc-45aad8357b17"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/aeaf05c0-ebc2-4c70-a02a-8d5bf3aad0fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b0823273-1594-428d-9d1a-df181d6a7d8e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/55af9046-9300-4bb5-8be6-fa08d4381415"/>
    <rdfs:label>fluoxetine-estazolam drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5e9d3631-8b7e-4d3c-9d1f-4826ec019a63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/dcf6ca79-0e81-40c0-bd1e-bc7051064b9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b40760ea-ca0c-4329-b3fd-b54caf2f8363">
    <rdfs:label>ritonavir-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/51800fc6-1785-436a-b762-280654b73c28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/31968fb4-39ba-4137-b32f-e03234d69c98">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b812e817-755d-46a7-9bd9-68139d7ed18e"/>
    <rdfs:label>Fluvoxamine-thioridazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d5fde689-e500-4335-93ef-e294b1c9942d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/496d8251-03e2-4047-b53d-a98b7e2562a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25212">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/70d1854a-4d7c-4868-bd8f-ede3e99ce837">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/c7e98266-8ab6-41ae-988a-01de3fd34427"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/25088c28-d65f-441b-92b6-eaa278e84202">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/04158cd3-5a6c-43fc-812e-27d76932a9be">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e5d75528-cb50-4550-848e-d6ed32ef7d65"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/cdb684d1-8941-434a-9507-5defd3a6fdc5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/67118646-5e4e-41b2-8e18-d10babd6f730"/>
    <rdfs:label>zaleplon-diphenhydramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0ad3a12b-3815-47b2-8fd6-61cd473b926e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/e7ce7254-8b29-44f7-94a8-963f9eef7194">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cea34b46-c19a-4aae-9424-ec97bdbb9a96">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/aeec40d9-c97a-44f6-b4ef-b40cda3db263"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9c7a56bc-7dde-44d1-bbfa-dc5fecbf50db">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f0428cbe-3cae-48fe-9958-046362bde296"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ce44db78-5ae9-4ba9-860b-efbdbf91aa08"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/fbd4bb59-3716-42f5-9b3d-f5bb1f55d45b"/>
    <rdfs:label>simvastatin-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6768b7b5-2b47-4a95-a661-1f4048b64e75">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/73b7014e-9d1c-414e-9539-ea8aa8bd6152"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/0ed141f2-c290-48a2-b8ad-25e1a897feb1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9294b8ed-3ee1-4f50-a0c2-824600557a07">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/345445e0-bf4b-4fcd-86ac-2afe85d2a293"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/7757e5fb-83ac-40c3-a836-d9b90846c74b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/67f42763-8b46-4059-bfcd-8bd207b7bea0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/63dabd92-02b3-40ce-9b6e-11852bb4b2f8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3e075f13-2caf-43a1-a83b-de384e5a146d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e2bf4677-65b4-4b34-93f2-6c298d0502f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/17c7e85e-48d0-4d8b-b351-11e5648beed5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/badd9cb2-2056-42e5-a6c3-c334f1324859"/>
    <rdfs:label>carbamazepine-mirtazapine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7b7543ef-97d6-43d1-a203-4990a90e8646"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d03627cc-628d-451f-b2d6-08885d585dd5">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d1408dd9-589d-4469-b7fd-97437d043eb8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9b5bcd70-0ea7-4ccf-b343-ef1d74965520">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c4ef221e-5bf8-499f-8e1a-02f1d122c4c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/86f77267-22eb-4763-84fb-6175c0751e0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/47e25d19-ac3a-4ac6-a1dc-e835d87b32d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/15c41fc1-2ccb-4ee7-a6e8-effa460f80b3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/11b34b82-fa7a-4ec6-bf5b-398fe223160d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/4d0a137b-9a78-4f8e-9717-f22d30866f5a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/6b3fcded-7120-4fe9-a749-c0c0ccf68b95">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c31a354b-0f76-412b-8848-9c298efbb419">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/7c3977a6-5bf6-4869-90ed-3eb3bdc6890e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/548cbe02-4de7-4777-a2e5-c937554181b4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/782a5575-9980-4b4f-a28b-5165d17981cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/e35e7fd3-3631-41e4-a188-e243e2097f72">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/02d553bb-975c-44ac-a1fc-16e247ae03bd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f193a491-4153-44b4-871f-192ff29259c7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/f7d41328-a15d-43c6-be57-e430ae20ae6f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c4edcb18-d707-40de-a8da-720bfd2b4dcd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/61c33dca-b8ca-432a-9334-8d2ee73813da"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3849e58e-73a2-4885-b5da-4fb39b86ae5d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3017ee51-658b-40a1-9f6b-d034fa642396">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/a7f0370d-ad62-40c0-a948-538971ca5abf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2bba3a03-ac7c-4845-8d09-a18d07738482">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4e523daa-7470-49fd-946a-570e3925cdfc">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e38d86a0-884b-4a2e-b062-fbb13cbe046f">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/ab1889f3-69aa-489e-ad63-d2f0f88a5f7e"/>
    <rdfs:label>iloperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/fae389e8-625f-44b3-bfe0-9e049b2bf1cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/940f53c6-24e9-4f5d-96e7-db57c91fc29b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/cfb8301f-4204-40e6-8f98-4896be4ca62b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/4c8b78ba-3573-47bf-95c0-53dc826a3148"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/609bc74b-bc9f-490d-8430-2987d3f50d8d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/aec2c211-874a-4ee5-9624-9cff01408620"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/9df2b8b2-0b84-461c-b43a-79258a4d2b5d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/146e084b-3dec-441a-b27b-bdd781fd7c4b">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d3810190-ee44-43f7-a915-3af26a892742"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b3936b08-1d3d-4cc3-b94c-624c075c6843">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e252c60e-2dbf-4059-838f-1ba49d925228">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/ade8ee73-1ed9-4351-97e6-a44b4dc0507d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b42c32a6-0e78-41b1-bffb-ad2687c67e58">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/cc504921-c736-4fa2-bc4d-ff44ad12e1fa">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/5151eb23-5fc7-4bb1-ad21-3a27b0b39272"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/21fe3497-fc90-4a8d-a1d8-899845590f6c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/99776b6e-5268-418f-9a3b-a444c1088ff0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/a1bff998-9ae8-42b2-bcc4-22cfaa2058f2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9694df7e-a3ce-429d-b015-87ddec846260">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/08094fcd-e5f9-410f-bbf8-8c38677fef48"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e71ee9e6-a59e-4cef-a6c8-81e3a26f7c32">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/701db3a8-0fbe-4843-b25a-2802aabcbd8c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/732893ed-a389-4156-aed1-f3f6c203ce91"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/92a2190e-d621-4e51-839c-7a31eaf96c61"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7e09b619-2af8-4df5-86fe-0fa28a002f78">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c3e87dd3-248f-41c1-a371-30b50f6a2e39"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/41344670-c521-4e2a-8ab9-6b4b14072003"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/bf564162-3885-4cb8-b290-ff9a97d40484"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e6d3177f-eb5d-4e17-a5cb-7b9c4dbb52a1">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9c564480-5657-4ef4-83f3-54c446023613"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/813a1cd5-a944-4d0a-bf2d-276b51c2bd11">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/eed1a846-d35d-4601-9181-e24785dda5e6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/02c6875c-086b-4b43-8bc9-84904fa0c6a5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f541d0e2-31c9-4811-a10d-02f9a577e4d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/67203793-a2d2-4909-bf5d-16b321776ce9">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/f9140a6b-aebe-43ae-adcc-f4d1877e0930"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3a63fef8-ee00-45ed-a885-d38192395652">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/8068f57f-1583-4a85-8de8-6b280fb70123"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/15385147-22e1-4bc3-973f-d25090691ea7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8d0d498e-68c9-4702-a4f4-07cd14303e01">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d896a107-cb01-4fd8-be4c-40171d75d851"/>
    <rdfs:label>phenytoin-mirtazapine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7bcf8d48-2418-4c8d-81fa-3d79d8c0c24f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d399f4b8-33df-4ab5-8395-c746b9df8d19">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/26d71aa4-d2e0-44bf-9e7a-7fcf976764df"/>
    <rdfs:label>rifampicin-rivaroxaban drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b3029bc1-1161-4f75-8854-17fcd540a631"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1d3d7821-fe1a-4866-98e7-b3f2a294d359">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ae519392-5e30-4570-a323-a76e659c782e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0dbb12ff-e2b9-44a8-bca8-c9b62be506a9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5a92bf8f-fa8a-49a4-b278-5c20a6d9676d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/96d8d552-b922-442d-8ee3-7e7b96de916b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/dd1a5586-42b4-4760-ac3b-1475d5449d80"/>
    <rdfs:label>ABILIFY-fluoxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cd2f99d1-eb49-4f20-bfd8-7090c3aca658">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2f4763a9-b45b-4b9d-a712-faf2490c64b9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c265021d-5c07-4911-be12-d3a16e77ee32"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c81baac6-a3d0-46fe-b4a2-f7dc2d66dc90"/>
    <rdfs:label>LPV/r-Midazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d1ad3d50-324c-4664-ae9e-8cffa00b8a00">
    <rdf:type rdf:resource="obo:RxNorm_861634"/>
    <rdfs:label>pitavastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4919a47a-1653-48c4-9bed-ee90ddad29a8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d9e099d7-f2d3-45f1-b85c-2693fe7154ce"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/59e8dce4-4beb-4445-9042-cc527046bb88"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1e1a7139-bbf0-40cf-856a-887446cd7145">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/bf720357-c1db-4b8a-8bb2-6f6640266cd5">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/f02496d6-0156-4b6a-95c6-0ca44364113d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5c949236-1a22-4e33-a18e-f388542c4056">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/2081c08c-d37f-464f-ab76-decb0539feb5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/b8e34134-132b-4bad-b6ef-7071bd8b8690"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/90c19c61-c354-48bf-babe-7843210eea22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c7a939dc-85a7-4ffc-a001-171765c2930d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e8d0fbd6-2c58-4d68-b7d7-5d1f9780c362"/>
    <rdfs:label>nefazodone-alprazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e83cc1f7-8c18-4d2f-b43b-eb943e933ce9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/064ed001-18cd-45ea-83c1-0b4102564eab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9e42f17e-8c8f-4f68-ba3b-67eaa262946d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/b96c94f5-9f01-4122-a1fc-11425cfec2c2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4fae846f-1431-4023-b9cf-b8f2100c3f1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/dcb90c0b-6fd8-4e37-8cc3-1e6cc9ead6f3">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/485c2263-cc61-40cd-b749-6effca5b5788"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/a957fcfc-78f2-4a68-bc6a-64d5478c8966"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/4d77dd84-5795-4d6d-8502-0d14296afc18"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f43cc8ec-4263-4867-b86b-b82fd63ae3be">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/eb607d20-f868-4dd7-90d4-723ed93b9805"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/429c3e95-a755-40bb-80ae-d07fca183ce5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0c1982cc-8fd1-4af0-a9f8-1fa512070d88">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/9ebabe44-8202-442b-a91f-73c96471d5cb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/4d1a73c6-a5b4-4e8a-9269-921dedcaca94"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/1cac2545-b462-4741-a6a8-47010caee63a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a276f0ca-787b-4bf1-b184-4d3f2f55d00c">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d574d227-1dbb-4f7d-ad6b-d220114e12f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/29e54995-bbf6-48ff-8465-35fbb59b688a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/63e3e87a-bfaf-4035-a504-2f58d7a7d3e5"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/4e9a503e-a60f-479d-8194-0c0731a9b029"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9debde91-c2c9-4ac9-9381-db6e04a2d022">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/cc803649-5e52-4ee1-b510-6c0ad1e55785"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/a1f3a9a6-d0a1-4c15-9812-0fd00395a0f2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/71882ff6-da7c-4484-adac-4058e0abd7d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ed5a15cf-b6a1-44a8-935f-3822e4a89f33">
    <obo:OBI_0001937>9</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/9a45265d-9100-46a7-b47c-5871aa698b29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/6404abc8-bf54-4b3f-87f0-659327c3ed1e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9ca2fca2-baad-4db3-bc82-6c0014285679">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/67505592-2a37-46b3-a028-d9ff084198b5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3151fc30-1858-46dd-a6a6-d551298ccc74"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/f00ce7f8-315a-4494-9218-a5257c10ceb3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/ab1889f3-69aa-489e-ad63-d2f0f88a5f7e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0abd8fb2-6955-4453-9b28-21dfc547ccf3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/da251943-5226-46f6-baee-e20010680766">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/16abb491-ed43-47c9-ab39-c0c4f0985cbc">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/31e9198b-dba4-4e33-9e29-5d900c3bd5f0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/491f595e-e1b0-4b22-88e4-a2f738309ae6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0866c885-54ae-42b8-b21f-f46824b50383">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2ab67720-60e7-4e23-bcce-0660f12640af"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/956d7076-3c11-4211-a5a7-4c3e410ad08d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b737ce89-3e2a-4bb8-b8f1-5eb868222c80">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/208cf6b7-9f1a-4273-8bfd-9071928a14fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fc95fac6-1193-4561-9306-7ef12eee5d79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d453b7b1-fa22-4f01-962a-4634fd98d313">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/066ef4f0-7a29-4f51-9025-d04d76d3a83f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a36087e8-2a7c-4a4e-93fe-f6a492dc30da">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7c3977a6-5bf6-4869-90ed-3eb3bdc6890e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/3f1713a8-c041-4628-bfab-c799e80828f1">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/1f3aac81-2aed-4b9e-a6ce-03a16efe32a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7557d550-8b00-438e-96f0-15214cab85cf">
    <rdfs:label>ketoconazole-desvenlafaxine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/e3106d6a-7180-4fa4-8e5b-9c9c10e9dc3f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/919cd707-fdf0-4c03-9255-ef5dc654dbdc"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a5c81b2a-4105-4e58-a1fc-8904ff201352"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6bcad680-f671-4122-8531-1d4419208b11">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/9fda9350-9b40-48c5-8d09-6f84800d682b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0e2d1f24-b320-4777-b611-0ce01851da3d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/8152d9c4-272f-4d8c-bfca-75c9191f9767"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/5f075353-ad77-4eef-ae5e-ecc1e544fb43">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/37695767-0a1e-4ac1-94e4-364fdfb40575"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a841c2fa-ddfc-4fc7-a01c-c4c51f6fc5e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/39099ce7-152a-43fd-a9fd-9d637394ed91">
    <obo:OBI_0001937>.25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/8a542ff5-0357-4089-86b2-329902fa4a5d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9ab9594f-a707-4e92-aecc-4dea1942fbd3">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/f2089b5e-b895-42dd-916a-d61a6b61017b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c77c7109-6715-4e4d-81b6-c7d6ffd455a2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/74c4eaa4-19c7-44ab-8253-d371c10545da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4fd3f95b-b714-4814-a076-2d2027cffe35">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7e2c8918-3233-4bd1-8450-6d4898a39395">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/743d5863-e237-43fc-973e-190d322e0923">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/a8a9fe3f-8ae3-414f-8bad-9b56842e04bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2869d0fd-88a4-42e3-8721-3b7273660b40">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b553b729-a3c8-41e8-b24d-d9f866329df1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c9ecff2d-d6b0-44f7-ac43-e52cca23a1c4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/da7d421e-e87b-47f0-8be1-a5223dfb9aab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2de68fcc-9f7e-4ac4-b93a-402940ae5ebb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0c7d6288-ff52-4205-aae0-ce41588a629f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/e7a531f0-ce43-4f9a-88ff-e4a69bebe438"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ecc2aff6-10d4-4cff-80e6-65e5491ff06b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/7fcb76fd-ca17-4905-9a40-50daade6ffa9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/1b6ae78a-2cd9-4495-9f36-5d34169467f3">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/603cabf9-c853-4d74-afc1-47625c5a6b41"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/68ed4798-302c-4b2e-9936-9c32c796936d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5fea5a92-acba-435f-8ce6-0704f7621fcc">
    <rdfs:label>fluvoxamine-ramelteon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/244e35d9-1b71-4af0-b5fa-50989bc6a9bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b07b6184-1c90-4c06-86a8-b2040e4b888c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c3248a3f-29f5-469c-96b6-5b3f4703b5d0"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/94d3083f-410e-496b-8a74-8b8606c111ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/da79498f-c0e0-4702-80a4-8e77d341df2f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/6059d8a3-db73-4ed0-956b-b46614c80dc0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/823f1b55-0b40-4f17-a79e-cd38ff03ff98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cc4416b9-a1c6-443a-bd53-b86f4d78c523">
    <obo:OBI_0001937>22</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d0aa7119-408a-4fad-b32d-99230b9af903">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/06302345-5a5c-47cb-b06d-bf9f2fd863ca">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/80116197-8ea0-4414-b91f-106b1cb93194"/>
    <rdfs:label>ketoconazole-zolpidem drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4f9235ca-5f26-40b4-8c88-f16d123d08d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/8562bbb2-cd0c-4e2c-bfef-29143d0ed3c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/04cc938f-63e1-4018-be01-747c6c4cc617">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/29f8ce49-c33b-4df4-a295-465e906d0c8b"/>
    <rdfs:label>bupropion-desipramine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/44e3800f-34d2-4364-ad82-9760b1c9bb6a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cb656049-1df9-47ab-a0b0-2491ee8f870a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/63ad08e9-8654-4b0b-a88b-1b5573d77231"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/83da40c6-87d0-4d80-88a2-13110ee8fda2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/682b0c79-01c3-4e9c-b109-b7da1542f036"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/74b25851-33ee-41fc-bcdd-14e0c7a6e449"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/02d553bb-975c-44ac-a1fc-16e247ae03bd"/>
    <rdfs:label>nefazodone-triazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/be2a38b3-581c-4916-bb7e-77e667a14066">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b6e4a345-e17a-4c0c-830a-a62505f4dac4">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/71ca8eae-100a-4eb7-b31e-ead8111417c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7e3b130c-eae3-4e49-8249-d2fbcbf7cbc2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a9dabd75-03bc-40a3-bcc5-11bb49b9df80"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/94e854eb-252b-4de4-8e0f-3c0847939c83"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c10c0d10-355b-4691-b2e1-d2d3d59757c1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/13e61073-d15e-4535-92d4-e521daacd362"/>
    <rdfs:label>atorvastatin-verapamil interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/84365b3a-9b98-4e61-82de-fae7c5f58194">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/85669fe3-1e00-40d2-a66f-b60818b4b5fc"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/882bc1d5-ba28-441e-a357-5cf88a0068d5">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/b72c5120-0869-4456-9462-ac94b9a31a9b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8cf6368c-f444-484a-9bf2-b98b34171c78">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f0c3b41d-a27a-4754-b8c7-fd4fcb98f76d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/2a22fd76-d3ed-4482-84f3-de06393b92d5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/c93d18ad-aef7-4695-9459-12a24d7f64e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1f005577-33c7-42c9-8fe1-a67661049543">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/af04881e-f536-4a44-b0fa-f7bf58339c8b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/bd7fdea9-5e8b-4f33-b78f-91e39ab4355d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/b6be80e7-95a7-462f-9566-acff90b14401">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d6659e60-3f26-490b-9b7c-763cbffa8ad2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c96427f4-5ece-4bf0-9979-3241f6e89fd0">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6b0e8203-e53d-49cc-9a96-8f73b340ab33"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/92341cf2-9ca0-42f6-83d6-da5b8781a389"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7333c436-8c8e-444a-971b-d6a882671b82">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/22500248-e8fa-40c5-a6b9-99a1373ec1d6">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4ba92fbb-78ba-49fe-8069-3cd760658b40">
    <obo:OBI_0001937>81</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/af9b0431-7c75-4b0d-b6b6-46350682019f">
    <rdfs:label>fluvoxamine-duloxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/4dfa2d0f-96cc-45d9-ac21-c8fb296a335e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6f5854ca-501b-4792-bf5d-60fd3cf0943c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/701db3a8-0fbe-4843-b25a-2802aabcbd8c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0929e202-bf38-424a-a3c8-5953f9f5aef8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b305faa1-9bfa-4534-8112-f7e985c95f4a">
    <obo:OBI_0001937>3059</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1d320311-39e7-42cd-a5eb-801a1e76876f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/a6fbe587-4a1d-45a1-ac0e-bdbc737c917e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/2562ec60-02b8-42f9-9b7f-a424af52d977"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/d2ae4c15-4b27-4ff7-9d0f-bc9e9e246f84"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/ff36b19d-3d71-4bf5-8e26-e10e3cccc20e">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/e959f5e5-ed66-44b4-bbf4-3c9062c14e8f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/265008fc-448a-415e-a2a8-e721694933e7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/3d0eba5a-17ff-443c-9dcb-4507c04952a5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3b808b40-c531-48c4-8c46-bfa51f84bbe1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/476f81a7-20fe-42b4-a794-91f7eb7736ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/24ea7085-12ce-41e7-9454-db88da26413a">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/dd532d32-91a4-4fa5-a139-d92297869d81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/732a5154-e174-447d-af3e-5878fc6de75a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/aaa416ef-857a-4b6a-8b41-b4297aeb40b9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/90dc14ee-1f5d-43e3-af66-c5d438c8b07b"/>
    <rdfs:label>vildagliptin-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/cddb3669-19ca-4b93-b166-821a1bc52779">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/74d66c67-73bf-4ada-9513-28aaeacd0066"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/31070c4d-54a7-45cd-9962-5976055733dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/7461542f-12fa-4ed9-b599-c6e852436cbb">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/6e693a19-2a6a-46ca-98a2-980a3de8694f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e63b53c8-63f6-4217-9252-587a236970b3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fed4ebf9-ab70-4874-a95d-0bd4c865cbe0"/>
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d0bc7443-e71f-45cc-b1e4-032ca2666e84"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/db09a046-52a4-4eea-a6f3-5743150f456d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d373d067-c452-4008-af90-a3b32de980b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/875d76d6-525b-4f7d-807d-92c3dfa04303">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b72585be-6100-4fe5-a65a-0d16c17b69ae">
    <obo:OBI_0001937>74</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0b70d585-4854-4118-9e91-0b2489dde090">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c5589969-634f-42c1-a5a5-335b8b69e61e"/>
    <rdfs:label>amiodarone-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/fd14a1aa-f913-46fc-8025-b8d54c38323e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/665b2630-d786-4005-afa0-1945541dc846">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2571d441-7b4e-4dd1-903b-03d095c5729f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/326163fc-113d-4f62-aea8-8740504a9e3c"/>
    <rdfs:label>fluoxetine-mCPP drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a64c5eb0-5b24-4895-bb68-09acccf7ebd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4ce2400d-61cf-44b0-beec-7c391317b377">
    <rdf:type rdf:resource="obo:MeSH_C060062"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/6e9e4b6b-b6dd-4b7c-8071-28528da12ca0"/>
    <rdfs:label>mCPP</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/d24905d4-4fc9-4eae-b7b9-9fdc9391f400">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c92cd40a-ff12-4f9b-9c9f-5e06fbbb7dfe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b477b2e0-203e-49f4-b762-6dd00df5bdf8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/682b0c79-01c3-4e9c-b109-b7da1542f036">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/67375ca1-a6fc-4921-a828-d5a7274aaae1"/>
    <rdfs:label>nefazodone-triazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b3936b08-1d3d-4cc3-b94c-624c075c6843"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/08e370fd-8037-4a11-990e-3f4fea495c4c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c7158986-3eb3-4631-959b-07c412b7996f"/>
    <rdfs:label>atorvastatin-aliskiren drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/26df2320-c2b9-426b-a789-876879db07d2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/91310d5d-35b2-4341-9aa8-4b33abff3dcd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1421745d-b5d5-4c59-b426-5e6bc27c4aaa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/b4dbb304-b543-48d0-917f-9e822ebb5b11"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/54b8345f-57ed-4b4d-a463-70dc36bfb51b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/68348751-e9f4-4c0a-85c0-fc1397faa1d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4b097c4b-6e4b-4c8a-937b-b56d4411cb7c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ec80bb9a-afd0-4a7e-a5f8-2ff1b0320f3e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/3db8dc01-3da7-4308-a820-6e11b389fbed"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ed21ff6f-4965-4b2a-991e-a240662de149">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/086ab0b6-497e-493d-b675-663dc960f44d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0d9648c3-a344-4919-bfba-3c61343d32f1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/63b987d0-1e24-4485-be59-cae8865f5440"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/562a5a77-e22e-40d2-ba74-174c15e62b62">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/da52b3a9-d16b-44e0-bbfe-6dcf461dfa20">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c46688dd-594f-4b59-9b22-24ff831d2b4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/397f3ba4-d889-411e-9e1e-742dd73d902a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3c785bbe-d5f1-4462-8d80-e8892d28d367"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3499a189-d428-4aab-a82f-e868785fefd9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ed965d8c-ff5e-45c5-80af-da64542c5a6f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c69c724d-980e-424d-ad82-069820f74b09">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6da0f9de-b3cc-4944-aba6-de9a8f748617"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/d0e2fc18-9075-41c1-9d39-89cd3846b4e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/37a5e315-a83f-4d6b-b5e7-73f89845345f">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/6a95f270-ef3f-4598-b412-6e2609c50c2a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c1cfbcdf-f571-478f-832b-c9675c79234b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef0a5b7a-989d-46f2-bbcb-6d5c6908e454"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e12d9a7d-4cd1-4aaf-892f-a78ee5713041"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f99deb6c-3587-408a-ace6-73bae8d4603e"/>
    <rdfs:label>theophylline-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/95e80f8e-e59f-49a7-911d-5d04b4dabceb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2c01abac-aae8-495b-bc3a-8d2781c1c519"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/434711c8-7a11-423f-a4f8-badddb90723a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3405f165-a372-4f60-8f20-cd5fc96f495e"/>
    <rdfs:label>risperidone-valproate interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/02d58923-1bb3-4c0b-832f-8f32b642b51c">
    <rdfs:label>divalproex sodium-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/052f168b-05a7-4859-a500-4bd47c8867af">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/8b57055a-4729-406a-91a0-7cecf89606f0"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/9e81cced-5aea-48f1-a917-f7091037d557"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b1964e63-8f7c-46a9-a966-3c80d273372d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/43b8da23-30b2-42a9-abd0-1883fa91ab8e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c88714ca-5db6-472a-b05d-223f8f3694cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/900b978d-c7ba-495f-8b32-279c477bcfe1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e8d0fbd6-2c58-4d68-b7d7-5d1f9780c362"/>
    <rdfs:label>nefazodone-alprazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3049eec6-abbe-4169-a5fe-bc8fd6102234"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4419f639-7af3-4d91-93bf-132d6c6f14ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/88f8a6bf-5cde-444c-bb18-3b70d52411dc">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/386244fa-1e74-4e46-a98c-d103fb6411d8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ec51f41a-68bb-435f-910f-f693290a7142"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e45284e5-9c9e-4308-9765-e5af0eb54287"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/ad21d82d-22cf-4d0d-9aa3-8c35dbd200a1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/4e7a3ba0-4a66-45cd-a385-9753430e4b97"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9339d70d-46a6-4257-82b9-308d912473ec">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/46a1fbfb-a946-46d2-be66-5b61b58579f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0f168714-3741-4026-af78-681d315a80ea">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b88b2797-841e-4306-9762-e0f5d69f87cb"/>
    <rdfs:label>Nelfinavir-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/6f597323-22ae-4e62-86ee-dd4cd9f068fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/30da640e-fc99-4e84-a293-8aceebdfde06">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/89f1275e-5d4e-4cae-abb8-b561df255cbb">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ae33e4f2-a9e4-4de0-bd97-526a363948b6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/17937be6-6e99-490d-8ba1-6c3205dc3dac"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e78b74ad-d4d6-40e3-b450-ecb18c172b8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/46fde10f-c621-4745-8d27-2e106d452518">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/107f3607-c24c-4955-bb46-230b5166eb20"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/03aae529-c936-4ba8-8dda-1ff27b7b4953"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f3bd2e72-b696-4c66-9f80-448859d583e1">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/91581307-98a4-4a64-bfd3-26fd30301af9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3bca1cdc-bede-4a74-9f53-8629408097db">
    <rdfs:label>sertraline-pimozide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b39b6a9e-7c12-489e-8bc2-8a1436c5bb77">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/82d5071d-b98f-460a-af15-fce78d1a3f8c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/220a4872-f0e7-4d30-9951-a87e8a1e8ff0">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/baa3ec08-4141-4a6b-adc5-5af1a36bee21"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7c37a933-96da-4b72-9f2f-15c33aa83b6f">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/0f8b5fbf-f034-4625-ae84-859c846cd261"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/1a18e539-38a5-4555-83e8-127630c477e0">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7d0d6db0-9b5b-496e-8c40-a58c30603205"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/a97be386-77e6-40ea-b86d-a6bf45ba9166"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/d40c8c9a-aaac-4eda-bd11-5e0726eccc71">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b0fc47ab-a55f-4e04-a53e-2b8ba3454c03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0e2ce794-db88-428f-9ba7-3cf34a5100cb">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/039e62a7-1d07-4326-b8f0-453f25b5a7d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f99deb6c-3587-408a-ace6-73bae8d4603e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e8b56d63-503d-419b-b523-8d0f5f1c59b2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/9c95405c-7a47-49da-8a60-4b1a9bcbef7d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4644c1f5-6f8e-409e-845e-027b51491c75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/47b87358-fd9b-4389-84cd-211defecf3a6">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/faaf4299-eb17-4be7-b330-e085982bd820"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/54ad54e0-a846-4234-892e-33c70db3ab32">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/20e032c1-6df1-4f45-bed7-751d434cebfd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c17865f1-b208-4d7f-bd79-d8d826843849"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/774af029-964a-4edc-8cea-88571e5a4ea9">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/408de211-d49f-4c49-bd8f-accfc7d4eaa1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a5df73ae-2330-48ac-9ffe-456a14784a7a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b7292454-c8b2-4808-9ed0-13123904cf9a"/>
    <rdfs:label>Diltiazem-Atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/bcc6cd3f-c43c-402c-8166-f689b53335b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d21e58ae-dc00-4903-8451-637d356c82a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/27ee1a7f-e1ef-4d5b-9cf2-30dd4399354c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/9702903c-92f7-4c69-9903-34441490d9c7">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/fce4b28f-da9c-44b5-8227-4478230dd422"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ab4d84c2-f122-4ce3-9005-ebab480ce235"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6760f124-0044-4916-b6ff-de96c39d7418">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/0a6c2a12-206c-4818-bc6a-a4bc5f15d6d4"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/fbc38c28-e69b-4b7b-92ad-e7c8f99b1c39"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/36cf32f7-5b77-4a0e-a5b3-cbd617568dde">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/1c69569c-836b-4036-823f-ab3aac10d4c9"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/b4666e6d-e3f0-459a-a399-9b5b8cb41afe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/08a29594-d991-4dd1-963f-bb4c7608ff74">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/97193f8f-f844-477a-88bc-959413df9a66"/>
    <rdfs:label>Fluvoxamine-alosetron drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/81f6baf1-7044-45fe-9d2e-ceabe65264ca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b69dd0d0-304c-4a47-b137-72aa9a344941">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e49fa751-370b-4133-83bb-3a4794b43bb6">
    <obo:OBI_0001937>2.84</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b0dace87-49e6-4aa4-8cb0-b17e11272534">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/35bf2275-97f8-4b1f-abc4-d87be08ccd89"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e18b4278-9317-47ab-a4f7-c65f33fed509"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e085c3d8-7662-4249-a2a6-5141e8fef6a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/4d8610ba-dd0b-4c2d-980e-6c1b85be1e81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/35bf2275-97f8-4b1f-abc4-d87be08ccd89">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/42eb7f98-e8b1-4fd4-a28d-75d6308aeb1d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/6a910a27-3a46-4267-a005-3688b85fe47c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/88c9bf01-bfe7-4a75-9d00-50546dcd7b04"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6e58569c-4dc5-4eb2-9edf-4baeb6e818e2">
    <rdfs:label>alitretinoin-ketoconazole DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ae2c51ba-ff96-4d74-862d-fad5fe44fdb9">
    <rdf:type rdf:resource="obo:RxNorm_61381"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/f3ea7b60-2b37-435b-b5df-55d12a913c8a"/>
    <rdfs:label>olanzapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7519dae2-a6ab-4acb-9218-1ffa08852b3c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/752212a1-e53f-4cff-9ba9-27cc9add1105">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/feb5d44a-ccf4-444d-8223-7aea37a11aa6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/da2b489d-75c3-488f-81ef-baaaa19bb36c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/dbe72482-147a-4a33-af6e-d976f1ac89c0">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0cfee536-de55-4a4f-a0d6-3fad469a1bde"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5d27368f-f63d-41a9-8771-9af7d3a61419">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8310a5b2-d825-4eee-bad2-a2bc186a6c40"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e22bf70f-b935-4342-b951-51300d6ee301"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a5247d93-8665-48ab-97ae-0fe3a3672627">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/cc80228b-b8c9-4777-86b8-6d87b565c793"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c3399f13-45af-40fb-b55b-f27215958f75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/72514684-8493-4f72-bfd6-e66d739c8952">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/e3323dcf-3984-433b-8b14-b4dbbc84a3f0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/1847c4d6-24e2-464d-8012-5d2ab4d47b3c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/09ae1a1b-2dc3-4a04-ae26-cf1e760f47d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4f4968d1-bd1d-4d18-bbd8-10c77aae7d78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1aafed34-754e-461f-a44a-19cdf4002155">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/70016345-2a88-4dd0-b6e7-2506a6e954db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/43096a1c-7796-4104-8ac6-01e0b5946ce1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/39a386c1-8f28-415e-b917-b0c5de8c1174">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c93d18ad-aef7-4695-9459-12a24d7f64e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/66654d61-fb1a-469e-942b-189cb645aa3d">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ab34fb8c-3a8e-48dd-9ce5-84bc544db38f">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/c214d9e5-7e3d-48ce-92de-a542d0784e9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7f2aeb52-e824-40a6-809f-68f00ffadc95">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/37041681-d087-427e-8359-87af1e370686"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/13d7c981-6903-4127-ac7b-252342c2359d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e8249a04-c832-4f1d-9206-693493d75a11"/>
    <rdfs:label>Celexa-metoprolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/45bce811-3cce-4bca-9b53-f349a53a23c0">
    <rdfs:label>ketoconazole-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5e15e152-54b9-4021-a284-10dff36d7086">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9a4b8332-0c22-4502-8695-5a38df6ebb46">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ffbdbd11-83dd-41ea-b21d-6de6f826c6a7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/242e2398-0e5f-41b7-91bc-971029ac2605"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c7a60128-e21f-4ff7-8a0e-aadd083664de">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/6c9c55f1-4278-4535-bdb7-8204a84ee8c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6c78ba32-dcf8-4e73-97af-164ef04b08ec">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f089c69c-eac6-46b3-8ed5-726e8edea36c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/127ac3b3-c6ee-4689-9435-f6d5dc554cbf"/>
    <rdfs:label>simvastatin-alitretinoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6cade93e-5f3f-46c8-83e8-81b75d2128b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/24ecdc12-7413-4fe1-99fa-7ec1225c197c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/de6e9f7e-7f2d-417a-995a-05db5bd848fb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/cb2e5710-e61d-4515-a80e-80e80dcff276"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/02a230ca-d2dd-4adc-bad3-b3cdef9997be">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ee686ba9-b07a-4086-982c-f57cfed31f7b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/1fd9821d-f64f-495c-b00d-c99ea5b09edf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/26c049e7-3ffb-408c-9150-761cde9ac3eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2f6a8f64-e63e-40f8-97cf-bb3dfcf00889">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4f3263cf-67dd-4a2b-83d6-cc333bf9d1eb">
    <rdfs:label>paroxetine-P88 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/8bf8a278-8b41-4771-a894-6a451fd59f9a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/65bd2aa4-1221-494a-adfe-cb82309c8744"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/16ad9fc2-7bb6-421a-bc65-f66c7c59a8c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a4cc407b-ca4a-4fe5-9f30-4ba566f964db">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/fe5f92bd-d642-4561-8440-1bfde143e1c7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/41b7b894-5290-4ee6-8f8e-0d78058dc024"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/f4373c58-704b-40fc-8772-ec64c2748341"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c5589969-634f-42c1-a5a5-335b8b69e61e">
    <rdfs:label>amiodarone-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f2fe23e8-3804-44a8-b4a8-128114112c6c">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/8fe5aaa9-3d2e-435c-a635-5d3c22a474c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6d329d80-bd63-4335-8ed3-663b26177399">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cbe560d2-c988-4ff5-b04f-e7ecae84b804"/>
    <rdfs:label>clopidogrel-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1ece3a7c-990d-4ca0-9ce1-ec22a4c4f56a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1bc19e57-4e2e-4d1e-814e-435d03c74a61">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3e4df98e-e3a2-4ecf-8435-d29ce57ad2f3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e54bbe8c-9252-456d-92b0-aa1f7a5faeb3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e8b904b4-1daa-44c8-b240-81404c9f2036">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/dd277735-85ba-4af2-8aa2-9cd5473d52a8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/750f0d38-da7c-4121-a8a9-1eb69b8d0b58"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/43335489-21c4-4749-86e1-55e6ddda1bf5">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/13c8fed3-df5d-40b6-8eb9-8834a3d5d78e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/af8c9dbd-ff05-4b08-a4b4-472ae464354f"/>
    <rdfs:label>nefazodone-alprazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/26b26d13-94ec-45f8-9edf-ac7155075eb5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f0840363-a8fb-44fb-a9a6-cea43a7e6a85">
    <obo:OBI_0001937>27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/062e60c2-6265-4c9d-b81c-98e8107d0642">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4b3b63ff-bdc2-4a35-9979-4babf9d71200">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1bc19e57-4e2e-4d1e-814e-435d03c74a61"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d755b5cf-708f-49a1-b0f3-a92b18a6d52c"/>
    <rdfs:label>Rifampin-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/47f78d43-5952-4205-bc5f-1ede08995031">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/866a5eb1-9539-492a-8e73-7c23ab4dfcbd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9c733e2c-6f73-4aee-b865-520b7aba0e46">
    <rdf:type rdf:resource="obo:RxNorm_8703"/>
    <rdfs:label>fenofibrate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c5ff6627-f598-457c-bbf7-72338575f983">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5ea950ba-8275-40a0-b67e-83ec290f118c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f07f6e39-93bd-4228-b2df-72a42d9fd482"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c971258b-e4c7-4748-b1a0-02efda8ecf06"/>
    <rdfs:label>rosuvastatin-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/899a87d1-67d4-459c-920a-d9247437eb32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c617ebe3-4073-4e12-8982-c74f94ea3282">
    <rdfs:label>LPV/r-Midazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e9b90be7-abcc-4fbf-8c78-c2d4ce4109e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/11ce757a-487b-4324-b050-9224368fe82f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dc1184ea-4b92-434e-bc3b-f41ea18b35f2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b2d7f11f-fbbe-400d-88e5-6b2d93dbf510"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/022344c0-ba73-4dcb-b132-3f9410a78dc7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a4b1ba3c-ee6b-497e-b8f4-ccc81ac2c7ca"/>
    <rdfs:label>paroxetine-procyclidine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/b103878b-d937-465c-9268-c76a57895915">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bf79ed0d-9843-4a93-9786-40432cf0142d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b0542d55-936d-48d1-8789-f5af33a66fa2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/57941b20-f33f-4807-8da6-fd65d1ff2c99"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/952d032f-1912-487b-a0b6-9bb3ef6c7a80">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6969d802-e80a-427a-928d-3743e61c8b75"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/8f47f424-adf0-4813-b674-a77a781611ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/79327a32-f367-4ba1-9a83-fcd7a00df2d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f0e7817c-79f9-427f-82f6-7ada09409c83">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/eb6a6f8e-b8a8-4abe-abcd-e7dc603ca68b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/5f200e11-9eed-4b4b-8413-01b666eee568"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6d6e358a-1b7f-421c-95c8-e6305cf31a1f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/39bb8598-8c1c-43d6-9bc2-56be4f54cd8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/dacc2c6b-a301-4621-8def-60c8c70cf0ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c083736f-f065-4c1a-9cd6-7eb247433f12">
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/168db372-a308-43c4-b860-f90c26ed3310">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fd79c17c-f063-4bec-bd3e-4dd783869852">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/76392b67-e746-4198-817f-a9ea5bc8ecf6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/62004d4a-e9e8-4a03-ba37-432f15005a86">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/5151eb23-5fc7-4bb1-ad21-3a27b0b39272">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/519764b6-30b3-41e1-9fca-d36be4d2720f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b2cf0ab3-fef7-4acb-934c-9292ae951c0d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f0ef881e-ee36-4d5b-a78b-62e692ae715e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/1d0dab70-b316-431e-af17-fdee4f040ca7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/cf031cb4-27d3-43ac-a96b-8770ff98edc1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/20a7c410-aa24-4152-ad88-342013b38578"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f5e63084-7d35-4c54-8964-0fd38c6a6df8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/1a6c8723-9056-4c68-92d4-51bd26c30b1a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f65d2107-22c2-4d04-9c96-2082a4d265f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/4c45e299-24c6-4eaa-bbd5-cf2e370b4879">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7be77f3d-740b-4e36-9ebc-6834b948f070"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/0bee23e6-d3c2-49bc-956c-f779f045d1ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0de4f891-0fe3-4d3b-b414-dcf0cd2f6f68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4663e6ad-7a5f-4f77-b741-eccd13497eb4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/4ef0d1f3-be4b-42fe-9be7-d575e6db649c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/13dea4f9-0d63-43e5-8864-03803092e0f5"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/c20209b5-a13a-4610-8a76-e3a6bda9c303"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/95b8382d-2871-418c-a48d-4e156653a414">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c5589969-634f-42c1-a5a5-335b8b69e61e"/>
    <rdfs:label>amiodarone-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1aafed34-754e-461f-a44a-19cdf4002155"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dc680f76-3ef0-4026-af7b-548a97750767">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/723ce614-8329-439a-bc84-9060d5135d62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/57d7c280-0dba-45fc-bf03-9e14c0451efd">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b4c2f4d9-9baa-4039-b253-67df761923af"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9b6c6636-1901-402d-97ce-9830f887b62e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0c9dff06-6d03-43fd-a480-d1feef1c1ecb"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4617964e-ae5e-458b-a752-5e580e037868"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/37695767-0a1e-4ac1-94e4-364fdfb40575">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ae00cd30-13aa-42ef-8eb0-1c75f9c4dbe3">
    <rdf:type rdf:resource="obo:RxNorm_42463"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d0862589-fbcf-4821-b072-d823aed77f57"/>
    <rdfs:label>pravastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/73b7014e-9d1c-414e-9539-ea8aa8bd6152">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0099b479-867b-4367-976a-35be161200de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/71eeca92-5727-43ee-8fbc-0d7518086210">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b63d3753-496c-415a-8e6c-37ec087977a2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/db22aa0b-1ee1-4470-987e-d0fe14f496d4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e95e6c76-ab83-476c-a830-f8ea0d488a1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/7e8e8deb-bb3f-4c34-8321-21c719ba085e">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/57fbafef-c2eb-4b02-9e4b-e0bfe6b9d36d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f8c4d36a-f8d0-4192-859c-1de6b65538a8">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/2081c08c-d37f-464f-ab76-decb0539feb5"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/919d020a-c61d-42c3-a8fd-e1bc58c52785"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/88b2f7d9-62c2-4854-95a7-cbaac01b2fa9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6c0038ad-836d-44ea-b196-0e81a8ea3b32">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/a9668a74-cc2b-481b-832a-572bed1aeefe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/ac70a60d-2bff-453e-ba16-7c10370baf3d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/584a8e66-0a18-4d24-8df1-d30ecf6170b7">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/a1ec86f6-dc67-419a-acf1-aea860aaef6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6241e31c-9557-4114-8c64-f8f2bf42217c">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/74d66c67-73bf-4ada-9513-28aaeacd0066">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/6b41eb31-e60b-4af6-a198-ec2ae6f25334"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b06ce3d2-fa43-4ad3-ba26-d4818b16c8c7">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/940cab3e-c914-4dfc-9502-637a16214167"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/303a9524-830f-4bc0-a83e-062e609d0580"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/2febeb29-8784-4242-a526-7a3d3b33d539">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/d4870d2b-3e5e-44a4-8322-1ecdcf0a9973"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/14aaeef8-78e0-4e41-9b36-448e771e48fe">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/67596121-8d52-41f3-8168-1ba4675c84de"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/59cfeba4-d496-4e1a-b951-7ecb3f219f2c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/aecfba7f-fa25-4c27-8f4b-b191a116fe18">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/e0444010-fa3d-4d70-bb48-992ba7a329fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/14a6dab3-8810-462e-ad7b-1bd33e7179be">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/27c70717-1aa0-4643-be8a-80b1cbedc344"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8794729b-b160-4340-a071-caedaa33b186"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/a1cc5958-5987-42f0-835f-e673d9ad01dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9f6af65a-758f-4e1c-a138-0f28926523fb">
    <rdf:type rdf:resource="obo:RxNorm_195085"/>
    <rdfs:label>Efavirenz</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ea22245b-a1a2-4e41-9fb7-588e09769ba5">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c256f483-e428-4dc5-9e5f-c540c1a2c2fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9a3c3c44-e078-4676-962d-7808fd13b2db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/922450f6-2bea-4f00-9ce9-9dd2c6de0781">
    <obo:OBI_0001937>3 to 4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fa376aaf-69fe-4893-a77e-5996bb2778e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/cdb13835-c498-42bb-b5e0-3508f6b95fa2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c00e41d5-0788-46b2-b3cf-12b9d48aedeb">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/ff1c277a-d6d3-43af-af64-97c8d2d35d63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9aa98115-bd8d-4e5b-833e-8103b6515d2b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/06709f26-c349-4126-8557-f28ffab88d91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d98c420d-2550-4b09-9136-306ca598822b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eb1db512-77cf-4b5c-8d97-33072f0deeeb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/19f43838-ae5f-4d22-8748-12bf75158b31"/>
    <rdfs:label>ritonavir-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b39b6a9e-7c12-489e-8bc2-8a1436c5bb77"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5bb7677b-70e9-4890-b852-12be74090557">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/32e8d61e-b092-4aa4-ae75-3b91079abe5c">
    <rdf:type rdf:resource="obo:RxNorm_1102261"/>
    <rdfs:label>Telaprevir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/33729d78-6717-4e63-8bae-3dd0c7ea38b7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3967b527-6194-44b2-8999-fc47960a7b2e"/>
    <rdfs:label>ritonavir-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/383d05ff-039a-46ac-a114-c99a322bb548"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c2c1d12f-8638-4618-9344-d710d3aea147">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1a280a4d-14e9-428c-8244-1b5dd8fb37ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0264d459-5be3-4c7f-bbb8-632f9bf721e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/1d8f34e9-e032-425b-a984-4177c3c7a4d7">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/d6ebd0af-822c-499d-bcbf-2ac6d65dcad3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/0d073e2d-6ceb-4257-817e-273048a425cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2868b415-7e03-407c-bdd1-3c8b7cb8d8a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e199b114-ccf7-4d27-88e3-5f15c5354e16">
    <rdf:type rdf:resource="obo:MeSH_C016904"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/4e29c59c-5c56-4920-8f7d-afe8e727a801"/>
    <rdfs:label>norverapamil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/601f2014-fa01-441d-8b2f-17bd7e737d6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2fac14be-b310-40a7-93b6-b2f8d7783aca">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c091ffab-c9db-425a-b614-9636d9701199"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/b62e17f9-150f-490f-b151-8e38b16c7d97"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8536ad87-8d5a-42ae-8b5a-b2d7d2ad57c1">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/66b3736f-0461-4892-a39b-239db928aa48"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6595e743-ebe7-4b1c-a4cf-f9ad9fdec08e">
    <obo:OBI_0001937>2.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a637ffc1-baef-48ed-9fe9-af7db77144e3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4971aa39-de44-4ca4-b885-65fc58a41ed0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b0dace87-49e6-4aa4-8cb0-b17e11272534"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0dee754b-feb7-4c62-9a5b-afcef3fda6ae"/>
    <rdfs:label>paroxetine-phenytoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/65cfb88d-9513-4e4d-9c8f-20759171b9e6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/7c3977a6-5bf6-4869-90ed-3eb3bdc6890e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ea226712-7c6b-4a83-8d7f-1d5cd26bd5bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/82d15239-3da1-4b3b-9495-dbf48d0dc7e7">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/3dee7c6c-d376-49f5-bb96-6d1fec1b65b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9e81cced-5aea-48f1-a917-f7091037d557">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/3491a3a3-4aae-4b30-ac8b-c85e1e5a1433"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1e5a0269-4c63-4184-a3e5-4627cee4c4dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b8965c52-4f8f-4329-bb0d-e7bc9b3c3c7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8a77b977-1c98-4e4a-aa23-ade4224c8127">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b7ed6049-bcad-41c6-baf0-ffe4f73a9c12">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/268da38c-16d4-4185-9d9a-7af748770228">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bcd228e7-1a14-4d52-b0cf-fca046e7bcc7"/>
    <rdfs:label>paroxetine-iloperidone drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/875ec477-bfdc-4835-a29e-d439761e121c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ef9bffb1-581c-4a09-9ee5-77f7c54d29ae">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/7ad073f8-867f-43e9-b757-29511cd3c85e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/c6a4bf5b-e8bd-4825-a5bc-70bd3f1a6e11">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/2993a043-e33c-4ae2-b8b9-6596d3ac51c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2f77e42f-e564-41c2-b755-cdfa6aa5b2b1">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/8af7bf86-585b-43c6-8101-55d4a786cd9f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c1f366af-9bd4-499e-95d0-8387ac01406e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/47c9921a-3fe8-4a55-bc88-b59bf127a277"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/54bd602d-b002-4beb-a954-af58a62b576e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/53e585ad-7190-4001-89ab-af80dcd06177"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d00d0626-4f4a-4113-956c-22ea435feaf0"/>
    <rdfs:label>Amlodipine-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f8773333-d9a8-45f8-8222-cf63b648e8bc">
    <rdfs:label>clarithromycin-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f05f44c4-8b7e-45ad-9fd7-64aca49d985a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1472d054-f943-4437-aaa8-be301d3ab2e6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e60596b9-1866-4fdc-a33b-e017cf86e668"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/8820bc3d-968f-46cb-9fe1-b06933678f73">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a64c5eb0-5b24-4895-bb68-09acccf7ebd8">
    <obo:OBI_0001937>3 to 6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/157f5f6e-9770-42c5-b076-a5c8138690ad">
    <obo:OBI_0001937>66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a1140840-bbef-4521-b5c0-cf370a68aec2">
    <rdfs:label>telaprevir-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/46a38f6f-056f-4748-8afe-a92d573ecaa6">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0a5e84c1-e101-480d-b043-ea1ac83f9f14"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f0433377-b239-4b0a-8735-5536064da6e2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7e9c6f07-0339-4245-8e97-b422b4d8e9ad"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/64f11bae-4242-4f57-9fcf-59d57cb2ba7c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/67457d9d-5d60-4699-98e1-84b6a7f990bc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/11166dad-ddd7-4cb3-b899-d9b439bc96fb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/20b109e3-99db-4599-a6e6-5df1ef543f90"/>
    <rdfs:label>carbamazepine-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3bca1595-99f4-4f3f-a99b-0282f1bbbbbd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f1fd4379-5bc0-4341-a414-ed5dbf257697">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/79f1f46a-2ddb-4cfb-b890-03280d16bfa9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/29419461-d79c-4e97-a2b0-9a9e305b7b94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/3490d4a4-2a2f-4ad0-8b37-d02ff81a08a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5b6e502d-b1a7-4ad9-9936-81ce8c16ac03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f6e22821-16cb-4fdb-b469-92c638c5f73f">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/1281369e-06c3-489c-8834-550a65e937cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/df0eaf20-7016-4d70-9edf-56ec35f92942">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/22d7c04f-d1b2-4caa-9523-8c896db375e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/61f9af2c-0cbf-4848-b590-cde5fcb117f0">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e908de91-1fe3-4218-947d-c11f9aa6e60c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5a0bd569-67fd-4249-8b42-f0b29778143b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/32283199-2d88-43ca-87ac-7238caf8f35b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/96aaa8c2-1dc8-4c63-bbcb-8a71f7fc9ccc">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a0f2013f-c2c8-4c3d-9b0e-d785e2bd6331"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/015a545f-8da9-40c0-a6f4-cb6a96d40c62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ea6fa8dc-9f11-47d9-9840-80d756f7c1a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/47c594b8-aa1d-4bc1-9718-4f05053303ce">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/42688900-033b-48c0-919a-2540da33ac56"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/57edb2bf-d07e-4a94-80c6-63fccd5cd0e4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/21fe3497-fc90-4a8d-a1d8-899845590f6c"/>
    <rdfs:label>Fluvoxamine-sulforidazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/daa9c6fa-a314-498f-a09d-f2984ab0751f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/bb1c6bde-f19e-4359-afc1-fa0a7aea95dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/105495dc-2431-4aab-a946-561e2a6b2872">
    <obo:OBI_0001937>.2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/c4eb441b-83f7-4a50-9f48-f8172363287f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/aebfef67-c6b7-45cc-ae0e-871b51dc5f60">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8722fd3a-6696-42fa-a628-2b7cabd0aca1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/15f56680-225a-4b8a-be6f-e4e78bb8d1dd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9f9fb71b-fa02-461d-9e26-b3b5e7cb1be8"/>
    <rdfs:label>midazolam-rivaroxaban drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/32a3642d-3b1f-4209-852c-7f5619416c4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/33eb02e1-4346-4063-8b26-f6df3bc13063">
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/cf8a61d7-df1d-45e3-9568-3b8503a29be3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/af505ebc-377a-43c0-9497-34f62e092bd8">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/39324f96-87c5-4819-b373-f0825fb4350c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f9e63662-5f48-405a-a5a1-76035be08ad1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b6221133-6c6a-465c-a339-105b2833fd20">
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e6802d14-f067-423d-b576-0a78291ea1fa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2dbda8e2-1a18-4933-8255-2915f4bf1875"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/27ee1a7f-e1ef-4d5b-9cf2-30dd4399354c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b96a8f4b-c1a2-4baf-8c69-7a50bc6e51f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f7540f0f-e0a9-4a83-9ee8-bf9bf22dc658">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/c8c5c4ba-deeb-4676-ad0a-316350e83993"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2c4aad37-57a2-4aed-9d2f-f9f663231170">
    <obo:OBI_0001937>36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ea5c8edc-50a1-4325-b084-f486d74cd83b">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ceb54003-bbc9-4ddf-b6de-3a16b1347e6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/27ec4a4c-3ffe-4be9-a3ba-15f2322b147b">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c8bab9c4-6441-4e56-b9d1-5b6bfa48d03a"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/9b989b61-ab8d-4a1a-a801-0f591ed7b8ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e08a4910-5953-43ac-83a1-4552bd298707">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c8bab9c4-6441-4e56-b9d1-5b6bfa48d03a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ca395a08-29f1-4abe-aff0-20985eed674a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/38085864-b0e7-46c3-a4a9-c76776cfc153"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/959d0ead-d4c7-4137-b406-1a68f8d14a23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3dbf7cec-237c-4e19-ac22-916714e8b44e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/da1e8110-6ec6-461a-ba2e-8270ee5e73ff">
    <obo:OBI_0001937>160</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/a86836c4-4214-4fc1-883a-43d3424cad7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e34d3e43-df26-4f5b-b36a-353afcd4cfe0">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/ae8be822-4fe7-4beb-a914-567ab0ef8240"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2ab67720-60e7-4e23-bcce-0660f12640af">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/aa053813-059e-41b8-9e0d-c8ed0e21c15e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/cc29632e-7ebd-4cb1-8f8b-e484c82b917d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/558d113e-ca67-411f-8340-da6e039eefd0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f6fe28f1-6994-4442-b3c5-cc31504bfe9a">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/25528eb9-d3df-4b4b-9732-e245d8419d12"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5f509aa6-d4da-45f5-90c6-35d37b3163bb">
    <obo:OBI_0001937>.3ng//mL</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/80ac9763-4a19-48b8-98be-e9ba7da8805e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/170c8a23-be86-4856-b86a-adcda8853595">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ce231d1d-3232-4a5d-b0bf-701f07768be0">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/245feef1-e3cd-48b3-b0a5-90917fd4363a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/41fb9228-ccbe-4895-a945-7c1043564056"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d4fda971-8499-4354-b4ec-4590afebd1ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/74c4eaa4-19c7-44ab-8253-d371c10545da">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <rdfs:label>lopinavir/ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/33ee1d77-7ed2-43c6-b10f-8fd9542a72b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/84986370-ccbd-45cb-8265-2d6f55417012">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2e2e40d8-c550-46d2-98cb-987b3e53708a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/785df0e2-5466-40fc-aef9-aa5e7d8a4c8a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/3ecade7a-dc75-4d2c-8226-56d28be95d89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/25153fc3-876a-4100-947f-7c250fcf993f">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a979a1fb-1aed-462f-8a37-93f2353d3252"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2eebe661-8fb8-4039-926b-b009182dd698">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/43a3267f-f038-41e6-bd2c-9a8948e36fec"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/55d9dc88-20e3-4494-8ef8-8fbae4b42f0b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3fe12c2f-0b4d-45a0-a2cf-0c1de1ffd99f">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/8ab0ddde-cee0-4eca-bf85-da9ee6ce879a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4038e2e5-f248-4255-9b48-59934a12675e">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/e82d7c19-119d-49a0-8eed-85b53ded226e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1617591a-46ae-42fa-b77e-573693978479">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/8cf92603-402e-4364-a5fc-0878c167c99d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e47d2225-0403-4dac-9433-aa3aac00d330">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0d29e46f-a416-466a-87bf-0b28ec36c7b1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/d244c150-e345-4be2-80de-f98155264616"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/4baf166a-2b0b-4fda-b4ae-2e060bd8f339">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/ee06dc9b-8e76-4ce0-8118-5a0bbb3e724d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e090e2e8-050b-40ac-8b80-318f6f69ff10">
    <rdfs:label>rifampin-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/89ee17b5-5ba0-4354-8c9e-8e7fee08c5ec">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/849cae07-6f4e-4693-b136-c76e14b84af9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/9f2c9b14-4ca9-4a74-acc7-b84adaced2f2">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/0264d459-5be3-4c7f-bbb8-632f9bf721e2"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f6e22821-16cb-4fdb-b469-92c638c5f73f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/eb6f4411-ed61-4c36-b5ea-c9342e057e18">
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5fbdf490-3ff8-48a7-93cb-7a7e453dc49a">
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1a9a3f25-997a-42c3-960e-5538b9569df8">
    <obo:OBI_0001937>48</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9171219e-51e9-4caf-8f56-c05fd2fac53d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/65bd2aa4-1221-494a-adfe-cb82309c8744">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/e8865a2e-ef6f-419d-be47-d4c30a1ca32d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a77f3611-fb00-4b60-8d37-ddbbba47e236">
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/eed55f23-b897-4687-a544-33be65d7bdac">
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e83cc1f7-8c18-4d2f-b43b-eb943e933ce9">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a7578590-15e0-4e17-b7fd-6586c2f7c12f">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9aa98115-bd8d-4e5b-833e-8103b6515d2b"/>
    <rdfs:label>hydroxybupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7db66d43-e412-4608-bdc5-0493489ce31f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cae485f9-3567-476f-a36c-ac8395661e01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/395d6944-ef3d-41a3-af6b-0239d1836201">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d1ac8ba9-f03c-4b16-8b06-c235fa32ddda">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/bbbcffc3-ba9a-4bc5-b757-575896288f3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2143f70b-4dc6-4536-8289-1d670d42e349">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4c918720-adee-4e1b-86ac-0ae3f6363752">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/c79dbfb9-c5b5-437f-af7b-282d9813f62d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ffe11a73-c4a5-4042-ac07-c74831192385">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e7955efe-b081-4eea-857b-ae16eea1dcda">
    <rdf:type rdf:resource="obo:MeSH_C062257"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/23a94776-fc69-4a01-b72f-14be9ebc9569"/>
    <rdfs:label>P95</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4b91ab92-06a1-4bf2-9cac-983869d52d55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ffe57c4e-19fc-475f-b7f5-f9e73653c933">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/8877c71f-3125-4b1d-a6f1-d3eaab586a4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/756ca6c9-c78e-45fd-b36a-51648158377c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/6b4179ef-0eb6-4448-84c4-8a2091db0954">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/db22aa0b-1ee1-4470-987e-d0fe14f496d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/89a77876-a060-40d6-9487-f1a5062a2311">
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/6b41eb31-e60b-4af6-a198-ec2ae6f25334">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cb53205d-aa0c-4491-a46e-c1db23dfb1fa">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d8f8b779-b48c-4f57-8845-62f34f72961d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/013dbfff-5696-4390-a7f2-4a867ccfe2de">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/fce4b28f-da9c-44b5-8227-4478230dd422"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ae00cd30-13aa-42ef-8eb0-1c75f9c4dbe3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/8d3d86a3-8d51-4823-b6c2-a6a03f8f600a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1288dbda-130c-4701-acc0-ab52cdb162a1">
    <rdfs:label>nefazodone-haloperidol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/c61568d7-6c67-4047-8585-4146d7245568">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/408de211-d49f-4c49-bd8f-accfc7d4eaa1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/338759f9-1394-4f54-b4fd-e1114d6946a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f40bca32-a807-401c-b1e8-1a7b2c5ca363">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/43bd8360-ad32-4142-9c3d-643ff5a91d2f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/2bf69073-8185-4601-a15a-856546c5ee50"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/101fa98c-4a5f-4d0c-9a0e-470fabfedcca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2300cad9-89a2-4b6d-9ee3-88400f3b53ee">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/1fedcfa5-9379-4766-b056-03f18646120b"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/43562543-39ae-4d66-83e2-59ac6b44a4c5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1120c78d-7ed0-4573-81de-7f30945a8dd6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/58e30436-f6e4-4470-8949-300abc5aebdc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6cdf1a51-d10a-4400-94b0-c247c5eeaf75"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/46886e49-38c2-4440-8e7a-c51cd15a13af"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e908de91-1fe3-4218-947d-c11f9aa6e60c"/>
    <rdfs:label>fluvoxamine-thioridazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e3323dcf-3984-433b-8b14-b4dbbc84a3f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/78e0cfc0-40ad-4d55-8ca3-ecd029549496">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/461c05da-2611-42fa-861f-203b8134218d">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/80dab70c-4bb9-40af-9655-7fd586e551df"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/59cec642-41ac-4eb2-92af-cbf85f557b59"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3cb18f86-5079-42f7-9af5-c35c868e9d3d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/02203534-c061-4f93-ba5f-6c39f2cba5e8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/5c707045-af37-46d9-b9c8-be6258b90b92"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/3ffbc459-5cab-4f9e-ae72-f093522687d6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/207236dc-dbe5-47e7-ac14-1a2b25ddc229"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/b66ad089-1049-443f-9560-428827d117f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3348f3ea-efd8-46f0-8a2e-bd183f75bf38">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/009169d6-a444-4c17-a92e-2b4559f9e5ed"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/6cd993df-f817-4252-bd48-40b26a365a15"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/2cc67450-f23e-4706-a552-53dc1dc36d51"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f2fdb3b7-077c-4ff1-9e15-45040addd2a0">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/49d1a01a-9818-4c40-ae6e-a151861a9e6b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/23afd9bb-a446-4762-846a-be036ed9b2e6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/881d70a8-d16d-4c8a-8a86-b6aa609ca7de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b10f0c80-baeb-489a-b883-d40cd80cc2a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/30c6b03a-78bb-4c86-a6c0-d65b89f863bd">
    <rdf:type rdf:resource="obo:RxNorm_10318"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/440c19b9-560b-4086-9d7f-65df28f33602"/>
    <rdfs:label>tacrine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ee686ba9-b07a-4086-982c-f57cfed31f7b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f9d2570f-6c18-4236-a7c4-be53dab350ce"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e38d86a0-884b-4a2e-b062-fbb13cbe046f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/7c4525b8-d149-433d-b417-84b92937476a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/dbc3d1f2-a550-42d5-a95e-8284bc4cd46b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c144a65d-a3d2-4c3e-833d-8c8cb6134ddb">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/5e07b09f-9d0d-430c-b790-eed61adcbae8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b5f882a5-8400-45d3-9567-8bb3b2f96b38">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/25278d2b-9d93-4651-8c3c-1ca7dc644d3b">
    <rdfs:label>paroxetine-duloxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/414258a7-d4ac-4470-b074-4e995ab82386">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/bd7e9d81-1afd-4651-830d-863cb7fb0fe9"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/2995efd8-f564-41c1-9964-8aed5cde26b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b7c11e73-0bfe-4489-9239-077e00673290">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ce1bcfbe-8e17-4108-a2f3-4d6e61da520e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/6088b3b5-88ba-494b-8cb6-74628f94d120"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c1d4a65d-dd3d-470a-8a26-f5e01f7453c8">
    <obo:OBI_0001937>3-4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/086d58c2-30c0-48cd-ad97-a50ab9b1caa0">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/202ff503-9574-4a68-99ff-fd6fb1e8f495"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4fbc3f5f-8b9a-4157-b43a-baaa2e5f2e9d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/27f71454-4319-4f05-b0fb-6f6eba2daf62"/>
    <rdfs:label>Erythromycin-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ce403fe0-0f60-4eea-a74b-bd4038fff614"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/1925330a-03b4-4512-bd17-31c61a617d7c">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/eb85ddca-da21-438e-b1db-2e7973292b6e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/e9923da1-297f-416c-9da5-ee6bf3e88f3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a78eefcc-adbe-4dc1-af69-4cf1bed44cd0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/73f15f3c-cf73-4121-9573-12b1999b1ff7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a2668210-1118-4fab-abd9-a351989ad406">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/97767157-178c-469c-9e0a-7bd2dff895c9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/11db43a2-68ec-43be-a430-430a1f23f1ff"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/15436976-d070-4a2b-9bb8-eff0d6e8dfc8">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/37bd015c-4ea9-4b0d-9327-53237a66fe07"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7791af1c-7cf9-419e-939a-9f94dc6d4e54"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a0a54fd6-c9ef-4d7c-86e0-1d19a95f398a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b1b85a9f-735d-4784-bda5-5506c76186fd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/2b3bbe35-80c6-4e7c-a7ba-544c80800401"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/55a22f47-249b-4695-bd03-5fca4d258280"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/433c8102-adf4-4c40-8a9a-e26ee241d1b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/df3b2879-6ef0-4833-973e-2af0ee4d0bc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0216e54b-04dc-4339-b079-06f9356d8ed7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/1ed99d6a-4dfd-4c3e-9b2a-a38088a978b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1d0dab70-b316-431e-af17-fdee4f040ca7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/872a3e8b-9cbf-4293-864a-edf216ee3de1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/42a394f1-09fe-480e-a504-9613e08b0ed5">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b02b5ed6-7b01-4bc9-8b46-707b953a4711"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b370c31f-4e34-4cc9-9914-505526836cf9">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/387fa893-6e26-4c22-86bd-a0b4f6b5eb42"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/1c5d01ce-df86-4791-b9b3-cb86289b5a23"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/537febb0-2fba-4a94-a622-870fcbfbe45f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/fbce5a2c-f071-4413-ab2d-664e9351bdff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/37f04bd6-e17e-471f-b7d1-ee576ab35371">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/2ad5f17f-b0dc-4b3a-a2c6-4d2d201901a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/284714b1-8ec8-4382-b3c0-47c02df7315f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5218d9cc-d400-42b1-9f11-d2d2b8fa5be9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/a87aa98a-3113-491e-8d6f-fad8aac33fc4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/36382a24-966f-4983-b221-5494c6d66abc">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/20238c69-be93-49bc-b035-084112e62d8d"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/340832f3-e5a6-4567-a652-7423e215695c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/28543ee2-318c-4fa8-80f1-6dcaf9791de2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e40b43c7-7ac0-4445-a101-dbd0e176d42e"/>
    <rdfs:label>cimetidine-mirtazapine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/14d694fa-cc50-42a9-840a-3c17433406b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/db231ef3-d990-4a4a-9bc3-66a5c04cac1d">
    <rdf:type rdf:resource="obo:RxNorm_4719"/>
    <rdfs:label>Gemfibrozil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a77d06a7-f312-43f5-82b1-86aa8df08b75">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/a8e17485-1010-4d4b-905c-b5e928bf2423"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bcb143b9-36c0-454e-955d-7644ee88e201">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/28a1202c-7c90-4394-a083-e79b5977041c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d58f49de-7cdf-4e3a-9de5-ddbe3e850cf0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/b9cd7a23-170c-4aa0-8f45-3d3b9abf3dee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/59c3adbe-8e65-4668-aa4f-d8b88f34e134">
    <rdfs:label>buspirone-mCPP DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/113b4439-085f-4fae-9186-a281189b9158">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ca287d22-802d-427b-8ecd-a74a38fa3532">
    <obo:OBI_0001937>300 or 600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/8fb8d4b8-b184-4465-aff3-f41caf4041ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0788401e-8e8e-4a9e-9d7f-eef7140a56d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6944fe3a-173f-4373-b76e-856c95b272ae">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/e7ce7254-8b29-44f7-94a8-963f9eef7194"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/0f5586fc-8aed-49a6-a58b-c8ba914e6884">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c82df4c2-05e4-4f2a-9446-272d137be792">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a90c6df0-1910-4532-900e-87643cab8d8d">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/d4870d2b-3e5e-44a4-8322-1ecdcf0a9973">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c543821f-2db8-49f4-a51b-977189aeaba6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fec2512d-37f7-4826-bfe2-27badfd0164f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/dc680f76-3ef0-4026-af7b-548a97750767"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0c8f2ab4-3713-4c61-ad7a-a0b91edb4ef1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/ec04afab-6192-45a5-b399-6eeb00587eb0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9ebabe44-8202-442b-a91f-73c96471d5cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f369584f-68a6-453f-8180-14061b643be0">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/14fe77ed-8a87-41ff-872a-abaf20793ddc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/7af1c396-506d-4cda-a27a-b97bde558870"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/153615f8-9914-4bc1-b6c2-69d01cd453f3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/8fa759c3-ad8a-472c-b17f-f9485aa74d73">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/fb27ec17-602d-4a1d-bf38-b4f86c79ac64"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/88b2f7d9-62c2-4854-95a7-cbaac01b2fa9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/85641382-e424-4935-91d1-c0cbf7db68e6">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/97ca516e-1464-4f4e-8f36-ae9828a773ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/163d8c12-283b-4414-afcd-bc33565af328">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/bd4a9e77-17db-4002-afb0-d4544692387b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8720c63f-410f-42a7-9f11-7c526ec5c4ed">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/dcb90c0b-6fd8-4e37-8cc3-1e6cc9ead6f3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/0e2bb83b-cca4-4ac4-b37d-5aa07aec2c4b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/513151cd-a936-467d-9dde-65f75e4372ac">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b8604fc2-c103-481b-b40b-33afe0f3c531"/>
    <rdfs:label>ticagrelor-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b093edc4-4e31-4216-94a2-df060145bec0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/33656b8a-9264-493f-aa8e-75e3a4808a17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d23d089d-7d77-4dd0-a62c-0bc4c6f4a230">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3f3f0e35-da7d-446e-ae1e-8213bf668bab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5cea5d6c-240a-4048-962a-07f082c59564">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/a77099d4-75e7-4ea8-8cc5-5db086d68f21"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/4663e6ad-7a5f-4f77-b741-eccd13497eb4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/63de6cb7-7d8c-4954-8043-b9d99470721d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/dc3eeafa-a449-4ec4-9601-8fdee673f1df">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/dc2ebea9-fee0-4e19-a035-6a13a469b498"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/bac1cf19-6eed-4b14-87e7-c6feef1ff3f5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/847a8a4e-9dcf-4166-8395-3d4dbd2f6ae4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dd65ade0-224e-4e8f-93f9-c472f0586993">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/577fbd36-7f53-4fae-a273-cee15bfd8f1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/39179215-227c-47a4-9d8d-c2635c05118a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1140840-bbef-4521-b5c0-cf370a68aec2"/>
    <rdfs:label>telaprevir-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d6743a09-b3d8-4462-9f24-9254817f8209"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/39cac0aa-80dc-4025-af22-140da984000b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ab8dd3b9-2719-4eae-8fea-d83e657c33bc"/>
    <rdfs:label>ketoconazole-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/26aed168-1a25-4210-9a51-39e20c697061"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/26aeaf0c-ec92-466e-98ee-742bd73a8059">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/db8df768-75eb-4cc1-8158-583305f5d0d4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/f3f0477e-2ca3-4530-b88e-23439300a9e3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/cabcc62f-6001-4d8c-9a35-08ae4ac68b49">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/7a9e0a43-41e6-4d76-80c2-cec3ce36fb2c"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/b37dcd90-b72e-48b2-8507-109dc2a11e99"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ad28ab2a-113a-44f8-848a-f9a48033d0d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5e16282e-783d-427a-aa48-cc0f5e980d15">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4be60b54-418a-41fb-8803-e5c0fd3f3a4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a6868230-bebc-4bff-9611-e2a5ac64e264">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bbe14fb4-ea64-44d9-ae84-beee29275547"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/dd2c9b00-33ae-4ec0-be27-5f4931eaaa5c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b9fa57db-def0-45be-bcd8-560e44591c75">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b08b9fe2-4ea0-440a-a093-7e3cdc7fdfe0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2bc0f713-a3d5-4ec1-b2b9-69763eb165e8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3a252341-89e7-4e21-8fef-a24c71474d76"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e63b53c8-63f6-4217-9252-587a236970b3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/56e5f901-2403-43a9-b68f-74c21861a50c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1a9b8cb3-7c2d-4840-a8a7-d47eb7d57798"/>
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/865a70d0-b430-43ca-bc11-2bf31e280c33">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/67f6003e-0d0d-4291-89d7-b749d5512292"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e1555a57-f5c5-4e63-ba7d-c4568f00357f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/fb8c3392-25e4-46f7-bceb-d254bfb5141a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f0ce8810-6f5b-4ddc-89f7-5938f0cdb42f">
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/257454db-3019-4529-85ac-abb346c865c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/94e6c3ee-924f-42d9-a2f8-ae13a9ca2aac">
    <obo:OBI_0001937>70</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d8f8b779-b48c-4f57-8845-62f34f72961d">
    <obo:OBI_0001937>51</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4b304111-e7a4-41f9-b8fd-3e6d4c13f471">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e7c75baa-9d57-4c10-98e3-86e3f0eae8ee">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/67203793-a2d2-4909-bf5d-16b321776ce9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1ece3a7c-990d-4ca0-9ce1-ec22a4c4f56a">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/8f485472-25ff-4e41-b5f9-fc05211307ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/1810dc3f-2d34-4be8-8c76-d5dfa21dd201">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/d7fa6e63-9549-4d71-bde2-072e55142d13"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ac0531a9-3b72-4cf2-9218-c6fc455305d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f360e3aa-021c-4d9b-806b-c5671b661ce2">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/66c4c46b-61fe-46d3-9575-14ba053a547e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dc95c40e-cb1c-4f6c-a81f-6af792f4dd63">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/244aeb82-3aa1-4b56-ac28-d55e1803c061"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6f8c282c-1ea4-47e9-afe5-5d8218ffea4c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f829bbec-0b32-4d8d-b216-7fa149ee3898"/>
    <rdfs:label>BRINTELLIX-salicylic acid interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8bdef1f6-49f5-4398-946b-081a79529425">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b69dd0d0-304c-4a47-b137-72aa9a344941"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/777f82b9-92b5-4acd-b862-960743a67c03">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c7aa3074-e1ef-4cae-9f6d-8accf506e969"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/388c5b4d-61ea-4ecc-ad69-bd3cf2c68e7e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7d5eee06-7f6b-4e4a-b53e-35cc49aa2d06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/7dabeefc-a0fe-4f86-9ac1-3c704b9dbc90">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c83b9671-4585-4d0f-9721-533d1884b032"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8b57055a-4729-406a-91a0-7cecf89606f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d172c7c0-41d9-4a32-bbc6-3fac2b8da540">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fb8f23c6-2061-4a11-a33b-fa63f0e2ddab"/>
    <rdfs:label>Nelfinavir-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c2020db5-b6d5-40e4-b2b6-76b8dba10a6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4dec2c40-4e44-41f5-a2de-f7bc5bd293f7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c3565774-c745-4507-8cf0-680504fba908"/>
    <rdfs:label>Fluvoxamine-tizanidine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b1d530f9-78c2-409d-b002-f3f4b38a417f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/49993d60-6970-49da-9000-07c1d48bb340">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c445ec31-e8ca-456c-b8e2-b91e9314d04c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/60b47984-7d16-4f75-9b81-3ea4fc1ce92a">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cda145cb-e039-494d-be41-b2a9b09e1a02">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/de0290d7-9f2b-439d-9212-2ab3e23c3c28">
    <rdfs:label>clopidogrel-fluvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f81d216e-cb2c-4433-81e9-a14bba65d297">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/fdc47acd-e0b6-4b8c-bf77-596bdd628a04"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b22424de-3e48-4c4f-bc85-b80f19cf3927">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/87e18731-d526-4249-999a-694366dbbb27"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/1cb29685-0466-4bed-9fd8-77556bb96c16"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/219c21ad-8e3c-4609-a470-084df95d5c43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/76e1db83-49ea-4e1b-ba10-46639e1ed451">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c1cf3dbc-f4b4-4416-804b-512f049eb21e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/98c2fa84-7a25-43e7-9f87-62fe7f043839"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/6847a043-2429-4903-8fff-21c11e4206c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/e5bef6f2-33c4-404c-b7b6-e66bb33dea84">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/011723e2-7547-4453-b80e-3749c6e8f53f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/062e60c2-6265-4c9d-b81c-98e8107d0642"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7191fd16-d050-4ebb-bd11-12b0a018384e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/50e26331-dd62-4f1e-a3ac-bbbd993d62b6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d6166d79-8cb1-4a32-930e-ecb78201e18e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/2ccc8c9d-aba2-454d-bc85-04aab3e82dbf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/678367d5-261c-482a-82e3-893124d10cdc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f29a21c8-baa3-433b-a81a-b99f7450e2cf">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/34b4f055-eb1c-42ae-a670-e1f21f744dd6">
    <rdfs:label>itraconazole-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bbba79e2-09f0-495c-b2b9-82fab0208db0">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/39330cc2-2b04-43a6-a5e5-d95b087bea40">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/4a8a1900-c6f4-47b3-9f8d-330cc93d21a9">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/0e2ce794-db88-428f-9ba7-3cf34a5100cb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/6d2130a8-c99a-4898-98e3-128a2c29438b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/826d6ec6-5b3c-4e1f-b818-98599179e05e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f2fda246-842e-4811-96dd-10a63c346fb0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a0ee16dc-cec1-4318-a343-9ab6062a3b29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0d073e2d-6ceb-4257-817e-273048a425cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/395fdf06-7d5e-4454-8cd0-9d1f7807a807">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/afb56c16-7183-4680-810c-1c87f647b480"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/cd0a8672-0a48-446f-8266-48e51dd7344d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d7db5bfd-9eb9-4a26-b38d-43f3d1aea432"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a52c5029-c053-4dc2-863b-1adbef703ddd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2571d441-7b4e-4dd1-903b-03d095c5729f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5d27368f-f63d-41a9-8771-9af7d3a61419"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/451971eb-6d6e-42d7-923d-0fcdc22a9bcf"/>
    <rdfs:label>fluoxetine-mCPP interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cb2e5710-e61d-4515-a80e-80e80dcff276">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b4d7be75-66f3-4245-b046-310864b63655">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/2a1bdfca-5091-4a21-bb85-05e19f168474"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/80ac9763-4a19-48b8-98be-e9ba7da8805e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/97f457b8-b218-4745-911c-b0c9916877c9">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/43b8da23-30b2-42a9-abd0-1883fa91ab8e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f6b0e156-2b1c-49e1-a085-a72a51121921"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/18039aba-cd97-4a04-8ce5-6d8f7f3bd7bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6911500d-2c87-41fb-8c23-709da13b575e">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1ed45d39-86e4-447d-a2b5-73398cd581cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/03f75a1c-a273-4d3a-b187-1a7d1f4ca89c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/859170b3-2187-4714-9a23-490f2fcd5d3f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/b4045706-8669-4c4a-be52-b1c1f76315d5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1fda5386-2092-483a-a14d-5ae39e43dcf5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e8668e10-0672-4ac6-a771-6ebbfa6172f8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/5aadfe38-c0be-4c03-8af8-288d70424810"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/433570e9-4719-4572-8d0b-44aedaa8d751">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/448669ec-3325-45ab-9f7e-d92aec1a423f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/cac22422-02ff-4c94-aa1d-834ba45827cf">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/7e51e868-a655-454f-bb38-e85cd01c7c04"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e34d3e43-df26-4f5b-b36a-353afcd4cfe0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/75104da2-53cb-4d57-8dc1-b2ecd143c0f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d40b62db-b10a-4465-b9cc-fcb37bb74b9c">
    <obo:OBI_0001937>no change</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/89c2311c-fe02-4f14-938e-6bed79f4d73b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/d0a22074-ba0e-4e95-9d05-fcbaa27dd6cb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/4419f639-7af3-4d91-93bf-132d6c6f14ff"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/e676f225-9a60-49a9-a230-7f1f0318e4ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/32ec0fa0-14c1-413f-8946-de95c1e5563b">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/14cb27af-bbc6-42af-8aab-7b78d19e12b7"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/4512654c-728b-434a-b65d-9ae91e480512"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ce6c051f-d4ed-438e-a0db-2d86b7bf229f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/1c69569c-836b-4036-823f-ab3aac10d4c9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/bca915b5-6609-474a-ae49-5415084793f2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e8ebac1e-e293-48a6-bdc8-33d9b4f7b744"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e576ae50-6158-4090-a3c9-3580c8d3f3f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/99c61077-ab70-443d-8a27-9d268d5a71d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/8968b58c-661b-4144-8a4f-58535dec2d6c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/11f1fa4b-a20a-4761-8cf4-3891ca914630">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5c269f5a-5f68-4820-a6fd-ef6040bcead5">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/8e92ba75-b622-4db8-aa6d-72f9f1814e90"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/aaa416ef-857a-4b6a-8b41-b4297aeb40b9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/557afcf6-bcb5-4edd-817c-52b49736a4be"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/44887abe-e507-4919-8cbe-204826448e81"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8dab20fb-2503-4578-a64f-033f15f90e2d">
    <rdfs:label>paroxetine-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/428eb471-fc38-4f31-8e3a-e841ed03973e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/42a394f1-09fe-480e-a504-9613e08b0ed5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/a8074b5b-3be8-4f63-9b1d-9c8978c4132f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c6ece8d2-859e-4c63-9fa0-75679a4de03d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4d0a137b-9a78-4f8e-9717-f22d30866f5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1a5da5c8-57ae-4492-b01b-4e71d29d43e6">
    <obo:OBI_0001937>58</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a02485e2-9c41-4578-8e3e-d7ac40653c71">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/da1e5c6d-77aa-4619-bd0f-a4a27acc9489">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/187a4fb3-bc26-463a-bd5d-e40459d19167"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a4369021-5e46-458f-8f87-a85b72d4f967">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/ba7a9aa3-6fe5-4d40-b132-ab871d12c637"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/562cb15f-9e52-45d8-b0c2-b42119129477"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/b4a96776-2214-44b2-9078-a1817dbd69f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/67d9a513-2573-401e-932d-39cd55bb6c4f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/427d64d9-b398-4484-a411-b6dfb5aa6808"/>
    <rdfs:label>digoxin-aliskiren drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7cb8ecac-fb2f-4888-9c91-efc48eddc1d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c93907ab-a7b1-4523-bf10-3b4f658bdfbd">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7617642f-8c66-4c64-9076-ea595da1ed53"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/efb20375-f920-4435-a018-f9ad09153ea3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/8914d7e1-15f6-4e7d-8a13-00fd9fb57bd1">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/da3203eb-fdb2-4618-981c-33e8073e51a4"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/40bb24bd-421d-4e0a-aba0-309be380d193"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/71e940c0-0819-45ef-b66e-83d1148842aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0612485b-9041-4506-b085-d56c8ec1e53f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/faf37be0-c4a3-495d-b934-62176c0dd2ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5da32783-b987-44ea-bbee-973161ea6bf4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c3fe6e08-3403-4408-bbca-4a75a7161425">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/6d2130a8-c99a-4898-98e3-128a2c29438b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/7da78c9e-a6ca-4bcb-875f-fafbe7879daa"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/17bf60c5-96a6-4635-b5e4-080b15bd7ec1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7a82612e-11ac-468e-ac17-a00699702c00">
    <rdfs:label>simvastatin-bosentan DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5fee9039-d26e-4803-9637-7f1d2c8cd72e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/19ad0c67-3c7b-47f5-a6d9-b5db804bd9cb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/51b4d4f9-be2a-4a71-afe3-43275e4d6bf6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/44d4c9ec-67d4-4f89-88e6-f6d7e0cff748">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b9ffad39-ac65-405f-a023-22e7877c6151"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d9f82bed-33bb-4e48-86bb-a016e287d270"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6eba7d08-80ad-41f2-9e00-473aaa90ec75"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9346cde2-3714-4b04-b38a-5b6ba990c618"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c70237f5-127d-4c4a-97e4-e3842e25fd00"/>
    <rdfs:label>fluvoxamine-duloxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/14fe77ed-8a87-41ff-872a-abaf20793ddc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8144eaff-79be-4cf8-89f6-2aba38d02d74">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7aed8a59-5068-4985-b3ac-e88a6bf8389c"/>
    <rdfs:label>fluvoxamine-N-desmethyldiazepam drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/321099f2-91df-44aa-856d-41a301252436"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/03ec9b46-e92b-4cdf-89d0-febe3f71fa03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7c510007-a6ec-44a3-83ad-5b0b90c70768">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f9f5ddcb-bdee-4cba-a135-d064730c124d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/40d3b0ca-c5db-45d8-8d4d-fb077122fc4a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f16453f2-a4ae-4764-a3c9-c7f9dd1f5940">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fd175277-08f7-4df0-ba14-9eb9169078d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d804a822-08f6-479c-bb89-1ac05825f549">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/045faefd-6f57-4115-bbb4-8703ae933bb7">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/a902c170-0cb5-4870-81ed-d26f0d2e5f5e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/da5ed69b-9c38-402d-83f7-027356673dfe">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/9a69dbe5-7a63-42e0-9b04-dc535c81fb6b"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/6a9e3cb5-b00b-4407-82bf-fcce7c13bf5f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fade63b8-147c-436a-9ed4-f8b8c5c7a034">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/96f370a5-c947-423c-8e1d-ccfa963c142a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/cc0936ae-a7c6-4f6e-b61c-57d5f18411b0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/29ba2658-fb2a-45bb-9b99-7bf04412b3bd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c536bbc5-c94a-4a74-9c21-be0d99f13cc4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8b2a85d4-4bbe-4b37-a66c-1529b29e7aba">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/18634f56-2faf-4b7b-8cd5-7f26c7c6e596"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/9ea20d3c-7c8b-4222-adcd-9d326dbfe29e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/43b89483-a5ae-46c4-9c49-9e889db1f2dc">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/340832f3-e5a6-4567-a652-7423e215695c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/6059d8a3-db73-4ed0-956b-b46614c80dc0">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/83dc5887-03cb-4084-94de-b2335357802b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/91579c42-7789-440b-a942-a24bae00bb53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a6d5088b-7db7-4458-bcdd-8806f116eb1f">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/fb4bd432-af1a-4edc-9563-e50c74929485"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a51eeecb-2576-42d2-a6f7-d339f32f6896">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/103aa585-5351-4f32-b9b2-5aa27ad3aef5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/6fd41eb3-aab8-4747-b8cd-421005550632"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/45bd3a6e-06f3-423a-bb32-284caa4704ef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3296ae8a-88f4-4a8f-835a-062b2f5a8704"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/c380f8c9-c1d7-470c-92de-392014c49980"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/5c65a962-0f11-4641-8f46-157df71d01e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/bef61128-bf35-441b-8317-bd429e507f41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b104fce2-30a4-4d8e-b412-5d2fb769a386">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/fed1e732-c622-417d-9ec6-d9b2ea7a0aaf">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/0421a8e1-8445-49ed-b9ea-31ff93b23e8a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/71dca410-9717-46ad-b2e2-5f0076e30a38">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5a0bd569-67fd-4249-8b42-f0b29778143b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/3eb3385d-d064-41bc-9179-a536496ccda5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/07221774-c46e-40fc-a667-d7887c966af2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/8f32fc4a-d9ed-43eb-93dd-7643742e9965"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/246b4204-614d-46bd-80c3-7f671964685f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8d4af701-03bb-4089-986a-ce03ff14ff07"/>
    <rdfs:label>ritonavir-hydroxybupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2701fb3b-0dc1-4e0b-8a03-7a73092ecf3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bea75444-f882-4f77-9b9e-77badc917069">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f7a2b760-e4e2-4d35-99a5-e7e96e73e0da">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c0df8f40-4278-44f9-83de-09eab40a0bd1">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/8ff524f6-4eb5-4023-a7e1-5c62a0f329a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/37bd015c-4ea9-4b0d-9327-53237a66fe07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/754d73af-17a5-423b-bb90-2c93f3d1de64">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a3b5d0b1-f3e7-4bbe-84fe-13f4e181cc9a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/14ad3942-9f0a-45fd-a5db-48a2604551e3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/710fa37d-f7d2-49d6-9e74-39c2145f6811"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/09ec43fd-d046-43e3-854e-a63000630edd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/9cc16f0e-8ff0-499b-8e80-4cf9de2ccf15">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/0ca6e364-746a-49fa-8545-76669c5562d6"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/dbf7a6d4-59eb-4e6c-a474-4eed7515832c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/648f5e17-e2b4-4122-8a8d-b0413ae0e233">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/d50bf92a-8af1-4b9c-92bc-d177695f56cc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/ab1a2295-3a2c-44cc-a489-76ae75b32112"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/ae8f5de5-9153-4924-b8b4-4d83f229c384"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/7e66ae3c-baae-4022-8def-f9bd442c974b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/73f6c04c-8e64-4fff-8fd6-0ad177909dd6">
    <obo:OBI_0001937>1.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f6e9a7ab-992e-4d1d-9e43-344d62d8ac87">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1f72b87c-65cd-416d-af09-9152bdae68df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8b7e05d4-ba5a-4b78-8eb6-d5ca739fafd4">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b527706c-cfab-4b42-8bcc-343974446f87">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f05121f9-6009-446a-a9c3-9210815af0c6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/0929e202-bf38-424a-a3c8-5953f9f5aef8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1157af5e-0ee8-43f5-9e8e-09535a489863">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/34482022-7b4c-42e3-a04c-90ba761ecf8e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dfde1778-c4b9-4739-bdd9-61aef0a9951c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3dba0757-fcdb-403f-a806-690812fb1bcd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/02621c51-f5a5-420d-bd6f-01ef8a31ff2d"/>
    <rdfs:label>Fenofibrate-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/81d350cd-ddc4-4fe6-8a37-1518cf352c8f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f2aef478-42fb-4069-b2fc-410a75360aad"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0ea6f548-1741-4f83-9195-fe4a86244c72"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/7dc4642d-324f-4406-8b93-3f17dc098242"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/f47a47b6-9c8f-42e4-b1f4-ac86398e2727">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/e6a7bfb6-4a72-43b5-b36d-735acc6f4830"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/1e1a7139-bbf0-40cf-856a-887446cd7145"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/d000efcf-2908-4654-b5d8-f6aafb589784">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/790da156-e762-47d1-905c-28fd39b0037b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9936f8b6-736c-4622-abb5-3ed4749b9a59">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/02500bd4-563f-4cca-9465-209968540242"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b36b0465-80a7-4d49-ba76-ea58cb88562b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/42c9eb20-ecae-48df-85b4-0e299806cc57">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/73fe60bc-4678-4012-a140-1a4508869c55"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/fc9afc56-9db5-4bff-b23a-00e538911943"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fee1d7b0-178b-499e-ae9c-793d1feae774">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/19f43838-ae5f-4d22-8748-12bf75158b31"/>
    <rdfs:label>ritonavir-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/bccc00bb-a4d2-4a20-8fa2-38fcecd98919"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/92569e2a-13df-4e6f-b316-cd4b0ca0911b">
    <obo:OBI_0001937>62</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a19f531e-14fd-4704-9089-955d45b23a16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7aed8a59-5068-4985-b3ac-e88a6bf8389c">
    <rdfs:label>fluvoxamine-N-desmethyldiazepam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/e315ee01-07bd-42ef-904d-a90413975a3e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/11836ec5-bbe3-40f3-86c8-066b595f1914">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f2ae6782-72aa-4658-9954-d27769d9a12d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/98388819-f19b-47c6-b9ef-dbc12a030dbd">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c3399f13-45af-40fb-b55b-f27215958f75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d3281496-5550-41e1-bba4-0abf4a714dc9">
    <obo:OBI_0001937>78</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3a3fbaa0-f77b-4492-8d09-8a0caf4a3267">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/dde4df2e-206e-4f81-b7e3-b0d183724f31"/>
    <rdfs:label>Clarithromycin-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7c0edc82-38d9-4780-bf03-816cedf27d27"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3fd1a889-0a30-4614-8fa9-5147ba3eb7f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/830e9d1e-5290-4c91-aa3a-760c0a2a376b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a2668210-1118-4fab-abd9-a351989ad406"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/edd460ee-448f-4979-a363-d3c0d6cdfac2"/>
    <rdfs:label>ABILIFY-paroxetine CR interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d8fbf006-c513-4009-9d55-bd826555a1ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/80782e83-e907-421c-9fd1-62c59aaa69f6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c6ca4c1d-a062-4e0e-a0b8-f3489896335d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/2f7ff75b-f4c8-494b-9977-5a8a9d63ceff"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/fe35b04d-3741-431c-8980-7e0525e727ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/d1a29f06-62fb-4a99-bf9e-889696680dff">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/3778d837-f72f-43cc-8d94-b9af74a462ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2fee694f-5ed5-4f16-b4cb-d385a1d97924">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/909fbd65-def5-44b7-9b4a-b080b9965ddd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/58b9856b-4077-42f6-90d2-2a767515ab1c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4e53fc2a-bfe5-4d49-afc1-d02e2edcdb9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/dcf9ee72-a27e-4a47-86f6-98d271bb059c">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/272c65a3-b91b-4513-8c65-413430c0e011"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/dfda5356-1fc3-426c-b5c3-f1e0e86f4168">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/34c1615b-21bd-4b2b-ac89-e6626be21483">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c4b75155-4bb1-4759-9685-bcdc1531e922">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d944a312-1405-45dd-9f6b-d26aae7631b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a308c3bf-0cf7-46e8-bd56-f6dccf9aec4d">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/809ac1c9-f6a6-4f72-90f8-d59e37230f2f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/57e5d818-1e0c-4596-81c0-3bd9598ec22e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2574056e-3607-4476-84f5-b99d6394e1ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7c142a49-6250-40ea-973c-86b5a7e9fae5">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/122e63be-099e-42c6-b003-81ce10e7b06c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/577c675a-43c8-4095-a0a5-79efd4249e67"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/71588a82-89cf-47a7-9115-1daf43592cf0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/67985e88-be6c-416e-9dd2-f558578ff18f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5f2aef47-c8b1-4e63-94d5-a905a5123e1e"/>
    <rdfs:label>nefazodone-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/245f5724-1a4c-4707-a018-8d9e7904d30c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/ca261d57-0ea9-4a9d-a9d7-6127654a558a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/35da02ee-886a-4aec-82a9-03b2bbdad798"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/ebbbd0d1-0f07-407d-a340-3a60247f50f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e1e6d874-a737-4c28-9d69-7eacd79f2a0f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/43b89483-a5ae-46c4-9c49-9e889db1f2dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c256f483-e428-4dc5-9e5f-c540c1a2c2fe">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/564d2f02-a41b-4e23-9ae3-65f2b7a0a21c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/e8ad4454-b553-4944-ba8b-5ad8db3037ec">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/8e65b738-ad85-48fd-9cc6-325479a81c16"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/5bc17749-8c91-4dc7-9de6-092f4aa4fec0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/af443f8f-c835-447c-af21-c68f0e5e94a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/77911102-c58e-498e-a505-d0b90af3cbc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/2cb974b7-167f-41c3-b3bd-d1b5406391a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b5eb351b-f5c0-4e88-a1f7-b10e2f4f9fe1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/207236dc-dbe5-47e7-ac14-1a2b25ddc229"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/309b4459-9f9b-4364-9154-f1c073e0bb6d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/eabc3445-49f3-450b-be7b-b2907102581e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/430dbcc4-484e-4f7f-a5fa-0055c32a46a6">
    <rdfs:label>desvenlafaxine succinate-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/51b77b7e-af82-43db-b1a1-0ba4825b78a7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/95272d67-07f1-45f3-8fe0-cc39120f28c8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e7f302a3-64db-4664-a67c-2e1cee4d442a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3d9f2bc2-dff3-4d91-9b09-c08e3dfe472c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/22e2c4d0-609a-4b6c-a054-54d5cff4e145"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/22678013-deb1-4460-a3e0-6b1c7f30fa54"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/99a51f9b-5177-4574-a32b-d45b1556c06f"/>
    <rdfs:label>erythromycin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/99531d82-ba72-4eb4-8ef8-bc55c8e3a53e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ae33e4f2-a9e4-4de0-bd97-526a363948b6"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/3ed1de7e-7ac5-4ed2-87a2-a1012fea2f6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6e57c4f2-deeb-49d0-baf7-775069942800">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f311e45f-5896-4648-8224-6df4a2e6cb34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/750fcaf0-088d-4b52-817a-e3e6906bb8bd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/29aeed67-0440-4d08-a0c3-168d1bcf813b"/>
    <rdfs:label>nefazodone-propranolol drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7e4f78db-2d6d-49cb-a026-1bc4ee82129a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/a1ec86f6-dc67-419a-acf1-aea860aaef6c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/793218a5-d9f3-429f-b19f-02a0f3a624e3">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/038778e5-295f-4c48-84ff-bc1a929f2ec6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/9ee94b38-445a-4feb-8ed9-e0cbbfe756ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/65789cac-9bc3-4619-993c-6addc8dc9226">
    <obo:OBI_0001937>14</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/c4eb441b-83f7-4a50-9f48-f8172363287f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b0e94204-626b-4b84-ae20-eaf2130c2ff4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/3f429969-2a4e-4a82-a11d-f0ad2c9b75ef"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/4644c1f5-6f8e-409e-845e-027b51491c75"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/000c5ecf-1577-44a4-92d3-8fe612d2f6dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d0b1aae4-8cbf-472e-a11d-aff405677536">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/eed55f23-b897-4687-a544-33be65d7bdac"/>
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f94a764d-4584-41f4-a2fe-956508faa273"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a7c10dc2-cc67-4b45-a09c-4482178b1772">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/98ca6594-a86f-4129-a6d9-f4513ed4de19"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/71882ff6-da7c-4484-adac-4058e0abd7d1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/263bb750-52f2-41f8-89f8-bb69e052280e">
    <rdfs:label>ketoconazole-P95 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f1c6f75a-1cfd-428a-ad2e-d3f5fc482709">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4f8c08ac-cc6a-4412-bb8a-238a6f6c2dcd"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/065fe845-6839-462d-95c8-e4976dbcc1ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e8e1625e-2c5c-47a9-bde8-62f45caae380">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7b9bc58c-c57c-4010-b847-5ed312ce9647"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8936f8de-52df-4465-9fb9-3e8ab010b422"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/50bce766-a17c-4dac-bb0e-0458167b3013"/>
    <rdfs:label>ketoconazole-P95 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/909e7c51-c85e-4d18-9d7d-5d4fa8143259">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2905a24e-04ab-4e97-aea9-11b4a14a9bd8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/fb0d3fdd-e1b2-4ff1-9295-1bf5fcc0e480"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/5dd3a42b-79da-46bb-8860-98a4d7e4108c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b7be0c29-4ecb-43a1-9766-d02e7bf77685">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0f646fd3-4e2c-4a5a-aa3b-711a3ccfd3e4">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/59fb8bb2-3ccc-4f57-875d-0455a81713f0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d4f92a66-5339-4000-8f1c-221e461dc9b5"/>
    <rdfs:label>ketoconazole-alitretinoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4d15d011-5059-4948-bd9b-65ec2977a63d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/af8c9dbd-ff05-4b08-a4b4-472ae464354f"/>
    <rdfs:label>nefazodone-alprazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7e2c8918-3233-4bd1-8450-6d4898a39395"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/68cc7eb2-806f-4c32-a7e2-fa6819502b74">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/556a4d14-5e21-44b9-bf14-b7b1feb4f525"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f4ad79eb-97ee-454e-a196-de059e1362f8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/07072321-8abd-4cab-b7a5-9a425b21f4b0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5e6a9700-4407-491c-9e85-c2fb6d63ccd5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/2fd8e6e2-22da-4ef6-9045-6d94e0ff02be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/d03b4c4b-3f75-429e-ab6d-fa988ec77263">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/fdc9e75c-898d-43fb-b76d-41b2c0645ba4"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a56f9f90-d581-480b-9f3c-0cb8aa744832"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5d87a0aa-c86c-4e36-a9a7-ac312676e7ad">
    <rdfs:label>clopidogrel-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/3332ae8f-dc5e-49b3-8b85-a9990a6eb208">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/a315895e-9fc6-442d-8878-ae77ca18fdfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f0c3b41d-a27a-4754-b8c7-fd4fcb98f76d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ece881a7-2726-4ab3-ab9d-41cbbe7014ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/08094fcd-e5f9-410f-bbf8-8c38677fef48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/70508ace-12b0-4774-bb60-5db4375a5b0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9364cb98-93ae-4c92-bb56-f0e27285c602">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/8e65b738-ad85-48fd-9cc6-325479a81c16"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/fc8d0fd7-6eda-47b8-941a-ef7bc8d6d53e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/653cc16f-3dc4-4f42-8826-f5e8e2b9b1d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4b95b69e-f3f3-4050-b2f0-5412024cd669">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/d34e8de0-197b-46d0-847b-b516767eaca7">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/487c0e3f-2bca-4b1c-b5b1-256eae176125"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/8384cd5b-2f90-43dc-832b-e9d535e90b4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cb8e15ec-bf4d-4913-ae97-832e733d3a77">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/70094589-4e43-4d0b-a6e4-bb40721bb79c"/>
    <rdfs:label>Lexapro-metoprolol drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b63a9f90-d79c-41e5-ac04-3b35ffc45690"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a195cb86-e328-492e-a2a7-02e68b063683">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/28399945-2bb8-4a1d-9674-987ecf6317a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/50586b5e-750f-4d3a-a6d1-4d1d295289e2">
    <rdf:type rdf:resource="obo:MeSH_D012293"/>
    <rdfs:label>rifampicin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3ca5c2c8-4354-4ffd-99fc-07e09617eefc">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/fbb23c34-5fa5-4e1f-b9a1-a039bae39c6d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/793e2347-5c59-492e-99bb-07d39c139566"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/32288c14-3692-4f6c-8ff1-87a7a59d15a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/7bd16592-44f1-477e-ac08-6165238a8465">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/8c7a313d-5df8-4c6b-aefd-99700240dcad"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ae10f31e-e184-442e-bc5c-dbef7232e0da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/abc6b6c6-f88f-4bbe-b778-99287e99edc2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0d884d43-0db2-44f7-bf6e-3877b141b361">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/7d54bd7d-910a-4833-a71b-20273f0839bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9b7aa7a1-db19-43c8-8ac7-387af2b7a1f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f089c69c-eac6-46b3-8ed5-726e8edea36c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/441dfe87-d78d-4155-a853-df5491a64a02"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e4337801-feff-4d89-9e9f-0add1108a831"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ef83fd36-3ff6-4f65-91fa-bc9193f97ec3">
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/523d6350-9dc1-4c88-9c8f-a58c071d1cfe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/df62ac4b-6c24-4265-bd6e-d647f0dc7720">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/682131da-f5e9-43de-9e23-cc5d836217f5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e1d0f2bb-fad8-497d-99a9-6884435f9349"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/d6c5e2e1-17ac-41d8-9b02-815f8569a95c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7adf4f6e-2712-4a8e-b0be-a52273bdd7e1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/d7fa6e63-9549-4d71-bde2-072e55142d13"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/3771ca2d-b654-4c08-bc47-dd30e034c2d4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/8b111c59-39d4-4158-8296-0a974e9e91e9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a5009832-2df4-431f-8e0f-5e16035a654f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7c707770-52bc-4c39-b554-096c0e432343"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/6144f6b2-51b8-4971-bc1c-db1ce9a65c1a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7515e9a3-145a-417f-896e-ce3c9406ec02">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d220551b-92ab-4ce6-921b-b00fab32e416">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/052e13ae-eed5-4fed-a95d-dbeccfe64648"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/5d2d63db-7e4f-4b8d-973e-5611ba862a5b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/6e63d108-95ae-4ba2-b3e4-8a1531c0ec44"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3f39e2ee-3c21-4b57-b51b-10ed5f1af48e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/45bce811-3cce-4bca-9b53-f349a53a23c0"/>
    <rdfs:label>ketoconazole-mirtazapine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a26074b6-bacf-4d9b-b9cf-4bbe4aeadf10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/538a49dc-556d-4d9b-917f-ff5d3048e1fc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5f075b36-f05b-4e48-a4f1-d970021505fc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/d767c3be-4f23-4153-9985-35b07383a883"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/dd02ef09-67ab-4d2b-b2d1-1b5aef340222">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b7ce3bde-d894-490f-8add-33c72d487d5a"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/6201f164-913a-40d9-9df3-24f870af8221"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/483a0d25-58da-4212-acf3-813dcd2060b1">
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/f02496d6-0156-4b6a-95c6-0ca44364113d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/281b5467-5c67-4678-a60d-f493a2082e33">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/129882c4-51ef-4425-89ae-b66383fdb3d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1f3b77d8-0c8a-456c-a2dc-767a1b3aff00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5d6b0922-5d9b-4973-8d25-c5908a5938e3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2869d0fd-88a4-42e3-8721-3b7273660b40"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/891c7309-b405-402c-af41-72367f579253"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/82ae1774-3d8e-479d-a8a9-bb0d100bf15d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/7ae979d9-54d8-4341-9d78-51fe986c2e75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9bb42fb1-3596-4b97-80eb-7cb54314341c">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e5bd6faf-79ce-4c02-a3de-49d3a1a2354a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/468a3c34-2868-4e3d-a428-89d73a831ba0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/51a6cba6-e340-4760-8306-d24a1004403c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/31e9198b-dba4-4e33-9e29-5d900c3bd5f0">
    <obo:OBI_0001937>600 to 1200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/601a83ca-752c-4049-ab60-4efd7b1906ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/53bf1b87-ced7-48d0-b171-765e4e402ef3">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/8d7373b0-52d3-4dc4-bd02-7e16f1ab4339"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f99c1cb0-b1c2-4b72-beae-ecfd900618ba">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/6d8688cb-7c76-45fb-96e4-f13a0178ab4d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/dacd736e-0095-4942-abc9-ee3971f7167d">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/eac40c06-2e3d-4bc2-93ea-d23a6185c3e0">
    <rdf:type rdf:resource="obo:RxNorm_8703"/>
    <rdfs:label>Fenofibrate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5c62becf-0ede-4be5-8c55-51c3b0564d4a">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/760dbe28-30a7-4bd4-8481-c2998ffccdea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b576e14d-a8e0-407b-adda-8248d7686210">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1fad4c5c-f57a-4a51-9ada-7b1fdc45e291">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c8666948-c7d2-4673-94fa-b2194b6d3089"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e3efd91b-6aff-4ac6-a5d9-c4cec24c29ad"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/978e562f-cfdd-4eed-88f4-3059bcc0ab38"/>
    <rdfs:label>fluoxetine-P95 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/16f57902-1e19-44a5-9694-b0fa8d5c22b3">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/8a4d070e-e6e1-4eaa-bdaa-6683067bea96"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/8b46f983-c719-4263-8c24-0da5fc14a6f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2741ab20-aa1e-47d8-a3e2-faca5f198ee0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2baf6d42-40af-47bc-a726-8d0d1856053f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6177e90d-d12f-4493-b659-e90871724316"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d46c9880-d1c2-4c72-a7a5-69c0aa0b2518"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d48b5241-9899-472f-9786-98e8b8177cc5"/>
    <rdfs:label>fluvoxamine-theophylline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4bd95b26-80bf-4cbe-a7dd-3f9f3608d3c1">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/2593966a-a17f-4874-b214-46ace585a1e6"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/20d0edd0-c3e8-41d3-8e5e-9d58b4cbb06d">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9e10af0b-7bd9-464f-a1b8-cbe021121101">
    <rdf:type rdf:resource="obo:RxNorm_9068"/>
    <rdfs:label>quinidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0ba911e9-d600-4812-b970-1b743c7a21b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/88deb09b-d868-4e72-b407-a173b331c93c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/29cf73d7-7b60-4037-836a-d82d5378b452">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/57521a2f-5a66-47de-b0f7-a294e87bc70b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/68c0ad8e-bfad-4356-8fda-fe017a3c72ee"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3f8a638b-a493-41b0-8c52-53b166d09935"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/be5e0f28-8379-493d-afd9-661db19a6b51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f9749fbb-aa17-411e-8df0-03cc2dbfa70b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/43ca301a-48a8-420e-b869-187302aa4596"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/7afa0795-602c-4ebf-a144-0957d54ffca7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/c073e573-57ce-4f8c-a55c-b7f6cb47a08c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9d655b95-4b36-40f2-acf7-a0c41e339cdd">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/7cbe7659-18fd-4dfb-b704-8f143d99e090"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ca73521b-28e2-4dee-867a-9e673bc6273f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/3a5feff0-6cde-4a88-bc09-ec4fc34d1662"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/adf33749-2a12-4411-ac4d-c3ce9cc0a66f">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ee8882df-9e21-43b0-bc56-9441dac0252b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8d409b06-3bbf-444b-993f-5e7afdd38335">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f3bd7bfc-e361-4735-9f28-75a4c6ad38b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/00995dac-20c5-4725-bdda-9b85e0812ef8">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/cdeb40c9-4bc1-4a5c-931e-48120992a8d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/27508b6e-022f-4a7b-854f-8a3448f27a5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3420d7d4-4890-4586-ab7a-3606f9af3c19">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7569aaaa-66de-46ed-a40f-d2d94020d6a6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c62a09fc-56c1-428b-8fde-d215d6366aa9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ab8436ce-ae2c-4830-a774-30bdf392b698"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/06d26e0b-6554-4141-b6e7-b0161adf9311"/>
    <rdfs:label>cimetidine-citalopram interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/eec9a663-a1cc-4aa3-b076-fad5ad8bcf47">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/245f5724-1a4c-4707-a018-8d9e7904d30c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/4eaa5bd9-e132-428e-8f33-2df89f23e8dc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e1e0e7d5-dff7-4feb-a991-400303dbb80b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cbc01ea0-10bd-45c5-99a7-cec3491a4cfd">
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/41ca22cd-b638-4480-a5b4-ff3ea5b2aca1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/10f49f70-7e08-4fc4-9ae5-a1ddffeb38a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/40b4f8f9-1748-4977-a74f-9ee133ba3fc3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/7ac66711-9dbd-4485-a872-1801916f7f99">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ed993fa8-fbe9-4e4d-b6f8-582c275fe99f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/GO_000B152">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/fa157462-3486-41a8-b5a2-c57449f6e58a">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/4a3cbfa6-583c-401a-8cfe-56a60b4e5f19"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/e0444010-fa3d-4d70-bb48-992ba7a329fe">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/366894c5-1292-4667-aaa5-10359beb4192"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a2499dd6-a94a-409b-a20d-58b2e483fc80">
    <obo:OBI_0001937>38.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7c2e4d52-7a99-4a4c-87b6-6228f0ab3b15">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/fc9afc56-9db5-4bff-b23a-00e538911943"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/23d1d08c-8fac-4ebd-9e74-4c934bd4e793"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/6c4d7e5f-c509-423e-ac5b-db972ed79f5e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/c0e975e2-4f48-4ea8-b3dc-fd5e07edccd0">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/7ae949c8-1a16-4b9d-95d3-1585f6efa0c0"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e83ad0ad-2d6b-488b-9688-af56081cd9c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cc83c9f7-690c-4091-ba80-e9f1ff18066e">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/58b64041-e017-4e4f-9ab2-2a880e9fe525"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a25a6989-10b3-4357-ad5b-5e1683eb704b">
    <rdf:type rdf:resource="obo:RxNorm_686438"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/fc0a8827-b547-419f-afef-8e0cfb7c96c2"/>
    <rdfs:label>INVEGA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8c5592a8-ebc9-4b09-8632-f3415e747b18">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d804a822-08f6-479c-bb89-1ac05825f549"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bac334f6-812d-454c-80d1-c24db2ff31e0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3c118670-e655-4d0e-98ee-89fc347bc548"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/57040f10-88c7-4111-87af-f91e29db008d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2dfdfeb8-7acb-4b2a-83bb-12548e16e10e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2b1f4ac1-e8d4-472d-a019-ad9a35a15710"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/f64cd4be-7d22-4f0c-8f63-a5ab0e1fc00a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1360b475-88f5-4419-931c-7a68a2d7803e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5a92bf8f-fa8a-49a4-b278-5c20a6d9676d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/df7b0964-2712-4473-8983-5df1997ed151"/>
    <rdfs:label>ABILIFY-fluoxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/29adb58f-52ce-4c7f-bcc4-1dcd71902ef8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/deb08a01-6db9-4260-803b-d5d5814d6c5a">
    <rdfs:label>fenofibrate-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4e9a503e-a60f-479d-8194-0c0731a9b029">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/bb52b04e-5fa4-4769-9689-44b568e3ae8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/a8e75a9f-9dc7-46ac-a91c-493d1565c019">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b29b5694-acc9-4528-9fdf-2d1109f5acb9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3c78c1dc-a57d-45b7-869c-b0408c481480">
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/28e512af-4b20-44f1-ae51-9467f0499c7b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/48cc0b53-dda1-4314-b4ce-ede6ec06a691">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0437ef6c-2f81-420b-a403-25d8b22113e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/502006a5-1bd1-4a01-ae6e-c566c54995fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/42eb7f98-e8b1-4fd4-a28d-75d6308aeb1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/84062dec-2d4f-4221-bc2f-45207dc59e15">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/5aee8931-6a9d-49e9-af2a-a7acdf7df5e3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f108eb70-bdf9-4734-8e35-9eebb2d0b60b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/18f605fa-fde4-44f1-8611-5024057ff89f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5ce7e783-d318-4e18-9896-091d042e67b9">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/03cedf3d-ff96-45a0-8b83-2a73a7707233"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0f83784e-a31e-47a7-8baa-b2ccbf89b5a0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8794751a-c9fa-4b32-a366-9eb3f6995fa5"/>
    <rdfs:label>Fluoxetine-olanzapine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2f58076b-ddc6-4de7-8a0a-32be4a8493de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7dadd0a6-8e41-4ff0-8364-89e349bcf0eb">
    <rdf:type rdf:resource="obo:MeSH_C062257"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7b489cbb-2a78-4c66-8aaa-9de464a42938"/>
    <rdfs:label>P95</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/92a72227-c433-4188-a282-a293cdc5d8f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/df7b5fb9-1dbe-4d1b-9034-bef219401669">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3acfbcc3-cb3e-4b0a-bb82-cd7e42686d29">
    <rdf:type rdf:resource="obo:RxNorm_10438"/>
    <rdfs:label>theophylline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/52d373ba-e879-4dcc-b34b-fae53ec732a6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/deb08a01-6db9-4260-803b-d5d5814d6c5a"/>
    <rdfs:label>fenofibrate-atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0ffce663-19e3-4aee-a8ec-cb24c6ccf937"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/eccb8fa9-88c1-41f9-9ad2-0a261001c7a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a30c1bbd-f178-44cb-b6e2-2c70590ed2bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a3ff280a-a3c8-4f18-8dbe-4c2d5dd76067">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/563bd86f-a742-4e00-bd1e-ad8e4c48f009"/>
    <rdfs:label>erythrohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6766b392-2923-44d2-9c49-192898143bef">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/93ffc8b5-36a4-433a-802b-5834a5e1fc49">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/c331a70d-0285-4b0b-ae7f-7586ff50b67c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/9cf25550-4cfd-4809-8903-900da73f6039"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/296b5a7d-3341-4f1b-8947-8ece089aea68">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/87226fe8-b421-45b6-816e-7272726f3110"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/094ffe9b-fbe9-47cb-9d24-7e33657cc662"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e3cdb126-9fef-497f-9db7-d277ba5d816e">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/41defff3-429d-4b0a-b411-828188b42ae2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a317cf42-42c9-4610-a326-d27e4a3f64bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/db3ddeb1-9b12-4f5e-815f-bc7265a426bf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f31a1940-36a3-4b1e-b3c7-f637d6545b85"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/86f77267-22eb-4763-84fb-6175c0751e0d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/51adc763-d272-43da-87ee-f388f506d0d6">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7e51e868-a655-454f-bb38-e85cd01c7c04">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1ac2f10b-06b7-4e3b-b77e-6bd75003403b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/86a97769-b51b-4572-a2c1-b94234920d22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8cd3de9c-9d08-4c37-8fff-3c025403fc83">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b511e8b7-a4e3-44c2-976b-2dc99689fad4"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/251d06f3-eb78-4ba7-b2ae-ad53a55b81c5">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b093004a-58fe-4a83-bdd4-9f8303c67169"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d3f703f4-028c-4bdd-9116-0458ee7a22c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/4b76c6c1-ddb3-40eb-a54c-14f45ce27219">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/5369ddf2-86c4-447e-8c07-9c706cd974e0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/efd97c65-e190-49cf-8d20-c11eb6d9fb7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/52481e7e-9408-4e72-902c-60d45cd86821">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3f65a0e5-493f-40d6-9907-ef3f57e4b417"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/34056b5a-a306-4b95-9025-49a7170e4579"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7d51aeaf-9d1e-46cc-82b8-c1d48aac5e71"/>
    <rdfs:label>itraconazole-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b8e34134-132b-4bad-b6ef-7071bd8b8690">
    <rdf:type rdf:resource="obo:RxNorm_115698"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/2a80a3cf-ace5-42d5-a017-d87b6d08b463"/>
    <rdfs:label>ziprasidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/128a7467-ab1e-4eea-80e0-f0484b6cf60c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/a57af603-6ca0-4af2-aee1-c69fe40719de"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f30789ec-88d7-4f29-8401-f7013845dfbf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c97fd263-3759-47ed-859e-71077749bd7c">
    <obo:OBI_0001937>24</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c5dd151b-c549-4bae-a0de-a16fc6b0e8e3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/14a6dab3-8810-462e-ad7b-1bd33e7179be"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/452c6c4a-6537-4efc-84e6-738f3cd8556c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1cb29685-0466-4bed-9fd8-77556bb96c16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e75b54e7-8b9a-4107-b348-1f925357c948">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2e7a1895-cf71-4663-bef9-df0c061c0dfc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a94ad750-4f90-486a-bdf5-1948eb89c3fa">
    <obo:OBI_0001937>2.29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/13f959d7-30ba-4828-95af-f35b578f6ad5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/589479f8-aa00-4f42-b187-5d34baf29481">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/15f894b6-d47b-48f5-97b6-fe83286cc157"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e0def113-132f-4171-8034-d7c3a3e05967"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/0bc8d76e-03ac-479b-9eb8-a84ff40af43d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d24df3b3-7b96-4a8a-a180-ebd7c60ddf10">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/127f3e24-39c1-4b45-9db3-e9b86a9ddc17">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/1249b2ee-0aed-4bb3-a37a-8311958b0857"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/3e15f316-308d-4f0d-a6fc-42f69aa2d6ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7150c237-60b0-4405-b30e-e1e29a36dea2">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c46688dd-594f-4b59-9b22-24ff831d2b4e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/caaf307b-604e-423b-a681-af3120331c2b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/9653097f-88a3-4ad6-a4b8-070ed1367e5c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a7f8b00e-6539-4985-b48a-3e3d39beb332">
    <obo:OBI_0001937>138</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5980ff93-ccd6-4347-973d-3d663f54c282">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f166ad79-4ad1-449e-b1a6-23c1c4f092c1">
    <obo:OBI_0001937>67</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/91b07be2-393b-4037-8d95-0d47f39a1712">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/429c3e95-a755-40bb-80ae-d07fca183ce5"/>
    <rdfs:label>paroxetine CR</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/aaaf96b2-160c-4986-a93c-1ff5d4bd0047">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/995eb5c9-21d0-404b-9a5e-50eb079abedd">
    <obo:OBI_0001937>3.9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/02621c51-f5a5-420d-bd6f-01ef8a31ff2d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2f818f25-ea51-454b-ab68-dee036732bab"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/33656b8a-9264-493f-aa8e-75e3a4808a17"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/547442b3-ef75-4d0f-998a-251781ede046">
    <rdfs:label>sertraline-cisapride DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0d1b3a89-bf1c-4640-abf6-b68e63506dbb">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b36b0465-80a7-4d49-ba76-ea58cb88562b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/d613d12a-24e7-476a-9f05-fc8cc7dea0f2">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/d499954e-009f-44eb-b85d-5a6bf68ef88a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/51a666ea-14d7-4f4a-9199-36078c9710fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d37d5182-a001-490e-81ad-5826cd46c46c">
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6c085bd5-6327-45c4-b3a6-61ca94ca3846">
    <obo:OBI_0001937>32</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/88185170-148c-4618-af7c-9d4bfc68093f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e47d38c7-bb51-4d51-bb92-e8d8386c3b10"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/129882c4-51ef-4425-89ae-b66383fdb3d3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/da0954d3-87e6-484c-af13-2a479c7584c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c61ca58c-038c-4081-ad2b-cfadfcdf4dd5">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/8536ad87-8d5a-42ae-8b5a-b2d7d2ad57c1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/946180a9-fad0-45ec-829e-0fd0f392e9af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3bb477a8-cb9b-4579-81a7-4dd07404917c">
    <obo:OBI_0001937>70</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c091ffab-c9db-425a-b614-9636d9701199">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/d252fc18-7d0f-4655-a676-a0dc86a1009d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e7955efe-b081-4eea-857b-ae16eea1dcda"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/dcf6ca79-0e81-40c0-bd1e-bc7051064b9a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/34056b5a-a306-4b95-9025-49a7170e4579">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/12c71d28-07a3-41f5-9920-4b9af671dda7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/415e6cb1-00b2-4ef0-b123-d6a311e0bfe8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d834c9f3-a720-46d2-a07a-5a64e02e774d">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/76ff3ea7-b266-4ffb-bc3f-7656bafd3e92"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c3f6f18c-8f72-4d6b-988e-be6d84a6f3cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/303a9524-830f-4bc0-a83e-062e609d0580">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7d5eee06-7f6b-4e4a-b53e-35cc49aa2d06">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/03aa1ca6-6be8-4a88-bdb2-fe7ed25b010e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0a7384dc-d136-44c4-a992-0ec0496d6f1b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/d39a4203-3f14-4f56-b824-dd4f18264694"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/fadf9140-a553-486d-b7df-b2250f321e4c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/691ed5d3-7b1d-4737-a365-628804d5d34d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/4bf3193c-6f51-49a5-a815-78f4688c7e02">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/5554b46c-1fa7-453b-8a6f-fbf0c8d50a33">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/27fe1d55-6d48-4eed-b528-f4657b3b8682"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b2470394-5868-47a0-9371-76ae22a48fd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b40e7a06-1edd-4e77-b195-8d3bef2610a1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/86f0ce75-5ce5-4ccd-acd1-a93c77564873"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/668b9039-666d-46c9-bf4e-a94e2b593a40"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/64f11bae-4242-4f57-9fcf-59d57cb2ba7c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/19d03e70-8ced-44c2-8bea-6f7972cd3a54"/>
    <rdfs:label>carbamazepine-INVEGA drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7cbafc44-4fea-4e9d-a0e8-dfe42cda45c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d7b14074-2e56-4519-be83-40a5f57aaef4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/d172b616-d0ea-47b7-9548-b4156e44f32b">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/384cb342-97ea-4c7e-addf-a2c044fd7385"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/02cef4b6-9088-4bb8-b6a8-86676894a2f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/14e13845-5278-4231-a4ee-e692f8e24bd1">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f1e21605-8552-442e-99a0-ac4b27dbc6ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c75fdfe1-e377-44aa-81fe-34a230a545e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3405f165-a372-4f60-8f20-cd5fc96f495e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f0227d65-275a-4521-aaab-eca946e6ee51"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/754ae681-a47b-44ca-ae67-6010c219bcf4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/82adb3a9-6167-4bcf-949f-e8848e4f4ba3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/41e3401c-c8f3-4d9f-9b24-b574f6dd5a85">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5dca4653-a2e1-465d-88dc-57a82215ff58">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/39e30541-207b-40dd-a105-bf6c48fe4117"/>
    <rdfs:label>telaprevir-amlodipine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/75b32ae0-69dc-4930-9168-55c97c78123c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2c24b990-6da7-48d3-9c17-0ebd843800e8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9718685f-9353-4d21-8bab-692533126782">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/7e6b4916-7405-4ed9-b23d-cf9b5a42a139"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2a1bdfca-5091-4a21-bb85-05e19f168474">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/de378ddf-576e-49aa-b708-bce99c3ba932"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/29b429f4-8f20-45c4-a50a-de61574d8f93">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/53723908-a5a3-4b9c-9bd1-92f33d751a77"/>
    <rdfs:label>fluconazole-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d16b3adb-320c-42be-acda-945502614978"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/281bb97c-e64c-4a53-be15-bbcc0103dad8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/03cedf3d-ff96-45a0-8b83-2a73a7707233">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8e65b738-ad85-48fd-9cc6-325479a81c16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/4344d219-577b-4918-bd16-82a821aac11b">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/88af871d-db86-4d79-9e29-42ca8e9ad3ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/658f9b95-bee3-4064-b63e-e80ff0b8b91e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/16ad9fc2-7bb6-421a-bc65-f66c7c59a8c7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/52ca92d5-6b2d-4b57-adf3-fcda3caa3c9b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/41bc7a0a-b81f-4ac2-b973-f5fab7646571"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f651eb0d-760d-459b-8912-473b9479e81a">
    <rdf:type rdf:resource="obo:RxNorm_686438"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/6404abc8-bf54-4b3f-87f0-659327c3ed1e"/>
    <rdfs:label>INVEGA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/884d7bde-0b90-4169-95b3-49485ce8782d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3771ca2d-b654-4c08-bc47-dd30e034c2d4">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7383c614-7025-4be1-8e5b-c1a43b16da9a"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4c77e5e9-1ff6-437c-9c8d-402eeb4018fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/c0cdf8fb-6445-4eca-beaa-843afc11f7d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/076d9980-ec24-4e6d-90f6-2e3b52edd188">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a4e22140-dacf-42c2-8b9b-252a444b327d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c7158986-3eb3-4631-959b-07c412b7996f"/>
    <rdfs:label>atorvastatin-aliskiren drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/eb6f4411-ed61-4c36-b5ea-c9342e057e18"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/52a4bb57-faa8-47d1-a9b4-b33a317cba22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/43ca301a-48a8-420e-b869-187302aa4596">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c84e84c9-5a75-475a-ac9d-df01fca3ebd3">
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6eba7d08-80ad-41f2-9e00-473aaa90ec75">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d217418b-e285-4a40-9971-4841cba2cb3a"/>
    <rdfs:label>fluvoxamine-duloxetine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cf2f5ee6-d3cd-41a0-9f2e-69a7ad4c11c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/3ea2113c-f66e-4bd3-a5df-147e24a52bb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c7158986-3eb3-4631-959b-07c412b7996f">
    <rdfs:label>atorvastatin-aliskiren DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c7b0f26d-e190-48ef-8dcb-418ed4fbfdbf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/30ebd72e-a5d1-4750-a8fe-44b123c3fa56">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1a95b7f1-2f24-416a-bce9-bc77b2d0f87e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1140840-bbef-4521-b5c0-cf370a68aec2"/>
    <rdfs:label>telaprevir-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cfb6ea7b-0ad2-4fe5-a8bb-c309ec869e7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/80587164-1cea-4969-bdb0-d5e518bc6e91">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f03ddd80-b1d1-44d4-97d7-4fdc87232ab9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/54cb1140-9038-4e7e-9188-0b265fe88e07"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/ffe11a73-c4a5-4042-ac07-c74831192385"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e85b97cf-bc3e-418d-8a0b-f560acf0b9ba">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a0f53e69-f281-4499-bc5d-b909a7d41084"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9ee94b38-445a-4feb-8ed9-e0cbbfe756ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e0a296f2-9613-479c-871b-e45b15d140cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8384cd5b-2f90-43dc-832b-e9d535e90b4f">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0f9918f8-9d64-4240-b58e-635a9b7372ca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000039">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/60e8383e-4a09-45ea-bb29-8b6c90c2026a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f286db98-f2c7-4bb6-8c98-b7c56e2eb8b5">
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/8a2fa2bf-323b-4e58-817f-af50a172f975">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/41b7b894-5290-4ee6-8f8e-0d78058dc024">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1684617f-f216-4dd9-a3be-0eea73aa4180">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/db8df768-75eb-4cc1-8158-583305f5d0d4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/72d5340b-18da-4117-af2f-4ef3c071f26f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ab657d98-9ef1-454a-a471-ff29099392ab"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/0437ef6c-2f81-420b-a403-25d8b22113e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/685beabd-9b96-4744-b7db-7d3780251b0f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/7cbe7659-18fd-4dfb-b704-8f143d99e090"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f638ce10-8662-4ec5-a104-99ff27a8bd91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/538d377b-0a62-4fcb-ab77-fcdc53d9bd7a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/07494846-cfd4-4a83-97c5-e5dcd13547f5"/>
    <rdfs:label>duloxetine-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5c9c9a10-f83a-4948-a3fd-fcc431e8ec29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/4c3484ee-f108-4061-a7d0-091878488c75">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c538fe3d-7f42-47ab-9fcb-fda411cee7ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/9bc415ca-9637-4fc6-ac2f-4f7e30c8c3de">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a3d90672-48fa-4c47-8c90-60e6c3d77479"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/81a7e52f-7842-4d24-b1bd-b5b377afb874"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/afe1061a-2ac2-4a0a-b8b5-9201bb67fd85">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/702bdcdb-b28c-4964-82e2-50cabc6c43f0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6250cc5f-ec3f-4fd3-bd37-55ccee9bd50b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/931589d8-f0df-4288-9b3c-df119e147e69"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/01e7f7da-a555-43da-b709-6477bc22f843">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7df9b47d-2c65-4e13-ad6f-c7d6279d4e0f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3af90123-46e2-4baf-86da-7dfbd1b5deed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bac334f6-812d-454c-80d1-c24db2ff31e0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/999ec5b0-dc65-40c5-bb73-edb44bc16e08"/>
    <rdfs:label>ritonavir-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7be77f3d-740b-4e36-9ebc-6834b948f070">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/6d34530c-ebb4-40e8-8a96-f04e3a14b634"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5f50bb5a-8afc-4f78-81f2-c7a28a9dcb2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b7039deb-4987-4b36-be33-dd2252ccafc3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e3572943-5a8f-424f-998e-cbb6ec520cf5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2db4b9b9-ee08-4ee0-97e8-0fc698bcb2b8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c94e3da0-8a1b-4266-b4c5-a69db0a20d43"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e97e258f-6fd6-4f49-bb57-19c0751f7da1"/>
    <rdfs:label>mCPP-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/68ed4798-302c-4b2e-9936-9c32c796936d">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/b5020419-bb94-419d-a61a-2dc3d66b415b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6c4d7e5f-c509-423e-ac5b-db972ed79f5e">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e4a90831-76d7-4a7b-b02d-f46e044a15f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/3c2eda15-d785-48cb-9dfd-b9ab497afc27">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/01a5bf2c-e4b6-47fd-a7a0-cdeb00d0cb4a"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/94df721c-b53b-41a0-8a22-4c8e616c9a94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7966350a-1a15-47c3-9800-36feed2738ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bc02e0c8-ccca-4045-9c74-ebbaa41662d2">
    <obo:OBI_0001937>2.53</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3f65a0e5-493f-40d6-9907-ef3f57e4b417">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/34b4f055-eb1c-42ae-a670-e1f21f744dd6"/>
    <rdfs:label>itraconazole-zolpidem drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/39a2489c-0b04-4e02-b210-822032d51125"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c8953c30-9be0-4f85-af0a-8648397d2db9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1f12f21a-91a8-4b48-8850-d015dd86a1c8"/>
    <rdfs:label>nefazodone-haloperidol drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b2760ef1-0c8e-4760-baaf-78e7b2b2776e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/107c5116-3357-476d-b2b8-3cd452fd70f9">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3137a62a-8869-4957-8393-1c1d078bd31f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/73fe60bc-4678-4012-a140-1a4508869c55">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/8e66b0db-bb09-4076-a863-39e5d11b2ca0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/59e8dce4-4beb-4445-9042-cc527046bb88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5610c7fc-12cd-45a5-aa70-2ffc91a09024">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/432d3ecf-d605-4863-8174-a70f112c6303"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/f19966e2-8c39-4d16-92e4-0e8bdaa94247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/4a7dfb4f-972e-4e55-9149-d6ff1962d69a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/62eded95-b885-4398-8f0f-4a5bd87a9aaa">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/00ebb741-02f3-4cfe-985e-4b07a8d694ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8e96114f-ee16-4d15-a445-b86f3639c3cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a4eff39a-625c-499a-861c-3a278c786155">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f4ad79eb-97ee-454e-a196-de059e1362f8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/77280095-cd51-43e5-84cf-ed774098bdbb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0ba7bb0a-98c0-43ce-9685-f7c3fade63d4">
    <rdfs:label>iloperidone-dextromethorphan DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/52463fdf-bb85-46eb-ad58-fe86c9f45b93">
    <rdf:type rdf:resource="obo:RxNorm_195085"/>
    <rdfs:label>efavirenz</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3845322a-ae6a-40c1-a600-d0c54c79936a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/d5da530d-45b2-4ab1-8515-489f1f561bac"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/6af36176-549f-481b-afe8-50a99bfc8639"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6991e5b7-9ed8-4fe4-9744-4796948b7f47">
    <rdfs:label>Boceprevir-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/affb77c2-0d9a-4969-a2b7-a53f3c89c34a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5c6bf1eb-e64e-430c-a017-d8cda7aa1af3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/1beb7dc5-2fcb-4579-b2c6-368376014dd8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/78d42d4b-7d40-4a31-a240-5968ecdba922">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/744a69a8-6eb1-4caf-bd0e-8a16a1077e0e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/04827bdb-6994-432f-b47d-89ed2d7e6ae9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/eaaa8b07-b453-4992-9838-43787caec712">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/23eac9a6-a219-4053-849f-d963a998f729"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8b46f983-c719-4263-8c24-0da5fc14a6f7">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/244f4d2d-936c-4678-8f90-5244f3bce4d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/29f8f69c-23db-4d38-bd65-3b9447eefee3">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1632c23b-1518-467a-b109-43578f3920e8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9d655b95-4b36-40f2-acf7-a0c41e339cdd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/d7f93cbc-f325-4d10-acb8-548c31ade9c7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/366894c5-1292-4667-aaa5-10359beb4192">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/fdc47acd-e0b6-4b8c-bf77-596bdd628a04">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a54b6be8-ac05-4062-991a-a9bee4063937">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/6822eebb-7f8a-4dce-b4a9-a0db87383d67">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8b2a85d4-4bbe-4b37-a66c-1529b29e7aba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/38c0fd83-882e-435a-857f-e5af2eec1b86">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fdc9e75c-898d-43fb-b76d-41b2c0645ba4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4c2bd1e7-cbaa-4aa1-94fa-c4ae3689f132">
    <obo:OBI_0001937>53</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/23a94776-fc69-4a01-b72f-14be9ebc9569">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3b4389ad-bf24-4b35-a2e2-71dac009735b">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/d35a3e01-ffbe-4ac2-ae6a-158e74506072"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f8bf11f1-0f5b-4548-9a38-820d2049f6c9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4f3263cf-67dd-4a2b-83d6-cc333bf9d1eb"/>
    <rdfs:label>paroxetine-P88 drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/92259737-5220-4b93-8391-e7c1672e0ae4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0359e638-794b-45a0-b774-1c32fe4b3093">
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/bc4b2ebf-6f0c-4a4a-a115-a0409ca8d72d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/2593966a-a17f-4874-b214-46ace585a1e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f829bbec-0b32-4d8d-b216-7fa149ee3898">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d4d2537c-9934-4c56-bbd9-ee8dad901581"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/86f2297d-d81d-4fac-81fb-9502187e438f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef0a5b7a-989d-46f2-bbcb-6d5c6908e454">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d7335e36-4bab-4f9a-8f2a-b7cdd2b7902d"/>
    <rdfs:label>theophylline-nefazodone drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e975a8c0-f41f-4782-a2fe-ba30d711a5db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f49fdb03-34e1-40c8-aae2-6311b2e299e2">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/35332a45-ff84-4acc-a8a0-ae05633cfc14"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/382d65a3-af96-4162-bdf0-b9ff9d738bad"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/698842c9-2233-4d4b-ad1f-8e45282dc075"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4f4f2387-9299-4c44-a7a2-917ca546963f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/39cac0aa-80dc-4025-af22-140da984000b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/605e1fed-86da-496c-a999-763ff0796775"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0f19e7e2-a9f3-4132-a48b-7ea3fa21379c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f6e2f8eb-3f85-438b-9915-d50da86d89fe"/>
    <rdfs:label>ketoconazole-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cccdcacd-be85-49ba-a5d6-a728efe34eeb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c73f2f36-063b-4eff-9203-ac3a92499dc4">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/3c70a4a5-dd02-49c5-acd7-aab32eb2250d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/35129132-8a82-4193-a0cc-01b676dad580">
    <rdfs:label>nefazodone-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3d43c31e-4f36-402a-b0f3-6d43d8b49258">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ae06c72b-b870-4f1d-be08-263649a9dccf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/6cdcee96-b9cb-4484-8ce6-78bba20652b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/72577f38-71a5-4a77-b2c7-77c9ddbb574c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a6bcbbfe-1e81-4d4b-801d-157ee15a9e59"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/26590079-7806-4a92-a631-5fad4554277a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0a6c2a12-206c-4818-bc6a-a4bc5f15d6d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/fe69d20c-485c-4808-a235-b1db4cab157a">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9694df7e-a3ce-429d-b015-87ddec846260"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b97075e9-ac3e-4667-bc81-502081028e83">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/34482022-7b4c-42e3-a04c-90ba761ecf8e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a74fcf7a-6c90-43f6-8ee8-beec823f28f9"/>
    <rdfs:label>Fenofibrate-Atorvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c1519326-4437-444c-9c89-701a8ed295c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e3f46ce7-7210-4648-a944-48757c02547f">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/895e8768-670b-4c5f-b10a-18c3e1acd59e">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e8668e10-0672-4ac6-a771-6ebbfa6172f8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/7305b68b-e4aa-4d1b-a4d6-af1534b6c285"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/bfbb4a3b-7a61-41d1-b37a-f5aaaa89005c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/1e9ddeee-054e-42f7-bdee-5b30601b95c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e741eabb-0a11-4a65-a398-a8a2677915de">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/16641bfd-47d7-4c1d-ab70-12d10a756c59"/>
    <rdfs:label>ketoconazole-citalopram drug package auc UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/19dc76ed-8c11-4cc9-9b91-7cfcb50a5296"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/75e96017-cf69-4384-88e5-2c2491d3941d">
    <obo:OBI_0001937>no change</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/668b9039-666d-46c9-bf4e-a94e2b593a40">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/adf0509d-0017-49ac-b7fd-1d22d4433c42">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/bd72a16d-07b3-4dfd-949e-44efb8e039c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2084505c-af52-4775-b605-da1f894a1d33">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c72cb449-f007-4766-ad99-da69862989e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c9ff7448-6dde-45c9-8e71-168a09450091">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/98502d5e-6cc7-4ef2-a6d9-2644898361dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1a6c8723-9056-4c68-92d4-51bd26c30b1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e22bf70f-b935-4342-b951-51300d6ee301">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cd569fdf-0a9c-4039-983b-c971c09f8983">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/02d58923-1bb3-4c0b-832f-8f32b642b51c"/>
    <rdfs:label>divalproex sodium-INVEGA drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a57561b9-7bfe-4eb8-8723-58a1830a9ad7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/eabc3445-49f3-450b-be7b-b2907102581e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e070902b-d2fe-44b2-bcd8-17852a8df64d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7e4f78db-2d6d-49cb-a026-1bc4ee82129a">
    <obo:OBI_0001937>14</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d6d00280-c79c-410f-9d86-ddddbf989471">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b0e94204-626b-4b84-ae20-eaf2130c2ff4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/79e26b6e-dab0-4d25-83f3-5f9d433dcc5d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9e0e562e-a99e-4a42-970e-c88181b5cc43">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/80ac9763-4a19-48b8-98be-e9ba7da8805e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c24e3607-2272-4f58-a9f6-ccfc626ad1b6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/37c11c1c-66e2-49bd-9f46-47dafb25b2f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/7e9d9735-28f7-4f17-b4f0-622401b1c40e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d119c10a-946d-431e-8522-1a8db2f18a0a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f9e63662-5f48-405a-a5a1-76035be08ad1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/63f88971-f278-4a67-895e-f761e5e5a2e6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/18691c4c-0b61-41a1-a51d-7aec50b1e32f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/440c19b9-560b-4086-9d7f-65df28f33602">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a26074b6-bacf-4d9b-b9cf-4bbe4aeadf10">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/da7d421e-e87b-47f0-8be1-a5223dfb9aab">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
    <rdfs:label>low-dose ASA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a4e43709-06f2-4ae7-ac95-e2fa4bea4771">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a6bcbbfe-1e81-4d4b-801d-157ee15a9e59">
    <rdfs:label>ketoconazole-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/44467522-be5f-4172-997e-4339c24a46f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/26590079-7806-4a92-a631-5fad4554277a">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/24486274-edee-4cd3-bb85-89c9a1e53228">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/3dbf7cec-237c-4e19-ac22-916714e8b44e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/9df727ad-fad4-4a2e-b4d8-03dc5ed6f320"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/6bf3f228-0bdc-4c58-ad29-540f09853402"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3009b4ed-1b7d-49a2-a8db-bd529a1f7826">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/086d58c2-30c0-48cd-ad97-a50ab9b1caa0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/56ffa390-ffb6-4d78-b7db-c5028f30996e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f93737b8-bac2-4c40-ba91-370bfd5fadc5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f37a8977-0307-4b30-a778-b241b51dfc2b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/54240f9f-0fca-4821-8e66-d3a19f642278"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3b91d5ec-d4eb-4dcf-8dc1-c100c21b908b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5d6b0922-5d9b-4973-8d25-c5908a5938e3"/>
    <rdfs:label>low-dose ASA-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/830b499c-e7c1-44a0-ba25-fc1a78a6d5e7">
    <rdfs:label>S-warfarin-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d839d65a-10bf-40d5-ab71-e8acc73dc615">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/634b186f-662f-484e-91d1-878dcfafc429">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/44301a1c-58ca-4070-b769-618857c80cb0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f13eaf45-e4d9-4624-9629-e63999e32b54">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/884d7bde-0b90-4169-95b3-49485ce8782d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/b477b2e0-203e-49f4-b762-6dd00df5bdf8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/72b5d3cc-7b81-4912-abd9-4f979abc0309"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/46029062-9da6-4eee-a942-55259ea4aa49">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b925a2ca-d1f8-44e1-8aa1-dc55c8dc0a8e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/5f9dece8-90b9-40d4-8fb1-54c53d665f98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/22b62b7c-9d42-4cf5-bd03-4fe9b7b6326b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/e23318c1-8d48-4871-af3b-a8e01ee7cfcc">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/790da156-e762-47d1-905c-28fd39b0037b"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/0740e7d9-21f7-4194-960b-21c4313929f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e2de0afb-1d74-4519-a850-1fc3e37d29d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/64f1abe1-0ed7-4ec8-9923-8cc6642b4388">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/691cdf4f-2ab1-4153-bd37-e401d8b18e67"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/614887e0-aa56-42b8-a08d-14e3a4b0e077"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/875e876b-5d47-4d4c-817f-88d0aa4ab8a9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e090e2e8-050b-40ac-8b80-318f6f69ff10"/>
    <rdfs:label>rifampin-zolpidem drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2c4aad37-57a2-4aed-9d2f-f9f663231170"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ec80bb9a-afd0-4a7e-a5f8-2ff1b0320f3e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/7b6d0c77-1551-4515-a0ed-f8f95f4d3ec8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/aa26f9ab-67b1-4b8e-abc9-c25cf4f2af15"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/b2571353-2142-4858-a184-40d947d4271f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e6aff6ea-93fb-4649-9c6c-efb78414c121">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/32672355-ffb2-4c28-aefd-d845d7f5bbc0">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/78ad9777-59f4-4383-acf6-1a35be72976f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7114d45d-78bd-4422-ad7a-3694f509efbc">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b0a55ce7-9225-4f9e-b0ea-ccb5d47bd962"/>
    <rdfs:label>Midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b29b5694-acc9-4528-9fdf-2d1109f5acb9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e368d78d-8d7b-4f95-8a34-d608085f0b6f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7569aaaa-66de-46ed-a40f-d2d94020d6a6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/617d5c7b-74a0-4f88-bb7e-48e2963a8879"/>
    <rdfs:label>cimetidine-citalopram drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/87d60474-3de4-4d34-a01d-22755ce542dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/a26f8c0b-e674-48bb-b993-9c4eb1cbfecc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b116cab1-6ad9-4f95-aed4-0b8d41e2ed5a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/386244fa-1e74-4e46-a98c-d103fb6411d8"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/2f197377-b6cc-4b60-ab5b-5759e3d52010"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/732fc5f4-6e13-4995-afb0-a8ebc5eb6228">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/68adef3c-42ad-4072-be02-8470e978b539">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/98ec3ff0-9e76-40d5-8646-5981c83a69a2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/45f2041e-30ac-4700-8984-9f19f92a4a54"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/35abe52b-24bb-49ca-99fe-ceb10ab36350"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/71223b03-9c73-4246-8226-b2f60f718c62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/17140432-7c57-49bb-b5cc-b36d824546ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/8b15d3e4-1c9d-4579-8be8-f460c8d9b658">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/5829e6b4-185f-4776-9862-74902274a16a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/23b410f5-db12-41fb-ad58-b11efdc56133">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/f81d216e-cb2c-4433-81e9-a14bba65d297"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/e0a296f2-9613-479c-871b-e45b15d140cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a4b1ba3c-ee6b-497e-b8f4-ccc81ac2c7ca">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b370c31f-4e34-4cc9-9914-505526836cf9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/2c0650db-6d1d-4360-b493-544512cca91b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/958d60b2-f410-4f1a-b6a6-f8e06997da18">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/e2bf4677-65b4-4b34-93f2-6c298d0502f2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/3ce710cf-27e3-4db9-ae78-290749dac7dd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/10095d99-07ac-40a6-9431-d9b3d9fd5db7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/5f844793-95d9-4011-8741-d85d6f598234">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/d0d86c31-3e20-46d7-9205-1a783f8795af"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2ba321a3-1408-4a32-903f-86564e66f0c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e8249a04-c832-4f1d-9206-693493d75a11">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/47cbdf28-cb04-4aee-970e-5305ccb4d81d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/da251943-5226-46f6-baee-e20010680766"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3bb4660a-3549-45be-8300-cb4777d40686">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/cc28fe8b-9753-42d3-be8e-c52baf1fe5c7">
    <rdfs:label>nefazodone-triazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c93549b7-81f3-49d6-badc-bd4eef7e6db1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4fbb9658-9c8b-4b75-b451-3b069c3d8db4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/480f36c7-c472-4110-8346-6e25da1cc763"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/65327887-52eb-4935-953f-bb13638ffaf6"/>
    <rdfs:label>carbamazepine-hydroxynefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8c166835-c1b4-4926-9fef-f970e6848911">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/68293420-1d9e-43d6-9cf9-a9c7384fc476"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ec2e6abd-5d38-421b-97dc-071227beea58"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/8e9c059b-f2c6-41b9-afbe-4bc2b580db7f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/7b05ed4a-c180-462f-943f-7ec8c3790d28">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/1e2009ab-7367-44da-aa7c-f7dc60958a92"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/328eb1f9-3b2a-483b-86d6-54739aa9037c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/8bbacc7b-9a0d-4923-9331-b93cc37f2be0"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a276f0ca-787b-4bf1-b184-4d3f2f55d00c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/6e55cc1f-7a39-4ccd-a962-69d89914e364">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/bef61128-bf35-441b-8317-bd429e507f41"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5e86cf60-25f4-4e3b-8627-cecf27c4fcbb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/244818e8-87f0-40bf-85c3-6cae1a87ce24"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e070902b-d2fe-44b2-bcd8-17852a8df64d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f9a763f2-4699-4785-933f-def0265af91e">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/5ab995af-634c-47e8-bff4-bf61e9fe3c7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/5a942bcd-5614-401e-a7ce-575bdd6ba85d">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/20a7c410-aa24-4152-ad88-342013b38578"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/5ac1775b-8131-4645-825d-8a6708a79384"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6876740c-2376-41b7-8aa7-d8edc2412217">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/7aea56aa-cff2-410a-83c5-ef30ff6767a5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5cb8625f-5183-4fd8-837e-7f829d7d5f27"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/8639ceaf-b744-40b3-a637-539e6b560e74"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ac78eb40-cfa8-4c24-bbfb-f56a0fe0ec1c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/69fefe8b-ec4b-4d06-b547-6c40a60166a9"/>
    <rdfs:label>paroxetine-9-hydroxyrisperidone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/939d6c53-f044-4e8d-9b12-543093ef4481"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/aaab652c-96cf-40f0-9d81-d45e05e2d5cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/23eac9a6-a219-4053-849f-d963a998f729">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c7d0cd96-6a90-4e41-8a44-923786fb422c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/97e96fb2-7ad8-404f-b6fd-b4875709405c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/bc85cdb9-114a-495c-b3d3-e4f50e2785c0">
    <rdf:type rdf:resource="obo:RxNorm_114289"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d7db5bfd-9eb9-4a26-b38d-43f3d1aea432"/>
    <rdfs:label>indinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c77c7109-6715-4e4d-81b6-c7d6ffd455a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2c01abac-aae8-495b-bc3a-8d2781c1c519">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6bddb3a5-5d0a-46ef-8f5f-475a7b1f1c30"/>
    <rdfs:label>risperidone-valproate drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0dfcd18f-ba59-4f54-aa3c-144ce3cc8c3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1542dc40-ac48-43c7-b9c2-e4e248d71f22">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/1c26b3b2-5fad-4375-8223-573a5d62cadd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c97d8f60-8578-469a-8460-bf5054068c08"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/68455c9f-4386-4279-8005-5b61e8b91319"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b9d5f3f8-0256-4f67-a8da-8a18a319f365">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/98bb2109-ef8c-47b5-a0d0-25902923646e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7a9e0a43-41e6-4d76-80c2-cec3ce36fb2c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/771b9653-498f-4029-a581-49f02c5437ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/07614f54-1386-4f4f-bfd6-f596289593ac">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/7e697b44-af26-4648-8a17-778d90f92308"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9a95d68d-8e27-47f9-9d5a-5ac0f858c44b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/72b3e145-cd54-462b-bbc1-c5e3de9ea05c"/>
    <rdfs:label>warfarin-Rosuvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/55c41cbd-8c19-4587-9f4f-295f3df7235d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/751db5e1-a1f9-43b7-9992-999e4aeec9e1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/9b7aa7a1-db19-43c8-8ac7-387af2b7a1f9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/0a979e34-ab3f-4315-bc11-791b68128546"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/96d32ebb-0920-489c-ac13-ee918602ec6f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/bb86b421-c52a-4722-988c-30438fae6e99">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9c357197-88f9-4d10-8c67-95644a66fd82"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d58f49de-7cdf-4e3a-9de5-ddbe3e850cf0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fb441f11-30dc-490a-a87b-5c33a73f39dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/449df209-3be9-4f32-89b0-5dbbd7b69bcd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/dffb6c9c-f190-4302-924d-c7faedab3c91"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/032be1ee-c21e-47b8-abbd-dd08fc0e2f11"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f75db935-df55-46d3-a6ea-22a58da8baf6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/6640be46-1ebf-4a19-80e5-c1efd00157e7"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/9027db15-65e3-4405-b3b3-e5c0e43217c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/aa050b27-fb0d-47e7-b4b2-26fc8ae54c7e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7acb9858-b96a-42ba-b048-ad8ca71f1498"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/8fbd57b1-99ea-430a-9281-4eccdb885c29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/56671035-4aaa-459a-905c-b6272814b3e3">
    <rdfs:label>ritonavir-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/de6e9f7e-7f2d-417a-995a-05db5bd848fb">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/0d073e2d-6ceb-4257-817e-273048a425cb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/ff7121fa-e85e-4e35-97c1-5fdd1a315ea9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/e3a23e07-97fa-4ee5-9e8b-94291adce86c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/11fdf92d-6a64-4e48-8ba8-21774361197c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f4d7310d-a582-42bc-bf3a-493d7610790d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7ea9e2c7-9038-46e7-9e62-82067b4e1722"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8d066cb2-8cdf-4905-87fd-da6b78695d30">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/8f525e56-4206-4263-a665-cf0d0989e767"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a3c7be66-3cfc-4c4c-bd62-43067243eaa9">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b7a1cdfd-45df-4a8f-8d55-50b53d0cadaa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3b836bc6-a02d-462f-abc5-ab16997af13b">
    <rdfs:label>cimetidine-zaleplon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/a63b06af-81ce-4fd5-b539-1fdd1cc38036">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5b54ec5f-0c9d-4ff4-9e0a-300c03c4110c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4d5d2b02-329e-453c-b366-6446983c8dbd"/>
    <rdfs:label>sertraline-tolbutamide drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b42c32a6-0e78-41b1-bffb-ad2687c67e58"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/362ec07c-69cf-4e42-83c2-97d8dae16763">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5b38d096-15fb-46cb-8660-1386e7cdee7e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/94a00ae3-7d10-4363-b044-0dafe6d1b8e3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/45464d7f-debb-4933-9513-fac785c98a49"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/284714b1-8ec8-4382-b3c0-47c02df7315f"/>
    <rdfs:label>nefazodone-buspirone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/72f5f07f-9e08-486f-b505-4941d6b5c399">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/21528712-6380-47b8-8fe2-9c91029d77e9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fc9afc56-9db5-4bff-b23a-00e538911943">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/79f1f46a-2ddb-4cfb-b890-03280d16bfa9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b8df5d8e-f2c1-4cf3-a55f-58f8a7b1f1bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7a4131e5-b470-406c-9f8d-2d97d3f9986a">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/648e940e-fea6-43f7-a304-f76b2e926c51">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/771b9653-498f-4029-a581-49f02c5437ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/75104da2-53cb-4d57-8dc1-b2ecd143c0f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/20cad964-72bd-475b-a120-db4cad122d80">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ae231f99-322e-49c0-8b91-9a2f6330ac47">
    <obo:OBI_0001937>11</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b6c51c86-afc8-41db-adbe-6d2e97d99e29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6e589ebb-123f-49e8-86db-d8dbd199851e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/62776982-355e-4540-899d-93cdc909b373"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/cc5655c3-9248-4ea6-86ff-9e68bcb2a867"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2edc9751-4533-4be4-a7e5-5e26595c68f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c123348f-9c14-4f8a-9248-dac5948a114a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0e2bb83b-cca4-4ac4-b37d-5aa07aec2c4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/da19d135-996c-487f-a870-4ae5d6d8fefb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6c4201ec-d2a8-4453-b1fd-970aa247ae1e"/>
    <rdfs:label>Ticagrelor-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cc04d585-6f46-4def-bb4c-5848008e222b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/788aa38e-3406-4f8e-8fb6-3ac95d75ce64">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/528cb9c5-485a-43f5-918e-75d18225e8d6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/baa697de-40bf-4d80-9549-083c5876c5ea"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/ebaaa561-a709-4cf6-9f2f-181ac2531fa9">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/e2eb657b-586b-4182-bc8b-3bc9dbf0c24c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7c1f3ca0-5774-43e7-a731-563a5dedd0b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/362fc083-1254-440a-84fc-90c2e5377d4f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3f79c7d6-2183-4fde-82c9-332878548768">
    <rdf:type rdf:resource="obo:RxNorm_32968"/>
    <rdfs:label>clopidogrel</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ddca84cf-f054-4ef2-b85d-69b2f020ca0d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c99a0982-ce0d-410d-827e-759ca5ca47a2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/eac477dd-7466-40f3-a753-df07092fdf4a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e252c60e-2dbf-4059-838f-1ba49d925228"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ced5cf38-a9f6-4515-8b19-70bf1e977943">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7ab5c129-c949-4a93-8cb7-e1616cad395b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/a482b865-f623-4245-9233-cd4d3f07f59c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/066601bf-4488-4785-8a49-e428a8a6e88b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/90dc14ee-1f5d-43e3-af66-c5d438c8b07b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0ca88310-ec67-4dcc-a0da-b0a9cbcea1bd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/df0eaf20-7016-4d70-9edf-56ec35f92942"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fe42d554-68c9-48be-b06d-6383b9debcef">
    <rdfs:label>erythromycin-zaleplon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/7ad073f8-867f-43e9-b757-29511cd3c85e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/baa697de-40bf-4d80-9549-083c5876c5ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/827bc7fb-877d-4235-a429-2fbe4a36aaae">
    <obo:OBI_0001937>0.25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/20a78859-ed8f-4365-8124-60e9bbde43c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/972d42de-894f-4dd0-a365-e04fd71da8e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0bc432bc-6c40-4c95-bbcf-bdaee64294d4">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/43e8cf86-42a1-4497-8d7b-b1825b10db87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c380f8c9-c1d7-470c-92de-392014c49980">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/db63cfbe-7f52-4d19-8d30-86d19558c3cb">
    <obo:OBI_0001937>36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/04a00cb3-f733-43be-8b76-d81174e5088a">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/79464a97-6a93-4218-b2cd-62eb3d5346db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4cc71f9f-4183-4a07-a299-6aa4f1781c98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b511e8b7-a4e3-44c2-976b-2dc99689fad4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4cabe1a4-3edf-4217-a2a4-26adad0e6ea3">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/303a9524-830f-4bc0-a83e-062e609d0580"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/9335a340-21ca-4b48-901a-e8b97db9f6a1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/34c1615b-21bd-4b2b-ac89-e6626be21483"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c7ca8296-799c-451c-8100-663416c62a2e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7e4e3c55-0106-42d4-aad7-697eac9860e9"/>
    <rdfs:label>rifampin-pitavastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a2499dd6-a94a-409b-a20d-58b2e483fc80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/02203534-c061-4f93-ba5f-6c39f2cba5e8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/e591bf70-e542-4edf-a5b0-70cd06156867"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8ae65b55-b611-40d9-8162-faa76b686c2c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/ced5cf38-a9f6-4515-8b19-70bf1e977943"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d98a524e-9ea6-499b-93ea-5fc8f2cdc0e0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bbe8739c-ca20-4717-b7d4-a42ae4c3f423"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/fd175277-08f7-4df0-ba14-9eb9169078d8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/92259737-5220-4b93-8391-e7c1672e0ae4">
    <obo:OBI_0001937>1.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4b44d089-225e-40f0-8842-c14582e5f591">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/dbe8d42f-3297-479c-aae2-9861f99afb94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/24ffae3c-313e-4759-b79e-4107107b73a3">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/eccb8fa9-88c1-41f9-9ad2-0a261001c7a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7071a248-ff3c-45fe-887f-4f684721563c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/5dace64e-d8d7-4541-aeb7-fe1e0c80d748"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/6f40f1a0-7631-47e7-af0c-6a169f13965a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/db231ef3-d990-4a4a-9bc3-66a5c04cac1d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6f4f5f3f-6327-4576-b68d-df27059b0f86">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>Rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b4f07803-cafd-47fc-b534-5d6c6aee94ec">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7330540b-d18d-4dca-9cb2-0690018d46ec"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/f288a9d4-0885-4bc2-988a-51cb0caf4b47"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/01424c91-f51a-4cb4-8fef-32d4c1c2b3fb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/97f457b8-b218-4745-911c-b0c9916877c9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/34d428e3-33f4-4f76-adfd-89a6a8572ec7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/41222aec-60ad-4ac9-ab0d-ca65d13ca446">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d3b65a33-e558-4183-a205-2015389d20dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ac934016-78af-4ff9-8d2b-fc08d1215b93">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c1c0c760-c380-4e10-9070-919fa0e0e37b"/>
    <rdfs:label>rifampin-dabigatran drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/157f5f6e-9770-42c5-b076-a5c8138690ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d5c6901b-e3b7-426c-9f14-4b22d559ca7c">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/0d4784b2-e58a-4b91-934a-cef274c24577"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b553b729-a3c8-41e8-b24d-d9f866329df1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7657ab8a-d9a0-4e0f-974c-8bc84eb3e59c">
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8a66d889-d2c2-4806-819c-797af3eefb54">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2ba37d89-702f-4881-87ae-bf07f548c04b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/e1f83b50-8699-422b-bdc4-1fe11f6f944e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/7e975cdf-1905-46a4-af9e-f642c951de55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d3dd09c7-a842-4c02-bdb0-79f367aabb57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/45464d7f-debb-4933-9513-fac785c98a49">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/10c9d2fe-4fc8-4af6-8aa8-5e0fe224f883"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/c7b0f26d-e190-48ef-8dcb-418ed4fbfdbf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0456d159-3a7e-4c71-8888-c36d706ddf3a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/0493bdb2-8b3c-423d-929a-540fd6fd33b0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/b32b116e-5041-477a-a801-01af5023cfe3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e2b18583-8b09-4458-8c8a-177db92c210e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cc04d585-6f46-4def-bb4c-5848008e222b">
    <obo:OBI_0001937>36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/21b04ab7-09d5-418e-aac7-96bfb8501ab3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/76c1651f-26de-45c6-9e42-254c67d7a809">
    <obo:OBI_0001937>65</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7da78c9e-a6ca-4bcb-875f-fafbe7879daa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8c7a313d-5df8-4c6b-aefd-99700240dcad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/6af18487-103b-42e4-b005-1f5bb73c9a65">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/abb13e3d-60cf-4468-9031-c4fdf36d4aaf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d7b2bad1-1e8b-4a7a-99db-4f502a6ec891">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/79e34d33-3e29-4626-8e95-903907cbd5d6"/>
    <rdfs:label>duloxetine-warfarin drug package auc UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d40b62db-b10a-4465-b9cc-fcb37bb74b9c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/e61dadd3-86eb-4ca9-b77c-f54f76e51ec0">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a6cdbce9-ffd2-42c7-bced-95a9037d6d2a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/eaacbb6f-086c-4121-bf3a-a22e4dfa42e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/fbd4bb59-3716-42f5-9b3d-f5bb1f55d45b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3a743daf-16c2-4598-9a28-99ca0a16110c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/cbdfcb11-304d-434d-aa02-754a6f4455ee"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/14b9af17-d59b-409d-ad3e-b8567d18d480">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5ac1775b-8131-4645-825d-8a6708a79384">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f667835c-4e11-4ba3-87d6-9a71402d3b46"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b55ed1d9-b586-4b4d-b5e3-2b0160645d76">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/37d3762b-7dc6-4bbe-a1cd-e05469b2b620"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/68014db0-20df-496c-a763-5e5ec8e360ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f10324d3-0d0b-492f-9d17-14f79750fa68">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f6628ca1-1d51-4f85-b8ad-dd6875690ef0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fbb23c34-5fa5-4e1f-b9a1-a039bae39c6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/657672b6-0082-4ea9-92f8-16986deee6d3">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/21418ee9-611e-4abd-92ee-9477936f9ef3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/351f4e5a-8d0c-4515-a8b5-8dff7a30501b">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/77aedba8-6a09-4f45-bb0f-afc12a34ef4f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fea2b148-3068-4084-9a47-6c6f0a82fac4"/>
    <rdfs:label>paroxetine-risperidone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e88482e3-19bb-4189-9dda-c60236fe9bd2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/df5675fd-8481-4869-bda4-cbf773d08beb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d1980a80-5402-4604-aa68-8e4dfede5b4b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/f660b000-0b36-4304-a059-48fcbcb9d52f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0ed9085f-e25e-4cb3-8817-38683228634e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/09bfe692-778a-400c-a736-4a99b6779b3f">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/42958174-7fd8-4959-98e7-d5e7efc2657e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/58d333d8-1244-41a1-9a4b-9110617b4bce">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/7e5d9f03-9474-424e-8822-54b7a5751cb7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/57e5d818-1e0c-4596-81c0-3bd9598ec22e">
    <obo:OBI_0001937>1.18</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/2a879e35-6dfb-4476-a06a-4bbfcf1bc277">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ef652e75-89f6-4c72-81c4-85a3dbbf8c40">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/afd52010-b834-4f50-8aad-e70e63dd2a29"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/ddc9ec3c-1823-4e8d-8e5e-4987efe24287"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/caaf307b-604e-423b-a681-af3120331c2b">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/4fa60e77-6c53-4eaf-ae44-3e6121f773c3"/>
    <rdfs:label>digoxin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/96d32ebb-0920-489c-ac13-ee918602ec6f">
    <rdf:type rdf:resource="obo:RxNorm_683693"/>
    <rdfs:label>desvenlafaxine succinate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0105385c-8f8c-415a-b1d7-c94e43261169">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ab1a2295-3a2c-44cc-a489-76ae75b32112">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b32b116e-5041-477a-a801-01af5023cfe3">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/711dff74-6d1c-451f-ab74-62919365cb92"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5a2063df-48f5-4995-87e9-e175de263d8b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5361d6c5-f78e-4cf0-93b0-af8e24d41f67"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/408c6a31-b90a-4196-88e6-2d943f53341c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0674093c-d916-4d2e-bf0f-6d7e47800fc5">
    <obo:OBI_0001937>153</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/95372371-d4dc-46b6-a6d7-6f7084b2c4c0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/16641bfd-47d7-4c1d-ab70-12d10a756c59"/>
    <rdfs:label>ketoconazole-citalopram drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3bfacee3-f9dd-4c62-93a6-3088b56949d2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b2dafe1e-76a6-4d94-9ec7-0fb575fba754">
    <obo:OBI_0001937>15.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b2d20151-4110-421e-8ef2-487445a3cd35">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0ba7bb0a-98c0-43ce-9685-f7c3fade63d4"/>
    <rdfs:label>iloperidone-dextromethorphan drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/da54cbeb-c879-408c-8123-4db69b8b6aa2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/472185e6-59e7-4d64-bac9-3c82d35cd4a8">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/98297b6b-3e63-47da-acb1-0f292c64233e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/365710ce-3abe-4afe-b6ee-7199b8916e24"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/54cb1140-9038-4e7e-9188-0b265fe88e07">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a4e43709-06f2-4ae7-ac95-e2fa4bea4771"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7c1d3d2f-748f-4345-a513-a5e22ec6af3b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/53723908-a5a3-4b9c-9bd1-92f33d751a77"/>
    <rdfs:label>fluconazole-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d83f00a0-49d5-4bf2-9855-1f27e65919e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/698c8304-beb5-4a98-a7ba-6f334f788c9d">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/1edeb059-b3e1-490b-8db6-7734c0ca6117"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1a230555-73a2-4d7b-adce-6d8e7bfcd6fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8c16b112-e752-458c-9e28-039d3dd894fb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9c5abe9c-8534-449c-923d-8c4216f7c993"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/973e5d6e-0b86-4294-acb5-baebed794e35"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cc79bbbf-ccdb-4f95-ab9b-3f87de0575ce"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/cfa4f58d-b8aa-4cc9-85af-ed6c88ed8462"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c5a8a18c-2838-4b4c-b874-8320463f9075"/>
    <rdfs:label>nefazodone-triazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/99a3762e-b339-4c56-b78e-1efb93973df9">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/17cec174-08b5-4f99-8256-0fa28d550420"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4152e755-2de3-48bf-8905-31ee645e7bfa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d39446e3-0416-4cae-a7e8-af590cfa6db0">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/99a89f5c-b3db-44f2-a6ec-91a50a7eeaad"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d8fbf006-c513-4009-9d55-bd826555a1ef"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/f4004ce7-9c54-433f-9e4a-c3b4cf3d5a4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d951852c-d029-456b-9b41-3c709c27b4cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2b86866a-bba7-4193-bd8d-efea3044dcf6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/aa39ac01-37de-4519-b6ab-d1d657f4e180"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3990338b-9ec2-4c32-b92f-6638aee8da51"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/891973eb-c449-456d-b77c-5e634c54ffd4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/08d777c9-47e1-40ca-9628-92ff7bd33171"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/076d9980-ec24-4e6d-90f6-2e3b52edd188"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/958a5f37-3115-4b0f-8760-d397ff92d644"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6b0c5303-ba92-4fce-bc86-8bb06be82cca">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/c618d455-83d4-4504-8f7b-27f2c914ffbe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2db4b9b9-ee08-4ee0-97e8-0fc698bcb2b8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e3bf4399-72df-4a32-8059-c87b058849eb"/>
    <rdfs:label>mCPP-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1a9a3f25-997a-42c3-960e-5538b9569df8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/84eac68a-2d96-4912-95c0-9cf355f8fb71">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b88b2797-841e-4306-9762-e0f5d69f87cb"/>
    <rdfs:label>Nelfinavir-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0359e638-794b-45a0-b774-1c32fe4b3093"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/74d2fd6d-fce7-46a6-879d-ce962473173e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9ba29066-7939-4f1a-b16e-d1810883ed50">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/67b8e8b4-7b3e-4d96-a735-148187d1d03f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/a181fc4e-c63f-4f99-b1e7-d2784f027d6d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/abbb097f-ada8-489c-9056-bfbaddddcfef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/117c306f-ad05-4662-960d-529c70368e48">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/ea294457-f081-4e60-b10b-cc913f3edde9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/33f0357e-bed3-4f30-a606-40703f1a2620">
    <rdfs:label>high-dose ASA-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a6b74bc1-33c3-45a1-b55c-2aab4b7c7d5d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/35fb8294-5d47-4481-a240-f5522a517bee"/>
    <rdfs:label>mesoridazine-Fluvoxamine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a33fff60-6833-4607-9dee-490cb01d84a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f8b9877b-2cc7-45f0-bde0-a59896ba0b03">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7209f765-b121-46dc-9522-607177cb3338"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e368d78d-8d7b-4f95-8a34-d608085f0b6f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fe5f92bd-d642-4561-8440-1bfde143e1c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/97568829-802c-4717-a8da-a7111dc03efa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f0e29bc5-e393-415c-93d2-3d832cc0bbba"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e9e03845-8c93-4d04-bb07-72d6a0d3fe06"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/15c41fc1-2ccb-4ee7-a6e8-effa460f80b3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/91fe5427-16bf-48fd-91a2-1af21574ba5b"/>
    <rdfs:label>clopidogrel-fluvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4265d243-17e1-4607-b0d2-e60c28d62953">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a82dd3d2-f243-4ab5-840e-d69185a444f5">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/842fb6ae-653a-4e80-b9b8-7d2ebab84cc5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/787ecffc-9bbe-4b2a-a821-2cc406a144d6"/>
    <rdfs:label>ticagrelor-simvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1d3367a5-4efb-4c7e-bd96-131b49bcba34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b91858c7-5b21-4fda-b4f7-d21bcb513888">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/7fe4d60b-56b4-4592-8500-9d691891de1c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c394a05b-05f7-47d0-8aec-21701c447aef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/c23a9bc4-f037-4f2b-b5cd-14757d8193db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/929d183e-23d1-40af-9ab7-b40488375c0c">
    <rdf:type rdf:resource="obo:RxNorm_8331"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/4c6fb32b-6c83-4f56-a922-0dbd767b64a4"/>
    <rdfs:label>pimozide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/de7b757f-f9fd-4788-a0a8-4d994669f5b2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0ba7bb0a-98c0-43ce-9685-f7c3fade63d4"/>
    <rdfs:label>iloperidone-dextromethorphan drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c3644e51-d422-4de3-b096-4e13bb542a0e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/32283199-2d88-43ca-87ac-7238caf8f35b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cde7d363-bcca-4a3a-9c3a-9f94502c9958">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e718144e-8c57-482a-ade0-a47233deda87"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7a7c03a4-e3ae-4fdf-af9a-f44de8271663"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/51cf122b-874e-43ac-8dc6-298167e000be"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6185a606-ff3a-4e29-a52c-98b0b4ac6921"/>
    <rdfs:label>carbamazepine-selegiline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d46c9880-d1c2-4c72-a7a5-69c0aa0b2518">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/291afffe-6d16-4799-bad5-934cd94f824f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/4557b118-ec47-4dd3-8e8a-7d9c63f1c6bc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/202ff503-9574-4a68-99ff-fd6fb1e8f495">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/73107815-ea8b-4c6c-83e6-a490a712c49e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/1dba3948-f300-425d-b0f0-74a606c5527d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4c0482b9-fe1c-450e-824b-062f3c645e9d">
    <rdfs:label>Lovastatin-verapamil DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/23636ed6-0b8d-4447-bb1d-8e2d9a56d5ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/d0b6c183-a466-4b80-aae0-2125221eb92a">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/344ec73d-781b-44ba-8484-37f0e4f41e25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2ae51667-bb6c-4de3-9c20-89b1b27b3ded">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/384cb342-97ea-4c7e-addf-a2c044fd7385"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/5ab0ee8a-517d-42b7-97e6-c1df1cf13205"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/fb03eea0-090e-4e83-91fe-d78bb400ce98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/981b17e7-178a-49b1-ae2e-aaccebea0131">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/a8f52966-6d50-444a-a1ab-0be0cfecce97"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/2b20d7a3-3875-4772-be5c-0d7f9dbeacd7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8ad6eed1-2320-4ced-a0f9-04d729d2c2ad">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/8cf92603-402e-4364-a5fc-0878c167c99d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/52dad1b7-1537-40f8-a879-e40c156aa80b">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2283cfb9-441a-4672-b6b5-b7833c1a592b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/da275fc7-408b-44b4-a2da-b78925621783">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/babbfa46-21bb-4ca0-b984-f6128bae9060">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d144e4cd-6877-4419-83f1-f9c2e2b0ab2f">
    <obo:OBI_0001937>28.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c9a4beb4-c8fa-4f34-9db0-6a1a560d7da4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/da26e33b-aa87-41d0-a67a-1ec122d3bbbd"/>
    <rdfs:label>Cimetidine-Atorvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/040213a7-d4ce-4e63-978e-f3c61a0dacc0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7d91d527-f459-47b4-b07d-52203cdb568b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/02107953-d93d-4d69-8c31-f160bd032c13">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/156d519d-6b45-47cc-8bd5-d116997232a8"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/37a5e315-a83f-4d6b-b5e7-73f89845345f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/3c70a4a5-dd02-49c5-acd7-aab32eb2250d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ae451a72-7b19-4cf2-99ff-103daaaf0001">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/042e13da-94d5-466b-b625-e8019589f70f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/70550ca5-7f1c-4689-ae26-357150a63cc5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/629170ed-66dc-4519-9386-b86f7bea0309">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/bd916aba-f23f-426b-a93c-0473f68a782d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/4be2bceb-f420-4b08-aa6c-ca1f053e690b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/67d7ea1d-9501-4b62-b288-6cc6312094ba"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/387fa893-6e26-4c22-86bd-a0b4f6b5eb42"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/86f0ce75-5ce5-4ccd-acd1-a93c77564873">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/7acc6c1e-d166-4394-b820-98efdb743a49"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/899a87d1-67d4-459c-920a-d9247437eb32"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/07cbe6c1-23fa-422f-af2e-ef74c83e0b95"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c8b40202-2ba7-46fe-ac95-a01ad79826d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/07279f34-8c51-4c64-9bdc-80a3bc7a1fd4">
    <rdf:type rdf:resource="obo:RxNorm_61381"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/47f463f1-2f5d-41ec-b9a8-a588c5d192a6"/>
    <rdfs:label>olanzapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/679a2320-77f0-4761-b21b-ff76df1e6913">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/57521a2f-5a66-47de-b0f7-a294e87bc70b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3625bf4a-d42f-4355-9dae-785cdfdb4f5f"/>
    <rdfs:label>ciclosporin-alitretinoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/10b6b80c-ce90-434f-8134-5e71aa0f40ab">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/74f4a4e0-0118-4456-bbfe-4480e0bac32d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2aed9bb8-8cd1-471a-b1bc-5b1a5094ab5d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/efd6e117-3a13-431e-985e-5bbaa2c2c636"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ca13a743-2e29-440a-918c-2b584e9d59fe"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/263efd4b-eb2a-4c5a-abe5-a9a12769fa7b">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4a5831f3-a9c1-44ee-b25b-ab15a6445bb2">
    <obo:OBI_0001937>160</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/a4cb1836-4c9e-4626-b70e-604c1d52b8f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/94f11835-77dd-4a59-8e55-17761800b675">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c62a09fc-56c1-428b-8fde-d215d6366aa9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/617d5c7b-74a0-4f88-bb7e-48e2963a8879"/>
    <rdfs:label>cimetidine-citalopram drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1f6a45e2-30f7-4652-a8e5-ba8bd3a66019"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/35735507-dea3-4025-a9eb-749e11158a74">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/43a449c8-049b-403f-bf70-ca5ea0ff80f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/43a3267f-f038-41e6-bd2c-9a8948e36fec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b96c94f5-9f01-4122-a1fc-11425cfec2c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/47024f77-f692-4fc3-9a45-f5fa4f730229">
    <rdfs:label>ritonavir-erythrohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2c5ea276-a81e-46bd-a2e9-6647f4be790d">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
    <rdfs:label>iloperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/48ff1d1a-6ea8-4e3f-b640-f849a9b61cd5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0839a4a9-cd7c-4399-996c-9f9662b28435">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/dd31fe64-8f85-4a2e-8159-0096522c7800"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/4b304111-e7a4-41f9-b8fd-3e6d4c13f471"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b485979a-1bb0-4266-9a1c-17d5e4187535">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c7a094e5-7bf1-4422-b716-6b3cc9e9f5fc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/681fbcd7-ab25-4675-864f-8b4567ff125f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/34f10520-e117-4a74-9404-e78c7b931b51">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/df68e5fb-36cf-4ea8-a9e4-29a285b5b77b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/b9d24a97-4561-4ebb-895d-9901d0ed33d4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c17865f1-b208-4d7f-bd79-d8d826843849">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/19d03e70-8ced-44c2-8bea-6f7972cd3a54">
    <rdfs:label>carbamazepine-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/46c712a7-de61-4dad-b2f8-cea7b466afd8">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/f45a1498-73fa-4cd4-b409-1808fe27069a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2005b147-f588-4294-8db8-33d9814ccbbd">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c83b9671-4585-4d0f-9721-533d1884b032"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b478bec8-4f0e-4218-8db7-c9e14cab56d1">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/5a648d61-95ad-4e18-9854-25e0ec5d14c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9eec1a1b-3293-4241-ae89-8967546c0dcd">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/cbb8f058-b7ec-472e-9314-bbf50e7a3899"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4b8ab8f3-8e21-4587-a535-3dee8927e9cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c43f621a-bac6-4a38-9f47-1da001e592b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/75b05871-793a-4dd5-8add-2606d908d4a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/0c532fed-e625-49b0-a08c-d71933af1180">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3830b5de-f2c9-4443-ae73-8dc2182c7825">
    <rdf:type rdf:resource="obo:RxNorm_703"/>
    <rdfs:label>amiodarone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d7f93cbc-f325-4d10-acb8-548c31ade9c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ffaa4617-e9b1-4dab-879e-49c761cda802">
    <obo:OBI_0001937>103</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/94aa3964-b5df-4175-a459-8583ba7bb2d0">
    <obo:OBI_0001937>2 to 3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/5805f049-70f9-4be2-8030-270f5e76ce91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8e15a06e-a964-4841-8a19-4f0cd17069a6">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/6e656818-ae4e-4256-8cf4-eb4447154b90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/f747f5ac-1a4c-460f-acdc-5059b6941b4f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b5509f02-4821-4a74-8f91-a69d83a986cb">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2bdd40a6-e061-41a1-b4a9-656d3137f22d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/43fa180b-bc54-444b-b7bd-bc939a6018cb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/26d55180-e62e-4810-8a40-dac4faa8f8b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/31cf2b2b-bc12-4a10-9246-cffe32f238ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/114119db-f40e-4ca1-970e-28d9879a4a9a">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/ec7f6823-c77f-4a3e-8ffe-72f9548b3bf7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6d4fb606-8e58-400c-b698-e74b4715d8f6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/adff4cde-3535-49d2-9cfd-d655abd862de"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/d8c5b927-2445-463b-933b-d8186b4994c6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/15742939-b965-413c-b114-b363dff5270e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/99d085b2-1444-44be-9356-24d43e8e99a6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/ad3c0d25-cf1d-4fcd-9b2f-941b655314c9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4c7bc710-ec53-4d97-a1aa-e2cf14ad2e9e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c33e1658-4013-4c2a-896c-13fd93746f79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5acb61ad-c20b-4069-a396-bef5ec933b2f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/db63c14a-4024-4759-8dc6-ac60ad850059">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ab2a4075-cdda-4a9b-b15c-c3426067ba72">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/da19d135-996c-487f-a870-4ae5d6d8fefb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/265837e9-508e-4ec4-a4ef-8368a2ea729b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/37914da0-7398-4ec9-8037-d8110eab50d8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7680ecb3-4c2a-4ac7-a141-7c649d99bd03"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f806f041-17eb-45d1-89fd-95f764b74ea8"/>
    <rdfs:label>Ticagrelor-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ba143b3b-cfba-4003-9253-21ba983122fe">
    <obo:OBI_0001937>0.92</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/48d85242-8400-4041-a43b-24a65486c91c">
    <rdf:type rdf:resource="obo:RxNorm_6779"/>
    <rdfs:label>mesoridazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8c8dcbd1-6dc4-461b-81a8-f68c14a4d891">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5e9d3631-8b7e-4d3c-9d1f-4826ec019a63">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fce4b28f-da9c-44b5-8227-4478230dd422">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1f12f21a-91a8-4b48-8850-d015dd86a1c8">
    <rdfs:label>nefazodone-haloperidol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ab8cd829-f29e-4deb-a008-4640f845c5ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/cc265fab-208c-468b-a174-45ca11de36c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/57a58c1a-20d6-49ef-8a6a-1ff72ef36eca">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/310f102b-bf10-4537-a327-cf3d81427882"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0b86ab65-1917-4f7e-9632-c192e92a2190">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/dd9d7b4a-6889-4631-b925-8869c548265b"/>
    <rdfs:label>ticagrelor-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3dae5713-c9c6-4fa6-927d-71a53cd43086"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9f55fea1-b928-4111-94bf-7ef70bf38bab">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/abb820fd-b036-4eca-bddb-7d7c289e89f3"/>
    <rdfs:label>cimetidine-sertraline drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/581c3d33-2b0e-417d-987b-5d9b74dc9a03"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/16bc845f-d2a8-409f-b1e5-49d73eb6b05f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0c65a3e4-87a7-4a2c-a7ff-a0e102b97a94"/>
    <rdfs:label>ticlopidine-bupropion drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cf751db1-93ac-4895-b45d-b6bc02f9afbc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/2593966a-a17f-4874-b214-46ace585a1e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/41a923ed-2fad-446e-aa6d-60119ddb3435">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/f6f174ce-e36e-42fa-beee-c049acf03356">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/529bcfc9-3791-4581-8dbc-5963de29fc05"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/7e1c4642-4116-489f-8694-e97e17490c29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cd0839e0-f141-41bd-a4e3-b2e2e793615d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a56f9f90-d581-480b-9f3c-0cb8aa744832">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/b08375a5-37bd-439c-9931-8b90d4770f4d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/78e4c9d3-661b-424c-89b6-c5a8829a5f69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e0e91fa5-7038-47a7-adcb-f56f84645217">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a36087e8-2a7c-4a4e-93fe-f6a492dc30da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/00baf8d6-6fe3-43bf-9482-ba2b103119b5">
    <rdf:type rdf:resource="obo:RxNorm_352741"/>
    <rdfs:label>Lexapro</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e0c01287-56a8-40a5-aab6-773f08462d80">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/29f8ce49-c33b-4df4-a295-465e906d0c8b"/>
    <rdfs:label>bupropion-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0e03c5e9-b5cc-450b-b3bb-3bfa0bc5af29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c153536c-422c-4ea0-8c83-c2bea442281e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/22d7c04f-d1b2-4caa-9523-8c896db375e9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8df3b101-c6c4-4625-8d84-3e74d092860a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/79047103-3217-4bcc-84dc-86390d75f835"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a20e2be6-815d-41b2-a911-b80481704f5d">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/2deb7a35-5d4a-443c-9197-6c0fa6127db7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/4482e28b-3da1-42a3-a87c-239aa78a07af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b812e817-755d-46a7-9bd9-68139d7ed18e">
    <rdfs:label>Fluvoxamine-thioridazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/7b53fa43-f481-491f-b6dd-87a7c79f3f0b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5eb0e78c-e01e-4d00-835e-e251c1b1f4a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/5c8c8363-b9c3-4e41-861b-e927c4e6d8f1">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c133f023-69af-4418-8790-8ed4c331fde9"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/2334319d-9a70-4b56-8e28-49ed144ab3a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/cc80228b-b8c9-4777-86b8-6d87b565c793">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/f3ea7b60-2b37-435b-b5df-55d12a913c8a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ba96d8cd-7e13-43b1-a0b5-912e53cd3d9f">
    <rdfs:label>paroxetine-phenytoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b2c5527a-5b2c-47be-ab4b-2908b5a9d903">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/9ee31983-9043-445a-b1ae-86cd4099d3c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/c35db21b-208a-4802-9ad1-a53ab42b04bd">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/4fae846f-1431-4023-b9cf-b8f2100c3f1a"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/3e0a6bc8-ab01-4927-86ce-6dd1cc909e5d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c12eb2af-c377-4a2c-a0d1-5e065cb75d81">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/7ae381c1-9674-4706-a818-5c16f2a045b0">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ec1364e3-ef06-410c-ab91-c338a4df2564"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/4dbf5ee8-da89-4f2c-b256-bd6508dd2fe6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7962b702-509d-480b-a352-d3b1e126a5fe">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2084ca5e-f487-4abd-aeb0-67b405ed0ea4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/32cdf3ae-b83b-4045-acf6-001978c3f625">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/97c15031-e508-4eaa-8d29-902b347f35ab"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/5854ba6d-c6fe-4d34-b48b-b8b7d549fb99"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/3313b469-1267-4eb5-b0b7-349f6815316d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e64ce42a-46a3-47d6-9a0d-72c5a4639cb1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/06167574-a08b-49e4-83ad-8901886ed397">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/32da0293-6551-4c24-96fc-5d9be3d855f8"/>
    <rdfs:label>citalopram-ketoconazole drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/42eb8d22-2a06-4df7-a84c-3f1b8bdcc90c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/02d3a694-339e-46b8-87e4-bb04403e2b18">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/6847a043-2429-4903-8fff-21c11e4206c0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/564d2f02-a41b-4e23-9ae3-65f2b7a0a21c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/9c733e2c-6f73-4aee-b865-520b7aba0e46"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e6a1271d-f406-4c74-89eb-7c4ca6fff6dc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/16a80745-29d8-41c4-b793-6870a8dad90e"/>
    <rdfs:label>Fluoxetine-olanzapine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/511fe8d8-ba19-458b-a8ac-f748727a7ef6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ae58a3e3-0f61-4242-a04c-bda29ce8a02a">
    <rdf:type rdf:resource="obo:RxNorm_352393"/>
    <rdfs:label>ABILIFY</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/da59119b-b8f3-4686-8b19-babfde81b5e8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/5aeb63c6-5a54-48c5-92d1-77804dbd8130"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5f74e8c5-62e1-4841-8775-d11fad55dab1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/22d668cf-8cb4-40c6-af3b-f92878030327"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/18e585fa-18d5-4538-a7c8-074dec6e1356">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/8741fdae-91ba-451a-92d7-ffbf7cc149a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/35e150ea-bda8-4513-9cd4-768b68afed92">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/25fc9a78-82e9-48de-8260-318448862d65">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/77aedba8-6a09-4f45-bb0f-afc12a34ef4f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e9bf34b7-b149-4e91-8bb9-c4760d24ddfd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d673b308-917d-4693-a93c-83b823790ba0"/>
    <rdfs:label>paroxetine-risperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ccc047fd-d053-42ce-9d96-51bf039dd526">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/55009242-38ac-43d6-aedc-a301ff6bb24b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a2cbe4db-2c63-4c33-8379-71f7c3cd0b25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2014640d-6f45-4b33-a0a5-ddf87449415b">
    <obo:OBI_0001937>4.23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/37914da0-7398-4ec9-8037-d8110eab50d8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6c4201ec-d2a8-4453-b1fd-970aa247ae1e"/>
    <rdfs:label>Ticagrelor-atorvastatin drug package halflife  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/09ba62b8-ebb9-440e-bab9-7ff1472a92ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/06d41978-eb1e-46d7-9813-6f8146fda969">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/191cf435-4ea9-4d1d-8390-bb3eb36f8850"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/0ad3a12b-3815-47b2-8fd6-61cd473b926e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9280fcc0-e65b-4df1-94a8-d3358586f61a">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a61b6c0b-a6c3-4760-8d92-305f8ad8612e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fbf101fe-858e-4330-a7ed-fc054b7ec19e">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/2c482e39-273f-4247-b35a-e90be7b9bc15"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/4321db07-75ce-4a33-9110-079631879981">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b105eaad-f564-4ef8-9b89-9808e03207b2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/826d6ec6-5b3c-4e1f-b818-98599179e05e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2334319d-9a70-4b56-8e28-49ed144ab3a4">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/7912d25d-e9d4-4605-9eee-e4d719ee11ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8af7bf86-585b-43c6-8101-55d4a786cd9f">
    <obo:OBI_0001937>2.27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4f242242-7385-4a5c-abfa-8f4094556773">
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b95ca4dc-db3a-46d6-8501-3ac4c1576d2e">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/cf4ecb2b-8e73-4908-8bd2-a440c52ff946"/>
    <rdfs:label>digoxin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/cbe560d2-c988-4ff5-b04f-e7ecae84b804">
    <rdfs:label>clopidogrel-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5095c52c-0c15-4120-a73e-2e029ad805d4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b0d2fe27-4554-41cf-adb2-abe2e4eb44a8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5e15e152-54b9-4021-a284-10dff36d7086"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/3fe12c2f-0b4d-45a0-a2cf-0c1de1ffd99f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/91fe5427-16bf-48fd-91a2-1af21574ba5b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c4e7af8b-a329-4a69-9fdc-c9c8d228049a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/a2406ec3-74d9-4207-9668-f5617378bbd6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/52ba74a7-23eb-4de9-a1b9-20db8b47b712">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6c547164-349c-4ca7-ad04-161baa4c2999">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/43096a1c-7796-4104-8ac6-01e0b5946ce1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7ff0ba46-f18e-4ad8-ac71-fc837f00aebe">
    <obo:OBI_0001937>37.5-50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/5ec849c4-0c47-4858-ab1a-e7e2a1fd7247"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/8357199f-fab0-46be-bc6f-ed97224ee8f6">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/16cdfee2-1eef-4d27-9371-7e5869c90f14"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/09f9da0e-9ab2-4974-81cd-af510c7345e3">
    <rdfs:label>nefazodone-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/a7edb3d5-5aba-484c-8912-62f37a026773">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/798813e9-637e-43b9-ba30-49b9d977bb47"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/26934f5a-ff2b-46eb-a79c-e782413f98da">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/109c0623-b643-42a0-b65e-5d227a04b6fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2ef89d81-c840-4417-98a2-a2731055448a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e47d38c7-bb51-4d51-bb92-e8d8386c3b10">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/47e25d19-ac3a-4ac6-a1dc-e835d87b32d7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c629bed5-36ae-456c-8e03-21f605203121"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/7864e567-bb49-46c6-936e-65f3cfc189b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/974a79f5-8ce9-4de9-bb65-c9ca80954469">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9910e5c3-bf20-4557-9aec-f5e9fddf7558"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/43748790-cdce-4b22-9a91-c1e643660373">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e0c01287-56a8-40a5-aab6-773f08462d80"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/95645cbe-744d-48b6-b255-23b419b01e9e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/04cc938f-63e1-4018-be01-747c6c4cc617"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a37fb4ac-3a5e-4936-a43d-85e0c519d8ab"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e4357a79-28bc-40c9-aecd-28197bcdadd7"/>
    <rdfs:label>bupropion-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0df830cb-e498-4a3d-8225-dc4f593ee73a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/e576ae50-6158-4090-a3c9-3580c8d3f3f4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/76388de8-46c5-423e-b908-c1ea115027b3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/7b6826e7-8509-4ace-8eda-c77eaafbabca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7dc4642d-324f-4406-8b93-3f17dc098242">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/4185ad70-2c03-4598-a166-e3006562ff23">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/37429b17-c4ec-4e44-ac9c-498dae68095e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dfc74994-e3c6-420c-a01a-69789a8be87c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/07221774-c46e-40fc-a667-d7887c966af2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2ccc8c9d-aba2-454d-bc85-04aab3e82dbf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/2c22c802-42a3-4aa1-af8b-ed9711595d2f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/1fc987ea-8c69-4c52-b788-85e0a6cc2cf4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/59b7e95b-722a-4fb0-887e-88aeab262922">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/e4ae2d3d-e65c-456f-b76d-482f5b6c893c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/1a49fa0f-5b47-482d-b56a-bc1df3d529d5"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/46a38f6f-056f-4748-8afe-a92d573ecaa6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ecb747db-f541-414e-b1f8-7eed874ba72e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d3a5fbd9-7e6c-40f4-8108-5b2c8550b86b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e9b90be7-abcc-4fbf-8c78-c2d4ce4109e9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7d96f3a4-6987-47c5-875d-34df2929262e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f52a692e-196a-4eb0-955e-6608afb7738b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/452c6c4a-6537-4efc-84e6-738f3cd8556c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3a66734f-fc5a-4ea9-9b83-6c42e583f567">
    <rdfs:label>citalopram-ketoconazole DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/74d8edf9-dcfa-4ee0-9111-22e67aef7ad2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/657364bc-1293-4136-b35f-c2c1119add88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6b0e0d15-74a3-421b-a706-f81d5dbbb688">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d4b2293e-aa4b-4746-a1ad-95865568a86d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/2f8e6848-9faa-43ec-b712-07d92b1b6c31"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bf66fd7f-112a-4d18-b1ef-d837dfacf4ce">
    <obo:OBI_0001937>1.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2fd5e27e-9951-4949-8534-8f18ccb471e9">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/d945a0fe-d0e3-4f62-828f-c4d12003377e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/96e50ae0-9cb7-4e30-b984-2adf60f76c8b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/36bbdde9-bcba-46cf-81c5-f531f9bde193"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4b9ca595-753a-4412-adec-0fbf422c2cde">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8eb3f4f0-002f-438a-ae8d-0bce720f09d5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/15f56680-225a-4b8a-be6f-e4e78bb8d1dd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/537f2887-f71a-42df-85e0-ceef28a81389"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/449df209-3be9-4f32-89b0-5dbbd7b69bcd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e4bc2ba4-a1c0-4f98-9669-924a0f4babdd"/>
    <rdfs:label>midazolam-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/819ce0fe-bdbc-4a86-8913-84fb459eea8f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/cefef994-298e-4394-9532-bdf0d3e32cf0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8abac66b-c4bd-4270-a8e4-c527f7f3d3f3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/fa5be84e-efaa-48bf-851a-e4facf4be73e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/66df7561-8cff-4f0c-96c0-3d9f45dff586">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/616b5918-444e-456a-b092-aa814c56cad4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6f39ca7d-c9f9-4e45-8f91-09a0848d9f71"/>
    <rdfs:label>desipramine-HO-NEF drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4268270a-3c2f-4bf2-9d7b-ceec50b5e298"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/13508f36-0ba0-4c33-aedb-bc912c4a71e0">
    <obo:OBI_0001937>31</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a443a639-c392-4bc5-a841-69bdc8bd1d10">
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/4e7a3ba0-4a66-45cd-a385-9753430e4b97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bb60293f-e750-45dd-ba2c-8317bffd6b3b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4fbec673-4357-44cf-b51a-6f3f9ad032cd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/14b9af17-d59b-409d-ad3e-b8567d18d480"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f05121f9-6009-446a-a9c3-9210815af0c6">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/0d81bc54-4139-4cea-8bb3-605b66e6dc55"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/9e120a06-a981-48dd-a673-7102b4abab72"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/0057438f-c8b8-4919-8aa9-d2adeda38a7b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/6fc94869-ba3d-491b-8a8d-7da553454268">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/239f133d-b07b-4472-ae83-53dbb0a9a545">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c81baac6-a3d0-46fe-b4a2-f7dc2d66dc90">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/cf18f56b-c30b-41c4-b952-df3725a8319f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/4eba9ac3-9f98-43b7-83c3-641c9960c053"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/5a1dc7fe-66b4-4d94-9ea5-746f6ac67d60">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/298dc36a-ac79-4b1a-88f0-f2e675da1f39"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/1c26b3b2-5fad-4375-8223-573a5d62cadd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/6e9e4b6b-b6dd-4b7c-8071-28528da12ca0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/67983452-dddb-4136-90b7-9c65e99503c2">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/548cbe02-4de7-4777-a2e5-c937554181b4">
    <rdf:type rdf:resource="obo:RxNorm_40254"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/e15e4e15-5695-4794-b63c-ccb2bd53221b"/>
    <rdfs:label>valproate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d9cdc57e-4ea6-4a87-85a2-4637e45b6858">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9e0e562e-a99e-4a42-970e-c88181b5cc43"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e16a4fed-eb5a-410b-9128-0d45f318584a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8936f8de-52df-4465-9fb9-3e8ab010b422">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/813a1cd5-a944-4d0a-bf2d-276b51c2bd11"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/5cae03b4-f0a7-4ef3-bf2c-d2895e9e3137"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6da0f9de-b3cc-4944-aba6-de9a8f748617">
    <obo:OBI_0001937>7.5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/4ebf7807-7890-4f31-8abb-b1b7147a0cf8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/266b4e5f-cc05-49d4-acb0-ddee2fadbf9f">
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/27fe1d55-6d48-4eed-b528-f4657b3b8682">
    <obo:OBI_0001937>up to 1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/0f5586fc-8aed-49a6-a58b-c8ba914e6884"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2a36ac53-3f5e-4a77-b060-80bcf723be0f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/39e30541-207b-40dd-a105-bf6c48fe4117"/>
    <rdfs:label>telaprevir-amlodipine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/149811a0-ead8-477d-80fa-f3e7d1ce5478"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/461ababc-a372-4860-a8b5-2170942b6e17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6201f164-913a-40d9-9df3-24f870af8221">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/8be36338-96da-4352-9cfb-7fd1ebc84f05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0aac6d77-313a-415b-b08a-8bac6b25f2bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f3bfe85c-5031-469f-a0f9-8249b77d2a5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/98975724-2374-4cdc-8ede-01f0d43419e4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bda76542-df8a-40f3-9ed6-f10ccf3e6ee4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/48ff1d1a-6ea8-4e3f-b640-f849a9b61cd5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/16ad9fc2-7bb6-421a-bc65-f66c7c59a8c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cab19d37-b268-4147-b4e9-1d1a0ca18edf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6d2e7aca-4b98-4163-8f01-da8c9070fb98">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/77e13b87-5973-4ec7-a631-1650886fd010"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/b7436fac-a58b-4d61-a48d-bd8fd073d536">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b0a55ce7-9225-4f9e-b0ea-ccb5d47bd962"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c187f89c-7f29-48de-9e08-e82f634e701e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f8acbf23-3fb8-419f-b9f4-5cdbd15e85dc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/df758007-1616-405e-84ee-2185fea4cf20"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/662ab7ea-fba5-4b6e-8cfc-7d7164227311">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4dbc5abe-4cbd-4118-bea9-1130d41bc00b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/60d8dabf-2d12-4476-939b-3a6d995fb9a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/40bbb41b-6cba-4cae-8502-343959cd34b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/66614504-f480-4e5a-b062-69b7bfc200f6">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/88e7ae72-328f-4e6b-993e-59491c3bad70"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/c09749c6-fa50-4923-bd9c-28ffbac34b05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c0b70277-d488-4053-9cc4-828164d54f1a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/787ecffc-9bbe-4b2a-a821-2cc406a144d6"/>
    <rdfs:label>ticagrelor-simvastatin drug package halflife  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/6241e31c-9557-4114-8c64-f8f2bf42217c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0ac0081c-0d52-4285-a58e-1bd4434ccd86">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/708028d2-bbcd-4f27-addc-91660471f2ac"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ddc6b33a-1034-42a7-8886-6db208aea1af">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/28b0649e-3771-4a45-899e-77bd5539c0a2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/fd79c17c-f063-4bec-bd3e-4dd783869852"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/6a14bdf2-04d2-4a5a-85b0-834b1096c846"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1b6fd323-5c5f-45e1-ac63-cafcf68719de">
    <obo:OBI_0001937>57</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b553b729-a3c8-41e8-b24d-d9f866329df1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d0bc7443-e71f-45cc-b1e4-032ca2666e84">
    <obo:OBI_0001937>31</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/a902c170-0cb5-4870-81ed-d26f0d2e5f5e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/0c72bd1e-3c18-4746-8ae3-12302c58d345"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/24b0fc13-6704-47cd-a2ce-9d283c97809a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ac561c89-8d29-49e9-ade1-e2c883147548"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/d0087c6d-4f16-4278-914a-66ae09e75b9a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0118d59a-3bb4-4c6e-9416-d5036939157d">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/44551efa-9262-4325-a058-16be39c4c233"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9a4b8332-0c22-4502-8695-5a38df6ebb46"/>
    <rdfs:label>Lovastatin-verapamil interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d9f82bed-33bb-4e48-86bb-a016e287d270">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d217418b-e285-4a40-9971-4841cba2cb3a"/>
    <rdfs:label>fluvoxamine-duloxetine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/53c1bc80-e919-42aa-8903-273be038a264"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b0a55ce7-9225-4f9e-b0ea-ccb5d47bd962">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ccae0bc0-3bb1-4cf0-93c3-ae8943e6be7c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2ae51667-bb6c-4de3-9c20-89b1b27b3ded"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3c6b76f7-2107-4d61-bc7f-ec08eb2d2117"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6185a606-ff3a-4e29-a52c-98b0b4ac6921">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/35711a84-110a-472f-9a8b-359e74b00157"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/abc6b6c6-f88f-4bbe-b778-99287e99edc2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/7fada32f-9a1e-4b19-82ff-f2eda8295e34">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7b489cbb-2a78-4c66-8aaa-9de464a42938"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/af247b77-b73b-427f-af54-ecb662a81757">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/cf031cb4-27d3-43ac-a96b-8770ff98edc1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3c43a6f7-9aa1-4a19-a2b9-1f17f567a856"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/27d80099-9858-425e-9f31-f3a017d37ac8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8310a5b2-d825-4eee-bad2-a2bc186a6c40">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/8bbacc7b-9a0d-4923-9331-b93cc37f2be0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/af8d64a1-c27c-467a-96bd-2f08e458923f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/02f98ef7-9f50-4bac-99a6-479fac62454e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2ef91e09-2bd5-4a6b-a8ba-586462aca9e9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/81b6431f-5ce5-4ba0-b58d-188a2086d9c8"/>
    <rdfs:label>Nelfinavir-simvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/59ca36c6-c912-4186-865a-239a549c8be6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cd9f7fca-967d-4704-932b-83f2870490fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/d499954e-009f-44eb-b85d-5a6bf68ef88a">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/052e13ae-eed5-4fed-a95d-dbeccfe64648"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/92894203-0ff4-48e0-a668-683481fa5f98">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/ca163884-8ea7-493d-b1fc-6822cf7c94a3">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/1dba3948-f300-425d-b0f0-74a606c5527d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4cd9d6cb-6d09-4934-ba74-93d12504124d">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/76d08407-0268-4409-a03a-b5a6b05bd422"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/276e1989-deca-4b02-bd54-4ba4f29a516c">
    <obo:OBI_0001937>1.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/bd7cd005-2460-457a-aef9-4566b3b5c6b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/40f85f5f-6730-4451-8bc7-951e8ae40ec5">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/d453b7b1-fa22-4f01-962a-4634fd98d313"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/99a89f5c-b3db-44f2-a6ec-91a50a7eeaad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d5b4831a-6502-4489-b205-6f9c9f4de1f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4dbf5ee8-da89-4f2c-b256-bd6508dd2fe6">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/577fbd36-7f53-4fae-a273-cee15bfd8f1b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/18cba3cf-cc96-4e53-919f-4022d8ef8a44">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a885f0cc-8084-4e83-a6a6-d66b6c7a9e7e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f023cc54-9607-45a8-97d7-1f97f59564be"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/4f3828f6-d75f-4061-bee8-093dedf11118"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/db2d3ec8-38ed-4fa7-83c1-3baca647851a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/8f525e56-4206-4263-a665-cf0d0989e767">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/cb35659c-55f0-41c6-8509-69bdb5feac6f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f4ef780f-07a0-4674-a5e9-b4462345c3e5">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/81923509-4500-40b9-be29-e1cd71ad971e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/15385147-22e1-4bc3-973f-d25090691ea7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c41b9fb7-c651-4566-bd02-493590245bf0">
    <rdfs:label>nefazodone-buspirone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/86f2297d-d81d-4fac-81fb-9502187e438f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/dff053b3-b1ea-46a6-98d4-07d288393506">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/522bed55-56d0-47c9-82bb-88b7aaf121e7">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/c3953c13-a2f6-413b-8393-279f908ed777"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ec140947-152f-453b-8f51-6b80b5157a79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2fc675db-a765-42ea-98c4-a5ef6918d992">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/e79b69a3-a3c2-4e3d-82a7-1ab368f28341">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/e82d7c19-119d-49a0-8eed-85b53ded226e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/828a8548-a1e6-4fab-b22e-d44aee67d62c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/23551626-07c0-4bdf-bf41-89aeefcaa672"/>
    <rdfs:label>fluoxetine-iloperidone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/94aa3964-b5df-4175-a459-8583ba7bb2d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ac642ea0-2ef1-4908-8192-2a4912e3665b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/301d6547-d5b7-4f47-9ba3-4e7c375c6395">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/ade8ee73-1ed9-4351-97e6-a44b4dc0507d"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b798dcd0-aaf6-4d3a-afcc-025c77f242d3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/adb80a4a-d257-469e-b937-835c95ea61f2"/>
    <rdfs:label>fluvoxamine-tacrine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/562a5a77-e22e-40d2-ba74-174c15e62b62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/86a921f8-7a63-4167-8bf6-81c9188ff2ed">
    <rdfs:label>sertraline-diazepam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/23aea571-1ded-49b8-94b6-6ade0153c262">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/493f8cb1-e971-4833-8d70-6560c33d2941"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/25a2e9ea-72b6-4ecf-8813-30e2c7f00183"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9a1fc3ff-7da7-4294-8a86-21fcab56b9b4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5610c7fc-12cd-45a5-aa70-2ffc91a09024"/>
    <rdfs:label>Cyclosporine-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/900a34ef-5edc-4be9-b0f0-d174bedff34b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b4a756ad-f9e2-445a-85b3-3a2096c29cfd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/74c8332b-b008-4601-92f8-834ba64109d1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/1f549da1-0b14-4b91-b2e7-3330c9410241"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9f9fb71b-fa02-461d-9e26-b3b5e7cb1be8">
    <rdfs:label>midazolam-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/1c171ef0-4807-427b-9d97-1f1220cca346">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f8da27fa-1ac4-4226-a8a2-d66e01a148dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2943f042-aa8d-49d6-ae8d-968fa453ea55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7cb6bef7-5563-41b4-ab30-83906d15c0cd">
    <rdf:type rdf:resource="obo:RxNorm_4450"/>
    <rdfs:label>fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ac8547d3-ebbb-45d1-8d4d-9737ad83b4c5">
    <rdf:type rdf:resource="obo:RxNorm_3289"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/8877c71f-3125-4b1d-a6f1-d3eaab586a4e"/>
    <rdfs:label>dextromethorphan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f1192df4-04a7-45b9-a020-8884b6ab6b03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/401473c3-e0e3-4ef2-899e-e4b50846e69a">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/4bbb14b3-f0c5-474c-b4b9-326c237e3b31"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e4bc2ba4-a1c0-4f98-9669-924a0f4babdd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/21032974-6bdc-488a-89dd-400bf7810f9c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/ae7a1382-73ce-4101-8bf2-8b1fa68d6719"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c2fe8a57-47a2-4968-86df-345560e7faf4">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b69b0668-3543-400f-8440-26eefdcbf716"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9b460c73-df93-4fb0-8042-f33a2694c4e8"/>
    <rdfs:label>Gemfibrozil-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/a95a6dde-e193-4fe8-bb06-330469066317">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/de0dad14-f2d6-4a04-90bc-735432bcd6cd">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a12f0f12-ba23-4aab-9cb0-143422d01c6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5daef3bd-f1f6-4262-9b2f-84092e200d75">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/86ddc510-370d-4140-aa5f-81355d6b2ece"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/bea75444-f882-4f77-9b9e-77badc917069"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7a475b66-97ca-497b-b943-00405fb85532">
    <rdf:type rdf:resource="obo:RxNorm_3008"/>
    <rdfs:label>Cyclosporine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/69decde2-6d23-4666-9e52-907d88d20cd1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4cfd91de-7583-495f-8e42-c51664b39a91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/68821892-c796-4b35-a14f-66450871c2be">
    <obo:OBI_0001937>2.66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8a15e6e9-c45b-4f22-884e-ee11bbdbd42e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d0862589-fbcf-4821-b072-d823aed77f57"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8adb3e43-e997-40e3-b7e3-5f4bf8fb189d">
    <rdf:type rdf:resource="obo:RxNorm_195085"/>
    <rdfs:label>efavirenz</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a8074b5b-3be8-4f63-9b1d-9c8978c4132f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fd14a1aa-f913-46fc-8025-b8d54c38323e">
    <obo:OBI_0001937>58</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3600d68c-2d14-423a-a37a-e2357074044b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/41dc76b0-d7dd-4910-8d14-1c4ec47a0d11"/>
    <rdfs:label>Efavirenz-Atorvastatin drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/26cb53ed-76b3-4228-a217-64bf8460aa01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7c81670e-6075-4fd5-b8da-d72ab8f25532">
    <obo:OBI_0001937>95</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8c1bf3d1-20f5-4285-a5e4-48d935edd346">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/3515aa21-c23a-43bd-9328-8d85a9285dde">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/a7475178-6056-4dc5-bcee-783271d51030"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/bcd228e7-1a14-4d52-b0cf-fca046e7bcc7">
    <rdfs:label>paroxetine-iloperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2e0eb92d-b9bf-472a-bc93-28d90e8f3b86">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/8fbd57b1-99ea-430a-9281-4eccdb885c29"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/be5e0f28-8379-493d-afd9-661db19a6b51"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/8ff9892b-2ca6-44ba-a958-ab39e4046a87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/36541b58-d349-4199-a888-d758481d0a00">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/8f712374-8d45-4958-8bdf-027c4c2ff410"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4414a9bb-8b73-4512-827b-58bc2ae83dcf">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/98ab9fc0-646c-4ce6-bcc8-5a0c1a6097c6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/a072369d-cbc5-4e17-bef1-936288ffee0e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/dedfac88-ce57-4e81-ab28-ecbe9d90ac34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/8823f4e3-2109-48b2-9beb-6272b70bb108">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/4344d219-577b-4918-bd16-82a821aac11b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/61964558-267f-45fd-8919-b756ecaed52c">
    <rdfs:label>paroxetine-P95 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e1a6bab6-c545-455f-a245-e3f0380f10b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/719c56ed-9a35-4958-a04c-78a0b7aa2c93">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/4dc20e3f-08e6-45ae-93fb-fb9f0e673418"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/c9ff7448-6dde-45c9-8e71-168a09450091"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d7026c05-acee-4721-a6a7-103c7ec19edf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e2614381-1565-46a8-8884-428d942be2df">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ba87e8db-854a-4334-bade-05b42ca6d706"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/7d8ac2c7-2b57-4493-b62e-94fe19111868"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/e8865a2e-ef6f-419d-be47-d4c30a1ca32d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b0ec26b1-805e-401b-aa99-41380228c9e2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/895920f9-eb6d-48fc-8f2c-3de8fa53b34f"/>
    <rdfs:label>rifampin-zaleplon drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5f862b8c-a8df-4509-9016-d16a314e1c3b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/572be5c0-6c7c-4a99-9cbd-3a94a80a003a">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/fee55c76-17ea-45aa-b95f-65ea64b29ef5">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/db22d823-9ba6-4940-a61f-2b1e317f3a46"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/4b7b108f-355d-4d74-9f56-7ac33a2e3164"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/ae58a3e3-0f61-4242-a04c-bda29ce8a02a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/190df6d8-fc6f-4111-98bc-ca8df5416a3d">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/78e4c9d3-661b-424c-89b6-c5a8829a5f69"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b5ffd9f0-bb3e-4f65-8fe8-f99bcdf95837">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/042e13da-94d5-466b-b625-e8019589f70f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f4fbc3b5-07cb-4d1b-aae8-e84955e28994"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/7e8bd0f4-604b-4d11-b775-7e35eec3cb5c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/219c21ad-8e3c-4609-a470-084df95d5c43"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0a4e1212-9d4b-497b-8d88-d8bf9e0cae04">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5b121a57-0683-4ab7-a0fd-bfed2bf1322c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b34a4a95-3c8a-414d-a2f3-549b5a227793"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9e05a73d-2e50-4cc4-9baa-fd65f7935208"/>
    <rdfs:label>duloxetine-theophylline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/99c27f7b-f381-4c93-993d-7fed9eb89890">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/fe6cb57a-3920-4b94-a01b-2013065542f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/1e2b560e-3eaf-4218-838a-e4fa92f39901">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8622a464-5187-4636-9934-383cf6f277e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1285c481-f16e-4b49-ad7a-1079faf54b0b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8b111c59-39d4-4158-8296-0a974e9e91e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/16459a2c-40f9-431d-ad08-e3efd46680e5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cb6033ac-9055-412a-b623-1940e3c4e28e"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cd79e1c2-bfb6-4165-a46c-7eaedb686722"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/ae1d2960-6fe2-49aa-a3af-237e548cf549">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/0d81bc54-4139-4cea-8bb3-605b66e6dc55"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7cc7000b-55d4-4ae9-879c-f7827eb69ce1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d59ecc0f-8946-451d-a712-602e1b705258">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c5aa76a5-3ac8-459a-bd7b-23038d221e79">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/268da38c-16d4-4185-9d9a-7af748770228"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/142c172f-31c1-4475-b6af-74ed8f0a28ed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f4cfbf39-4bb4-4f27-9aee-fad1de00b8a4"/>
    <rdfs:label>paroxetine-iloperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4e7495ec-804b-45ec-9f30-673772862d3a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c8588781-a828-4b3c-a866-39d552f2a925">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/1a49fa0f-5b47-482d-b56a-bc1df3d529d5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/16df100c-a648-4fb4-9a7d-3563c49f8639"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/17140432-7c57-49bb-b5cc-b36d824546ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b2cf0ab3-fef7-4acb-934c-9292ae951c0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bf6cfc7f-e38a-49d8-b871-97d9070401fb">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1dd15bed-fe22-40ec-8ef7-d03e7801af1a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/13d31732-c38c-4458-bb52-02266254854a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a9bfcd6e-f7d4-4b58-8146-9be4ebedae47"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/1617591a-46ae-42fa-b77e-573693978479"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/64811d72-be2f-49ba-b481-951471ba6616">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4634d0db-1058-46f9-8830-3cc9aec4d3a5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ae011b91-6b5b-4a7b-9acf-6cd38f36c016"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3aa44e2c-a8f9-424c-9190-bdce8a5ca3a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d4c5e1e3-fdb5-40cd-a6c0-34b5e8897dc7">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7dd4b7ed-da2c-489b-8791-ad94ac46a037"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/26222652-365c-4ecb-96d8-273861d9f4b2">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/fbcd86f4-dc2c-4281-89fc-452209ff5e65"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9e120a06-a981-48dd-a673-7102b4abab72">
    <rdf:type rdf:resource="obo:RxNorm_6816"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/5da7e0ed-2d59-4860-9c78-575ce559f8ae"/>
    <rdfs:label>methamphetamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d48050c9-c0b7-48bd-91ba-d63d1b425931">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fb8f23c6-2061-4a11-a33b-fa63f0e2ddab"/>
    <rdfs:label>Nelfinavir-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b72585be-6100-4fe5-a65a-0d16c17b69ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c54d91e2-ed81-400a-a525-bdc8d80c24bc">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/6d6e358a-1b7f-421c-95c8-e6305cf31a1f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5ad5a3d7-2ebd-4649-b198-2f375576f3d0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/1c3755bd-5abf-46ab-813e-2955e75f0039"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/121848bb-7017-41d6-8340-0be9e49aa98f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/321489bf-3714-488e-8fb5-2404b0c0627f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/5e399782-c1c3-44f9-94d9-5a6cd7c86f8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2e36a2d6-eb1d-4c32-8505-44729acdc747">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b44de1e8-715c-4c06-9861-fffa915076a9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2e0eb92d-b9bf-472a-bc93-28d90e8f3b86"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/9c8e3e88-b179-41e8-9f4f-67434fb78666"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7acc6c1e-d166-4394-b820-98efdb743a49">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6bc78b47-81cd-4be8-8fde-5f8b6fef3767">
    <obo:OBI_0001937>149</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8cc287da-45a9-4dc2-b374-b25c72a30af4">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/e1b9e512-f65f-455e-88e2-7a2ed481a4a7">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/3b4389ad-bf24-4b35-a2e2-71dac009735b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/985be040-3e2e-41d9-aa1f-8f572dc0bbba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/76da3030-e284-4c89-94a3-71da00b6e264">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/6d60cc6d-49ec-4fdc-8318-e1545670fb41"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/5cc076cc-6eb3-4c72-9eb0-19e0b87cd08e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c9f78b3f-98fa-46c7-a828-9547805935de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/6f5c52a7-9dbd-40d7-bbf9-91ddd9ba7dfd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6a3933ab-47c9-4897-aa1c-5df8e5ceb496">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/547442b3-ef75-4d0f-998a-251781ede046"/>
    <rdfs:label>sertraline-cisapride drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a0280e44-b7ff-4338-a725-08a2200bf1bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f8acfb11-63aa-4b6d-a581-0713c5eb60ba">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a04abc61-ed65-4353-a414-ae85276a2056">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/46e42764-109f-4cd2-86ed-c45cbacfdff4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0d29e46f-a416-466a-87bf-0b28ec36c7b1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/67f6003e-0d0d-4291-89d7-b749d5512292"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/5db1d799-40f1-4311-ae90-b10a4d94ab68"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/fb441f11-30dc-490a-a87b-5c33a73f39dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/66628f1d-ac8a-425f-a915-c3bd3811bc0b">
    <obo:OBI_0001937>5.2mg/kg/day</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b5619af1-e5fb-4704-af51-3ee6042e8799"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/10c9d2fe-4fc8-4af6-8aa8-5e0fe224f883">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/40dcbb12-ee4f-4ac0-8c17-e1ba7b502f5c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/b80ec41b-fcb1-43ea-a78c-07b3f8da7e8f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/3aa44e2c-a8f9-424c-9190-bdce8a5ca3a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f69bc4ea-f638-44d1-b539-e5b6c758c20f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/14cb27af-bbc6-42af-8aab-7b78d19e12b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/487c0e3f-2bca-4b1c-b5b1-256eae176125">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e92b34c1-ded4-4add-8ca1-6a6e5bebeb93">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6711911a-6b45-43ff-b343-3b2904398413">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/fcde91e2-6909-4a12-aa19-1014c74f220d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/aa1acf8d-d2ae-4041-8f0e-57f4c3abf067"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ab4d84c2-f122-4ce3-9005-ebab480ce235">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/ce51a764-4ca7-4669-b9c8-b54c19581023"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/20cbce40-4f26-41a2-bf26-062be7ff4d7d">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0fd8e5a5-19c9-47bc-a162-cca94fe72e67"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/40334b1a-7479-4c02-8a56-0068278314b4">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/8260d7ea-f7e1-416d-9661-eda663726642">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/64ecd84b-bb62-4459-a2aa-1ff5de6260b8"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e1077bbf-6f16-4605-b2d1-3e476728020e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/91581307-98a4-4a64-bfd3-26fd30301af9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7dca8973-7d6e-4308-a2c5-35d5eefaef3b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5d0937a0-92a6-4826-b311-826d60bdb44e"/>
    <rdfs:label>warfarin-ambrisentan drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/adf33749-2a12-4411-ac4d-c3ce9cc0a66f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/60c6f103-065c-4e0c-8396-56f45f78987c">
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6a36d1d0-0708-4b84-b501-07c9d6de038c">
    <rdfs:label>aspirin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/653cc16f-3dc4-4f42-8826-f5e8e2b9b1d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/556a4d14-5e21-44b9-bf14-b7b1feb4f525">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/fe0919fc-b678-4196-9a79-83bbc6ea3081"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/e35ef57f-2bae-43bf-9086-6a90940bac6b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a742060e-6c10-4fc2-a383-a80931b380bd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/1b6b3daa-1288-4445-9c4e-1e21ef72e4f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/73328129-ec6d-454b-b1bd-55c1e4fb1d3a">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/b191fd3e-c175-4167-8eb7-8a77a46ef198"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b9cd7a23-170c-4aa0-8f45-3d3b9abf3dee">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/10e605de-f666-469d-be1e-ab068d4e409f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d9932e33-255f-4373-aab3-3cd40771f0a3">
    <rdfs:label>fenofibrate-pravastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c449b739-921b-47bc-9f7c-b60c078ac3c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dcd0641b-0a91-4bba-9ff9-61d6f893fbf6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/632a09e2-5c16-4d86-a55b-ad5133c226a4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7a562513-da60-4f8f-b9a7-f18e0d8acd70"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ac6a0697-7cfb-4be0-b5b3-686d52d4ef27"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4919a47a-1653-48c4-9bed-ee90ddad29a8"/>
    <rdfs:label>Fosamprenavir-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/582ac135-5190-49bf-8b7c-2607accf3353">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/21f6c5ba-97d7-4973-b0e8-cde9356bb9a3"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/8bbad936-3e00-4e9c-94ae-e20659e84e4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/40715ed1-4875-4661-ba1b-9843999db021">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a5e1b25a-39cd-486a-a3b8-c1a5829cecad">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/81fd1190-d27d-4499-b442-a1b9cfd37c5a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/51800fc6-1785-436a-b762-280654b73c28"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/eb1402b3-abee-40c4-94e6-3b6ad6854a25">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f8bf11f1-0f5b-4548-9a38-820d2049f6c9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/45bd3a6e-06f3-423a-bb32-284caa4704ef"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bc6b6ae2-0786-4094-98dd-3de372c6d855"/>
    <rdfs:label>paroxetine-P88 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ab4fdf90-e88f-4656-9cd1-214387850e33">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/309e5d73-e09e-43f1-8a1c-f67391b5ef63"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/dd65ade0-224e-4e8f-93f9-c472f0586993"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8e80afc8-58e9-4b4e-a482-4f22f8e9c3ed">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/d577a1d6-d1ff-4415-b8cb-8ff4aaa322a3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c939cfad-d707-452e-acb4-98bf179bd4a0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/7963b197-1600-4b3b-81c5-ac3d5f7aa664"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/a4cb1836-4c9e-4626-b70e-604c1d52b8f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3b0b3596-3b2d-4f3e-a3d3-86f491ab09e1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b3dd49aa-7300-48f6-8292-a177a1421baa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/1588f2cf-3f00-4b95-b9dc-6157c5ee71ec"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/ec788340-0a04-4965-afdb-30c84fd0daf9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/344ec73d-781b-44ba-8484-37f0e4f41e25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/10034a77-5eb2-4a0b-a031-2ec5e26be342">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/4093a75a-8a43-4cc8-8705-5bdc440e75b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b4369e0c-a4f7-4743-ae8d-b0ed753254da">
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2701fb3b-0dc1-4e0b-8a03-7a73092ecf3d">
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5c707045-af37-46d9-b9c8-be6258b90b92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/8e92ba75-b622-4db8-aa6d-72f9f1814e90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d5da530d-45b2-4ab1-8515-489f1f561bac">
    <obo:OBI_0001937>1400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/3313b469-1267-4eb5-b0b7-349f6815316d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2a24fdc3-d8cd-418e-9748-74b2edb97fb1">
    <obo:OBI_0001937>1.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/e2eb657b-586b-4182-bc8b-3bc9dbf0c24c">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/341033ce-55c2-4ff3-9c74-3c962e6ca626"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/5154b81a-d60c-4ace-876a-c1c8e76642ab">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/388c5b4d-61ea-4ecc-ad69-bd3cf2c68e7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/cbb8f058-b7ec-472e-9314-bbf50e7a3899">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/0869ca70-5f94-4df8-b14d-6419e627d5bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/39c882aa-3f4a-4bea-8d53-98031fd0b91a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e8e1fde7-b802-47a4-a2ce-0f495b540fc0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c52cb0f2-7ea7-44b7-b8cc-cebdba10b7c7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ab8a5a49-4683-484f-8051-2941ef8b2734"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/41fc075f-204d-405c-941c-72c8aeb66d4f"/>
    <rdfs:label>efavirenz-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/706af5e0-49b1-42a9-9fa7-dedd8de7b9f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9fa3e3d4-0c0e-4442-813f-de3706eddbe0">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/76392b67-e746-4198-817f-a9ea5bc8ecf6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/040213a7-d4ce-4e63-978e-f3c61a0dacc0">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c6608370-0359-4f47-b95c-c5132b3c4d25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/31e44177-e848-4893-87c7-a2cfd22a2e19">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/4843c8ff-fd99-4657-8199-1e04f6b41758"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/d8e79090-b8d9-4d1f-9299-eb8bbb588237"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/6f915ca9-6c4d-4f2d-9ee1-a927e8c67e7f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d6e71238-4b1e-4140-bb8c-4e5814997669">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/26934f5a-ff2b-46eb-a79c-e782413f98da"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2f6a8f64-e63e-40f8-97cf-bb3dfcf00889"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/686e4da7-c50e-4deb-9674-9f9c1aab4330">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/869783c9-e648-4b6e-899d-610196622e83">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/6e9e4b6b-b6dd-4b7c-8071-28528da12ca0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/05a364fb-a26a-487c-8f44-e157f5fb43ff">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b3fd944d-d8bd-4204-9ae6-871022d20807"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a77d06a7-f312-43f5-82b1-86aa8df08b75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fc382fd7-a792-46f1-99fd-05211e8fe92b">
    <rdf:type rdf:resource="obo:RxNorm_21212"/>
    <rdfs:label>clarithromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5e6a9700-4407-491c-9e85-c2fb6d63ccd5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ea8aac60-ad93-4938-9ab9-b393a485ea66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/93ed2292-0351-4c05-86cc-c8f6d561604b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7b32b9d2-5e9e-414e-bae0-c462a2167648"/>
    <rdfs:label>fluvoxamine maleate-propranolol drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1561df0e-6956-4498-97c1-f08544b5a867"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/eb7cf5b1-496a-458f-985f-711580e63ba1">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/be7db0b7-72f5-4796-848b-58e32dbe04c2"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/1e8b2291-55ce-46df-8dc0-27cec7612649"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/47a93efc-76a4-4608-9b41-aa82a158ebd9">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/47f22569-e217-4714-959f-e5bda30c2f02"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/866a5eb1-9539-492a-8e73-7c23ab4dfcbd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4ff1094b-6889-4dfc-b26c-bea87ce82953">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/2d12b5b6-aeb3-404b-9a6f-4baa2c790721"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8f87fee3-a353-4152-bc63-e7af59239e4b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f7511bbe-e566-4dc3-8991-19d4fd4c59a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a2637983-6958-4749-9637-b4553df30d4b">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/300482dc-e8d7-4966-8552-2358aa04c21d">
    <obo:OBI_0001937>48</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5ab7cde8-1e4f-4bb9-820a-2c13e4227d4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/db22d823-9ba6-4940-a61f-2b1e317f3a46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5334e76e-7231-4054-9b74-c8c423ef64d7">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/847efe93-7d4e-4758-90f7-4d3df4d276af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/ecd66037-9e3f-4ae6-97c4-67d5f3efc3da">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/cd9ed6eb-e13b-4f5b-8825-197f75e941ed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2e36a2d6-eb1d-4c32-8505-44729acdc747"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d11dd36c-35c6-4bee-86c7-fb59da1ea355">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/d3563391-eb40-4023-ad0c-07a81f8fa7d9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/d577a1d6-d1ff-4415-b8cb-8ff4aaa322a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c331a70d-0285-4b0b-ae7f-7586ff50b67c">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1d3d7821-fe1a-4866-98e7-b3f2a294d359"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DRON_00000028">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8f47f424-adf0-4813-b674-a77a781611ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/46f9da4d-2a0f-44c3-900d-307414a7c220">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/e1a6bab6-c545-455f-a245-e3f0380f10b9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/ec140947-152f-453b-8f51-6b80b5157a79"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4e523daa-7470-49fd-946a-570e3925cdfc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/613f9941-7d50-4a7b-b3da-1d2203c1c841">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4dd4b186-c515-44e8-b341-cf502201cb91">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/768955d9-9d1a-42f6-bb0a-b70324c4d2ab"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e42e2ed8-f859-4286-b75f-f45cea667ed8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/94e854eb-252b-4de4-8e0f-3c0847939c83">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fc9e7600-3d7f-4ee0-9dc9-a016fda4ec7a"/>
    <rdfs:label>atorvastatin-verapamil drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b87ddbda-aa59-4b66-8444-304360f88602"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f90aa4c8-3cb9-4cd1-b32f-d63d4605c8f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8df3b101-c6c4-4625-8d84-3e74d092860a">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/340832f3-e5a6-4567-a652-7423e215695c"/>
    <rdfs:label>mirtazapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/732bee1f-300f-4339-a270-6a45b9af643c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bb10ec14-b23c-44e5-bb85-f918761ab1e5">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/4b8ab8f3-8e21-4587-a535-3dee8927e9cb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/17ac8ecd-3d6b-4025-bf9c-95421d7763c7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f3bfe85c-5031-469f-a0f9-8249b77d2a5a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/245feef1-e3cd-48b3-b0a5-90917fd4363a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c133f023-69af-4418-8790-8ed4c331fde9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/609da682-375c-4ae0-9e32-0c398e3febf0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/698842c9-2233-4d4b-ad1f-8e45282dc075">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f04facf8-bdab-430c-89cb-33684fa2cbfb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/76d0ec65-026e-4c5c-99cd-f38a277391a0"/>
    <rdfs:label>paroxetine-atomoxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/05fe7dde-f492-4c97-8514-777f8d723e42"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9e05a73d-2e50-4cc4-9baa-fd65f7935208">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1c96bc8f-634d-409c-ad65-66e4ad40a780"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/be69a478-27aa-40ca-8211-6ec357d55459"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8222ffed-6e6f-411f-a89b-85c4e7b37556">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/28543ee2-318c-4fa8-80f1-6dcaf9791de2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1e7bd53d-c9e2-48c5-8e55-2c289bc3b3fe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/739376d4-65ea-4145-9e6f-7123dd334f1c"/>
    <rdfs:label>cimetidine-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6f190a01-018d-431f-a09c-357a0235b78c">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/43335489-21c4-4749-86e1-55e6ddda1bf5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d83a83b2-f0b9-4f01-bbdc-7103764e4540">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/80c07bb1-025b-4ab5-95cf-a17c2517913a">
    <obo:OBI_0001937>10.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/e1dcc20a-dce3-4447-a402-895b4ed6384b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/dddcb370-af6f-437a-a771-93ff8fb8fd9b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/64ecd84b-bb62-4459-a2aa-1ff5de6260b8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8bdef1f6-49f5-4398-946b-081a79529425"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/168db372-a308-43c4-b860-f90c26ed3310"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/028aea1f-12aa-4554-9d35-df042ccd555e">
    <obo:OBI_0001937>135</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/182a6f35-e524-406a-8547-a34d487d0731">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b63b79dd-c0e5-4df5-9048-7602270c4a3a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/12ef826b-be6e-4d81-8db8-8d2dd9e7c46f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/59cec642-41ac-4eb2-92af-cbf85f557b59"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/ec6574a1-e3b0-449e-b1a6-839bec12e2b6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/7c142a49-6250-40ea-973c-86b5a7e9fae5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8ae65b55-b611-40d9-8162-faa76b686c2c">
    <rdf:type rdf:resource="obo:RxNorm_75207"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/8cf92603-402e-4364-a5fc-0878c167c99d"/>
    <rdfs:label>bosentan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/976486fb-2165-4ba6-99e1-3257a9df1ec3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7cc7000b-55d4-4ae9-879c-f7827eb69ce1">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f44dc4e2-6bd6-49b1-be5f-57d2ffdd0c9e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/b6404cd9-79ef-47e4-b932-19432bfa5fd0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f108eb70-bdf9-4734-8e35-9eebb2d0b60b">
    <rdf:type rdf:resource="obo:MeSH_C001422"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d951852c-d029-456b-9b41-3c709c27b4cf"/>
    <rdfs:label>4-hydroxypropranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b4a756ad-f9e2-445a-85b3-3a2096c29cfd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/11b34b82-fa7a-4ec6-bf5b-398fe223160d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/1249b2ee-0aed-4bb3-a37a-8311958b0857"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/26c65a68-9e16-4c56-a2ac-d3e1c3cf4114"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/191baf73-ef06-4aba-bc2d-3ae702c51eb0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e13c6bf0-e2d7-4623-a6a9-d9a6bd0d4e3f">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1b880187-8518-4a71-a4fb-e1422ea1e546">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d0e50687-6e68-4887-915e-96152658b15c">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/67d7ea1d-9501-4b62-b288-6cc6312094ba">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/d000efcf-2908-4654-b5d8-f6aafb589784"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/0421a8e1-8445-49ed-b9ea-31ff93b23e8a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7963b197-1600-4b3b-81c5-ac3d5f7aa664">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/15bf202a-1c1d-4d16-9b48-81f2e1d34342">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/06158a46-c8be-4358-aaee-37de7f09d073">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a956af43-85de-4893-aab3-9b9df8c6cd33">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a9177094-8352-47bd-b352-88db469a6e2d">
    <rdfs:label>paroxetine-tramadol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b673ccbd-1505-4b29-ace3-2092dd53ad56">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/bc02e0c8-ccca-4045-9c74-ebbaa41662d2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/3c575a79-ce7f-4b2d-b623-5fb441097015">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/46c712a7-de61-4dad-b2f8-cea7b466afd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/97a261d2-836d-42a2-bb68-3f2b8989fea7">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fde52ac6-d2a9-4b84-b42b-57259e1a633e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/538d377b-0a62-4fcb-ab77-fcdc53d9bd7a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2aed9bb8-8cd1-471a-b1bc-5b1a5094ab5d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0eb057a7-7ea2-49aa-99ad-04498a9d0caf"/>
    <rdfs:label>duloxetine-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fc6b673e-a3d3-40cd-b2d9-118042e1cc00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ae7a1382-73ce-4101-8bf2-8b1fa68d6719">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/11e133c3-5451-4e01-875f-82fcd273087d">
    <rdf:type rdf:resource="obo:RxNorm_358262"/>
    <rdfs:label>Fosamprenavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/23b8d7f5-6c29-482d-b722-fd48de3f4b06">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f9f09722-9946-43d8-a0d1-0950218e0f07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5fa84026-4137-4e21-ba3c-aa9b701b7f5b">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/e82d7c19-119d-49a0-8eed-85b53ded226e"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/8a542ff5-0357-4089-86b2-329902fa4a5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ca395a08-29f1-4abe-aff0-20985eed674a">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/0f0c9e52-babb-4feb-a4c8-e96df80b87e3"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2e8c1880-1699-47f5-a12e-87ee28788410">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/662ab7ea-fba5-4b6e-8cfc-7d7164227311"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d2d9065f-ea0a-42c9-b949-3eba11966c93"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/e13c6bf0-e2d7-4623-a6a9-d9a6bd0d4e3f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/8fb8d4b8-b184-4465-aff3-f41caf4041ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/90c19c61-c354-48bf-babe-7843210eea22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c9c65c23-2da6-41c0-8c4c-a0d09df9cd70">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/1a6eb501-2401-4fde-987c-dbb997a4fcb3">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/763d459b-ef8a-48dc-984e-7d53c51cd427"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bbe8739c-ca20-4717-b7d4-a42ae4c3f423">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/bbd2f240-cd5c-4009-9ee4-287f3853f6a8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ff593cef-cec4-4393-881f-b20e9b3a8f1c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/60f5ec95-a527-43a8-a3f6-1cd0107ea2a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8c2c98cd-3b24-4bcb-ab7e-da0823cad540">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/9007db60-6536-4af4-a450-1f1a7ec67146">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/a0ee16dc-cec1-4318-a343-9ab6062a3b29"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/1a615024-1a0e-456c-a735-3ab4e404e2cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/09219c87-f058-482c-9fde-ed54315242d0">
    <obo:OBI_0001937>2.25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/678460ec-dcb1-4d03-973f-1fedf0e56f43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/611b995f-1364-4bf2-b4c6-5bf260bff0ec">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/7dd60ee5-cdc9-4070-b1da-9d9a082b79b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/43e8cf86-42a1-4497-8d7b-b1825b10db87">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/66f227be-c2e7-4238-a406-db1d9f4f8e83">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/bcfda25c-f9f9-458b-988f-913988e6c0ac"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7ff0ba46-f18e-4ad8-ac71-fc837f00aebe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d6166d79-8cb1-4a32-930e-ecb78201e18e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/fcbd2788-9054-4be0-8ce9-764ecf6e7d73"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/d220551b-92ab-4ce6-921b-b00fab32e416"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/40615b5c-9298-4121-b137-2eea124fc9b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/68014db0-20df-496c-a763-5e5ec8e360ad">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/ad9d6775-8644-4458-836d-9d3f056eddee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c971258b-e4c7-4748-b1a0-02efda8ecf06">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b3aba74d-0983-4cb6-a54f-c65206c7191c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/b58bd362-e443-4f80-9e8e-ff0a57e8941a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/be33dc9a-9a53-4e8e-9e1a-0fcd749e55e6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/3fb627d5-d271-4db7-aea6-ad04778a19fc"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/d62f6090-ec03-40ad-8859-86b699e85722"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5ab0ee8a-517d-42b7-97e6-c1df1cf13205">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9b5203b7-c582-4ae6-87bf-f172daebf6c3"/>
    <rdfs:label>threohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/52ecf674-618c-4b35-805c-58f1e4e3a631">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/165a8f47-dece-48c7-b908-0c12eda433b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/39349f18-3cba-4fbe-88d5-7f87dd433046">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/396e457c-63ed-4801-ac78-14b308cd4e36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ab353f2b-6200-4284-8cce-61cd56782ccb">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/f65d2107-22c2-4d04-9c96-2082a4d265f7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d0aa7119-408a-4fad-b32d-99230b9af903"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/69c30196-07d9-43f5-b5e5-31281ce306f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d19de9ea-409e-4328-9f50-7fd4d84f93e5">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/68c0ad8e-bfad-4356-8fda-fe017a3c72ee">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ae30ad1b-3313-48c8-8668-e49d12600e19"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/779b272e-0f1d-4c38-afd6-49a3d6160580"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/c82df4c2-05e4-4f2a-9446-272d137be792"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b6c071c0-8e1a-4ffc-a157-a21b469da842">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/00a67608-5e9b-489c-9c12-58ede2a9fba3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/896794a0-9901-42a3-971f-c9c94012b947"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/828c4d15-b88b-4e52-b973-832e3507e462">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/3b8bd4ff-5794-4704-a2e4-423819d5aecd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/79327a32-f367-4ba1-9a83-fcd7a00df2d3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/f1ca93c6-c5b0-4ac6-8bdc-35882e8c414e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/36e481b8-81c1-4139-ae65-bde58ce78d25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/cdfdb476-4668-4daf-b744-7c2433cb0527">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/ae8be822-4fe7-4beb-a914-567ab0ef8240">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/91b769ca-0076-47ae-b0c7-cfa85470fd83">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f998450e-3f75-4160-a776-09f70a60ae27">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/395d6944-ef3d-41a3-af6b-0239d1836201"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/98bb2109-ef8c-47b5-a0d0-25902923646e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/a7f31847-a942-4f88-9e4f-c0c8f81b59f0">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f9e63662-5f48-405a-a5a1-76035be08ad1"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e8049e6e-00c2-4894-ad8d-184f5ca7897c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/ec8c45ab-d761-4682-a26b-a0f75e2429e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9ee63dd5-940b-44a6-aa40-ef1318f01a41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1c89d404-ac76-4af5-9924-e3d3194aeba3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/49cba39b-cd80-4804-a5a5-0456f0df634e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/8f6c528a-8d0c-4e44-8227-cc7a426e5916"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f4fbc3b5-07cb-4d1b-aae8-e84955e28994">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3e3758a0-ce1a-4275-bb09-c1d647a91c91">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8a5ed469-90b8-4d62-8e6a-d1f3a73d7a33"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/ee8882df-9e21-43b0-bc56-9441dac0252b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/63bdaf72-d290-4eea-9566-a166f40deb84">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1676006a-018a-404e-84f2-5544fea8a25f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/0abd8fb2-6955-4453-9b28-21dfc547ccf3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1a37b2f3-d5f1-43a0-9b9e-c0461c9b1789">
    <rdf:type rdf:resource="obo:RxNorm_358274"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/53f94489-5d48-44a6-b1bb-36bb23b3759a"/>
    <rdfs:label>ambrisentan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f94a764d-4584-41f4-a2fe-956508faa273">
    <obo:OBI_0001937>4.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/03d78909-91aa-4e0f-a20a-436b30bbccda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4cad9643-120c-4213-a747-eee78200a1da">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a82dd3d2-f243-4ab5-840e-d69185a444f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/338759f9-1394-4f54-b4fd-e1114d6946a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/80c05d27-a205-4e7f-a8eb-ceec8c9649c6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/22d6ec90-fdd7-452a-8dc4-097dbf351112"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/f90362b7-d826-4f0f-9bda-a58e1baf01e2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cd9ed6eb-e13b-4f5b-8825-197f75e941ed">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1a280a4d-14e9-428c-8244-1b5dd8fb37ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7078a39f-01c5-4de3-a3fb-a30ee0fe9839">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8b3c5a95-f221-4888-be08-802358946c61">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/f687c19b-05db-4138-833a-dff57c2cd3c6">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/69decde2-6d23-4666-9e52-907d88d20cd1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5cc076cc-6eb3-4c72-9eb0-19e0b87cd08e">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/ef2994c1-20d0-4455-8be1-faa1a3206502"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/94e2b2a7-4ddf-4d0f-a576-17ff6101298b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9c5d6069-a657-4870-bf45-a2f7fafac982">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7795f138-5a90-40a0-a40b-6e9749f3b535"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d48244f5-fb54-466b-ad62-76f582bd6a6e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d2c46dea-f1b6-419f-96cc-f31d1d4d5e90"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/37d5faa8-7645-47af-b8f9-330e0ce7c3a7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cb4a9a3c-be47-4d04-b351-c041c90ece57">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/93ed2292-0351-4c05-86cc-c8f6d561604b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/779752b0-874d-45be-bcd4-e9b99ce1b1e3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1b277f66-ca9f-4e5a-b22f-46f25a8e9c3a"/>
    <rdfs:label>fluvoxamine maleate-propranolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0b2cb6f0-17a2-46d6-bbcb-2c9cfca00081">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bf564162-3885-4cb8-b290-ff9a97d40484">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a4477f23-c9cf-4c48-9411-b0b970f5592d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/01a5bf2c-e4b6-47fd-a7a0-cdeb00d0cb4a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1f90a783-2b9e-4196-b862-569374d87457">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/77fd73db-76ff-41fa-a623-26a01c8e0b79">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/2a288151-d4c8-414f-b2dd-7c9e81bab110">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/ca1dae6a-d7da-4c97-9a9a-7662c96552c6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/fe5f92bd-d642-4561-8440-1bfde143e1c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ed376ee7-44f7-4144-93bb-a60d11e1fef7">
    <rdfs:label>pravastatin-NFV DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/41defff3-429d-4b0a-b411-828188b42ae2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8e63351f-3a1d-46dd-b21b-565b75b633d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e9dfeb99-825a-4132-801b-66cb32d6c5bf">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/41222aec-60ad-4ac9-ab0d-ca65d13ca446"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/7f8b2e7b-a667-49ec-8826-05113c1e8ca8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/ca287d22-802d-427b-8ecd-a74a38fa3532"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/013597dc-0557-4d85-8b0a-820eba873871"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9c163b5d-b89a-4a47-9aba-08345f8047ab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/850cea49-46d2-48ed-a710-688288049535"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f0785051-2c34-4d07-8e9f-f6f0a0fa0fa2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1f005577-33c7-42c9-8fe1-a67661049543"/>
    <rdfs:label>fluoxetine-P88 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b026f92f-3efe-4a7e-b445-d120ea9c9785">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6c0038ad-836d-44ea-b196-0e81a8ea3b32"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/4cc71f9f-4183-4a07-a299-6aa4f1781c98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ec8b0d3b-bf1a-42e1-afc6-1c49e3a3ed60">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/01a5bf2c-e4b6-47fd-a7a0-cdeb00d0cb4a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/fb8d611f-2537-4c16-80a6-cff536cef806"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/ee44ccfe-2c29-44f6-a061-a87fde5be49f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/807d010a-7c7c-49ed-b0a9-c1d13a9f3c57">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e6d9b578-6c9a-4bf9-8525-a7bb684b9297"/>
    <rdfs:label>nefazodone-4-hydroxypropranolol drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/65789cac-9bc3-4619-993c-6addc8dc9226"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/abb13e3d-60cf-4468-9031-c4fdf36d4aaf">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/11f3066b-7702-496a-b7fa-b259c1ab5109"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a63b7541-c846-4da9-87c7-14879c038ac5">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/39a386c1-8f28-415e-b917-b0c5de8c1174"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/20cad964-72bd-475b-a120-db4cad122d80"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4484f446-05cd-4ffe-b521-a6fde832db67"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b4f6c986-e9d7-43a6-8876-dbb6d43c4e3f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/0ed9085f-e25e-4cb3-8817-38683228634e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/85b33c5b-3c12-46f1-bb16-5e04208bd638"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/cc265fab-208c-468b-a174-45ca11de36c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d6955e58-9a53-4b7c-9003-26addbf1f203">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ce231d1d-3232-4a5d-b0bf-701f07768be0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/629e3dc1-c9a8-4109-b3aa-1654ba97e74f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/facf6c18-1fc3-4b15-bd73-b4c11999e63e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/85669fe3-1e00-40d2-a66f-b60818b4b5fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/37a4e0a7-04ac-499a-94fc-a132c2ba1e15">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e9f99dd9-5927-42ac-bd93-1b258a308ab4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/244e35d9-1b71-4af0-b5fa-50989bc6a9bd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/45ca3bfd-ae92-4d44-8c16-5c8d67a0e43f">
    <obo:OBI_0001937>4.13</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8f2a077d-c8c1-46d2-9964-b88d41709d64">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/70e557fb-f4cc-4af6-9789-30c4d56cd49a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/343bf2d3-bbe7-4090-bb14-2ed34d779e6b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/eb1db512-77cf-4b5c-8d97-33072f0deeeb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fee1d7b0-178b-499e-ae9c-793d1feae774"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/007b2e82-bb08-4622-a6f6-9eaa6ee17bf8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e50bbfe6-cf0a-4a11-bc01-bcce26dfc704"/>
    <rdfs:label>ritonavir-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8c397521-4f9d-4bc6-9e8b-0b147a4ae9ca">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c3565774-c745-4507-8cf0-680504fba908"/>
    <rdfs:label>Fluvoxamine-tizanidine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a078944c-1c5c-466d-aac2-d1175e17f034"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/47138573-752f-4fe4-a8b8-73def3fb11df">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/07fd9e8e-35db-4b2a-9881-5894d34db630"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0d9648c3-a344-4919-bfba-3c61343d32f1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/92341cf2-9ca0-42f6-83d6-da5b8781a389"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/04e40d4e-5a69-4dce-ba84-fe334570774b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/edc82b9e-4de4-4eed-9edd-fb88a1107c3c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e0def113-132f-4171-8034-d7c3a3e05967">
    <rdf:type rdf:resource="obo:RxNorm_3498"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9b624909-121e-4214-992c-07a0e32bbb79"/>
    <rdfs:label>diphenhydramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/c029db1f-e950-4f68-902e-022d1e9247ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/f99bacb9-75a4-428b-879b-2d7fe0ff2265">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c5a8a18c-2838-4b4c-b874-8320463f9075">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bcb143b9-36c0-454e-955d-7644ee88e201"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/044ff11c-9625-41aa-a6f3-ceb8b0a7f3dc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/41bdf757-0934-42ee-a812-adcc0c01afb8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/dc4b4f54-ec47-47a5-832d-837a918d2978"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d839d65a-10bf-40d5-ab71-e8acc73dc615"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/12a472d2-9755-4322-8451-0f56402eb9fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/563bd86f-a742-4e00-bd1e-ad8e4c48f009">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bd7e9d81-1afd-4651-830d-863cb7fb0fe9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/20799405-5c0e-454c-b245-dc0391238e63">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c2002fbd-9de1-4824-bcba-3b4c06e4d99d"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bba0a45c-2c92-4787-83a1-a4522f8ce1fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e01c074d-c31d-4655-858e-e5261df94567">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3b836bc6-a02d-462f-abc5-ab16997af13b"/>
    <rdfs:label>cimetidine-zaleplon drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7f294209-04e3-4f00-a76f-48fc395aee3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e6f83fb2-8b8f-486a-ba96-ae81cbf7a6bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c4140706-cc18-4cff-973d-ecaaa9cd08dd">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d03f9fbc-eeb7-4bbb-881f-a90d267fd5d2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/dcc0797b-e828-4eae-9c1c-40bd0150057b">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/df981430-e312-43ce-b8f1-2d33c635c061"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fb625ccb-9dc0-48e5-94e0-b00e362802ac">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/31968fb4-39ba-4137-b32f-e03234d69c98"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a9ad2929-5121-4c15-973f-b602aa7dafdf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9f1c3fe8-5206-4e49-9996-3c61a7a20fa9"/>
    <rdfs:label>Fluvoxamine-thioridazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/421e76d6-e71f-44c4-a715-d45af0fa170e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/07fd9e8e-35db-4b2a-9881-5894d34db630">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/933b18fd-05d6-42da-9c33-4cf74633cc97">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/0d0543ee-f64e-4e33-8816-bde4a09f2961"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/65627c3e-3e0c-40f7-95d7-957ace05d200"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fc976b7a-d6f8-4c7d-af00-3f3ec86d48db">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0dbb2aa6-d6a6-4762-97cb-e30837e29055"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ef1577d3-438f-4309-9788-e9aef1988962"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/de47029a-3fbe-4ccd-be30-4222a7714bf1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7b2700f1-0061-4286-a018-0c39288a4baf">
    <rdfs:label>carbamazepine-hydroxynefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3ecade7a-dc75-4d2c-8226-56d28be95d89">
    <rdf:type rdf:resource="obo:RxNorm_1102261"/>
    <rdfs:label>telaprevir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/85ac5b06-9e82-4982-a84f-7cb44f2bdcd1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ee9a99fd-57b8-4259-9753-b4a78b68e183"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0839a4a9-cd7c-4399-996c-9f9662b28435"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b485979a-1bb0-4266-9a1c-17d5e4187535"/>
    <rdfs:label>clarithromycin-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a7a5d919-e8a6-43f1-be9c-61e8c93fda81">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/64078e13-ee47-411c-a0ae-15a6a0b7c342"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/01401575-c71c-4637-bd53-8e62a162f919"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/92a72227-c433-4188-a282-a293cdc5d8f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0ddb7d50-228e-4b5e-b333-34ec03b6c411">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/61ba5995-4f27-4663-856a-4566eda2e763">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7455a610-1f30-4ae9-a065-cee4ae35468a">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/17eb5327-2ca6-4454-b4cd-ae04b99be4d7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bef719da-cc94-4c51-9c9e-cf710a31aaf4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/f2ee30a9-fe06-461b-b9e3-ddcb7b0335f1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5cae03b4-f0a7-4ef3-bf2c-d2895e9e3137">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1472d054-f943-4437-aaa8-be301d3ab2e6">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/e0a296f2-9613-479c-871b-e45b15d140cc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/98f63d31-124e-4818-a524-e1215c952ef2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/6e57c4f2-deeb-49d0-baf7-775069942800"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/55154cb9-0479-4b9c-a54a-eaf1698bfc40">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7d76e6e9-4df8-469e-b1d3-d34ad9c51567"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/f65d2107-22c2-4d04-9c96-2082a4d265f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4e9ac79c-1779-4461-ac9c-1a93790e736f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0a7384dc-d136-44c4-a992-0ec0496d6f1b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/578d0045-d465-4cf7-a0a2-6e74fd9ff9e5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6969d802-e80a-427a-928d-3743e61c8b75">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b5c69074-006b-43c0-8418-28626245752a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4737110c-5607-4368-bad2-e06998eb1c58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/02d19506-8e8c-4b2b-bfc9-a902e5cb1934">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9294b8ed-3ee1-4f50-a0c2-824600557a07"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/34f10520-e117-4a74-9404-e78c7b931b51"/>
    <rdfs:label>pravastatin-indinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/43fda1ea-2ac0-49a8-b79a-df7d24dc1a9f">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/01fdc7fd-8f19-4b4c-ac95-6a3cbef472aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/99d95aa0-4f92-45d3-aa8e-5a4ded2daf4e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9ae54f91-1962-472a-832b-afa92c1dd4a1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f1fc83e3-e352-4133-84dd-271e2aedac85"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0663ea2a-c184-40be-95e2-4b49df471dc2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a885f0cc-8084-4e83-a6a6-d66b6c7a9e7e"/>
    <rdfs:label>Boceprevir-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/65e0b714-23db-43c0-a4b9-6eea9848aa5c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/a8074b5b-3be8-4f63-9b1d-9c8978c4132f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/64052a9c-a261-446c-8b56-7f3093ba7b84"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/eb3a5254-3a09-4117-bb11-2d3530ef6fa0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/35c417fb-dae0-4e72-a403-0e6c371ca1d8">
    <obo:OBI_0001937>180</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/754d67cd-3950-455b-9432-5756b41c1119"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/67c8a499-5c2b-4fd6-8931-3855879f9e11">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/56d6939f-77db-4633-89dd-f19a66cd81d2"/>
    <rdfs:label>buspirone-nefazodone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f286db98-f2c7-4bb6-8c98-b7c56e2eb8b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4c2cb218-9af7-475e-bcf9-d18df8bfd7dd">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a23f71ff-7024-4bb1-9855-59d09c26191c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/46886e49-38c2-4440-8e7a-c51cd15a13af">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f63963b4-2390-42a8-a275-764b6b364815"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/73338175-4768-474a-83e5-9046232c92e0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6c85e8ee-ea5f-4cd4-80a6-5c821a06fc31">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/547442b3-ef75-4d0f-998a-251781ede046"/>
    <rdfs:label>sertraline-cisapride drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4ee6a2aa-013e-43c0-a31d-60f7b7ca6206"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/172185e9-9407-4ba7-bdad-5bec95dcb162">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/09471c30-3194-4b99-84bd-2f5cc99a781c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1ec40b2a-73b7-47ae-b465-5c49b35b60d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/b23d4aec-aa5e-4d1c-9ed5-39a559a91d8a">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/ab1889f3-69aa-489e-ad63-d2f0f88a5f7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/04564a90-8355-46a2-922b-795ec167395a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8a4d070e-e6e1-4eaa-bdaa-6683067bea96">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/708d9c91-af11-4e0c-997a-00e797aeb241">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/65422c7e-450e-4bc4-a8b8-340618c895eb">
    <obo:OBI_0001937>1.19</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/08958f26-1f42-4768-8b89-9e54f83d9ca6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/caf9b62a-c55d-4c98-9e02-dd4c560706f9"/>
    <rdfs:label>quinidine-dabigatran drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4f242242-7385-4a5c-abfa-8f4094556773"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4c8b78ba-3573-47bf-95c0-53dc826a3148">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/3c85a4e0-ac9f-4d63-af3c-4805a5c1596e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/95780e12-6d66-4657-9898-40bf45b75d18">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/38565de2-9447-411d-89c7-a3aeec8a0213"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/ac5501c2-4412-424e-9cc6-ff9989545384">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/ca163884-8ea7-493d-b1fc-6822cf7c94a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/4d88de11-80fa-478d-a4e2-e05521fb8acb">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/5f50bb5a-8afc-4f78-81f2-c7a28a9dcb2e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7d806e53-e38d-4de3-bc4b-c20e27f3f7fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/dd5e2d84-c687-4db6-8855-08e7895c37b0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/36d1ad6e-e289-43e0-9618-52d8e01df573"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/0884336f-3fc2-4020-a3a6-ea22bb6d11f1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3db8dc01-3da7-4308-a820-6e11b389fbed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/207ae366-db8a-432d-98cb-bc8edcf89848">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ae30ad1b-3313-48c8-8668-e49d12600e19"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/2dc77fa1-a047-4be4-9b3b-030bffff6cec"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/dd2bf615-7106-4fd3-8828-ab499c2472e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a57af603-6ca0-4af2-aee1-c69fe40719de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/7e2b8646-3bbc-4983-ab1d-079958a5f49f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/42eb7f98-e8b1-4fd4-a28d-75d6308aeb1d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ab34fb8c-3a8e-48dd-9ce5-84bc544db38f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/7614cae8-cb1c-4a72-b966-49339596a4b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8741fdae-91ba-451a-92d7-ffbf7cc149a3">
    <obo:OBI_0001937>65.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/67985e88-be6c-416e-9dd2-f558578ff18f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7150c237-60b0-4405-b30e-e1e29a36dea2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/c45f66f1-db21-42e2-9762-8e04fff21c38"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/744a69a8-6eb1-4caf-bd0e-8a16a1077e0e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/78ee8441-2f21-4f02-a89f-0c10064e9815"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e619ca9a-2a25-4eb8-b123-1676d7f6e8e9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/c84937ec-80ae-48a5-a1b9-a0379a859eda"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/477ea326-52f3-4511-b6de-492d0625d9ab">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/b3de6934-e045-4d24-9b08-a5a8e469db34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/ecc8edda-6dae-452f-ac08-881acef0da46">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/97bd2614-d1df-4158-9be4-d64d1a570377"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6436ee1f-ead4-4aed-833b-a0a2222bde90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6cd993df-f817-4252-bd48-40b26a365a15">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/49008723-a95d-4206-930d-fad0bb46a6b7"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ff28e32e-7950-44d0-886f-9f2b7e6083a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f9fb52df-8849-4602-a5a9-1f228060ae55">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5f5d175c-5802-435d-9e69-1ea9aacb73aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/4fa60e77-6c53-4eaf-ae44-3e6121f773c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/629e3dc1-c9a8-4109-b3aa-1654ba97e74f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/537f2887-f71a-42df-85e0-ceef28a81389">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9f9fb71b-fa02-461d-9e26-b3b5e7cb1be8"/>
    <rdfs:label>midazolam-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2421ccac-1ff1-4c3d-acef-6b03dda92231"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/41cc2ffd-05aa-4956-b6cb-b9b660702fed">
    <rdfs:label>ritonavir-threohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d574d227-1dbb-4f7d-ad6b-d220114e12f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5e3ab0f9-a897-4e79-b429-5656934ed9ea">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/dde4df2e-206e-4f81-b7e3-b0d183724f31"/>
    <rdfs:label>Clarithromycin-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e42ae263-8f7c-4c34-bd51-8dd50ac2af3b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e2c89053-ad81-4fae-acc1-66130de12754">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/7614cae8-cb1c-4a72-b966-49339596a4b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/fb06cf37-3592-4f87-b464-8fce98736fde">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a6d5088b-7db7-4458-bcdd-8806f116eb1f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/c9c65c23-2da6-41c0-8c4c-a0d09df9cd70"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7e496a25-6590-4a3c-b5c6-002e61624059">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c5f67c2a-fbb3-4bb7-abad-594281becbbe"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/7e0a9709-3119-4f54-9172-7948cff7884f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/236a5671-ac8c-4ab8-b757-75f84ca32c65">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/a8a9fe3f-8ae3-414f-8bad-9b56842e04bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/692b92bf-b254-4d26-9e7f-c9d5feba7f05">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6c0cfe03-8451-4e06-801b-459fc55a6017">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/875d76d6-525b-4f7d-807d-92c3dfa04303"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/04c56f6c-f226-41de-9b10-1fbc3bfcd273">
    <rdfs:label>alitretinoin-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b4a96776-2214-44b2-9078-a1817dbd69f6">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>Ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/cc803649-5e52-4ee1-b510-6c0ad1e55785">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ab10bc8e-d0c6-48f9-ba1f-861ef203aec3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ac8547d3-ebbb-45d1-8d4d-9737ad83b4c5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/20a5db7f-ce8a-42f1-8586-345762c5c929"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fee51e00-73cd-4303-bb80-50ad8d9d226e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/97bf3c40-58aa-4f52-a5fa-2b76dd8ad215"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/475d17a4-4664-4e32-a8a7-672506a1ade0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1d22e83b-12e7-4751-9099-bfa8412221ef"/>
    <rdfs:label>fluvoxamine-mexiletine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fc96f61a-a2aa-44d9-b89f-9b527d652ca1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3e27bfab-cee4-4e8f-b889-d73ded991d15">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c3f6f18c-8f72-4d6b-988e-be6d84a6f3cc"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d9ca63a9-0243-42c6-a412-eb25dfa5e76f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/f1fd4379-5bc0-4341-a414-ed5dbf257697"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/c7861393-b812-4e02-b74f-4cb4f521f6ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/57da0fdc-9ba7-4b8f-b934-1c161a68a588">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/2993a043-e33c-4ae2-b8b9-6596d3ac51c7">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/ba88005e-8fac-4fbc-b013-7baad3cca5ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/03ab7b64-d67b-4e4a-adf2-561f123d7354">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/88b2f7d9-62c2-4854-95a7-cbaac01b2fa9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/a99306c5-24f1-4e3d-ac10-252313ef9e5f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4648459c-d94e-48c8-bc75-b2cccedc861a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d5fde689-e500-4335-93ef-e294b1c9942d">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/01eaa627-ae44-47bc-82ef-e3948d392440">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/d5744a31-624e-4922-b068-0bf47379b80d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/8e63351f-3a1d-46dd-b21b-565b75b633d4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4e041a2f-7fe2-4ab0-890e-8fc323689ed6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f44dc4e2-6bd6-49b1-be5f-57d2ffdd0c9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/25a2e9ea-72b6-4ecf-8813-30e2c7f00183">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5c1a5a69-0686-4cf1-a074-81582fa3712b"/>
    <rdfs:label>Cyclosporine-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/096782a9-ffeb-4161-9253-c81dc93c1a8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/91f382c7-edc9-4c0b-aa89-87311a78db8b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e08a4910-5953-43ac-83a1-4552bd298707"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e9d9e3fc-9929-4bac-8638-6abf2e009917"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/95ab95da-1147-4c13-93e8-322f1c9f4a56">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a97d78fb-3649-4963-9dc8-94827e00e933">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0c9dff06-6d03-43fd-a480-d1feef1c1ecb"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/771ac50b-38af-40f1-aefb-1b49aee3f42b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/679d7169-533f-46a4-ba8b-2ba4af34bcb1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/051e91b7-ea70-4f93-9c65-575dc5108c87">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/23355d40-2330-45cc-9178-411b1826b5ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/85caab8d-908e-4d45-abe0-b7dc9a4721f1">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/976223ef-4a64-4bf1-9c7b-6234f668a875"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6e9921f5-6070-4061-8ff7-4355cc4d2cee">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/f07e13c6-5404-4ae4-9168-6e6b4114986a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/aefbb4af-1eff-4d1e-b642-0f76ba7a3fbe">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/daadcfc7-efbe-4438-a089-ae2bec1732d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/64078e13-ee47-411c-a0ae-15a6a0b7c342">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/937dc719-2b34-40d2-ad09-549e2eb675fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9282a976-da6e-46f7-a868-0d13b7992819">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bc997f4c-5f4e-4e08-876f-8b12cac924e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fb0d212b-dd93-4c33-b3e9-9ae06442b23e">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/7ceaf780-d798-4fbd-9ee9-9e02e3a3eb3b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/4e7e9213-6381-445a-be4a-795c2a76d4a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/a79f0fee-c3cc-46d1-8694-cc9e95e34559">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/39a62fdc-4f92-4716-94e0-5995e0175bde"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/0c9b4d04-050b-44b9-b1f0-53670ad120bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/45665fcb-17bb-41a6-89f5-592263ea0eb1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c6608370-0359-4f47-b95c-c5132b3c4d25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e14dd4e4-48b9-43d5-b287-cd9cd69220c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/445bf064-2da9-4513-9506-ca951894b8c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8b538190-dd33-49da-9ab7-6af1505cb527">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/00d2d382-69cd-4271-b48c-362f09cb1321"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/bc997f4c-5f4e-4e08-876f-8b12cac924e5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/e3f3d8ff-5d76-40df-8c0d-05b30e5d6cf1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/edf8411e-1667-4a2e-9d75-403fc894e5d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/309e5d73-e09e-43f1-8a1c-f67391b5ef63">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/c9ff7448-6dde-45c9-8e71-168a09450091"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/41e3401c-c8f3-4d9f-9b24-b574f6dd5a85"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/32e8d61e-b092-4aa4-ae75-3b91079abe5c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0d17b6ba-16a0-4f21-88a2-78fafe333449">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5cbdd743-053d-40d1-af2a-09ed6b669e4b">
    <rdfs:label>ketoconazole-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/ce4539e2-cfe1-4490-b65c-a327203cf5f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a9206c6e-2985-4f75-84d9-c98da885103f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b8a6cfbc-cece-4a87-9fd3-71a9984a59bb"/>
    <rdfs:label>duloxetine-warfarin drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7ec4f57b-e6de-4b8e-810f-608c0b1f5eb7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a3ed315f-d619-4df5-86bf-a8b69d1ade74">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/4b653027-2592-49f5-9ae5-274f742e07fb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/408c6a31-b90a-4196-88e6-2d943f53341c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/bc813fba-cbc4-4ce8-a6e0-8398a1b2546d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ece3c37a-7d94-4175-93a0-c7435a5b4ddb">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/ec8c45ab-d761-4682-a26b-a0f75e2429e0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/14384bcb-fe9e-4f63-b408-97a69e94d78c">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/69decde2-6d23-4666-9e52-907d88d20cd1"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/26c65a68-9e16-4c56-a2ac-d3e1c3cf4114">
    <rdf:type rdf:resource="obo:RxNorm_41127"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/2720a1b7-2fc1-411a-ad7f-808aa2d0c92a"/>
    <rdfs:label>fluvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/67457d9d-5d60-4699-98e1-84b6a7f990bc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/19d03e70-8ced-44c2-8bea-6f7972cd3a54"/>
    <rdfs:label>carbamazepine-INVEGA drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/21a016a2-7a61-4836-838e-e191ffde122b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/05bcd16c-d09b-4918-a025-e5ee1aa4c044">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3af90123-46e2-4baf-86da-7dfbd1b5deed">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/56671035-4aaa-459a-905c-b6272814b3e3"/>
    <rdfs:label>ritonavir-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a9f57c38-a6e1-4522-8a68-2d2b86d30d1c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/7e5f44cc-cab8-4fe8-b9cf-204b064b2923">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/98e12aab-943f-429d-a423-b6392f828906">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>Fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/91171fcd-70f3-4b6f-8678-d42f2afc831f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/088c9293-023c-4af0-98f7-33b2e2a7a06c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/f45a1498-73fa-4cd4-b409-1808fe27069a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/a3618cb6-ff6f-4077-98fa-1ebb01ee7789">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bbbcffc3-ba9a-4bc5-b757-575896288f3e">
    <obo:OBI_0001937>0.84</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b981761a-f22c-4701-a783-1f6129b64fd8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c3565774-c745-4507-8cf0-680504fba908">
    <rdfs:label>Fluvoxamine-tizanidine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/72419d9b-4c2a-4f5e-bf24-44c39d4003cb">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/e7a531f0-ce43-4f9a-88ff-e4a69bebe438"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/04a00cb3-f733-43be-8b76-d81174e5088a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/66592b0e-e8d3-4465-b92e-4e8946141131">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/eed1a846-d35d-4601-9181-e24785dda5e6"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/2be81782-6480-4e53-af06-46fcedad04e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/cb6033ac-9055-412a-b623-1940e3c4e28e">
    <rdfs:label>clarithromycin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/aa8a24dc-3eed-4431-871b-aa12a7bfe399">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/e9f198d4-d88e-4001-a131-186f1f27ab53"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/fbb23c34-5fa5-4e1f-b9a1-a039bae39c6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/78ad9777-59f4-4383-acf6-1a35be72976f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/07494846-cfd4-4a83-97c5-e5dcd13547f5">
    <rdfs:label>duloxetine-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/49cae87f-eb68-49ec-a662-a3ce6d1e7a16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f75160be-4a72-4f7e-a685-ca3f2d7f1f1c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/04504a61-e0e9-432d-a8e0-4a2e5869ab70"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/8247d3f5-f257-4dff-84db-941795bbfea6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/30fdeca8-3180-4d81-94c3-7fbdad3db96b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c4147637-26bb-466c-8b30-c05f9fcfc41e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/5acb61ad-c20b-4069-a396-bef5ec933b2f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/26efab14-78c9-45fa-8cee-ae2c374f1f78">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b63b79dd-c0e5-4df5-9048-7602270c4a3a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/f262b7d6-8fad-4ad2-8cef-558dd5e6e860"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d0e28599-eb6d-45e2-b666-9e94aba52b0e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fc3c3895-a82f-4b57-b948-b1b3fcfadb19">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/a4e5cb3b-ca28-4621-a2e1-c880ca67d683">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/d05a3c56-a4ea-4843-84a9-f919f5ef0f04"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/6fe17c34-6401-49bb-b413-d4ae345698e4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/114119db-f40e-4ca1-970e-28d9879a4a9a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/22a0350f-fc4f-467c-b94f-5bf277fa0211"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a0bf7520-cb96-4387-8ab7-ec7c464188d8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/066601bf-4488-4785-8a49-e428a8a6e88b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/39856106-ca4d-447f-b297-cd6ff15e2a98"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/3ffc8d83-1d0c-42e3-9591-b3c7dcb46b61"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/54098f1e-1691-4edc-a49b-a5953580fa00">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f2ff7a7c-7d7e-4b83-80a3-07958c4ff013">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/321099f2-91df-44aa-856d-41a301252436">
    <obo:OBI_0001937>unmeasurable</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/31593052-9a69-4b03-bb16-61df7321f182">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7ab5c129-c949-4a93-8cb7-e1616cad395b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/973a1c71-73bd-459c-9f3c-30abc4429778">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/85b096f2-993a-4a32-806b-3620e5c7b4f0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/eb1dad1e-df64-41da-be8c-668d407a0d97"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/08a29594-d991-4dd1-963f-bb4c7608ff74"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fa39f4d3-c0bb-464b-abae-8d5b632feafe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/54ad54e0-a846-4234-892e-33c70db3ab32"/>
    <rdfs:label>Fluvoxamine-alosetron interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0c9f6e11-18b4-4930-84ec-86eee1c4c922">
    <rdfs:label>alitretinoin-ciclosporin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f67dd231-47ca-40d4-9a51-d1044becbce4">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1285c481-f16e-4b49-ad7a-1079faf54b0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/998084dc-c9c0-44d4-8ddd-3fef0b165fb1">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/87e18731-d526-4249-999a-694366dbbb27">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/dad5c3d6-936a-416b-91f6-b29c9ca4ff22"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/02300a26-3481-4c63-bff9-aa053d36a1a0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/7cb6bef7-5563-41b4-ab30-83906d15c0cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/90a6d243-b96f-48a6-8ba3-8f2227ddb5c7">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a1532324-8ec0-46fb-b216-72dac661083e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c0a5302a-60e0-4dd5-8e86-56c526f28d0b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b8db0eba-32dc-47a2-8168-7df33c1d13c2">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/977ebcf9-18ce-45b8-b0b4-a9b4f27e6955"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bd7fdea9-5e8b-4f33-b78f-91e39ab4355d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c0038d3a-f10c-4a55-aad3-bb2078f3bc52">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/e2b5179c-30be-4f36-98e5-6ce700a1e800"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b0f8faf0-f0cb-4460-98eb-de383d7ab34c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5cea5d6c-240a-4048-962a-07f082c59564"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/d373d067-c452-4008-af90-a3b32de980b6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8152d9c4-272f-4d8c-bfca-75c9191f9767">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b093edc4-4e31-4216-94a2-df060145bec0">
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e51191d7-59b8-4b25-ad55-a61dedd5d47d">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/678367d5-261c-482a-82e3-893124d10cdc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b2a45c57-b931-4402-aa6b-7b74109aa137">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1ed4d7c4-6541-41d3-a6f1-1db77587eeb8">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/298dc36a-ac79-4b1a-88f0-f2e675da1f39">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2f004cea-abc5-4769-abe7-db79c9fbab9e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3795f5bb-facf-486c-9c71-ae7efe26188a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1450e5b3-4d28-4bbd-b7cc-9e6811f381c7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e2ce0187-bbbe-4368-8dbf-7c33503e605c"/>
    <rdfs:label>pitavastatin-R-warfarin drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a3fcd0e8-8da6-4459-849e-7a949912abf2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/654fe1d4-b034-4421-bdbe-fcd746d8f8b6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/78533cb4-6bbd-4450-a580-17699510960a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c215f5ed-9f1d-4a44-b84c-0c1caf314f79"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/590a55b2-4bed-4841-98e3-b79ed7f1e0c3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/46fde10f-c621-4745-8d27-2e106d452518"/>
    <rdfs:label>rifampin-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/434dccb7-2efc-4117-ad01-0a62741b7ef1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/0612485b-9041-4506-b085-d56c8ec1e53f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5bb7677b-70e9-4890-b852-12be74090557"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/c83da0ba-4149-4e32-9689-7697314d4fb6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5aafa404-55fc-4d1f-8068-ac7fb9b49d9d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/89bfb778-2c26-4a16-be7b-a8519502881f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4f1f02a6-bbdd-460f-ac92-2a4b2250c262"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/55b34f9e-a93f-4202-92f1-057f7cfaff77">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/31593052-9a69-4b03-bb16-61df7321f182"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/e898f5d9-4869-46e3-ab05-f2887671b379">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/844cbb42-b6b7-4c7f-b01e-a992c9b6a4cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b4c2f4d9-9baa-4039-b253-67df761923af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b639aa97-1af6-453a-907f-641ba88f5101">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/24ffae3c-313e-4759-b79e-4107107b73a3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/3f429969-2a4e-4a82-a11d-f0ad2c9b75ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/37c8e874-8cef-4113-903e-1e526326e275">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e090e2e8-050b-40ac-8b80-318f6f69ff10"/>
    <rdfs:label>rifampin-zolpidem drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cbe0b0d6-f1a4-4d0e-8791-91fed5852c90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9052bdcd-4c65-4465-ab8f-dde52e21c6e9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/da171fb7-b711-48f8-9ad2-8df32e9f04eb"/>
    <rdfs:label>ritonavir-threohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/26bb2247-09d8-4802-ac24-7a508ccfeedb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4d029698-a8bd-4356-9dc8-c97c8894a6af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5dc6330e-baaf-4d63-b99e-fcca733b8787">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4da60106-e89b-43b0-a5f6-bc9e7443c426">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f1c6f75a-1cfd-428a-ad2e-d3f5fc482709"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ab4d42c9-fe6e-469c-b8fa-0db4905239e7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/694d6e05-da43-4b32-8aa2-82c168222f80"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2282d89f-f889-40d9-90a8-3153a29bbeab"/>
    <rdfs:label>desvenlafaxine succinate-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/641816d9-7f00-4113-80db-dcf137b66a84">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/3601aca8-0f2f-4467-9715-6f98a154a7c2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/04564a90-8355-46a2-922b-795ec167395a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5c923a35-3462-4254-a917-c543b8eb3ffe">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/809ecc65-f100-47aa-94a1-74f36eb685c1"/>
    <rdfs:label>paroxetine-pimozide drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/92569e2a-13df-4e6f-b316-cd4b0ca0911b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/78533cb4-6bbd-4450-a580-17699510960a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4d32829c-4614-474a-b4ad-faa9b67f8150"/>
    <rdfs:label>rifampin-dabigatran drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b687a4cc-265c-414b-a771-e4e969532950"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ee0c1de6-3854-4530-a723-8e4b452f6ed8">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/de6f7393-a119-44f8-8f0b-0fb03bec8757"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/5ef18917-0931-4a03-a963-2ff0a3ebd9ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/127ac3b3-c6ee-4689-9435-f6d5dc554cbf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6876740c-2376-41b7-8aa7-d8edc2412217"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/4152e755-2de3-48bf-8905-31ee645e7bfa"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ae30ad1b-3313-48c8-8668-e49d12600e19">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3c875814-ce0a-463f-af83-fe4da7de3a6d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c3fe6e08-3403-4408-bbca-4a75a7161425"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/b0fc47ab-a55f-4e04-a53e-2b8ba3454c03"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ded164cb-a385-4c35-9b55-0dd40f209d3b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bda76542-df8a-40f3-9ed6-f10ccf3e6ee4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/9a69dbe5-7a63-42e0-9b04-dc535c81fb6b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/632b79de-919d-46c0-908f-c4d523983986"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/732bee1f-300f-4339-a270-6a45b9af643c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8f402fb5-ea24-42d3-9436-12d13f2b14a1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c3565774-c745-4507-8cf0-680504fba908"/>
    <rdfs:label>Fluvoxamine-tizanidine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/25088c28-d65f-441b-92b6-eaa278e84202"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ff5704df-7694-430f-9846-4229b71895d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/47669ddb-edc5-4d98-a817-411b4677fddf">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/66df7561-8cff-4f0c-96c0-3d9f45dff586"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/24af9672-b957-4d22-8922-a374d03b129c">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/53a73fdc-4830-40a5-9243-69790f847860">
    <rdfs:label>simvastatin-Nelfinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/02300a26-3481-4c63-bff9-aa053d36a1a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6d8e1b5e-7a96-40c3-85fb-61f883d622ca">
    <rdf:type rdf:resource="obo:RxNorm_10502"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c43f621a-bac6-4a38-9f47-1da001e592b2"/>
    <rdfs:label>thioridazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c58bd4ee-bd31-4dab-8905-5821552d6b35">
    <rdfs:label>fluoxetine-P95 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/cada25c8-7816-45a5-bff0-ccd9f0c48779">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a63b7541-c846-4da9-87c7-14879c038ac5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/8a304211-4ac7-497d-9ab4-60e13a3a7c00"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b80610ed-7f5e-47bd-a1c5-fefa689462c9">
    <rdfs:label>citalopram-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ab8a5a49-4683-484f-8051-2941ef8b2734">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/958d60b2-f410-4f1a-b6a6-f8e06997da18"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/1534dc7c-11e4-499b-bb84-2bb0f786aa8a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f2073e9c-2694-47ed-a4af-4ba8c70a1e6a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b0a78382-15dd-4b36-a81c-bbae4a72e057"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2f8098be-1085-48fa-b538-cb9d636a5c7b"/>
    <rdfs:label>alitretinoin-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2c7a5fdb-af22-435d-b323-cab19c5fb791">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1beb7dc5-2fcb-4579-b2c6-368376014dd8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/26bb2247-09d8-4802-ac24-7a508ccfeedb">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/844cbb42-b6b7-4c7f-b01e-a992c9b6a4cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b1788393-201f-407e-9488-4f0e7b590e9d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/0ba6a3eb-1f64-4114-91a2-ffc9d202fb7b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/01c5ded1-7cab-4648-aead-a4925ae973b9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/08d777c9-47e1-40ca-9628-92ff7bd33171"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/33ebe71e-7339-4c9c-bb51-06ebe89326d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3b236891-b8fc-4393-9b66-f73cf321c17d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c0491905-fbdc-472c-8b98-d2e194332299">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/26ef6d84-9e50-42bb-83a5-93b968ac6d4f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/3d0eba5a-17ff-443c-9dcb-4507c04952a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/51681399-2d78-4795-9f47-40b5f507f9d9">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/594b1264-112e-4b86-9ea9-8a9e93314d48"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6f40f1a0-7631-47e7-af0c-6a169f13965a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/feb465ca-0711-479e-bd18-0655de2f8936">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c5b0ab14-dd57-4f44-a45d-9e1eefbbfc9c">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/60f6acfa-76aa-4bed-b00c-5f5fbe69ce41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fa7e33ed-febf-45cb-b502-3cddf51002e2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/32da0293-6551-4c24-96fc-5d9be3d855f8"/>
    <rdfs:label>citalopram-ketoconazole drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/732fc5f4-6e13-4995-afb0-a8ebc5eb6228"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8232dd4e-c603-4dd4-bb53-a120bd09c79e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e377cfff-9383-484a-a5a4-42571c6c9567">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c3798e4d-0c9a-43e6-8bec-e7fc38dbf5e8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3386e74e-1949-42fe-9c93-d9235a03e820"/>
    <rdfs:label>simvastatin-vildagliptin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b69b0668-3543-400f-8440-26eefdcbf716">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/721f358b-3dd3-4f29-8185-5ba6c3149c90"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/f041a1a5-a0cb-4b81-befc-d4d7ce1fde28"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/fc8d0fd7-6eda-47b8-941a-ef7bc8d6d53e">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/2076d8b4-74f1-4b4d-baaf-d111d044b124"/>
    <rdfs:label>midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/aafe92a2-be4b-400b-9e57-d79b6775501c">
    <obo:OBI_0001937>1.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/21e9b1bf-0b75-4b57-8f48-9ab3352c95f9">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9f3094f4-7a2f-4a56-b76d-ddd691fd5130">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9171219e-51e9-4caf-8f56-c05fd2fac53d"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c49cb6d2-8f79-4cad-bcb9-f01e09a23715">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c2a11acf-09a4-483d-975a-78b0395e7b25">
    <obo:OBI_0001937>8.61</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/236dcf03-a979-408d-b082-0a9930a2bec4">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9fc130da-0964-4105-b8d2-a49144657c31"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6af36176-549f-481b-afe8-50a99bfc8639">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/69c30196-07d9-43f5-b5e5-31281ce306f0">
    <rdf:type rdf:resource="obo:RxNorm_3443"/>
    <rdfs:label>Diltiazem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c073e573-57ce-4f8c-a55c-b7f6cb47a08c">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9ae54f91-1962-472a-832b-afa92c1dd4a1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6991e5b7-9ed8-4fe4-9744-4796948b7f47"/>
    <rdfs:label>Boceprevir-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/6595e743-ebe7-4b1c-a4cf-f9ad9fdec08e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/3c799bba-9636-424a-a5e9-82c30c19b835">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/3a55701e-9c0a-4194-a445-216cf0bb51f1"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a8fa911d-c3fa-4e75-983b-a128693929b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b6c0ee14-570d-4f2c-ac3e-7b93996a1628">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/eb85ddca-da21-438e-b1db-2e7973292b6e">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/6b4179ef-0eb6-4448-84c4-8a2091db0954"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/74b25851-33ee-41fc-bcdd-14e0c7a6e449">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/819ce0fe-bdbc-4a86-8913-84fb459eea8f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/2ce9d0c8-c896-4d94-9ae0-076b78cbfbb7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/e71e3977-2801-4494-ab1b-2e1ddb51a0cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1fd9821d-f64f-495c-b00d-c99ea5b09edf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/61c33dca-b8ca-432a-9334-8d2ee73813da">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c6dc112d-3d44-4518-963c-8a1c3886545e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/d775b3a5-f802-4c14-8a6b-320effda822c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/b737ce89-3e2a-4bb8-b8f1-5eb868222c80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b908b19d-43e2-425f-9e08-5eb31ee62b37">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c2a11acf-09a4-483d-975a-78b0395e7b25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/50938b8e-d9fd-448a-b490-2b26d20c1fac">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3aa14565-c7b3-4157-bf9d-216809a68f61"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/fc07487d-dd13-4a20-b1b4-1f97bcd8455c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bbd9e453-275d-4b83-843d-22bbe0c95cd1">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/e6bdfd3c-fec1-44d9-8211-5152869ed1b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/7b8cbb96-af2d-41cb-88a5-069da0985bfb">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/8d1810d1-f940-4c77-a93e-cc82f8274a86"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/513cf7f6-cd25-4dd7-9e54-f7614dc14b50"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ebdf3c57-675a-4bc2-8c1c-d27eba24fb33">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f5440d6a-9bb8-4329-b150-176db1646c2b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c040c03f-f099-4a9f-b71d-2cfca8425b68"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/06302345-5a5c-47cb-b06d-bf9f2fd863ca"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4f1be6df-1285-49e9-afd4-62ff1ec25009"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d5329057-f479-4346-b8d2-371223416e4a"/>
    <rdfs:label>ketoconazole-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b0a78382-15dd-4b36-a81c-bbae4a72e057">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0fafe663-f0cb-4886-9324-8077ba9efef0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/1120c78d-7ed0-4573-81de-7f30945a8dd6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0cfee536-de55-4a4f-a0d6-3fad469a1bde">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/7931daf9-70b1-4ae2-bfc4-a82445a9e0ba">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/1be58969-f778-41f5-ab36-6f196ef365ff"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/1d1b0bdf-7e31-4d73-ae58-38f298f543b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/088c9293-023c-4af0-98f7-33b2e2a7a06c">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/cdfdb476-4668-4daf-b744-7c2433cb0527"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/11a538a3-f2fb-4520-8e8c-897dd3bbdf90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/409a2234-2def-4035-851a-8a647edf77e6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/e8976942-a378-44be-bebe-7befd7f5d979"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/00995dac-20c5-4725-bdda-9b85e0812ef8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d6743a09-b3d8-4462-9f24-9254817f8209">
    <obo:OBI_0001937>10.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9c95405c-7a47-49da-8a60-4b1a9bcbef7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/2a80a3cf-ace5-42d5-a017-d87b6d08b463">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/490e553c-d8f8-43a1-a34a-547db9423bff">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3600d68c-2d14-423a-a37a-e2357074044b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/00439eac-a497-46fb-901d-97dcd03304e3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/788aa38e-3406-4f8e-8fb6-3ac95d75ce64"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ffb8fd13-e47c-466e-92c4-49d402871cf3"/>
    <rdfs:label>Efavirenz-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8abac66b-c4bd-4270-a8e4-c527f7f3d3f3">
    <rdf:type rdf:resource="obo:RxNorm_10767"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7966350a-1a15-47c3-9800-36feed2738ab"/>
    <rdfs:label>triazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bff1ea4e-dac8-45d3-a7de-1ef4059a84ed">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b80610ed-7f5e-47bd-a1c5-fefa689462c9"/>
    <rdfs:label>citalopram-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/28947c4d-4b9f-400c-ae1a-cc59bd2bb1a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5334118c-fedc-407e-8be6-d6b62e0c3b81">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/7712ebb2-9743-43ec-bfab-13068e524e81">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/4a5831f3-a9c1-44ee-b25b-ab15a6445bb2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2ba37d89-702f-4881-87ae-bf07f548c04b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0ba3ce91-8c57-45fc-a241-4552e321b184">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b29b5694-acc9-4528-9fdf-2d1109f5acb9"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/6b528215-095f-41fa-8ac3-dacea497f2ef">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/68467955-6819-44ab-9713-59e2b40dcffd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/66fda0ac-4002-4dea-8e8e-6c57cee07d13">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/378096c0-bc7a-473d-aeb0-1d76bce14e56">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c7593d57-53e7-4314-b64d-1de01081aac4">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/91579c42-7789-440b-a942-a24bae00bb53"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/03aae529-c936-4ba8-8dda-1ff27b7b4953">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/eb5387a7-9bab-4eb1-8a6e-33ee0767d6f1">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/36e481b8-81c1-4139-ae65-bde58ce78d25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0c9dff06-6d03-43fd-a480-d1feef1c1ecb">
    <rdfs:label>fluvoxamine maleate-alprazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3411a84f-bbea-4746-9813-5be8b56a24d5">
    <obo:OBI_0001937>81.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/650de49a-d4da-4ab8-a6bc-80b925604b3c">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/bc9837b6-8b89-4940-a48c-e46e10365ddf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0942ab66-8aa2-46fb-ab5a-e70faa901382">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ddc60b4c-d7c4-4a78-8eda-360037a1581c"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/b5452931-4edf-478a-b1a8-fbb7e645ffdc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/779752b0-874d-45be-bcd4-e9b99ce1b1e3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/03658e42-b191-41e9-820e-4e0994a07cd1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/fd61cc40-4754-4ab3-bf8b-32f99bce2044"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b49b50af-755a-48d9-b5c9-9299f937953e">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a61b6c0b-a6c3-4760-8d92-305f8ad8612e"/>
    <rdfs:label>NFV</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/97dae30c-fcdf-4747-896e-8c5c869bca0f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/679d7169-533f-46a4-ba8b-2ba4af34bcb1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/5ce76b7b-357d-4d7a-bf7d-9d625bac5a7b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/3137a62a-8869-4957-8393-1c1d078bd31f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b8e07ed9-2cfe-436e-9f52-c958458fe3f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/481d2cfc-e173-4cfd-bc70-afbcba257315">
    <rdf:type rdf:resource="obo:RxNorm_42463"/>
    <rdfs:label>pravastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0189c45e-fb22-41d4-b24a-7d6128c5b89e">
    <rdfs:label>ritonavir-erythrohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/39ba790c-a444-4b9d-996e-6ca6cbdf96e1">
    <rdfs:label>Amlodipine-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/30ae7bb1-cbba-469a-a412-7b7ea77673b5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/23a0580d-cefd-4e74-b93a-ac9b0a90f114"/>
    <rdfs:label>atorvastatin-norverapamil drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/aadeb983-f009-475e-82b8-71a60be559c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e5d75528-cb50-4550-848e-d6ed32ef7d65">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9a070f5a-a2f9-43c0-a384-95362d3a5a6b"/>
    <rdfs:label>zaleplon-diphenhydramine drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d37d5182-a001-490e-81ad-5826cd46c46c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c24fb7d5-6681-4d13-9025-869bbe15760a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a742060e-6c10-4fc2-a383-a80931b380bd">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/0a0ab399-c7eb-403a-9f22-25dfc817fad1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7dd2b0e4-a445-4fa7-bbbb-4fe18854e1c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/97767157-178c-469c-9e0a-7bd2dff895c9">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/bcfda25c-f9f9-458b-988f-913988e6c0ac"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/91b07be2-393b-4037-8d95-0d47f39a1712"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/d2124407-5648-4ceb-8043-1da8a90d56f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b8604fc2-c103-481b-b40b-33afe0f3c531">
    <rdfs:label>ticagrelor-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c649ec52-eeaa-41a7-9a5b-270cc15d36e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/afb56c16-7183-4680-810c-1c87f647b480">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/afa2ba75-71af-4f13-b88f-05d7d0fce615"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7e975cdf-1905-46a4-af9e-f642c951de55">
    <rdf:type rdf:resource="obo:RxNorm_8703"/>
    <rdfs:label>fenofibrate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/81923509-4500-40b9-be29-e1cd71ad971e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/2c11d8e3-08de-4dbb-8700-e790f840eded">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/02dd53a5-566b-46c2-8ff1-1f10582898bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/20078381-9107-4e1d-9eca-78a4acbcbc24">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/1f633857-6649-4373-8619-03f327ccbff7">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/d7026c05-acee-4721-a6a7-103c7ec19edf"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7e125144-76d3-423a-a62e-3cf7bb1cebd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7fcb76fd-ca17-4905-9a40-50daade6ffa9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c4008ef8-df7a-46b3-ac75-7cc1575de5e9">
    <rdfs:label>citalopram-pimozide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/60f5ec95-a527-43a8-a3f6-1cd0107ea2a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/822cb936-ddfd-4ff3-bf87-34daecc15ca7">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
    <rdfs:label>aspirin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ab203163-116d-4fff-bc2a-49ecd82bf669">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/48528b16-59ea-4d60-9ac0-9c9c8b3d9fc1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/eed873a6-4b57-4783-b28c-3184da9314e0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/85fd7a8c-c608-442d-87f8-4d0030d5ad03"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/739376d4-65ea-4145-9e6f-7123dd334f1c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f94ca445-eebc-447c-a257-97ce17b8bc10"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/708d9c91-af11-4e0c-997a-00e797aeb241"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4c363f07-4c76-4f46-974d-b99ae8b28db7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/03ec9b46-e92b-4cdf-89d0-febe3f71fa03"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3bce7540-bc15-4d52-8650-5dec57f3d37a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/da97ba4c-1dff-4c88-891e-54b4215a5d4c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d729f362-68d5-4874-9127-2f0e9fe85e5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/985be040-3e2e-41d9-aa1f-8f572dc0bbba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/244f4d2d-936c-4678-8f90-5244f3bce4d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/68d850d0-c3bb-4006-ab4f-3b1050cb3654">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/4c918720-adee-4e1b-86ac-0ae3f6363752"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/857a9605-ad35-44a6-b99a-a354c9fb2196"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/e58151be-d384-45d9-837c-4ca9dc97ba35">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/00142e37-3182-43e8-a466-2ebaa422e5b9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/aaadb285-dc3b-407f-950b-1f586a38a1ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ce69424c-572c-4715-b5b1-ac78a7e9e3f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/81b465a7-f561-4217-ac69-3b8d89c2e772">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/18634f56-2faf-4b7b-8cd5-7f26c7c6e596"/>
    <rdfs:label>mirtazapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/298efe8e-580f-44cd-822e-544866bc93d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/ea294457-f081-4e60-b10b-cc913f3edde9">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/49008723-a95d-4206-930d-fad0bb46a6b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/88147728-7973-4ce4-82b5-15feb3817577">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/2ae4ab71-55f7-4921-8ce0-a89a4161f0fd"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/d07c47b2-fc01-4f1c-bbb3-e111c2f3a994"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/cf252504-02f9-477f-a1af-86c2a2517a33">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/673b10d0-6cf0-426f-addf-b02d41a07154"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/2200b3d3-613d-432e-a5d9-140cdcd8b120"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/c98619c2-53b7-4864-a009-ce391ec71ab5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0e42a2dd-484e-4b60-8b24-2ec01fa40fda">
    <rdfs:label>buspirone-hydroxynefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/5829e6b4-185f-4776-9862-74902274a16a">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/defd87d7-2b87-4d3d-8550-111336ddfdf6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fb946672-c887-457f-bcb4-331fd5a5d8f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/df981430-e312-43ce-b8f1-2d33c635c061">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2bf69073-8185-4601-a15a-856546c5ee50">
    <rdf:type rdf:resource="obo:RxNorm_10635"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/38565de2-9447-411d-89c7-a3aeec8a0213"/>
    <rdfs:label>tolbutamide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8068b5c9-0c45-49f0-b38d-c48c4ecbec02">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d7b2bad1-1e8b-4a7a-99db-4f502a6ec891"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a8e19b9e-f084-47d3-af3c-d7bfb088dd9d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e6802d14-f067-423d-b576-0a78291ea1fa"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5fa8a4b9-c8b1-4430-9cbf-3701c5ee6e83"/>
    <rdfs:label>duloxetine-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2a57ba9a-ceb1-43fa-a24a-895f890245b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4dc20e3f-08e6-45ae-93fb-fb9f0e673418">
    <obo:OBI_0001937>750</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2943f042-aa8d-49d6-ae8d-968fa453ea55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e6d9356d-d587-4ce4-bdbf-f0f9b883da7e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cb6033ac-9055-412a-b623-1940e3c4e28e"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5dc6330e-baaf-4d63-b99e-fcca733b8787"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c8d25d84-ac3c-48d4-8ad9-0c52cf0e31ab">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/bc2ffee8-7b96-48c7-9a97-847af57b9746"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1fd222e6-37d2-4797-b12a-fb88627fabce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d00d0626-4f4a-4113-956c-22ea435feaf0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a66f2bfc-67f9-497d-bd02-ff9d472078d7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/7dd2b0e4-a445-4fa7-bbbb-4fe18854e1c1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/9a766f53-5b0f-4a94-aba6-daf269398cb8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/21ae1efc-77a6-4847-a3b6-e5db2dc53232">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/72b5d3cc-7b81-4912-abd9-4f979abc0309">
    <rdf:type rdf:resource="obo:RxNorm_32968"/>
    <rdfs:label>clopidogrel</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/39b5a577-5a25-404d-85cd-5e06044f71ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/44ea4f37-7612-420e-af1c-4fd3967a535a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7d8ac2c7-2b57-4493-b62e-94fe19111868">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/867b58e5-4e31-4f15-bd89-6a02cac55d9b">
    <rdf:type rdf:resource="obo:RxNorm_703"/>
    <rdfs:label>amiodarone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/02b08dbf-085a-479a-8549-ad0b908b4d8f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5d87a0aa-c86c-4e36-a9a7-ac312676e7ad"/>
    <rdfs:label>clopidogrel-bupropion drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ac10970d-2437-4a50-882c-ed65df4fcace"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/78753bb9-bc97-488b-9a8d-6a6647a8bbe6">
    <rdf:type rdf:resource="obo:RxNorm_11170"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a12f0f12-ba23-4aab-9cb0-143422d01c6b"/>
    <rdfs:label>verapamil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f42cdc0e-19a5-43d1-8857-7a23a6185dc2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/fd73c18a-4ead-4cb3-92de-29fceb468f23">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b6daef22-5a77-4bcc-8911-4a6a7ba49183"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/c4b75155-4bb1-4759-9685-bcdc1531e922"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0e282dd3-3e08-4ba5-9e9d-1f7e54b3f905">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/94f11835-77dd-4a59-8e55-17761800b675"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/62d84e7f-9933-491b-b56b-216d2f43c974"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/9f6af65a-758f-4e1c-a138-0f28926523fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e42e2ed8-f859-4286-b75f-f45cea667ed8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/258d350c-dc94-4230-a39e-66e972c3319b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/88cc3832-42a7-44e2-87c2-d2a852b829fa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/37861ca5-ea26-47d2-ba31-cc24e6740d20"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/a15a103a-3af9-4343-8350-0b0a27593a72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/998187bd-1916-4e29-ab89-f1772262eb49">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7962b702-509d-480b-a352-d3b1e126a5fe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/7305b68b-e4aa-4d1b-a4d6-af1534b6c285"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0a637b6e-94ec-423c-8364-196d2c835cd0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/78a2443a-51b6-4e2d-8ded-a286dc6995b1"/>
    <rdfs:label>desvenlafaxine-midazolam drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/13508f36-0ba0-4c33-aedb-bc912c4a71e0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/51a6cba6-e340-4760-8306-d24a1004403c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1472ad26-e41a-436a-8e3a-c18bd0238c30">
    <obo:OBI_0001937>39</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/076c020c-0aa6-45e0-b1b4-4706d588c1a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a7186f6f-8cd5-44a9-a761-73ed93f55183">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/65e0b714-23db-43c0-a4b9-6eea9848aa5c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/5a93f3c6-1d9c-451c-9f7a-6ee99338168b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8622a464-5187-4636-9934-383cf6f277e1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9ee63dd5-940b-44a6-aa40-ef1318f01a41"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8794729b-b160-4340-a071-caedaa33b186">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7515e9a3-145a-417f-896e-ce3c9406ec02"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ac0ab53a-4087-49c5-aa7d-5d59f960fa73">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/1c171ef0-4807-427b-9d97-1f1220cca346"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/58e49731-b4e8-4750-9dcb-fefee04e6acf">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/8f47f424-adf0-4813-b674-a77a781611ef"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/634b186f-662f-484e-91d1-878dcfafc429"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/dacd736e-0095-4942-abc9-ee3971f7167d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/caad8737-5af3-4304-9049-82ba14d5be99">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/cb35659c-55f0-41c6-8509-69bdb5feac6f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f290c506-2bb8-4b02-9821-4bf85a2e1f48">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/98388819-f19b-47c6-b9ef-dbc12a030dbd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b3665c7d-5637-4bf8-b943-ce49d5830e27">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7864e567-bb49-46c6-936e-65f3cfc189b0">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/5d001088-73cd-452e-9371-e4153e5aba2c">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/251d06f3-eb78-4ba7-b2ae-ad53a55b81c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/268c7ca0-580e-4d02-9e78-918d5cda0173">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cd79e1c2-bfb6-4165-a46c-7eaedb686722">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/1287fcc6-e90a-4c0b-b7a2-b14eda6e53f0">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9b3c3207-228f-4128-be33-4ef306f60284"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/f6291a43-a197-4aae-b31d-e6fe98b34578">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/be46f3e5-9bc2-4566-b25c-3a7653bd64af">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a1140840-bbef-4521-b5c0-cf370a68aec2"/>
    <rdfs:label>telaprevir-atorvastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d144e4cd-6877-4419-83f1-f9c2e2b0ab2f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9fda9350-9b40-48c5-8d09-6f84800d682b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c3a92021-f7ee-42cd-841d-734aa8a11ac2">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dc8f87a5-aaca-4b57-99de-3d573fde00b4">
    <obo:OBI_0001937>42.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4563b344-82b1-48e5-896e-f34b2d2cd0fe">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/1b6b3daa-1288-4445-9c4e-1e21ef72e4f7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d02cdf55-0bea-437b-b83e-87c277bc3deb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/5a85db01-bee9-4266-9445-3f8aab910308"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5f200e11-9eed-4b4b-8413-01b666eee568">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/207236dc-dbe5-47e7-ac14-1a2b25ddc229">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b58c0a2e-54ea-4084-aeeb-83a3ed7a4c5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e404e19d-21a2-41f7-9c7b-d5d65b46b816">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b3665c7d-5637-4bf8-b943-ce49d5830e27"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/9289d9ee-ca13-4d1d-a020-9ac3c7f310d9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/ba26a965-9dfd-41b3-b740-b03efcb0acd9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2b3bbe35-80c6-4e7c-a7ba-544c80800401">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/36f76507-dc46-40d4-be14-ceccf4a16aaf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/afec15bc-ce58-4455-a7cb-82abe2761db5">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6944fe3a-173f-4373-b76e-856c95b272ae"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/0788401e-8e8e-4a9e-9d7f-eef7140a56d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3e220779-3b10-4a46-bcf8-6b2ea1997695">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/eefcdc9b-c7c6-461c-8499-a40931acb7dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d8b02527-47e4-496d-95af-e586f6423961">
    <obo:OBI_0001937>9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/6e693a19-2a6a-46ca-98a2-980a3de8694f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b1360e45-68e5-4dba-b45d-37d72d9644f5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/092b8925-1526-4f54-834c-499bf6fd23a1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/385c9427-3520-4bdd-be10-901af13eb661"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/41a5fcbb-594e-47b2-a1c3-9c6ba35b7803"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/06d41978-eb1e-46d7-9813-6f8146fda969"/>
    <rdfs:label>desvenlafaxine succinate-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b05634af-ada2-4c6a-a561-e8632d62999c">
    <rdf:type rdf:resource="obo:RxNorm_10689"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c781da63-54b0-492c-af19-14a58144ce00"/>
    <rdfs:label>tramadol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/68348751-e9f4-4c0a-85c0-fc1397faa1d7">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/4bf3193c-6f51-49a5-a815-78f4688c7e02"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3c0215b9-0dd1-4b22-b5a5-19e5facd1c78">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/deb08a01-6db9-4260-803b-d5d5814d6c5a"/>
    <rdfs:label>fenofibrate-atorvastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c6224d78-801a-49df-b653-5d08263fc546"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/4d9a1667-0f3d-4356-b35b-131906bd6136">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f1f8f444-f659-41fd-9d1b-ff658f3d545e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/099ff3e4-f3ac-47ef-96c5-543ace727d9b">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c72cb449-f007-4766-ad99-da69862989e4"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/6efa24df-1ff7-42d1-be89-4f2903c312b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/7e6b4916-7405-4ed9-b23d-cf9b5a42a139">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/686e4da7-c50e-4deb-9674-9f9c1aab4330"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4f22fde0-3d7e-4832-b8a6-bb1340a12d58">
    <rdf:type rdf:resource="obo:RxNorm_325646"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/38c0fd83-882e-435a-857f-e5af2eec1b86"/>
    <rdfs:label>aliskiren</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/4a7877c7-7102-41a3-a39d-a76e653a80ae">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/d7f186ff-04f0-4cc8-b2af-368413543901"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/7b184007-1114-4023-95f0-e90141e3fcb5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/51cf122b-874e-43ac-8dc6-298167e000be">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ab203163-116d-4fff-bc2a-49ecd82bf669"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/cccdcacd-be85-49ba-a5d6-a728efe34eeb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/db7cf377-5800-4fe4-940d-526b2686c82f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/e49a039d-0a27-4a67-ad74-b7f9324b08e1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0b9112e5-c43d-4cd0-9789-19b408de2c7b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/aef00996-9032-49bf-91ae-332ac1533967"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7f5b3806-a41a-4c64-b7a2-b0bf26f6ddb4">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/6b3fcded-7120-4fe9-a749-c0c0ccf68b95"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5db1d799-40f1-4311-ae90-b10a4d94ab68">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b1b6a239-29b5-444a-91bf-e23357a56149"/>
    <rdfs:label>iloperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6e91888d-8614-4e82-a74e-6cd654784a98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/adfeaea5-d15b-402a-abb1-748b28695fb5">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/475bd951-46e6-4a87-854f-285d751f9d60"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/abdd1b5a-5f6e-4df5-a586-718028bd1afb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/bf60b148-de58-4866-96df-0cd68681f787">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fce19286-84e4-4b21-b5f9-66a09a0aa1a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0e7b8929-178b-4fe9-9b3c-0d6cdb800c06">
    <obo:OBI_0001937>125</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/73f15f3c-cf73-4121-9573-12b1999b1ff7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8ca33ea7-06dc-446c-92a7-0a3b04f082d0">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/250477d4-25b5-4cdb-bfcc-a8337703dd96">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7c7f8602-c150-4afd-ba11-51edd2a867d3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/da6e3c99-462d-406b-9e65-0983ebbb6c61"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/90febc13-1a54-4b01-a88f-880c442a6873">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/34de9287-25de-4b10-8adb-c4a363b9d17e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/179eb2a2-3334-41aa-8d22-68e3ef64fe0f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/976486fb-2165-4ba6-99e1-3257a9df1ec3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/398a7130-d5ad-411e-88b1-5972593900bf"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/b58c0a2e-54ea-4084-aeeb-83a3ed7a4c5e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/086e733c-7ad5-44d5-b79e-74e9acdee492">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/80587164-1cea-4969-bdb0-d5e518bc6e91"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/75b7c3b3-4547-4e4f-97d2-16670839f0d0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/511fe8d8-ba19-458b-a8ac-f748727a7ef6">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3bf92b3f-e5f1-4068-9d8c-9cea1de22cd3">
    <rdfs:label>carbamazepine-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ab1aa918-c0e3-453f-95b2-f744c31dad57">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/2c5e76a6-f4ac-4a1b-9b1c-566ccc45cd9a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0eaba5d2-f3a6-452c-8c18-52ca888a11bb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/2601b923-f8d4-4092-8518-ec09742d59ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/29d92d17-fc83-46d0-9b1e-01f04e792290">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/471f44a7-387f-4d98-832b-570d72422459"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c1e9f7f2-52a6-40ee-a299-eda5c15c5bcf"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/67983452-dddb-4136-90b7-9c65e99503c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/53d042c7-417f-46a0-80c6-a3ab0f199203">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f52a692e-196a-4eb0-955e-6608afb7738b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/07a5c3b7-db0c-4c42-a0d9-c97896c110aa">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/e733764c-b527-413a-b686-2f155983c912"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/d0a22074-ba0e-4e95-9d05-fcbaa27dd6cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cf25c889-5c34-4e41-915f-bf2f75224d68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/eac26e1d-90cd-4932-9abc-5de84db41b9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ee1349f9-515f-40d4-bc76-c6fb93654b33">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/bcaeadab-9b6a-4928-b87e-317e43ea646f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/d8df8a9d-3780-41f3-8b0f-2d63de0b4042">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/35b5ad52-e398-4274-a574-e1b8ecddadce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9a070f5a-a2f9-43c0-a384-95362d3a5a6b">
    <rdfs:label>zaleplon-diphenhydramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a74fcf7a-6c90-43f6-8ee8-beec823f28f9">
    <rdfs:label>Fenofibrate-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fa9d8158-7218-478f-a076-fee359d719eb">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/8aa5737b-2e58-4e58-a531-173e832df18d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/60cc9ac8-d8b0-420c-87be-4748989633a5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f4b839a6-c88d-472f-b317-860d11cef106"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/083d7385-589f-44f5-86b0-4a2f10b2ee2d">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ee1349f9-515f-40d4-bc76-c6fb93654b33"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/cbc01ea0-10bd-45c5-99a7-cec3491a4cfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/98acc68d-76b3-4d1e-abed-2fa7cc5c0813">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/05d2c037-298f-45bf-965e-8c56ca46cf87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/02500bd4-563f-4cca-9465-209968540242">
    <obo:OBI_0001937>1.12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1e6ccdbb-4d02-4e95-a589-39c3166c4879">
    <rdf:type rdf:resource="obo:MeSH_C092333"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/42e2bfb4-0528-42b9-be41-70e879a64cbb"/>
    <rdfs:label>hydroxynefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c7af70d2-3943-439e-bb51-98aaa07b75ae">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/df3b2879-6ef0-4833-973e-2af0ee4d0bc5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cf5bcbad-7bfe-4a43-875b-f7a253190db2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/503e7a34-3447-42a7-9444-a85b8f381a56">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7f5b3806-a41a-4c64-b7a2-b0bf26f6ddb4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/343fc49c-a686-4d17-affa-fd0a571677ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a87aa98a-3113-491e-8d6f-fad8aac33fc4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9cd9f5de-6693-40b3-bdbc-3aeb4b7765fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5f648526-db33-4467-b810-3638eb9d3fa8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d2603b9c-e13f-4093-90fa-758353ba4788"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/91310d5d-35b2-4341-9aa8-4b33abff3dcd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/940f53c6-24e9-4f5d-96e7-db57c91fc29b"/>
    <rdfs:label>paroxetine-tramadol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/49d1a01a-9818-4c40-ae6e-a151861a9e6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c13714ae-ec77-4f9f-bae0-d88bff6c81e5">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/9c88087c-8ada-4f2f-803a-0d857ca8cc52"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/f6dd2289-6ebe-405f-8524-f67f0fa1fa94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/cea29ae4-b999-463c-8b1b-27649097c163">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0f2aa808-314a-4789-8037-df5bbf99189c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3e79511e-830c-4014-ade3-531f19a8d2d2">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/fed1e732-c622-417d-9ec6-d9b2ea7a0aaf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/aebe7ae2-c4eb-4687-ab5b-8ec47914052b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/e798f48b-8618-472c-b577-4fc42ceef216">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/3f12343c-5fec-4ef7-91e7-5138a17d10d8"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ec35ff82-33e1-4c10-b570-51d0e7e8c268"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bb848e58-3318-4cc3-93a1-6a8bda091351">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/8b7e05d4-ba5a-4b78-8eb6-d5ca739fafd4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2937aa85-0b23-4218-8dd9-d7be093b6e75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7226e225-dff1-45ff-9609-3294276ad5fe">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/5f9dece8-90b9-40d4-8fb1-54c53d665f98"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/59b7e95b-722a-4fb0-887e-88aeab262922"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/bd6b4ef4-576e-4f4a-84c2-0d93f771b504"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/23ae732d-ce4c-45bb-a156-a96055e6ebf7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3cb66b1c-fd9d-4a49-aebc-94733002b5b1"/>
    <rdfs:label>Gemfibrozil-Atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ea5c8edc-50a1-4325-b084-f486d74cd83b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6128b707-c195-4c97-8d6c-64aa76df937b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4dac567d-28a5-44c0-82fc-9229624545fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/23178614-d64c-4b94-8c05-e47f7a45f787">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/84e00839-8e42-410b-92c5-8f178a4ce8e5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b4a756ad-f9e2-445a-85b3-3a2096c29cfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e8049e6e-00c2-4894-ad8d-184f5ca7897c">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f527d6f2-817c-41a9-8a6e-7b8aefadb62e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7daf676a-ef31-4a8c-9d22-59a30b5d2932">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6250cc5f-ec3f-4fd3-bd37-55ccee9bd50b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/a97be386-77e6-40ea-b86d-a6bf45ba9166"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/faf37be0-c4a3-495d-b934-62176c0dd2ac"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/5f166504-1ebd-4ea0-bff3-728a724c7bea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/633fce1b-7170-44ee-a8e8-edf3c6071fd6">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/88c89458-5049-4a1e-8900-d9b96099f62e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/57140fcb-3a92-4b89-9ae3-9bd5a703534c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5369ddf2-86c4-447e-8c07-9c706cd974e0">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/0ef8a4d8-3743-4ce8-9224-527a705ed699"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f0f3c80d-31e3-4d62-a5d8-00ff2a76ca57">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/badd9cb2-2056-42e5-a6c3-c334f1324859"/>
    <rdfs:label>carbamazepine-mirtazapine drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/478073fb-e884-48fb-8d51-4b99aba39da1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/396e457c-63ed-4801-ac78-14b308cd4e36">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/8353a441-915b-4fe0-baa4-19647f8e15cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/29adb58f-52ce-4c7f-bcc4-1dcd71902ef8">
    <obo:OBI_0001937>18</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5571de5c-550f-46b8-9017-50e1f1acc73c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6a5fbe89-244f-4321-a3b2-916d51a1e926">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2ba321a3-1408-4a32-903f-86564e66f0c5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/21692adc-25f8-4ec4-bba6-4d7c28aaa645"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d0e50687-6e68-4887-915e-96152658b15c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b35e9485-8703-44a0-9646-bb1e5424f50c">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/6cdcee96-b9cb-4484-8ce6-78bba20652b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e12a3804-6c89-49d2-9dad-1bddf97adf59">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/b6404cd9-79ef-47e4-b932-19432bfa5fd0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/a746f03f-acbc-4db7-92ec-44fec9258d0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d84e8839-38d9-468e-a411-8d8d4fcb1021">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/81a7e52f-7842-4d24-b1bd-b5b377afb874"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/9d9fe7a3-158d-4979-b980-77d8de9fd5c4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/bebded05-bd37-43af-8a02-bc5957506fd5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8f87fee3-a353-4152-bc63-e7af59239e4b">
    <rdf:type rdf:resource="obo:RxNorm_596"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a1532324-8ec0-46fb-b216-72dac661083e"/>
    <rdfs:label>alprazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/039e62a7-1d07-4326-b8f0-453f25b5a7d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/51d86981-a369-4a9c-ab7b-6e6cceafae0d">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/41ca22cd-b638-4480-a5b4-ff3ea5b2aca1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/2000/01/rdf-schema#label">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b9d6352f-98f3-486f-a365-c2950c021f3e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/08595208-719e-409b-9bee-8465c0197870"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b8cdb992-477b-46dd-b6a8-d52c022dc7cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7b88cd94-085d-4063-a09f-738ce75a6a0e">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/8e9c059b-f2c6-41b9-afbe-4bc2b580db7f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0f19e7e2-a9f3-4132-a48b-7ea3fa21379c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/588bc802-d4b5-4881-ba1b-7a34087a8dc1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ab8bb100-a810-43bb-bec3-fa05d79b171f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e2a7feb0-3898-4ac2-b860-64475c122fc2">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/2ee61a39-ec59-40a8-839a-e2dc11f8c87b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6dcf9b2f-b430-421d-9165-62c4071e35f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/cf252504-02f9-477f-a1af-86c2a2517a33"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c595713f-dfaf-4a2b-b7e3-ef1b1d6bdc43"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e7932942-1803-4138-b857-072e25522841">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b4f6c986-e9d7-43a6-8876-dbb6d43c4e3f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/c2aeae5b-fa14-426c-a4bc-6bf772f762ad"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9aa25238-b608-4a93-bab6-4890bfabb713">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/265c0686-5fcf-402c-a953-870c9e0d26ab"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d930aac9-e947-4f37-abd1-e327e41528ed"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/8adb3e43-e997-40e3-b7e3-5f4bf8fb189d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/2972b6de-c015-4de6-82c4-3fec74bbbc4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8716bdc3-a083-4449-9604-016d3dc4daf7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/edd460ee-448f-4979-a363-d3c0d6cdfac2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/fee55c76-17ea-45aa-b95f-65ea64b29ef5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/68adef3c-42ad-4072-be02-8470e978b539"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c579ee39-37d9-4133-8394-1584fa44268e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/13c558ae-2536-4872-8369-e8c3bd71e9ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/aa053813-059e-41b8-9e0d-c8ed0e21c15e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/cda60141-0d2b-4f2a-8391-8d88e00cc9b8">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a23f71ff-7024-4bb1-9855-59d09c26191c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/21fb8bdb-a6ca-4e97-a49b-002a2116cfd4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a4d20153-a30f-40fb-94b2-3b61f539d95f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/774bcd7a-d5f0-404d-bfc4-7fa6f47caf78">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/f687c19b-05db-4138-833a-dff57c2cd3c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/a8113b6a-a743-4075-b7cc-e06c90537028">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/baf13946-e8ca-4002-80a2-ed36ceb156de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/1a75b24f-4b42-4fb4-8dfa-82967431ef7f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/bc4b2ebf-6f0c-4a4a-a115-a0409ca8d72d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/105da791-7aa2-480f-a7ec-12cb7c5232c5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/70820378-b851-4857-89a0-c8b563a562ca"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/785358bf-4860-4b85-b806-f839c3345658"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/296d1c21-d840-4df7-a6a3-790b27e29094">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1e8b2291-55ce-46df-8dc0-27cec7612649">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0b2cb6f0-17a2-46d6-bbcb-2c9cfca00081"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4ee8e852-f150-4a3e-84ba-64500dd96630">
    <obo:OBI_0001937>26</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d61ab4d7-aa7a-4099-a43e-947e6fda90d2">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b96a8f4b-c1a2-4baf-8c69-7a50bc6e51f2"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/122202af-6b4b-4962-aaf2-c7953272ca6b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dcbedba9-d65a-463c-b04c-8ae89f5696a1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/615731f1-e5ef-4612-980a-360b8e9525ff"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/50e26331-dd62-4f1e-a3ac-bbbd993d62b6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a4eff39a-625c-499a-861c-3a278c786155"/>
    <rdfs:label>phenobarbital-paroxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f2ee30a9-fe06-461b-b9e3-ddcb7b0335f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ffc456c8-ac16-4100-8a0b-227002bbdefc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5f862b8c-a8df-4509-9016-d16a314e1c3b">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/6a95f270-ef3f-4598-b412-6e2609c50c2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e9ce9d88-d848-4217-a3a2-0ef84c280ff1">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c4ef221e-5bf8-499f-8e1a-02f1d122c4c3"/>
    <rdfs:label>iloperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d8e79090-b8d9-4d1f-9299-eb8bbb588237">
    <rdf:type rdf:resource="obo:RxNorm_9525"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/366894c5-1292-4667-aaa5-10359beb4192"/>
    <rdfs:label>salicylic acid</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c50cd07c-d72b-45f6-bab6-2f42c46dab74">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/094ffe9b-fbe9-47cb-9d24-7e33657cc662"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d36320ed-9dbd-4d4b-8ebf-1f604533ef24"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/00c10bda-aab0-401c-ac0b-d4b447152e07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f5e63084-7d35-4c54-8964-0fd38c6a6df8">
    <rdf:type rdf:resource="obo:MeSH_D014859"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/686e4da7-c50e-4deb-9674-9f9c1aab4330"/>
    <rdfs:label>R-warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a5c81b2a-4105-4e58-a1fc-8904ff201352">
    <obo:OBI_0001937>110</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/b441d6ce-39de-46c5-8e52-31b555776f07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/07ea6b3e-133f-4008-af4b-7fd97df4c313">
    <obo:OBI_0001937>67</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f84a0da8-9b91-4a47-aedd-040283f0d24c">
    <rdf:type rdf:resource="obo:RxNorm_596"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d729f362-68d5-4874-9127-2f0e9fe85e5b"/>
    <rdfs:label>alprazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/bd4a9e77-17db-4002-afb0-d4544692387b">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9d888302-b370-497d-856c-d5960acecdb8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3a5feff0-6cde-4a88-bc09-ec4fc34d1662">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/838e44e1-5ef5-4f0e-b537-c9e3a2ba622e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/dc271693-80ec-4b31-83e5-5caa47f784fb">
    <rdf:type rdf:resource="obo:RxNorm_10438"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/13c558ae-2536-4872-8369-e8c3bd71e9ea"/>
    <rdfs:label>theophylline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b93b97c2-3fe0-4877-a657-0cb1d8ba9e27">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/827cda9d-38e6-4c2c-8ca4-1819e38168d6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/2bca8b0f-ecd6-4786-8914-2306cef41880"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/691cdf4f-2ab1-4153-bd37-e401d8b18e67">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/62776982-355e-4540-899d-93cdc909b373"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/3e27bfab-cee4-4e8f-b889-d73ded991d15"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/7c2be797-47d2-472b-9c65-29b860abb29a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e975a8c0-f41f-4782-a2fe-ba30d711a5db">
    <obo:OBI_0001937>UNKUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/b13ca699-ff63-4ec4-9579-aa9153588716">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/de0dad14-f2d6-4a04-90bc-735432bcd6cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/d05a3c56-a4ea-4843-84a9-f919f5ef0f04">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/8968b58c-661b-4144-8a4f-58535dec2d6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a89d03d4-ff4f-4731-ae5f-96299d33655d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/0bee23e6-d3c2-49bc-956c-f779f045d1ce"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/e3fc5f2b-9fec-4fc4-aa1d-9b46e9990782"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/10b6b80c-ce90-434f-8134-5e71aa0f40ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/30d8e80c-1840-4e29-8ca3-da6f2197f977">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/7e66ae3c-baae-4022-8def-f9bd442c974b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e8b56d63-503d-419b-b523-8d0f5f1c59b2">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/491f595e-e1b0-4b22-88e4-a2f738309ae6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/f7a2b760-e4e2-4d35-99a5-e7e96e73e0da"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/3acfbcc3-cb3e-4b0a-bb82-cd7e42686d29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/382d65a3-af96-4162-bdf0-b9ff9d738bad">
    <rdf:type rdf:resource="obo:RxNorm_6918"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/305ef049-b33e-4e8a-b6f4-c16ad4248a80"/>
    <rdfs:label>metoprolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/80277618-43b6-4278-925b-fcc3acd2939d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/67505592-2a37-46b3-a028-d9ff084198b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/2df12e8c-442c-432a-8958-9e37e89f79f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4c58186a-826c-4ee8-b88b-381ccf1c2251">
    <obo:OBI_0001937>4.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8aa1e308-04d2-4014-b6c0-5407b0222e69">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/17ed1cd5-143e-4285-b41e-d8368a3c1164"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5ab7cde8-1e4f-4bb9-820a-2c13e4227d4e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/6edbd7c7-62b0-4e49-b4c3-9392a5ac4c4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/76b2a95c-69cc-4832-bf81-0ba4bb4de3ed">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d98a524e-9ea6-499b-93ea-5fc8f2cdc0e0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/91ddb120-df34-4638-9448-4db8a3b5f51f"/>
    <rdfs:label>amiodarone-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/badb22b0-6d51-4d2c-ab99-7d0ef12a492f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/2c0616d0-1a28-45be-b72c-7df9fa4c6c6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/da77a1bb-5109-4489-a270-a67368129de2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3bba7da9-4340-48f7-bc89-1c3e0d5cc9be">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
    <rdfs:label>midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/2943a8da-63e6-4ff5-98c3-811a65113266">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c33e1658-4013-4c2a-896c-13fd93746f79"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/0fc17cef-b479-46a8-b1db-77725bd35254"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4c7bc710-ec53-4d97-a1aa-e2cf14ad2e9e">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/be74dce8-7107-4f81-8079-0dfc2f0e683f">
    <rdf:type rdf:resource="obo:RxNorm_10594"/>
    <rdfs:label>ticlopidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9ccbbfee-0484-47f9-838f-31cfd8359a49">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/3d43c31e-4f36-402a-b0f3-6d43d8b49258"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/dbd78ba9-c955-4383-a02c-17b6bf666d08"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4d717a00-06d2-4a33-b03f-19a7c460a816"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/81e38840-0f94-4fe4-8dd4-3d8c799e8b66">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/9ea0618a-24fc-4586-b22b-02077a8f320c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b5f882a5-8400-45d3-9567-8bb3b2f96b38"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e78e1e09-7677-4afc-9bdf-4bec20b17326">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/802f1cd7-ceb0-4557-8dd3-036a438d9208"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/2ef89d81-c840-4417-98a2-a2731055448a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/41fc075f-204d-405c-941c-72c8aeb66d4f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/428a3888-f97c-4608-bfce-f21a2c252424"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/1c3d9e52-9808-4ee1-8f4a-13ca26b26977"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d227ee3a-5a01-4d08-8434-54aa5ef017a2">
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/dd1a5586-42b4-4760-ac3b-1475d5449d80">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/658f9b95-bee3-4064-b63e-e80ff0b8b91e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/0ddb7d50-228e-4b5e-b333-34ec03b6c411"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/26b1f549-dc6b-4cfa-a769-3b2904a80d11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/42eb8d22-2a06-4df7-a84c-3f1b8bdcc90c">
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bcc6cd3f-c43c-402c-8166-f689b53335b6">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/23387610-0397-4260-9535-476ae113e624">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/342d2937-70ab-4ffa-bb4e-92dd54865934"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/3e8d47b2-dbc1-4e69-973d-71dce86ff085"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a41cf0f2-659a-4b44-ad01-d62fef2c8abd">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/004448fe-ee93-4a8e-9612-9440667e006c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/f2089b5e-b895-42dd-916a-d61a6b61017b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4b3fa050-e898-447c-9d44-b6dc6b197d07">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d48050c9-c0b7-48bd-91ba-d63d1b425931"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d172c7c0-41d9-4a32-bbc6-3fac2b8da540"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0884f0e1-29e6-4d10-a96d-3dceb3deedcd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/105da791-7aa2-480f-a7ec-12cb7c5232c5"/>
    <rdfs:label>Nelfinavir-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/69b9d62a-2b67-4473-ac90-f0312590dee2">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/461ababc-a372-4860-a8b5-2170942b6e17"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/84365b3a-9b98-4e61-82de-fae7c5f58194"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/2b73c3fc-6f1a-4a78-b4e3-2a21275be117"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/427d64d9-b398-4484-a411-b6dfb5aa6808">
    <rdfs:label>digoxin-aliskiren DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2283cfb9-441a-4672-b6b5-b7833c1a592b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6ea17474-6e52-4386-988a-f95b5691298a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e404e19d-21a2-41f7-9c7b-d5d65b46b816"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ed993fa8-fbe9-4e4d-b6f8-582c275fe99f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/96421545-87f6-4981-9fe0-6156e0004270">
    <rdfs:label>pravastatin-indinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/c0e57f6e-4999-44d3-975c-036aa8aeb368">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/1f68703d-5e2b-439f-93a2-f4ffdd762b6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5aeb63c6-5a54-48c5-92d1-77804dbd8130">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/589efe58-9ca0-437c-800c-81cb95e77f88">
    <obo:OBI_0001937>32</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3b0be9be-a7db-49cb-af83-1e5125e2657b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7e842811-eb05-4433-8fbb-605f8b587bcf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/9aec8da7-2478-4d99-b9de-0213726592a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/873b1917-fbad-4343-b940-4e8c4361b162">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ce6c051f-d4ed-438e-a0db-2d86b7bf229f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/678460ec-dcb1-4d03-973f-1fedf0e56f43"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3d9c98be-8397-4fb3-8b4f-19dc548bae9f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/4cfd91de-7583-495f-8e42-c51664b39a91"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/bda68ac9-ccc8-4d46-8515-5dcf78449ad2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/3f79835c-9ba3-40bb-b34e-9db2ba97eafe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8722fd3a-6696-42fa-a628-2b7cabd0aca1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/47f463f1-2f5d-41ec-b9a8-a588c5d192a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b1b6a239-29b5-444a-91bf-e23357a56149">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8457b80b-2177-4f93-b2b7-937a1157b6b1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f5092445-a3db-49a4-99af-828130d15e67"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/ec5ca415-4e55-4dee-be3b-a8282d5aa35b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/478bab01-0ccf-41be-83c5-feb5da6b5421">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/594b9150-bdb6-4ec9-aec4-7a2d067943a5">
    <rdf:type rdf:resource="obo:RxNorm_8331"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/2a879e35-6dfb-4476-a06a-4bbfcf1bc277"/>
    <rdfs:label>pimozide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/547edffe-5c13-4a96-931f-769b2bfca6ea">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/cb9abc51-96eb-4bfc-abfe-6d680071c41d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/187a4fb3-bc26-463a-bd5d-e40459d19167">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/440c19b9-560b-4086-9d7f-65df28f33602"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/061346de-f723-4425-822c-a4d384c00918">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/358a2b73-7e2b-4b75-b8c2-0d1945aece4d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/62ba6917-f5a6-45cb-b758-0da4d9ed9f91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/4ea3f288-810e-4938-916a-fe0c8bbe2fed">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/49e99463-5f60-4af4-b8b2-32ac602cc25b"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f2fe23e8-3804-44a8-b4a8-128114112c6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/22d668cf-8cb4-40c6-af3b-f92878030327">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/73558b38-db96-45e2-81d0-5a5a175d02b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e4df45d5-f7a0-4ff0-aeb9-4a905c992d12">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/31db9f3a-25cb-4ab4-b8d3-fa2b3285286c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/69da7ab5-8cb8-482a-b0f1-21f00ca58929"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2dfdfeb8-7acb-4b2a-83bb-12548e16e10e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3a93f888-5b00-4866-92f8-bf52268252d2"/>
    <rdfs:label>aspirin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/96c545ce-ac74-4900-99d3-6ce0a28ec25d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5017d2a2-eee9-4e4f-b9c8-32f56e803444"/>
    <rdfs:label>rivaroxaban-midazolam drug package auc None information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3760fb43-defc-436a-8d8a-5a9e18ad3af0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3dba0757-fcdb-403f-a806-690812fb1bcd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b5eb351b-f5c0-4e88-a1f7-b10e2f4f9fe1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/100c80d0-df94-430b-8f2a-4829d95ac3e3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/a239eed1-d31a-4ba6-afa1-c43e16df9f64">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c99a0982-ce0d-410d-827e-759ca5ca47a2"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/c4140706-cc18-4cff-973d-ecaaa9cd08dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a7e5c46f-6012-455a-804d-906d132b4513">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d1980a80-5402-4604-aa68-8e4dfede5b4b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/ae06c72b-b870-4f1d-be08-263649a9dccf"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/f42cdc0e-19a5-43d1-8857-7a23a6185dc2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/43cf6685-e0a7-4490-9625-3dd4015d2143"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/d3a54116-243d-419c-82b7-314d74107139">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/dc3bb6da-76a9-4475-8485-65695645a857">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d3dd09c7-a842-4c02-bdb0-79f367aabb57"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/901faed3-e6bc-4b35-bb88-5438df96af53">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a000c708-f152-4b8c-8942-9f7ae94fd0f6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/a1bc0b15-672e-4336-98b9-7aa42e179d3f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/dc8e965f-d126-4704-822d-d1bd301cd4e3">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/51681399-2d78-4795-9f47-40b5f507f9d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/04a34225-7830-4e64-955e-40e8965d9b55">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ad480095-5c78-4ee3-ae2e-fd42f17c2011"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/414fb82a-66c8-45b6-9073-5473650ff987"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/af2790a2-f84d-462b-8fe5-6d9a4d7bc866">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4bf4cb2d-c46f-4609-a15a-bdf2bee37d8c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/f6b3bd32-32f1-431c-9126-c21d50feae14"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/bcb981c9-a02c-4155-9c8f-3da68c92ba4c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/43fda1ea-2ac0-49a8-b79a-df7d24dc1a9f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c7aa3074-e1ef-4cae-9f6d-8accf506e969">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bbb2f220-3122-4dcb-b5d3-c41a3e6e714c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/07923610-f593-4b77-80e2-e41b8d4e45c5"/>
    <rdfs:label>efavirenz-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5fbdf490-3ff8-48a7-93cb-7a7e453dc49a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6e23b288-78bb-49af-9e06-c1bc11b435e1">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c46688dd-594f-4b59-9b22-24ff831d2b4e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/105495dc-2431-4aab-a946-561e2a6b2872"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/be3e4233-c353-43db-8a20-2a3ee5b1900f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f13eaf45-e4d9-4624-9629-e63999e32b54"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/d066b5c9-7be1-4628-843a-24b86fc53217"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/88bb92e1-00c9-4baa-9715-27f21b33170b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cb6033ac-9055-412a-b623-1940e3c4e28e"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/fcd933b1-a91c-4608-855a-8ba5a10dd458"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2f8098be-1085-48fa-b538-cb9d636a5c7b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a89d03d4-ff4f-4731-ae5f-96299d33655d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/2c731795-ca3e-4cd3-9743-a5abb17f1fd2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/3778d837-f72f-43cc-8d94-b9af74a462ab">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d0c74e0c-b248-4a9e-ba0d-1d77e9f9a948"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1d3367a5-4efb-4c7e-bd96-131b49bcba34">
    <obo:OBI_0001937>56</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/41805942-42f2-4707-8cc3-53c48412b595">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/29419461-d79c-4e97-a2b0-9a9e305b7b94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f241b922-e111-4f11-b336-3787f08bac16">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9ac6a5e4-a062-49d4-86e5-4452c143eeb7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e5200f96-3dc7-481e-886e-fec9c0ccceb6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/aedba7ac-a3b5-490a-bca3-dec3c713e782">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/fe4e3b53-1ca7-4a1e-861d-84cde1414735"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/af22c24a-4469-4147-9424-027abe0f64e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7c7f8602-c150-4afd-ba11-51edd2a867d3">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b3fd944d-d8bd-4204-9ae6-871022d20807"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/47e49f6d-f15e-4bcc-99b8-e8c2a1a4b4aa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/823f1b55-0b40-4f17-a79e-cd38ff03ff98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/5dc4f41d-3ee9-4c33-b529-fbdadf16e3a6">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/7b747600-35ce-4a8b-9583-f3af37610513"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ac10970d-2437-4a50-882c-ed65df4fcace">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7795f138-5a90-40a0-a40b-6e9749f3b535">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4971aa39-de44-4ca4-b885-65fc58a41ed0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ba96d8cd-7e13-43b1-a0b5-912e53cd3d9f"/>
    <rdfs:label>paroxetine-phenytoin drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b7be0c29-4ecb-43a1-9766-d02e7bf77685"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2ae4ab71-55f7-4921-8ce0-a89a4161f0fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/483fc526-6018-4371-ad94-992fe1b3c00a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f6d93287-3001-4871-b9b5-5e33f630392d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/aa6071e6-ede9-4f0f-9baa-9887de2c395c">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/611b995f-1364-4bf2-b4c6-5bf260bff0ec"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/1ae9d072-fa45-4d28-91ea-bf2887035cca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9713f4ef-a883-4946-8398-aaaa34ed4b2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1fea1a9d-5751-4d69-b3aa-954fecb4ad22">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c4008ef8-df7a-46b3-ac75-7cc1575de5e9"/>
    <rdfs:label>citalopram-pimozide drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2f0402d6-6888-4210-a097-42617e910e7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/811631cc-1968-4ea8-b361-0fe27d68d6b7">
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4aad59e7-7565-46e9-9e7c-afdb8bfc0152">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/7e027785-e614-4769-9cd3-f30b6c9958a6">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/3e3e6d7a-ee4c-4bfb-891c-b336a01e4f6e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e3efd91b-6aff-4ac6-a5d9-c4cec24c29ad">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/887a1831-837e-4dfd-8b45-2354aca95936"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/22736392-e335-49d4-be1a-3ca66e380584"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5aee8931-6a9d-49e9-af2a-a7acdf7df5e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b5f301d4-4144-49c4-ad97-d6b6eb3cf3c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8ab6a47b-707c-4e71-b9c2-e67881c97c77">
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9ea0618a-24fc-4586-b22b-02077a8f320c">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/40bbb41b-6cba-4cae-8502-343959cd34b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ab575b86-446b-40ed-adc3-b6f580078dba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/76d0ec65-026e-4c5c-99cd-f38a277391a0">
    <rdfs:label>paroxetine-atomoxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/76ff3ea7-b266-4ffb-bc3f-7656bafd3e92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6bc43290-afb2-4b9a-b38f-9e32bc06ffd0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ba26a965-9dfd-41b3-b740-b03efcb0acd9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/5da7e0ed-2d59-4860-9c78-575ce559f8ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/fa900196-2cba-4873-8321-16319570ba59">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a4cc407b-ca4a-4fe5-9f30-4ba566f964db"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/d1408dd9-589d-4469-b7fd-97437d043eb8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/64ecd84b-bb62-4459-a2aa-1ff5de6260b8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cdd19d03-db03-4c37-add8-576c0c0ef0fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3c09a953-ba58-4b5a-9ab4-66df1551e6fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/aef00996-9032-49bf-91ae-332ac1533967">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b2d7f11f-fbbe-400d-88e5-6b2d93dbf510">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bef98d8a-fbed-4991-9b69-e48ec6ce2830"/>
    <rdfs:label>paroxetine-procyclidine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/dd23a799-a457-4cda-bf75-88b4184fe436"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3c83cefb-f500-48a1-9862-0cfe200edf23">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/c0df8f40-4278-44f9-83de-09eab40a0bd1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/d503179d-fecf-4b4c-9faa-8c4b879b328e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/c214d9e5-7e3d-48ce-92de-a542d0784e9d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/87226fe8-b421-45b6-816e-7272726f3110">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b9e3cfe1-4288-4aa4-8d2c-f2e0485acd14"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dd23a799-a457-4cda-bf75-88b4184fe436">
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ca1e2d31-b825-4113-ae9f-740d61da6631">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/01eaa627-ae44-47bc-82ef-e3948d392440"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/efd3506e-278e-4b2b-b082-66f4aa0eb635"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/c5853e5a-a0c8-4fe3-b208-32a121a22afc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4caab834-cde5-4341-a926-5cdfbf734923">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a5cbaec5-24ba-4fc5-9697-161714f9fa8c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c6294d5a-b3a5-4585-815c-55e24c5b94f3"/>
    <rdfs:label>ketoconazole-rosuvastatin drug package cmax None information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0df068d6-8e7e-4ead-be6d-572b0558d9c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/411043ce-be82-472a-90d3-fb0542c95879">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>Fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6838569e-b5dc-4aad-b96f-a9e82acce371">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/020060ac-f758-4ae4-8df9-c8664a2eb068"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/6cb20e2f-9dfd-4f60-acad-f1c9491a35c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7fde6d46-9663-4c34-84a7-85d2e9490772">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/94e2b2a7-4ddf-4d0f-a576-17ff6101298b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/0f44868b-518b-43f8-ab09-21a1467e2777"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/fcc33416-2fc9-46dc-8e80-51a3712e089c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a0a53edf-4ead-4b0b-b2af-c44fb9b52f68">
    <rdfs:label>fimasartan-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9c5abe9c-8534-449c-923d-8c4216f7c993">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cc28fe8b-9753-42d3-be8e-c52baf1fe5c7"/>
    <rdfs:label>nefazodone-triazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b6af93f1-e3ab-4c2b-a9ce-9dd9119d32e9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/91c2508b-3972-49b5-a18e-dc74a8bc5c4d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0e2df1e6-ff08-494b-81c4-8f285058d23c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f4d0b7ef-36cc-4237-8b6d-1ba3b90f924d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a5009832-2df4-431f-8e0f-5e16035a654f"/>
    <rdfs:label>ABILIFY-norfluoxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/e3c999af-8a74-4429-830e-ec8cb70cd2b0">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/3412d47a-f3a8-4d2b-b711-6aaac826230c"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/3bb71cd9-8c0e-4b87-b34f-134604b80ebd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ddc60b4c-d7c4-4a78-8eda-360037a1581c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bac1cf19-6eed-4b14-87e7-c6feef1ff3f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f3beca23-ff99-4e44-ba1a-95e80e8934dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5716c1c5-47da-48de-a9ca-883be3d0e3e2">
    <obo:OBI_0001937>180</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/69b079b9-0303-4cad-9ff3-923e0fb6c7f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5f458412-93ce-4245-bb28-ce55b32ab0cc">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
    <rdfs:label>buspirone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/538fc41b-0226-4801-83ab-37d71e02d6c4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ddc82f6a-cd09-4646-9fb0-161e832bfe1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f32ff892-f049-4a44-a227-79b9916aa34c">
    <obo:OBI_0001937>25.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/829c3ad1-5cf8-4e8c-a524-fcc154f53475">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/68ac5bb5-aaab-4c8c-be0a-2f4c98686971"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/dad5c3d6-936a-416b-91f6-b29c9ca4ff22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/da3203eb-fdb2-4618-981c-33e8073e51a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0b63425d-bbd1-4767-a82c-795487c041b8">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7078a39f-01c5-4de3-a3fb-a30ee0fe9839"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/59cec642-41ac-4eb2-92af-cbf85f557b59">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9289d9ee-ca13-4d1d-a020-9ac3c7f310d9">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/97ab51f9-05e6-466a-8f82-98603636354f"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/78f824ba-0c8f-425a-8fdc-111d6e4b8112">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/39e30541-207b-40dd-a105-bf6c48fe4117">
    <rdfs:label>telaprevir-amlodipine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/fc3e6c1e-1a51-412b-bdaa-b1b46edaf616">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6b3682fa-933e-493c-a3d4-a4f93eed4d9b">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/9892e298-3b04-456d-b0c6-71898826cb75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ca1dae6a-d7da-4c97-9a9a-7662c96552c6">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/91b769ca-0076-47ae-b0c7-cfa85470fd83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/a9f4b04d-9c2c-45bb-b15b-c5c7c201dde5">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f0c3b41d-a27a-4754-b8c7-fd4fcb98f76d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a673dd0a-c468-4fe5-868f-4b2f20c04d1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8f69d5c7-3a16-4c53-8fb7-8696dea0b170">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d767c3be-4f23-4153-9985-35b07383a883">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/475d17a4-4664-4e32-a8a7-672506a1ade0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bb10ec14-b23c-44e5-bb85-f918761ab1e5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/fac597f3-ddfc-471a-9ccc-73ce25f7fc92"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/79464a97-6a93-4218-b2cd-62eb3d5346db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/35b24d8f-14f9-4ef7-b3b5-83ed2de7dc4d">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/9b8b6048-b919-4c79-93e3-b5951280b4ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/8be36338-96da-4352-9cfb-7fd1ebc84f05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/026393ab-ac4a-4500-9552-5e3befcd0ac1">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/6e39e748-9152-4411-84ff-f12a5cd2da57"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/5334e76e-7231-4054-9b74-c8c423ef64d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0057438f-c8b8-4919-8aa9-d2adeda38a7b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9fd8a03d-2879-4038-9201-8648e29dd3c2">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/4f55526e-424e-41b4-a733-a2bdfdfe779d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9172b4ee-2e03-4367-968d-7636ea8e1987">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/86ebb0f5-16a3-4d6f-ba23-92d59964b7a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/43cf6685-e0a7-4490-9625-3dd4015d2143">
    <rdf:type rdf:resource="obo:RxNorm_734064"/>
    <rdfs:label>desvenlafaxine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d3d60a81-ef59-4f5f-a2ac-f132ead225d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a18518d1-25d2-4e3c-b83e-f4cbced190bf">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d2363a2e-2a80-4d9b-99ac-a92e948dc515"/>
    <rdfs:label>carbamazepine-ziprasidone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/22500248-e8fa-40c5-a6b9-99a1373ec1d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b9d24a97-4561-4ebb-895d-9901d0ed33d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/05bae3e2-9cfe-4a50-a19a-0c810bf7e216">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/0216e54b-04dc-4339-b079-06f9356d8ed7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/77195caa-96a6-4759-8c68-0c7c2fba0d2a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/62d6e99f-5e39-4af5-aa71-807008434983"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/26df9ae3-534f-4db1-b9bf-93d13ca4d4aa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a0bf7520-cb96-4387-8ab7-ec7c464188d8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/202ec196-0ccb-4564-988b-fa4fb802a8bd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c68de4be-2ce2-45dc-9413-12fa8a75fcf8">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/f6dd2289-6ebe-405f-8524-f67f0fa1fa94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3e4df98e-e3a2-4ecf-8435-d29ce57ad2f3">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/75b05871-793a-4dd5-8add-2606d908d4a9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/08b3b2ae-ee1c-4044-82c7-bb10b9393be9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/a956af43-85de-4893-aab3-9b9df8c6cd33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b6af7a81-6622-4211-91f1-afeef0b5c93e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0b70d585-4854-4118-9e91-0b2489dde090"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/95b8382d-2871-418c-a48d-4e156653a414"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a7148789-1090-4822-9b73-c2b081694585"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6ea17474-6e52-4386-988a-f95b5691298a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4928a021-a47a-4dea-843a-ec8e58ad64ee"/>
    <rdfs:label>amiodarone-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/56ed600c-3bd7-4e90-9e11-c616a1da4c23">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/52ecf674-618c-4b35-805c-58f1e4e3a631"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/e099fd12-1525-4aec-aa3e-b544deb10655"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/859170b3-2187-4714-9a23-490f2fcd5d3f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/2ad9f2da-c9b5-4470-a9a9-444738e19e91"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/83299b3f-4611-4536-9ac6-b19ee2c6cb86"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/cbed80ef-94cd-4b70-8c3d-e26fa31b7954"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/2739a87b-3e70-447e-a58e-10c972ea8c9b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/368ee7ed-f2b7-4635-a394-88292c2f5f8b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/6141eadc-c614-4fe7-80ad-2b8215125794"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9b18ac95-523b-4aa8-bc46-5ddc63123343">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/90f9746c-5ccc-4cd7-8316-072d3f751fbe"/>
    <rdfs:label>propranolol-m-chlorophenylpiperazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c89c661c-c640-4ea2-a0d0-aaadb72ae7c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d8bec01b-ba75-4a78-a604-d596f8a3eabe">
    <obo:OBI_0001937>44.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c6e9f49d-0937-4fb0-a47b-de349684d589">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/65dce9a8-feb1-4558-9461-c2be2b2a4a41">
    <rdfs:label>nefazodone-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/aa434c0f-17c4-4ccb-8325-62a5c809938c">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8a15e6e9-c45b-4f22-884e-ee11bbdbd42e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0dab49cb-8295-444b-86e0-9d41cc987a8c">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/28e17724-ddd8-4006-8a00-efc386f1ea11"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d9bd6f35-7ece-4b61-8c96-b720a46f9aed">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/54ba1611-1d39-4d08-9c70-71b8fb9933c2">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/8a77b977-1c98-4e4a-aa23-ade4224c8127"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/c445a3e6-0db3-4d50-8e87-87c2a45a6aff"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/02dfa7a3-91e2-4113-b0c1-8f88fdba4c3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/94d3083f-410e-496b-8a74-8b8606c111ad">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/3f270f41-feac-42b2-b39b-e0a271fa52a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/517e1cbc-1746-41e2-b6f0-ff724497218a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8cf6368c-f444-484a-9bf2-b98b34171c78"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/41a923ed-2fad-446e-aa6d-60119ddb3435"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2282d89f-f889-40d9-90a8-3153a29bbeab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/751db5e1-a1f9-43b7-9992-999e4aeec9e1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/10e605de-f666-469d-be1e-ab068d4e409f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/802f1cd7-ceb0-4557-8dd3-036a438d9208">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/6d60cc6d-49ec-4fdc-8318-e1545670fb41"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/aaf64024-252a-4159-8149-e2ee8b6293a5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/35486bb6-ddd9-458e-8578-bbd7af42e6a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/975b98c2-7c72-4df0-911d-5964129e5eca">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a94ad750-4f90-486a-bdf5-1948eb89c3fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/39324f96-87c5-4819-b373-f0825fb4350c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c66ae96c-7d8e-4417-8080-c9d241736ea1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/717fc334-687a-4716-b131-430ba543ffbd">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000969">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/ac6d4129-eb89-415f-94bf-3d03856b15f6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/dacc2c6b-a301-4621-8def-60c8c70cf0ba"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/53d042c7-417f-46a0-80c6-a3ab0f199203"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0470bbd1-6ff1-4fbc-847a-68dbde740941">
    <obo:OBI_0001937>53</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c6b72769-06f0-43ee-b961-d58f393cbfa8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ec078e5e-5a03-4b73-91ee-35b648fc0082">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8e80afc8-58e9-4b4e-a482-4f22f8e9c3ed"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/eac26e1d-90cd-4932-9abc-5de84db41b9a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ed49b73f-06e7-4bc5-9d38-446eb38fad3b">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/40b4f8f9-1748-4977-a74f-9ee133ba3fc3"/>
    <rdfs:label>zolpidem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/4ebf7807-7890-4f31-8abb-b1b7147a0cf8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/16958742-0405-4862-8d2e-1e4e883ba180">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/f477d410-fb41-4f9a-91ad-e9297ea0749e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/47e25d19-ac3a-4ac6-a1dc-e835d87b32d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7e8bd0f4-604b-4d11-b775-7e35eec3cb5c">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/52bdecb7-a832-40ad-8293-7c78aae1fbe7"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5c9c9a10-f83a-4948-a3fd-fcc431e8ec29">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e42ae263-8f7c-4c34-bd51-8dd50ac2af3b">
    <obo:OBI_0001937>5.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/09471c30-3194-4b99-84bd-2f5cc99a781c">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/6e46828c-3eec-414d-ba15-c68d3744d225"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/41e18712-a7ca-4452-81c0-c29c0303129d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/768bd941-0997-4e2e-a29f-dbe63e34178d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7e4e3c55-0106-42d4-aad7-697eac9860e9"/>
    <rdfs:label>rifampin-pitavastatin drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3411a84f-bbea-4746-9813-5be8b56a24d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d2603b9c-e13f-4093-90fa-758353ba4788">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a9177094-8352-47bd-b352-88db469a6e2d"/>
    <rdfs:label>paroxetine-tramadol drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/6c085bd5-6327-45c4-b3a6-61ca94ca3846"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/aa9dfa4c-534e-4e8c-a01c-2e7d01235c7c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b40760ea-ca0c-4329-b3fd-b54caf2f8363"/>
    <rdfs:label>ritonavir-hydroxybupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d3281496-5550-41e1-bba4-0abf4a714dc9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/684a55af-ab03-41fd-b604-61cd70612f8f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/21f6c5ba-97d7-4973-b0e8-cde9356bb9a3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/fe41e91e-537a-4e8a-8973-bc388cfa1813"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/445bf064-2da9-4513-9506-ca951894b8c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/be22b23d-76e5-4b3d-89ae-8fd9dd05f570">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e768cd08-91b1-42fd-9c4f-6209c2795368"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/08e370fd-8037-4a11-990e-3f4fea495c4c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a4e22140-dacf-42c2-8b9b-252a444b327d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fd6637b0-c9cc-41a9-90aa-841608bfa4f9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/06fcd968-2c44-413c-ba3b-f108e1f03a1f"/>
    <rdfs:label>atorvastatin-aliskiren interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f71876e3-457c-43e9-b46e-f1bc962ed189">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a78a0c8b-ac43-45af-8f13-c747e749e5ba"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/04c7e7a5-adbd-4c59-9b30-27747143815d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7b6d0c77-1551-4515-a0ed-f8f95f4d3ec8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6ee8b4a9-f330-4ff4-aabb-11ff1ef120cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/02007c79-42d0-4a8d-8abb-61cde12fb1c4">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/21b04ab7-09d5-418e-aac7-96bfb8501ab3"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/dd8b5b3d-b885-46a2-a044-69575b2c988c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/548d8d8c-e0c4-4b92-be88-e1e14b30c65f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b5265e30-a552-48ec-9a34-4b205449e2e4"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/dcc3e96f-4d44-44ed-9461-d42cd7dcffad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0fd8e5a5-19c9-47bc-a162-cca94fe72e67">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/f3ea7b60-2b37-435b-b5df-55d12a913c8a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6946dc3d-01ab-4935-9a1a-1f78e5cff094">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/29aeed67-0440-4d08-a0c3-168d1bcf813b"/>
    <rdfs:label>nefazodone-propranolol drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/10ad44de-096a-453e-90b3-4609ba5d7d15"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/02dfa7a3-91e2-4113-b0c1-8f88fdba4c3d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/dc02a7c0-1e2f-483c-b105-5e2a0d9bc34e">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1444cc27-4eb9-4aab-8ad4-1bbd17fa4564"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/265ffa1f-6726-487f-89d9-c0a4ca38f5c7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/a3125932-d483-4bad-a7ee-b1fa0a22f59d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/cfbf2cdd-d5d1-4a43-ba1e-d7f6c08cec5b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/6ee8b4a9-f330-4ff4-aabb-11ff1ef120cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/779b272e-0f1d-4c38-afd6-49a3d6160580">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a14ef24c-1e57-45be-a4c2-1ecf6a3a96fc"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/70ca3042-a888-4ccc-8e54-44cf13160fd7">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/09105f3b-a225-45e3-b2a2-f50b632f6aa3"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a37fb4ac-3a5e-4936-a43d-85e0c519d8ab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ec8b0d3b-bf1a-42e1-afc6-1c49e3a3ed60"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ed965d8c-ff5e-45c5-80af-da64542c5a6f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef8baec2-6e99-4bbd-8131-06bdc21205c0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fe42d554-68c9-48be-b06d-6383b9debcef"/>
    <rdfs:label>erythromycin-zaleplon drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/97a261d2-836d-42a2-bb68-3f2b8989fea7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e4357a79-28bc-40c9-aecd-28197bcdadd7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f68d7515-1e71-48c3-b7b7-7fe6843a7df7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/dda9bdbf-1452-48d4-9a0d-b3e48f99600a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/b59b2038-39e9-4543-ae97-d5ec05e17a56">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8c5f3616-212e-49f5-89a9-096cda399c3b">
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b9eea5f4-91d6-41c6-bedc-e2ebd5ffddc3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d81a44e2-e9be-4120-b36f-bff1a69100cf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b527706c-cfab-4b42-8bcc-343974446f87"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1b32a7cf-8aa6-446c-9949-9c6a6a59dd8d"/>
    <rdfs:label>carbamazepine-methamphetamine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ea005c02-1887-46e5-808e-7eb94889c050">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b5509f02-4821-4a74-8f91-a69d83a986cb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c0a5302a-60e0-4dd5-8e86-56c526f28d0b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/384ae7ad-7920-4040-b96b-1fd154d1ba13">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/cddf8cc1-ded1-4e1e-93ea-c831bd2e87f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ecec9ab0-b4a0-4f80-8f6b-deee66f43b84">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/f6dd2289-6ebe-405f-8524-f67f0fa1fa94"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4512654c-728b-434a-b65d-9ae91e480512">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/973a1c71-73bd-459c-9f3c-30abc4429778"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0a34f946-acd0-480b-9b6a-232933d82489">
    <rdf:type rdf:resource="obo:RxNorm_8787"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7795f138-5a90-40a0-a40b-6e9749f3b535"/>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/763d459b-ef8a-48dc-984e-7d53c51cd427">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/81a1f90e-8ab2-4a76-b0b2-1e0562f0ad63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/19f43838-ae5f-4d22-8748-12bf75158b31">
    <rdfs:label>ritonavir-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c21d5eeb-6b26-480c-9379-4ac3b49dfd11">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/cdfdb476-4668-4daf-b744-7c2433cb0527"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/45c6df92-4932-4acf-a9d7-079ef6369076">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/84110e9c-ba82-4e93-b5e8-ae333ea50704"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/208cf6b7-9f1a-4273-8bfd-9071928a14fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9689d1bf-39a0-4750-afc7-d143c76e1995">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/efda5618-eca9-4889-b89e-ac6359c6f428">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c6608370-0359-4f47-b95c-c5132b3c4d25"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f9e90fdb-5c81-4c16-bb8c-f5d4f9723672">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/caf9b62a-c55d-4c98-9e02-dd4c560706f9"/>
    <rdfs:label>quinidine-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d351197d-998c-45f4-9e18-a6c3604a7ab6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1e980784-0842-4d9f-b9e6-6ab4fd6b5502">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef8baec2-6e99-4bbd-8131-06bdc21205c0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2ac7194a-532e-425b-b1d4-c02783aa1bc1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/95d3df2e-8821-42e0-ad5a-1ca42ac5d1d9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8457b80b-2177-4f93-b2b7-937a1157b6b1"/>
    <rdfs:label>erythromycin-zaleplon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/372873be-8970-4f99-997f-4f0ba39b344a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f90aa4c8-3cb9-4cd1-b32f-d63d4605c8f2"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/2821577e-6e73-484f-9cb1-d19a116207c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3770c62a-e7e6-4e52-a4d4-bfbf3ea01959">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0b853b29-717b-45af-8044-ede8744e6f91"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c0d2d87f-a7e0-4990-bdfe-78dfee9929df"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0884336f-3fc2-4020-a3a6-ea22bb6d11f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/105133ca-e6f3-4ef7-b39e-7b30afee1792">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5e601c16-6f73-4e74-a077-a5b7aac11660">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0c9dff06-6d03-43fd-a480-d1feef1c1ecb"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cec4a4ed-71c5-46d6-9b58-1650c18a84d2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8c99772b-e7fb-4910-816b-58533d9de52b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/5eb0e78c-e01e-4d00-835e-e251c1b1f4a2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e8fb5a1f-ccab-46bd-a00c-6e673eb56098"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/4ad198fc-4c5a-4dbc-add6-f17e584c1f6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/dbcfb8fe-70bf-4c91-a0a9-8794f2ede31f">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/7ac66711-9dbd-4485-a872-1801916f7f99"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2a2b1a31-0c46-4aaf-88d6-e7fba6cb3b01">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/0c532fed-e625-49b0-a08c-d71933af1180"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/aacc2036-c5e3-44b6-bedf-d7c50ed9b3bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/81fd1190-d27d-4499-b442-a1b9cfd37c5a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/9aec8da7-2478-4d99-b9de-0213726592a9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3078e599-e2be-43cb-be11-dc5e3b09b85e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/65fbc448-28ec-4399-8ec2-4f11ed358b11"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/93f4cd84-f7d3-477e-9054-04353426b278">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8191d2bd-da29-425e-a852-4c708f0ffadd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4eaa5bd9-e132-428e-8f33-2df89f23e8dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dc4c67a8-d856-4ceb-bb6f-8fef5e71ef38">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8a1b6cae-9092-48bd-b77e-646b8f82ab9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eabebf6c-db4b-414f-b391-ae5d1dfb6ba9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c1c0c760-c380-4e10-9070-919fa0e0e37b"/>
    <rdfs:label>rifampin-dabigatran drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/07ea6b3e-133f-4008-af4b-7fd97df4c313"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/750f0d38-da7c-4121-a8a9-1eb69b8d0b58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/02191c9b-1e94-4277-ab04-a3b38559a87a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8a66d889-d2c2-4806-819c-797af3eefb54"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/d9a6655d-44b5-4e28-8544-19f3d570e4fa"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f4b66a38-0751-42aa-a758-13b7321782d4">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/018c45c6-a1d4-4fe3-8352-1679bf9fb46f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b80ec41b-fcb1-43ea-a78c-07b3f8da7e8f">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/4ba4bca3-ef31-4e85-a158-bb41b4c494e7"/>
    <rdfs:label>buspirone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/52bdecb7-a832-40ad-8293-7c78aae1fbe7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/49cba39b-cd80-4804-a5a5-0456f0df634e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/3412d47a-f3a8-4d2b-b711-6aaac826230c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/57d7c280-0dba-45fc-bf03-9e14c0451efd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/02dd53a5-566b-46c2-8ff1-1f10582898bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/235198a3-9f51-44fa-8a38-c221ed3c79e6">
    <obo:OBI_0001937>2.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/3466649a-d00e-46e8-8e08-444f635362b1">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/d965c7bd-195b-4b3e-ab93-d41871bcca63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/44899183-cee3-400e-81c2-3d1dec2d3cfa">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ae519392-5e30-4570-a323-a76e659c782e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/dbe72482-147a-4a33-af6e-d976f1ac89c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/eec84a6b-843c-47fa-8ca8-d805e145a329">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/7b2c2725-7aea-4474-9800-358b696cad55"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/5c269f5a-5f68-4820-a6fd-ef6040bcead5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/b42f1f3d-192d-4c91-b626-2f49a5fdc1bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/17bf60c5-96a6-4635-b5e4-080b15bd7ec1">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9c3cad5d-4b0b-486e-8f38-8a596bfb3dd3">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/5154b176-fba9-48e7-823e-2ab1f6d3dabb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/ac2e7376-1866-4e3d-8bd8-af48a708fd51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0c896c39-7837-4cbc-989f-18ecbe0b79f7">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/cdd19d03-db03-4c37-add8-576c0c0ef0fb"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a56f0653-fc9e-4259-a38c-efac0d627e47"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a5669d7b-d478-4313-8549-0dfb2d123687">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0fa6e7f8-b747-4ed9-9371-903015d714b0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/840c2237-70c3-40b8-9751-583b18bf5ebe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/97d7bd65-fbe0-48c4-a895-69c6b3bb44b5"/>
    <rdfs:label>ritonavir-erythrohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/491f595e-e1b0-4b22-88e4-a2f738309ae6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e2d97364-693d-4258-a920-09d56550c5cc">
    <rdf:type rdf:resource="obo:MeSH_C102211"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7d5eee06-7f6b-4e4a-b53e-35cc49aa2d06"/>
    <rdfs:label>P88</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/04ab1455-2f67-4c1c-adb0-2a27ce869a90">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/34ee20ca-17bd-4765-a3cb-63318f517842"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/bcc567e7-c65c-4de8-adad-c8188df3b8af">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/7dfc59eb-5e88-4a85-85ac-f4663e1e2cfa"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/9339d70d-46a6-4257-82b9-308d912473ec"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/40dea6da-8e7b-40ca-9698-efbf95cfd158">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/89c2311c-fe02-4f14-938e-6bed79f4d73b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/65536bff-f9a4-425a-8b69-c883c00e39c0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/895920f9-eb6d-48fc-8f2c-3de8fa53b34f">
    <rdfs:label>rifampin-zaleplon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fd0b18b8-b7fe-4b55-83dd-8e1147b95058">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0969af4b-9db0-4751-b1de-d11fdf79496e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/1e5a0269-4c63-4184-a3e5-4627cee4c4dc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/dd8e36de-8458-45f4-845b-da9d61eb7347"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/522b2565-14d3-4b83-b2c3-23bc8fbfe9ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d25d79ba-b30a-4d79-9d0a-ba30f9e9fe56">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/49530a0c-e978-431e-ad66-c6e98858d0d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/98056286-5a17-453e-be90-7f3513f536ae">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/40b3cb1e-b33d-4f6d-99f5-c964c4c30ecb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/25fffe35-f692-4398-9f1b-10639aa7efd7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/4ba478e3-ef08-4841-971f-94236c0561c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e4d27942-81f9-44d7-9f29-280d902d91fe">
    <rdf:type rdf:resource="obo:MeSH_C102211"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/2972b6de-c015-4de6-82c4-3fec74bbbc4e"/>
    <rdfs:label>P88</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a99f0809-0b69-4650-9ae0-b15831188913">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ab4063aa-71cd-4c0a-a85f-08549322c3d8"/>
    <rdfs:label>ketoconazole-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a7f8b00e-6539-4985-b48a-3e3d39beb332"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/81f6baf1-7044-45fe-9d2e-ceabe65264ca">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cd3ca106-e7a7-4ce5-bbf0-c9711eee6529">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/81b6431f-5ce5-4ba0-b58d-188a2086d9c8"/>
    <rdfs:label>Nelfinavir-simvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/dcf798b9-c276-4c08-9ba9-02d8630b3a75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8aa5737b-2e58-4e58-a531-173e832df18d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/22803a6e-a569-45c4-846e-2ff0b08e52fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/ce4db868-3778-44b5-a4de-24324d9ccc3b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dd18e958-76b1-4320-bd0e-2354f6b55301">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/427d64d9-b398-4484-a411-b6dfb5aa6808"/>
    <rdfs:label>digoxin-aliskiren drug package clearance  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/aefbb4af-1eff-4d1e-b642-0f76ba7a3fbe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/414fb82a-66c8-45b6-9073-5473650ff987">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/850cea49-46d2-48ed-a710-688288049535">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2f0321af-714e-435c-942c-5236454fdf45"/>
    <rdfs:label>fluoxetine-P88 drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e5c416ee-b4e1-44b4-ace9-77fb8f868817"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f1c7c1a8-5916-4207-8b0f-58fef7e37b87">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6e39e748-9152-4411-84ff-f12a5cd2da57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/53e585ad-7190-4001-89ab-af80dcd06177">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/71e30071-01b1-452f-a4f6-2e9c62d08cce"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ac31291f-d6f6-4964-a43a-150c8f38fa4a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d2ae4c15-4b27-4ff7-9d0f-bc9e9e246f84">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/9ee31983-9043-445a-b1ae-86cd4099d3c9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/17ed1cd5-143e-4285-b41e-d8368a3c1164">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e676f225-9a60-49a9-a230-7f1f0318e4ee">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d52f42cc-27e8-4280-85a1-04a6e3a15ad5">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f193a491-4153-44b4-871f-192ff29259c7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/04564a90-8355-46a2-922b-795ec167395a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/dd19cd90-8898-4e64-b118-54771ceb4c6e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/ee815aa3-6848-421c-967e-c30abd6330ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/d235aa9a-cdb7-40ed-bced-9a56ef699174">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/cf4ecb2b-8e73-4908-8bd2-a440c52ff946"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d4cc3a2d-d92d-40c5-b99a-77807dc7601f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/593fd1ea-5517-4d94-b0e1-2da747944bfe"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a5df73ae-2330-48ac-9ffe-456a14784a7a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/32827b39-9223-4416-98b8-a91729488e89"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/fcaa5b3d-eea3-4311-af56-7f1de088a367"/>
    <rdfs:label>Diltiazem-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dbf70092-d402-40b8-adc1-b351ac2f7b30">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6f06df1a-f0d5-40b8-9c23-99b8628b2420">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9d483798-fe98-4ff3-b380-f7b470b64888"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0b86ab65-1917-4f7e-9632-c192e92a2190"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b80e1ff8-4eea-47ba-aa0c-4fb25f2fdea6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b0f8faf0-f0cb-4460-98eb-de383d7ab34c"/>
    <rdfs:label>ticagrelor-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/af19e43e-5310-4e3d-a3d2-7ca4ac1ba65d">
    <rdf:type rdf:resource="obo:MeSH_C558933"/>
    <rdfs:label>fimasartan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0f2aa808-314a-4789-8037-df5bbf99189c">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/42e2bfb4-0528-42b9-be41-70e879a64cbb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f9b7abf6-c917-4959-aebd-09a32c20d012">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e7f302a3-64db-4664-a67c-2e1cee4d442a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a9e9c432-d8f5-43f1-a61a-6d34d0a528ed"/>
    <rdfs:label>erythromycin-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c84e84c9-5a75-475a-ac9d-df01fca3ebd3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/742afcc8-7298-4b8e-95fa-c52e0212511f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/e9da2e15-ad4c-4dfd-a0ee-8dbd4b53d850"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/d0786735-cc45-4877-9266-6658cc323585"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/3bca1595-99f4-4f3f-a99b-0282f1bbbbbd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7be35763-83f0-4594-8cc6-dfaa46836cc8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/00ad7b80-c7fb-49a1-b4bc-e14ad6d07f31"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/66c9a9fb-cbf7-41c7-9c08-2df042cb8e2c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1c89d404-ac76-4af5-9924-e3d3194aeba3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9f134ac8-0dc5-4233-977a-bc95cb47a057"/>
    <rdfs:label>escitalopram-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6f915ca9-6c4d-4f2d-9ee1-a927e8c67e7f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/39856106-ca4d-447f-b297-cd6ff15e2a98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/03fdb9c2-1c7a-4c0e-aa80-be302aec4c4c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/53723908-a5a3-4b9c-9bd1-92f33d751a77"/>
    <rdfs:label>fluconazole-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4ffbd2bf-bf22-4d3d-9ff7-8c2bfd2630c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/160e10c3-76dd-4cda-8945-40be320524f4">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/97ab51f9-05e6-466a-8f82-98603636354f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/af47a55f-adc9-427a-91e6-0b3e8f50a63a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/271d1c11-dbe8-4b14-9ab7-2ac480420fa5">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c55b5cdc-2f43-4f41-8636-8fb2ab905f2e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ed65b6df-4cea-4142-beae-e3e3755c0900"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f1b6d5bc-6168-4b51-8a38-4e22eea8ad99"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1dd15bed-fe22-40ec-8ef7-d03e7801af1a">
    <obo:OBI_0001937>8.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/1c448bb8-ff0d-4b18-a041-96834b141b50">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/165e26bb-8bfa-415e-8b2c-7c3f29df97a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/fb8d611f-2537-4c16-80a6-cff536cef806">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a4d20153-a30f-40fb-94b2-3b61f539d95f"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f711cfd9-39d3-4957-a15e-37bd0781c51b">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/8f485472-25ff-4e41-b5f9-fc05211307ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/1a2d4f45-3342-4ef4-a41f-d3b7638cd0ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2f197377-b6cc-4b60-ab5b-5759e3d52010">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/fbce5a2c-f071-4413-ab2d-664e9351bdff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fea2b148-3068-4084-9a47-6c6f0a82fac4">
    <rdfs:label>paroxetine-risperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d2d9065f-ea0a-42c9-b949-3eba11966c93">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1e5f26cd-8b90-4993-8b92-1e793e18792b">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/a26f8c0b-e674-48bb-b993-9c4eb1cbfecc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/75b7c3b3-4547-4e4f-97d2-16670839f0d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/084f392d-ebbe-4536-855d-3da254164e9f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/dbabe25f-85c0-459f-8fac-b25f69b6d137"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7c6852b7-e6d4-4dec-a058-7442c0efdcfa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/2077b56b-10bf-4711-89c7-a491189cfdd6">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/160e10c3-76dd-4cda-8945-40be320524f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/83b85526-56aa-40a9-867f-3ec6fe95b80b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/dbcfb8fe-70bf-4c91-a0a9-8794f2ede31f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/cdab9130-a3e9-4b56-8ec1-f51b22c0e977"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f4d7310d-a582-42bc-bf3a-493d7610790d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/a6089ff0-b4f0-41dd-b611-990b46bc0725">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/5aee8931-6a9d-49e9-af2a-a7acdf7df5e3"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/d1b21de5-5fb9-4de3-90d4-4e3508c61245"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9ac6a5e4-a062-49d4-86e5-4452c143eeb7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/13dea4f9-0d63-43e5-8864-03803092e0f5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/70ca3042-a888-4ccc-8e54-44cf13160fd7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/fc6b673e-a3d3-40cd-b2d9-118042e1cc00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef6e2ce9-62a4-45ee-90c0-ae0a76ed70cc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/809ecc65-f100-47aa-94a1-74f36eb685c1"/>
    <rdfs:label>paroxetine-pimozide drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d726ca3d-a8ba-4a1e-8980-f915e9f91c6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/302f193c-c99e-4245-8da2-9761f94d1103">
    <rdfs:label>Rifampin-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0dee754b-feb7-4c62-9a5b-afcef3fda6ae">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c50cd07c-d72b-45f6-bab6-2f42c46dab74"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/8b3c5a95-f221-4888-be08-802358946c61"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0fa6e7f8-b747-4ed9-9371-903015d714b0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0189c45e-fb22-41d4-b24a-7d6128c5b89e"/>
    <rdfs:label>ritonavir-erythrohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/300482dc-e8d7-4966-8552-2358aa04c21d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c290a788-a934-4338-9421-56114ac36c2e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ac561c89-8d29-49e9-ade1-e2c883147548"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/fb08037d-fb60-4e3c-b7f6-22bb805cebcb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/195be405-ee31-4f32-aedf-f7a38ca05067"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f848f368-32cb-4568-b0cd-5afe40f32fac">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/27c70717-1aa0-4643-be8a-80b1cbedc344"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/dc3bb6da-76a9-4475-8485-65695645a857"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/849cae07-6f4e-4693-b136-c76e14b84af9">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/39bb8598-8c1c-43d6-9bc2-56be4f54cd8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ddc9ec3c-1823-4e8d-8e5e-4987efe24287">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eeee44f6-e5f9-4c0f-b37c-97928ab0e559">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/abc11a13-c38c-44bb-9375-c32c31650adf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ec788340-0a04-4965-afdb-30c84fd0daf9">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7df9b47d-2c65-4e13-ad6f-c7d6279d4e0f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/56671035-4aaa-459a-905c-b6272814b3e3"/>
    <rdfs:label>ritonavir-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cc4416b9-a1c6-443a-bd53-b86f4d78c523"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c35f0e8b-7f71-44f4-b0a9-3e54af49a8ab">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ecca74fc-d594-4ab9-a54f-7e75dc3778ad"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/efda5618-eca9-4889-b89e-ac6359c6f428"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e95e6c76-ab83-476c-a830-f8ea0d488a1d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/8c1d262f-5df7-46cd-ba95-aa1b9d784dc9">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/c0038d3a-f10c-4a55-aad3-bb2078f3bc52"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/28a1202c-7c90-4394-a083-e79b5977041c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/99dd4ddc-0696-4fe0-b6e1-70a4804bfe7f">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/66fb6759-20c2-4f7c-83d4-53db9784e868"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/008f8f1d-7ee2-4f5e-9582-e241017fb296">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/271d1c11-dbe8-4b14-9ab7-2ac480420fa5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/6e91888d-8614-4e82-a74e-6cd654784a98"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d3eaef13-e6d3-4bbe-9141-4c10d1a16d48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f39cb110-408f-4828-9755-d6612783fe2a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/d252fc18-7d0f-4655-a676-a0dc86a1009d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/fa494592-4e48-49e9-b3c4-1f42a67f18fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/88cc3832-42a7-44e2-87c2-d2a852b829fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/84f9a151-766b-4c50-94b7-db7a926cce07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/2617098b-89fd-43a6-ab96-bbd7462fb7cc">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/02be8092-7cac-4652-b498-757c8b5b8d18"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c1a33f10-b90a-44d3-abdf-4b6d646060a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c0dc8f81-7f08-480a-bdf8-2190ca0e8e7b">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/c5853e5a-a0c8-4fe3-b208-32a121a22afc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/53f5d8d6-b48f-49be-b4a5-fde634b90ee3">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/49d1a01a-9818-4c40-ae6e-a151861a9e6b"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f4ef780f-07a0-4674-a5e9-b4462345c3e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dce968c0-f708-4356-89aa-85577f0e65f4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/09219c87-f058-482c-9fde-ed54315242d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5f2aef47-c8b1-4e63-94d5-a905a5123e1e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0d66e3ee-cb99-4fd8-9eb3-627a3c047d0b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/55e6885c-066b-46f4-be94-05d8cd0862e1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/21c52b30-da64-418f-9bcb-7ff4296886f6">
    <obo:OBI_0001937>0.23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f0e29bc5-e393-415c-93d2-3d832cc0bbba">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/de0290d7-9f2b-439d-9212-2ab3e23c3c28"/>
    <rdfs:label>clopidogrel-fluvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/71bbef92-d235-45b4-9cce-98b37dcf0502"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2d8b0168-64ac-4a5a-a9fe-3f08a01dd4f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8e383a6f-cac9-4ed6-9bef-5931158407a8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/684a55af-ab03-41fd-b604-61cd70612f8f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/53de0816-8217-4ec3-8eb9-1b45fc1f263a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9027db15-65e3-4405-b3b3-e5c0e43217c5">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/e35e7fd3-3631-41e4-a188-e243e2097f72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3c06bdc6-a33e-4d38-a0c0-90e2e84cdbfc">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1a06fb17-33ae-4d97-b281-c808b90e7cc3">
    <rdf:type rdf:resource="obo:RxNorm_4053"/>
    <rdfs:label>erythromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/da5fc962-6f94-495b-acb3-e0886126917c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/593fd1ea-5517-4d94-b0e1-2da747944bfe">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b7292454-c8b2-4808-9ed0-13123904cf9a"/>
    <rdfs:label>Diltiazem-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/de573374-97f7-4b95-9977-dfe14a7fafda"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/32674ca4-e7aa-45a0-93b8-aedb8f05bec0">
    <rdf:type rdf:resource="obo:RxNorm_114289"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/88af871d-db86-4d79-9e29-42ca8e9ad3ff"/>
    <rdfs:label>indinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/32924a5c-1336-498f-851b-5b92c6cbf5a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5738e8f1-4890-4df3-a0de-cc374469286f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/020060ac-f758-4ae4-8df9-c8664a2eb068"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/a842d73b-82ea-43eb-ba74-4dacf9a4172f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/6436ee1f-ead4-4aed-833b-a0a2222bde90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002353">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8a9029ba-5bbd-4117-9284-a7ea829d6c79">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/8e92ba75-b622-4db8-aa6d-72f9f1814e90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/30b2d3f9-358b-4bb3-a4ba-4b6d341e1956">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/fe4e3b53-1ca7-4a1e-861d-84cde1414735"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/9a2032e8-287f-4412-8939-7f1a9f990550"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/cddf8cc1-ded1-4e1e-93ea-c831bd2e87f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/96f370a5-c947-423c-8e1d-ccfa963c142a">
    <obo:OBI_0001937>3.08</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7fad19a4-0656-48c4-a1da-0cd432cbb9f7">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/82f0efa3-2213-4ca7-9555-4a87bc9a568a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/14a97214-d48b-4359-8787-29fcda9fedc2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fc07487d-dd13-4a20-b1b4-1f97bcd8455c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b20cda72-2237-4984-8b64-974f8447f57f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b02005f3-06af-45ab-b7f7-0afad78b7cd3"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/fc156710-c2f0-4845-aef8-3b37d86c5bac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2ac7194a-532e-425b-b1d4-c02783aa1bc1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fe42d554-68c9-48be-b06d-6383b9debcef"/>
    <rdfs:label>erythromycin-zaleplon drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b4369e0c-a4f7-4743-ae8d-b0ed753254da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/be69a478-27aa-40ca-8211-6ec357d55459">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/357b39c7-6ba8-4934-ad0b-dc678ffba06c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/f438e733-570f-4986-ae18-9a012a1b1e5f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c6b72769-06f0-43ee-b961-d58f393cbfa8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4b95b69e-f3f3-4050-b2f0-5412024cd669"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7380776d-71b4-4e93-ad30-b7dcf1fceb14">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/487c0e3f-2bca-4b1c-b5b1-256eae176125"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0ffa9899-a66c-41c8-b905-56743ff05472"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/d018efce-c9df-4e1d-90d4-0d8dbdc1e10c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/265837e9-508e-4ec4-a4ef-8368a2ea729b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6c4201ec-d2a8-4453-b1fd-970aa247ae1e"/>
    <rdfs:label>Ticagrelor-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d227ee3a-5a01-4d08-8434-54aa5ef017a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/3e2d85f0-eb21-40e0-9db1-c633a8de454b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/45665fcb-17bb-41a6-89f5-592263ea0eb1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a3125932-d483-4bad-a7ee-b1fa0a22f59d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e12d9a7d-4cd1-4aaf-892f-a78ee5713041">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/373164c0-df07-4a15-8904-fe91f30348d4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/66fda0ac-4002-4dea-8e8e-6c57cee07d13"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/aca23aac-723b-4156-b930-9b70f67e3cc5">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/107f3607-c24c-4955-bb46-230b5166eb20">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/c808ef60-033d-4744-b62d-a0d85ca75ab6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/b4e57a66-e027-412b-98ce-3f31d0f55494"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/c3a92021-f7ee-42cd-841d-734aa8a11ac2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f6628ca1-1d51-4f85-b8ad-dd6875690ef0">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d0f8b4b0-7b59-4874-adba-9d51093bed04">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/08d6fbd6-e7af-4ebb-b61d-77a305698cf7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ffed47c7-a323-469f-83d7-b476684d67b5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8794b9ba-7595-446d-b599-13fe841e10f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/51c9493c-3b39-40a9-902b-d4c17eed116f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/ab35fe21-3217-40aa-8ff9-bfd046bebd56">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/00a67608-5e9b-489c-9c12-58ede2a9fba3">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/c394a05b-05f7-47d0-8aec-21701c447aef"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/4fd3f95b-b714-4814-a076-2d2027cffe35"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/5f458412-93ce-4245-bb28-ce55b32ab0cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d57a5250-89d4-4699-bd9b-e24cba90c3b4">
    <rdf:type rdf:resource="obo:RxNorm_5093"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9f9418ae-fd5d-4c94-9781-cb5842506cf0"/>
    <rdfs:label>haloperidol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e9e03845-8c93-4d04-bb07-72d6a0d3fe06">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/de0290d7-9f2b-439d-9212-2ab3e23c3c28"/>
    <rdfs:label>clopidogrel-fluvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b2dafe1e-76a6-4d94-9ec7-0fb575fba754"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002352">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/26df2320-c2b9-426b-a789-876879db07d2">
    <obo:OBI_0001937>1.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/1ddb593b-8ea0-4418-bd8f-514aed2fedad">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/cefef994-298e-4394-9532-bdf0d3e32cf0"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/827bc7fb-877d-4235-a429-2fbe4a36aaae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bd618b2f-ef9f-4251-b92b-4ff721820b01">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e3f46ce7-7210-4648-a944-48757c02547f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6124412e-bcbe-43dd-9ee4-39a7ef5fee17">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/11836ec5-bbe3-40f3-86c8-066b595f1914"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/fab2d287-2945-435d-9667-121044cb2d8d">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/40dcbb12-ee4f-4ac0-8c17-e1ba7b502f5c"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/88f67ca1-99e2-4c31-8a8e-21773ef629e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/13d7c981-6903-4127-ac7b-252342c2359d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f49fdb03-34e1-40c8-aae2-6311b2e299e2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/c649ec52-eeaa-41a7-9a5b-270cc15d36e7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d0a22074-ba0e-4e95-9d05-fcbaa27dd6cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/efd6e117-3a13-431e-985e-5bbaa2c2c636">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/37d3762b-7dc6-4bbe-a1cd-e05469b2b620"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/5fa84026-4137-4e21-ba3c-aa9b701b7f5b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/4e447fa4-9e30-4afa-92f2-877c0ecd1447"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d2fc8409-3b14-43eb-91e9-009b6eeae1d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/317914c2-b7d3-4b2a-92c1-5e4bb8f52124">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/0ed9085f-e25e-4cb3-8817-38683228634e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/418ca3b4-7ee7-48ca-9370-0c224b82fe3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a99b7888-ada4-47db-aea2-10d54b8ef8f8">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6d60cc6d-49ec-4fdc-8318-e1545670fb41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7bdd45f3-51f8-410b-81ce-168dcb9fd9b1">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/defd87d7-2b87-4d3d-8550-111336ddfdf6"/>
    <rdfs:label>zaleplon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a04768d6-eaa0-423e-90af-1a7c313bde71">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/47138573-752f-4fe4-a8b8-73def3fb11df"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/dc4b4f54-ec47-47a5-832d-837a918d2978"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/522b2565-14d3-4b83-b2c3-23bc8fbfe9ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/86dc5522-c988-40e9-904f-a89d10d59fc8">
    <rdfs:label>fluoxetine-triazole-dione DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/720ff35d-5e90-4954-9557-5102f165a5bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/b0ea4655-4a4e-43e6-8230-7094d98082cb">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9a930ce2-ae3b-4958-8735-8d0e6597b8dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d351197d-998c-45f4-9e18-a6c3604a7ab6">
    <obo:OBI_0001937>56</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/eefdf5e5-ba3f-4289-869d-770ea2d00de6">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/522bed55-56d0-47c9-82bb-88b7aaf121e7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/8c1bf3d1-20f5-4285-a5e4-48d935edd346"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/27275a2a-ba22-4253-aee5-6b23786e4ca1">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/b7436fac-a58b-4d61-a48d-bd8fd073d536"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3c68c3aa-5b96-4a8e-a481-22026d8122ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/99b94fbc-57cc-4e0d-ab99-fbfe0f119018">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ac0531a9-3b72-4cf2-9218-c6fc455305d3">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/1735caa8-ea04-46f1-9802-11f1c0885f89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/47b5a1af-f3ca-4851-98a5-9b56660ac6df">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/fe986b9c-1ee4-4a0f-b627-d25679a47c4f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cf92a655-027a-4385-ac30-60e05e3dd8dc">
    <rdf:type rdf:resource="obo:RxNorm_1102129"/>
    <rdfs:label>Boceprevir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/76ad827f-8699-4a2a-b613-2f0cf061ffb2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/43709ed3-bc18-45f8-b16c-6ec98f19b38e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7c54fcaa-1372-4e82-9321-0867e5bca79b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f394512f-77ae-486a-85d0-886de72fc651">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0941ab47-1ac4-40f9-9ba0-60f08a57a1e8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d6ebd500-b680-43dc-ba8f-fa26b4388ee1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f438e733-570f-4986-ae18-9a012a1b1e5f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ab10bc8e-d0c6-48f9-ba1f-861ef203aec3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e4fcd024-a95b-4210-b1f1-af76cd4cc3a6">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/3f12343c-5fec-4ef7-91e7-5138a17d10d8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ea21e94e-5506-4a62-8956-1f2c35644ced"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/47d76cc1-897b-4d79-bb40-e55cc0ee5240"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d7931892-b983-4b46-8b45-d3d052a4394c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e2dbc87a-19c6-494d-a956-985d48d5388e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e6f7a3fa-a495-4d16-b37b-cc352e34fcb0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/eb881951-2346-406d-a26d-3639909cf9b8">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/bc9f8631-4014-44b8-b759-4d061002bd22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/81b6431f-5ce5-4ba0-b58d-188a2086d9c8">
    <rdfs:label>Nelfinavir-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d9e099d7-f2d3-45f1-b85c-2693fe7154ce">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/6af36176-549f-481b-afe8-50a99bfc8639"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/714a4b78-dc47-46c7-9b70-27300dd1c5c3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/11e133c3-5451-4e01-875f-82fcd273087d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0bd50c1e-35a7-432b-8479-428e5cbb5a2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cbe0b0d6-f1a4-4d0e-8791-91fed5852c90">
    <obo:OBI_0001937>73</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/d15ddab5-fef3-4817-9b96-b0412651aa95">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/11836ec5-bbe3-40f3-86c8-066b595f1914"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/66b97f26-9239-4429-a99a-6d9ff63f9884">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/720b66f8-7444-498f-82eb-556107e8c2bd">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9d253e6c-df12-4fc1-bdee-d70ebb555784"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a82c34fd-d420-43b0-8b00-9a0133ed6e4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/affe0619-1ecd-4574-912d-66be93eeedf8">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/8562bbb2-cd0c-4e2c-bfef-29143d0ed3c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6a39998a-e57b-42a0-8780-86055aa203f6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/5a1bf7dd-33df-4d41-8763-738e99c48934"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/236a5671-ac8c-4ab8-b757-75f84ca32c65"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/20a7c410-aa24-4152-ad88-342013b38578">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/90366e41-be33-4b29-b5c4-3cfadea4e9d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e578513b-5a6d-4c4a-9fba-d99fe26117cf">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/3bffee20-9f2e-4abd-a9d8-70d3f44d30b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0ddda011-8480-4e50-92fa-7edf2ea7cb6e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/603cabf9-c853-4d74-afc1-47625c5a6b41"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ca798237-74d9-4753-871e-66cde709d722"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/ad28ab2a-113a-44f8-848a-f9a48033d0d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/75014af3-7c88-463b-8715-1e328c4720df">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/a8e75a9f-9dc7-46ac-a91c-493d1565c019"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4e5e0cfc-778f-40c9-a3d9-3751c0ac257d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8142ee63-d52a-4370-bff7-88f49358c9ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/889ac315-1ff3-4c58-8584-e065c554881c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ed21ff6f-4965-4b2a-991e-a240662de149"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/648e940e-fea6-43f7-a304-f76b2e926c51"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/59d73727-992d-49ee-b8bb-5797b2b06513">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f40bca32-a807-401c-b1e8-1a7b2c5ca363"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/dd2bf615-7106-4fd3-8828-ab499c2472e9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/b5020419-bb94-419d-a61a-2dc3d66b415b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e83ad0ad-2d6b-488b-9688-af56081cd9c5">
    <obo:OBI_0001937>2 to 9</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0829d223-6e1e-4d9c-8a4c-0e00804a9784"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1e7bd53d-c9e2-48c5-8e55-2c289bc3b3fe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c153536c-422c-4ea0-8c83-c2bea442281e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/298efe8e-580f-44cd-822e-544866bc93d6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/75f0c55d-88ec-4349-97b2-3662b697334b">
    <rdf:type rdf:resource="obo:RxNorm_10767"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/2df12e8c-442c-432a-8958-9e37e89f79f0"/>
    <rdfs:label>triazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9a930ce2-ae3b-4958-8735-8d0e6597b8dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/32288c14-3692-4f6c-8ff1-87a7a59d15a8">
    <rdf:type rdf:resource="obo:RxNorm_203143"/>
    <rdfs:label>fluvoxamine maleate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ca13a743-2e29-440a-918c-2b584e9d59fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f276a3fb-3f15-46c2-9c01-4f3f8c9a4118">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2f55c00b-9932-4d1e-bfb2-16db4df7f76d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/ff9535f6-af4b-49da-8ba1-2cd2396dbe5f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/49117207-5417-4563-b234-953b592ebc45">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/08ef6775-a2de-4f24-bde6-a16809419d80">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/09f9da0e-9ab2-4974-81cd-af510c7345e3"/>
    <rdfs:label>nefazodone-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/922450f6-2bea-4f00-9ce9-9dd2c6de0781"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/cfa4f58d-b8aa-4cc9-85af-ed6c88ed8462">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/57603e47-d2a3-4c72-b301-ebcd3e790059"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/c579ee39-37d9-4133-8394-1584fa44268e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6ebec28b-4633-476c-9cc2-e2f03cef2225">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/833f8824-2abc-4183-bc98-037a1dd430d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fda354e9-5034-43c9-a442-e1b498108fed">
    <obo:OBI_0001937>190</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bc900083-c663-44b1-870c-db0735e0eafb">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/9ea20d3c-7c8b-4222-adcd-9d326dbfe29e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1c1fa313-f208-4244-a692-1696368bc779">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c1e4d702-3712-4a65-8f53-220d708bd78b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3643556b-a437-4115-94f5-eb537c04f798"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b9f968bc-045c-444a-818a-2caf9ccd1743"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/26df9ae3-534f-4db1-b9bf-93d13ca4d4aa"/>
    <rdfs:label>sitagliptin-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/f8aefa05-a3cd-46f1-9821-c70ed92c73e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a6d72189-c6bd-4ade-a124-fd7d8ab62e0e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6ec46d92-d7e7-40e0-b028-67b8dc284301"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2e387f65-c662-4cbe-a7d5-d8b32e763e53"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/96c974ce-7570-4cd7-8d3f-5a8a65aeb4b7"/>
    <rdfs:label>sertraline-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f74538f7-28ac-4050-9b43-798f32e9c095">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/1954668c-af4b-493e-8c20-da319285083f"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/5ce7e783-d318-4e18-9896-091d042e67b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f8709c3f-4cda-4a3e-8f60-ecde83c2be2f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/6f7bf756-a358-49a3-8f91-6d2c46684844"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/41805942-42f2-4707-8cc3-53c48412b595"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/6f753723-cd80-4902-8926-dd84e5689c36">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/a9e2f030-d160-4804-88c5-8604ced74fa1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b5265e30-a552-48ec-9a34-4b205449e2e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/f80eeb2f-928b-462c-9764-59ae454f7da3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3fd8c580-feee-4c7a-b757-4ee189d4cf8c">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7ffac3fb-89e3-406b-afcb-ebca7e7a1b88"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2dc6d1fc-e015-46c4-b9c6-6284da946572"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c89c661c-c640-4ea2-a0d0-aaadb72ae7c3">
    <obo:OBI_0001937>28</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/6d34530c-ebb4-40e8-8a96-f04e3a14b634">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/b4e45684-26ca-4c92-8de5-11c4c4b7cd47">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6c56ae99-2f94-44e8-9b64-d062611afc7e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4fbc3f5f-8b9a-4157-b43a-baaa2e5f2e9d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4ad6f7e7-d790-4cc4-b2f6-5efb965f07b7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bcd08180-6cab-4277-9a5e-93cbaf17e18e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/63bdaf72-d290-4eea-9566-a166f40deb84"/>
    <rdfs:label>Erythromycin-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c82f7f8b-958d-41c3-abc4-62d3e66a3b0b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/30834154-ae74-444a-b59b-6a5b2662d937"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4f2bf4c1-acb9-4450-948c-e86b0be34275">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b614c831-2207-42cc-bccc-cb1258b35ae3"/>
    <rdfs:label>phenytoin-paroxetine drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/8cc287da-45a9-4dc2-b374-b25c72a30af4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c8f9af6f-907b-4590-b321-88969c2333bc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/75c42cd3-9893-44f6-bbf0-db93004531ab"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/7191fd16-d050-4ebb-bd11-12b0a018384e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/5c4f24ce-42bf-4762-90e9-87a4bf1869af">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6e9921f5-6070-4061-8ff7-4355cc4d2cee"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/7b6d0c77-1551-4515-a0ed-f8f95f4d3ec8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e718144e-8c57-482a-ade0-a47233deda87">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f566b09f-723b-4cee-b88e-4ca2950c6ae1"/>
    <rdfs:label>carbamazepine-selegiline drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/8b8868d3-2299-4158-9e9b-0d846bd201ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0d0543ee-f64e-4e33-8816-bde4a09f2961">
    <obo:OBI_0001937>50-200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/88727bcd-991b-4ba9-bde5-a18c291ccad7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0dbb2aa6-d6a6-4762-97cb-e30837e29055">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/37bd015c-4ea9-4b0d-9327-53237a66fe07"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f0318415-8ca5-48f5-916f-ff075e071911"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/6c4f74ce-7813-46d4-81ed-152829dd0c88"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/28933684-db59-4813-ac8f-15f12e82e5b8">
    <rdfs:label>carbamazepine-methamphetamine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8d4af701-03bb-4089-986a-ce03ff14ff07">
    <rdfs:label>ritonavir-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3597bc69-842e-4893-af09-20d32fe2155e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2cdb684e-04a3-49f5-8872-8910951ffb6e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/89fc92af-b9e4-43fc-b4fb-7102ccea3e3f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/41bdd51e-53d5-4ee7-aad9-6c5459d93f02"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bf79ed0d-9843-4a93-9786-40432cf0142d"/>
    <rdfs:label>ketoconazole-desvenlafaxine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/39c3d034-afc8-451c-b994-b0dcfb0845d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e6a7bfb6-4a72-43b5-b36d-735acc6f4830">
    <obo:OBI_0001937>50 to 200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/57140fcb-3a92-4b89-9ae3-9bd5a703534c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d706e397-b856-4704-9174-f74354ea09a0">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/8277cd88-2eca-4765-bc41-2e8cc0a76c07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/46e42764-109f-4cd2-86ed-c45cbacfdff4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/23694461-a8c5-43ce-b3a2-96403bbc9184">
    <obo:OBI_0001937>17</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6df0ad3d-37bc-4585-ae16-7c1d7e2d836f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/fb90658a-15db-4e70-b752-049a07b662c1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/34fee07e-a147-439c-8c8e-2225a53b8b3e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/142c172f-31c1-4475-b6af-74ed8f0a28ed">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6cd52630-f1d3-43a8-8ce6-c2089798d1b9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/52ba74a7-23eb-4de9-a1b9-20db8b47b712"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/93432714-23bb-4c31-bf79-aec7680ab26e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ad480095-5c78-4ee3-ae2e-fd42f17c2011">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/1eccefe2-cfc2-43d9-98fa-a6f776211a49"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/076c020c-0aa6-45e0-b1b4-4706d588c1a1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/572601f8-e4a4-447a-b306-cd65a8fe77b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1bb27b0d-8197-4299-bb10-2bf4ecb7a62e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/d503179d-fecf-4b4c-9faa-8c4b879b328e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/421e76d6-e71f-44c4-a715-d45af0fa170e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/a308c3bf-0cf7-46e8-bd56-f6dccf9aec4d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5c6bf1eb-e64e-430c-a017-d8cda7aa1af3">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/543fff0d-f78c-4fcc-85ed-966626c83b87"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3db849d1-72f9-4d89-9e35-bfabcae32157"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/2e794354-4a52-4f30-9f60-89b878c458c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/160127f2-5741-4fa3-9dae-1ea90fbd0acf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/bb0b6b66-fc69-44d8-9596-c3d4db9b6987">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/0fc5929f-cbb8-463e-b579-14edabd95916"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/6c0cfe03-8451-4e06-801b-459fc55a6017"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f0ef942c-b856-49e9-898a-b45adb587a5f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7226e225-dff1-45ff-9609-3294276ad5fe"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/52ba6ec0-2ecd-436e-a93a-b41081768631"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8a4f0e67-99cb-419d-890b-0862ff11fd59">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/83993b05-73d5-4e11-adca-1c5686c5750b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/8b38fa6f-35be-4097-9b40-8d5ff5c42d29">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/67807e17-1a05-4c97-b33c-8bfef457e7da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8f1ea85b-927a-479c-9a94-4c5a7ef4b1a3">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/42f3303f-8b14-44fd-b28d-7205da03d8e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/387fa893-6e26-4c22-86bd-a0b4f6b5eb42">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2b20d7a3-3875-4772-be5c-0d7f9dbeacd7">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/523d6350-9dc1-4c88-9c8f-a58c071d1cfe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fb00bb38-dc7a-460b-9114-896687c25361">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ec1364e3-ef06-410c-ab91-c338a4df2564"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/977beebd-f438-4a9f-bfd4-f944cfde44d9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/9623afec-4dfe-40bc-b66f-251a2a8005a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/21e1270f-7796-4598-9519-2f89bc47a376">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0e2d1f24-b320-4777-b611-0ce01851da3d">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9a930ce2-ae3b-4958-8735-8d0e6597b8dc"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3b45288b-4aef-42b8-8ad6-cf6831df6af7">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6a50a97a-674b-4fe8-9e75-2daaa564fbb1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/03ec9b46-e92b-4cdf-89d0-febe3f71fa03"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/97193f8f-f844-477a-88bc-959413df9a66">
    <rdfs:label>Fluvoxamine-alosetron DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7330540b-d18d-4dca-9cb2-0690018d46ec">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/f99bacb9-75a4-428b-879b-2d7fe0ff2265"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/89f93d8a-def8-41b9-aa9d-ed265e229373">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/55e6885c-066b-46f4-be94-05d8cd0862e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59999">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8846cd28-bc41-4151-9305-796d93361360">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/8249e32c-a43c-49c7-b5aa-51c5eee56464">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/cc0a332d-cdaf-4f24-9ec1-caa69c01cbda"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f3bd2e72-b696-4c66-9f80-448859d583e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e0a8b3db-a51b-4d0e-89fc-45aad8357b17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/16682296-b557-4929-b6f9-2eb0f9af0028">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f69bc4ea-f638-44d1-b539-e5b6c758c20f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/840c2237-70c3-40b8-9751-583b18bf5ebe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d119c10a-946d-431e-8522-1a8db2f18a0a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/fd0b18b8-b7fe-4b55-83dd-8e1147b95058"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/71417e60-e07a-4404-a289-0f1db1b243b3">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4482e28b-3da1-42a3-a87c-239aa78a07af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b454049f-48a1-43b0-9eee-59243294b4e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/70550ca5-7f1c-4689-ae26-357150a63cc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/62817ecc-fd90-4c87-9917-526c4734a3ff">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/27cba158-bd72-47c3-a9aa-6352c5ac89b5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ed49b73f-06e7-4bc5-9d38-446eb38fad3b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/2868b415-7e03-407c-bdd1-3c8b7cb8d8a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e0eb7473-0588-41c5-81a8-264b5700fba8">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c7a60128-e21f-4ff7-8a0e-aadd083664de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/974debea-8a56-4ff9-aaed-f49bf022eb9b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/16980631-98e2-47b5-8a99-3b0cd012962a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1f3f797a-966e-449a-ab00-c17e5f25ac01"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c55c6e19-c8fc-49a2-a582-f8521f78450d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/db9e74b6-d96b-4f85-b518-4b39b70d9828"/>
    <rdfs:label>sertraline-pimozide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/dffb6c9c-f190-4302-924d-c7faedab3c91">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/a57af603-6ca0-4af2-aee1-c69fe40719de"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/2005b147-f588-4294-8db8-33d9814ccbbd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/26c049e7-3ffb-408c-9150-761cde9ac3eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/21fc2962-19d3-43a8-aaf5-7119ddc082b5">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f6d93287-3001-4871-b9b5-5e33f630392d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/931589d8-f0df-4288-9b3c-df119e147e69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/96d2f6d7-8f82-4777-838b-87e59e6b8a29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/199081f1-1a02-499f-8f9e-d268ab32ff8f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f1f888dc-f11e-4e1d-bc12-c0ba45d92a6a">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0914b7f6-599d-416e-88a9-660176bb2282"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/682131da-f5e9-43de-9e23-cc5d836217f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/232a0ffb-2a03-4a83-aeb4-d4e3ef2e4a25">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c94f88ef-699f-4f1e-beae-294b873b67f7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/723f4e77-f1fc-42d4-8d79-e1543e1dcc17"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/7f6492af-8e5d-4d49-9c53-9480ce2c0f0c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/69fba152-bb7b-4e1c-b7cc-777cde4d31b9">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b7fa673f-78fe-4b53-ba04-8b919c843f8a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/391592a6-1de2-47d4-b362-d43477be151c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/105133ca-e6f3-4ef7-b39e-7b30afee1792"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/27993099-6f93-4ec6-8707-289e24fd2cdf">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5346ebc3-1e80-44fc-8721-95afd9ce1041"/>
    <rdfs:label>lopinavir/ritonavir-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1b6fd323-5c5f-45e1-ac63-cafcf68719de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8be20b97-0878-4baf-922f-965665ff2eee">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b55ef9ee-bf39-4eaf-b56d-ff1822d9902f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ac31291f-d6f6-4964-a43a-150c8f38fa4a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0d4784b2-e58a-4b91-934a-cef274c24577">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/06709f26-c349-4126-8557-f28ffab88d91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e95dc6b4-36f5-4d2c-b30c-cb5e07ca4cee">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/64b6fdcd-3da5-468e-961d-8789dbd32cd3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3f3f0e35-da7d-446e-ae1e-8213bf668bab"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/692b92bf-b254-4d26-9e7f-c9d5feba7f05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2601b923-f8d4-4092-8518-ec09742d59ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/5c156421-a4f1-47ce-9c77-de08f7bf1447">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/70508ace-12b0-4774-bb60-5db4375a5b0e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/8e15a06e-a964-4841-8a19-4f0cd17069a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/345445e0-bf4b-4fcd-86ac-2afe85d2a293">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/14cb27af-bbc6-42af-8aab-7b78d19e12b7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/bc85cdb9-114a-495c-b3d3-e4f50e2785c0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f16453f2-a4ae-4764-a3c9-c7f9dd1f5940"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/65627c3e-3e0c-40f7-95d7-957ace05d200">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/84110e9c-ba82-4e93-b5e8-ae333ea50704">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/6f5a3644-9694-4db1-84fd-a0635fe3f99e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6b7874e9-eb27-4486-b89b-b4f2ca80668a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/5eb0e78c-e01e-4d00-835e-e251c1b1f4a2"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/689301bf-242c-4af5-892c-8a10feb91bc1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9015a72c-15b2-4bf1-8b40-2601d0b7f84f">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9653f3ab-c26e-475b-ab0e-35244fa11e39"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/15612b10-48c9-40bc-ad6e-04007fdc609d">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/52dad1b7-1537-40f8-a879-e40c156aa80b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/d50bf92a-8af1-4b9c-92bc-d177695f56cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/39173ca3-f1c5-4105-b479-0b865d089492">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/91cdf5f2-e08c-4ab9-87f8-775e1f943a16"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7ebf436d-1b94-4136-9fd0-d253177a2a76"/>
    <rdfs:label>simvastatin-ramipril interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/824e3bba-77c0-4253-89fe-1a91c92cb2a4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/e2c89053-ad81-4fae-acc1-66130de12754"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/673b10d0-6cf0-426f-addf-b02d41a07154"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/06008f41-984b-49e3-9d18-f660e59b938d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/86dc5522-c988-40e9-904f-a89d10d59fc8"/>
    <rdfs:label>fluoxetine-triazole-dione drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/73f6c04c-8e64-4fff-8fd6-0ad177909dd6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3b3c2156-c815-4f7a-a8f7-71ebad4004a4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6f2c688b-a705-4be9-aecd-3a9c5ec7e103"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/60e8383e-4a09-45ea-bb29-8b6c90c2026a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/74b7d61a-acb1-441f-86e3-9067730a43f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/62ba6917-f5a6-45cb-b758-0da4d9ed9f91">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/57033c0a-1ac0-4190-89b4-4b0dc9ace61f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/41766142-5635-4daf-8490-b4cb1e4737c8">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/cd0839e0-f141-41bd-a4e3-b2e2e793615d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e0544712-44f5-4601-93d3-134eb9e2c047"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/defd87d7-2b87-4d3d-8550-111336ddfdf6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b08862cf-0aa2-4f20-9ea4-28f971fdb16a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/26d71aa4-d2e0-44bf-9e7a-7fcf976764df"/>
    <rdfs:label>rifampicin-rivaroxaban drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/9282a976-da6e-46f7-a868-0d13b7992819"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a86ac461-c8bc-415a-9185-fe6120f42b23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/17ac8ecd-3d6b-4025-bf9c-95421d7763c7">
    <rdf:type rdf:resource="obo:RxNorm_6926"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/f45a1498-73fa-4cd4-b409-1808fe27069a"/>
    <rdfs:label>mexiletine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c2e308a1-3115-4c27-b2c2-beba6bcaa12d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/abd69b8f-0227-4ac2-a482-174744951f56">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e9144196-d77d-422d-be51-46a453488a4a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/941811e2-c2fb-45d7-9023-8296054dbff2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5fee9039-d26e-4803-9637-7f1d2c8cd72e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6df0ad3d-37bc-4585-ae16-7c1d7e2d836f"/>
    <rdfs:label>high-dose ASA-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/eed873a6-4b57-4783-b28c-3184da9314e0">
    <rdf:type rdf:resource="obo:RxNorm_9639"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/3490d4a4-2a2f-4ad0-8b37-d02ff81a08a3"/>
    <rdfs:label>selegiline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1b32a7cf-8aa6-446c-9949-9c6a6a59dd8d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e87ba6a1-36b5-4fbc-ae46-767ee795fe2f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/af33769d-3535-4daf-a2ba-9bf2ff4f46fb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/844364c8-7e65-4934-969d-5005e26767da">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/57a58c1a-20d6-49ef-8a6a-1ff72ef36eca"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/58efc232-6620-49e1-ba88-1d0d34bc99f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/3ba419cf-7112-4c5c-9e9d-3c2384509ba4">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/e591bf70-e542-4edf-a5b0-70cd06156867"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/0e7b8929-178b-4fe9-9b3c-0d6cdb800c06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/909fbd65-def5-44b7-9b4a-b080b9965ddd">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/013597dc-0557-4d85-8b0a-820eba873871"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/2e7a1895-cf71-4663-bef9-df0c061c0dfc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/2e23fc6a-abe9-4661-9e1b-f28cde72156d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d9546a13-0cd1-4c50-9df5-e099b84873a9">
    <rdf:type rdf:resource="obo:RxNorm_4719"/>
    <rdfs:label>Gemfibrozil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7305b68b-e4aa-4d1b-a4d6-af1534b6c285">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/657697cc-699d-4aa8-95b4-1e518c7d1972">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c3981ef7-01eb-4c5d-be1d-fbdf315bfb2a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/2143f70b-4dc6-4536-8289-1d670d42e349"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b3fd944d-d8bd-4204-9ae6-871022d20807">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7ffac3fb-89e3-406b-afcb-ebca7e7a1b88">
    <obo:OBI_0001937>325</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/bd7cd005-2460-457a-aef9-4566b3b5c6b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f6948c89-4498-4b4e-abef-3d197264e7d5">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/48528b16-59ea-4d60-9ac0-9c9c8b3d9fc1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b3139efe-fdcd-488b-b605-1d2d91198986">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0ab451ca-ca5b-4061-a962-b01b67751491"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0791463a-8336-4d6f-862a-c4a8b4656f05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/29009b1a-9130-45cc-bc7f-e05cf9407c0d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b6c51c86-afc8-41db-adbe-6d2e97d99e29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/316d778f-f284-4e1f-a833-1eabf9af994d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/750fcaf0-088d-4b52-817a-e3e6906bb8bd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6946dc3d-01ab-4935-9a1a-1f78e5cff094"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/35282cae-2626-4a4a-adf0-72abc32bca4f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6b8b3b25-b773-4af5-bf33-cbf8db24fba2"/>
    <rdfs:label>nefazodone-propranolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e606da95-e696-427b-8358-1ab51efdca56">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/aec2c211-874a-4ee5-9624-9cff01408620">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ac642ea0-2ef1-4908-8192-2a4912e3665b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/a25a6989-10b3-4357-ad5b-5e1683eb704b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/db2d3ec8-38ed-4fa7-83c1-3baca647851a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1d7256bf-af4b-4d68-9799-287d68f940fd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0a637b6e-94ec-423c-8364-196d2c835cd0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/26d5be33-00c5-40b9-a153-1240c12cad89"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/65985032-e103-436f-8e1d-467cd33b8547"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/df5675fd-8481-4869-bda4-cbf773d08beb"/>
    <rdfs:label>desvenlafaxine-midazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/04e40d4e-5a69-4dce-ba84-fe334570774b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/67596121-8d52-41f3-8168-1ba4675c84de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/899d3984-9b4b-4d2b-aa87-5cbc2c34697d">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/65b9f06c-befb-4b81-8075-9409b80e6ebd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c3e87dd3-248f-41c1-a371-30b50f6a2e39">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3f12343c-5fec-4ef7-91e7-5138a17d10d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2cf41260-99da-449a-8026-0b73258a70b8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/49e99463-5f60-4af4-b8b2-32ac602cc25b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/135aa127-c84c-401e-8d25-2bf4a4805edf"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e6017180-eae7-42de-b525-95bdaf93170b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ef1aafb3-4fe8-4d99-a3e3-0d98f754b6b1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/742afcc8-7298-4b8e-95fa-c52e0212511f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/a82c34fd-d420-43b0-8b00-9a0133ed6e4c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a8e0d3de-9ff9-4b93-91a7-9e6a50036d21">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/af8c9dbd-ff05-4b08-a4b4-472ae464354f"/>
    <rdfs:label>nefazodone-alprazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/71417e60-e07a-4404-a289-0f1db1b243b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e47426d6-aa3c-4d9a-9b99-7f277d40cab8">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/29009b1a-9130-45cc-bc7f-e05cf9407c0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2a12d9b7-156c-432e-9c14-0a22d9ca338c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/db725e64-f774-467d-8e7b-9fc032875b50">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/10034a77-5eb2-4a0b-a031-2ec5e26be342"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/6d6e358a-1b7f-421c-95c8-e6305cf31a1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b3029bc1-1161-4f75-8854-17fcd540a631">
    <obo:OBI_0001937>22</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0cacda5e-ce79-40a3-9796-91e107439348">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/720b66f8-7444-498f-82eb-556107e8c2bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e9f99dd9-5927-42ac-bd93-1b258a308ab4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/60d8dabf-2d12-4476-939b-3a6d995fb9a9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f57e75ee-56de-4379-9755-aa73e46fe8ef"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/0689f0c4-cd74-474d-ad1b-28f0224084b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c7d0cd96-6a90-4e41-8a44-923786fb422c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ac6a0697-7cfb-4be0-b5b3-686d52d4ef27">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/622ce4ef-521a-4a61-9097-cf7bd5757812"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/5e13efb4-b7f3-4416-9130-229093a99d94"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7be6be37-118b-45e6-b527-17e433c1e1b8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dda9bdbf-1452-48d4-9a0d-b3e48f99600a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b7d751a3-9bca-4138-927b-4948e77f3dfe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1a95b7f1-2f24-416a-bce9-bc77b2d0f87e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/39179215-227c-47a4-9d8d-c2635c05118a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cf5ad0c2-27c1-42dc-ae90-8c5af46ff95c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/be46f3e5-9bc2-4566-b25c-3a7653bd64af"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b27f22bd-13be-4176-b17a-076be419e7f9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e71de17d-7258-42ba-be1e-bb1f64a91129"/>
    <rdfs:label>telaprevir-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/ac04748a-9703-46e6-bcbb-98a3414c2fc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a78a0c8b-ac43-45af-8f13-c747e749e5ba">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/22e54ab0-5108-4135-bf8d-59879c73dc37"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/30c6b03a-78bb-4c86-a6c0-d65b89f863bd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/0bf0059f-0f18-4c05-9f6f-8217e3d2bb59"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/9cbda72e-6318-4439-80c4-ca446f4222bd">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/48528b16-59ea-4d60-9ac0-9c9c8b3d9fc1"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/083ab3ff-cf9e-4f16-a25b-67e07b32b3de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/94a00ae3-7d10-4363-b044-0dafe6d1b8e3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c41b9fb7-c651-4566-bd02-493590245bf0"/>
    <rdfs:label>nefazodone-buspirone drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a2dd1aa5-520f-495e-b8d9-96f15d90836b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/97df25f0-10a6-430c-b637-cfee3e8c4525">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/88c88d8e-4d89-4a35-8cf2-b67eef9272a4">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b4408195-29af-482e-a5eb-531b5207908e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/95c9f562-f9df-45d1-9cc1-449bfde727f9">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/094ffe9b-fbe9-47cb-9d24-7e33657cc662">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0ed141f2-c290-48a2-b8ad-25e1a897feb1">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/facf6c18-1fc3-4b15-bd73-b4c11999e63e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b1afe52b-59f0-43ea-addf-5c94f63ed2f7">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/8bc98a4a-5992-4ef2-a7ed-aab88fb19fa2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/73085157-0fd9-4b8e-9715-3547f344c8ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/581c3d33-2b0e-417d-987b-5d9b74dc9a03">
    <obo:OBI_0001937>26</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/04b06629-6b20-4e37-83ba-708341cd5c9d">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a4477f23-c9cf-4c48-9411-b0b970f5592d"/>
    <rdfs:label>midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/10fa6800-9a18-41a6-ae2a-093ed615f590">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a5d29af0-936a-4457-953a-54754539ba33"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4f2bf4c1-acb9-4450-948c-e86b0be34275"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/64f1abe1-0ed7-4ec8-9923-8cc6642b4388"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/97c09091-3e7f-41ee-8e38-9de6309869c7"/>
    <rdfs:label>phenytoin-paroxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/cb6582d1-9f9a-4660-9fdb-43f0d0e35012">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/2eb2a904-98df-43cf-8538-51aaebebe015"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/7acc6c1e-d166-4394-b820-98efdb743a49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8d8b4a28-063b-4170-9727-deec43e7528a">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d1cfc9e4-60ba-4640-943c-4c2224666305"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/79e34d33-3e29-4626-8e95-903907cbd5d6">
    <rdfs:label>duloxetine-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cf84f7c5-9595-4c4a-9a7b-8994c30a8353">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d726ca3d-a8ba-4a1e-8980-f915e9f91c6d">
    <obo:OBI_0001937>151</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fdfcc76e-1e64-4444-b432-30845d5ae268">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/45ca3bfd-ae92-4d44-8c16-5c8d67a0e43f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b4dbb304-b543-48d0-917f-9e822ebb5b11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7d67c5b8-2c0a-4533-9f92-aa1e2cb0a970">
    <rdf:type rdf:resource="obo:RxNorm_6472"/>
    <rdfs:label>Lovastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/57040f10-88c7-4111-87af-f91e29db008d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e9825417-e6e3-4c2a-b7b5-04f75768bb8e">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9280fcc0-e65b-4df1-94a8-d3358586f61a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/21f6c5ba-97d7-4973-b0e8-cde9356bb9a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b6a05419-359a-41a1-9bea-52ec3b490aae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d07c47b2-fc01-4f1c-bbb3-e111c2f3a994">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/68960a59-23eb-4a8a-9a86-ac646763c882"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/fc82596b-d8ad-4c43-8bbf-e6b88b670ab8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/8a4f0e67-99cb-419d-890b-0862ff11fd59"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/36f76507-dc46-40d4-be14-ceccf4a16aaf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/711dff74-6d1c-451f-ab74-62919365cb92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/08bd7b75-a7b5-4b80-863e-80f8569219bc">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8b0d050e-bdfb-4576-9066-c08af8b8546a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4fce4ce6-d619-4a99-822b-c344afb913f4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/86a921f8-7a63-4167-8bf6-81c9188ff2ed"/>
    <rdfs:label>sertraline-diazepam drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/409e20da-4a61-4eb5-abff-d41ada62246c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b6324cce-3413-46fb-a4d0-ee664c1e2374">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dba52a23-99c3-4332-8983-c74b5c832562">
    <obo:OBI_0001937>2.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4b653027-2592-49f5-9ae5-274f742e07fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d642868e-78a7-45c8-bfe9-94fac0e4b305">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/f6e9a7ab-992e-4d1d-9e43-344d62d8ac87"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/4b653027-2592-49f5-9ae5-274f742e07fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0e2df1e6-ff08-494b-81c4-8f285058d23c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6892fd67-1062-4e0c-be31-0ac70eda756c"/>
    <rdfs:label>ABILIFY-norfluoxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/db63cfbe-7f52-4d19-8d30-86d19558c3cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6f7455d8-bc73-4b81-b34c-1fe31a5cb919">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/0f8b5fbf-f034-4625-ae84-859c846cd261">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/39edacd4-20b2-4b8b-b7ec-dab473befdb7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2a57ba9a-ceb1-43fa-a24a-895f890245b1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/30e37f0d-2cfa-41dd-afcd-175a29d7eb25"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/9bb42fb1-3596-4b97-80eb-7cb54314341c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6d2130a8-c99a-4898-98e3-128a2c29438b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/22678013-deb1-4460-a3e0-6b1c7f30fa54">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ad629c4d-e7aa-4c46-a291-169586acbd7e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/dff053b3-b1ea-46a6-98d4-07d288393506"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/55af9046-9300-4bb5-8be6-fa08d4381415">
    <rdfs:label>fluoxetine-estazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b4e57a66-e027-412b-98ce-3f31d0f55494">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/71f6f131-c3ea-4d43-9051-d9a30f3111bb">
    <rdfs:label>Gemfibrozil-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d2363a2e-2a80-4d9b-99ac-a92e948dc515">
    <rdfs:label>carbamazepine-ziprasidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6b27cefb-56fe-4f08-bc73-291b93223096">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6a910a27-3a46-4267-a005-3688b85fe47c">
    <rdf:type rdf:resource="obo:RxNorm_8183"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c3399f13-45af-40fb-b55b-f27215958f75"/>
    <rdfs:label>phenytoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6177e90d-d12f-4493-b659-e90871724316">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fa74aa59-5b0a-4a51-8845-de1950785639"/>
    <rdfs:label>fluvoxamine-theophylline drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e0b5f455-ec60-4ebf-9713-5749acc32529"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/956d7076-3c11-4211-a5a7-4c3e410ad08d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/fbcd86f4-dc2c-4281-89fc-452209ff5e65">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/ade8ee73-1ed9-4351-97e6-a44b4dc0507d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/844daebc-66ad-4598-aac0-cb5b5ee12a7d">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ee3645f5-41fa-4dde-b6df-66d8859e7e2e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/08ef6775-a2de-4f24-bde6-a16809419d80"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ee4a5225-dc56-4b02-9630-5c670d7797a5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/738494d5-9c7c-4c40-bde5-7ee2cd2a6faa"/>
    <rdfs:label>nefazodone-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a6ebfa1b-ecae-4f47-a3c5-ff9c3e8fc5ec">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/23636ed6-0b8d-4447-bb1d-8e2d9a56d5ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d6659e60-3f26-490b-9b7c-763cbffa8ad2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3849e58e-73a2-4885-b5da-4fb39b86ae5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7a024d35-c044-42d6-a3e1-5d46f4455cc0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/828a1c37-eb4a-4fc1-82e4-58e646d2453c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b798dcd0-aaf6-4d3a-afcc-025c77f242d3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f71876e3-457c-43e9-b46e-f1bc962ed189"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ea005c02-1887-46e5-808e-7eb94889c050"/>
    <rdfs:label>fluvoxamine-tacrine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/dcc3e96f-4d44-44ed-9461-d42cd7dcffad">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/8bc98a4a-5992-4ef2-a7ed-aab88fb19fa2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/8d1bac29-63fe-40f7-969f-fb8a008d0b6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/45af2585-0f83-4f02-a0bc-05bfb402bdf3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/e6bdfd3c-fec1-44d9-8211-5152869ed1b8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/cbb26c2f-0da2-4ebf-93c1-2d8bd63cb504">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/433c8102-adf4-4c40-8a9a-e26ee241d1b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fb0d3fdd-e1b2-4ff1-9295-1bf5fcc0e480">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/58b64041-e017-4e4f-9ab2-2a880e9fe525">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d39c6dcf-7f6d-4778-8828-4c64a45e8965">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0e5f8de1-02d4-4cea-b79f-9c59ddc22392">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7e4e3c55-0106-42d4-aad7-697eac9860e9"/>
    <rdfs:label>rifampin-pitavastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/9b80e1c3-256f-4eee-ad99-35891e181fd3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/3c939db7-292a-4a53-bcc4-bdfcccd3394e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/5b6e502d-b1a7-4ad9-9936-81ce8c16ac03"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/9211440f-9ade-40c4-9615-ede1213ac050"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9369d712-9761-41bf-b07d-7ee335cb4f44">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b1070e86-8600-409a-b50b-8efd0bc6cfbf">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/2eebe661-8fb8-4039-926b-b009182dd698"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/db22d823-9ba6-4940-a61f-2b1e317f3a46"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/32da0293-6551-4c24-96fc-5d9be3d855f8">
    <rdfs:label>citalopram-ketoconazole DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b880d6f5-cd3a-4b5f-9f8b-8474c173306e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e1abe6d5-2bd0-41e4-aea6-22602752e137"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b0823273-1594-428d-9d1a-df181d6a7d8e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/76373aa3-0d35-45f3-9c74-aa7eb0f696fb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3770c62a-e7e6-4e52-a4d4-bfbf3ea01959"/>
    <rdfs:label>fluoxetine-estazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ebbbd0d1-0f07-407d-a340-3a60247f50f8">
    <rdf:type rdf:resource="obo:RxNorm_42463"/>
    <rdfs:label>pravastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/abdd1b5a-5f6e-4df5-a586-718028bd1afb">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0105385c-8f8c-415a-b1d7-c94e43261169"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/434711c8-7a11-423f-a4f8-badddb90723a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c31a354b-0f76-412b-8848-9c298efbb419"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/b4332f8e-8d54-40b6-8e38-7d5355acafa7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/bf54b229-2808-4982-8666-d7665e4497ec">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/cfae3dcf-1cc2-441f-81a4-56281cfb785f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/3dbdb212-37e7-40fa-a490-52ec77d211d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d7800520-a576-4d86-b371-76fab60f5b1f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/143a0311-0239-4f8f-b936-07286210d14e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3d9f2bc2-dff3-4d91-9b09-c08e3dfe472c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a9e9c432-d8f5-43f1-a61a-6d34d0a528ed"/>
    <rdfs:label>erythromycin-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/759cc221-8b97-4af5-b554-0ca2f17dad4c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/66f92631-6803-49a2-9e9e-f8c10e21b330">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9171219e-51e9-4caf-8f56-c05fd2fac53d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7d5c04d0-54de-4c4e-824b-55ea039f119c">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a23f71ff-7024-4bb1-9855-59d09c26191c"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0eb057a7-7ea2-49aa-99ad-04498a9d0caf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/58e49731-b4e8-4750-9dcb-fefee04e6acf"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/cf6aa7d0-b5fa-407b-ab14-53ef2f4d484d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/044ff11c-9625-41aa-a6f3-ceb8b0a7f3dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8d3d86a3-8d51-4823-b6c2-a6a03f8f600a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/48855b1d-4423-4fec-bd20-1cee118c7592">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/7dfc59eb-5e88-4a85-85ac-f4663e1e2cfa"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/496c46c2-368c-455a-b1b8-9f0bf4b59b8b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/c9f78b3f-98fa-46c7-a828-9547805935de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/1472903a-afde-43e2-8b06-8a4dfcc7d661">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/884af1c8-83d6-4bbb-8089-75b5df4cdb0e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/4ad612d1-478e-4f2f-a5a4-63dd8bffab90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/9225f071-9ee6-483a-b1f7-fe8f20c722a2">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/4843c8ff-fd99-4657-8199-1e04f6b41758"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ae1bb5a9-3d0b-48c2-b442-b3044d7aae3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/940cab3e-c914-4dfc-9502-637a16214167">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/93cfa88b-a92d-4cec-9700-035a98f93078"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/020060ac-f758-4ae4-8df9-c8664a2eb068">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ba7a9aa3-6fe5-4d40-b132-ab871d12c637">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/999b531d-3fab-40c4-8493-113d8d8bd81f">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fa1d4495-f3ba-46c3-8866-eac690a83eb6">
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/8d7373b0-52d3-4dc4-bd02-7e16f1ab4339">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cc0a332d-cdaf-4f24-9ec1-caa69c01cbda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f75509a8-ca1e-4552-8369-5ee33212d531">
    <rdfs:label>naproxen-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dd7a19a5-9e96-402a-b345-bd9e6b460c1f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/310ecfcc-5d4b-4527-99a1-52b564ab7220"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/676e4d86-6446-4cbc-9149-8f3748c1ac8a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c9f6d60d-d5c1-4c6a-b143-694e22f6922d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/24ecdc12-7413-4fe1-99fa-7ec1225c197c"/>
    <rdfs:label>fluvoxamine-duloxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0bc8d76e-03ac-479b-9eb8-a84ff40af43d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ec1f1558-1401-4adc-aa81-df68b2c964f2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/39e30541-207b-40dd-a105-bf6c48fe4117"/>
    <rdfs:label>telaprevir-amlodipine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/67f18091-582b-41a9-b6f7-a5bd712369ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/32a3642d-3b1f-4209-852c-7f5619416c4f">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dd0f210b-0825-4e8f-917a-42fc159c6324">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b1e03bb5-4240-470b-903b-92f378cfd446"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/98ec3ff0-9e76-40d5-8646-5981c83a69a2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b6c071c0-8e1a-4ffc-a157-a21b469da842"/>
    <rdfs:label>buspirone-mCPP interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f2562df6-b947-43b2-a280-58b07273f935">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/561f5b16-b3b3-42e6-b253-e73b925769de">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5017d2a2-eee9-4e4f-b9c8-32f56e803444"/>
    <rdfs:label>rivaroxaban-midazolam drug package halflife None information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/84cf8313-9b4e-4ba5-832e-ae6278014ae9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b687a4cc-265c-414b-a771-e4e969532950">
    <obo:OBI_0001937>66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/913ea853-ca23-4243-8c0a-66620a2f1c89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/21119903-1876-415b-bde7-236ef69fb7aa">
    <rdfs:label>simvastatin-vildagliptin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/ffe55449-f71b-492b-b9ab-c18450f2f810">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/27cba158-bd72-47c3-a9aa-6352c5ac89b5"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/24ea7085-12ce-41e7-9454-db88da26413a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/52f75856-f8db-4429-b7fb-50c005db6ad2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/265ffa1f-6726-487f-89d9-c0a4ca38f5c7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/2dd91b6a-4ff0-48e4-82d8-91e22d896dfb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b1eebff2-aed5-4391-af88-6421f3424863">
    <obo:OBI_0001937>57</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e6d9b578-6c9a-4bf9-8525-a7bb684b9297">
    <rdfs:label>nefazodone-4-hydroxypropranolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/88c89458-5049-4a1e-8900-d9b96099f62e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/743d5863-e237-43fc-973e-190d322e0923"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3a55701e-9c0a-4194-a445-216cf0bb51f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0a979e34-ab3f-4315-bc11-791b68128546">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a56f0653-fc9e-4259-a38c-efac0d627e47">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/1a677d3f-7189-4a39-9062-6f09a8679918"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fac597f3-ddfc-471a-9ccc-73ce25f7fc92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9d68b7e1-f43d-422c-be00-3e038b68df47">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1d22e83b-12e7-4751-9099-bfa8412221ef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9088d514-4cca-4d26-be4b-fd02e0435da9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/b1788393-201f-407e-9488-4f0e7b590e9d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/1e2009ab-7367-44da-aa7c-f7dc60958a92">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/31a73510-4821-46ae-b63b-7f5100220bbe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/dde4df2e-206e-4f81-b7e3-b0d183724f31">
    <rdfs:label>Clarithromycin-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/eed1a846-d35d-4601-9181-e24785dda5e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/941811e2-c2fb-45d7-9023-8296054dbff2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/33f0357e-bed3-4f30-a606-40703f1a2620"/>
    <rdfs:label>high-dose ASA-Edoxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/44c936a0-c1ab-406e-a486-e0a6b365e7a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3412d47a-f3a8-4d2b-b711-6aaac826230c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f288a9d4-0885-4bc2-988a-51cb0caf4b47">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/622ce4ef-521a-4a61-9097-cf7bd5757812">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/6640be46-1ebf-4a19-80e5-c1efd00157e7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/6124412e-bcbe-43dd-9ee4-39a7ef5fee17"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/8716bdc3-a083-4449-9604-016d3dc4daf7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ae1bb5a9-3d0b-48c2-b442-b3044d7aae3e">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/18cdd0d1-bb58-4bff-a3dc-cc2986cca358"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1fda0320-e312-4785-8c81-33e4f88c0b16">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f3f0477e-2ca3-4530-b88e-23439300a9e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/ed494293-bc79-4b09-beb3-1ee24721cd8b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/654da176-be7b-43a6-8325-31e9bf936c82"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/ca261d57-0ea9-4a9d-a9d7-6127654a558a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1528ee46-2eb3-4fcc-9dac-b799162800ab">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7a82612e-11ac-468e-ac17-a00699702c00"/>
    <rdfs:label>simvastatin-bosentan drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/613f9941-7d50-4a7b-b3da-1d2203c1c841"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c8666948-c7d2-4673-94fa-b2194b6d3089">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c58bd4ee-bd31-4dab-8905-5821552d6b35"/>
    <rdfs:label>fluoxetine-P95 drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5c62becf-0ede-4be5-8c55-51c3b0564d4a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/e89715bd-2e19-434f-9c7b-695bb5d2d8ee">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/4c31a58e-f278-4dfe-981f-a56b0b4c1b9b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/fce19286-84e4-4b21-b5f9-66a09a0aa1a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/857a9605-ad35-44a6-b99a-a354c9fb2196">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1d17271a-958a-44e0-ab79-0b74280d8931">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/deb08a01-6db9-4260-803b-d5d5814d6c5a"/>
    <rdfs:label>fenofibrate-atorvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3c06bdc6-a33e-4d38-a0c0-90e2e84cdbfc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fee4b041-dee7-4f2b-8462-e8d57e354519">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c6485d76-4449-4d14-90c8-1f72e3a10be1">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7f803a97-57c6-4ff9-8671-85304b2c39d5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/51a666ea-14d7-4f4a-9199-36078c9710fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3c43a6f7-9aa1-4a19-a2b9-1f17f567a856">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/77195caa-96a6-4759-8c68-0c7c2fba0d2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bbf720a6-4d8f-46ec-909e-da8ac8c63b71">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7a82612e-11ac-468e-ac17-a00699702c00"/>
    <rdfs:label>simvastatin-bosentan drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/40334b1a-7479-4c02-8a56-0068278314b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/08c4cb38-07fb-4933-a813-4100673edfe0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/37c8e874-8cef-4113-903e-1e526326e275"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4470336d-c6ac-452d-b668-1dceabd5279c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/875e876b-5d47-4d4c-817f-88d0aa4ab8a9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/80c05d27-a205-4e7f-a8eb-ceec8c9649c6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f875be39-0ddf-49be-9a8a-bd59cca924aa"/>
    <rdfs:label>rifampin-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bed3035f-a419-4cca-acb6-369ffa2d74b2">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f4daee1c-842e-4acc-ad43-e8a8d3bc3f5c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ae8f5de5-9153-4924-b8b4-4d83f229c384">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/65c0ed0e-7982-4a35-bb1c-2a33a53aa578">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/20a5db7f-ce8a-42f1-8586-345762c5c929">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/79047103-3217-4bcc-84dc-86390d75f835">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/22fd94d4-6d8b-4519-8aed-658700143f75">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/475bd951-46e6-4a87-854f-285d751f9d60"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/2b752d62-9979-4ff5-b08e-62d7049f671e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/ca8b2004-7d1c-42ed-b5c1-7104a6a75eef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/dbf7a6d4-59eb-4e6c-a474-4eed7515832c">
    <obo:OBI_0001937>8 or 12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/92a5945c-f3b8-40c5-a19d-246e26a958fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/dcbb609f-79ee-4ec1-acf1-9c899f6c4a1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/21032974-6bdc-488a-89dd-400bf7810f9c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/d0e2fc18-9075-41c1-9d39-89cd3846b4e1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/701b2f48-ed9d-42d3-b2c0-224153c8f499"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/3bba7da9-4340-48f7-bc89-1c3e0d5cc9be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/53499f0d-5377-4e2a-a232-193764564e78">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/611e5601-478e-431d-916f-7b53e533f4bd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/496d8251-03e2-4047-b53d-a98b7e2562a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a14ef24c-1e57-45be-a4c2-1ecf6a3a96fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bd85bf6c-4c00-4afd-b1a4-211a737e1f8d">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4f1be6df-1285-49e9-afd4-62ff1ec25009">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7e09b619-2af8-4df5-86fe-0fa28a002f78"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/0eca4c7d-b2e5-474a-8781-042f9586651c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/4e7ce66c-7a18-4c20-9497-dba43a7e7b84">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8f780704-e55b-4ca7-a6cb-ca161ae0e78c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0b91328c-9589-463a-842b-fdc94905e118">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a8b3353c-b1e0-44c4-bb33-cc450fe60d72">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e4584037-ff70-45b1-945e-d51757975476">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/03d78909-91aa-4e0f-a20a-436b30bbccda"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/eb73e100-a009-4a90-a0e3-12c09b5ecfd7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6bddb3a5-5d0a-46ef-8f5f-475a7b1f1c30">
    <rdfs:label>risperidone-valproate DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e0544712-44f5-4601-93d3-134eb9e2c047">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/5eb56960-5017-4dc1-a78f-12c6e502f9c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d6ebd0af-822c-499d-bcbf-2ac6d65dcad3">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/73107815-ea8b-4c6c-83e6-a490a712c49e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b80e1ff8-4eea-47ba-aa0c-4fb25f2fdea6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/72514684-8493-4f72-bfd6-e66d739c8952"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e085c3d8-7662-4249-a2a6-5141e8fef6a6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0ca6e364-746a-49fa-8545-76669c5562d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/2e641752-6485-43b1-a952-081ad44946f9">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/a2c7f287-07ba-4169-bc3e-ab94bf858624"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/cf750a56-054e-4711-b331-bbd3b2489f27">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b6ffc719-f74e-4829-b568-c95f4b862c95"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/cfe8d0e8-c347-485d-8adf-09d5ef53b9f9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4c31a58e-f278-4dfe-981f-a56b0b4c1b9b">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/6fc94869-ba3d-491b-8a8d-7da553454268"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/667fe52a-3426-4654-af22-f7c43c1be0ab">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/fe35b04d-3741-431c-8980-7e0525e727ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/33741462-5b14-4f77-8392-6af6b0ab4b48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f875be39-0ddf-49be-9a8a-bd59cca924aa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2e8c1880-1699-47f5-a12e-87ee28788410"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c6ece8d2-859e-4c63-9fa0-75679a4de03d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5854ba6d-c6fe-4d34-b48b-b8b7d549fb99">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/55936487-dad7-405e-9828-9f7c6ad3ca0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/2422eb6c-721c-4bd0-a42e-0ab52ccb9264">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b9d5f3f8-0256-4f67-a8da-8a18a319f365"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/74d2fd6d-fce7-46a6-879d-ce962473173e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/038778e5-295f-4c48-84ff-bc1a929f2ec6">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/657364bc-1293-4136-b35f-c2c1119add88"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/977ebcf9-18ce-45b8-b0b4-a9b4f27e6955">
    <obo:OBI_0001937>1.12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0e2d9bfd-0ff8-4f3d-ba66-68a361586cb4">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/22803a6e-a569-45c4-846e-2ff0b08e52fb"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/5d05dcdf-726f-4d98-942d-209872bd34b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3a743daf-16c2-4598-9a28-99ca0a16110c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/3c68c3aa-5b96-4a8e-a481-22026d8122ce"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/73eb9444-4070-4764-ba8d-9e32f3bca352"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/7f0ef433-aafc-4e00-9457-5e6aef5f74a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/31595b44-6528-47ba-9f76-08ba5d811732">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ba143b3b-cfba-4003-9253-21ba983122fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/cf4ecb2b-8e73-4908-8bd2-a440c52ff946">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fc156710-c2f0-4845-aef8-3b37d86c5bac">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d4b16ce6-27a6-4cda-a704-0bd44b928cf5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/3f439175-44f7-4323-b878-f8d11b19b576">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/711dff74-6d1c-451f-ab74-62919365cb92"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/89816a9f-fcc0-45bf-aef4-e15168aa42ab">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8068f57f-1583-4a85-8de8-6b280fb70123">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/7051fedc-22e6-4413-873c-a89b3b13c656"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/15d76ab0-deb3-47be-a668-b8fc14c1c1d1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2a64edb6-0359-4c80-8ff2-d4fd099af379"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/6ceb5043-937b-4567-ab06-2a910284f683"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/21e9b1bf-0b75-4b57-8f48-9ab3352c95f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d7fa6e63-9549-4d71-bde2-072e55142d13">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a1bc0b15-672e-4336-98b9-7aa42e179d3f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e8e1fde7-b802-47a4-a2ce-0f495b540fc0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b110f347-f4c5-48ba-a6e8-d1b0a95116cb"/>
    <rdfs:label>efavirenz-hydroxybupropion drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e25ff6f1-6490-421d-8235-5f65e7c84505"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/491e18f8-3017-4557-acc5-7be063fc9120">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/23a94776-fc69-4a01-b72f-14be9ebc9569"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/09ba62b8-ebb9-440e-bab9-7ff1472a92ce">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a1bff998-9ae8-42b2-bcc4-22cfaa2058f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/74c8332b-b008-4601-92f8-834ba64109d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ae33e4f2-a9e4-4de0-bd97-526a363948b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c59d11b2-3124-42f6-83ae-ada41849ac2c">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2014640d-6f45-4b33-a0a5-ddf87449415b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/56e5f901-2403-43a9-b68f-74c21861a50c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/22dae535-923f-4893-8ad2-958c76774a83"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/31cf2b2b-bc12-4a10-9246-cffe32f238ef"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/e8293ff8-dab3-4e57-ba46-eacb0a69e83f">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/53af0cc1-4a84-4f64-afb2-18218b2b9114"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f806f041-17eb-45d1-89fd-95f764b74ea8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a4369021-5e46-458f-8f87-a85b72d4f967"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/09ec43fd-d046-43e3-854e-a63000630edd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e3d048a1-00a1-4d6a-8867-0e04754f4d1e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6c4201ec-d2a8-4453-b1fd-970aa247ae1e">
    <rdfs:label>Ticagrelor-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d0862589-fbcf-4821-b072-d823aed77f57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/71588a82-89cf-47a7-9115-1daf43592cf0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/35129132-8a82-4193-a0cc-01b676dad580"/>
    <rdfs:label>nefazodone-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ef83fd36-3ff6-4f65-91fa-bc9193f97ec3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/88061dc4-903e-4def-bde2-3f0e4320d736">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ad6ef1f5-26d9-423a-89b6-40b7cad663f8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b2c5527a-5b2c-47be-ab4b-2908b5a9d903"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/2d7898a5-435a-44a6-8c6f-93bd21aec031"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/6766b392-2923-44d2-9c49-192898143bef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/38ea7cef-8b9b-4b86-8d52-69391ca07e55">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/855ac767-27a0-4f10-a9bd-4aa97e10f918"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b44de1e8-715c-4c06-9861-fffa915076a9"/>
    <rdfs:label>alitretinoin-ciclosporin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8070f37f-bb25-4a7c-81dc-04453d9b01de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5060ecff-3e2a-410b-846a-a746c69caa34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ecfb6b95-528e-45f4-b72c-87ddff108913">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/da3d3ec2-2bcc-408e-9a31-f9a4c0279686"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/3d5801db-597e-47fc-b55c-87b2867771f8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/ece3c37a-7d94-4175-93a0-c7435a5b4ddb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/80d9d8e3-62c9-4de6-aefa-7c7856742a36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9211440f-9ade-40c4-9615-ede1213ac050">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/8820bc3d-968f-46cb-9fe1-b06933678f73"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7c54fcaa-1372-4e82-9321-0867e5bca79b">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/4094efbd-dcb1-4913-9e76-e2b6af8c3dbd">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9f9418ae-fd5d-4c94-9781-cb5842506cf0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e29699d2-5a0a-447d-8d3f-b87f53462e4b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f75509a8-ca1e-4552-8369-5ee33212d531"/>
    <rdfs:label>naproxen-Edoxaban drug package auc UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3b371cf3-9bb7-4dae-af16-bb7ac444f278"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9321212f-d509-4c27-b4bf-fe8ad8ecb04a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f99706fc-e8c3-4a17-871c-244740a71ceb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/1968bee1-bd76-4700-b4a9-0f46504d0668">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/dd469721-3a66-4ed8-bf56-ab38dc6ba4f6"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/21fc2962-19d3-43a8-aaf5-7119ddc082b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/fb4bd432-af1a-4edc-9563-e50c74929485">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/de573374-97f7-4b95-9977-dfe14a7fafda">
    <obo:OBI_0001937>51</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/621ee676-a3f6-4b4f-891b-87b45d3f4d70">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d896a107-cb01-4fd8-be4c-40171d75d851"/>
    <rdfs:label>phenytoin-mirtazapine drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/457eea09-f643-40f5-900d-71287b5d879a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2d5e64ef-8948-43c4-bb82-219723e7407a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/224603c6-5faa-4908-a361-c8528fe953f2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d59ecc0f-8946-451d-a712-602e1b705258"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/999b531d-3fab-40c4-8493-113d8d8bd81f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001938">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b59166e3-a2c0-4485-b4ab-143dab918c6a">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1c2279a9-f40c-4386-a5c6-1679d64649d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/715d1a6b-c299-4422-8435-e53e8aa2a5cb">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2534bfa1-8976-4715-ad76-75f05335874b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/10ad44de-096a-453e-90b3-4609ba5d7d15">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/3f270f41-feac-42b2-b39b-e0a271fa52a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/a0750537-f1c5-4e62-87c7-c40931b29c4b">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/8a2fa2bf-323b-4e58-817f-af50a172f975"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/11eef13b-afad-47a0-bfbf-b16ad7e2f18f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0df068d6-8e7e-4ead-be6d-572b0558d9c1">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/cbaebd33-6691-4bf1-a2da-037da610dd97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/06d26e0b-6554-4141-b6e7-b0161adf9311">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/46f9da4d-2a0f-44c3-900d-307414a7c220"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/aeaf05c0-ebc2-4c70-a02a-8d5bf3aad0fc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a06414c5-9f60-43c6-ad34-c7f1cd3a7c06">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/37305890-7376-407e-897f-013d6872ab30"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c85c3e15-bb0e-4cad-8c85-319fb6db0ee7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bb68beb0-643b-476d-845b-b4aaac755f03"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e3d048a1-00a1-4d6a-8867-0e04754f4d1e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0bb5616b-0610-4938-bbc8-934478303dfa">
    <obo:OBI_0001937>99.9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/57033c0a-1ac0-4190-89b4-4b0dc9ace61f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/fb27ec17-602d-4a1d-bf38-b4f86c79ac64">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1360b475-88f5-4419-931c-7a68a2d7803e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/312e55a6-3db2-46b0-a03c-3e4e9e4f4d93">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/eed55f23-b897-4687-a544-33be65d7bdac"/>
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/235198a3-9f51-44fa-8a38-c221ed3c79e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/d4c09ca9-190f-4182-8e0c-277642652bfc">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8709aefb-9f18-498f-9865-4d7d08d99e60"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a838b094-383d-471d-9c7f-e10cd8d7a6d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2f818f25-ea51-454b-ab68-dee036732bab">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/9f2d335b-e534-4cbd-ad4c-b8c3ae32e315"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/b22aca7f-3fb0-4bd5-8262-fce130b3a75e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/eac40c06-2e3d-4bc2-93ea-d23a6185c3e0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4fc2bf22-dce1-49d2-8584-555db4505015">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/59aaa133-6592-43b1-8618-b7da88cfc50f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/d544c218-2243-4eb5-b647-7bc03ce4892e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/93562201-825f-4578-a079-88a0301e324a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/38085864-b0e7-46c3-a4a9-c76776cfc153">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/847a8a4e-9dcf-4166-8395-3d4dbd2f6ae4">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <rdfs:label>rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0c5ae7bb-9027-45c8-9cd5-219a3a17b1c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a0f53e69-f281-4499-bc5d-b909a7d41084">
    <obo:OBI_0001937>3 to 4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d0786735-cc45-4877-9266-6658cc323585">
    <rdf:type rdf:resource="obo:RxNorm_8331"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/341033ce-55c2-4ff3-9c74-3c962e6ca626"/>
    <rdfs:label>pimozide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8e5b3875-e8c5-4588-9738-9acd7a098316">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/84062dec-2d4f-4221-bc2f-45207dc59e15"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/872a3e8b-9cbf-4293-864a-edf216ee3de1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/4b302ba8-996b-4652-9620-d16624210ead">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/4094efbd-dcb1-4913-9e76-e2b6af8c3dbd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/3c99ea9a-ff14-43fd-9abd-64bf56ead638">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/2ad9f2da-c9b5-4470-a9a9-444738e19e91"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/bbd9e453-275d-4b83-843d-22bbe0c95cd1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7085afda-905c-465e-b87d-8623907013d8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/579720b0-ef24-4ca9-8759-859662bd945c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0f83784e-a31e-47a7-8baa-b2ccbf89b5a0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3314ae9b-6b4e-4bbb-9127-f6d6f3ef1dbd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b7c11e73-0bfe-4489-9239-077e00673290"/>
    <rdfs:label>Fluoxetine-olanzapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/df0cd431-5a95-4828-af37-480790ff5847">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fb660485-5b15-42bf-9344-af826409e95f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7dca8973-7d6e-4308-a2c5-35d5eefaef3b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5643eff3-0029-4681-b555-ff86cdf161fb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6493c6f5-1601-4695-be44-1ae8b176a9d6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c85c3e15-bb0e-4cad-8c85-319fb6db0ee7"/>
    <rdfs:label>warfarin-ambrisentan interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6892fd67-1062-4e0c-be31-0ac70eda756c">
    <rdfs:label>ABILIFY-norfluoxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/da54cbeb-c879-408c-8123-4db69b8b6aa2">
    <obo:OBI_0001937>17</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/0b10b5c9-e89d-472f-8161-5cfd784ad6c4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6dd024b8-5f27-4132-a998-07a3e7970957"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b97075e9-ac3e-4667-bc81-502081028e83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5017d2a2-eee9-4e4f-b9c8-32f56e803444">
    <rdfs:label>rivaroxaban-midazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1db6522c-ec49-427b-82df-a17171e51428">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/351fbb03-f9cb-459d-a91d-d223665df4a2"/>
    <rdfs:label>carbamazepine-L-amphetamine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/61f9af2c-0cbf-4848-b590-cde5fcb117f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9bef547f-5da1-4ba2-87f5-166ffb30e24d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/5da32783-b987-44ea-bbee-973161ea6bf4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/594b9150-bdb6-4ec9-aec4-7a2d067943a5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/fcf723df-6883-4fe9-9400-eeb568ab8ae8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/16142984-197e-4be0-9dbd-ca8820945953">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9713f4ef-a883-4946-8398-aaaa34ed4b2a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3e0a6bc8-ab01-4927-86ce-6dd1cc909e5d">
    <obo:OBI_0001937>375</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/601f2014-fa01-441d-8b2f-17bd7e737d6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d4fd9eca-bd7a-4fae-8cca-90f8ea28064b">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/107cb94a-8ad6-4b7e-8ba9-8d6c58c40b93">
    <rdfs:label>ketoconazole-iloperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/55c41cbd-8c19-4587-9f4f-295f3df7235d">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f1818552-63c8-417d-ab09-35d88552d7c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5b121a57-0683-4ab7-a0fd-bfed2bf1322c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ba57edab-f099-4f47-ad6f-8f8f0e6a1a99"/>
    <rdfs:label>duloxetine-theophylline drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1f211658-4033-4181-8e41-d13eba748c92"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/805c649b-751f-4c51-a985-21a62552500f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3a66734f-fc5a-4ea9-9b83-6c42e583f567"/>
    <rdfs:label>citalopram-ketoconazole drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/66654d61-fb1a-469e-942b-189cb645aa3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6144f6b2-51b8-4971-bc1c-db1ce9a65c1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6f9b631b-f951-4c0f-84c9-9646b0859e1f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/5ae47ed6-165f-45ff-91a8-d34aff6653c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4843c8ff-fd99-4657-8199-1e04f6b41758">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/200faf39-882a-4c75-9595-2b6a367fe162">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4c2ea3ec-c0f2-4f79-b764-692014ce0e39">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e49fa751-370b-4133-83bb-3a4794b43bb6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fd99ac75-8530-4d7b-bfad-f18f7be7e7a2">
    <obo:OBI_0001937>2.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d1cfc9e4-60ba-4640-943c-4c2224666305">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/343fc49c-a686-4d17-affa-fd0a571677ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a6cdbce9-ffd2-42c7-bced-95a9037d6d2a">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/0c9b4d04-050b-44b9-b1f0-53670ad120bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/ad9d6775-8644-4458-836d-9d3f056eddee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/35da02ee-886a-4aec-82a9-03b2bbdad798">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f03621dc-00ae-4262-8bd4-51e3b37ac039">
    <obo:OBI_0001937>20-40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/e025bf15-603b-496e-ae47-b07ff5779560"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/3d7464ec-4d84-44e0-9efe-dd558d63ae2d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/429c3e95-a755-40bb-80ae-d07fca183ce5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/bfcaf589-d721-40f0-b5d2-c4f0eee3c7e0">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/7149a0ec-143b-4e92-bd46-1a944de16c43"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c62e4717-cd66-4296-a297-338aeb4114cc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4fce4ce6-d619-4a99-822b-c344afb913f4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f4b02476-a654-43f0-88ae-63376f8699c5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f276a3fb-3f15-46c2-9c01-4f3f8c9a4118"/>
    <rdfs:label>sertraline-diazepam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/afd52010-b834-4f50-8aad-e70e63dd2a29">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2fc675db-a765-42ea-98c4-a5ef6918d992"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/99c61077-ab70-443d-8a27-9d268d5a71d8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/572be5c0-6c7c-4a99-9cbd-3a94a80a003a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0689f0c4-cd74-474d-ad1b-28f0224084b8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6f39ca7d-c9f9-4e45-8f91-09a0848d9f71">
    <rdfs:label>desipramine-HO-NEF DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3a93f888-5b00-4866-92f8-bf52268252d2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/16fb3250-b20a-4a76-8550-4c1d8eaa1e7a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/dc86f689-58ba-45c6-9326-7ca37e25a11f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/55969c0a-f666-4df3-b2e4-35c176c41bc1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/20e032c1-6df1-4f45-bed7-751d434cebfd">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/1e1a7139-bbf0-40cf-856a-887446cd7145"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/4f4968d1-bd1d-4d18-bbd8-10c77aae7d78"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/97b4c405-4eaf-49c6-b043-b34244173fd3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c95f54de-f3b9-4324-88f5-3336f1c9d5fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bcb981c9-a02c-4155-9c8f-3da68c92ba4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000003">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/96f03f69-24a5-440e-9341-40dcaea8d94e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/502006a5-1bd1-4a01-ae6e-c566c54995fd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/dbf70092-d402-40b8-adc1-b351ac2f7b30"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/9be91319-ab7d-4d73-888f-eb399c66a555"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e2ce0187-bbbe-4368-8dbf-7c33503e605c">
    <rdfs:label>pitavastatin-R-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/37429b17-c4ec-4e44-ac9c-498dae68095e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/5151eb23-5fc7-4bb1-ad21-3a27b0b39272"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/100c80d0-df94-430b-8f2a-4829d95ac3e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9f6699bc-7916-4ad3-8957-302d9764a305">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/b23d4aec-aa5e-4d1c-9ed5-39a559a91d8a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d54f7613-301d-41a8-82ee-5803f94bead1">
    <obo:OBI_0001937>85</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1f3f797a-966e-449a-ab00-c17e5f25ac01">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3bca1cdc-bede-4a74-9f53-8629408097db"/>
    <rdfs:label>sertraline-pimozide drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b104fce2-30a4-4d8e-b412-5d2fb769a386"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/529bcfc9-3791-4581-8dbc-5963de29fc05">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2c7a5fdb-af22-435d-b323-cab19c5fb791"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/637b7140-7bdb-4058-9c5d-30eed0475288">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7757e5fb-83ac-40c3-a836-d9b90846c74b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c4ef221e-5bf8-499f-8e1a-02f1d122c4c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/00ad7b80-c7fb-49a1-b4bc-e14ad6d07f31">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/20dec8e2-8d0b-48f5-923a-105a38b07fa5"/>
    <rdfs:label>escitalopram-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7648c4b0-6835-4ded-be96-f8bebe652001"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/594b1264-112e-4b86-9ea9-8a9e93314d48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/aa26f9ab-67b1-4b8e-abc9-c25cf4f2af15">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001933">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2f0321af-714e-435c-942c-5236454fdf45">
    <rdfs:label>fluoxetine-P88 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/244c58ea-d05c-489e-9b22-a18fd942b23a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b902a4ee-3414-4489-8004-e9136966453b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3625bf4a-d42f-4355-9dae-785cdfdb4f5f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c54d91e2-ed81-400a-a525-bdc8d80c24bc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/5aafa404-55fc-4d1f-8068-ac7fb9b49d9d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ec6574a1-e3b0-449e-b1a6-839bec12e2b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/c5c21bb2-28de-49d9-85c9-0bad8cc1412e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/5da32783-b987-44ea-bbee-973161ea6bf4"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/efa9bccc-d17c-46a3-8807-dd8e787d26c9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/cdb684d1-8941-434a-9507-5defd3a6fdc5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/589479f8-aa00-4f42-b187-5d34baf29481"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/fa376aaf-69fe-4893-a77e-5996bb2778e2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/d965c7bd-195b-4b3e-ab93-d41871bcca63">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b181ddf9-dda1-4ad5-b680-dd8ec6297df9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/52650933-0472-4781-8c3a-24a83f911e57">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b35e9485-8703-44a0-9646-bb1e5424f50c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/5dace64e-d8d7-4541-aeb7-fe1e0c80d748"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/63b987d0-1e24-4485-be59-cae8865f5440">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/ba9d8dff-8a1b-4097-bd4e-908f19141b97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/e98fb7fc-04e5-4d37-97c4-7591b8ef6255">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/de657bf4-4058-445e-a5c8-c2c92e8a9aaa">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/e9923da1-297f-416c-9da5-ee6bf3e88f3d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/2ab62ac3-ba47-4481-82a1-1174dbd3729e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/51d86981-a369-4a9c-ab7b-6e6cceafae0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0bf0059f-0f18-4c05-9f6f-8217e3d2bb59">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0cb1ba50-713b-4729-a98b-47c2294c2e59">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/998084dc-c9c0-44d4-8ddd-3fef0b165fb1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9ecb62e5-485b-49ca-8aba-dd816453c61b">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3bce7540-bc15-4d52-8650-5dec57f3d37a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/48e0cca1-4eda-467c-a11d-bd06b1668720">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1c18047d-3776-4f70-bfc3-2429627c35bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/da3d3ec2-2bcc-408e-9a31-f9a4c0279686">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/00d2d382-69cd-4271-b48c-362f09cb1321">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/156d519d-6b45-47cc-8bd5-d116997232a8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f28a5f8d-9679-407e-bf86-a11ad55bc2c0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/a54b6be8-ac05-4062-991a-a9bee4063937"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/11db43a2-68ec-43be-a430-430a1f23f1ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d6c5e2e1-17ac-41d8-9b02-815f8569a95c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c3981ef7-01eb-4c5d-be1d-fbdf315bfb2a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/14fb24d9-1ce0-4aa8-9f6b-ca13acd9c836"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/bd71ffa6-b68e-44b5-b0f5-deef5282a386"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/be74dce8-7107-4f81-8079-0dfc2f0e683f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/428a3888-f97c-4608-bfce-f21a2c252424">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/ff5704df-7694-430f-9846-4229b71895d0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/70016345-2a88-4dd0-b6e7-2506a6e954db"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/52463fdf-bb85-46eb-ad58-fe86c9f45b93"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3f5b89c4-5838-41ae-b72a-a1fb52b9b335">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7d6acf9b-44e8-4d9a-bfbb-cad14ed84763"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/5897d996-77f4-490f-af7b-23fcfab4986f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/5eb28d78-768e-47cc-8d09-5f2dadb79912">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/e2bf4677-65b4-4b34-93f2-6c298d0502f2"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/de057359-44bb-41bf-b75b-c9d8db7a12c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/46a1fbfb-a946-46d2-be66-5b61b58579f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8709aefb-9f18-498f-9865-4d7d08d99e60">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/3a1c0da7-4034-4364-8798-39fc8ea62fc4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4415c073-f68d-42da-8192-b9f0e98e993e">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2b73c3fc-6f1a-4a78-b4e3-2a21275be117">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6f2c688b-a705-4be9-aecd-3a9c5ec7e103">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/c76e8520-f6e0-4f12-8dbb-969de23a2704"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ce6e6110-639d-4ce1-9745-390fa7fb3690">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <rdfs:label>LPV/r</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e85669c6-be95-47dd-b8f5-aff4d6672414">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/828c4d15-b88b-4e52-b973-832e3507e462"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/b576e14d-a8e0-407b-adda-8248d7686210"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/877e5bb2-6602-4744-a46b-d3d1fe317751">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/66628f1d-ac8a-425f-a915-c3bd3811bc0b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/fb6e47f3-b74d-4bb4-bdd2-e35ea9d7d086"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e280c2b2-5d54-4c51-99b8-f26986fd4774">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/89c3898f-4e86-4db9-86c6-3b9445871c11">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3bf92b3f-e5f1-4068-9d8c-9cea1de22cd3"/>
    <rdfs:label>carbamazepine-nefazodone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7c81670e-6075-4fd5-b8da-d72ab8f25532"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/628ef87d-1685-4e71-bffa-e798bad1aed8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/e718eb1d-5a4f-4f5a-a1fb-a5b5e7102ae5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/5aeb63c6-5a54-48c5-92d1-77804dbd8130"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/acaef35f-1fe9-4a39-be04-27f80eb805b5">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/37f49358-d694-4e01-9263-6ec3069ff379"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/aaf64024-252a-4159-8149-e2ee8b6293a5">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/866a5eb1-9539-492a-8e73-7c23ab4dfcbd"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/498a11d1-b8e5-413e-a509-d6fa2fd5f258">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/d91877e3-2264-4414-aff4-3efd0d8b7672"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/a77592c1-b2fd-49ba-aa11-781150c37f10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/00015f8d-17c3-46c9-a0b4-94114878e9f2">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f03ddd80-b1d1-44d4-97d7-4fdc87232ab9"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/399514cc-6bb0-4c14-bed1-2ed1e25aa706"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/93cfa88b-a92d-4cec-9700-035a98f93078">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f5440d6a-9bb8-4329-b150-176db1646c2b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/80116197-8ea0-4414-b91f-106b1cb93194"/>
    <rdfs:label>ketoconazole-zolpidem drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/94e6c3ee-924f-42d9-a2f8-ae13a9ca2aac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/244818e8-87f0-40bf-85c3-6cae1a87ce24">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/be7db0b7-72f5-4796-848b-58e32dbe04c2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/b290a6c3-b3d9-4a01-9738-6b1308f76afd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/eb4e0d26-60b6-4917-81f0-ea195c6c8302"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001937">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d3a5fbd9-7e6c-40f4-8108-5b2c8550b86b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/9369d712-9761-41bf-b07d-7ee335cb4f44"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/041e5cab-1564-4bfb-ad7d-71f2c1b5a74d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/665b2630-d786-4005-afa0-1945541dc846"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a9a303ba-ca84-473b-8a62-2ab1686fc680">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/1aeda51f-190d-4a2a-b42f-6d85e59446e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e0b5f455-ec60-4ebf-9713-5749acc32529">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/05c58bfa-5fdc-47d7-8e80-6e48e61c8fb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/673b10d0-6cf0-426f-addf-b02d41a07154">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/5039f176-ccbf-48eb-9aaa-01351780a673">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/98acc68d-76b3-4d1e-abed-2fa7cc5c0813"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/40615b5c-9298-4121-b137-2eea124fc9b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/15f894b6-d47b-48f5-97b6-fe83286cc157">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/140613c2-63b8-4136-845e-c4260ed7bb19">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8d68dfa4-7852-45b6-8a00-acb97b5f92cc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/da30edf4-1a47-4ee7-84e5-5a63ee1d5c78"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ae451a72-7b19-4cf2-99ff-103daaaf0001"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0bd64522-51a4-483c-8693-7a7c8e9de19b"/>
    <rdfs:label>cimetidine-citalopram interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/88eb7c74-e75c-46c8-af6e-8a8239211688">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/fb08037d-fb60-4e3c-b7f6-22bb805cebcb">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/eeb4b9b1-9ef6-43ca-88aa-f20514225f1b"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/578d0045-d465-4cf7-a0a2-6e74fd9ff9e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d252fc18-7d0f-4655-a676-a0dc86a1009d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c445a3e6-0db3-4d50-8e87-87c2a45a6aff">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/8562bbb2-cd0c-4e2c-bfef-29143d0ed3c8"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ab75c13f-ef6f-42f3-85b3-cf509d07acfc">
    <obo:OBI_0001937>123</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/82ea228d-3f8b-49bb-a0dd-a4ddaa9c7580">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/761723a7-4209-4b42-8a38-6c44105d2d16"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1450e5b3-4d28-4bbd-b7cc-9e6811f381c7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/af247b77-b73b-427f-af54-ecb662a81757"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c39c91ce-506b-4b5d-827d-9f20396e43c0"/>
    <rdfs:label>pitavastatin-R-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7648c4b0-6835-4ded-be96-f8bebe652001">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2deb7a35-5d4a-443c-9197-6c0fa6127db7">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/ef99de22-336c-4cb0-a418-2f15bda7d39e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7aea56aa-cff2-410a-83c5-ef30ff6767a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/cf18f56b-c30b-41c4-b952-df3725a8319f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b8cdb992-477b-46dd-b6a8-d52c022dc7cd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5e16282e-783d-427a-aa48-cc0f5e980d15"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/ce6e6110-639d-4ce1-9745-390fa7fb3690"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/a315895e-9fc6-442d-8878-ae77ca18fdfd">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/8277cd88-2eca-4765-bc41-2e8cc0a76c07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7cb8ecac-fb2f-4888-9c91-efc48eddc1d4">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a25d231e-73a2-4dc1-a3c2-fc34a378e058">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c187f89c-7f29-48de-9e08-e82f634e701e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/901faed3-e6bc-4b35-bb88-5438df96af53"/>
    <rdfs:label>fimasartan-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7c0edc82-38d9-4780-bf03-816cedf27d27">
    <obo:OBI_0001937>4.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9aec8da7-2478-4d99-b9de-0213726592a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1ae9d072-fa45-4d28-91ea-bf2887035cca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/29aeed67-0440-4d08-a0c3-168d1bcf813b">
    <rdfs:label>nefazodone-propranolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/041e5cab-1564-4bfb-ad7d-71f2c1b5a74d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/22b209e2-02e2-43f8-a234-a62674d67bdd">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a101654d-79b9-44f5-ad86-ef12e2a0fe7c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/f6b3bd32-32f1-431c-9126-c21d50feae14"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6b4d3f6b-e81a-4ccf-a738-24a150cce329">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a9206c6e-2985-4f75-84d9-c98da885103f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/04a56965-d694-4e7d-9877-5e63e7cedc69"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0fc8d811-5449-4708-84de-7b6e34732b16"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/592af8b8-0658-4af6-a2db-23760d022878"/>
    <rdfs:label>duloxetine-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/8740f11b-7842-437f-85db-4440cb3e118d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/08d777c9-47e1-40ca-9628-92ff7bd33171">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/a2c7f287-07ba-4169-bc3e-ab94bf858624">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b2e3b1e9-2301-4b0f-b515-9a0ad3139e37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/596a2fd9-b54f-46b2-835d-21ef97fef632">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9aa25238-b608-4a93-bab6-4890bfabb713"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/8794b9ba-7595-446d-b599-13fe841e10f6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6cb20e2f-9dfd-4f60-acad-f1c9491a35c2">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/4d8610ba-dd0b-4c2d-980e-6c1b85be1e81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7cbafc44-4fea-4e9d-a0e8-dfe42cda45c1">
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/02e39baf-0750-45ad-a07b-0c4cab129d93">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ac934016-78af-4ff9-8d2b-fc08d1215b93"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/eabebf6c-db4b-414f-b391-ae5d1dfb6ba9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/250477d4-25b5-4cdb-bfcc-a8337703dd96"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1dfa0477-d115-4a9b-81a1-0e462885c56a"/>
    <rdfs:label>rifampin-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e0dedc34-10fc-49c2-8a85-0d0dabd9c703">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d454d342-5e5f-41ff-aa93-6b555bddf305"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e9bf34b7-b149-4e91-8bb9-c4760d24ddfd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7d40ebf5-bc3a-4c1c-8bba-6998b93fa0ff"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/af47a55f-adc9-427a-91e6-0b3e8f50a63a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/43a449c8-049b-403f-bf70-ca5ea0ff80f8">
    <obo:OBI_0001937>0.97</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d0087c6d-4f16-4278-914a-66ae09e75b9a">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/b59b2038-39e9-4543-ae97-d5ec05e17a56"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a31929ca-46f8-4ed9-af8e-4a32449e0052">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8eb3f4f0-002f-438a-ae8d-0bce720f09d5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9f9fb71b-fa02-461d-9e26-b3b5e7cb1be8"/>
    <rdfs:label>midazolam-rivaroxaban drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b1afe52b-59f0-43ea-addf-5c94f63ed2f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/37d3762b-7dc6-4bbe-a1cd-e05469b2b620">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/976302ee-c5ee-4854-a75f-6ddd6c46f907">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/7a9e0a43-41e6-4d76-80c2-cec3ce36fb2c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8e75f62e-657c-4c44-8ff9-643e8274068f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/880acbe5-7866-4187-b63d-04dee36c2537"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/182a823e-232c-4284-8561-3ec7a059cb25">
    <rdfs:label>amiodarone-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000124">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fb8f23c6-2061-4a11-a33b-fa63f0e2ddab">
    <rdfs:label>Nelfinavir-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/40fcbbfd-1e14-4b71-a067-bb003ae6dd5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/075e3a2f-19e0-4e65-8bf6-f1d33a66586b">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/732893ed-a389-4156-aed1-f3f6c203ce91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7bcf8d48-2418-4c8d-81fa-3d79d8c0c24f">
    <obo:OBI_0001937>45</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/dd8b5b3d-b885-46a2-a044-69575b2c988c">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/478bab01-0ccf-41be-83c5-feb5da6b5421"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c957f8d3-07be-4e2f-a914-ed993e699404">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a94d0894-f2ef-40ea-b6a1-4d0a9b5f9c04"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/94358fba-4a61-47d5-a806-910b3258ea05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c84937ec-80ae-48a5-a1b9-a0379a859eda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/e025bf15-603b-496e-ae47-b07ff5779560">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/7051fedc-22e6-4413-873c-a89b3b13c656">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/acef1a42-e282-464f-a81f-2500028e0f04">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/f3ed3738-a252-4942-9572-3b353e224724">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/5fb31571-705d-4b1d-9a05-b55414b8d8eb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/211e87cf-3e0a-41dc-ae5e-b4463b56acba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/fd1ffb1c-60c2-4f35-aa11-102090bed6f3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6fb28161-451c-47f8-9495-0ae615393058"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/b1964e63-8f7c-46a9-a966-3c80d273372d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d91877e3-2264-4414-aff4-3efd0d8b7672">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/ccfb7639-4699-469a-8e01-0e892f009f27"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/65985032-e103-436f-8e1d-467cd33b8547">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f799556e-3e2d-4743-87f0-92615e492d75"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/01fdc7fd-8f19-4b4c-ac95-6a3cbef472aa"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/9892e298-3b04-456d-b0c6-71898826cb75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/20a78859-ed8f-4365-8124-60e9bbde43c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/1f68703d-5e2b-439f-93a2-f4ffdd762b6d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7515e9a3-145a-417f-896e-ce3c9406ec02"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/04c7e7a5-adbd-4c59-9b30-27747143815d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7e12720e-5e97-4990-991b-db9d7be5ed60">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ab4063aa-71cd-4c0a-a85f-08549322c3d8"/>
    <rdfs:label>ketoconazole-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/336faae2-2c34-4e4a-afa7-cf96214b9db5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/92a2190e-d621-4e51-839c-7a31eaf96c61">
    <rdf:type rdf:resource="obo:RxNorm_4053"/>
    <rdfs:label>erythromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c939cfad-d707-452e-acb4-98bf179bd4a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/59555a6d-d9de-476e-a5f2-1fa81ebf0053">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ab75c13f-ef6f-42f3-85b3-cf509d07acfc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f3bd7bfc-e361-4735-9f28-75a4c6ad38b5">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/17308daa-0992-4dbd-8c67-52dd36d4389e">
    <rdfs:label>sertraline-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f2bac52a-0532-4005-aac6-d808439cfc43">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/491e18f8-3017-4557-acc5-7be063fc9120"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/18634f56-2faf-4b7b-8cd5-7f26c7c6e596">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/5a6d1598-fcd5-4a92-869b-6797881c686a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/30cb01f3-3083-4e0e-abb8-3989bc92d915">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5e601c16-6f73-4e74-a077-a5b7aac11660"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/43d90ce9-e358-4cf1-9977-2d95e071d186"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a97d78fb-3649-4963-9dc8-94827e00e933"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9b6c6636-1901-402d-97ce-9830f887b62e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2527065f-c39c-4504-9950-efbe6ce8e3f8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8e510937-4cee-4910-aad7-090a0c148886"/>
    <rdfs:label>fluvoxamine maleate-alprazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/ec24eb3c-d720-4754-b1c2-851e9656e37d">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/3ad5ccdd-1b2e-4e5b-ae84-74e6fe31d996"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2a64edb6-0359-4c80-8ff2-d4fd099af379"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7c348e79-e686-4a0f-830c-e5bfdef79268">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/200faf39-882a-4c75-9595-2b6a367fe162"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/394f7269-9bf6-4b8e-baac-73562f992f16"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/1fda0320-e312-4785-8c81-33e4f88c0b16"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/bc4149e4-e5a2-4a97-ad65-8e1a1da1ceaa">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/8877c71f-3125-4b1d-a6f1-d3eaab586a4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/94df721c-b53b-41a0-8a22-4c8e616c9a94">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/154a8a5a-037c-46b1-88a5-7270e21798a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5485ac24-68d6-4350-b055-66d5cd344a7e">
    <rdf:type rdf:resource="obo:RxNorm_1439824"/>
    <rdfs:label>BRINTELLIX</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/4f55526e-424e-41b4-a733-a2bdfdfe779d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b96a8f4b-c1a2-4baf-8c69-7a50bc6e51f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6f135b4f-03d3-44d6-a333-9479c4a68d1c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/60d8dabf-2d12-4476-939b-3a6d995fb9a9"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/dc0ecf50-12a8-4477-9ef5-1aaeebee6d35"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/78ee8441-2f21-4f02-a89f-0c10064e9815">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/7a69520d-a869-45bf-9d4a-d973e1c4d0b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/24190362-e767-48ab-bbb8-4e608e2b7946">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bf813895-7a46-4453-aa48-554187ae8dc1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/11a93951-9589-4767-b16b-cc1265970c02"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b02b5ed6-7b01-4bc9-8b46-707b953a4711">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/35711a84-110a-472f-9a8b-359e74b00157">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/710fa37d-f7d2-49d6-9e74-39c2145f6811"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c2c1d12f-8638-4618-9344-d710d3aea147"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/7813fb34-648d-42de-98fc-33ed36803fca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9910e5c3-bf20-4557-9aec-f5e9fddf7558">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/38c0fd83-882e-435a-857f-e5af2eec1b86"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8090dad6-6e79-4199-afc6-4812eb92cdc3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/36a7bf5c-4c43-4e45-aa1b-9e22cae81e93">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b02005f3-06af-45ab-b7f7-0afad78b7cd3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/b49b50af-755a-48d9-b5c9-9299f937953e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/c8d81eb0-befc-4291-8a9d-aaf2d07f8ba5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/81a7e52f-7842-4d24-b1bd-b5b377afb874">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/56f702f4-9ab0-4dad-8d83-7994a2382a94">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/54ba1611-1d39-4d08-9c70-71b8fb9933c2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/959981af-b588-4c72-aefe-c6b93388791f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b0542d55-936d-48d1-8789-f5af33a66fa2">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/44301a1c-58ca-4070-b769-618857c80cb0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/a86ac461-c8bc-415a-9185-fe6120f42b23"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4b56c425-e780-44d2-ab6d-231082f2043b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ea21e94e-5506-4a62-8956-1f2c35644ced">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a31929ca-46f8-4ed9-af8e-4a32449e0052"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/20b109e3-99db-4599-a6e6-5df1ef543f90">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1542dc40-ac48-43c7-b9c2-e4e248d71f22"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/55dd99de-4ce6-4a8b-9067-463a9fbfada6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f64cd4be-7d22-4f0c-8f63-a5ab0e1fc00a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/68467955-6819-44ab-9713-59e2b40dcffd">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/0f0c9e52-babb-4feb-a4c8-e96df80b87e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/01b8244f-cfe4-4f25-b2df-0af60577928b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/252f5f67-62f3-49c1-8bee-b4eec7a36c07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/42e2bfb4-0528-42b9-be41-70e879a64cbb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/da97ba4c-1dff-4c88-891e-54b4215a5d4c">
    <rdf:type rdf:resource="obo:MeSH_D014635"/>
    <rdfs:label>divalproex sodium</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/d6e11ffa-35df-43c4-bffd-9e3b9131c037">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/368ee7ed-f2b7-4635-a394-88292c2f5f8b">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/756ca6c9-c78e-45fd-b36a-51648158377c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/475cc532-4154-419e-97fc-fcd458e0392a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7eff2c69-40f3-4c54-a485-f89d98d2157a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0c65a3e4-87a7-4a2c-a7ff-a0e102b97a94">
    <rdfs:label>ticlopidine-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/98297b6b-3e63-47da-acb1-0f292c64233e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9f8091e5-d438-4ae0-9f4f-86c5b91a3297">
    <rdfs:label>Fluvoxamine-sulforidazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/21f551b3-dd55-4ec8-a5c2-ad3419cb7567">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <rdfs:label>lopinavir/ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e366da4c-fcb4-4fdb-a22c-9e91f002a9db">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/66c9a9fb-cbf7-41c7-9c08-2df042cb8e2c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/20dec8e2-8d0b-48f5-923a-105a38b07fa5"/>
    <rdfs:label>escitalopram-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d52f42cc-27e8-4280-85a1-04a6e3a15ad5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ba98a724-c325-4362-b120-21d9c7c3effa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8f664be7-37c4-4e92-bc0c-2cdb8c3dddce"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3017ee51-658b-40a1-9f6b-d034fa642396"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a9dabd75-03bc-40a3-bcc5-11bb49b9df80">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fc9e7600-3d7f-4ee0-9dc9-a016fda4ec7a"/>
    <rdfs:label>atorvastatin-verapamil drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/dc8f87a5-aaca-4b57-99de-3d573fde00b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/d02adaf7-59f4-405b-b8e6-1f7c0474bb6a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/976486fb-2165-4ba6-99e1-3257a9df1ec3"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e3cdb126-9fef-497f-9db7-d277ba5d816e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/56ef0b0b-2713-476d-9e1a-dd6fa8bba50c">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/547edffe-5c13-4a96-931f-769b2bfca6ea"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/9b7aa7a1-db19-43c8-8ac7-387af2b7a1f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0493bdb2-8b3c-423d-929a-540fd6fd33b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f68d7515-1e71-48c3-b7b7-7fe6843a7df7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/760f6d49-ab2e-4134-b7a9-c19a1ca3e86e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/37624cbd-3a55-4646-b5fd-2e88f02b084c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/daaaa0e7-481e-48e4-9093-c9aa8e8b6982"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ddc82f6a-cd09-4646-9fb0-161e832bfe1f">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/225b05a3-d0ab-40a6-8f90-116a8ac20423">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b6c51c86-afc8-41db-adbe-6d2e97d99e29"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/37861ca5-ea26-47d2-ba31-cc24e6740d20">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/73e8eed1-2c36-4637-bc45-772c87e23df6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c98619c2-53b7-4864-a009-ce391ec71ab5">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0942e7dd-eef7-4a3b-9e1a-c1211b732fb5">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c1e4d702-3712-4a65-8f53-220d708bd78b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ed9bd682-73bc-4499-b196-5a18cb4fed62"/>
    <rdfs:label>sitagliptin-simvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d9bd6f35-7ece-4b61-8c96-b720a46f9aed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4b7b108f-355d-4d74-9f56-7ac33a2e3164">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fe4e3b53-1ca7-4a1e-861d-84cde1414735">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/514d29c3-2212-4bcb-ba4d-7e70345570a5">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b618f65e-c58e-4db1-a085-73a879c567c7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/a7df3001-d457-4711-862a-ba0917a6dce4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ae0d5d55-94b3-49dc-95b4-33b29d65f184">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0ba4bab5-a221-4015-a111-c6d7643ddaf2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b9ffad39-ac65-405f-a023-22e7877c6151">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d217418b-e285-4a40-9971-4841cba2cb3a"/>
    <rdfs:label>fluvoxamine-duloxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/107c5116-3357-476d-b2b8-3cd452fd70f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7b7543ef-97d6-43d1-a203-4990a90e8646">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/bde7f96f-88f9-4f60-be53-352884e70744">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/bf720357-c1db-4b8a-8bb2-6f6640266cd5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ee4a5225-dc56-4b02-9630-5c670d7797a5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/cac22422-02ff-4c94-aa1d-834ba45827cf"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/d21e58ae-dc00-4903-8451-637d356c82a7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/22b21f8f-f44c-4bcc-a862-8e9f7912cb4d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f96e07aa-9efe-49bd-b42f-b49a34e9e980"/>
    <rdfs:label>Carbamazepine-olanzapine drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/6d5b5d99-54f3-4764-9318-b030ad2b561d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/00c10bda-aab0-401c-ac0b-d4b447152e07">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bd6b4ef4-576e-4f4a-84c2-0d93f771b504">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d4fda971-8499-4354-b4ec-4590afebd1ea">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9653f3ab-c26e-475b-ab0e-35244fa11e39">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e78e3d2a-7f5d-4a6f-bf18-ae9b258d5611">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/612bd226-22e5-4966-a27b-cf85cc8f478f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/361f07fe-d056-4943-afa5-b9f32331c4f2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3d8462f2-02f5-49d3-9886-a9f37f2a7b2d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/01424c91-f51a-4cb4-8fef-32d4c1c2b3fb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7e496a25-6590-4a3c-b5c6-002e61624059"/>
    <rdfs:label>ketoconazole-eszopiclone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/212179a7-0433-42ce-9b42-0d4189a6070b">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/0cbfb9c8-5b2f-4ada-96b4-4dd64732feca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/a9e2f030-d160-4804-88c5-8604ced74fa1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/563bd86f-a742-4e00-bd1e-ad8e4c48f009"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/103aa585-5351-4f32-b9b2-5aa27ad3aef5">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/94358fba-4a61-47d5-a806-910b3258ea05"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/456fbcfd-8c3e-4ec4-b7fc-c76f7155d960"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/50586b5e-750f-4d3a-a6d1-4d1d295289e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f88c5838-51a1-4458-a594-bf16b257bca1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d16b3adb-320c-42be-acda-945502614978">
    <obo:OBI_0001937>28</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c05921ac-f2ac-41f7-83aa-d2060b75391a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/dacc2c6b-a301-4621-8def-60c8c70cf0ba"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/07279f34-8c51-4c64-9bdc-80a3bc7a1fd4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/52819d27-003b-4563-ae9b-fffc0cfe6a0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/99c92a07-5b27-4254-ac7c-8b78fcd9001d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7e4e3c55-0106-42d4-aad7-697eac9860e9"/>
    <rdfs:label>rifampin-pitavastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/8f37b14e-3d9c-416a-a490-4ebf5b2d7a09"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/5ab995af-634c-47e8-bff4-bf61e9fe3c7d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/eeb4b9b1-9ef6-43ca-88aa-f20514225f1b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b6af93f1-e3ab-4c2b-a9ce-9dd9119d32e9">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d9219a5a-5a8f-46bc-a326-3a1901d70693">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/33729d78-6717-4e63-8bae-3dd0c7ea38b7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5853f3b4-55dc-4888-a342-5dbc52ad0de5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f241b922-e111-4f11-b336-3787f08bac16"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6dcf9b2f-b430-421d-9165-62c4071e35f8"/>
    <rdfs:label>ritonavir-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/5ec849c4-0c47-4858-ab1a-e7e2a1fd7247">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/91526c61-404f-4653-8e7a-76ad4ffb3f92">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/43b8da23-30b2-42a9-abd0-1883fa91ab8e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/09c03ef2-bf3e-4ccc-b18d-f978b3bac9f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d30e6f9a-e9b9-4531-9446-017b45356ff9">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c5b0ab14-dd57-4f44-a45d-9e1eefbbfc9c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bbd2f240-cd5c-4009-9ee4-287f3853f6a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/86085762-06d6-44f7-a557-50768cc81eed">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b3813376-a293-49eb-9f48-11696f1286b4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ff28e32e-7950-44d0-886f-9f2b7e6083a6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000127">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0ee9a966-0c19-401b-a692-3f6ca833d35b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/e3f3d8ff-5d76-40df-8c0d-05b30e5d6cf1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3a811862-9aa5-4ca3-af2a-d5edea4eb8f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/22b21f8f-f44c-4bcc-a862-8e9f7912cb4d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/538a49dc-556d-4d9b-917f-ff5d3048e1fc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3e3758a0-ce1a-4275-bb09-c1d647a91c91"/>
    <rdfs:label>Carbamazepine-olanzapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/87280165-1d55-4f40-929b-5858f0bac0ed">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4e1bd65d-3024-47bb-9c50-77e15e6d8b68"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/7be6be37-118b-45e6-b527-17e433c1e1b8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7544f71b-db4b-4e88-8e27-71210a6472ba">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/6141eadc-c614-4fe7-80ad-2b8215125794"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d4923128-f504-4575-b8b5-8e2484a470ef"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d1ad3d50-324c-4664-ae9e-8cffa00b8a00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/46c08cb7-75f4-4db8-afa8-2c42f629cc06">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/cda60141-0d2b-4f2a-8391-8d88e00cc9b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3a8e7546-d556-4e33-a9dc-5e7185711295">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/adff4cde-3535-49d2-9cfd-d655abd862de">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/a838b094-383d-471d-9c7f-e10cd8d7a6d7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/81b465a7-f561-4217-ac69-3b8d89c2e772"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/a195cb86-e328-492e-a2a7-02e68b063683"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/836f8108-b8e3-472c-bdaf-829478eb4123">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/065fe845-6839-462d-95c8-e4976dbcc1ba">
    <obo:OBI_0001937>90</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7c707770-52bc-4c39-b554-096c0e432343">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/4dfe79c6-2af1-4052-8b00-fcbcba6abafc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/05bcd16c-d09b-4918-a025-e5ee1aa4c044"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/cb88ff85-58e0-4e1b-a0c9-ddc7416f0c7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bb4cc3f4-b514-4880-a55e-6ac9d9a68fcc">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d2fc8409-3b14-43eb-91e9-009b6eeae1d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/dbabe25f-85c0-459f-8fac-b25f69b6d137">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/c900a8e6-fb52-4ef2-9a61-1fa14dc92ed1">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0e2be841-27ca-47a8-8dca-34bcb3286c00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/22e54ab0-5108-4135-bf8d-59879c73dc37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/a21f43ff-3889-46cc-98c1-93f6e239e103">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b981761a-f22c-4701-a783-1f6129b64fd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5f075b36-f05b-4e48-a4f1-d970021505fc">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b6daef22-5a77-4bcc-8911-4a6a7ba49183"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ae2c51ba-ff96-4d74-862d-fad5fe44fdb9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e5209d7c-5f1f-4b38-b5b1-ebb276f2a106"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/1aeda51f-190d-4a2a-b42f-6d85e59446e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2cdb684e-04a3-49f5-8872-8910951ffb6e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7557d550-8b00-438e-96f0-15214cab85cf"/>
    <rdfs:label>ketoconazole-desvenlafaxine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7a8436e0-4dc6-4a49-8197-72b1dec25069"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/882e3ce0-3a10-4cf1-889b-0ea3f7638c19">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/bc4149e4-e5a2-4a97-ad65-8e1a1da1ceaa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e8fb5a1f-ccab-46bd-a00c-6e673eb56098">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/051d7153-e715-4244-a9ed-d598a6967080"/>
    <rdfs:label>Lopinavir/Ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/05a3ac72-44f3-498c-a770-606d397c5186">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/665f0836-b32e-43df-9a18-b5d216440279"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7ea9e2c7-9038-46e7-9e62-82067b4e1722">
    <obo:OBI_0001937>8 or 12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/bcaeadab-9b6a-4928-b87e-317e43ea646f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/aa7958b6-91c5-40d2-a17d-dd7fd5f2785a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1588f2cf-3f00-4b95-b9dc-6157c5ee71ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d945a0fe-d0e3-4f62-828f-c4d12003377e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/8a0ff8e6-7367-43cb-ae05-0049d37c0764">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f2aef478-42fb-4069-b2fc-410a75360aad"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/bb4cc3f4-b514-4880-a55e-6ac9d9a68fcc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b6ffc719-f74e-4829-b568-c95f4b862c95">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/22a0350f-fc4f-467c-b94f-5bf277fa0211"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/06e92631-85d3-4894-aca3-be0a2bb0e632"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/48d85242-8400-4041-a43b-24a65486c91c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c8ff8084-a193-4542-9966-80a27490c3bf">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0e42a2dd-484e-4b60-8b24-2ec01fa40fda"/>
    <rdfs:label>buspirone-hydroxynefazodone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/23694461-a8c5-43ce-b3a2-96403bbc9184"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/06e92631-85d3-4894-aca3-be0a2bb0e632">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f0785051-2c34-4d07-8e9f-f6f0a0fa0fa2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/df62ac4b-6c24-4265-bd6e-d647f0dc7720"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/b2d331b2-9e9a-430b-a3d9-cb33a2da6109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/13360d0f-6fa4-4f40-9b3c-61b2f05c691e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/a19f531e-14fd-4704-9089-955d45b23a16"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/8d066cb2-8cdf-4905-87fd-da6b78695d30"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4ad612d1-478e-4f2f-a5a4-63dd8bffab90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e97e258f-6fd6-4f49-bb57-19c0751f7da1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/af27f440-b344-4907-943f-e43952007ced"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/d39c6dcf-7f6d-4778-8828-4c64a45e8965"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e8976942-a378-44be-bebe-7befd7f5d979">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/478073fb-e884-48fb-8d51-4b99aba39da1">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/904ed246-44e5-4fb5-8319-f49acc8a8f5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2869d189-835d-40dc-90a4-d00426d4841b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f6948c89-4498-4b4e-abef-3d197264e7d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b4045706-8669-4c4a-be52-b1c1f76315d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ec35ff82-33e1-4c10-b570-51d0e7e8c268">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/a95a6dde-e193-4fe8-bb06-330469066317"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/76373aa3-0d35-45f3-9c74-aa7eb0f696fb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4d29091c-e9dc-405a-804a-78a35aabda52"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/6e15f84a-b046-41a6-9afe-1ff9e83638d7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fc9e7600-3d7f-4ee0-9dc9-a016fda4ec7a">
    <rdfs:label>atorvastatin-verapamil DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2eb2a904-98df-43cf-8538-51aaebebe015">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2d8b0168-64ac-4a5a-a9fe-3f08a01dd4f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/827cda9d-38e6-4c2c-8ca4-1819e38168d6">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/a317cf42-42c9-4610-a326-d27e4a3f64bd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/2b7050ef-c620-4665-8fc5-aa5acfdc72a4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/aacc2036-c5e3-44b6-bedf-d7c50ed9b3bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/83f3bc9c-5594-4822-a30a-1df0e48fa2eb">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b1d4dbae-c2bd-4d82-bee6-b5c18e6abfdb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ceec9015-1eaf-47aa-a09a-2507ba774a68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2a836791-73b8-4d64-8a12-64826032b5d4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c9a4beb4-c8fa-4f34-9db0-6a1a560d7da4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0eb8cdf6-2521-4dc5-89e9-f86173b918a2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/98975724-2374-4cdc-8ede-01f0d43419e4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/24190362-e767-48ab-bbb8-4e608e2b7946"/>
    <rdfs:label>Cimetidine-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/61f2fae0-4610-4a8e-9801-96d983329b9a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/ee5bea21-b8fd-4897-bda1-2c7f8e5e58ce"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/09666b5c-e33f-4253-95d2-3e382f50fc4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/101fa98c-4a5f-4d0c-9a0e-470fabfedcca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/562cb15f-9e52-45d8-b0c2-b42119129477">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/eb6a6f8e-b8a8-4abe-abcd-e7dc603ca68b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/70508ace-12b0-4774-bb60-5db4375a5b0e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/636d60ac-1847-4eb5-b036-4d5906d4c5bd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e280c2b2-5d54-4c51-99b8-f26986fd4774"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/49e99463-5f60-4af4-b8b2-32ac602cc25b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1f72b87c-65cd-416d-af09-9152bdae68df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c1eebefc-cfbe-4ae9-bcff-41d4e92ef13b">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/cf8a61d7-df1d-45e3-9568-3b8503a29be3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/1ced0bf8-85db-4e85-a760-e0f4e6213ca2">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9aa98115-bd8d-4e5b-833e-8103b6515d2b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2fd8e6e2-22da-4ef6-9045-6d94e0ff02be">
    <rdf:type rdf:resource="obo:RxNorm_8134"/>
    <rdfs:label>phenobarbital</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/fae8dc23-980f-483d-bddd-956bbab2f65b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b88b2797-841e-4306-9762-e0f5d69f87cb">
    <rdfs:label>Nelfinavir-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/12246b4a-cf98-474e-89e7-dde0744ae83d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/45bce811-3cce-4bca-9b53-f349a53a23c0"/>
    <rdfs:label>ketoconazole-mirtazapine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/bd85bf6c-4c00-4afd-b1a4-211a737e1f8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e78b74ad-d4d6-40e3-b450-ecb18c172b8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d944a312-1405-45dd-9f6b-d26aae7631b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1a9b8cb3-7c2d-4840-a8a7-d47eb7d57798">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/47d49937-8032-4375-adf7-2223a81a19bd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/fc96f61a-a2aa-44d9-b89f-9b527d652ca1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/35abe52b-24bb-49ca-99fe-ceb10ab36350">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/dd9e4f03-8ec1-4199-af0f-89b3663a84fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e301748c-af76-4715-b459-4dbe42058b0d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/616b5918-444e-456a-b092-aa814c56cad4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8e383a6f-cac9-4ed6-9bef-5931158407a8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f05f44c4-8b7e-45ad-9fd7-64aca49d985a"/>
    <rdfs:label>desipramine-HO-NEF interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/416199b4-d4a5-402a-9b55-1c5439343214">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8ec699ef-5953-4e58-8c86-4893ab18619c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7b5314cd-df04-4131-b79e-07248ac943d6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/05886ff6-a667-44f3-a402-571852dfa736"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/46262719-5a79-4191-98ac-b7435fba81f6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5aaf56e9-5073-4e0a-bbb8-e73d2f9da6b6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef380a3a-9218-4674-87a7-94665c3b9552"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1874217e-a81f-4bb1-b269-e144f63a5489"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/33a195e7-9de7-4794-bce7-f0593781da5e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/827c88d2-06fe-442a-927c-95e73794c08c"/>
    <rdfs:label>ticagrelor-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/59229394-eecf-4b70-904f-6fbf04acae3e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/23a0580d-cefd-4e74-b93a-ac9b0a90f114"/>
    <rdfs:label>atorvastatin-norverapamil drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/115281a0-9162-4072-85c7-9255daf46861"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e3af2b19-e38b-4626-a201-f85d7033aa74">
    <rdf:type rdf:resource="obo:RxNorm_215928"/>
    <rdfs:label>Celexa</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/433f0cd1-50e7-4309-b27e-37d3e7eecdb1">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/7fada32f-9a1e-4b19-82ff-f2eda8295e34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/de2aa8e3-c967-4336-ae29-de1e90337d8a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/12a07d04-5379-4068-bda2-11f3ac517a91"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d48244f5-fb54-466b-ad62-76f582bd6a6e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a5e1b25a-39cd-486a-a3b8-c1a5829cecad"/>
    <rdfs:label>nefazodone-simvastatin acid interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/21f58888-bb3f-402c-af7e-691a90fe0cc6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9b18ac95-523b-4aa8-bc46-5ddc63123343"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5a7d93cd-c360-4f7f-98a6-481f18975aa4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e5bd6faf-79ce-4c02-a3de-49d3a1a2354a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1fda5386-2092-483a-a14d-5ae39e43dcf5"/>
    <rdfs:label>propranolol-m-chlorophenylpiperazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fc0ff910-1da8-499d-92bc-27719009f845">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c3a7472f-3b45-4c41-b21c-900119afa0b1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/4b44d089-225e-40f0-8842-c14582e5f591"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/51f559a3-b161-4741-964a-605cffda634e">
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/db4130fd-214e-48f7-b837-6b77e603173e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/6404abc8-bf54-4b3f-87f0-659327c3ed1e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3b487908-0a3f-4d36-84a8-ec35fca28159">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/768ddb65-9240-415e-a067-233fb946769b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ca8b2004-7d1c-42ed-b5c1-7104a6a75eef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/de0435c7-c904-4eff-a815-00c0456c8c89">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/143a0311-0239-4f8f-b936-07286210d14e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6a9d9ad0-f5ec-4063-9026-3d87aa1937ba">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/a76d383e-3891-4ba9-a035-1b0a673c1214"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/3e9353be-6549-4c1c-86b8-d3194e578a4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/bb52b04e-5fa4-4769-9689-44b568e3ae8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1042477f-3e8a-4bcb-93a2-0fb248e9b31a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/807d010a-7c7c-49ed-b0a9-c1d13a9f3c57"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8e5b3875-e8c5-4588-9738-9acd7a098316"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/271d933d-8544-447f-aa03-71bdb7d09ede"/>
    <rdfs:label>nefazodone-4-hydroxypropranolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0960f36c-f09d-49d0-abb7-b801b68b10de">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ecca74fc-d594-4ab9-a54f-7e75dc3778ad"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/146e084b-3dec-441a-b27b-bdd781fd7c4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/e285a269-07f9-4e44-ae39-ea735b67320d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2a233252-8358-43b2-bb46-0241eec8af43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6edf4ad3-f1b7-4fec-ac65-fae06e464ebf">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2b86866a-bba7-4193-bd8d-efea3044dcf6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/22ef554a-416c-4917-8478-9301708095fc"/>
    <rdfs:label>Fluvastatin-indinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5483f6a1-abaf-4fda-b934-a0e05303e7a9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ddca84cf-f054-4ef2-b85d-69b2f020ca0d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/22634003-e5f9-4c55-ab09-a7449de56c7d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1dd4f6a4-e5f3-4d27-96af-e08b06f4732e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/69fba152-bb7b-4e1c-b7cc-777cde4d31b9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/cf84f7c5-9595-4c4a-9a7b-8994c30a8353"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/55a22f47-249b-4695-bd03-5fca4d258280">
    <rdf:type rdf:resource="obo:RxNorm_321988"/>
    <rdfs:label>escitalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6a9e3cb5-b00b-4407-82bf-fcce7c13bf5f">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/39b5a577-5a25-404d-85cd-5e06044f71ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ad76f20d-85e9-430e-be82-5f80dfc14177">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/36a7bf5c-4c43-4e45-aa1b-9e22cae81e93"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/7b91a97d-bf9b-4b42-8813-43cf2b942e06"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/54d9b4e6-22f0-45ae-a5ea-7f94fdceea3b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/498bae25-9842-4b17-a2a6-d988540fba69">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b8604fc2-c103-481b-b40b-33afe0f3c531"/>
    <rdfs:label>ticagrelor-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4ee8e852-f150-4a3e-84ba-64500dd96630"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fa81c822-d2f5-4a99-96d1-c3937a2ba7c2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0c65a3e4-87a7-4a2c-a7ff-a0e102b97a94"/>
    <rdfs:label>ticlopidine-bupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/33eb02e1-4346-4063-8b26-f6df3bc13063"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7ee62673-41cb-48c0-9305-9f49fd596c32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/840c7dbf-fa56-4afd-bdd2-68ff7d1bafe8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ab6551f3-3c2b-4ac7-8756-cb8c2181a580">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/33ee1d77-7ed2-43c6-b10f-8fd9542a72b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5fb31571-705d-4b1d-9a05-b55414b8d8eb">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/e9274d77-bc8b-4213-ab8e-eaa9ff403ddc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ff466fb2-e1eb-4601-b52d-c4a8a4cf7487">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dc8785b9-72cb-4afb-a44e-e998abff2a0e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/629b6c15-8f58-47a8-b9b9-2a2dd22be63a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4b39124e-0ddc-42c3-b703-cd1bc7faa1c0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/52181dd1-516a-4539-ab6b-f38182c99352"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/797ec913-c2df-4e76-8b84-a087964b9a88"/>
    <rdfs:label>fluvoxamine-ramelteon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/7912d25d-e9d4-4605-9eee-e4d719ee11ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8743f73a-16fc-49b4-b94d-eccce4189992">
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/6f4b6589-34d4-4f01-975b-9d5c0364d65d">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/ee0c1de6-3854-4530-a723-8e4b452f6ed8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/7d96f3a4-6987-47c5-875d-34df2929262e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/41a5fcbb-594e-47b2-a1c3-9c6ba35b7803">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0e398653-2f6f-46fe-ac0a-8411497e7373"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/d853bf18-810f-438f-9314-71e04b267777"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a101654d-79b9-44f5-ad86-ef12e2a0fe7c">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/ac70a60d-2bff-453e-ba16-7c10370baf3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/26d5be33-00c5-40b9-a153-1240c12cad89">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/78a2443a-51b6-4e2d-8ded-a286dc6995b1"/>
    <rdfs:label>desvenlafaxine-midazolam drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/05cdd4ac-fec4-4b9c-a959-0e410eb09c32"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7680ecb3-4c2a-4ac7-a141-7c649d99bd03">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3348f3ea-efd8-46f0-8a2e-bd183f75bf38"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/296d1c21-d840-4df7-a6a3-790b27e29094"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/797ec913-c2df-4e76-8b84-a087964b9a88">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/29d92d17-fc83-46d0-9b1e-01f04e792290"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c2e308a1-3115-4c27-b2c2-beba6bcaa12d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/d7722fc8-f925-470f-99f9-c05a5e686991">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6141eadc-c614-4fe7-80ad-2b8215125794">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8a5ed469-90b8-4d62-8e6a-d1f3a73d7a33">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/06158a46-c8be-4358-aaee-37de7f09d073"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/a6220dc8-43f0-48cd-a050-b4c46c7cfcc5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/b38c66fd-f34b-44e6-9f43-6b5c3de59120"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f4f32efe-d704-4617-952a-a7d9efcf8cfd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/476f81a7-20fe-42b4-a794-91f7eb7736ba">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2dbda8e2-1a18-4933-8255-2915f4bf1875">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/7ae949c8-1a16-4b9d-95d3-1585f6efa0c0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/9f3094f4-7a2f-4a56-b76d-ddd691fd5130"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/feb465ca-0711-479e-bd18-0655de2f8936"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/3e3e6d7a-ee4c-4bfb-891c-b336a01e4f6e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7078a39f-01c5-4de3-a3fb-a30ee0fe9839"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/358ff7bf-3685-4702-acf6-275e9df65068">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/00f2350a-d041-41a0-9e0c-0876060856fd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/84986370-ccbd-45cb-8265-2d6f55417012"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/b0332091-0018-4258-af5d-ea49b3f0b9c3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0792a92f-d52c-4a38-9a49-808d943c6e8d">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/a63b06af-81ce-4fd5-b539-1fdd1cc38036"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fc2e07e6-2360-41cf-bb91-4909ea35c897">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/69b9d62a-2b67-4473-ac90-f0312590dee2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e6aff6ea-93fb-4649-9c6c-efb78414c121"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8018644e-acee-4eec-86b2-d11fc95edd0f">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2cc67450-f23e-4706-a552-53dc1dc36d51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/56763ae2-d41b-426e-bc03-6e1736b5b8d7">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/268c7ca0-580e-4d02-9e78-918d5cda0173"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/af505ebc-377a-43c0-9497-34f62e092bd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c3644e51-d422-4de3-b096-4e13bb542a0e">
    <obo:OBI_0001937>26</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2f4763a9-b45b-4b9d-a712-faf2490c64b9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c617ebe3-4073-4e12-8982-c74f94ea3282"/>
    <rdfs:label>LPV/r-Midazolam drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/21c52b30-da64-418f-9bcb-7ff4296886f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/2c482e39-273f-4247-b35a-e90be7b9bc15">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f10b9f51-0bd8-472a-b86f-32ca3792d192">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ee5c1891-79d5-4c9d-9a03-a6aa2b58481c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/9da38d9a-1918-464b-a6f9-c7d20cb8b9f6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3263f4f6-90a9-41e5-adc3-4a87b07e0826">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bff1ea4e-dac8-45d3-a7de-1ef4059a84ed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1a235355-2e6a-4f06-aad6-8f1a125c27cb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a6a07591-241c-485b-9e5d-8a3a7aae9bab"/>
    <rdfs:label>citalopram-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/66fb6759-20c2-4f7c-83d4-53db9784e868">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a297fffb-eda4-4efe-92c2-6f08965dae3b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/2076d8b4-74f1-4b4d-baaf-d111d044b124">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/bef98d8a-fbed-4991-9b69-e48ec6ce2830">
    <rdfs:label>paroxetine-procyclidine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b9bff2be-b409-464b-a114-40cca81b29e5">
    <rdfs:label>Celexa-metoprolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1b277f66-ca9f-4e5a-b22f-46f25a8e9c3a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3ca5c2c8-4354-4ffd-99fc-07e09617eefc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/f1818552-63c8-417d-ab09-35d88552d7c0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6d5d6985-1a3d-456f-971c-3cb7651a3e82">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9ab9594f-a707-4e92-aecc-4dea1942fbd3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/43ebb7b8-b78f-4806-bc16-5af50ebf82b9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/c1905787-6bdb-4b10-b6f7-0866f4419081">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c590b33d-4f3a-4c89-a49f-132092fbb318"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6cdf1a51-d10a-4400-94b0-c247c5eeaf75">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/680d0f2a-b817-49e6-8784-ebcbaeaafe86"/>
    <rdfs:label>fluvoxamine-thioridazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/47b5a1af-f3ca-4851-98a5-9b56660ac6df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/69ae47f0-ffad-4b90-8b30-6e6359a8d8c5">
    <rdfs:label>cimetidine-citalopram DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/912992b9-c53b-4a4f-b797-01db53109e89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ff593cef-cec4-4393-881f-b20e9b3a8f1c">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b55ef9ee-bf39-4eaf-b56d-ff1822d9902f"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f660b000-0b36-4304-a059-48fcbcb9d52f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c83da0ba-4149-4e32-9689-7697314d4fb6">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b245ef2d-3c86-4f0a-8a00-12ed25d32d74">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/0ba911e9-d600-4812-b970-1b743c7a21b1"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/cb2e0372-0c96-44a3-b70c-c56c0fcd3e9f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1444cc27-4eb9-4aab-8ad4-1bbd17fa4564">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/f9e6959c-2d4d-48f3-9689-eef61e843b1e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b6e4a345-e17a-4c0c-830a-a62505f4dac4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b63b79dd-c0e5-4df5-9048-7602270c4a3a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9fc130da-0964-4105-b8d2-a49144657c31">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/2720a1b7-2fc1-411a-ad7f-808aa2d0c92a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ebe96c8d-9f0c-4cd5-b9be-9d0f89da9f8d">
    <rdfs:label>rosuvastatin-Lopinavir/Ritonavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/4112abbf-9448-4ad8-b0da-b50ad098436f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/833f8824-2abc-4183-bc98-037a1dd430d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/04aa77f6-acd3-4b86-af88-1686afa4ab81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/ce51a764-4ca7-4669-b9c8-b54c19581023">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b12cab6f-c794-4e23-bc48-061d85ab7a98">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/c35b8a77-2e18-40e7-a7c2-b01e4519d8a6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b1b85a9f-735d-4784-bda5-5506c76186fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/785e0384-829d-4d72-85e8-851d6ea57496">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a335cd31-6d38-4e2b-91b9-c925594d459f">
    <obo:OBI_0001937>60  or 120</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/7ae979d9-54d8-4341-9d78-51fe986c2e75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/896794a0-9901-42a3-971f-c9c94012b947">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8f81d889-67a4-4bc2-8f08-d487df2fcbf1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d3eaef13-e6d3-4bbe-9141-4c10d1a16d48"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5853f3b4-55dc-4888-a342-5dbc52ad0de5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3967b527-6194-44b2-8999-fc47960a7b2e"/>
    <rdfs:label>ritonavir-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/37a76bc1-76c5-47ee-ae35-9bf10a59d248"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/c10b6706-72fe-4bb1-95b2-1192488e2b3f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5c1526ea-b4aa-404c-847c-45ae124dc032">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/0a6c2a12-206c-4818-bc6a-a4bc5f15d6d4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/387aec09-5bde-4adf-971b-3b37fd0ec563"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/b5f301d4-4144-49c4-ad97-d6b6eb3cf3c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/e2f46d86-fa2c-4d02-84f7-e04d60f2c9fe">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/a838b094-383d-471d-9c7f-e10cd8d7a6d7"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f998450e-3f75-4160-a776-09f70a60ae27"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6c532c38-0cda-40ce-bce1-e16ecd6803b4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5cbdd743-053d-40d1-af2a-09ed6b669e4b"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0d2007c7-ad97-4c4d-b513-19c6d02e2fa7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/02c6875c-086b-4b43-8bc9-84904fa0c6a5">
    <rdf:type rdf:resource="obo:MeSH_C062257"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a979a1fb-1aed-462f-8a37-93f2353d3252"/>
    <rdfs:label>P95</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1421745d-b5d5-4c59-b426-5e6bc27c4aaa">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/44028c09-3b11-431d-804b-bff84c772e79"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/b05634af-ada2-4c6a-a561-e8632d62999c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/39c3d034-afc8-451c-b994-b0dcfb0845d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ffb8fd13-e47c-466e-92c4-49d402871cf3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0e282dd3-3e08-4ba5-9e9d-1f7e54b3f905"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/f2a23aee-5d78-4ac2-9556-239d963e21a6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/603cabf9-c853-4d74-afc1-47625c5a6b41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f2aef478-42fb-4069-b2fc-410a75360aad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/47d49937-8032-4375-adf7-2223a81a19bd">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/32462b2d-abe1-40ab-8823-9b058e80280e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/ce69424c-572c-4715-b5b1-ac78a7e9e3f3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/21f551b3-dd55-4ec8-a5c2-ad3419cb7567"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/63de6cb7-7d8c-4954-8043-b9d99470721d">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4634d0db-1058-46f9-8830-3cc9aec4d3a5">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/790da156-e762-47d1-905c-28fd39b0037b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/36382a24-966f-4983-b221-5494c6d66abc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/b6c0ee14-570d-4f2c-ac3e-7b93996a1628"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/01c5ded1-7cab-4648-aead-a4925ae973b9">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/959d0ead-d4c7-4137-b406-1a68f8d14a23"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/04827bdb-6994-432f-b47d-89ed2d7e6ae9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dcf798b9-c276-4c08-9ba9-02d8630b3a75">
    <obo:OBI_0001937>505</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3b5a35b8-7b2d-4703-8911-7233e9f8d82b">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/0459c4fe-aead-4371-8cfa-c2f3a863b9a9">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/1d42081e-2228-45ed-b0fc-4384e364659d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/471f44a7-387f-4d98-832b-570d72422459"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/14459b11-ab75-41a6-b819-342926a15d93">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/951f9e6e-fc91-49e7-a646-cda9bf5031a8"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/c8dc1918-59de-4089-9780-e42f989a42d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1554fef6-13b5-4485-95cf-ebdfcb222855">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/cdcbf07e-62da-4774-918e-3eb52244ee8f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/3d7464ec-4d84-44e0-9efe-dd558d63ae2d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/30b27cde-a7db-4d0b-ac79-2db4ed055976">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/db992d3b-77af-4fb3-8954-c6261a22d081">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/2d12b5b6-aeb3-404b-9a6f-4baa2c790721"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/b478bec8-4f0e-4218-8db7-c9e14cab56d1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cd042286-7404-4b43-afc9-78a2c82f3682">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/8ab6a47b-707c-4e71-b9c2-e67881c97c77"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9a69dbe5-7a63-42e0-9b04-dc535c81fb6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f63963b4-2390-42a8-a275-764b6b364815">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/33763e38-a4c0-4fe7-b474-04c2232ba64d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/6d8e1b5e-7a96-40c3-85fb-61f883d622ca"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/86da0515-1f70-4d2f-afad-60b36fd8dc07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d6e2e03f-cc18-48a0-8e10-a189b231087b">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/db8b837b-7ab7-4112-83a7-747cf8fae834">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f4373c58-704b-40fc-8772-ec64c2748341">
    <rdf:type rdf:resource="obo:RxNorm_7258"/>
    <rdfs:label>naproxen</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7e842811-eb05-4433-8fbb-605f8b587bcf">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/e285a269-07f9-4e44-ae39-ea735b67320d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c0d2d87f-a7e0-4990-bdfe-78dfee9929df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/58455577-b171-4f24-8993-f11f0ad7702e">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/13f959d7-30ba-4828-95af-f35b578f6ad5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/24265b62-fadb-491b-852f-783b80916ba7">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/ac04748a-9703-46e6-bcbb-98a3414c2fc5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d1dc1925-17b7-46fa-8f56-4918b937dbc6">
    <rdfs:label>ketoconazole-P88 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fcbd2788-9054-4be0-8ce9-764ecf6e7d73">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7c7231e9-a8ed-4d9e-b7fc-669a061992ba">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/60c6f103-065c-4e0c-8396-56f45f78987c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/ee980018-2955-4dc5-a4f4-2bb4238d7a86">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/de0e3152-d581-427e-9ed8-d72d4d17db30"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/ff5704df-7694-430f-9846-4229b71895d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/709312a5-9190-4b95-815f-1b19cc9e3091">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/8a77b977-1c98-4e4a-aa23-ade4224c8127"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/09bfe692-778a-400c-a736-4a99b6779b3f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7b9bc58c-c57c-4010-b847-5ed312ce9647">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/263bb750-52f2-41f8-89f8-bb69e052280e"/>
    <rdfs:label>ketoconazole-P95 drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/bd167d16-e88e-4520-bf28-38b2475f36af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/637c2a5e-0d30-475b-8327-9079ea5e101e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/7e51e868-a655-454f-bb38-e85cd01c7c04"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/283449c6-cedf-4d2f-8fa4-853589ce4bdd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f1e21605-8552-442e-99a0-ac4b27dbc6ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/43bd8360-ad32-4142-9c3d-643ff5a91d2f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/43214708-a312-4579-80ee-f09f5ad17126">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/fae389e8-625f-44b3-bfe0-9e049b2bf1cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/19ad0c67-3c7b-47f5-a6d9-b5db804bd9cb">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ae519392-5e30-4570-a323-a76e659c782e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f8e4cf2f-c6cc-44d0-b255-c578c549c070"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/73558b38-db96-45e2-81d0-5a5a175d02b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a478af71-c88d-4703-958f-c6d07321df03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/54251bef-7c90-435e-856d-648f063fe09b">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b69dd0d0-304c-4a47-b137-72aa9a344941"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2287759f-d4cb-4074-be4c-db3f24b97f42">
    <obo:OBI_0001937>1.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/89e8d078-6cb1-43a0-8b6f-fd447aa540b7">
    <obo:OBI_0001937>158</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/dc6aae1b-b3e5-4001-ba46-a626c2f4ef57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f1acb20e-cd12-41fb-b720-a0c102d24fbd">
    <obo:OBI_0001937>8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5b89d9cb-1644-42ec-8d8b-0be084100f74">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/36d2f4c3-66ff-4ab1-8b44-312e9bf8f1ae"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e47d2225-0403-4dac-9433-aa3aac00d330"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/88185170-148c-4618-af7c-9d4bfc68093f"/>
    <rdfs:label>ketoconazole-iloperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/61662131-0f65-4b9e-905b-e175ae8906d0">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/0fc5929f-cbb8-463e-b579-14edabd95916"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f651eb0d-760d-459b-8912-473b9479e81a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/fee4b041-dee7-4f2b-8462-e8d57e354519"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9f7b566b-dadd-4645-b444-72f4d20515b6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7a58e018-0f2e-49fb-b3fd-6abcaa254099"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package auc UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0bb5616b-0610-4938-bbc8-934478303dfa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/2423e15d-6e68-4d48-b145-4c011f49ee16">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b05da33a-31a0-4fbc-b825-4c44a79118af"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e12a3804-6c89-49d2-9dad-1bddf97adf59"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2081c08c-d37f-464f-ab76-decb0539feb5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/cc034f45-a3f9-4111-97c2-7f97d57d563e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a5cc2a85-1823-4bad-b503-936805dc3213"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/5cc0acce-615c-44f0-bdf3-055791802e9a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/dd277735-85ba-4af2-8aa2-9cd5473d52a8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/9cf25550-4cfd-4809-8903-900da73f6039"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d5b4831a-6502-4489-b205-6f9c9f4de1f8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/b7ed6049-bcad-41c6-baf0-ffe4f73a9c12"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ce403fe0-0f60-4eea-a74b-bd4038fff614">
    <obo:OBI_0001937>33</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/00439eac-a497-46fb-901d-97dcd03304e3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/41dc76b0-d7dd-4910-8d14-1c4ec47a0d11"/>
    <rdfs:label>Efavirenz-Atorvastatin drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d8c4169f-faf9-484b-bdd1-0e6987d1cf23"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ad429ecc-6976-4284-9497-fd6e21d2aaac">
    <rdfs:label>Fluvastatin-indinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/69b079b9-0303-4cad-9ff3-923e0fb6c7f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e3fc5f2b-9fec-4fc4-aa1d-9b46e9990782">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3990338b-9ec2-4c32-b92f-6638aee8da51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7617642f-8c66-4c64-9076-ea595da1ed53">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b82e863e-3e24-4701-aa04-216217a6b9ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9201e88a-c7fd-4ca7-b1f3-ea08c6abdfee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a15a103a-3af9-4343-8350-0b0a27593a72">
    <rdf:type rdf:resource="obo:RxNorm_28031"/>
    <rdfs:label>itraconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/06e87bb3-7639-4373-9966-c35dd62c3b48">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/e3323dcf-3984-433b-8b14-b4dbbc84a3f0"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a34f8c80-a99b-4700-a238-934084c6976a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/35fb8294-5d47-4481-a240-f5522a517bee">
    <rdfs:label>mesoridazine-Fluvoxamine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b9e3cfe1-4288-4aa4-8d2c-f2e0485acd14">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d7212f8c-9346-4441-8384-f976315a1ead">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/457eea09-f643-40f5-900d-71287b5d879a">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e9d9e3fc-9929-4bac-8638-6abf2e009917">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1d1b0bdf-7e31-4d73-ae58-38f298f543b8">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/40d3b0ca-c5db-45d8-8d4d-fb077122fc4a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/04504a61-e0e9-432d-a8e0-4a2e5869ab70">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ed2e456c-af7a-4f00-bb06-c036133a6fe0">
    <rdfs:label>rosuvastatin-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9ebde0d9-cdd4-486a-a4f9-e41341045808">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/a7df3001-d457-4711-862a-ba0917a6dce4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/40fcbbfd-1e14-4b71-a067-bb003ae6dd5b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/56aacf21-d90d-43bc-acd6-d88e53f1339a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c92cd40a-ff12-4f9b-9c9f-5e06fbbb7dfe">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/f80eeb2f-928b-462c-9764-59ae454f7da3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e45284e5-9c9e-4308-9765-e5af0eb54287">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#type">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b7a1cdfd-45df-4a8f-8d55-50b53d0cadaa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0884f0e1-29e6-4d10-a96d-3dceb3deedcd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7adf4f6e-2712-4a8e-b0be-a52273bdd7e1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/b751ea00-088e-40ef-935f-e1f8fa62349d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8e510937-4cee-4910-aad7-090a0c148886">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/62f8bc99-430a-4295-9844-d265518d49b1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/7ee62673-41cb-48c0-9305-9f49fd596c32"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9623afec-4dfe-40bc-b66f-251a2a8005a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/459d7c51-51aa-42e2-be10-e5e0d3539ef9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/ff1c277a-d6d3-43af-af64-97c8d2d35d63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4b56c425-e780-44d2-ab6d-231082f2043b">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ea226712-7c6b-4a83-8d7f-1d5cd26bd5bc">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/baf13946-e8ca-4002-80a2-ed36ceb156de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/620a0980-1a19-4921-bbc8-dcc5902f9494">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b58bd362-e443-4f80-9e8e-ff0a57e8941a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2be81782-6480-4e53-af06-46fcedad04e3">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/972d42de-894f-4dd0-a365-e04fd71da8e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3181bc2d-db7b-461a-bee4-dcfa9852ff4d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3b91d5ec-d4eb-4dcf-8dc1-c100c21b908b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f2fdb3b7-077c-4ff1-9e15-45040addd2a0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/1cb23868-5b47-4f33-9a5b-ce2061dc9781"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/02483205-2773-44ef-a349-5cf9b1c90416">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9c5d6069-a657-4870-bf45-a2f7fafac982"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/577c675a-43c8-4095-a0a5-79efd4249e67">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/35129132-8a82-4193-a0cc-01b676dad580"/>
    <rdfs:label>nefazodone-digoxin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/6ba80459-124a-43fe-b311-25c3c8bbbc03"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d049f8ac-4cf6-48fc-aacf-dcea036ea40e">
    <rdf:type rdf:resource="obo:MeSH_C063287"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/844cbb42-b6b7-4c7f-b01e-a992c9b6a4cd"/>
    <rdfs:label>simvastatin acid</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/57d367da-c2d0-4c42-aca7-dedb530359ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7b6826e7-8509-4ace-8eda-c77eaafbabca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cf939099-5e8f-48fa-bcc7-07f6040c324c">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/7e5f44cc-cab8-4fe8-b9cf-204b064b2923"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9c2378bb-9344-4ece-a069-dea4db05bdd4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1781377c-d04d-4a9d-8f3c-4ce0fa6dfd17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3bdabe8e-33fa-4ffd-aa5d-056964b3a280">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/9c60f7e2-ead1-4bf1-b462-57a228723b8d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/1a37b2f3-d5f1-43a0-9b9e-c0461c9b1789"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/8f1789df-e4e6-4471-a25c-5c064bb2d3ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/bca76ea1-58e1-4b86-9209-69c21aeee782">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/4c6fb32b-6c83-4f56-a922-0dbd767b64a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/769f2487-41e2-4278-b574-530e7a95cf82">
    <obo:OBI_0001937>90</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/ca1d5cf2-40a3-4f10-a98d-7d20baf400af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c3248a3f-29f5-469c-96b6-5b3f4703b5d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a518584f-6c9f-47b7-bcb5-5e713925c0ef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1d17271a-958a-44e0-ab79-0b74280d8931"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/52d373ba-e879-4dcc-b34b-fae53ec732a6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3c0215b9-0dd1-4b22-b5a5-19e5facd1c78"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/129d24e4-a197-49c5-ac26-f55cc713c4b9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/02191c9b-1e94-4277-ab04-a3b38559a87a"/>
    <rdfs:label>fenofibrate-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8448edcc-2999-484b-a23c-8e254b72af30">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0d7eb534-84c6-4f2f-8a5a-ab705e0c6752"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7b26e6e6-1028-489c-8961-d43e77dcb733"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/086e733c-7ad5-44d5-b79e-74e9acdee492"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ab4fdf90-e88f-4656-9cd1-214387850e33"/>
    <rdfs:label>Telaprevir-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b22aca7f-3fb0-4bd5-8262-fce130b3a75e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/aa067385-fa2c-4849-a93d-891cd7771dcd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/708028d2-bbcd-4f27-addc-91660471f2ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c265021d-5c07-4911-be12-d3a16e77ee32">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a387a5e9-0858-47e7-ac9d-1815d3a9aec2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/24e2a20c-8f6c-4b62-9904-886aa2a577a7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7b2c2725-7aea-4474-9800-358b696cad55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/31070c4d-54a7-45cd-9962-5976055733dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/c7e98266-8ab6-41ae-988a-01de3fd34427">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c99a0982-ce0d-410d-827e-759ca5ca47a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f28a5f8d-9679-407e-bf86-a11ad55bc2c0">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7c1f3ca0-5774-43e7-a731-563a5dedd0b9"/>
    <rdfs:label>threohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/228ac81b-79d6-4cf6-a6da-c15d9b0a035d">
    <rdf:type rdf:resource="obo:MeSH_D000068882"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/8f712374-8d45-4958-8bdf-027c4c2ff410"/>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4f3828f6-d75f-4061-bee8-093dedf11118">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/5623a222-e598-45c9-863f-c1a9378187f0">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/e7854d81-23c6-482b-bbdc-798baa36e8bc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/f438e733-570f-4986-ae18-9a012a1b1e5f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b62e17f9-150f-490f-b151-8e38b16c7d97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/34de9287-25de-4b10-8adb-c4a363b9d17e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e54bbe8c-9252-456d-92b0-aa1f7a5faeb3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/793e2347-5c59-492e-99bb-07d39c139566">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/6e63d108-95ae-4ba2-b3e4-8a1531c0ec44">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/53f94489-5d48-44a6-b1bb-36bb23b3759a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2fd4187d-a330-41f0-bb71-73150d25dd4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a6a07591-241c-485b-9e5d-8a3a7aae9bab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4cabe1a4-3edf-4217-a2a4-26adad0e6ea3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/706af5e0-49b1-42a9-9fa7-dedd8de7b9f1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a1532324-8ec0-46fb-b216-72dac661083e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/47f22569-e217-4714-959f-e5bda30c2f02">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b751ea00-088e-40ef-935f-e1f8fa62349d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1b31f14c-634d-4e43-8e87-969987c7d683">
    <rdfs:label>ambrisentan-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/aebe7ae2-c4eb-4687-ab5b-8ec47914052b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/05d2c037-298f-45bf-965e-8c56ca46cf87">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/326163fc-113d-4f62-aea8-8740504a9e3c">
    <rdfs:label>fluoxetine-mCPP DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e88482e3-19bb-4189-9dda-c60236fe9bd2">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1c1ee95d-6495-4c70-bb87-681cc915a169">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a18518d1-25d2-4e3c-b83e-f4cbced190bf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6712afe0-5a29-4ed9-b6a5-5b413140fb66"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0fdf05d8-670a-4fe1-a4e5-300dae2bb26f"/>
    <rdfs:label>carbamazepine-ziprasidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5f9dece8-90b9-40d4-8fb1-54c53d665f98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e064be55-14f5-4e56-87a4-20d14c804802">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4bf4cb2d-c46f-4609-a15a-bdf2bee37d8c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/a78eefcc-adbe-4dc1-af69-4cf1bed44cd0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/17937be6-6e99-490d-8ba1-6c3205dc3dac">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/281bb97c-e64c-4a53-be15-bbcc0103dad8"/>
    <rdfs:label>hydroxybupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9ef5b6a8-7abf-4847-9ec1-2c20d86ba246">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9c883b27-8f37-467b-bfbf-dd007c3ff061">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/3f439175-44f7-4323-b878-f8d11b19b576"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e49a039d-0a27-4a67-ad74-b7f9324b08e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/760f6d49-ab2e-4134-b7a9-c19a1ca3e86e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dd19cd90-8898-4e64-b118-54771ceb4c6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/322e9b89-8123-46cd-8078-4ca9fe3b0df5">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0bee23e6-d3c2-49bc-956c-f779f045d1ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/efcf34bc-605a-4e0a-96e5-abc526f3c0b3">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/08d6fbd6-e7af-4ebb-b61d-77a305698cf7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ab575b86-446b-40ed-adc3-b6f580078dba"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/929d183e-23d1-40af-9ab7-b40488375c0c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/036c93e3-f9c5-41a1-a8de-cfd1deaf0328"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/441dfe87-d78d-4155-a853-df5491a64a02">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/5b6e502d-b1a7-4ad9-9936-81ce8c16ac03"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/33d66447-6273-4081-a2d1-c187fab689cd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/8232dd4e-c603-4dd4-bb53-a120bd09c79e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5e13efb4-b7f3-4416-9130-229093a99d94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/138ef4f4-9d8d-4820-8b26-f5175246296c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/bd72a16d-07b3-4dfd-949e-44efb8e039c7">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/eb607d20-f868-4dd7-90d4-723ed93b9805"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/482adc86-5d1a-4f87-8fce-e69aa0f98498">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/aac9d729-a302-4fba-8fb4-1d7242a6c53b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/cd485d03-2b2c-4e59-a65b-2708225dfd42">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0d27e922-05d1-4df5-8b07-3d634bb73b8e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bfdb6ac0-1112-49cf-bb17-14e0d295e914">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4ad198fc-4c5a-4dbc-add6-f17e584c1f6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ca6cd1f1-74f3-4964-a5d2-b9f3e5e3f631">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/37d5faa8-7645-47af-b8f9-330e0ce7c3a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/265c0686-5fcf-402c-a953-870c9e0d26ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0698ad72-c83e-4eb1-8ec4-aa9386feac00">
    <obo:OBI_0001937>7.88</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/be65f7b4-6539-42f6-852e-e3457ccb778c">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c781da63-54b0-492c-af19-14a58144ce00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/30834154-ae74-444a-b59b-6a5b2662d937">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d195bd7f-3257-4c95-9888-a06b0209c6e4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/8b57055a-4729-406a-91a0-7cecf89606f0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/9015a72c-15b2-4bf1-8b40-2601d0b7f84f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/80277618-43b6-4278-925b-fcc3acd2939d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c5f67c2a-fbb3-4bb7-abad-594281becbbe">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/7afc4300-3042-4ecc-bc06-a844fe22ed1e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/f9d255e9-5531-4554-8812-ae87c5e39724"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/bc89a490-f1c1-4bdf-a004-52c6174de6c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/e8aa89cb-4d77-4512-976a-20cef26b82ba">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/bea03b8f-f622-4d68-99f6-3b6d5bb6cd75"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/df5108b8-1127-4a5f-a329-65ad063365e4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c1c0c760-c380-4e10-9070-919fa0e0e37b">
    <rdfs:label>rifampin-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ec51f41a-68bb-435f-910f-f693290a7142">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/ba88005e-8fac-4fbc-b013-7baad3cca5ab"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/80dab70c-4bb9-40af-9655-7fd586e551df">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/630173ea-53c0-4e4b-9d7e-67bd6f3ac568"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a12f0f12-ba23-4aab-9cb0-143422d01c6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ab8dd3b9-2719-4eae-8fea-d83e657c33bc">
    <rdfs:label>ketoconazole-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/30e37f0d-2cfa-41dd-afcd-175a29d7eb25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c35b8a77-2e18-40e7-a7c2-b01e4519d8a6">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/7d54bd7d-910a-4833-a71b-20273f0839bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/337e066b-d5e8-435a-9cf8-1d4d5ef8d994">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/679d7169-533f-46a4-ba8b-2ba4af34bcb1"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/14e13845-5278-4231-a4ee-e692f8e24bd1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/23539e7b-c533-4411-bf68-8ac5bba0be43">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/35332a45-ff84-4acc-a8a0-ae05633cfc14"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/4711ecb1-9575-4bb5-89a6-a0305d2b035e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f2a23aee-5d78-4ac2-9556-239d963e21a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f0f8bf49-02dd-4955-8f0a-54f6f03e18c3">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ac642ea0-2ef1-4908-8192-2a4912e3665b"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/8e2ed16f-cf00-4e9d-b20c-36ecceb913ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/53af0cc1-4a84-4f64-afb2-18218b2b9114">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/65f40cc0-a7ab-4c40-a43b-9d804742a998">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a6bcbbfe-1e81-4d4b-801d-157ee15a9e59"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/003bb95d-b0ea-4a27-8fcc-9e984f6d79a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d577a1d6-d1ff-4415-b8cb-8ff4aaa322a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/8d18468e-f276-442f-a94e-ba5cca1cefb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/58be97a5-db98-4cbd-a098-d13d1607b393">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/81d350cd-ddc4-4fe6-8a37-1518cf352c8f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/233321ab-deb2-488e-a21e-993ed0092a35"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/64b6fdcd-3da5-468e-961d-8789dbd32cd3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/95ae9689-d2a4-4665-875f-e6e29c2befea">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a0f2013f-c2c8-4c3d-9b0e-d785e2bd6331"/>
    <rdfs:label>zolpidem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/dd9d7b4a-6889-4631-b925-8869c548265b">
    <rdfs:label>ticagrelor-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/64052a9c-a261-446c-8b56-7f3093ba7b84">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e5c416ee-b4e1-44b4-ace9-77fb8f868817">
    <obo:OBI_0001937>2 to 3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/23afd9bb-a446-4762-846a-be036ed9b2e6">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/0869ca70-5f94-4df8-b14d-6419e627d5bc"/>
    <rdfs:label>Edoxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b67bf448-aaa0-4027-bb49-a573b8a8275e">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/40b7d792-a95b-44d0-a973-bbbfd2cdd30e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6493c6f5-1601-4695-be44-1ae8b176a9d6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3bdabe8e-33fa-4ffd-aa5d-056964b3a280"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ff466fb2-e1eb-4601-b52d-c4a8a4cf7487"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d6c6df31-69c5-4f20-a764-79f718b5a4f8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6ebec28b-4633-476c-9cc2-e2f03cef2225"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/98ab9fc0-646c-4ce6-bcc8-5a0c1a6097c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/5260e851-6ee7-4c8f-a506-263c7e1f302a">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/82ae1774-3d8e-479d-a8a9-bb0d100bf15d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/62d6e99f-5e39-4af5-aa71-807008434983">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a2406ec3-74d9-4207-9668-f5617378bbd6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0d2007c7-ad97-4c4d-b513-19c6d02e2fa7">
    <obo:OBI_0001937>82</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2a22fd76-d3ed-4482-84f3-de06393b92d5">
    <rdf:type rdf:resource="obo:MeSH_C092333"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b981761a-f22c-4701-a783-1f6129b64fd8"/>
    <rdfs:label>hydroxynefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5330b2f8-d7f3-4c2b-831f-d32c21a4b739">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/fcafd151-c45e-4db8-93a1-659fb968ed7c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/264610f0-fb81-4b2e-9084-188ba49b4ce7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/113b4439-085f-4fae-9186-a281189b9158"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cc5655c3-9248-4ea6-86ff-9e68bcb2a867">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/3c167399-425d-4215-a36f-36ad334b24e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/84fc0c79-4908-40f4-8776-91ef18f1867b">
    <rdf:type rdf:resource="obo:RxNorm_35636"/>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/35519b5a-774c-4f41-88f6-db8123811773">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/1ed99d6a-4dfd-4c3e-9b2a-a38088a978b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a387a5e9-0858-47e7-ac9d-1815d3a9aec2">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/268c7ca0-580e-4d02-9e78-918d5cda0173"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/7114d45d-78bd-4422-ad7a-3694f509efbc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f2348e38-9633-4709-bb08-ba6905b01fce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e02d433a-acac-4f75-b1d4-8a8fcd070b1d">
    <rdf:type rdf:resource="obo:RxNorm_8787"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/1dba3948-f300-425d-b0f0-74a606c5527d"/>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ca261d57-0ea9-4a9d-a9d7-6127654a558a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0dd1663e-0a0e-4649-a22e-09e894b0d941">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/0a0ab399-c7eb-403a-9f22-25dfc817fad1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/f004524a-2e50-4eda-a329-e04479ec3a89">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/9d500e71-0135-4eca-a745-589efa9df0bc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/07072321-8abd-4cab-b7a5-9a425b21f4b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/6eae85fe-9d13-4093-8b16-0bb6b6c5f42c">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/de0435c7-c904-4eff-a815-00c0456c8c89"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/0216e54b-04dc-4339-b079-06f9356d8ed7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/11166dad-ddd7-4cb3-b899-d9b439bc96fb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/61662131-0f65-4b9e-905b-e175ae8906d0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/cf5bcbad-7bfe-4a43-875b-f7a253190db2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8f1789df-e4e6-4471-a25c-5c064bb2d3ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6fd41eb3-aab8-4747-b8cd-421005550632">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/4d956b01-cbb6-499b-8925-787210f5e658">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/72d5340b-18da-4117-af2f-4ef3c071f26f"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/0792a92f-d52c-4a38-9a49-808d943c6e8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/67f18091-582b-41a9-b6f7-a5bd712369ee">
    <obo:OBI_0001937>2.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9c8e3e88-b179-41e8-9f4f-67434fb78666">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5fa8a4b9-c8b1-4430-9cbf-3701c5ee6e83">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f9749fbb-aa17-411e-8df0-03cc2dbfa70b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c88714ca-5db6-472a-b05d-223f8f3694cd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/224603c6-5faa-4908-a361-c8528fe953f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/fdd94271-9702-4a56-af84-f828a1cfe34b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/caad8737-5af3-4304-9049-82ba14d5be99"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/884d7bde-0b90-4169-95b3-49485ce8782d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/67807e17-1a05-4c97-b33c-8bfef457e7da">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/912992b9-c53b-4a4f-b797-01db53109e89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a09225ad-2c47-4eec-82fd-7de73b5c50c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/e959f5e5-ed66-44b4-bbf4-3c9062c14e8f">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/30b27cde-a7db-4d0b-ac79-2db4ed055976"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a57561b9-7bfe-4eb8-8723-58a1830a9ad7">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b614c831-2207-42cc-bccc-cb1258b35ae3">
    <rdfs:label>phenytoin-paroxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/05feb1eb-2493-496d-beaf-0144a6455b9b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/1e5f26cd-8b90-4993-8b92-1e793e18792b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/1f90a783-2b9e-4196-b862-569374d87457"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/964db0b8-0e7d-4165-b7e3-513b72e71b08">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d3a1ec0c-50c9-4132-bd39-5a8bd509098b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a04b4293-f767-4826-9431-329dd239cd6e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/abb820fd-b036-4eca-bddb-7d7c289e89f3"/>
    <rdfs:label>cimetidine-sertraline drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/77fd73db-76ff-41fa-a623-26a01c8e0b79"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/759cc221-8b97-4af5-b554-0ca2f17dad4c">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0bf449d0-b886-41bd-ae7a-f1dbca1e4d25">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/081e21d7-24f3-4ae0-b0fd-b9b20890bd8b"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e0dedc34-10fc-49c2-8a85-0d0dabd9c703"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/686fd467-b511-4ac7-84d9-882be43bf017">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/3491a3a3-4aae-4b30-ac8b-c85e1e5a1433">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/18696dcf-cc8a-40af-8097-c7eae0faef58">
    <rdfs:label>phenobarbital-paroxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/72f4e966-eb76-421a-8791-90e19afa46c0">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6e40a15d-67cf-4fc0-a8e6-df3d8516eef3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b9cc02c4-4cad-4a8d-9412-8a1f007237ba"/>
    <rdfs:label>amiodarone-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0a39d66f-cbf1-40c6-97a8-0abd5d59047b">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>Cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/386244fa-1e74-4e46-a98c-d103fb6411d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d775b3a5-f802-4c14-8a6b-320effda822c">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/11f3066b-7702-496a-b7fa-b259c1ab5109"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e9144196-d77d-422d-be51-46a453488a4a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/33f0357e-bed3-4f30-a606-40703f1a2620"/>
    <rdfs:label>high-dose ASA-Edoxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2a6543c4-cc78-4cfd-8782-a1022fe8b5b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ffed47c7-a323-469f-83d7-b476684d67b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1954668c-af4b-493e-8c20-da319285083f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a000c708-f152-4b8c-8942-9f7ae94fd0f6">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/e0a8b3db-a51b-4d0e-89fc-45aad8357b17"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/33741462-5b14-4f77-8392-6af6b0ab4b48"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/af19e43e-5310-4e3d-a3d2-7ca4ac1ba65d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/46262719-5a79-4191-98ac-b7435fba81f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b4ed3589-8d38-4e6c-9063-d07bdc2dbe6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5a93f3c6-1d9c-451c-9f7a-6ee99338168b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b4666e6d-e3f0-459a-a399-9b5b8cb41afe">
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/5dd3a42b-79da-46bb-8860-98a4d7e4108c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3b371cf3-9bb7-4dae-af16-bb7ac444f278">
    <obo:OBI_0001937>98.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7e1c4642-4116-489f-8694-e97e17490c29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/21692adc-25f8-4ec4-bba6-4d7c28aaa645">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4fbb9658-9c8b-4b75-b451-3b069c3d8db4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7b2700f1-0061-4286-a018-0c39288a4baf"/>
    <rdfs:label>carbamazepine-hydroxynefazodone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3fb21f93-a70f-40de-9556-929b8d58158a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/43962d9f-1685-4eb5-8e78-2cd3edd5abc9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/abb820fd-b036-4eca-bddb-7d7c289e89f3"/>
    <rdfs:label>cimetidine-sertraline drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c97fd263-3759-47ed-859e-71077749bd7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fcde91e2-6909-4a12-aa19-1014c74f220d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/887a1831-837e-4dfd-8b45-2354aca95936">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/081e21d7-24f3-4ae0-b0fd-b9b20890bd8b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/7dadd0a6-8e41-4ff0-8364-89e349bcf0eb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/0791463a-8336-4d6f-862a-c4a8b4656f05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3d0eba5a-17ff-443c-9dcb-4507c04952a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b6939aa3-bb9e-4eb9-abbc-7d1a0f336447">
    <rdf:type rdf:resource="obo:RxNorm_10502"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c1a33f10-b90a-44d3-abdf-4b6d646060a8"/>
    <rdfs:label>thioridazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ef79fac4-3aff-46a3-92a5-4caa01863069">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/985be040-3e2e-41d9-aa1f-8f572dc0bbba"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/61ba5995-4f27-4663-856a-4566eda2e763"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/6f4f5f3f-6327-4576-b68d-df27059b0f86"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6efa24df-1ff7-42d1-be89-4f2903c312b3">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d2fd4ebd-e9c2-41a8-a800-f6133024f7c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5a7d93cd-c360-4f7f-98a6-481f18975aa4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/90f9746c-5ccc-4cd7-8316-072d3f751fbe"/>
    <rdfs:label>propranolol-m-chlorophenylpiperazine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7657ab8a-d9a0-4e0f-974c-8bc84eb3e59c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ecc2aff6-10d4-4cff-80e6-65e5491ff06b">
    <rdf:type rdf:resource="obo:RxNorm_11170"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/dcbb609f-79ee-4ec1-acf1-9c899f6c4a1d"/>
    <rdfs:label>verapamil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/08f7feaa-26d7-4e98-a8eb-658b8268171a">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/2cb4a674-21c6-4e11-af8c-4def46abacb6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/84283031-0e5e-4609-93c4-273e935cf38d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2860cd84-4e25-4e97-b3a6-5b7f91c27bda">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c4008ef8-df7a-46b3-ac75-7cc1575de5e9"/>
    <rdfs:label>citalopram-pimozide drug package auc UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/51adc763-d272-43da-87ee-f388f506d0d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ab5ccb45-5947-472c-81cd-e21adcc9f70f">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/a8113b6a-a743-4075-b7cc-e06c90537028"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/88af871d-db86-4d79-9e29-42ca8e9ad3ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b5c69074-006b-43c0-8418-28626245752a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2f004cea-abc5-4769-abe7-db79c9fbab9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4617964e-ae5e-458b-a752-5e580e037868">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b08b9fe2-4ea0-440a-a093-7e3cdc7fdfe0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e8f9823d-fdf7-4c49-9542-f7725770648c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/97ca516e-1464-4f4e-8f36-ae9828a773ab">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/2076d8b4-74f1-4b4d-baaf-d111d044b124"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0d1aefa9-f0bc-4981-93b9-41f36dcbcfcd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0a323fd4-a7fc-4247-bca5-a4f3aa2f4d36">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fed4ebf9-ab70-4874-a95d-0bd4c865cbe0">
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/bc9f8631-4014-44b8-b759-4d061002bd22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/92341cf2-9ca0-42f6-83d6-da5b8781a389">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5346ebc3-1e80-44fc-8721-95afd9ce1041">
    <rdfs:label>lopinavir/ritonavir-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4f285cd2-d398-4766-9853-7db8029b750f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/830b499c-e7c1-44a0-ba25-fc1a78a6d5e7"/>
    <rdfs:label>S-warfarin-nefazodone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/657672b6-0082-4ea9-92f8-16986deee6d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/149811a0-ead8-477d-80fa-f3e7d1ce5478">
    <obo:OBI_0001937>1.27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d0e28599-eb6d-45e2-b666-9e94aba52b0e">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/129d24e4-a197-49c5-ac26-f55cc713c4b9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/63851f02-2288-447c-8ade-4b7b738f67ad"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/bbfb3a5d-c453-4d9d-9447-92a729bac7f3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/13e61073-d15e-4535-92d4-e521daacd362">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a3ed315f-d619-4df5-86bf-a8b69d1ade74"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/04aa77f6-acd3-4b86-af88-1686afa4ab81"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6c4f74ce-7813-46d4-81ed-152829dd0c88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/387aec09-5bde-4adf-971b-3b37fd0ec563">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/ce4539e2-cfe1-4490-b65c-a327203cf5f9"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3be41fd1-6091-4e18-8d60-b44217acbe06">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/74f4a4e0-0118-4456-bbfe-4480e0bac32d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/badd9cb2-2056-42e5-a6c3-c334f1324859">
    <rdfs:label>carbamazepine-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d4923128-f504-4575-b8b5-8e2484a470ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bc813fba-cbc4-4ce8-a6e0-8398a1b2546d">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/99a89f5c-b3db-44f2-a6ec-91a50a7eeaad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/fff63ee1-d2c3-4cac-a393-d654554dcdfe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2f55c00b-9932-4d1e-bfb2-16db4df7f76d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/65627c3e-3e0c-40f7-95d7-957ace05d200"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/33ebe71e-7339-4c9c-bb51-06ebe89326d3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/351f4e5a-8d0c-4515-a8b5-8dff7a30501b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d2793fdb-b90d-42dc-a73d-4785e52c1212">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/16a80745-29d8-41c4-b793-6870a8dad90e"/>
    <rdfs:label>Fluoxetine-olanzapine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0942e7dd-eef7-4a3b-9e1a-c1211b732fb5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/04dc8c18-0a14-4d38-80be-135a1049f6a3">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c2f32fb6-8f07-4e89-86e4-e82b275f5fc1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/68d09b51-9900-4b4d-98c4-7101d905b09b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c083736f-f065-4c1a-9cd6-7eb247433f12"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7b184007-1114-4023-95f0-e90141e3fcb5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3e26a917-0f6b-4ed6-af16-828db27c6c5c">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/7e697b44-af26-4648-8a17-778d90f92308">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/1fedcfa5-9379-4766-b056-03f18646120b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/13263258-91d4-4ec5-8ffe-31ae9cac7dfa">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/e9da2e15-ad4c-4dfd-a0ee-8dbd4b53d850"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/16682296-b557-4929-b6f9-2eb0f9af0028"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/7ecf72aa-d1a8-4493-b942-1d00260674fd">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/e898f5d9-4869-46e3-ab05-f2887671b379"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/63f88971-f278-4a67-895e-f761e5e5a2e6">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d83a532c-8c83-4681-abdf-32e17e5db227"/>
    <rdfs:label>erythrohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0f6c6f61-45bf-4558-bbf1-e4f59454105a">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/28ef9fe7-20eb-48cf-8cfe-7249840ad9ca">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/24486274-edee-4cd3-bb85-89c9a1e53228"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/5571de5c-550f-46b8-9017-50e1f1acc73c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/0d733971-67cb-44ae-aa02-3ee931fd0982">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/84c4a1c8-d6d7-4103-adc6-6e6ac351d0b1">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/dc02a7c0-1e2f-483c-b105-5e2a0d9bc34e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/64b6fdcd-3da5-468e-961d-8789dbd32cd3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/34fee07e-a147-439c-8c8e-2225a53b8b3e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/99d085b2-1444-44be-9356-24d43e8e99a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d71b9514-3371-410a-a1c2-9656fe506337">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0ba79fe8-b1fa-41fa-96b2-d45606137ffe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5dcc9dea-c53a-433c-af98-eb30fb225f88"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4e815629-fb32-4b09-b789-36dedb48875d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4fc2bf22-dce1-49d2-8584-555db4505015"/>
    <rdfs:label>ritonavir-erythrohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1ac5a8a0-4a3f-47ac-bb5d-e19a4fe3e122">
    <rdf:type rdf:resource="obo:RxNorm_683693"/>
    <rdfs:label>desvenlafaxine succinate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bd7cbe74-673d-42fc-a7c1-154dafb394a1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5cbdd743-053d-40d1-af2a-09ed6b669e4b"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4c2bd1e7-cbaa-4aa1-94fa-c4ae3689f132"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/c64bcb6b-8562-4e67-aa0a-6f687e1823fb">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/bbcdc2e8-ed0e-4942-8402-36f50266f0b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3049eec6-abbe-4169-a5fe-bc8fd6102234">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d7db5bfd-9eb9-4a26-b38d-43f3d1aea432">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ec2d525e-a310-4d3a-a271-3a2ab8b29119">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0d17b6ba-16a0-4f21-88a2-78fafe333449"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/164add38-af59-4f19-9ebf-cf09f245d055">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/05bae3e2-9cfe-4a50-a19a-0c810bf7e216"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/6f7455d8-bc73-4b81-b34c-1fe31a5cb919"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3dfd4014-c1b7-4303-8e31-29e9cc516962">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e40b43c7-7ac0-4445-a101-dbd0e176d42e">
    <rdfs:label>cimetidine-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/ab615e71-8f89-4f93-8cd4-3ca026711bae">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/1bff15a3-4bb3-460f-8841-a9588327f312"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/347f4c03-1bff-4410-a95e-d8dad62f4720">
    <obo:OBI_0001937>57</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8d68dfa4-7852-45b6-8a00-acb97b5f92cc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/69ae47f0-ffad-4b90-8b30-6e6359a8d8c5"/>
    <rdfs:label>cimetidine-citalopram drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/51f559a3-b161-4741-964a-605cffda634e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/dad5c3d6-936a-416b-91f6-b29c9ca4ff22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5f166504-1ebd-4ea0-bff3-728a724c7bea">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5352186a-4f2e-49de-9935-d0716f13a52c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/77c8d03e-6aff-4077-b0c1-00114937e58a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6d329d80-bd63-4335-8ed3-663b26177399"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/86085762-06d6-44f7-a557-50768cc81eed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2fee694f-5ed5-4f16-b4cb-d385a1d97924"/>
    <rdfs:label>clopidogrel-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/ea19e6a7-bb46-4c99-b36b-74bcd8216fc3">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/e9dfeb99-825a-4132-801b-66cb32d6c5bf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/e1a6bab6-c545-455f-a245-e3f0380f10b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/351fbb03-f9cb-459d-a91d-d223665df4a2">
    <rdfs:label>carbamazepine-L-amphetamine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8bc94e32-2753-4b8f-8402-88aa4e69132e">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d0c74e0c-b248-4a9e-ba0d-1d77e9f9a948"/>
    <rdfs:label>duloxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b0a53278-20fc-4072-afaa-1b0e03c1e83d">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/c09749c6-fa50-4923-bd9c-28ffbac34b05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4d77dd84-5795-4d6d-8502-0d14296afc18">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1e446c54-2aa4-4e54-aae1-2f50906bf7bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2f773e27-20de-41b7-8684-b0191744dc2d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bf813895-7a46-4453-aa48-554187ae8dc1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/e099fd12-1525-4aec-aa3e-b544deb10655"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/dc4c67a8-d856-4ceb-bb6f-8fef5e71ef38"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/0a39d66f-cbf1-40c6-97a8-0abd5d59047b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b34a4a95-3c8a-414d-a2f3-549b5a227793">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4ed105df-e70d-4816-a507-3889d365d4ea"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/c6e9f49d-0937-4fb0-a47b-de349684d589"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/947012aa-2450-4a4a-8339-c0bed8981eba">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2d5e64ef-8948-43c4-bb82-219723e7407a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/913ea853-ca23-4243-8c0a-66620a2f1c89"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1dea8d38-6dbb-4646-9710-8f9ac495d254">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/65c0ed0e-7982-4a35-bb1c-2a33a53aa578"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/08595208-719e-409b-9bee-8465c0197870">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/a7f0370d-ad62-40c0-a948-538971ca5abf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/96efa9cb-bdff-4cb6-9b37-8bd50b415fbb">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/afa2ba75-71af-4f13-b88f-05d7d0fce615"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/768bd8af-39ef-4d29-a61b-f82b4e3f9aa4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bc997096-9e35-4684-bbb1-be93e69f3d93"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/05c58bfa-5fdc-47d7-8e80-6e48e61c8fb6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/de6f7393-a119-44f8-8f0b-0fb03bec8757">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cec4a4ed-71c5-46d6-9b58-1650c18a84d2">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d48b5241-9899-472f-9786-98e8b8177cc5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9ebde0d9-cdd4-486a-a4f9-e41341045808"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/0d884d43-0db2-44f7-bf6e-3877b141b361"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7f6d0436-52b3-4ef1-805c-b13292fb3cec">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7380776d-71b4-4e93-ad30-b7dcf1fceb14"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/fe6fb303-1323-4320-9996-94545f5be6f7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e1769f07-93f3-4262-b3dc-28b4107f9b00">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/39e30541-207b-40dd-a105-bf6c48fe4117"/>
    <rdfs:label>telaprevir-amlodipine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ca27d23b-623e-46d0-8b0d-028c6a14096f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/99cab27f-91c4-4387-a9e0-029e92e3dff4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/637ea5eb-689c-4db1-b4c8-f1368b64bb68"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/f4f32efe-d704-4617-952a-a7d9efcf8cfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e87e01b7-1775-490e-a4c2-5cc98cb2d4d8">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/281b5467-5c67-4678-a60d-f493a2082e33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8b8868d3-2299-4158-9e9b-0d846bd201ff">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/67e26615-a36a-48be-8942-1bcd47f5e6ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8191d2bd-da29-425e-a852-4c708f0ffadd">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/aaab652c-96cf-40f0-9d81-d45e05e2d5cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f4004ce7-9c54-433f-9e4a-c3b4cf3d5a4e">
    <rdf:type rdf:resource="obo:MeSH_C558933"/>
    <rdfs:label>fimasartan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9332c4df-faa9-462d-94ff-9132b4bfe9b3">
    <obo:OBI_0001937>49.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/18039aba-cd97-4a04-8ce5-6d8f7f3bd7bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b03e1d4b-bdcf-4e9e-b6f4-10ee91b47ea0">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/e576ae50-6158-4090-a3c9-3580c8d3f3f4"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ef9bffb1-581c-4a09-9ee5-77f7c54d29ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/37f49358-d694-4e01-9263-6ec3069ff379">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d83a532c-8c83-4681-abdf-32e17e5db227"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b18c85da-3e4c-4a17-97aa-1d73116b6f06">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/35c417fb-dae0-4e72-a403-0e6c371ca1d8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b2c5527a-5b2c-47be-ab4b-2908b5a9d903"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/01401575-c71c-4637-bd53-8e62a162f919">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/31a73510-4821-46ae-b63b-7f5100220bbe"/>
    <rdfs:label>hydroxybupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e50bbfe6-cf0a-4a11-bc01-bcce26dfc704">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/da59119b-b8f3-4686-8b19-babfde81b5e8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/836f8108-b8e3-472c-bdaf-829478eb4123"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5d0937a0-92a6-4826-b311-826d60bdb44e">
    <rdfs:label>warfarin-ambrisentan DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/27cba158-bd72-47c3-a9aa-6352c5ac89b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9c564480-5657-4ef4-83f3-54c446023613">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/20238c69-be93-49bc-b035-084112e62d8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/a86836c4-4214-4fc1-883a-43d3424cad7a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f0b48de4-dd3b-421d-8108-6ce51c694955">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1288dbda-130c-4701-acc0-ab52cdb162a1"/>
    <rdfs:label>nefazodone-haloperidol drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4c2cb218-9af7-475e-bcf9-d18df8bfd7dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fd61cc40-4754-4ab3-bf8b-32f99bce2044">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/457e3a23-3bc5-4a4a-9159-2b07e869d22d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8e2ed16f-cf00-4e9d-b20c-36ecceb913ac">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/c23a9bc4-f037-4f2b-b5cd-14757d8193db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/26aed168-1a25-4210-9a51-39e20c697061">
    <obo:OBI_0001937>153</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/251c6393-bf3c-4d3f-892a-0b76387f265d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9fba5843-81a0-4f12-9c75-3e19b8a886bf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9a95d68d-8e27-47f9-9d5a-5ac0f858c44b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f0e7817c-79f9-427f-82f6-7ada09409c83"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a7186f6f-8cd5-44a9-a761-73ed93f55183"/>
    <rdfs:label>warfarin-Rosuvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/05886ff6-a667-44f3-a402-571852dfa736">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/fce19286-84e4-4b21-b5f9-66a09a0aa1a7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/7519dae2-a6ab-4acb-9218-1ffa08852b3c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/71dca410-9717-46ad-b2e2-5f0076e30a38"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5d05dcdf-726f-4d98-942d-209872bd34b9">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/4112abbf-9448-4ad8-b0da-b50ad098436f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/05d868ae-fb86-42fc-a535-ad196f9863cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2421ccac-1ff1-4c3d-acef-6b03dda92231">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d36320ed-9dbd-4d4b-8ebf-1f604533ef24">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a8e19b9e-f084-47d3-af3c-d7bfb088dd9d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/79e34d33-3e29-4626-8e95-903907cbd5d6"/>
    <rdfs:label>duloxetine-warfarin drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/75e96017-cf69-4384-88e5-2c2491d3941d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6baea4dd-c007-478d-84bf-4d27e510b2c9">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ddc60b4c-d7c4-4a78-8eda-360037a1581c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8bc94e32-2753-4b8f-8402-88aa4e69132e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/3c09a953-ba58-4b5a-9ab4-66df1551e6fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/62a96ba6-77ab-41f3-b33c-7e2788c45cc6">
    <obo:OBI_0001937>90</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/05d868ae-fb86-42fc-a535-ad196f9863cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/26330725-d43c-45b2-8240-edf32341076f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7a4131e5-b470-406c-9f8d-2d97d3f9986a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b2e3b1e9-2301-4b0f-b515-9a0ad3139e37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/5e07b09f-9d0d-430c-b790-eed61adcbae8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/80af108c-3189-4cc1-bcb2-23fbb88e3ef8">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/39b8ac43-aa09-444d-8e5e-b5ad05ef5589"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bcd08180-6cab-4277-9a5e-93cbaf17e18e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0969af4b-9db0-4751-b1de-d11fdf79496e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/b1d4dbae-c2bd-4d82-bee6-b5c18e6abfdb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0ffce663-19e3-4aee-a8ec-cb24c6ccf937">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ad629c4d-e7aa-4c46-a291-169586acbd7e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/67596121-8d52-41f3-8168-1ba4675c84de"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8f0fec97-b7b1-479e-b2ac-462976130a6d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/1b880187-8518-4a71-a4fb-e1422ea1e546"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/03150a6c-c5c4-4430-880b-a573082c0b37">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3d9c98be-8397-4fb3-8b4f-19dc548bae9f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/0d1aefa9-f0bc-4981-93b9-41f36dcbcfcd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9c357197-88f9-4d10-8c67-95644a66fd82">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/4a7dfb4f-972e-4e55-9149-d6ff1962d69a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/086ed17b-b899-4d3e-864a-8d61431229ca">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8be20b97-0878-4baf-922f-965665ff2eee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7acb9858-b96a-42ba-b048-ad8ca71f1498">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/d7722fc8-f925-470f-99f9-c05a5e686991"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6fef8007-45d7-41d1-a8a5-91e4574c22e4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/74d8edf9-dcfa-4ee0-9111-22e67aef7ad2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/d57a5250-89d4-4699-bd9b-e24cba90c3b4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/84f9a151-766b-4c50-94b7-db7a926cce07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2b7050ef-c620-4665-8fc5-aa5acfdc72a4">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/4bf3193c-6f51-49a5-a815-78f4688c7e02"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/8ff524f6-4eb5-4023-a7e1-5c62a0f329a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/022344c0-ba73-4dcb-b132-3f9410a78dc7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5738e8f1-4890-4df3-a0de-cc374469286f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/678467fc-b581-4131-a853-e14ee18e59f9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e1f83b50-8699-422b-bdc4-1fe11f6f944e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9e1f1565-eb94-47bb-8972-a9a306417c09">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/571ad28f-b60d-46c9-a88a-626c8f4459db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/637ea5eb-689c-4db1-b4c8-f1368b64bb68">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/3d086561-f17d-4d8d-9da4-93836ba2f07c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8ec699ef-5953-4e58-8c86-4893ab18619c">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/1a2d4f45-3342-4ef4-a41f-d3b7638cd0ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/73eb9444-4070-4764-ba8d-9e32f3bca352">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/37a76bc1-76c5-47ee-ae35-9bf10a59d248">
    <obo:OBI_0001937>62</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fe6fb303-1323-4320-9996-94545f5be6f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/45189915-c871-44be-b465-c1bcc993f521">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d195bd7f-3257-4c95-9888-a06b0209c6e4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/1684617f-f216-4dd9-a3be-0eea73aa4180"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a52039bc-4f61-48ce-9b40-d16f956f0e44">
    <rdf:type rdf:resource="obo:RxNorm_4077"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/433c8102-adf4-4c40-8a9a-e26ee241d1b0"/>
    <rdfs:label>estazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/650f1758-9c18-4f1c-a9b8-33031bd2f2bd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fb00bb38-dc7a-460b-9114-896687c25361"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/df0cd431-5a95-4828-af37-480790ff5847"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4e89c636-8e92-44fa-8127-00b0fc28075e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/27e1289e-ccdf-48f4-8d39-1c5afc9597b8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/da77a1bb-5109-4489-a270-a67368129de2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/73e8eed1-2c36-4637-bc45-772c87e23df6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/82044cbc-0726-48ed-b284-ea06f38f9fa0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1837a742-49c8-4a90-b88a-e81505b71a83">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/710fa37d-f7d2-49d6-9e74-39c2145f6811">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/714a4b78-dc47-46c7-9b70-27300dd1c5c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/71ca8eae-100a-4eb7-b31e-ead8111417c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/681fbcd7-ab25-4675-864f-8b4567ff125f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9e41f489-15be-48be-9b7c-2995f2a3e13d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fb6e47f3-b74d-4bb4-bdd2-e35ea9d7d086">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bc89a490-f1c1-4bdf-a004-52c6174de6c3">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/1edeb059-b3e1-490b-8db6-7734c0ca6117">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/243c0427-1441-4770-b4ea-233c02bb3000"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4e815629-fb32-4b09-b789-36dedb48875d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7e7edb2e-c5e9-47ec-8a2b-b66ba9b82e0b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/c10d970f-4f97-44e7-97b2-6823d8ae68c4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3760fb43-defc-436a-8d8a-5a9e18ad3af0">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a0280e44-b7ff-4338-a725-08a2200bf1bb">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/678467fc-b581-4131-a853-e14ee18e59f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3dad1bab-98e0-4408-8e05-133ff10e8fac">
    <obo:OBI_0001937>49</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b9f968bc-045c-444a-818a-2caf9ccd1743">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bbe40713-f6fe-4ed0-983d-1331e6efb170"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/2edc9751-4533-4be4-a7e5-5e26595c68f5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/dbce0e69-088f-4c89-8430-c2c09e5d29ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/71bbef92-d235-45b4-9cce-98b37dcf0502">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/244aeb82-3aa1-4b56-ac28-d55e1803c061">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/55e6febb-8ed2-4f2e-a014-4c66eea9b2cb"/>
    <rdfs:label>BRINTELLIX-salicylic acid drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/483a0d25-58da-4212-acf3-813dcd2060b1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/44989b53-0435-4a28-be0c-d94f43d128b4">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/f4fbc3b5-07cb-4d1b-aae8-e84955e28994"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/c0dc8f81-7f08-480a-bdf8-2190ca0e8e7b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/dc0ecf50-12a8-4477-9ef5-1aaeebee6d35">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/bc248f6e-1aef-47ff-b155-7d92a8b4a2ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ca798237-74d9-4753-871e-66cde709d722">
    <rdf:type rdf:resource="obo:RxNorm_35255"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/aaf291be-4166-414e-a2ce-dd30dfdd0b66"/>
    <rdfs:label>cisapride</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c2020db5-b6d5-40e4-b2b6-76b8dba10a6c">
    <obo:OBI_0001937>122</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/701db3a8-0fbe-4843-b25a-2802aabcbd8c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9c60f7e2-ead1-4bf1-b462-57a228723b8d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/45f522e6-eb81-4b58-8702-5a38a71ad109">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/409e20da-4a61-4eb5-abff-d41ada62246c">
    <obo:OBI_0001937>32</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2d7898a5-435a-44a6-8c6f-93bd21aec031">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/ccfb7639-4699-469a-8e01-0e892f009f27">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/86e8eb35-c6b8-467a-a204-89c98afaa496">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1554fef6-13b5-4485-95cf-ebdfcb222855"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/be4a0ec8-65b9-43a8-9f72-84da98e1c473">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/02d58923-1bb3-4c0b-832f-8f32b642b51c"/>
    <rdfs:label>divalproex sodium-INVEGA drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/fb0d212b-dd93-4c33-b3e9-9ae06442b23e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a89a889f-2e41-4845-b684-f2376015434a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/da3203eb-fdb2-4618-981c-33e8073e51a4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e4d27942-81f9-44d7-9f29-280d902d91fe"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/49530a0c-e978-431e-ad66-c6e98858d0d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0ff03303-c105-416f-83d3-8339969c1e74">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/427d64d9-b398-4484-a411-b6dfb5aa6808"/>
    <rdfs:label>digoxin-aliskiren drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/637b7140-7bdb-4058-9c5d-30eed0475288"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7b91a97d-bf9b-4b42-8813-43cf2b942e06">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f0b46919-6c6d-45e1-baeb-0e3ae96afb0a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/3a55701e-9c0a-4194-a445-216cf0bb51f1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/d834c9f3-a720-46d2-a07a-5a64e02e774d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/2a233252-8358-43b2-bb46-0241eec8af43"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/49c5c65d-d8f4-49d0-a0e7-5cf3b2647517">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/de657bf4-4058-445e-a5c8-c2c92e8a9aaa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/010ee264-f295-49a0-a256-f87bc5de3e63"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f9f5ddcb-bdee-4cba-a135-d064730c124d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/ddc1d1d9-ec27-4f53-a8ed-5c673537e3eb">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/fcafd151-c45e-4db8-93a1-659fb968ed7c"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/8b92877a-1a3c-4bb6-a883-e0bc44a7c8af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8b0d050e-bdfb-4576-9066-c08af8b8546a">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d1cfc9e4-60ba-4640-943c-4c2224666305"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/53c1bc80-e919-42aa-8903-273be038a264">
    <obo:OBI_0001937>2.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b2760ef1-0c8e-4760-baaf-78e7b2b2776e">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0b9112e5-c43d-4cd0-9789-19b408de2c7b">
    <rdf:type rdf:resource="obo:RxNorm_596554"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/53af0cc1-4a84-4f64-afb2-18218b2b9114"/>
    <rdfs:label>vildagliptin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/95a45b0f-93bd-4029-8904-8a29f170a948">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/9f58dbc3-2fa6-42c0-a179-9c692b38019e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e9da2e15-ad4c-4dfd-a0ee-8dbd4b53d850">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9df727ad-fad4-4a2e-b4d8-03dc5ed6f320">
    <rdf:type rdf:resource="obo:RxNorm_38400"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/338759f9-1394-4f54-b4fd-e1114d6946a8"/>
    <rdfs:label>atomoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/beca81ac-0d11-43e5-854a-bcc1d924eb1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/55dd99de-4ce6-4a8b-9067-463a9fbfada6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7cbe7659-18fd-4dfb-b704-8f143d99e090">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fcf723df-6883-4fe9-9400-eeb568ab8ae8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c8a174dc-42fd-440c-ac3f-50a35fdf381c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/946180a9-fad0-45ec-829e-0fd0f392e9af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3b8297a9-3c75-49c5-9514-6bb8e9140423">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/7b184007-1114-4023-95f0-e90141e3fcb5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/904ed246-44e5-4fb5-8319-f49acc8a8f5c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/322e9b89-8123-46cd-8078-4ca9fe3b0df5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cf6aa7d0-b5fa-407b-ab14-53ef2f4d484d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/471f3383-37fc-4e99-a474-b772dd80cdbb">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b9fa57db-def0-45be-bcd8-560e44591c75"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/da77a1bb-5109-4489-a270-a67368129de2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fa2196db-df3f-4804-88a3-6795dedf9a52">
    <obo:OBI_0001937>4.04</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/92a5945c-f3b8-40c5-a19d-246e26a958fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/39fc890e-ea52-4b93-a4a6-7a0f70e8db21">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c8b40202-2ba7-46fe-ac95-a01ad79826d6"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/9e000256-86f1-488b-bf8c-49586a542f34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2d12b5b6-aeb3-404b-9a6f-4baa2c790721">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9e9c2075-eb8c-4fbd-9497-4d008de399fa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9364cb98-93ae-4c92-bb56-f0e27285c602"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/67e26615-a36a-48be-8942-1bcd47f5e6ff"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/b441d6ce-39de-46c5-8e52-31b555776f07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/62f8bc99-430a-4295-9844-d265518d49b1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/4ad612d1-478e-4f2f-a5a4-63dd8bffab90"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/4aad59e7-7565-46e9-9e7c-afdb8bfc0152"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/e878f2ed-fc38-40c5-94e3-c08c9dd211d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/3c167399-425d-4215-a36f-36ad334b24e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7f273737-169a-4af6-b148-8878cd3e2933">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/03ab7b64-d67b-4e4a-adf2-561f123d7354"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/199081f1-1a02-499f-8f9e-d268ab32ff8f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6f597323-22ae-4e62-86ee-dd4cd9f068fb">
    <obo:OBI_0001937>74</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0cb309ab-718b-4ab0-8718-a61b95112e6d">
    <obo:OBI_0001937>120</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/5805f049-70f9-4be2-8030-270f5e76ce91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/16980631-98e2-47b5-8a99-3b0cd012962a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3bca1cdc-bede-4a74-9f53-8629408097db"/>
    <rdfs:label>sertraline-pimozide drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a2637983-6958-4749-9637-b4553df30d4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/53de0816-8217-4ec3-8eb9-1b45fc1f263a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/17dc4f42-8c86-4e99-acea-420e29674122">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2fd5e27e-9951-4949-8534-8f18ccb471e9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/ceec9015-1eaf-47aa-a09a-2507ba774a68"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4d32829c-4614-474a-b4ad-faa9b67f8150">
    <rdfs:label>rifampin-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/18691c4c-0b61-41a1-a51d-7aec50b1e32f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bebded05-bd37-43af-8a02-bc5957506fd5">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5897d996-77f4-490f-af7b-23fcfab4986f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f791d686-76be-4bd7-b3d5-5d1ec8dec7c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c83a8072-42ce-409d-8c1e-d8d7f121d29a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/fbc87786-5376-494a-8200-35f7c9984071"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/df0f1b8d-30f8-4ea2-8c32-97f3f4fcd496">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/39099ce7-152a-43fd-a9fd-9d637394ed91"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/a8b3353c-b1e0-44c4-bb33-cc450fe60d72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3e15f316-308d-4f0d-a6fc-42f69aa2d6ff">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d3b65a33-e558-4183-a205-2015389d20dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5ea950ba-8275-40a0-b67e-83ec290f118c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ed2e456c-af7a-4f00-bb06-c036133a6fe0"/>
    <rdfs:label>rosuvastatin-warfarin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/aafe92a2-be4b-400b-9e57-d79b6775501c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/39a2489c-0b04-4e02-b210-822032d51125">
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c3a7472f-3b45-4c41-b21c-900119afa0b1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c3248a3f-29f5-469c-96b6-5b3f4703b5d0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/d827399f-2383-4a09-b6cd-eaa20babb079"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/48cc0b53-dda1-4314-b4ce-ede6ec06a691"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/edc82b9e-4de4-4eed-9edd-fb88a1107c3c">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c445ec31-e8ca-456c-b8e2-b91e9314d04c">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/88e7ae72-328f-4e6b-993e-59491c3bad70"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/86ebb0f5-16a3-4d6f-ba23-92d59964b7a9">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/aaf291be-4166-414e-a2ce-dd30dfdd0b66"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1eb86f08-a1f2-42da-8004-695c56056b18">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6d5b5d99-54f3-4764-9318-b030ad2b561d">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/a8697ba1-d84a-41b9-a6e6-e6afbd41750d">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/1e5a0269-4c63-4184-a3e5-4627cee4c4dc"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/bc900083-c663-44b1-870c-db0735e0eafb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ff1852d6-a1ed-43a4-bbfa-a4b250511216">
    <obo:OBI_0001937>3-4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b7fa673f-78fe-4b53-ba04-8b919c843f8a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/191cf435-4ea9-4d1d-8390-bb3eb36f8850">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/f4f32efe-d704-4617-952a-a7d9efcf8cfd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/82d5071d-b98f-460a-af15-fce78d1a3f8c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/1ac5a8a0-4a3f-47ac-bb5d-e19a4fe3e122"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9c122269-d5a1-4b6b-b01d-50200bf6f1d8">
    <obo:OBI_0001937>106.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/94188994-5681-4133-a840-2156de10133e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8743f73a-16fc-49b4-b94d-eccce4189992"/>
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/589efe58-9ca0-437c-800c-81cb95e77f88"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b2d331b2-9e9a-430b-a3d9-cb33a2da6109">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bbe40713-f6fe-4ed0-983d-1331e6efb170">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/37695767-0a1e-4ac1-94e4-364fdfb40575"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0ac0081c-0d52-4285-a58e-1bd4434ccd86"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/76e1db83-49ea-4e1b-ba10-46639e1ed451"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/493f8cb1-e971-4833-8d70-6560c33d2941">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5c1a5a69-0686-4cf1-a074-81582fa3712b"/>
    <rdfs:label>Cyclosporine-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c7d77629-aaf9-494a-9204-6db41e5fba88"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/723f4e77-f1fc-42d4-8d79-e1543e1dcc17">
    <rdf:type rdf:resource="obo:RxNorm_85248"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/8968b58c-661b-4144-8a4f-58535dec2d6c"/>
    <rdfs:label>alosetron</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a957fcfc-78f2-4a68-bc6a-64d5478c8966">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/fe986b9c-1ee4-4a0f-b627-d25679a47c4f"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c1519326-4437-444c-9c89-701a8ed295c1">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3e3c4412-661f-4521-9f6c-f57bc774108f">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9302cddb-666d-4f6a-9cf6-5d2ab421ed24">
    <obo:OBI_0001937>44</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f7d41328-a15d-43c6-be57-e430ae20ae6f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/9d65a3e7-b39b-4dbc-b3de-68fce82a7b60">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/c83822f9-5495-41e1-a4d5-5ca32ff80fd2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b8df5d8e-f2c1-4cf3-a55f-58f8a7b1f1bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b54660c4-ea77-4e9f-8c39-8ab4db24e1ad">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e2a7feb0-3898-4ac2-b860-64475c122fc2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/77280095-cd51-43e5-84cf-ed774098bdbb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/af8c9dbd-ff05-4b08-a4b4-472ae464354f">
    <rdfs:label>nefazodone-alprazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/43ebb7b8-b78f-4806-bc16-5af50ebf82b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/6a2301f2-68bc-478a-86b5-c09b65c9ee73">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/265e7fee-18f0-4eb7-8744-96bff4ee2a75"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/cfde3535-1041-43fe-95e3-e0429e78ab32"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/05fe7dde-f492-4c97-8514-777f8d723e42">
    <obo:OBI_0001937>6-8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/272538d1-c126-483e-9a32-f30b19db907c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e29699d2-5a0a-447d-8d3f-b87f53462e4b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4129591f-daf1-4394-9675-63074f4e022d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/909e7c51-c85e-4d18-9d7d-5d4fa8143259"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/fa900196-2cba-4873-8321-16319570ba59"/>
    <rdfs:label>naproxen-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b1eedc52-448c-4752-9dd6-463f382d840f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2afbf8f7-8f18-4216-8249-8dd46d201be6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/bbf0df82-8fba-445f-ae81-021c074447a5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/eb607d20-f868-4dd7-90d4-723ed93b9805">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/72b3e145-cd54-462b-bbc1-c5e3de9ea05c">
    <rdfs:label>warfarin-Rosuvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c2179cd1-ba3b-4d91-aace-8e4eadeaaf8d">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b27d1359-3d75-4863-8fa1-d3e05b0ce0bf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/066601bf-4488-4785-8a49-e428a8a6e88b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/190a5d33-9b0f-4b2a-9067-5cb4faef3b14">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2c3a16a7-f39b-4e55-a5c4-9e72f7997570"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/761723a7-4209-4b42-8a38-6c44105d2d16">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e2ce0187-bbbe-4368-8dbf-7c33503e605c"/>
    <rdfs:label>pitavastatin-R-warfarin drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2e26f2fe-1a80-4b2c-a8f8-eb1c86691fc5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/975bcc87-fd8e-4057-a7f3-3d91648eb9ec">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0d1b3a89-bf1c-4640-abf6-b68e63506dbb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a5cc2a85-1823-4bad-b503-936805dc3213">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/430d9577-b939-47c9-9af4-d105ce6489d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9be91319-ab7d-4d73-888f-eb399c66a555">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/26d55180-e62e-4810-8a40-dac4faa8f8b0">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/faa32814-c453-4306-975e-7b3242b8e055">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/42ed57c0-9e60-4ef6-b436-f5b1c20c01dc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/23ae732d-ce4c-45bb-a156-a96055e6ebf7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/58be97a5-db98-4cbd-a098-d13d1607b393"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/064ed001-18cd-45ea-83c1-0b4102564eab"/>
    <rdfs:label>Gemfibrozil-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/66b3736f-0461-4892-a39b-239db928aa48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/468a3c34-2868-4e3d-a428-89d73a831ba0">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/63e3e87a-bfaf-4035-a504-2f58d7a7d3e5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/c6c247a6-274f-4d3a-b7d9-caf199effaec"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/a30c1bbd-f178-44cb-b6e2-2c70590ed2bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/07cbe6c1-23fa-422f-af2e-ef74c83e0b95">
    <rdf:type rdf:resource="obo:RxNorm_21212"/>
    <rdfs:label>clarithromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/26ef6d84-9e50-42bb-83a5-93b968ac6d4f">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/84d18140-df2d-4d92-95a0-7dfae43c6fcd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/41fb9228-ccbe-4895-a945-7c1043564056">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/4c6fb32b-6c83-4f56-a922-0dbd767b64a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f99706fc-e8c3-4a17-871c-244740a71ceb">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/41bc7a0a-b81f-4ac2-b973-f5fab7646571">
    <rdf:type rdf:resource="obo:RxNorm_352393"/>
    <rdfs:label>ABILIFY</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7d0d6db0-9b5b-496e-8c40-a58c30603205">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/aa9d63fb-3978-4668-aea6-db22b536f2e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3151fc30-1858-46dd-a6a6-d551298ccc74">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/57603e47-d2a3-4c72-b301-ebcd3e790059">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/0ba911e9-d600-4812-b970-1b743c7a21b1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/75f0c55d-88ec-4349-97b2-3662b697334b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/4c77e5e9-1ff6-437c-9c8d-402eeb4018fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/01f41eb8-67c8-4cd8-9179-0317d0ca9644">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d41bfa32-c76f-4fb1-ae9e-cf41df05dafa">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/fcde91e2-6909-4a12-aa19-1014c74f220d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/4bd95b26-80bf-4cbe-a7dd-3f9f3608d3c1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e52bea32-0a71-4aa5-9a75-851cd5b2fe86"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6edbd7c7-62b0-4e49-b4c3-9392a5ac4c4f">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
    <rdfs:label>ticagrelor</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d6bc9172-e94a-4264-9818-4fd7138a763e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/24265b62-fadb-491b-852f-783b80916ba7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/265c0686-5fcf-402c-a953-870c9e0d26ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/44e3800f-34d2-4364-ad82-9760b1c9bb6a">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/20af552d-6369-4898-99d1-8ae7cc8bd79d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4d15d011-5059-4948-bd9b-65ec2977a63d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/13c8fed3-df5d-40b6-8eb9-8834a3d5d78e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a8e0d3de-9ff9-4b93-91a7-9e6a50036d21"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5e86cf60-25f4-4e3b-8627-cecf27c4fcbb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e2614381-1565-46a8-8884-428d942be2df"/>
    <rdfs:label>nefazodone-alprazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a14e3229-55d6-421c-9079-3f205fbf7dc7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7832d0a6-b5d6-4043-91b3-6c7dbc9c8bd8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/53723908-a5a3-4b9c-9bd1-92f33d751a77"/>
    <rdfs:label>fluconazole-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/fa1d4495-f3ba-46c3-8866-eac690a83eb6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d544c218-2243-4eb5-b647-7bc03ce4892e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7586e89e-5c94-40f0-8eb1-ce9d81f9a897">
    <obo:OBI_0001937>.4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/57da0fdc-9ba7-4b8f-b934-1c161a68a588"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/320be492-a68e-4988-acb9-d7765445cbbb">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/5e399782-c1c3-44f9-94d9-5a6cd7c86f8b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c4787857-e8f3-4193-83b2-20324a2abcab"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/c12eb2af-c377-4a2c-a0d1-5e065cb75d81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/89dd6406-590b-47ac-9b5b-72c8bc30a2ff">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/995eb5c9-21d0-404b-9a5e-50eb079abedd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e5209d7c-5f1f-4b38-b5b1-ebb276f2a106">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/96c041eb-865a-4818-8a90-f37f50e6c039">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/3c85a4e0-ac9f-4d63-af3c-4805a5c1596e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/11085277-52f2-46a6-875b-027decb45095">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/58455577-b171-4f24-8993-f11f0ad7702e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/cd9f7fca-967d-4704-932b-83f2870490fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bb68beb0-643b-476d-845b-b4aaac755f03">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/513cf7f6-cd25-4dd7-9e54-f7614dc14b50"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/6cade93e-5f3f-46c8-83e8-81b75d2128b3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/61b77d7b-bfc9-4a81-aa15-9b2547673e10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2bdd40a6-e061-41a1-b4a9-656d3137f22d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b0d2fe27-4554-41cf-adb2-abe2e4eb44a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/fc0a8827-b547-419f-afef-8e0cfb7c96c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/ed6fac2e-2a7e-4189-8549-aec594e18805">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/62eded95-b885-4398-8f0f-4a5bd87a9aaa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b82d144b-08c5-414e-8f13-75404560a462">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1b68b626-f85f-4813-993d-b3da700b86de"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/7d91d527-f459-47b4-b07d-52203cdb568b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ab8bb100-a810-43bb-bec3-fa05d79b171f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/52ca92d5-6b2d-4b57-adf3-fcda3caa3c9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0cf8e710-90b7-4501-bf39-7d662ebcfe2f">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/87797b0c-422f-4898-a1c7-bda7b8eb68b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2e5ad88d-dd0b-4300-9766-2d2f4f803e3c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/30b2d3f9-358b-4bb3-a4ba-4b6d341e1956"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/3181bc2d-db7b-461a-bee4-dcfa9852ff4d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1c2fdede-335d-4a44-9bf8-af58936a16cc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/be4a0ec8-65b9-43a8-9f72-84da98e1c473"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cd569fdf-0a9c-4039-983b-c971c09f8983"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/609bc74b-bc9f-490d-8430-2987d3f50d8d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f69d23b6-2b90-481f-8f87-3cf62ebb3fd4"/>
    <rdfs:label>divalproex sodium-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/331ad3f4-0983-4251-b844-e358ae2d33e4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d2793fdb-b90d-42dc-a73d-4785e52c1212"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e6a1271d-f406-4c74-89eb-7c4ca6fff6dc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/17eb5327-2ca6-4454-b4cd-ae04b99be4d7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c8f9af6f-907b-4590-b321-88969c2333bc"/>
    <rdfs:label>Fluoxetine-olanzapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/1281369e-06c3-489c-8834-550a65e937cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6ec46d92-d7e7-40e0-b028-67b8dc284301">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/17308daa-0992-4dbd-8c67-52dd36d4389e"/>
    <rdfs:label>sertraline-zolpidem drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/811631cc-1968-4ea8-b361-0fe27d68d6b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/032be1ee-c21e-47b8-abbd-dd08fc0e2f11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b12f9603-2636-49df-add3-3869957ebd56">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a89a889f-2e41-4845-b684-f2376015434a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/37a0b926-2662-481a-b9cc-fbf1500aff01"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b82e863e-3e24-4701-aa04-216217a6b9ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/ef2994c1-20d0-4455-8be1-faa1a3206502">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f901fa19-7fdb-4b43-aaff-981bb8a51af2">
    <obo:OBI_0001937>0.09</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d0e2fc18-9075-41c1-9d39-89cd3846b4e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7d40ebf5-bc3a-4c1c-8bba-6998b93fa0ff">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f90aa4c8-3cb9-4cd1-b32f-d63d4605c8f2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/5cb70951-3668-4307-9b64-ba9bb3710a95"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/d247dda0-80e6-44d0-b2eb-fccdfbf879f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/305956eb-a06b-4bee-b720-e11c935d0e64">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/498bae25-9842-4b17-a2a6-d988540fba69"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/513151cd-a936-467d-9dde-65f75e4372ac"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b1eedc52-448c-4752-9dd6-463f382d840f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/19feb8c2-401c-4c2e-9f7a-9f37f0d03dcf"/>
    <rdfs:label>ticagrelor-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/52819d27-003b-4563-ae9b-fffc0cfe6a0b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a3edc939-0ab7-44fa-9d2d-6e209ef1f3ab">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/bc950713-c9c3-41d0-840f-870b272fde2f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/3c68c3aa-5b96-4a8e-a481-22026d8122ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8bbacc7b-9a0d-4923-9331-b93cc37f2be0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/cea539c5-b8fe-4c7c-ad81-9bf539bb7db5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cf2f5ee6-d3cd-41a0-9f2e-69a7ad4c11c6">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f0ef881e-ee36-4d5b-a78b-62e692ae715e">
    <rdf:type rdf:resource="obo:MeSH_C040634"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/6e46828c-3eec-414d-ba15-c68d3744d225"/>
    <rdfs:label>sulforidazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ee815aa3-6848-421c-967e-c30abd6330ab">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e535b0c4-3b57-43af-a632-ee21ffd98a87">
    <obo:OBI_0001937>72</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/6dd8d23a-ebc4-4553-9a57-e269309e88c2">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/06d4f329-4f23-4697-a0df-de94f6d73641"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8a304211-4ac7-497d-9ab4-60e13a3a7c00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a826b644-523d-4744-9cca-8d23de776af9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0ddda011-8480-4e50-92fa-7edf2ea7cb6e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/9e41f489-15be-48be-9b7c-2995f2a3e13d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/bc950713-c9c3-41d0-840f-870b272fde2f">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2741ab20-aa1e-47d8-a3e2-faca5f198ee0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7a562513-da60-4f8f-b9a7-f18e0d8acd70">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2562957c-0483-4bc8-8643-a6e69a2e05de"/>
    <rdfs:label>Fosamprenavir-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/fa2196db-df3f-4804-88a3-6795dedf9a52"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/b23bb959-37b9-4075-989b-5f0f429df7dc">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/e79b69a3-a3c2-4e3d-82a7-1ab368f28341"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/18932f81-01ba-44f1-b20e-727d19df2a10">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6593649d-b4a0-4a43-ab04-a94075251a67"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c8953c30-9be0-4f85-af0a-8648397d2db9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/75e96d6c-a939-4349-acea-91282afdfd2d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0866c885-54ae-42b8-b21f-f46824b50383"/>
    <rdfs:label>nefazodone-haloperidol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3d7155cb-ba6f-4d93-b296-fe4977fb0487">
    <rdf:type rdf:resource="obo:MeSH_C060062"/>
    <rdfs:label>mCPP</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4470336d-c6ac-452d-b668-1dceabd5279c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e090e2e8-050b-40ac-8b80-318f6f69ff10"/>
    <rdfs:label>rifampin-zolpidem drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1a5da5c8-57ae-4492-b01b-4e71d29d43e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b5619af1-e5fb-4704-af51-3ee6042e8799">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5b38d096-15fb-46cb-8660-1386e7cdee7e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c41b9fb7-c651-4566-bd02-493590245bf0"/>
    <rdfs:label>nefazodone-buspirone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d61a649e-0581-49aa-8c3f-2aca59f0ed9e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c10d970f-4f97-44e7-97b2-6823d8ae68c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e849539f-3159-493a-baa8-2331e4e4123b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3cb66b1c-fd9d-4a49-aebc-94733002b5b1">
    <rdfs:label>Gemfibrozil-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6095ea22-f2f4-4920-8f02-2638311958ae">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c6dc112d-3d44-4518-963c-8a1c3886545e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ec2d525e-a310-4d3a-a271-3a2ab8b29119"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/612bd226-22e5-4966-a27b-cf85cc8f478f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/18b94449-1b9a-429b-8c3c-d77f8139d433"/>
    <rdfs:label>ketoconazole-eszopiclone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f0ce8810-6f5b-4ddc-89f7-5938f0cdb42f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e1077bbf-6f16-4605-b2d1-3e476728020e">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/720ff35d-5e90-4954-9557-5102f165a5bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/632a09e2-5c16-4d86-a55b-ad5133c226a4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2562957c-0483-4bc8-8643-a6e69a2e05de"/>
    <rdfs:label>Fosamprenavir-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/fd99ac75-8530-4d7b-bfad-f18f7be7e7a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/399514cc-6bb0-4c14-bed1-2ed1e25aa706">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/dd9e4f03-8ec1-4199-af0f-89b3663a84fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/bbcdc2e8-ed0e-4942-8402-36f50266f0b4">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/85669fe3-1e00-40d2-a66f-b60818b4b5fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d454d342-5e5f-41ff-aa93-6b555bddf305">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/665f0836-b32e-43df-9a18-b5d216440279">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0941ab47-1ac4-40f9-9ba0-60f08a57a1e8">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/281bb97c-e64c-4a53-be15-bbcc0103dad8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1e0044fb-fc46-4ad1-ab52-86ca4e19437f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d12a7e1e-55c7-418d-84fc-8205de63c9b7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c4edcb18-d707-40de-a8da-720bfd2b4dcd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3c875814-ce0a-463f-af83-fe4da7de3a6d"/>
    <rdfs:label>paroxetine-duloxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/9548ee35-54cc-4642-bf42-bb354564ab5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1f549da1-0b14-4b91-b2e7-3330c9410241">
    <rdf:type rdf:resource="obo:RxNorm_358274"/>
    <rdfs:label>ambrisentan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f040a822-f087-4e08-a028-79e05a3097a1">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b36b0465-80a7-4d49-ba76-ea58cb88562b"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4fbec673-4357-44cf-b51a-6f3f9ad032cd">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/18cba3cf-cc96-4e53-919f-4022d8ef8a44"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/97e96fb2-7ad8-404f-b6fd-b4875709405c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/bbba79e2-09f0-495c-b2b9-82fab0208db0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3dae5713-c9c6-4fa6-927d-71a53cd43086">
    <obo:OBI_0001937>65</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b0332091-0018-4258-af5d-ea49b3f0b9c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c2002fbd-9de1-4824-bcba-3b4c06e4d99d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fa39f4d3-c0bb-464b-abae-8d5b632feafe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/232a0ffb-2a03-4a83-aeb4-d4e3ef2e4a25"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/a63aee53-1cff-4da2-a7e5-fba5af74e4ba"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7791af1c-7cf9-419e-939a-9f94dc6d4e54">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/7e9d9735-28f7-4f17-b4f0-622401b1c40e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2995efd8-f564-41c1-9964-8aed5cde26b5">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/300c02b3-b53b-4577-9986-f258f7d46869"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/48ee56b3-7af1-42ee-836f-39cdc2ea87c2">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/d98c420d-2550-4b09-9136-306ca598822b"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7586e89e-5c94-40f0-8eb1-ce9d81f9a897"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/07072321-8abd-4cab-b7a5-9a425b21f4b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f32b6d6a-5d56-4b26-937c-c14b8f32c888">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/bba0a45c-2c92-4787-83a1-a4522f8ce1fb"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/6d2e7aca-4b98-4163-8f01-da8c9070fb98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/faaf4299-eb17-4be7-b330-e085982bd820">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/708028d2-bbcd-4f27-addc-91660471f2ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/588bc802-d4b5-4881-ba1b-7a34087a8dc1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b7eed592-0875-464f-9d20-a71bc7c26d9a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/d61ab4d7-aa7a-4099-a43e-947e6fda90d2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/04cf576b-fadc-4b3e-aaef-fb33d93a9489"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e16a4fed-eb5a-410b-9128-0d45f318584a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/81db41e8-afdb-4aa4-bcc4-55afed96477f">
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7e125144-76d3-423a-a62e-3cf7bb1cebd8">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/7f709b7a-facb-48d2-8f7b-e7ce5989ee5b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/003bb95d-b0ea-4a27-8fcc-9e984f6d79a1">
    <obo:OBI_0001937>61</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c6224d78-801a-49df-b653-5d08263fc546">
    <obo:OBI_0001937>28.9%</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/ec04afab-6192-45a5-b399-6eeb00587eb0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/8fe5aaa9-3d2e-435c-a635-5d3c22a474c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/44c936a0-c1ab-406e-a486-e0a6b365e7a1">
    <obo:OBI_0001937>134.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e4337801-feff-4d89-9e9f-0add1108a831">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/654da176-be7b-43a6-8325-31e9bf936c82">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1053cb87-ee5c-4d5e-bfa1-89abaae77670"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/4c681d5f-ece8-4152-8e5b-b798219e840c">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/25153fc3-876a-4100-947f-7c250fcf993f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f8acbf23-3fb8-419f-b9f4-5cdbd15e85dc">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ecee1874-3b44-478f-b3e2-8cfdc3c42919"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/301d6547-d5b7-4f47-9ba3-4e7c375c6395"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/2a12d9b7-156c-432e-9c14-0a22d9ca338c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8f56f263-79c5-4711-8881-bec6fffe8bc4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/312e55a6-3db2-46b0-a03c-3e4e9e4f4d93"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d0b1aae4-8cbf-472e-a11d-aff405677536"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e7932942-1803-4138-b857-072e25522841"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6d5d6985-1a3d-456f-971c-3cb7651a3e82"/>
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6712afe0-5a29-4ed9-b6a5-5b413140fb66">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5c949236-1a22-4e33-a18e-f388542c4056"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/a09225ad-2c47-4eec-82fd-7de73b5c50c2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ae4c62c7-0966-4c41-a5f7-252ab24cd003">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2e2e40d8-c550-46d2-98cb-987b3e53708a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/046c2935-24ef-448e-b5b5-d4f1ea718a21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ac5b6b15-0c2b-4108-88a8-83fb8da2b4c3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fe3b3c48-d8d2-470b-ae9e-23a7a5197d93"/>
    <rdfs:label>Gemfibrozil-atorvastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f32ff892-f049-4a44-a227-79b9916aa34c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b7292454-c8b2-4808-9ed0-13123904cf9a">
    <rdfs:label>Diltiazem-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/036c93e3-f9c5-41a1-a8de-cfd1deaf0328">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3fb627d5-d271-4db7-aea6-ad04778a19fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/26cb53ed-76b3-4228-a217-64bf8460aa01">
    <obo:OBI_0001937>41</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0740e7d9-21f7-4194-960b-21c4313929f2">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/c61568d7-6c67-4047-8585-4146d7245568"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0fd86a3f-377c-460d-a9cf-f338085d36ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6bcad680-f671-4122-8531-1d4419208b11"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/73085157-0fd9-4b8e-9715-3547f344c8ea"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2bca8b0f-ecd6-4786-8914-2306cef41880">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/00e8f002-d026-4275-9467-242d0bda18c6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e741eabb-0a11-4a65-a398-a8a2677915de"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/95372371-d4dc-46b6-a6d7-6f7084b2c4c0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c7e310fa-0193-472c-a248-98fb0af4b8a5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/164add38-af59-4f19-9ebf-cf09f245d055"/>
    <rdfs:label>ketoconazole-citalopram interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2b1f4ac1-e8d4-472d-a019-ad9a35a15710">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ee1349f9-515f-40d4-bc76-c6fb93654b33"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/cc504921-c736-4fa2-bc4d-ff44ad12e1fa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/3a892d6d-ba6a-4d5f-949a-5f26177c95d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/827c88d2-06fe-442a-927c-95e73794c08c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8aa1e308-04d2-4014-b6c0-5407b0222e69"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/a478af71-c88d-4703-958f-c6d07321df03"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4962ad32-df1a-42bf-9682-a29ebf4c8f60">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d6659e60-3f26-490b-9b7c-763cbffa8ad2"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/24e2a20c-8f6c-4b62-9904-886aa2a577a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b54b5e13-a6c5-4512-bdd9-a9f1ffb81c19">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6a3933ab-47c9-4897-aa1c-5df8e5ceb496"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6c85e8ee-ea5f-4cd4-80a6-5c821a06fc31"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a826b644-523d-4744-9cca-8d23de776af9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/406b0e3e-e006-4c6c-b588-cf1705e60a56"/>
    <rdfs:label>sertraline-cisapride interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/e9be0a73-ff2c-400b-b0fb-e0c6d51ece07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0ca88310-ec67-4dcc-a0da-b0a9cbcea1bd">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/aaadb285-dc3b-407f-950b-1f586a38a1ef"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/b6a05419-359a-41a1-9bea-52ec3b490aae"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/a3f414bf-2e4b-475e-9601-93c7fe2074e9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0378edc4-f18e-4604-b8da-eaf00e88992a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/9ebabe44-8202-442b-a91f-73c96471d5cb"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a5247d93-8665-48ab-97ae-0fe3a3672627"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8f664be7-37c4-4e92-bc0c-2cdb8c3dddce">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/1be58969-f778-41f5-ab36-6f196ef365ff"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f040a822-f087-4e08-a028-79e05a3097a1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/297b74ef-4146-482a-8265-b479f83d09ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/bc248f6e-1aef-47ff-b155-7d92a8b4a2ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/70cabdfa-c330-48c3-85c3-97f852e9dad6">
    <rdfs:label>amiodarone-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1ca2060a-70ba-4756-9041-7fe22fd007fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d4edc368-68af-4190-857d-277b2e0ad6c6">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/582ee33f-261c-4e4e-9d97-297afc84c07a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/224603c6-5faa-4908-a361-c8528fe953f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/785358bf-4860-4b85-b806-f839c3345658">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/a692a4c0-6047-4845-9af2-9a7d2490233d">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/ee329f32-dac9-497f-be34-40391a208ee7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b0ee67a9-0558-4c3e-908d-2dc73102e6ce">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fa7e33ed-febf-45cb-b502-3cddf51002e2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/06167574-a08b-49e4-83ad-8901886ed397"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1632c23b-1518-467a-b109-43578f3920e8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/92640a85-575d-4340-bbac-3f91efe614e8"/>
    <rdfs:label>citalopram-ketoconazole interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6dd024b8-5f27-4132-a998-07a3e7970957">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/57d367da-c2d0-4c42-aca7-dedb530359ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6f8c282c-1ea4-47e9-afe5-5d8218ffea4c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/31e44177-e848-4893-87c7-a2cfd22a2e19"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/046c2935-24ef-448e-b5b5-d4f1ea718a21"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/6c718a6b-d976-462b-bcde-a32a5e9cc41d">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/5e63f70a-8694-4cb5-8153-6d60cc773ab5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c7835a85-3022-4266-9dd9-0b68482db9d3">
    <rdfs:label>ticagrelor-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/109c0623-b643-42a0-b65e-5d227a04b6fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cb2e0372-0c96-44a3-b70c-c56c0fcd3e9f">
    <obo:OBI_0001937>.25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/ac2e7376-1866-4e3d-8bd8-af48a708fd51"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f2089b5e-b895-42dd-916a-d61a6b61017b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/30b63ef2-4597-45b2-b9d8-092120b97e84">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8a431fc8-0d34-4c6a-b96e-6a88af94d665"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e0cf3871-9195-42d8-a156-6c23cc62166c">
    <obo:OBI_0001937>20-40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/06600300-99e4-41da-bb8a-777ccda09c7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/58efc232-6620-49e1-ba88-1d0d34bc99f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/09c03ef2-bf3e-4ccc-b18d-f978b3bac9f8">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/55969c0a-f666-4df3-b2e4-35c176c41bc1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/4bbb14b3-f0c5-474c-b4b9-326c237e3b31">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/4e29c59c-5c56-4920-8f7d-afe8e727a801"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/6a97b4f8-a4c4-4440-bcd2-615b8f7db321">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b105eaad-f564-4ef8-9b89-9808e03207b2">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/d6e11ffa-35df-43c4-bffd-9e3b9131c037"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a63aee53-1cff-4da2-a7e5-fba5af74e4ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/998a5076-dc52-496a-b239-d773376288eb">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/96aaa8c2-1dc8-4c63-bbcb-8a71f7fc9ccc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/0e974a6b-41bc-480b-aaa0-e5196a6ba2ad">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/bfcaf589-d721-40f0-b5d2-c4f0eee3c7e0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b91858c7-5b21-4fda-b4f7-d21bcb513888"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c215f5ed-9f1d-4a44-b84c-0c1caf314f79">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4d32829c-4614-474a-b4ad-faa9b67f8150"/>
    <rdfs:label>rifampin-dabigatran drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f166ad79-4ad1-449e-b1a6-23c1c4f092c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/485c2263-cc61-40cd-b749-6effca5b5788">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/5e63f70a-8694-4cb5-8153-6d60cc773ab5">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/3d3afba6-46dc-47c6-891c-eb015cad35c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f6506651-a3af-4241-b566-9f315a69e334">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/8c2c98cd-3b24-4bcb-ab7e-da0823cad540"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/4962ad32-df1a-42bf-9682-a29ebf4c8f60"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/bfdb6ac0-1112-49cf-bb17-14e0d295e914"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0ab451ca-ca5b-4061-a962-b01b67751491">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/68e6effa-4569-41cb-a8b3-f8432f757cf3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/df7b0964-2712-4473-8983-5df1997ed151">
    <rdfs:label>ABILIFY-fluoxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6606acdd-45ee-44cd-9998-262266ed0403">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <rdfs:label>rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b7f4e9a5-cf01-40ca-b66d-db5c24738d44">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5cbdd743-053d-40d1-af2a-09ed6b669e4b"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3e8c605b-6273-4568-9e1b-522ea9e203aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/689301bf-242c-4af5-892c-8a10feb91bc1">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/6a97b4f8-a4c4-4440-bcd2-615b8f7db321"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/6e46828c-3eec-414d-ba15-c68d3744d225">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2084ca5e-f487-4abd-aeb0-67b405ed0ea4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/37041681-d087-427e-8359-87af1e370686">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b9bff2be-b409-464b-a114-40cca81b29e5"/>
    <rdfs:label>Celexa-metoprolol drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d518c7af-44fd-481d-ad38-220512a53181"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b3dd49aa-7300-48f6-8292-a177a1421baa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/55e6febb-8ed2-4f2e-a014-4c66eea9b2cb">
    <rdfs:label>BRINTELLIX-salicylic acid DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/40b3cb1e-b33d-4f6d-99f5-c964c4c30ecb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/11171ff5-12bf-41e8-a66b-8e395422a7f4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/09666b5c-e33f-4253-95d2-3e382f50fc4e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/cbaebd33-6691-4bf1-a2da-037da610dd97"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/f2ff7a7c-7d7e-4b83-80a3-07958c4ff013"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/8c995b9c-8885-4f0a-a226-8967cf4ec0b4">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/14fe77ed-8a87-41ff-872a-abaf20793ddc"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f03621dc-00ae-4262-8bd4-51e3b37ac039"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/f740e592-19ae-41ad-92a7-29ba8964e05e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9cd9f5de-6693-40b3-bdbc-3aeb4b7765fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f041a1a5-a0cb-4b81-befc-d4d7ce1fde28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ae011b91-6b5b-4a7b-9acf-6cd38f36c016">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0fc17cef-b479-46a8-b1db-77725bd35254">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/dbe8d42f-3297-479c-aae2-9861f99afb94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4ffbd2bf-bf22-4d3d-9ff7-8c2bfd2630c4">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/ba88005e-8fac-4fbc-b013-7baad3cca5ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/45012a0a-9e2d-4dfc-9a6e-c5bda62e1de6">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b02005f3-06af-45ab-b7f7-0afad78b7cd3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/28b0649e-3771-4a45-899e-77bd5539c0a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cc79bbbf-ccdb-4f95-ab9b-3f87de0575ce">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cc28fe8b-9753-42d3-be8e-c52baf1fe5c7"/>
    <rdfs:label>nefazodone-triazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4415c073-f68d-42da-8192-b9f0e98e993e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2e379e7e-36b9-47dc-b75f-3bf59ab6d887">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c473d3d1-1972-4e08-9b71-bc2363855e36"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9bb019f8-06ae-409f-a79c-ea4af15c41f1"/>
    <rdfs:label>fenofibrate-pravastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c20209b5-a13a-4610-8a76-e3a6bda9c303">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0b91328c-9589-463a-842b-fdc94905e118"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/25528eb9-d3df-4b4b-9732-e245d8419d12">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ac87737a-4ce3-432b-a2c3-222b5ac86585">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/341033ce-55c2-4ff3-9c74-3c962e6ca626">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2f0402d6-6888-4210-a097-42617e910e7a">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/47e49f6d-f15e-4bcc-99b8-e8c2a1a4b4aa">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c543821f-2db8-49f4-a51b-977189aeaba6"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eb1dad1e-df64-41da-be8c-668d407a0d97">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/97193f8f-f844-477a-88bc-959413df9a66"/>
    <rdfs:label>Fluvoxamine-alosetron drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/075e3a2f-19e0-4e65-8bf6-f1d33a66586b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a77592c1-b2fd-49ba-aa11-781150c37f10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cdab9130-a3e9-4b56-8ec1-f51b22c0e977">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fbc38c28-e69b-4b7b-92ad-e7c8f99b1c39">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/7819ab85-350d-4bfb-a81b-928cd498e0c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/76021b57-24a3-43fc-8d27-15fa50f38c9a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/89c3898f-4e86-4db9-86c6-3b9445871c11"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ba98a724-c325-4362-b120-21d9c7c3effa"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/dd5e2d84-c687-4db6-8855-08e7895c37b0"/>
    <rdfs:label>carbamazepine-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a9de0538-05b6-4af6-a0ec-9a72d503b55a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ca27d23b-623e-46d0-8b0d-028c6a14096f">
    <obo:OBI_0001937>67.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/611e5601-478e-431d-916f-7b53e533f4bd">
    <obo:OBI_0001937>750</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/20078381-9107-4e1d-9eca-78a4acbcbc24"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/3dee7c6c-d376-49f5-bb96-6d1fec1b65b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e4d8f5ef-87f4-4b29-9efe-c94904812c50">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fe3b3c48-d8d2-470b-ae9e-23a7a5197d93"/>
    <rdfs:label>Gemfibrozil-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/028aea1f-12aa-4554-9d35-df042ccd555e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/ffc1b1fd-5d78-49e1-8cda-b5ffc1c3cb2f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/90febc13-1a54-4b01-a88f-880c442a6873"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/db09a046-52a4-4eea-a6f3-5743150f456d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b0fb7c5c-4b59-4a97-a362-9bd17d286b54">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/38236ae8-3490-408a-8db4-e5083567a7b5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/0612485b-9041-4506-b085-d56c8ec1e53f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/419bc65d-6f49-449c-99f2-0e10bfe8a3aa">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b7ce3bde-d894-490f-8add-33c72d487d5a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/1e6ccdbb-4d02-4e95-a589-39c3166c4879"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/2084505c-af52-4775-b605-da1f894a1d33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bc7a4a62-6267-43dd-934d-82ca5a5ac532">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/35e150ea-bda8-4513-9cd4-768b68afed92"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/68960a59-23eb-4a8a-9a86-ac646763c882">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c243c723-607b-4060-b7dd-1947e2b95772">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0ea6f548-1741-4f83-9195-fe4a86244c72">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/243c0427-1441-4770-b4ea-233c02bb3000"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/6ff392bb-cc78-483f-b806-7235b47d0739">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8f81d889-67a4-4bc2-8f08-d487df2fcbf1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/aaadb285-dc3b-407f-950b-1f586a38a1ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3768c93c-d554-4fa9-9bfa-d7b25e46dadb">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/26aeaf0c-ec92-466e-98ee-742bd73a8059"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2f4425ac-56be-40ba-9537-fc458dd28c9d"/>
    <rdfs:label>fimasartan-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/eb4e0d26-60b6-4917-81f0-ea195c6c8302">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f30ef31f-2c9f-422b-9b61-5bdc18811f87">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9052bdcd-4c65-4465-ab8f-dde52e21c6e9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ccae0bc0-3bb1-4cf0-93c3-ae8943e6be7c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e85669c6-be95-47dd-b8f5-aff4d6672414"/>
    <rdfs:label>ritonavir-threohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/75c42cd3-9893-44f6-bbf0-db93004531ab">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/7e1c4642-4116-489f-8694-e97e17490c29"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/8f69d5c7-3a16-4c53-8fb7-8696dea0b170"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/411043ce-be82-472a-90d3-fb0542c95879"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f964441c-3fc3-498a-aa14-ac9a4568c434">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c7a939dc-85a7-4ffc-a001-171765c2930d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/900b978d-c7ba-495f-8b32-279c477bcfe1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fe7df114-1cab-4a62-a94b-efb50ea14a09"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/03150a6c-c5c4-4430-880b-a573082c0b37"/>
    <rdfs:label>nefazodone-alprazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b1b85a9f-735d-4784-bda5-5506c76186fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2a64edb6-0359-4c80-8ff2-d4fd099af379">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e718eabf-4755-48d8-bc0a-78056f325837">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/98b2d0f7-0b37-46dc-b920-36fb4bc06d0e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2127675a-d54c-460c-9d60-fc5f2dd71cfb">
    <rdf:type rdf:resource="obo:MeSH_D014859"/>
    <rdfs:label>S-warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/67452058-ab1b-4335-8938-f2b42f891c7b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/65dce9a8-feb1-4558-9461-c2be2b2a4a41"/>
    <rdfs:label>nefazodone-simvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d6e2e03f-cc18-48a0-8e10-a189b231087b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/eeb4b9b1-9ef6-43ca-88aa-f20514225f1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/14d694fa-cc50-42a9-840a-3c17433406b3">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d2124407-5648-4ceb-8043-1da8a90d56f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/384cb342-97ea-4c7e-addf-a2c044fd7385">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/32827b39-9223-4416-98b8-a91729488e89">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0f5aadbd-e7aa-4219-9950-fb664fe4b1a0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/54d9b4e6-22f0-45ae-a5ea-7f94fdceea3b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5b5fe4b2-bc09-4df5-bb7f-a3aaa449ac6f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/73b7014e-9d1c-414e-9539-ea8aa8bd6152"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/7bdd45f3-51f8-410b-81ce-168dcb9fd9b1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/620a0980-1a19-4921-bbc8-dcc5902f9494"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/aeec40d9-c97a-44f6-b4ef-b40cda3db263">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f07f6e39-93bd-4228-b2df-72a42d9fd482">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/dddcb370-af6f-437a-a771-93ff8fb8fd9b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/9b0377c1-c6fd-46fd-b540-46da2c2e03fb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fe04341a-a0a1-4792-a459-5e126637d775">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5346ebc3-1e80-44fc-8721-95afd9ce1041"/>
    <rdfs:label>lopinavir/ritonavir-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b1eebff2-aed5-4391-af88-6421f3424863"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d5329057-f479-4346-b8d2-371223416e4a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/11171ff5-12bf-41e8-a66b-8e395422a7f4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e849539f-3159-493a-baa8-2331e4e4123b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/88f67ca1-99e2-4c31-8a8e-21773ef629e2">
    <obo:OBI_0001937>2.5 or 5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f311e45f-5896-4648-8224-6df4a2e6cb34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b1e03bb5-4240-470b-903b-92f378cfd446">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/59c3adbe-8e65-4668-aa4f-d8b88f34e134"/>
    <rdfs:label>buspirone-mCPP drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d8b02527-47e4-496d-95af-e586f6423961"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/243c0427-1441-4770-b4ea-233c02bb3000">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9b989b61-ab8d-4a1a-a801-0f591ed7b8ee">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/77911102-c58e-498e-a505-d0b90af3cbc5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c781da63-54b0-492c-af19-14a58144ce00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cfae3dcf-1cc2-441f-81a4-56281cfb785f">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/52a4bb57-faa8-47d1-a9b4-b33a317cba22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1847c4d6-24e2-464d-8012-5d2ab4d47b3c">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/30ebd72e-a5d1-4750-a8fe-44b123c3fa56"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/871f2a84-a2e8-4c3c-a2e2-5d5a170d3a19">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c3e87dd3-248f-41c1-a371-30b50f6a2e39"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7c510007-a6ec-44a3-83ad-5b0b90c70768"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d4f92a66-5339-4000-8f1c-221e461dc9b5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3b0b3596-3b2d-4f3e-a3d3-86f491ab09e1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/760dbe28-30a7-4bd4-8481-c2998ffccdea"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/b191fd3e-c175-4167-8eb7-8a77a46ef198">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b1b6a239-29b5-444a-91bf-e23357a56149"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/faff94e3-f929-48ab-b360-1930016be36a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1ed45d39-86e4-447d-a2b5-73398cd581cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fe7df114-1cab-4a62-a94b-efb50ea14a09">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/51e65a77-e7e7-4534-9958-f261386c9ce4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/a14e3229-55d6-421c-9079-3f205fbf7dc7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/6bdafaa0-30ee-481d-b028-f905d8150660">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/65536bff-f9a4-425a-8b69-c883c00e39c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a3fcd0e8-8da6-4459-849e-7a949912abf2">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9f2d335b-e534-4cbd-ad4c-b8c3ae32e315">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e3659905-b95e-4877-b0ad-de7bf0c352ba">
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/63ad08e9-8654-4b0b-a88b-1b5573d77231">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/67375ca1-a6fc-4921-a828-d5a7274aaae1"/>
    <rdfs:label>nefazodone-triazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4e573cab-6832-481f-8d06-385784870aa8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a9e9c432-d8f5-43f1-a61a-6d34d0a528ed">
    <rdfs:label>erythromycin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0e398653-2f6f-46fe-ac0a-8411497e7373">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/eb73e100-a009-4a90-a0e3-12c09b5ecfd7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/99dd4ddc-0696-4fe0-b6e1-70a4804bfe7f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/be2a38b3-581c-4916-bb7e-77e667a14066"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e18b4278-9317-47ab-a4f7-c65f33fed509">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/955dcc76-59a3-4851-8fa3-aabca6a3f25b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b8153947-2189-416a-a07f-7d08e39a445f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/d39a4203-3f14-4f56-b824-dd4f18264694"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ef6a2483-a9f1-476c-a507-c92a1dc4f4bd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f04facf8-bdab-430c-89cb-33684fa2cbfb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f2828dbf-1d16-4475-9291-a2d9fb7ed048"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/28ef9fe7-20eb-48cf-8cfe-7249840ad9ca"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4e9ac79c-1779-4461-ac9c-1a93790e736f"/>
    <rdfs:label>paroxetine-atomoxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e2dbc87a-19c6-494d-a956-985d48d5388e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2f773e27-20de-41b7-8684-b0191744dc2d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d0f1dc5f-853e-4551-9e89-241ef4cb87be"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/2c5ea276-a81e-46bd-a2e9-6647f4be790d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7c135798-d20f-4115-8a0d-3ce2c38e601d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a77099d4-75e7-4ea8-8cc5-5db086d68f21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/04a56965-d694-4e7d-9877-5e63e7cedc69">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b8a6cfbc-cece-4a87-9fd3-71a9984a59bb"/>
    <rdfs:label>duloxetine-warfarin drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d4fd9eca-bd7a-4fae-8cca-90f8ea28064b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b3aba74d-0983-4cb6-a54f-c65206c7191c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2f6a8f64-e63e-40f8-97cf-bb3dfcf00889"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/2574056e-3607-4476-84f5-b99d6394e1ac"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/6606acdd-45ee-44cd-9998-262266ed0403"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/fae19b28-dd38-4830-9760-fe0323068824">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/80d9d8e3-62c9-4de6-aefa-7c7856742a36"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/0c5ae7bb-9027-45c8-9cd5-219a3a17b1c7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/e366da4c-fcb4-4fdb-a22c-9e91f002a9db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e8ebac1e-e293-48a6-bdc8-33d9b4f7b744">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/009169d6-a444-4c17-a92e-2b4559f9e5ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/7f709b7a-facb-48d2-8f7b-e7ce5989ee5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1699dcc6-4bc8-4705-92f7-1afe8890d3ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0e2be841-27ca-47a8-8dca-34bcb3286c00">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/dcbb609f-79ee-4ec1-acf1-9c899f6c4a1d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c39c91ce-506b-4b5d-827d-9f20396e43c0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7544f71b-db4b-4e88-8e27-71210a6472ba"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/483fc526-6018-4371-ad94-992fe1b3c00a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/959b22b3-7f15-4884-90b9-74cec7ad1e26">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fe3b3c48-d8d2-470b-ae9e-23a7a5197d93">
    <rdfs:label>Gemfibrozil-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c7a094e5-7bf1-4422-b716-6b3cc9e9f5fc">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/f288a9d4-0885-4bc2-988a-51cb0caf4b47"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3244fce5-7b50-47d6-a851-04d83ca897ea"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/fc382fd7-a792-46f1-99fd-05211e8fe92b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/97685eb5-0963-4761-ad21-ee7b0735ae21">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4f285cd2-d398-4766-9853-7db8029b750f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0fd86a3f-377c-460d-a9cf-f338085d36ea"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/80782e83-e907-421c-9fd1-62c59aaa69f6"/>
    <rdfs:label>S-warfarin-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6e40a15d-67cf-4fc0-a8e6-df3d8516eef3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/48855b1d-4423-4fec-bd20-1cee118c7592"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/30da640e-fc99-4e84-a293-8aceebdfde06"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8e75f62e-657c-4c44-8ff9-643e8274068f">
    <rdf:type rdf:resource="obo:RxNorm_734064"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/11f1fa4b-a20a-4761-8cf4-3891ca914630"/>
    <rdfs:label>desvenlafaxine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f6e2f8eb-3f85-438b-9915-d50da86d89fe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3b8297a9-3c75-49c5-9514-6bb8e9140423"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/21418ee9-611e-4abd-92ee-9477936f9ef3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/5525ddda-02a7-4cde-bbe0-16c3fbb7aca4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/89b4cfe0-c4fb-47bd-86a5-1269ed9a916e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/a77099d4-75e7-4ea8-8cc5-5db086d68f21"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/53723908-a5a3-4b9c-9bd1-92f33d751a77">
    <rdfs:label>fluconazole-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5f5d175c-5802-435d-9e69-1ea9aacb73aa">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7b32b9d2-5e9e-414e-bae0-c462a2167648">
    <rdfs:label>fluvoxamine maleate-propranolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/691ed5d3-7b1d-4737-a365-628804d5d34d">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d81a44e2-e9be-4120-b36f-bff1a69100cf">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/28933684-db59-4813-ac8f-15f12e82e5b8"/>
    <rdfs:label>carbamazepine-methamphetamine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a7e5c46f-6012-455a-804d-906d132b4513"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/632b79de-919d-46c0-908f-c4d523983986">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/6f5c52a7-9dbd-40d7-bbf9-91ddd9ba7dfd"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dc3da98f-f731-41ba-834d-de94eb661f9e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5017d2a2-eee9-4e4f-b9c8-32f56e803444"/>
    <rdfs:label>rivaroxaban-midazolam drug package cmax None information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/92894203-0ff4-48e0-a668-683481fa5f98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b26fe61e-a2ee-4ea2-9ab9-45fd84661519">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9b624909-121e-4214-992c-07a0e32bbb79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f023cc54-9607-45a8-97d7-1f97f59564be">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/cfde3535-1041-43fe-95e3-e0429e78ab32"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/21fb8bdb-a6ca-4e97-a49b-002a2116cfd4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/cf92a655-027a-4385-ac30-60e05e3dd8dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/252f5f67-62f3-49c1-8bee-b4eec7a36c07">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c449b739-921b-47bc-9f7c-b60c078ac3c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4eba9ac3-9f98-43b7-83c3-641c9960c053">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b925a2ca-d1f8-44e1-8aa1-dc55c8dc0a8e">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/d40c8c9a-aaac-4eda-bd11-5e0726eccc71"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/31db9f3a-25cb-4ab4-b8d3-fa2b3285286c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6a36d1d0-0708-4b84-b501-07c9d6de038c"/>
    <rdfs:label>aspirin-rivaroxaban drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d71b9514-3371-410a-a1c2-9656fe506337"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fd6637b0-c9cc-41a9-90aa-841608bfa4f9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/43637599-0968-4d2d-803f-466c0bc4bc3c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/9ef5b6a8-7abf-4847-9ec1-2c20d86ba246"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3a04f565-b18e-4b7f-a554-aeb2d6542ea1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/1c471756-70e6-42fe-a689-3caceebdd670">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c68de4be-2ce2-45dc-9413-12fa8a75fcf8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2e26f2fe-1a80-4b2c-a8f8-eb1c86691fc5">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3296ae8a-88f4-4a8f-835a-062b2f5a8704">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f4d7310d-a582-42bc-bf3a-493d7610790d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e2d97364-693d-4258-a920-09d56550c5cc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/506786b7-164f-493f-8ed6-99214686e56c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4ffe111b-27e7-4e9b-a367-c06dbf26ad4d">
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/50deae25-b381-44a8-87c0-7901e2bdc67e">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/9a766f53-5b0f-4a94-aba6-daf269398cb8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bf846dfa-36f7-4260-b868-0dca0183787d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/265008fc-448a-415e-a2a8-e721694933e7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/1fd222e6-37d2-4797-b12a-fb88627fabce"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/55a22067-73f3-4ef4-94ac-0a525c2f17f1">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1b558e97-bb61-4e05-a5a7-bf779ff3e9bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a79b9057-478d-4a37-b5d3-b58af6b536e6">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d8bec01b-ba75-4a78-a604-d596f8a3eabe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f0a8e787-5029-4925-81c7-e3d1305161d4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2e36a2d6-eb1d-4c32-8505-44729acdc747"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/699efb6f-2521-4f85-9cc8-3909a2792b76"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/49117207-5417-4563-b234-953b592ebc45"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/13419dbe-ad01-4eae-bd24-e9a45cf6a69e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/cc29632e-7ebd-4cb1-8f8b-e484c82b917d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/415e6cb1-00b2-4ef0-b123-d6a311e0bfe8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/f7e2049e-0920-4587-9459-1e27df245506">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/67b8e8b4-7b3e-4d96-a735-148187d1d03f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/857a9605-ad35-44a6-b99a-a354c9fb2196"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c66ae96c-7d8e-4417-8080-c9d241736ea1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/0f6c6f61-45bf-4558-bbf1-e4f59454105a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2a6543c4-cc78-4cfd-8782-a1022fe8b5b8">
    <obo:OBI_0001937>129.9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cfb6ea7b-0ad2-4fe5-a8bb-c309ec869e7d">
    <obo:OBI_0001937>7.88</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/092b8925-1526-4f54-834c-499bf6fd23a1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/430dbcc4-484e-4f7f-a5fa-0055c32a46a6"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/90368d8d-775d-4ce8-b685-439f3e27486e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/c9806324-d854-4aee-85c1-096dd980ecc1">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/4b8ab8f3-8e21-4587-a535-3dee8927e9cb"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ea0a9e10-9b9b-4d63-b408-aed2694500e8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/c618d455-83d4-4504-8f7b-27f2c914ffbe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/21a016a2-7a61-4836-838e-e191ffde122b">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5c1a5a69-0686-4cf1-a074-81582fa3712b">
    <rdfs:label>Cyclosporine-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/70e557fb-f4cc-4af6-9789-30c4d56cd49a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/19f43838-ae5f-4d22-8748-12bf75158b31"/>
    <rdfs:label>ritonavir-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0674093c-d916-4d2e-bf0f-6d7e47800fc5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e45553d8-df82-4d15-9844-f61a1c15eaf9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b89d34d8-169b-4681-8e59-bf1fee7e1d77">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/c76e8520-f6e0-4f12-8dbb-969de23a2704">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/650da3c6-cc20-4a18-805d-63f7f5f92914">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/e87e01b7-1775-490e-a4c2-5cc98cb2d4d8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/51c9493c-3b39-40a9-902b-d4c17eed116f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9d483798-fe98-4ff3-b380-f7b470b64888">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/dd9d7b4a-6889-4631-b925-8869c548265b"/>
    <rdfs:label>ticagrelor-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3dad1bab-98e0-4408-8e05-133ff10e8fac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b7668901-96dc-4512-8c74-8b74657e1a22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/dc4b4f54-ec47-47a5-832d-837a918d2978">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dbc05749-6703-4576-8c00-c3b7cdff6bb1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/842fb6ae-653a-4e80-b9b8-7d2ebab84cc5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ec47c0e9-044f-4811-a012-147ea13d9e4c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c0b70277-d488-4053-9cc4-828164d54f1a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/87280165-1d55-4f40-929b-5858f0bac0ed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c87876bd-be57-497a-a85a-49da346a4060"/>
    <rdfs:label>ticagrelor-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/3d3afba6-46dc-47c6-891c-eb015cad35c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/6a78cc77-d27a-4a74-95f6-32e15be3678e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/04ab1455-2f67-4c1c-adb0-2a27ce869a90"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/1eccefe2-cfc2-43d9-98fa-a6f776211a49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/000c5ecf-1577-44a4-92d3-8fe612d2f6dd">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4f8c08ac-cc6a-4412-bb8a-238a6f6c2dcd">
    <rdfs:label>desvenlafaxine succinate-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a2432360-24da-4ab4-a088-41c56b10c15a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/ab6551f3-3c2b-4ac7-8756-cb8c2181a580"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/aa053813-059e-41b8-9e0d-c8ed0e21c15e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/19dc76ed-8c11-4cc9-9b91-7cfcb50a5296">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a34f8c80-a99b-4700-a238-934084c6976a">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/a400a687-0f27-4037-8c33-edbde920eb64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7f68e641-486f-4759-92fc-e696ccac586c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/22803a6e-a569-45c4-846e-2ff0b08e52fb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0b63425d-bbd1-4767-a82c-795487c041b8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/b26fe61e-a2ee-4ea2-9ab9-45fd84661519"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/bea03b8f-f622-4d68-99f6-3b6d5bb6cd75">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/7a69520d-a869-45bf-9d4a-d973e1c4d0b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/20dec8e2-8d0b-48f5-923a-105a38b07fa5">
    <rdfs:label>escitalopram-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/513cf7f6-cd25-4dd7-9e54-f7614dc14b50">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6a50a97a-674b-4fe8-9e75-2daaa564fbb1">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2fd4187d-a330-41f0-bb71-73150d25dd4c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c83822f9-5495-41e1-a4d5-5ca32ff80fd2">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/5ea6cc03-949f-44b4-8dd9-f7dcb491ec6f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/11420c0b-95cf-479b-8f26-0ee7a4509b42">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/242e2398-0e5f-41b7-91bc-971029ac2605">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c6ca4c1d-a062-4e0e-a0b8-f3489896335d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/5cc0acce-615c-44f0-bdf3-055791802e9a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/faff94e3-f929-48ab-b360-1930016be36a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/2127675a-d54c-460c-9d60-fc5f2dd71cfb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/92de4de3-a5a4-43f6-a4f0-e031d7f34c07">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/461ababc-a372-4860-a8b5-2170942b6e17"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/bb3d4b96-2156-45c0-a27d-4f5adf708ca8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8f32fc4a-d9ed-43eb-93dd-7643742e9965">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8ff9892b-2ca6-44ba-a958-ab39e4046a87">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3de2e8f6-e6b4-4f9f-8479-e684e041b6bc">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/93005775-a2c2-4bf6-ac2c-faa60582a052"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/82441e73-e2bf-4614-9cb4-04aef95db2df">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/82d15239-3da1-4b3b-9495-dbf48d0dc7e7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/94e2b2a7-4ddf-4d0f-a576-17ff6101298b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f2348e38-9633-4709-bb08-ba6905b01fce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e6017180-eae7-42de-b525-95bdaf93170b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7a7c03a4-e3ae-4fdf-af9a-f44de8271663">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f566b09f-723b-4cee-b88e-4ca2950c6ae1"/>
    <rdfs:label>carbamazepine-selegiline drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0cb16428-c1a9-425f-81a9-a029d06ee8fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/395e5d0b-e2a7-43c4-a107-a197232a0a0b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/96c545ce-ac74-4900-99d3-6ce0a28ec25d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dc3da98f-f731-41ba-834d-de94eb661f9e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/561f5b16-b3b3-42e6-b253-e73b925769de"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9e9c2075-eb8c-4fbd-9497-4d008de399fa"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7b5314cd-df04-4131-b79e-07248ac943d6"/>
    <rdfs:label>rivaroxaban-midazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a97be386-77e6-40ea-b86d-a6bf45ba9166">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0b853b29-717b-45af-8044-ede8744e6f91">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/db09a046-52a4-4eea-a6f3-5743150f456d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/d65b4e66-e67f-4c2d-88f0-08e82adde3b2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/e8774ea1-648c-43cf-a667-6fde5def8eea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/94f0db01-266e-4e81-8c8b-18237eb346b7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b91858c7-5b21-4fda-b4f7-d21bcb513888"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/71223b03-9c73-4246-8226-b2f60f718c62"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/0a323fd4-a7fc-4247-bca5-a4f3aa2f4d36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/36bbdde9-bcba-46cf-81c5-f531f9bde193">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/75b32ae0-69dc-4930-9168-55c97c78123c">
    <obo:OBI_0001937>2.79</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7a8436e0-4dc6-4a49-8197-72b1dec25069">
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/95d3df2e-8821-42e0-ad5a-1ca42ac5d1d9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5b5fe4b2-bc09-4df5-bb7f-a3aaa449ac6f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/21ae1efc-77a6-4847-a3b6-e5db2dc53232"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/41dc76b0-d7dd-4910-8d14-1c4ec47a0d11">
    <rdfs:label>Efavirenz-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d3810190-ee44-43f7-a915-3af26a892742">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/d8b507ea-5181-4849-9925-6c0f8b3f66d3">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b4c2f4d9-9baa-4039-b253-67df761923af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/232eb0fa-6d68-47f0-84bb-4b4d203e79f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d8c5b927-2445-463b-933b-d8186b4994c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/be7db0b7-72f5-4796-848b-58e32dbe04c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/22ef554a-416c-4917-8478-9301708095fc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ddc6b33a-1034-42a7-8886-6db208aea1af"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/da275fc7-408b-44b4-a2da-b78925621783"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0ffa9899-a66c-41c8-b905-56743ff05472">
    <rdf:type rdf:resource="obo:RxNorm_5093"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/1a2d4f45-3342-4ef4-a41f-d3b7638cd0ea"/>
    <rdfs:label>haloperidol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/dbfdc63b-b514-4479-bdbb-7170371457f9">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/48e0cca1-4eda-467c-a11d-bd06b1668720"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/d5744a31-624e-4922-b068-0bf47379b80d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/572601f8-e4a4-447a-b306-cd65a8fe77b8">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/754ae681-a47b-44ca-ae67-6010c219bcf4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7b489cbb-2a78-4c66-8aaa-9de464a42938">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0114d786-fe0f-43d2-95d8-2c2c943136ec">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b8df5d8e-f2c1-4cf3-a55f-58f8a7b1f1bd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5980ff93-ccd6-4347-973d-3d663f54c282"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/85a93e9d-9c46-40ef-93bc-740c9d6a8c2d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/84cf8313-9b4e-4ba5-832e-ae6278014ae9">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bd71ffa6-b68e-44b5-b0f5-deef5282a386">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f4b839a6-c88d-472f-b317-860d11cef106">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0506b075-0604-48d1-9574-20d38c797c37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/6d8688cb-7c76-45fb-96e4-f13a0178ab4d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9b624909-121e-4214-992c-07a0e32bbb79"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/672ade70-6e04-4194-8867-61b29a3753a1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d951852c-d029-456b-9b41-3c709c27b4cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/066ef4f0-7a29-4f51-9025-d04d76d3a83f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fcc33416-2fc9-46dc-8e80-51a3712e089c">
    <rdf:type rdf:resource="obo:RxNorm_21212"/>
    <rdfs:label>Clarithromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/14ad3942-9f0a-45fd-a5db-48a2604551e3">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/8740f11b-7842-437f-85db-4440cb3e118d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/de5a6249-d189-4804-bd13-a1fd4f6e3faa">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/0493bdb2-8b3c-423d-929a-540fd6fd33b0"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/648dd108-3faf-48a8-9a66-b6cb272ffae8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/82044cbc-0726-48ed-b284-ea06f38f9fa0">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/07923610-f593-4b77-80e2-e41b8d4e45c5">
    <rdfs:label>efavirenz-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/abc11a13-c38c-44bb-9375-c32c31650adf">
    <obo:OBI_0001937>9.36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/616dd07f-c6c2-4db4-ad0f-bfd04619e8d8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/1954668c-af4b-493e-8c20-da319285083f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/7d5c04d0-54de-4c4e-824b-55ea039f119c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/232eb0fa-6d68-47f0-84bb-4b4d203e79f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/537febb0-2fba-4a94-a622-870fcbfbe45f">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/1a677d3f-7189-4a39-9062-6f09a8679918">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2c5e76a6-f4ac-4a1b-9b1c-566ccc45cd9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/28a1202c-7c90-4394-a083-e79b5977041c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8dadae02-6d1f-47e8-8425-a8b4ef30f24b">
    <obo:OBI_0001937>750</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/d55e3d03-4372-4d4f-a13a-38191a2276ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/91ddb120-df34-4638-9448-4db8a3b5f51f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9ca2fca2-baad-4db3-bc82-6c0014285679"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/4e7495ec-804b-45ec-9f30-673772862d3a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e3bf4399-72df-4a32-8059-c87b058849eb">
    <rdfs:label>mCPP-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0f5607d5-e80a-45d6-9999-d8e7c1812b98">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/4ba4bca3-ef31-4e85-a158-bb41b4c494e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/528cb9c5-485a-43f5-918e-75d18225e8d6">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/fdc9e75c-898d-43fb-b76d-41b2c0645ba4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0540bd19-c4b5-4870-bbb5-b62b1bc8a050"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/6e7ae312-6eff-4681-a7df-4511845f37cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bbfb3a5d-c453-4d9d-9447-92a729bac7f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4648459c-d94e-48c8-bc75-b2cccedc861a">
    <rdf:type rdf:resource="obo:RxNorm_8183"/>
    <rdfs:label>phenytoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3a252341-89e7-4e21-8fef-a24c71474d76">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fed4ebf9-ab70-4874-a95d-0bd4c865cbe0"/>
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/15bf202a-1c1d-4d16-9b48-81f2e1d34342"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1d42081e-2228-45ed-b0fc-4384e364659d">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/051e91b7-ea70-4f93-9c65-575dc5108c87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e8774ea1-648c-43cf-a667-6fde5def8eea">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/da3cef89-ab21-464a-a6d3-d0786c30240f">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/2ee61a39-ec59-40a8-839a-e2dc11f8c87b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/db9e74b6-d96b-4f85-b518-4b39b70d9828">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f0a8e787-5029-4925-81c7-e3d1305161d4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/dd6755fb-4378-4dbb-9f53-b412483aa00a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7e9c6f07-0339-4245-8e97-b422b4d8e9ad">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/19d03e70-8ced-44c2-8bea-6f7972cd3a54"/>
    <rdfs:label>carbamazepine-INVEGA drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/81db41e8-afdb-4aa4-bcc4-55afed96477f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9d253e6c-df12-4fc1-bdee-d70ebb555784">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c02041c2-85e9-40c1-99bf-8df9766f1155">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a6b74bc1-33c3-45a1-b55c-2aab4b7c7d5d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4f61214c-412b-4b0d-a11e-0d31e749547e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/cf750a56-054e-4711-b331-bbd3b2489f27"/>
    <rdfs:label>mesoridazine-Fluvoxamine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0f44868b-518b-43f8-ab09-21a1467e2777">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8b41753b-3049-4f24-8d74-967d6bc47197">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
    <rdfs:label>high-dose ASA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/cfb8301f-4204-40e6-8f98-4896be4ca62b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/208cf6b7-9f1a-4273-8bfd-9071928a14fb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/1e446c54-2aa4-4e54-aae1-2f50906bf7bf"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/89816a9f-fcc0-45bf-aef4-e15168aa42ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ea0a9e10-9b9b-4d63-b408-aed2694500e8">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/98502d5e-6cc7-4ef2-a6d9-2644898361dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f978a7e0-856d-4452-9d08-d1fcb2c88efa">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/28399945-2bb8-4a1d-9674-987ecf6317a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/e9274d77-bc8b-4213-ab8e-eaa9ff403ddc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/9a45265d-9100-46a7-b47c-5871aa698b29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/37a0b926-2662-481a-b9cc-fbf1500aff01">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/12bb1d5e-096a-4fc9-a4cc-b0e4e9170361">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/51dcb979-afa1-42bc-8f4d-2cd8f097cc70">
    <rdf:type rdf:resource="obo:RxNorm_3322"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/4ba478e3-ef08-4841-971f-94236c0561c1"/>
    <rdfs:label>diazepam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f9d255e9-5531-4554-8812-ae87c5e39724">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/592af8b8-0658-4af6-a2db-23760d022878">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5095c52c-0c15-4120-a73e-2e029ad805d4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/9d68b7e1-f43d-422c-be00-3e038b68df47"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/590a55b2-4bed-4841-98e3-b79ed7f1e0c3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/97dae30c-fcdf-4747-896e-8c5c869bca0f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/dc6aae1b-b3e5-4001-ba46-a626c2f4ef57"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f2cc87fb-fa87-4130-9df4-eb6dd331c352">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/db8b837b-7ab7-4112-83a7-747cf8fae834"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a2cbe4db-2c63-4c33-8379-71f7c3cd0b25">
    <obo:OBI_0001937>1.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a66f2bfc-67f9-497d-bd02-ff9d472078d7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/459d7c51-51aa-42e2-be10-e5e0d3539ef9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/97831ed4-583c-47c4-bf26-509df67a102c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/279b69cf-198c-4846-b3f5-b859bbe28b73"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1920bf38-a694-4f78-8865-2004cea2c6db">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/5a300901-3ce0-49ce-8dd6-c4d7ac486143">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0a8967db-6230-474a-99d4-3be5c654a2ea">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/7dabeefc-a0fe-4f86-9ac1-3c704b9dbc90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3e075f13-2caf-43a1-a83b-de384e5a146d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/629b6c15-8f58-47a8-b9b9-2a2dd22be63a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5fea5a92-acba-435f-8ce6-0704f7621fcc"/>
    <rdfs:label>fluvoxamine-ramelteon drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/fda354e9-5034-43c9-a442-e1b498108fed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/af22c24a-4469-4147-9424-027abe0f64e3">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/170c8a23-be86-4856-b86a-adcda8853595"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/16a80745-29d8-41c4-b793-6870a8dad90e">
    <rdfs:label>Fluoxetine-olanzapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/406f0989-b197-43f2-adec-014f35b64c4d">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/22d7c04f-d1b2-4caa-9523-8c896db375e9"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/35519b5a-774c-4f41-88f6-db8123811773"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/27dd6778-c5dc-4105-ab82-059e58badac7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/31070c4d-54a7-45cd-9962-5976055733dd"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/b454049f-48a1-43b0-9eee-59243294b4e6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/29f8f69c-23db-4d38-bd65-3b9447eefee3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a94d0894-f2ef-40ea-b6a1-4d0a9b5f9c04">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/838e44e1-5ef5-4f0e-b537-c9e3a2ba622e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5dace64e-d8d7-4541-aeb7-fe1e0c80d748">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d61a649e-0581-49aa-8c3f-2aca59f0ed9e">
    <obo:OBI_0001937>up to 50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d518c7af-44fd-481d-ad38-220512a53181">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f8818b87-d140-485a-9693-b7c0d847a0b3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/88bb92e1-00c9-4baa-9715-27f21b33170b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/16459a2c-40f9-431d-ad08-e3efd46680e5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/212987e4-72dc-4934-9f11-ee25ade8c301"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e6d9356d-d587-4ce4-bdbf-f0f9b883da7e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a9c1eac6-8090-451a-a0d5-8178fe51065b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b40e7a06-1edd-4e77-b195-8d3bef2610a1"/>
    <rdfs:label>clarithromycin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/04c510e4-d470-4d20-bc6c-2ec82e201e62">
    <rdfs:label>ketoconazole-alitretinoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f8e4cf2f-c6cc-44d0-b255-c578c549c070">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b181ddf9-dda1-4ad5-b680-dd8ec6297df9"/>
    <rdfs:label>Edoxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4e1bd65d-3024-47bb-9c50-77e15e6d8b68">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/5f50bb5a-8afc-4f78-81f2-c7a28a9dcb2e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/96efa9cb-bdff-4cb6-9b37-8bd50b415fbb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f3beca23-ff99-4e44-ba1a-95e80e8934dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e7a531f0-ce43-4f9a-88ff-e4a69bebe438">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/14fb24d9-1ce0-4aa8-9f6b-ca13acd9c836">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c417a871-3911-44b4-9213-8eecf7649dd0">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/769f2487-41e2-4278-b574-530e7a95cf82"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/ba7a9aa3-6fe5-4d40-b132-ab871d12c637"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1c26b3b2-5fad-4375-8223-573a5d62cadd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ff9535f6-af4b-49da-8ba1-2cd2396dbe5f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/83da40c6-87d0-4d80-88a2-13110ee8fda2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/67375ca1-a6fc-4921-a828-d5a7274aaae1"/>
    <rdfs:label>nefazodone-triazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2287759f-d4cb-4074-be4c-db3f24b97f42"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/feb5d44a-ccf4-444d-8223-7aea37a11aa6">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/60e8383e-4a09-45ea-bb29-8b6c90c2026a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c24fb7d5-6681-4d13-9025-869bbe15760a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/20d0edd0-c3e8-41d3-8e5e-9d58b4cbb06d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1534dc7c-11e4-499b-bb84-2bb0f786aa8a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/aa39ac01-37de-4519-b6ab-d1d657f4e180">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/dd469721-3a66-4ed8-bf56-ab38dc6ba4f6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/32674ca4-e7aa-45a0-93b8-aedb8f05bec0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/d83a83b2-f0b9-4f01-bbdc-7103764e4540"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4d29091c-e9dc-405a-804a-78a35aabda52">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/8c7a313d-5df8-4c6b-aefd-99700240dcad"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/a52039bc-4f61-48ce-9b40-d16f956f0e44"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/cea539c5-b8fe-4c7c-ad81-9bf539bb7db5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cc44dbdb-0998-4b7f-839d-a0b0f89d35f9">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/97ab51f9-05e6-466a-8f82-98603636354f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4b9eda81-1e1e-4a77-82e0-79fc4bb1b9a1">
    <rdfs:label>ciclosporin-alitretinoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1eccefe2-cfc2-43d9-98fa-a6f776211a49">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e768cd08-91b1-42fd-9c4f-6209c2795368">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c7158986-3eb3-4631-959b-07c412b7996f"/>
    <rdfs:label>atorvastatin-aliskiren drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1bcdd8c2-7b26-4049-99aa-008823406dae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0aaddf66-8425-4ddb-ad0c-c4c473642524">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7c1d3d2f-748f-4345-a513-a5e22ec6af3b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/29b429f4-8f20-45c4-a50a-de61574d8f93"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7832d0a6-b5d6-4043-91b3-6c7dbc9c8bd8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/03fdb9c2-1c7a-4c0e-aa80-be302aec4c4c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/37a4e0a7-04ac-499a-94fc-a132c2ba1e15"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b22424de-3e48-4c4f-bc85-b80f19cf3927"/>
    <rdfs:label>fluconazole-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/85d30414-b8eb-47b8-9e6c-0e581618b89b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/67452058-ab1b-4335-8938-f2b42f891c7b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/45189915-c871-44be-b465-c1bcc993f521"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ec078e5e-5a03-4b73-91ee-35b648fc0082"/>
    <rdfs:label>nefazodone-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/98e8d761-f16c-4947-852b-4055356db45c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/27dd6778-c5dc-4105-ab82-059e58badac7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/ddd61976-f61f-4ef6-a858-9eef94b1f07e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/33763e38-a4c0-4fe7-b474-04c2232ba64d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ffbdbd11-83dd-41ea-b21d-6de6f826c6a7">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/ea6fa8dc-9f11-47d9-9840-80d756f7c1a9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/88061dc4-903e-4def-bde2-3f0e4320d736"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/7d67c5b8-2c0a-4533-9f92-aa1e2cb0a970"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/51b4d4f9-be2a-4a71-afe3-43275e4d6bf6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cd82be51-399a-465d-8be7-dbb74efb70f1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/67c8a499-5c2b-4fd6-8931-3855879f9e11"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/30fdeca8-3180-4d81-94c3-7fbdad3db96b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/23387610-0397-4260-9535-476ae113e624"/>
    <rdfs:label>buspirone-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8b92877a-1a3c-4bb6-a883-e0bc44a7c8af">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/babbfa46-21bb-4ca0-b984-f6128bae9060"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/94cf303c-0c30-49b2-b56a-0ddabe9e29ae">
    <obo:OBI_0001937>103.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1be58969-f778-41f5-ab36-6f196ef365ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/01d1c08c-4148-42ba-a970-74dcb5d1d006">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a04abc61-ed65-4353-a414-ae85276a2056"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/67505592-2a37-46b3-a028-d9ff084198b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/97c15031-e508-4eaa-8d29-902b347f35ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9f134ac8-0dc5-4233-977a-bc95cb47a057">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a0a54fd6-c9ef-4d7c-86e0-1d19a95f398a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/1d320311-39e7-42cd-a5eb-801a1e76876f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2b752d62-9979-4ff5-b08e-62d7049f671e">
    <rdf:type rdf:resource="obo:RxNorm_325646"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/58781b7f-7d04-410b-98be-4f09b0481635"/>
    <rdfs:label>aliskiren</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/68455c9f-4386-4279-8005-5b61e8b91319">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/165a8f47-dece-48c7-b908-0c12eda433b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/98c2fa84-7a25-43e7-9f87-62fe7f043839">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/01f41eb8-67c8-4cd8-9179-0317d0ca9644"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/da30edf4-1a47-4ee7-84e5-5a63ee1d5c78">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/69ae47f0-ffad-4b90-8b30-6e6359a8d8c5"/>
    <rdfs:label>cimetidine-citalopram drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1472ad26-e41a-436a-8e3a-c18bd0238c30"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/16df100c-a648-4fb4-9a7d-3563c49f8639">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c449b739-921b-47bc-9f7c-b60c078ac3c6"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/680d0f2a-b817-49e6-8784-ebcbaeaafe86">
    <rdfs:label>fluvoxamine-thioridazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1e9ddeee-054e-42f7-bdee-5b30601b95c2">
    <rdf:type rdf:resource="obo:RxNorm_8787"/>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/af6462ad-41a6-4bd1-9271-1bbd45428232">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a04b4293-f767-4826-9431-329dd239cd6e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/43962d9f-1685-4eb5-8e78-2cd3edd5abc9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9f55fea1-b928-4111-94bf-7ef70bf38bab"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8c166835-c1b4-4926-9fef-f970e6848911"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ca1e2d31-b825-4113-ae9f-740d61da6631"/>
    <rdfs:label>cimetidine-sertraline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5f8b722a-3a0f-4c50-abd1-bb89edbe9d07">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/85a93e9d-9c46-40ef-93bc-740c9d6a8c2d">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/be35a834-fa50-4eff-8a33-8c24e4261724">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/672ade70-6e04-4194-8867-61b29a3753a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0f5aadbd-e7aa-4219-9950-fb664fe4b1a0">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/04504a61-e0e9-432d-a8e0-4a2e5869ab70"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/2300cad9-89a2-4b6d-9ee3-88400f3b53ee"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f8da27fa-1ac4-4226-a8a2-d66e01a148dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9b80e1c3-256f-4eee-ad99-35891e181fd3">
    <obo:OBI_0001937>819.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e1a2ed84-46ff-436e-9f2c-a2c429bb588d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/44f7e520-e097-4133-8c13-2061976209ac">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/1ced0bf8-85db-4e85-a760-e0f4e6213ca2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/1c67b633-9c41-4164-9293-ff4dcf961a52">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/36541b58-d349-4199-a888-d758481d0a00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fcafd151-c45e-4db8-93a1-659fb968ed7c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/aa9d63fb-3978-4668-aea6-db22b536f2e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8247d3f5-f257-4dff-84db-941795bbfea6">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/50df314e-59b2-4390-ad82-b20f095b48c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/1fc987ea-8c69-4c52-b788-85e0a6cc2cf4">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/5ae47ed6-165f-45ff-91a8-d34aff6653c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f8a36cb2-b1c5-4fad-af07-1cdb49c05d53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/85fd7a8c-c608-442d-87f8-4d0030d5ad03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/787ecffc-9bbe-4b2a-a821-2cc406a144d6">
    <rdfs:label>ticagrelor-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7afc4300-3042-4ecc-bc06-a844fe22ed1e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d9a6655d-44b5-4e28-8544-19f3d570e4fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/59215365-5009-46ca-b9d5-092458618f4e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a6ebfa1b-ecae-4f47-a3c5-ff9c3e8fc5ec"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/7afc4300-3042-4ecc-bc06-a844fe22ed1e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/6c2bae23-d355-4b02-bbd6-49d3bf63008b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a335cd31-6d38-4e2b-91b9-c925594d459f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/43ca301a-48a8-420e-b869-187302aa4596"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d247dda0-80e6-44d0-b2eb-fccdfbf879f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d4b2293e-aa4b-4746-a1ad-95865568a86d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/1ae9d072-fa45-4d28-91ea-bf2887035cca"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/7c135798-d20f-4115-8a0d-3ce2c38e601d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/8e5b1bbf-d62d-4891-9366-55e71f30f8da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6fbbc3cf-99e6-45c0-8ffb-5aa03ad13e87">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/246b4204-614d-46bd-80c3-7f671964685f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ac31aef7-4d41-45fd-9007-5eef3d77c391"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b82d144b-08c5-414e-8f13-75404560a462"/>
    <rdfs:label>ritonavir-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/27f71454-4319-4f05-b0fb-6f6eba2daf62">
    <rdfs:label>Erythromycin-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/32ee39f7-0cd5-4669-8b8b-b831919ee09d">
    <rdfs:label>simvastatin-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a094e172-7496-4212-902c-5ca1beeee113">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/4a62b9b1-2557-4f2e-97b9-75bce65ad27d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/548ed102-ba75-4f30-ad6f-49c9662639d5">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ece881a7-2726-4ab3-ab9d-41cbbe7014ae"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/30d8e80c-1840-4e29-8ca3-da6f2197f977"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/426870e3-12bf-4af6-a81d-25b05721f65f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/a0750537-f1c5-4e62-87c7-c40931b29c4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3314ae9b-6b4e-4bbb-9127-f6d6f3ef1dbd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c05921ac-f2ac-41f7-83aa-d2060b75391a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/457e3a23-3bc5-4a4a-9159-2b07e869d22d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/35332a45-ff84-4acc-a8a0-ae05633cfc14">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/6c9c55f1-4278-4535-bdb7-8204a84ee8c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b2525215-05ac-4eab-8d2c-8a1e6c585517">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/fa157462-3486-41a8-b5a2-c57449f6e58a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/4dfe79c6-2af1-4052-8b00-fcbcba6abafc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/361f07fe-d056-4943-afa5-b9f32331c4f2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/18b94449-1b9a-429b-8c3c-d77f8139d433"/>
    <rdfs:label>ketoconazole-eszopiclone drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/276e1989-deca-4b02-bd54-4ba4f29a516c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a841c2fa-ddfc-4fc7-a01c-c4c51f6fc5e5">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/a35b0657-a8c6-47fc-87f3-4bd3f9842d8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f477d410-fb41-4f9a-91ad-e9297ea0749e">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b8965c52-4f8f-4329-bb0d-e7bc9b3c3c7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/44db9140-836e-4a67-adee-174c5f6e9c98">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/2e1cce99-69f3-4033-a34c-ff7c85ce27fe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/14fb24d9-1ce0-4aa8-9f6b-ca13acd9c836"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d4ad157c-dd43-4409-8c2c-bfa88810de60">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a33fff60-6833-4607-9dee-490cb01d84a9">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4ee6a2aa-013e-43c0-a31d-60f7b7ca6206">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8bdfa786-5527-4219-b700-e736ae1cf98b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d28c129a-b36c-4f5f-a758-6dbbe07e274a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a5149d13-2cbd-419d-9691-93d2475a0ce1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b12f9603-2636-49df-add3-3869957ebd56"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/49c5c65d-d8f4-49d0-a0e7-5cf3b2647517"/>
    <rdfs:label>ketoconazole-P88 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f00ce7f8-315a-4494-9218-a5257c10ceb3">
    <rdf:type rdf:resource="obo:RxNorm_703"/>
    <rdfs:label>amiodarone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dccbf505-dfa5-4d58-beac-608e43c20983">
    <obo:OBI_0001937>45</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/f1e97877-ccc0-4bed-95a7-6f442d388ebd">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/011b6e8f-2bf7-44dd-907a-615d8bf44cb6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/dc2ebea9-fee0-4e19-a035-6a13a469b498"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b27d1359-3d75-4863-8fa1-d3e05b0ce0bf">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/475cc532-4154-419e-97fc-fcd458e0392a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/0c7aa26b-b0be-436f-9e7a-c142d6aa7230">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/f2cc87fb-fa87-4130-9df4-eb6dd331c352"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/0ba4bab5-a221-4015-a111-c6d7643ddaf2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/739bf787-f70d-4458-a8da-6e93a8327357">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9d9fe7a3-158d-4979-b980-77d8de9fd5c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/36d2f4c3-66ff-4ab1-8b44-312e9bf8f1ae">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/107cb94a-8ad6-4b7e-8ba9-8d6c58c40b93"/>
    <rdfs:label>ketoconazole-iloperidone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/347f4c03-1bff-4410-a95e-d8dad62f4720"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6593649d-b4a0-4a43-ab04-a94075251a67">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1f12f21a-91a8-4b48-8850-d015dd86a1c8"/>
    <rdfs:label>nefazodone-haloperidol drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cc44dbdb-0998-4b7f-839d-a0b0f89d35f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/55b321d4-5252-46c0-a49c-6581769785a8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/55a22067-73f3-4ef4-94ac-0a525c2f17f1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/99d085b2-1444-44be-9356-24d43e8e99a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/282becac-5121-4b88-89a9-c09835114cb9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f437297f-938b-4dbb-8687-ca3035527312"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bbb2f220-3122-4dcb-b5d3-c41a3e6e714c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/91f382c7-edc9-4c0b-aa89-87311a78db8b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/596a2fd9-b54f-46b2-835d-21ef97fef632"/>
    <rdfs:label>efavirenz-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/26b26d13-94ec-45f8-9edf-ac7155075eb5">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/22f67b4a-a462-4b42-9bec-9c05c8572388">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ab10bc8e-d0c6-48f9-ba1f-861ef203aec3"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/23b8d7f5-6c29-482d-b722-fd48de3f4b06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0a46153e-6c6a-4ca1-9495-5d5eacfbf4ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b8f50323-6acb-4f99-a505-332922bec36a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5cbdd743-053d-40d1-af2a-09ed6b669e4b"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/dccbf505-dfa5-4d58-beac-608e43c20983"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/79c90f03-cbfb-4eab-a65c-661af457110b">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/485c2263-cc61-40cd-b749-6effca5b5788"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a9a303ba-ca84-473b-8a62-2ab1686fc680"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1561df0e-6956-4498-97c1-f08544b5a867">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/782a5575-9980-4b4f-a28b-5165d17981cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/59b74d35-17a6-4948-b3c0-919584bc782f">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/015a545f-8da9-40c0-a6f4-cb6a96d40c62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e718eb1d-5a4f-4f5a-a1fb-a5b5e7102ae5">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/e71e3977-2801-4494-ab1b-2e1ddb51a0cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d570ee01-027c-4fb7-a9d0-dfd77f46b8c3">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6b0c5303-ba92-4fce-bc86-8bb06be82cca"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/3b8bd4ff-5794-4704-a2e4-423819d5aecd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cf751db1-93ac-4895-b45d-b6bc02f9afbc">
    <obo:OBI_0001937>85</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/03658e42-b191-41e9-820e-4e0994a07cd1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/9a3c3c44-e078-4676-962d-7808fd13b2db"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e02d433a-acac-4f75-b1d4-8a8fcd070b1d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/d3d60a81-ef59-4f5f-a2ac-f132ead225d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4dac567d-28a5-44c0-82fc-9229624545fd">
    <obo:OBI_0001937>1.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b9d913db-27a8-444f-887f-a1fe6bac52a4">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/15f894b6-d47b-48f5-97b6-fe83286cc157"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/53bf1b87-ced7-48d0-b171-765e4e402ef3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ab657d98-9ef1-454a-a471-ff29099392ab">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/bc2ffee8-7b96-48c7-9a97-847af57b9746"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4ed105df-e70d-4816-a507-3889d365d4ea">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/dbabe25f-85c0-459f-8fac-b25f69b6d137"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f84e6999-1696-49e8-b71c-0ca3806ca5e1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/43562543-39ae-4d66-83e2-59ac6b44a4c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/1f3aac81-2aed-4b9e-a6ce-03a16efe32a3">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c70b177b-f2b1-4151-a4d0-818260203c7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8d1810d1-f940-4c77-a93e-cc82f8274a86">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/6bd1e43f-3806-4fd4-9a88-ed020c7b67a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/11a93951-9589-4767-b16b-cc1265970c02">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/04c3e7af-618c-459c-b1ef-c6af2174a717">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/16142984-197e-4be0-9dbd-ca8820945953"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/10095d99-07ac-40a6-9431-d9b3d9fd5db7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/8353a441-915b-4fe0-baa4-19647f8e15cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/0ef8a4d8-3743-4ce8-9224-527a705ed699">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/93005775-a2c2-4bf6-ac2c-faa60582a052">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/47d76cc1-897b-4d79-bb40-e55cc0ee5240">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/147c909d-531f-44fa-8a1b-c6bcac1fe1b3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ef2ba6ef-aa3b-4203-a1d9-4aa1e8552ba6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/0e1ef038-9940-4dff-a978-615d873f9b3f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/02f98ef7-9f50-4bac-99a6-479fac62454e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cae485f9-3567-476f-a36c-ac8395661e01">
    <obo:OBI_0001937>79</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bda68ac9-ccc8-4d46-8515-5dcf78449ad2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/321489bf-3714-488e-8fb5-2404b0c0627f">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/fb8c3392-25e4-46f7-bceb-d254bfb5141a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b7ce3bde-d894-490f-8add-33c72d487d5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3ac20fb7-9a8a-4655-ad84-084998188aee">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7e7edb2e-c5e9-47ec-8a2b-b66ba9b82e0b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/a0ee16dc-cec1-4318-a343-9ab6062a3b29"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/a3ff280a-a3c8-4f18-8dbe-4c2d5dd76067"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/1ac2f10b-06b7-4e3b-b77e-6bd75003403b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/fd2a1dff-8a76-498b-b4f1-494b3b173546">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/190a5d33-9b0f-4b2a-9067-5cb4faef3b14"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/7aea56aa-cff2-410a-83c5-ef30ff6767a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7b26e6e6-1028-489c-8961-d43e77dcb733">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f21cad99-2bae-4da8-ac2f-355a3d8e3a72"/>
    <rdfs:label>Telaprevir-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/80c07bb1-025b-4ab5-95cf-a17c2517913a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5218d9cc-d400-42b1-9f11-d2d2b8fa5be9">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/88eb7c74-e75c-46c8-af6e-8a8239211688"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/b4408195-29af-482e-a5eb-531b5207908e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/67ed4e95-568b-48a2-b486-15c8b8aad1d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/eca03b60-00e2-499a-b62a-69d5907a87b9">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b7eed592-0875-464f-9d20-a71bc7c26d9a"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f978a7e0-856d-4452-9d08-d1fcb2c88efa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7d51aeaf-9d1e-46cc-82b8-c1d48aac5e71">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/258d350c-dc94-4230-a39e-66e972c3319b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c123348f-9c14-4f8a-9248-dac5948a114a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/95272d67-07f1-45f3-8fe0-cc39120f28c8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a9e9c432-d8f5-43f1-a61a-6d34d0a528ed"/>
    <rdfs:label>erythromycin-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e3659905-b95e-4877-b0ad-de7bf0c352ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/33a195e7-9de7-4794-bce7-f0593781da5e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4297af0f-7fd2-44c8-9e30-90aaea3230c2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/b89d34d8-169b-4681-8e59-bf1fee7e1d77"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d018efce-c9df-4e1d-90d4-0d8dbdc1e10c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e5200f96-3dc7-481e-886e-fec9c0ccceb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ad9b8300-e7fc-408b-aedc-ebf991386278">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ab1aa918-c0e3-453f-95b2-f744c31dad57"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/8070f37f-bb25-4a7c-81dc-04453d9b01de"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/0cbfb9c8-5b2f-4ada-96b4-4dd64732feca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/a58cf5e6-028f-4a93-a737-a6c1640e08da">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/43bd8360-ad32-4142-9c3d-643ff5a91d2f"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a06414c5-9f60-43c6-ad34-c7f1cd3a7c06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/b6871b47-6754-4000-92c5-eb8596b6a4fe">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/4fa60e77-6c53-4eaf-ae44-3e6121f773c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/641a06c1-a900-4a5e-8cd4-9947fb0b2fe3">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/20da7f1f-d885-400f-8101-a09b0ed87842"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/eb881951-2346-406d-a26d-3639909cf9b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f4b02476-a654-43f0-88ae-63376f8699c5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d38a6fee-673c-4d4d-9609-69c4cbf996e5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/d7212f8c-9346-4441-8384-f976315a1ead"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ef1577d3-438f-4309-9788-e9aef1988962">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/a8e17485-1010-4d4b-905c-b5e928bf2423">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a072369d-cbc5-4e17-bef1-936288ffee0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b8153947-2189-416a-a07f-7d08e39a445f">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/bbedcc75-9175-4de6-b546-7da8bd87017f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dcbedba9-d65a-463c-b04c-8ae89f5696a1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/18696dcf-cc8a-40af-8097-c7eae0faef58"/>
    <rdfs:label>phenobarbital-paroxetine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/959b22b3-7f15-4884-90b9-74cec7ad1e26"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/37c11c1c-66e2-49bd-9f46-47dafb25b2f6">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
    <rdfs:label>buspirone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c10c0d10-355b-4691-b2e1-d2d3d59757c1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0c7d6288-ff52-4205-aae0-ce41588a629f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/cd1b30d9-894c-4c2f-9289-e9b24d31d000"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/047e7784-c243-4d20-a5f4-2d9f0c8dbf7f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/d98c420d-2550-4b09-9136-306ca598822b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/b95ca4dc-db3a-46d6-8501-3ac4c1576d2e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/ded164cb-a385-4c35-9b55-0dd40f209d3b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/081e21d7-24f3-4ae0-b0fd-b9b20890bd8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/84d18140-df2d-4d92-95a0-7dfae43c6fcd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6ba80459-124a-43fe-b311-25c3c8bbbc03">
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/2cb4a674-21c6-4e11-af8c-4def46abacb6">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/6f5c52a7-9dbd-40d7-bbf9-91ddd9ba7dfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/17cec174-08b5-4f99-8256-0fa28d550420">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/2a879e35-6dfb-4476-a06a-4bbfcf1bc277"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9d918bcb-21c4-47cd-a96a-c6dde090e9bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/385c9427-3520-4bdd-be10-901af13eb661">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/430dbcc4-484e-4f7f-a5fa-0055c32a46a6"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5334118c-fedc-407e-8be6-d6b62e0c3b81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ed65b6df-4cea-4142-beae-e3e3755c0900">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9d253e6c-df12-4fc1-bdee-d70ebb555784"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/54240f9f-0fca-4821-8e66-d3a19f642278">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8a7bbee7-f0ec-4994-a368-f668ace3fcce"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/9c122269-d5a1-4b6b-b01d-50200bf6f1d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0d81bc54-4139-4cea-8bb3-605b66e6dc55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/012b358e-ae6a-4a05-a6e6-3acc0027f613">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fa9d8158-7218-478f-a076-fee359d719eb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/603ff81d-4ae1-43ab-afd3-843c63cf41e7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/ec14ecbe-cd49-4daa-89e6-721b0eac0b39">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/6dd6dcdf-54c5-4248-85d0-6bb6ceb5b8c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a66de894-fabf-490b-82b9-7dc08bbaa24f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/95a45b0f-93bd-4029-8904-8a29f170a948"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/459d7c51-51aa-42e2-be10-e5e0d3539ef9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/aac9d729-a302-4fba-8fb4-1d7242a6c53b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/959981af-b588-4c72-aefe-c6b93388791f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c9f6d60d-d5c1-4c6a-b143-694e22f6922d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7f68e641-486f-4759-92fc-e696ccac586c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/160127f2-5741-4fa3-9dae-1ea90fbd0acf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/22736392-e335-49d4-be1a-3ca66e380584">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/59e81276-051c-4e8b-96fa-7696cc5fdc49">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/895920f9-eb6d-48fc-8f2c-3de8fa53b34f"/>
    <rdfs:label>rifampin-zaleplon drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7455a610-1f30-4ae9-a065-cee4ae35468a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4dfe79c6-2af1-4052-8b00-fcbcba6abafc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/18cdd0d1-bb58-4bff-a3dc-cc2986cca358">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5458e810-49f3-4d68-be24-72cb0cc3aa4d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/20da7f1f-d885-400f-8101-a09b0ed87842"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0ba3ce91-8c57-45fc-a241-4552e321b184"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/12bb1d5e-096a-4fc9-a4cc-b0e4e9170361"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/809ecc65-f100-47aa-94a1-74f36eb685c1">
    <rdfs:label>paroxetine-pimozide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ad63ad7c-3413-45b6-a3e5-51bb04710aea">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/f9140a6b-aebe-43ae-adcc-f4d1877e0930"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/195be405-ee31-4f32-aedf-f7a38ca05067">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9da95f79-a8bf-4ed3-9ab9-87744eee0c7a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/343fc49c-a686-4d17-affa-fd0a571677ab"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/32924a5c-1336-498f-851b-5b92c6cbf5a7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/ee9e7e3b-c72a-4b8c-a600-252b632e54b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/2c0616d0-1a28-45be-b72c-7df9fa4c6c6c">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/e15e4e15-5695-4794-b63c-ccb2bd53221b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d7335e36-4bab-4f9a-8f2a-b7cdd2b7902d">
    <rdfs:label>theophylline-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/dc2ebea9-fee0-4e19-a035-6a13a469b498">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/25ac761e-a854-41b7-825c-65444162b264">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/17c7e85e-48d0-4d8b-b351-11e5648beed5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f0f3c80d-31e3-4d62-a5d8-00ff2a76ca57"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/873b1917-fbad-4343-b940-4e8c4361b162"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bf846dfa-36f7-4260-b868-0dca0183787d"/>
    <rdfs:label>carbamazepine-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1bcdd8c2-7b26-4049-99aa-008823406dae">
    <obo:OBI_0001937>1.46</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d755b5cf-708f-49a1-b0f3-a92b18a6d52c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ef79fac4-3aff-46a3-92a5-4caa01863069"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/82adb3a9-6167-4bcf-949f-e8848e4f4ba3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/df68e5fb-36cf-4ea8-a9e4-29a285b5b77b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/dbc32d73-0c0f-4fa4-8166-f64e77854a08"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/47623859-156d-42df-8219-f056e6499d60"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/481d2cfc-e173-4cfd-bc70-afbcba257315"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4d1a73c6-a5b4-4e8a-9269-921dedcaca94">
    <rdf:type rdf:resource="obo:RxNorm_861634"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/5e07b09f-9d0d-430c-b790-eed61adcbae8"/>
    <rdfs:label>pitavastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/233321ab-deb2-488e-a21e-993ed0092a35">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4948cfec-b4f3-4e21-947b-4b7d8c947dd2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cb8e15ec-bf4d-4913-ae97-832e733d3a77"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2fd32aea-8470-484d-9db8-c0bb9d5eed89"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3f5b89c4-5838-41ae-b72a-a1fb52b9b335"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/cc0936ae-a7c6-4f6e-b61c-57d5f18411b0"/>
    <rdfs:label>Lexapro-metoprolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/eaacbb6f-086c-4121-bf3a-a22e4dfa42e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e2c835a8-a162-409d-a551-fcf80711e61e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/af8d64a1-c27c-467a-96bd-2f08e458923f">
    <rdf:type rdf:resource="obo:MeSH_C060062"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/344ec73d-781b-44ba-8484-37f0e4f41e25"/>
    <rdfs:label>mCPP</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/1e6c066f-3c31-4e40-9d77-e35ca4d54316">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/65fbc448-28ec-4399-8ec2-4f11ed358b11">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/34d428e3-33f4-4f76-adfd-89a6a8572ec7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/80d9d8e3-62c9-4de6-aefa-7c7856742a36">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/291afffe-6d16-4799-bad5-934cd94f824f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/4fae846f-1431-4023-b9cf-b8f2100c3f1a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/dc271693-80ec-4b31-83e5-5caa47f784fb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e92b34c1-ded4-4add-8ca1-6a6e5bebeb93"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/609d024e-c1e5-4ba5-89d3-074d10986a6f">
    <rdf:type rdf:resource="obo:MeSH_D016572"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/0d733971-67cb-44ae-aa02-3ee931fd0982"/>
    <rdfs:label>ciclosporin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/406b0e3e-e006-4c6c-b588-cf1705e60a56">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/15742939-b965-413c-b114-b363dff5270e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/1699dcc6-4bc8-4705-92f7-1afe8890d3ca"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/11f3066b-7702-496a-b7fa-b259c1ab5109">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1874217e-a81f-4bb1-b269-e144f63a5489">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c7835a85-3022-4266-9dd9-0b68482db9d3"/>
    <rdfs:label>ticagrelor-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ed2ed88e-fbf7-43ed-9416-cb0766290b30"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/475bd951-46e6-4a87-854f-285d751f9d60">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/27acd8c9-27a8-4dd2-8908-13b36175ee78">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/d3eaef13-e6d3-4bbe-9141-4c10d1a16d48"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/543fff0d-f78c-4fcc-85ed-966626c83b87">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0eaba5d2-f3a6-452c-8c18-52ca888a11bb">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/3d3afba6-46dc-47c6-891c-eb015cad35c7"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f7e5c390-8dbc-4ffb-bbc5-0138ba57ea47">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/4e7a3ba0-4a66-45cd-a385-9753430e4b97"/>
    <rdfs:label>Edoxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f69d5bb0-15c8-402a-b3c6-cd22340fc4b5">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/22e54ab0-5108-4135-bf8d-59879c73dc37"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f7540f0f-e0a9-4a83-9ee8-bf9bf22dc658"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c4b5a395-5246-40ec-8ac1-16ff593f1bf5">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a9d564db-5751-4a4e-959c-379bec66e194">
    <rdf:type rdf:resource="obo:RxNorm_6918"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/49cae87f-eb68-49ec-a662-a3ce6d1e7a16"/>
    <rdfs:label>metoprolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/43d90ce9-e358-4cf1-9977-2d95e071d186">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0c9dff06-6d03-43fd-a480-d1feef1c1ecb"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/8018644e-acee-4eec-86b2-d11fc95edd0f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/22d6ec90-fdd7-452a-8dc4-097dbf351112">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/bba0a45c-2c92-4787-83a1-a4522f8ce1fb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ad531e75-b42b-4a19-8dfd-aaed7c9f4bed"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/ea8aac60-ad93-4938-9ab9-b393a485ea66"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5aa5a178-7bd0-40c8-9436-eb111bf7e688">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ec47c0e9-044f-4811-a012-147ea13d9e4c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/787ecffc-9bbe-4b2a-a821-2cc406a144d6"/>
    <rdfs:label>ticagrelor-simvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4ba92fbb-78ba-49fe-8069-3cd760658b40"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/63851f02-2288-447c-8ade-4b7b738f67ad">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ed21ff6f-4965-4b2a-991e-a240662de149"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/225b05a3-d0ab-40a6-8f90-116a8ac20423"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/811f7725-e804-404f-852a-a7868b723571"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/69da7ab5-8cb8-482a-b0f1-21f00ca58929">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6a36d1d0-0708-4b84-b501-07c9d6de038c"/>
    <rdfs:label>aspirin-rivaroxaban drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/df7b5fb9-1dbe-4d1b-9034-bef219401669"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d156072a-4b15-4a5b-af4c-9872033cf739">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
    <rdfs:label>low-dose ASA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/d35a3e01-ffbe-4ac2-ae6a-158e74506072">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8e5b1bbf-d62d-4891-9366-55e71f30f8da">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6a894bca-9b1f-4216-b984-2186eb737e42">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/89a77876-a060-40d6-9487-f1a5062a2311"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/083ab3ff-cf9e-4f16-a25b-67e07b32b3de">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d3f703f4-028c-4bdd-9116-0458ee7a22c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9653097f-88a3-4ad6-a4b8-070ed1367e5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3386e74e-1949-42fe-9c93-d9235a03e820">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/fae19b28-dd38-4830-9760-fe0323068824"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/a297fffb-eda4-4efe-92c2-6f08965dae3b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b2300669-1f5e-4019-ad94-1d3c5e3ed27a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b7fa673f-78fe-4b53-ba04-8b919c843f8a"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/a094e172-7496-4212-902c-5ca1beeee113"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4e041a2f-7fe2-4ab0-890e-8fc323689ed6">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/67f6003e-0d0d-4291-89d7-b749d5512292">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/202ec196-0ccb-4564-988b-fa4fb802a8bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/70820378-b851-4857-89a0-c8b563a562ca">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/0ba4bab5-a221-4015-a111-c6d7643ddaf2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/af2790a2-f84d-462b-8fe5-6d9a4d7bc866"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/8a92762a-a595-4b59-a998-3737fce7e6bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6088b3b5-88ba-494b-8cb6-74628f94d120">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ca73521b-28e2-4dee-867a-9e673bc6273f">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/fe0919fc-b678-4196-9a79-83bbc6ea3081"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0663ea2a-c184-40be-95e2-4b49df471dc2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/89247057-f0ff-4ecd-895d-ad42dfe66573"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/51d474b5-58b2-4055-a2e7-83bd3eb54457"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f0318415-8ca5-48f5-916f-ff075e071911">
    <rdf:type rdf:resource="obo:RxNorm_57258"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b902a4ee-3414-4489-8004-e9136966453b"/>
    <rdfs:label>tizanidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/1fedcfa5-9379-4766-b056-03f18646120b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/958a5f37-3115-4b0f-8760-d397ff92d644">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c629bed5-36ae-456c-8e03-21f605203121">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef380a3a-9218-4674-87a7-94665c3b9552">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c7835a85-3022-4266-9dd9-0b68482db9d3"/>
    <rdfs:label>ticagrelor-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/75c3e059-2360-4e86-bb6a-4c644fbe523b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cfe8d0e8-c347-485d-8adf-09d5ef53b9f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c590b33d-4f3a-4c89-a49f-132092fbb318">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/76ff3ea7-b266-4ffb-bc3f-7656bafd3e92"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/90368d8d-775d-4ce8-b685-439f3e27486e">
    <obo:OBI_0001937>17</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/28e17724-ddd8-4006-8a00-efc386f1ea11">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/13c558ae-2536-4872-8369-e8c3bd71e9ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/dd8e36de-8458-45f4-845b-da9d61eb7347">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/ec04afab-6192-45a5-b399-6eeb00587eb0"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e2b18583-8b09-4458-8c8a-177db92c210e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/e15e4e15-5695-4794-b63c-ccb2bd53221b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0f9918f8-9d64-4240-b58e-635a9b7372ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/ee32166d-5ae3-4eeb-8249-8100b43ad788">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/90a6d243-b96f-48a6-8ba3-8f2227ddb5c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000013">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c24e3607-2272-4f58-a9f6-ccfc626ad1b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/456fbcfd-8c3e-4ec4-b7fc-c76f7155d960">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/65d3361a-1cc8-4658-9bfc-4252e65d98c1">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/8d18468e-f276-442f-a94e-ba5cca1cefb7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/6185bd95-5397-4f1a-b104-6fc0a4cc9d88">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/43214708-a312-4579-80ee-f09f5ad17126"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2f773e27-20de-41b7-8684-b0191744dc2d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3e8d47b2-dbc1-4e69-973d-71dce86ff085">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c97d8f60-8578-469a-8460-bf5054068c08">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f43f6dcd-8d71-4110-b211-b417540cdb2b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/d235aa9a-cdb7-40ed-bced-9a56ef699174"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/57edb2bf-d07e-4a94-80c6-63fccd5cd0e4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/519764b6-30b3-41e1-9fca-d36be4d2720f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/4e5e0cfc-778f-40c9-a3d9-3751c0ac257d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/96e50ae0-9cb7-4e30-b984-2adf60f76c8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6e7ae312-6eff-4681-a7df-4511845f37cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c52cb0f2-7ea7-44b7-b8cc-cebdba10b7c7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b110f347-f4c5-48ba-a6e8-d1b0a95116cb"/>
    <rdfs:label>efavirenz-hydroxybupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ca6cd1f1-74f3-4964-a5d2-b9f3e5e3f631"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2b420381-7903-479a-973b-311c733063f5">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/621990b0-7575-41a9-b906-85a938fe83e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/a76d383e-3891-4ba9-a035-1b0a673c1214">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fadf9140-a553-486d-b7df-b2250f321e4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/21f191c2-984f-4252-b33d-eb8e3dd54bf8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2ca52461-f5f5-4ee6-bd6a-d8e2aae5dd71"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/94188994-5681-4133-a840-2156de10133e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2e5ad88d-dd0b-4300-9766-2d2f4f803e3c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/addd3ded-8c24-4062-a387-c8e76fcc4ac1"/>
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b42f1f3d-192d-4c91-b626-2f49a5fdc1bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7ae949c8-1a16-4b9d-95d3-1585f6efa0c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/77c8d03e-6aff-4077-b0c1-00114937e58a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cbe560d2-c988-4ff5-b04f-e7ecae84b804"/>
    <rdfs:label>clopidogrel-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3ac20fb7-9a8a-4655-ad84-084998188aee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/558d113e-ca67-411f-8340-da6e039eefd0">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/19815740-a9c2-4cbc-867b-2ad90e04268e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ecee1874-3b44-478f-b3e2-8cfdc3c42919"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/3de2e8f6-e6b4-4f9f-8479-e684e041b6bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f24df5cc-483d-42d8-9c23-1b967302ae5f">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/daadcfc7-efbe-4438-a089-ae2bec1732d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9db4dad9-4889-49c6-ad4f-2fb4360fcc8c">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/ee86bd49-49a8-420a-8133-14aad592b4a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/760d6abe-194a-40ec-8f5c-72549edf2f2b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/39edacd4-20b2-4b8b-b7ec-dab473befdb7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/162ab60b-624b-419e-b413-4470f189b9f3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2afbf8f7-8f18-4216-8249-8dd46d201be6">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/919cd707-fdf0-4c03-9255-ef5dc654dbdc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ecec9ab0-b4a0-4f80-8f6b-deee66f43b84"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e12343e5-6a3e-45b6-895a-7e822e3462c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/383d05ff-039a-46ac-a114-c99a322bb548">
    <obo:OBI_0001937>66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/09ae1a1b-2dc3-4a04-ae26-cf1e760f47d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/bf599e1e-3de7-4ef3-9fc7-04f6340e7e50">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ab575b86-446b-40ed-adc3-b6f580078dba"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/2e181c53-55f1-4c2a-b3e5-2c4458eb6568"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7a58e018-0f2e-49fb-b3fd-6abcaa254099">
    <rdfs:label>low-dose ASA-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4f9235ca-5f26-40b4-8c88-f16d123d08d0">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3bfacee3-f9dd-4c62-93a6-3088b56949d2">
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef236120-f1e8-46e9-80ae-634dc64506bb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c6294d5a-b3a5-4585-815c-55e24c5b94f3"/>
    <rdfs:label>ketoconazole-rosuvastatin drug package auc None information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1ed4d7c4-6541-41d3-a6f1-1db77587eeb8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/18b94449-1b9a-429b-8c3c-d77f8139d433">
    <rdfs:label>ketoconazole-eszopiclone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9b5203b7-c582-4ae6-87bf-f172daebf6c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1c18047d-3776-4f70-bfc3-2429627c35bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3c118670-e655-4d0e-98ee-89fc347bc548">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/043703f0-ab96-49d9-8f88-b3dff2138778"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/44593f3a-79c4-423b-be69-ea5a9be343fa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/25fffe35-f692-4398-9f1b-10639aa7efd7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/40dcbb12-ee4f-4ac0-8c17-e1ba7b502f5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/22a0350f-fc4f-467c-b94f-5bf277fa0211">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/27738105-8d7a-40be-826b-28a5735164cf">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/e51191d7-59b8-4b25-ad55-a61dedd5d47d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/245feef1-e3cd-48b3-b0a5-90917fd4363a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9aa95175-0175-40f3-9e4c-446f5e59d1d4">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/b6be80e7-95a7-462f-9566-acff90b14401"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/695a5483-102d-45e0-8ee5-0f5c38f63bb0">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/2720a1b7-2fc1-411a-ad7f-808aa2d0c92a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e10d4510-9718-4e2f-8c08-7091fdbf7f57">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/bca76ea1-58e1-4b86-9209-69c21aeee782"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/96d8d552-b922-442d-8ee3-7e7b96de916b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f6506651-a3af-4241-b566-9f315a69e334"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/723ce614-8329-439a-bc84-9060d5135d62"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9c726a2d-1726-4f17-890d-735071410b5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8639ceaf-b744-40b3-a637-539e6b560e74">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1249b2ee-0aed-4bb3-a37a-8311958b0857">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/2398da95-cc9c-4f5a-b8fc-9823e084298e">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c8d25d84-ac3c-48d4-8ad9-0c52cf0e31ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/73338175-4768-474a-83e5-9046232c92e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c55c6e19-c8fc-49a2-a582-f8521f78450d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9bef547f-5da1-4ba2-87f5-166ffb30e24d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/5060ecff-3e2a-410b-846a-a746c69caa34"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2c731795-ca3e-4cd3-9743-a5abb17f1fd2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3d2253f4-78fa-431d-be17-afac04fd0304">
    <obo:OBI_0001937>4.23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/22634003-e5f9-4c55-ab09-a7449de56c7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fbf35688-cbe5-42b2-bacb-e880e96244be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2821577e-6e73-484f-9cb1-d19a116207c8">
    <obo:OBI_0001937>4-8</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/aa7958b6-91c5-40d2-a17d-dd7fd5f2785a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3ed1de7e-7ac5-4ed2-87a2-a1012fea2f6c">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/e66d246a-5924-48a0-b181-888e135e04e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000109">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a1cc5958-5987-42f0-835f-e673d9ad01dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/5a648d61-95ad-4e18-9854-25e0ec5d14c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/df5108b8-1127-4a5f-a329-65ad063365e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/fe0919fc-b678-4196-9a79-83bbc6ea3081">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/fe6cb57a-3920-4b94-a01b-2013065542f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3f79835c-9ba3-40bb-b34e-9db2ba97eafe">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bcfda25c-f9f9-458b-988f-913988e6c0ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f27142e0-5ed7-4943-bc0d-593498e68818">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6c532c38-0cda-40ce-bce1-e16ecd6803b4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bd7cbe74-673d-42fc-a7c1-154dafb394a1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b8f50323-6acb-4f99-a505-332922bec36a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b7f4e9a5-cf01-40ca-b66d-db5c24738d44"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/56f702f4-9ab0-4dad-8d83-7994a2382a94"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/086ab0b6-497e-493d-b675-663dc960f44d"/>
    <rdfs:label>ketoconazole-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7813fb34-648d-42de-98fc-33ed36803fca">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7dfc59eb-5e88-4a85-85ac-f4663e1e2cfa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/999ec5b0-dc65-40c5-bb73-edb44bc16e08">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/573f04d4-9e3c-49e9-9cd0-cba9d1154d83"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e2c835a8-a162-409d-a551-fcf80711e61e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a61b6c0b-a6c3-4760-8d92-305f8ad8612e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/8f712374-8d45-4958-8bdf-027c4c2ff410">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/79e26b6e-dab0-4d25-83f3-5f9d433dcc5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/1735caa8-ea04-46f1-9802-11f1c0885f89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0a909ada-3bf8-4ee7-9550-ff6600b82fb4">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/3dbf7cec-237c-4e19-ac22-916714e8b44e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/cf939099-5e8f-48fa-bcc7-07f6040c324c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/89bd41f8-27db-4e0b-9ab3-3efc9909002e">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6b996897-ea92-436a-8225-e36b0cba53be">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/75b05871-793a-4dd5-8add-2606d908d4a9"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f6fe28f1-6994-4442-b3c5-cc31504bfe9a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ba57edab-f099-4f47-ad6f-8f8f0e6a1a99">
    <rdfs:label>duloxetine-theophylline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/4093a75a-8a43-4cc8-8705-5bdc440e75b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d03f9fbc-eeb7-4bbb-881f-a90d267fd5d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/62776982-355e-4540-899d-93cdc909b373">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000052">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/4290f771-a481-4c05-a8a8-4d9f830f18d2">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/dff612f7-1901-4c7b-9347-1c602f965619"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/85b33c5b-3c12-46f1-bb16-5e04208bd638">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/3a1c0da7-4034-4364-8798-39fc8ea62fc4"/>
    <rdfs:label>Rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/1bff15a3-4bb3-460f-8841-a9588327f312">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a4d20153-a30f-40fb-94b2-3b61f539d95f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/47f7ac18-21f3-46e7-a48f-8b7ce8ad12a9">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/686fd467-b511-4ac7-84d9-882be43bf017"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/72f5f07f-9e08-486f-b505-4941d6b5c399"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/49008723-a95d-4206-930d-fad0bb46a6b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2dc77fa1-a047-4be4-9b3b-030bffff6cec">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/9d8cf3c6-6f32-49d8-8833-823621d4c6aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2562ec60-02b8-42f9-9b7f-a424af52d977">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/16fb3250-b20a-4a76-8550-4c1d8eaa1e7a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/eaacbb6f-086c-4121-bf3a-a22e4dfa42e3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/23355d40-2330-45cc-9178-411b1826b5ed"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/822cb936-ddfd-4ff3-bf87-34daecc15ca7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/6f5a3644-9694-4db1-84fd-a0635fe3f99e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/18ecc608-6c8e-4cd0-b208-2b97db83ab94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6f5854ca-501b-4792-bf5d-60fd3cf0943c">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/e9be0a73-ff2c-400b-b0fb-e0c6d51ece07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b9a918d2-cdb1-41eb-808d-bcce1bc305a8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/c9c65c23-2da6-41c0-8c4c-a0d09df9cd70"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/1a230555-73a2-4d7b-adce-6d8e7bfcd6fa"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d24df3b3-7b96-4a8a-a180-ebd7c60ddf10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/162ab60b-624b-419e-b413-4470f189b9f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/2a964c5c-4d2c-4172-be71-ff0c3c62c018">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3e8c605b-6273-4568-9e1b-522ea9e203aa">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d02cdf55-0bea-437b-b83e-87c277bc3deb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4484f446-05cd-4ffe-b521-a6fde832db67">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/44593f3a-79c4-423b-be69-ea5a9be343fa">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/e315ee01-07bd-42ef-904d-a90413975a3e"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/910b4e17-2a8f-4803-9265-8fba38aef007">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8dab20fb-2503-4578-a64f-033f15f90e2d"/>
    <rdfs:label>paroxetine-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/aca23aac-723b-4156-b930-9b70f67e3cc5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/165e26bb-8bfa-415e-8b2c-7c3f29df97a5">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/2ad5f17f-b0dc-4b3a-a2c6-4d2d201901a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e1555a57-f5c5-4e63-ba7d-c4568f00357f">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/3b146135-8360-452a-8972-51bf7bb983f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/22e2c4d0-609a-4b6c-a054-54d5cff4e145">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a9e9c432-d8f5-43f1-a61a-6d34d0a528ed"/>
    <rdfs:label>erythromycin-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/1920bf38-a694-4f78-8865-2004cea2c6db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c6dc112d-3d44-4518-963c-8a1c3886545e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/59aaa133-6592-43b1-8618-b7da88cfc50f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/0788401e-8e8e-4a9e-9d7f-eef7140a56d5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3dfd4014-c1b7-4303-8e31-29e9cc516962"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/8ca33ea7-06dc-446c-92a7-0a3b04f082d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/33fb4ee8-645b-42b9-984e-1396b70411f7">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/65422c7e-450e-4bc4-a8b8-340618c895eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/2c3a16a7-f39b-4e55-a5c4-9e72f7997570">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0d66e3ee-cb99-4fd8-9eb3-627a3c047d0b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/3dbdb212-37e7-40fa-a490-52ec77d211d7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/739bf787-f70d-4458-a8da-6e93a8327357"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/6b27cefb-56fe-4f08-bc73-291b93223096"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d0c74e0c-b248-4a9e-ba0d-1d77e9f9a948">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f84e6999-1696-49e8-b71c-0ca3806ca5e1">
    <rdf:type rdf:resource="obo:RxNorm_10438"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/8277cd88-2eca-4765-bc41-2e8cc0a76c07"/>
    <rdfs:label>theophylline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2527065f-c39c-4504-9950-efbe6ce8e3f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4ff1094b-6889-4dfc-b26c-bea87ce82953"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/6f9b631b-f951-4c0f-84c9-9646b0859e1f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/7bdf0354-007e-41eb-baed-b153a53c6592">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0301cf87-b960-4663-9624-ace4cf951c32"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dfde1778-c4b9-4739-bdd9-61aef0a9951c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a74fcf7a-6c90-43f6-8ee8-beec823f28f9"/>
    <rdfs:label>Fenofibrate-Atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/60b47984-7d16-4f75-9b81-3ea4fc1ce92a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a7148789-1090-4822-9b73-c2b081694585">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c5589969-634f-42c1-a5a5-335b8b69e61e"/>
    <rdfs:label>amiodarone-dabigatran drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/76c1651f-26de-45c6-9e42-254c67d7a809"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/b7b97734-3a11-4155-a204-080a00ed97c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c538fe3d-7f42-47ab-9fcb-fda411cee7ae">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/52bdecb7-a832-40ad-8293-7c78aae1fbe7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/dff612f7-1901-4c7b-9347-1c602f965619">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/58781b7f-7d04-410b-98be-4f09b0481635"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8a431fc8-0d34-4c6a-b96e-6a88af94d665">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7c1f3ca0-5774-43e7-a731-563a5dedd0b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2ca52461-f5f5-4ee6-bd6a-d8e2aae5dd71">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8743f73a-16fc-49b4-b94d-eccce4189992"/>
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5f8b722a-3a0f-4c50-abd1-bb89edbe9d07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/7149a0ec-143b-4e92-bd46-1a944de16c43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3348312a-9070-4b4b-8177-4dfdacd45701">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/aa9dfa4c-534e-4e8c-a01c-2e7d01235c7c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c6dbfe18-4c0f-4765-a966-f3607793f994"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/40dea6da-8e7b-40ca-9698-efbf95cfd158"/>
    <rdfs:label>ritonavir-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a9c1eac6-8090-451a-a0d5-8178fe51065b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c8588781-a828-4b3c-a866-39d552f2a925"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/378096c0-bc7a-473d-aeb0-1d76bce14e56"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/096782a9-ffeb-4161-9253-c81dc93c1a8d">
    <obo:OBI_0001937>10.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/43caa552-50c8-44f1-99c7-a332fb95f134">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4c58186a-826c-4ee8-b88b-381ccf1c2251"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0829d223-6e1e-4d9c-8a4c-0e00804a9784">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/53f94489-5d48-44a6-b1bb-36bb23b3759a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/52e5961b-6402-4712-8962-f2bbfd871e19">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/a3125932-d483-4bad-a7ee-b1fa0a22f59d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/3cde4fe8-c6a3-44c8-9ea3-d0345a33428c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/aaf291be-4166-414e-a2ce-dd30dfdd0b66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e024da4a-a236-47e0-8cb4-a8b54fe9dfd2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef236120-f1e8-46e9-80ae-634dc64506bb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a5cbaec5-24ba-4fc5-9697-161714f9fa8c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/78d42d4b-7d40-4a31-a240-5968ecdba922"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9ba29066-7939-4f1a-b16e-d1810883ed50"/>
    <rdfs:label>ketoconazole-rosuvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/08b3b2ae-ee1c-4044-82c7-bb10b9393be9">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/6c9c55f1-4278-4535-bdb7-8204a84ee8c3"/>
    <rdfs:label>atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/dd469721-3a66-4ed8-bf56-ab38dc6ba4f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a6220dc8-43f0-48cd-a050-b4c46c7cfcc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/57fbafef-c2eb-4b02-9e4b-e0bfe6b9d36d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c3f6f18c-8f72-4d6b-988e-be6d84a6f3cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/4090a7d5-bd4e-4119-9656-11eba97b4f83">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/afe1061a-2ac2-4a0a-b8b5-9201bb67fd85"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/f711cfd9-39d3-4957-a15e-37bd0781c51b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/41344670-c521-4e2a-8ab9-6b4b14072003">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/81a1f90e-8ab2-4a76-b0b2-1e0562f0ad63"/>
    <rdfs:label>zolpidem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/97d7bd65-fbe0-48c4-a895-69c6b3bb44b5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4414a9bb-8b73-4512-827b-58bc2ae83dcf"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/2937aa85-0b23-4218-8dd9-d7be093b6e75"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f4cfbf39-4bb4-4f27-9aee-fad1de00b8a4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9b15f53a-e862-4d3b-ba3d-05886e1b3124"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/937dc719-2b34-40d2-ad09-549e2eb675fc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f9f09722-9946-43d8-a0d1-0950218e0f07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d9456aaf-dcfd-49df-a850-603088d8680b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e01c074d-c31d-4655-858e-e5261df94567"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/44b7822e-f43e-45a4-95bb-f77f1d2194ac"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/768bd8af-39ef-4d29-a61b-f82b4e3f9aa4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bb60293f-e750-45dd-ba2c-8317bffd6b3b"/>
    <rdfs:label>cimetidine-zaleplon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/319cab52-0142-4a5d-b831-fe8b701b1a32">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f901fa19-7fdb-4b43-aaff-981bb8a51af2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/87797b0c-422f-4898-a1c7-bda7b8eb68b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/20238c69-be93-49bc-b035-084112e62d8d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/4689264b-b056-44ae-956e-113e49525226">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7966350a-1a15-47c3-9800-36feed2738ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7d76e6e9-4df8-469e-b1d3-d34ad9c51567">
    <obo:OBI_0001937>240</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/f8aefa05-a3cd-46f1-9821-c70ed92c73e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/212987e4-72dc-4934-9f11-ee25ade8c301">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cb6033ac-9055-412a-b623-1940e3c4e28e"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/717fc334-687a-4716-b131-430ba543ffbd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/67441125-357d-401e-8e29-96c33fd284f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/a35b0657-a8c6-47fc-87f3-4bd3f9842d8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0a4ae8d5-3fe8-41d9-bed9-bdb45de18ec6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/33763e38-a4c0-4fe7-b474-04c2232ba64d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/6f15d58b-ea9c-464e-a20d-2cfe2745b166"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f30789ec-88d7-4f29-8401-f7013845dfbf">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/96d2f6d7-8f82-4777-838b-87e59e6b8a29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b8a6cfbc-cece-4a87-9fd3-71a9984a59bb">
    <rdfs:label>duloxetine-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6fb28161-451c-47f8-9495-0ae615393058">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b2470394-5868-47a0-9371-76ae22a48fd8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/c75fdfe1-e377-44aa-81fe-34a230a545e3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/9e10af0b-7bd9-464f-a1b8-cbe021121101"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/373164c0-df07-4a15-8904-fe91f30348d4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/8a4d070e-e6e1-4eaa-bdaa-6683067bea96"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/2a2b1a31-0c46-4aaf-88d6-e7fba6cb3b01"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f2562df6-b947-43b2-a280-58b07273f935"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c41fc23b-199e-4329-a9a8-db2987bbcac9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1819d7ca-fbdf-4393-87c9-e67c89ae534a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8144eaff-79be-4cf8-89f6-2aba38d02d74"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/03f75a1c-a273-4d3a-b187-1a7d1f4ca89c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e064be55-14f5-4e56-87a4-20d14c804802"/>
    <rdfs:label>fluvoxamine-N-desmethyldiazepam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/43f6879e-6476-4341-82af-05b65383507f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/2c5e76a6-f4ac-4a1b-9b1c-566ccc45cd9a"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/bed3035f-a419-4cca-acb6-369ffa2d74b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/47623859-156d-42df-8219-f056e6499d60">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d930aac9-e947-4f37-abd1-e327e41528ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/76d08407-0268-4409-a03a-b5a6b05bd422">
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/5b52165f-6c49-4775-8098-c75e84d19c7b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/ad21d82d-22cf-4d0d-9aa3-8c35dbd200a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f566b09f-723b-4cee-b88e-4ca2950c6ae1">
    <rdfs:label>carbamazepine-selegiline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d7f186ff-04f0-4cc8-b2af-368413543901">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/1837a742-49c8-4a90-b88a-e81505b71a83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/dbb2f0c1-1e1c-4a31-9caa-b23e9f53f037">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
    <rdfs:label>lopinavir/ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/830e9d1e-5290-4c91-aa3a-760c0a2a376b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6830a000-91cf-44a7-8c74-b018c2be2b00"/>
    <rdfs:label>ABILIFY-paroxetine CR drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2e3650b2-4063-40de-b773-a307e339e204"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/448669ec-3325-45ab-9f7e-d92aec1a423f">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/5da7e0ed-2d59-4860-9c78-575ce559f8ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6cd52630-f1d3-43a8-8ce6-c2089798d1b9">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/0ca6e364-746a-49fa-8545-76669c5562d6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e9ce9d88-d848-4217-a3a2-0ef84c280ff1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/d5b8b54c-51b4-41cb-9117-919f3270f8c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f81e75a2-0c8f-4eb3-bc7f-bfa1ce0e0ba8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c1d4a65d-dd3d-470a-8a26-f5e01f7453c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5ce76b7b-357d-4d7a-bf7d-9d625bac5a7b">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/4a7dfb4f-972e-4e55-9149-d6ff1962d69a"/>
    <rdfs:label>dabigatran</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fa494592-4e48-49e9-b3c4-1f42a67f18fe">
    <obo:OBI_0001937>8 or 12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/ce4db868-3778-44b5-a4de-24324d9ccc3b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6acf68ee-b30f-4e38-91bb-c8587d837057">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/910b4e17-2a8f-4803-9265-8fba38aef007"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9d4e3f42-6f14-4d4c-a345-1068167ad9f1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/059e096e-86c5-415e-b57e-a8fad9db65dd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bd596230-488b-40ac-aadb-2a45cfd35e77"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/760d6abe-194a-40ec-8f5c-72549edf2f2b"/>
    <rdfs:label>paroxetine-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/88e7ae72-328f-4e6b-993e-59491c3bad70">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bbe14fb4-ea64-44d9-ae84-beee29275547">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/51a666ea-14d7-4f4a-9199-36078c9710fc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/78e0cfc0-40ad-4d55-8ca3-ecd029549496"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/40715ed1-4875-4661-ba1b-9843999db021"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/bca915b5-6609-474a-ae49-5415084793f2">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/83dc5887-03cb-4084-94de-b2335357802b"/>
    <rdfs:label>mirtazapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/e1f06ae3-47c0-4eb5-9102-a9b5ea61ae2f">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c2002fbd-9de1-4824-bcba-3b4c06e4d99d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/051d7153-e715-4244-a9ed-d598a6967080">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/013597dc-0557-4d85-8b0a-820eba873871">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/23d1d08c-8fac-4ebd-9e74-4c934bd4e793">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2562957c-0483-4bc8-8643-a6e69a2e05de">
    <rdfs:label>Fosamprenavir-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/82f0efa3-2213-4ca7-9555-4a87bc9a568a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1676006a-018a-404e-84f2-5544fea8a25f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/d7b14074-2e56-4519-be83-40a5f57aaef4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/45af2585-0f83-4f02-a0bc-05bfb402bdf3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/c8ab28a2-8541-485a-879c-d48eae6dafc9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/67375ca1-a6fc-4921-a828-d5a7274aaae1">
    <rdfs:label>nefazodone-triazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7ebf436d-1b94-4136-9fd0-d253177a2a76">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/15d76ab0-deb3-47be-a668-b8fc14c1c1d1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/ceb54003-bbc9-4ddf-b6de-3a16b1347e6b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fa5be84e-efaa-48bf-851a-e4facf4be73e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/58781b7f-7d04-410b-98be-4f09b0481635">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/b9e0de30-fd26-4bc2-a589-8bbb3f93e55b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/cd0a8672-0a48-446f-8266-48e51dd7344d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6bf3f228-0bdc-4c58-ad29-540f09853402">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/e18b8c25-7a71-4994-a82b-40e5e9aed82e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c55b5cdc-2f43-4f41-8636-8fb2ab905f2e"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/c73f2f36-063b-4eff-9203-ac3a92499dc4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000312">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3cde4fe8-c6a3-44c8-9ea3-d0345a33428c">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/cdb13835-c498-42bb-b5e0-3508f6b95fa2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c473d3d1-1972-4e08-9b71-bc2363855e36">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/013dbfff-5696-4390-a7f2-4a867ccfe2de"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/819b1748-1d4e-4233-b1b7-14013e238e44"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bef719da-cc94-4c51-9c9e-cf710a31aaf4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/3fb627d5-d271-4db7-aea6-ad04778a19fc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/7bbda2a1-26c9-44d8-842e-70edf7879316"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/da5fc962-6f94-495b-acb3-e0886126917c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/676e4d86-6446-4cbc-9149-8f3748c1ac8a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/af9b0431-7c75-4b0d-b6b6-46350682019f"/>
    <rdfs:label>fluvoxamine-duloxetine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c49cb6d2-8f79-4cad-bcb9-f01e09a23715"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/39b8ac43-aa09-444d-8e5e-b5ad05ef5589">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7daf676a-ef31-4a8c-9d22-59a30b5d2932"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fdc7a8f8-f7f7-4ba1-bbf8-ce3bc1073452">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8c679225-de58-46dd-ad3d-64f34793f7d0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/805c649b-751f-4c51-a985-21a62552500f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dc9407ee-71db-4c3c-a6fe-dc576b13fb94"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/64811d72-be2f-49ba-b481-951471ba6616"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4b097c4b-6e4b-4c8a-937b-b56d4411cb7c"/>
    <rdfs:label>citalopram-ketoconazole interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/9fa03e4e-2df4-4059-8788-857650f91c05">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/9fda9350-9b40-48c5-8d09-6f84800d682b"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/aaecc443-fd59-4b13-ae86-2524afdf6cf2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/c79dbfb9-c5b5-437f-af7b-282d9813f62d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/e2b5179c-30be-4f36-98e5-6ce700a1e800">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5a8a65f5-7b95-4988-aaa3-636c4abcd531">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8c397521-4f9d-4bc6-9e8b-0b147a4ae9ca"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8f402fb5-ea24-42d3-9436-12d13f2b14a1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4dec2c40-4e44-41f5-a2de-f7bc5bd293f7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fc976b7a-d6f8-4c7d-af00-3f3ec86d48db"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ef652e75-89f6-4c72-81c4-85a3dbbf8c40"/>
    <rdfs:label>Fluvoxamine-tizanidine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/50bce766-a17c-4dac-bb0e-0458167b3013">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4563b344-82b1-48e5-896e-f34b2d2cd0fe"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/95ab95da-1147-4c13-93e8-322f1c9f4a56"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b7a79c73-24da-4419-a8f7-d4b1455f9034">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fb03eea0-090e-4e83-91fe-d78bb400ce98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1b68b626-f85f-4813-993d-b3da700b86de">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/efb20375-f920-4435-a018-f9ad09153ea3"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/60fb48ee-d195-46eb-8c92-ff76bc16d300"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/182a6f35-e524-406a-8547-a34d487d0731"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f1fc83e3-e352-4133-84dd-271e2aedac85">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6991e5b7-9ed8-4fe4-9744-4796948b7f47"/>
    <rdfs:label>Boceprevir-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/68821892-c796-4b35-a14f-66450871c2be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/721f358b-3dd3-4f29-8185-5ba6c3149c90">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/358a2b73-7e2b-4b75-b8c2-0d1945aece4d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/14384bcb-fe9e-4f63-b408-97a69e94d78c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/27508b6e-022f-4a7b-854f-8a3448f27a5b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e1445d82-2d5e-48a9-a916-78d07566c51d">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/a21f43ff-3889-46cc-98c1-93f6e239e103"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/efd3506e-278e-4b2b-b082-66f4aa0eb635">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f6b0e156-2b1c-49e1-a085-a72a51121921">
    <rdf:type rdf:resource="obo:RxNorm_461016"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/a9de0538-05b6-4af6-a0ec-9a72d503b55a"/>
    <rdfs:label>eszopiclone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4d5d2b02-329e-453c-b366-6446983c8dbd">
    <rdfs:label>sertraline-tolbutamide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b677c79e-ac49-4df5-a5ea-eec5533d6c0d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8c99772b-e7fb-4910-816b-58533d9de52b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/f2fda246-842e-4811-96dd-10a63c346fb0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b9cc02c4-4cad-4a8d-9412-8a1f007237ba">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6d9d73c1-e26b-4c87-b465-8b2919430840"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e1e0e7d5-dff7-4feb-a991-400303dbb80b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/350d98d9-d732-4ced-8dc8-8afb05869de6">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/7383c614-7025-4be1-8e5b-c1a43b16da9a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3967b527-6194-44b2-8999-fc47960a7b2e">
    <rdfs:label>ritonavir-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/58a09a6b-07d0-4d75-a125-76405e5ce0d9">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/af443f8f-c835-447c-af21-c68f0e5e94a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/855ac767-27a0-4f10-a9bd-4aa97e10f918">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/479bedaa-a712-4142-a00c-04adb4d059f4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e4a90831-76d7-4a7b-b02d-f46e044a15f1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a078944c-1c5c-466d-aac2-d1175e17f034">
    <obo:OBI_0001937>33</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/5eb56960-5017-4dc1-a78f-12c6e502f9c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/cbed80ef-94cd-4b70-8c3d-e26fa31b7954">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2f4425ac-56be-40ba-9537-fc458dd28c9d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d39446e3-0416-4cae-a7e8-af590cfa6db0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/dfc74994-e3c6-420c-a01a-69789a8be87c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/86ddc510-370d-4140-aa5f-81355d6b2ece">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/5a1bf7dd-33df-4d41-8763-738e99c48934"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/e199b114-ccf7-4d27-88e3-5f15c5354e16"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/4dbc5abe-4cbd-4118-bea9-1130d41bc00b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3f8a638b-a493-41b0-8c52-53b166d09935">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/4d4886f1-acf0-4772-97e2-30e414a97bf6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/4a3cbfa6-583c-401a-8cfe-56a60b4e5f19">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/ee86bd49-49a8-420a-8133-14aad592b4a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/6f513f07-20de-45c9-910b-f103b03dbb7a">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/b0ea4655-4a4e-43e6-8230-7094d98082cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/141b7a80-0771-4a79-b281-03a465d9818e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ffaa4617-e9b1-4dab-879e-49c761cda802"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3c6b76f7-2107-4d61-bc7f-ec08eb2d2117">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b8cc1952-f152-47a3-886a-a8b31d65c805">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/828a8548-a1e6-4fab-b22e-d44aee67d62c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/02a230ca-d2dd-4adc-bad3-b3cdef9997be"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f0ef942c-b856-49e9-898a-b45adb587a5f"/>
    <rdfs:label>fluoxetine-iloperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bccc00bb-a4d2-4a20-8fa2-38fcecd98919">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/0869ca70-5f94-4df8-b14d-6419e627d5bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/115281a0-9162-4072-85c7-9255daf46861">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/77e13b87-5973-4ec7-a631-1650886fd010">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c683ca03-ba21-4544-8040-19748f667293">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9f7b566b-dadd-4645-b444-72f4d20515b6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/941bc456-e10a-4ca5-bbda-e75a1637f336"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4dd4b186-c515-44e8-b341-cf502201cb91"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/147c909d-531f-44fa-8a1b-c6bcac1fe1b3"/>
    <rdfs:label>low-dose ASA-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/9fd8364d-e087-48f8-9fe8-8ce5621aebaf">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/96270bff-ac2a-42f3-9cc1-45e00d75e3d5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/dbc32d73-0c0f-4fa4-8166-f64e77854a08"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1f211658-4033-4181-8e41-d13eba748c92">
    <obo:OBI_0001937>7-20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a4cd9bae-3bfb-41a9-a242-813919afde24">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/0c72bd1e-3c18-4746-8ae3-12302c58d345"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/154a8a5a-037c-46b1-88a5-7270e21798a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/50b8f37a-a7d5-4eb4-8ed8-7d598fcc6a94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b447c421-6c25-4583-8468-67ae3a0f52b4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a103e907-33e1-4295-a315-d94af381cf10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7dd4b7ed-da2c-489b-8791-ad94ac46a037">
    <obo:OBI_0001937>1.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ab4d42c9-fe6e-469c-b8fa-0db4905239e7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4f8c08ac-cc6a-4412-bb8a-238a6f6c2dcd"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/45012a0a-9e2d-4dfc-9a6e-c5bda62e1de6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/54bd602d-b002-4beb-a954-af58a62b576e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/39ba790c-a444-4b9d-996e-6ca6cbdf96e1"/>
    <rdfs:label>Amlodipine-Atorvastatin drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/efcf34bc-605a-4e0a-96e5-abc526f3c0b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/3d086561-f17d-4d8d-9da4-93836ba2f07c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/ec7bf94f-b28d-4ea9-ba39-f5a61dbc3143">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/350d98d9-d732-4ced-8dc8-8afb05869de6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ac31aef7-4d41-45fd-9007-5eef3d77c391">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/89f1275e-5d4e-4cae-abb8-b561df255cbb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e14dd4e4-48b9-43d5-b287-cd9cd69220c7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2ba321a3-1408-4a32-903f-86564e66f0c5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/571ad28f-b60d-46c9-a88a-626c8f4459db">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/0d733971-67cb-44ae-aa02-3ee931fd0982"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/de057359-44bb-41bf-b75b-c9d8db7a12c2">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f88c5838-51a1-4458-a594-bf16b257bca1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/847efe93-7d4e-4758-90f7-4d3df4d276af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/9bd5b884-7b41-42e5-ba34-b7e54a1d0c95">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/9fa3e3d4-0c0e-4442-813f-de3706eddbe0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/c808ef60-033d-4744-b62d-a0d85ca75ab6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/dcdd9f9e-23df-4162-be12-f0c04f67bd12">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/22fd94d4-6d8b-4519-8aed-658700143f75"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e606da95-e696-427b-8358-1ab51efdca56"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/89247057-f0ff-4ecd-895d-ad42dfe66573">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/bd7e9d81-1afd-4651-830d-863cb7fb0fe9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/27fa22e6-cfa4-44c1-adca-5e5e5c6619f6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/b8e07ed9-2cfe-436e-9f52-c958458fe3f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5ed7ce45-1410-4933-9e8c-f8630e82f6b8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5458e810-49f3-4d68-be24-72cb0cc3aa4d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/b7668901-96dc-4512-8c74-8b74657e1a22"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/01b7d9eb-a769-4424-90cb-4da482de77ba">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b0ec26b1-805e-401b-aa99-41380228c9e2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/59e81276-051c-4e8b-96fa-7696cc5fdc49"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4528c428-e147-4b9a-aa47-0445c886d031"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ecb747db-f541-414e-b1f8-7eed874ba72e"/>
    <rdfs:label>rifampin-zaleplon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/cdeb40c9-4bc1-4a5c-931e-48120992a8d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/92640a85-575d-4340-bbac-3f91efe614e8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/320be492-a68e-4988-acb9-d7765445cbbb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/d7800520-a576-4d86-b371-76fab60f5b1f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/451971eb-6d6e-42d7-923d-0fcdc22a9bcf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/357b39c7-6ba8-4934-ad0b-dc678ffba06c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/358ff7bf-3685-4702-acf6-275e9df65068"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/358a2b73-7e2b-4b75-b8c2-0d1945aece4d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/02cef4b6-9088-4bb8-b6a8-86676894a2f4">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/4b906e08-38e7-4686-9085-7ef2c0b83681"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0e1ef038-9940-4dff-a978-615d873f9b3f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/23551626-07c0-4bdf-bf41-89aeefcaa672">
    <rdfs:label>fluoxetine-iloperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/248aceae-d9b1-416f-9f99-9a8368aed2fd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/63695bca-6578-4425-8372-7e2111e0d042"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f9e90fdb-5c81-4c16-bb8c-f5d4f9723672"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/08958f26-1f42-4768-8b89-9e54f83d9ca6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/809b7f35-8ce6-45b7-8f1f-1d2918b94cfb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/fd1ffb1c-60c2-4f35-aa11-102090bed6f3"/>
    <rdfs:label>quinidine-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/59cfeba4-d496-4e1a-b951-7ecb3f219f2c">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/2cb974b7-167f-41c3-b3bd-d1b5406391a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/430d9577-b939-47c9-9af4-d105ce6489d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0bd64522-51a4-483c-8693-7a7c8e9de19b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e95dc6b4-36f5-4d2c-b30c-cb5e07ca4cee"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/beca81ac-0d11-43e5-854a-bcc1d924eb1a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/884af1c8-83d6-4bbb-8089-75b5df4cdb0e">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/3b8c8416-72e7-4d63-a683-cc8550450313"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2dd91b6a-4ff0-48e4-82d8-91e22d896dfb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/2ff57fa1-edc9-4754-83ae-112393cdddde">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/682131da-f5e9-43de-9e23-cc5d836217f5"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/0da86ba8-7e8d-490f-bf75-61e413a818ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/891c7309-b405-402c-af41-72367f579253">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f90362b7-d826-4f0f-9bda-a58e1baf01e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3601aca8-0f2f-4467-9715-6f98a154a7c2">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/fae8dc23-980f-483d-bddd-956bbab2f65b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/335aca78-9ed2-4df9-b131-34bb04f8ed3e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8aace609-781e-4569-9cbc-209eb8b6fa7f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/35953b2a-ef1d-421d-9343-efa998a63d0d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/60d0ad40-7dc5-4c60-822a-678c45212aaa">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c7af70d2-3943-439e-bb51-98aaa07b75ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/8c2c67df-46a3-4dd5-a10a-f74d189bb4d4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/da1e8110-6ec6-461a-ba2e-8270ee5e73ff"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/9f2d335b-e534-4cbd-ad4c-b8c3ae32e315"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1dfa4075-f6ad-47d3-8dec-789ff27f4475">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5c1526ea-b4aa-404c-847c-45ae124dc032"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/45f522e6-eb81-4b58-8702-5a38a71ad109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9da38d9a-1918-464b-a6f9-c7d20cb8b9f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/978e562f-cfdd-4eed-88f4-3059bcc0ab38">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6a5fbe89-244f-4321-a3b2-916d51a1e926"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/5f5e7cda-cb84-4035-ad21-825ac3d866e1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/44028c09-3b11-431d-804b-bff84c772e79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3a892d6d-ba6a-4d5f-949a-5f26177c95d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3ad5ccdd-1b2e-4e5b-ae84-74e6fe31d996">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/8d1bac29-63fe-40f7-969f-fb8a008d0b6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/b6fc6b41-617d-4a41-a7a4-e88cb0d47278">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/ce4539e2-cfe1-4490-b65c-a327203cf5f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bfbb4a3b-7a61-41d1-b37a-f5aaaa89005c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/615731f1-e5ef-4612-980a-360b8e9525ff">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/18696dcf-cc8a-40af-8097-c7eae0faef58"/>
    <rdfs:label>phenobarbital-paroxetine drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ef8212f0-8535-49c6-9b3c-f7d522e57e8c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/9cb9bf98-5a2f-432c-adf2-13f0ab829c34">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/95780e12-6d66-4657-9898-40bf45b75d18"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/67ed4e95-568b-48a2-b486-15c8b8aad1d6">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/52bdccb9-9bbf-48ea-83f1-3ed4e974b934">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/82ae1774-3d8e-479d-a8a9-bb0d100bf15d"/>
    <rdfs:label>zaleplon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a9bfcd6e-f7d4-4b58-8146-9be4ebedae47">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/cf3e1d47-1b4f-423c-9f87-41c9ecef21f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0e03c5e9-b5cc-450b-b3bb-3bfa0bc5af29">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d60d1bdc-e39d-4744-828c-85ca76ba7806">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/8f13424a-6e25-4b59-b597-3d5ef4d53491">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/7b2c2725-7aea-4474-9800-358b696cad55"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/ed5a15cf-b6a1-44a8-935f-3822e4a89f33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/b91522bc-217e-4f02-b0ca-173a187fb3aa">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/c144a65d-a3d2-4c3e-833d-8c8cb6134ddb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/059e096e-86c5-415e-b57e-a8fad9db65dd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8dab20fb-2503-4578-a64f-033f15f90e2d"/>
    <rdfs:label>paroxetine-desipramine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3a8e7546-d556-4e33-a9dc-5e7185711295"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bc6b6ae2-0786-4094-98dd-3de372c6d855">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6c394544-62e0-4115-9e65-a1bf7fd2cbbb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/8c8dcbd1-6dc4-461b-81a8-f68c14a4d891"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/153615f8-9914-4bc1-b6c2-69d01cd453f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6e15f84a-b046-41a6-9afe-1ff9e83638d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/604f3049-3761-497d-a634-33ccc865d3f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fb1b48c5-d5f0-4105-b4f4-1124d7c580d0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2fac14be-b310-40a7-93b6-b2f8d7783aca"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/947012aa-2450-4a4a-8339-c0bed8981eba"/>
    <rdfs:label>paroxetine-P95 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cbdfcb11-304d-434d-aa02-754a6f4455ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/63695bca-6578-4425-8372-7e2111e0d042">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/caf9b62a-c55d-4c98-9e02-dd4c560706f9"/>
    <rdfs:label>quinidine-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0470bbd1-6ff1-4fbc-847a-68dbde740941"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/066953d8-6b36-44de-b45a-2ac499e64809">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ac5cb73f-0dd0-4800-b713-2830ebb91406"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/609da682-375c-4ae0-9e32-0c398e3febf0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/dbc32d73-0c0f-4fa4-8166-f64e77854a08">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1053cb87-ee5c-4d5e-bfa1-89abaae77670">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/56aacf21-d90d-43bc-acd6-d88e53f1339a">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/daaaa0e7-481e-48e4-9093-c9aa8e8b6982">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/fb90658a-15db-4e70-b752-049a07b662c1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/2dc6d1fc-e015-46c4-b9c6-6284da946572"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/5fe3293a-903c-4ba5-bccb-445a13f8e2e5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/8b41753b-3049-4f24-8d74-967d6bc47197"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/b72c5120-0869-4456-9462-ac94b9a31a9b">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/2df12e8c-442c-432a-8958-9e37e89f79f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d62f6090-ec03-40ad-8859-86b699e85722">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/8ab0ddde-cee0-4eca-bf85-da9ee6ce879a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/efb20375-f920-4435-a018-f9ad09153ea3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2dc6d1fc-e015-46c4-b9c6-6284da946572">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5aadfe38-c0be-4c03-8af8-288d70424810">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d50bf92a-8af1-4b9c-92bc-d177695f56cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/09105f3b-a225-45e3-b2a2-f50b632f6aa3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/89fc92af-b9e4-43fc-b4fb-7102ccea3e3f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7557d550-8b00-438e-96f0-15214cab85cf"/>
    <rdfs:label>ketoconazole-desvenlafaxine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ace15ff9-cc32-470a-bd3c-07180f50744a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/de378ddf-576e-49aa-b708-bce99c3ba932">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8ec50a42-088d-49de-8b4d-8f0814cda1c9">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/ba9d8dff-8a1b-4097-bd4e-908f19141b97"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ee9a99fd-57b8-4259-9753-b4a78b68e183">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f8773333-d9a8-45f8-8222-cf63b648e8bc"/>
    <rdfs:label>clarithromycin-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/9332c4df-faa9-462d-94ff-9132b4bfe9b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7afa0795-602c-4ebf-a144-0957d54ffca7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/652310b6-0d62-43ec-93c3-0b727ba1c1e4">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d25d79ba-b30a-4d79-9d0a-ba30f9e9fe56"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/601a83ca-752c-4049-ab60-4efd7b1906ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000576">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f2828dbf-1d16-4475-9291-a2d9fb7ed048">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/76d0ec65-026e-4c5c-99cd-f38a277391a0"/>
    <rdfs:label>paroxetine-atomoxetine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ff1852d6-a1ed-43a4-bbfa-a4b250511216"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0540bd19-c4b5-4870-bbb5-b62b1bc8a050">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9ee63dd5-940b-44a6-aa40-ef1318f01a41"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3aa14565-c7b3-4157-bf9d-216809a68f61">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/1f90a783-2b9e-4196-b862-569374d87457"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/88deb09b-d868-4e72-b407-a173b331c93c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/272de90b-8170-4da4-8c56-65d8e068fdfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/a9668a74-cc2b-481b-832a-572bed1aeefe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5dcc9dea-c53a-433c-af98-eb30fb225f88">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/47024f77-f692-4fc3-9a45-f5fa4f730229"/>
    <rdfs:label>ritonavir-erythrohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/880cb54b-1feb-41e1-824d-a8c477cee5a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/61b77d7b-bfc9-4a81-aa15-9b2547673e10">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d65b4e66-e67f-4c2d-88f0-08e82adde3b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/01434ea3-adaf-4fe4-8fed-8e7f70d22b35">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/496d8251-03e2-4047-b53d-a98b7e2562a2"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/f9b7abf6-c917-4959-aebd-09a32c20d012"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/de179a3c-82ff-49b8-bc2e-2dc999e173e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ae10f31e-e184-442e-bc5c-dbef7232e0da">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/a482b865-f623-4245-9233-cd4d3f07f59c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/01423dbb-e589-4625-a9f0-9463ce613f9e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/89bd41f8-27db-4e0b-9ab3-3efc9909002e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/264610f0-fb81-4b2e-9084-188ba49b4ce7">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b2e3b1e9-2301-4b0f-b515-9a0ad3139e37"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0405abcc-228b-4617-abc8-3a1bd5a7ff51">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5dca4653-a2e1-465d-88dc-57a82215ff58"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2a36ac53-3f5e-4a77-b060-80bcf723be0f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e1769f07-93f3-4262-b3dc-28b4107f9b00"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ec1f1558-1401-4adc-aa81-df68b2c964f2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5483f6a1-abaf-4fda-b934-a0e05303e7a9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/00f2350a-d041-41a0-9e0c-0876060856fd"/>
    <rdfs:label>telaprevir-amlodipine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7af1c396-506d-4cda-a27a-b97bde558870">
    <rdf:type rdf:resource="obo:MeSH_C036139"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/00ebb741-02f3-4cfe-985e-4b07a8d694ab"/>
    <rdfs:label>norfluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/004448fe-ee93-4a8e-9612-9440667e006c">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/a3618cb6-ff6f-4077-98fa-1ebb01ee7789"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/28947c4d-4b9f-400c-ae1a-cc59bd2bb1a0">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/98f63d31-124e-4818-a524-e1215c952ef2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4129591f-daf1-4394-9675-63074f4e022d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f75509a8-ca1e-4552-8369-5ee33212d531"/>
    <rdfs:label>naproxen-Edoxaban drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f3c5bd1c-3f34-4a98-9bdc-23fca26160f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c70237f5-127d-4c4a-97e4-e3842e25fd00">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/891973eb-c449-456d-b77c-5e634c54ffd4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/4b91ab92-06a1-4bf2-9cac-983869d52d55"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bd167d16-e88e-4520-bf28-38b2475f36af">
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fc6cc211-7800-42eb-b82c-c680973f0824">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5cb70951-3668-4307-9b64-ba9bb3710a95">
    <rdf:type rdf:resource="obo:RxNorm_35636"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c7d0cd96-6a90-4e41-8a44-923786fb422c"/>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/007b2e82-bb08-4622-a6f6-9eaa6ee17bf8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/61df763f-2449-43c3-b738-e9c29e72054a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/840c7dbf-fa56-4afd-bdd2-68ff7d1bafe8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/81a1f90e-8ab2-4a76-b0b2-1e0562f0ad63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/4ba4bca3-ef31-4e85-a158-bb41b4c494e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3244fce5-7b50-47d6-a851-04d83ca897ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4e573cab-6832-481f-8d06-385784870aa8">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6b0e8203-e53d-49cc-9a96-8f73b340ab33">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/f7e2049e-0920-4587-9459-1e27df245506"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/15ecf868-7cd8-45f8-a177-a01d8a0a1c70">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/59229394-eecf-4b70-904f-6fbf04acae3e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/30ae7bb1-cbba-469a-a412-7b7ea77673b5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5daef3bd-f1f6-4262-9b2f-84092e200d75"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a82fe60a-8615-4f68-8329-a41b0be02cfa"/>
    <rdfs:label>atorvastatin-norverapamil interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c536bbc5-c94a-4a74-9c21-be0d99f13cc4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e619ca9a-2a25-4eb8-b123-1676d7f6e8e9">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b093004a-58fe-4a83-bdd4-9f8303c67169"/>
    <rdfs:label>rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1cb23868-5b47-4f33-9a5b-ce2061dc9781">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/c2f32fb6-8f07-4e89-86e4-e82b275f5fc1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/2c11d8e3-08de-4dbb-8700-e790f840eded"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/42688900-033b-48c0-919a-2540da33ac56">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9f8091e5-d438-4ae0-9f4f-86c5b91a3297"/>
    <rdfs:label>Fluvoxamine-sulforidazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/54098f1e-1691-4edc-a49b-a5953580fa00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/309b4459-9f9b-4364-9154-f1c073e0bb6d">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/ee06dc9b-8e76-4ce0-8118-5a0bbb3e724d"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/bd916aba-f23f-426b-a93c-0473f68a782d">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/ae8be822-4fe7-4beb-a914-567ab0ef8240"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/80116197-8ea0-4414-b91f-106b1cb93194">
    <rdfs:label>ketoconazole-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/75e96d6c-a939-4349-acea-91282afdfd2d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6fef8007-45d7-41d1-a8a5-91e4574c22e4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/785e0384-829d-4d72-85e8-851d6ea57496"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/573f04d4-9e3c-49e9-9cd0-cba9d1154d83">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/211e87cf-3e0a-41dc-ae5e-b4463b56acba"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/2c24b990-6da7-48d3-9c17-0ebd843800e8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4caab834-cde5-4341-a926-5cdfbf734923"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/6b300be2-9757-4a82-9a68-49aeb6664068">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/eb73e100-a009-4a90-a0e3-12c09b5ecfd7"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/71707e60-ab63-4455-a800-5522ef68b81a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1b558e97-bb61-4e05-a5a7-bf779ff3e9bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/9f58dbc3-2fa6-42c0-a179-9c692b38019e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c9ecff2d-d6b0-44f7-ac43-e52cca23a1c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/97bd2614-d1df-4158-9be4-d64d1a570377">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b511e8b7-a4e3-44c2-976b-2dc99689fad4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f541d0e2-31c9-4811-a10d-02f9a577e4d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/135aa127-c84c-401e-8d25-2bf4a4805edf">
    <rdf:type rdf:resource="obo:RxNorm_35296"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/743d5863-e237-43fc-973e-190d322e0923"/>
    <rdfs:label>ramipril</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/63dabd92-02b3-40ce-9b6e-11852bb4b2f8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/951f9e6e-fc91-49e7-a646-cda9bf5031a8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/aa22cd71-f93f-4b38-91d1-96ce59534d7a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/29cf73d7-7b60-4037-836a-d82d5378b452"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/e9827f9b-de33-4ba7-9231-a222e0d0ec68">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b2cf0ab3-fef7-4acb-934c-9292ae951c0d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/50deae25-b381-44a8-87c0-7901e2bdc67e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fbc87786-5376-494a-8200-35f7c9984071">
    <obo:OBI_0001937>82</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dffbfd01-c3d5-468c-9e7a-45dc70d3a822">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1c3d9e52-9808-4ee1-8f4a-13ca26b26977">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/87d60474-3de4-4d34-a01d-22755ce542dd">
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0c81295b-33d8-4b1f-998a-e461b622f6b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ec1364e3-ef06-410c-ab91-c338a4df2564">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/96c974ce-7570-4cd7-8d3f-5a8a65aeb4b7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/26efab14-78c9-45fa-8cee-ae2c374f1f78"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/22b62b7c-9d42-4cf5-bd03-4fe9b7b6326b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f638ce10-8662-4ec5-a104-99ff27a8bd91">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f2ae6782-72aa-4658-9954-d27769d9a12d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/3a1c0da7-4034-4364-8798-39fc8ea62fc4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5bc17749-8c91-4dc7-9de6-092f4aa4fec0">
    <obo:OBI_0001937>7.5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/b103878b-d937-465c-9268-c76a57895915"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/98ca6594-a86f-4129-a6d9-f4513ed4de19">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/6e39e748-9152-4411-84ff-f12a5cd2da57"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8d8b4a28-063b-4170-9727-deec43e7528a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/76ad827f-8699-4a2a-b613-2f0cf061ffb2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/97bf3c40-58aa-4f52-a5fa-2b76dd8ad215">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8410ff5c-21ff-40c6-9167-4e7bac4dfbfc"/>
    <rdfs:label>fluvoxamine-mexiletine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/4ffe111b-27e7-4e9b-a367-c06dbf26ad4d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/99776b6e-5268-418f-9a3b-a444c1088ff0">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/56ffa390-ffb6-4d78-b7db-c5028f30996e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3b236891-b8fc-4393-9b66-f73cf321c17d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/4038e2e5-f248-4255-9b48-59934a12675e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/7e5d9f03-9474-424e-8822-54b7a5751cb7">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a31929ca-46f8-4ed9-af8e-4a32449e0052"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d673b308-917d-4693-a93c-83b823790ba0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0114d786-fe0f-43d2-95d8-2c2c943136ec"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/acef1a42-e282-464f-a81f-2500028e0f04"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/efa9bccc-d17c-46a3-8807-dd8e787d26c9">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/c0cdf8fb-6445-4eca-beaa-843afc11f7d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/875ec477-bfdc-4835-a29e-d439761e121c">
    <obo:OBI_0001937>1.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/5ea6cc03-949f-44b4-8dd9-f7dcb491ec6f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e8b1a712-a29d-4d2b-b415-6921c76787ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1bb27b0d-8197-4299-bb10-2bf4ecb7a62e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/11a538a3-f2fb-4520-8e8c-897dd3bbdf90"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a82fe60a-8615-4f68-8329-a41b0be02cfa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/434dccb7-2efc-4117-ad01-0a62741b7ef1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/fbf35688-cbe5-42b2-bacb-e880e96244be"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1b6b3daa-1288-4445-9c4e-1e21ef72e4f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/8c43c61b-0f24-4421-a3d5-7a20aae8c5db">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/86e8eb35-c6b8-467a-a204-89c98afaa496"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/3eb3385d-d064-41bc-9179-a536496ccda5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/471f44a7-387f-4d98-832b-570d72422459">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a3d90672-48fa-4c47-8c90-60e6c3d77479">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b4ed3589-8d38-4e6c-9063-d07bdc2dbe6e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d4a31b54-1f4c-43b8-abca-f4d0825e3cdf">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/650f1758-9c18-4f1c-a9b8-33031bd2f2bd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/17dc4f42-8c86-4e99-acea-420e29674122"/>
    <rdfs:label>alitretinoin-ketoconazole interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b66ad089-1049-443f-9560-428827d117f9">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/ab35fe21-3217-40aa-8ff9-bfd046bebd56"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4297af0f-7fd2-44c8-9e30-90aaea3230c2">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c8b40202-2ba7-46fe-ac95-a01ad79826d6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/66614504-f480-4e5a-b062-69b7bfc200f6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/ae0d5d55-94b3-49dc-95b4-33b29d65f184"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c4e7af8b-a329-4a69-9fdc-c9c8d228049a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/df5108b8-1127-4a5f-a329-65ad063365e4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/6bc43290-afb2-4b9a-b38f-9e32bc06ffd0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/3f79c7d6-2183-4fde-82c9-332878548768"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/60fb48ee-d195-46eb-8c92-ff76bc16d300">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c45f66f1-db21-42e2-9762-8e04fff21c38">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3ce710cf-27e3-4db9-ae78-290749dac7dd">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9d888302-b370-497d-856c-d5960acecdb8"/>
    <rdfs:label>hydroxybupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/22dae535-923f-4893-8ad2-958c76774a83">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/71e940c0-0819-45ef-b66e-83d1148842aa"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/a7578590-15e0-4e17-b7fd-6586c2f7c12f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/4e53fc2a-bfe5-4d49-afc1-d02e2edcdb9c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/a7475178-6056-4dc5-bcee-783271d51030">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/fe986b9c-1ee4-4a0f-b627-d25679a47c4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a5149d13-2cbd-419d-9691-93d2475a0ce1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d1dc1925-17b7-46fa-8f56-4918b937dbc6"/>
    <rdfs:label>ketoconazole-P88 drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/266b4e5f-cc05-49d4-acb0-ddee2fadbf9f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c8dc1918-59de-4089-9780-e42f989a42d4">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/39330cc2-2b04-43a6-a5e5-d95b087bea40"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9346cde2-3714-4b04-b38a-5b6ba990c618">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6baea4dd-c007-478d-84bf-4d27e510b2c9"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/18ecc608-6c8e-4cd0-b208-2b97db83ab94"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/4a63ae9f-59dd-44f9-b126-8518d9049fe8">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8ad6eed1-2320-4ced-a0f9-04d729d2c2ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/9048d601-6108-4743-ac72-fc0ab61e70c8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/62a96ba6-77ab-41f3-b33c-7e2788c45cc6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/200faf39-882a-4c75-9595-2b6a367fe162"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d7191d58-d97f-4ab0-bd97-d5a66245799b">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/6bd1e43f-3806-4fd4-9a88-ed020c7b67a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/12a07d04-5379-4068-bda2-11f3ac517a91">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6d531528-c9d7-4e01-8dd3-79ff36f88af9"/>
    <rdfs:label>nefazodone-simvastatin acid drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5aa5a178-7bd0-40c8-9436-eb111bf7e688"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/faab0ac5-a1bc-49a1-bfe3-3813820a7e62">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c8ff8084-a193-4542-9966-80a27490c3bf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/517e1cbc-1746-41e2-b6f0-ff724497218a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d9cdc57e-4ea6-4a87-85a2-4637e45b6858"/>
    <rdfs:label>buspirone-hydroxynefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ed9bd682-73bc-4499-b196-5a18cb4fed62">
    <rdfs:label>sitagliptin-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3e73ac90-f6bd-47f4-b562-debbd64734f1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1db6522c-ec49-427b-82df-a17171e51428"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/52f75856-f8db-4429-b7fb-50c005db6ad2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a6868230-bebc-4bff-9611-e2a5ac64e264"/>
    <rdfs:label>carbamazepine-L-amphetamine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0301cf87-b960-4663-9624-ace4cf951c32">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9b5203b7-c582-4ae6-87bf-f172daebf6c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/35953b2a-ef1d-421d-9343-efa998a63d0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8ad7e3aa-7e1b-4a28-9359-da4d77bbffb5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2860cd84-4e25-4e97-b3a6-5b7f91c27bda"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1fea1a9d-5751-4d69-b3aa-954fecb4ad22"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d0f8b4b0-7b59-4874-adba-9d51093bed04"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f8b9877b-2cc7-45f0-bde0-a59896ba0b03"/>
    <rdfs:label>citalopram-pimozide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/b9293ebf-ac6a-465c-b1c7-4c332a0e305e">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/6e55cc1f-7a39-4ccd-a962-69d89914e364"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ecee1874-3b44-478f-b3e2-8cfdc3c42919">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/828a1c37-eb4a-4fc1-82e4-58e646d2453c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/adb80a4a-d257-469e-b937-835c95ea61f2"/>
    <rdfs:label>fluvoxamine-tacrine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f1acb20e-cd12-41fb-b720-a0c102d24fbd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4528c428-e147-4b9a-aa47-0445c886d031">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0df830cb-e498-4a3d-8225-dc4f593ee73a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/e8f9823d-fdf7-4c49-9542-f7725770648c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/56d6939f-77db-4633-89dd-f19a66cd81d2">
    <rdfs:label>buspirone-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/010ee264-f295-49a0-a256-f87bc5de3e63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/48ff8d03-1beb-46c6-9324-66080ea33098">
    <rdfs:label>simvastatin-alitretinoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a842d73b-82ea-43eb-ba74-4dacf9a4172f">
    <rdf:type rdf:resource="obo:RxNorm_8718"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/39bb8598-8c1c-43d6-9bc2-56be4f54cd8b"/>
    <rdfs:label>procyclidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/98ab9fc0-646c-4ce6-bcc8-5a0c1a6097c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/811f7725-e804-404f-852a-a7868b723571">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/23a0580d-cefd-4e74-b93a-ac9b0a90f114">
    <rdfs:label>atorvastatin-norverapamil DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/368fdedc-81c7-47aa-914d-938c41ff25cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/71707e60-ab63-4455-a800-5522ef68b81a">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/368fdedc-81c7-47aa-914d-938c41ff25cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c543821f-2db8-49f4-a51b-977189aeaba6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/76388de8-46c5-423e-b908-c1ea115027b3">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/2ad5f17f-b0dc-4b3a-a2c6-4d2d201901a9"/>
    <rdfs:label>zaleplon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/33d66447-6273-4081-a2d1-c187fab689cd">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/f6291a43-a197-4aae-b31d-e6fe98b34578"/>
    <rdfs:label>alitretinoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/293dad75-4a6e-4408-94bf-23bd3512c393">
    <obo:OBI_0001937>87.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ec5ca415-4e55-4dee-be3b-a8282d5aa35b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1a476f72-7c06-4e6c-9aae-46c68b336371">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3a3fbaa0-f77b-4492-8d09-8a0caf4a3267"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5e3ab0f9-a897-4e79-b429-5656934ed9ea"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/397f3ba4-d889-411e-9e1e-742dd73d902a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5933b615-6c65-4705-ba80-30977fdd084e"/>
    <rdfs:label>Clarithromycin-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c8d81eb0-befc-4291-8a9d-aaf2d07f8ba5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/aefece42-68ef-4309-aa94-05afa588f30b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/480f36c7-c472-4110-8346-6e25da1cc763">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/419bc65d-6f49-449c-99f2-0e10bfe8a3aa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/dbce0e69-088f-4c89-8430-c2c09e5d29ed"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/809b7f35-8ce6-45b7-8f1f-1d2918b94cfb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/179eb2a2-3334-41aa-8d22-68e3ef64fe0f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ab8cd829-f29e-4deb-a008-4640f845c5ad"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6640be46-1ebf-4a19-80e5-c1efd00157e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f1b6d5bc-6168-4b51-8a38-4e22eea8ad99">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f262b7d6-8fad-4ad2-8cef-558dd5e6e860">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/65b9f06c-befb-4b81-8075-9409b80e6ebd">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d729f362-68d5-4874-9127-2f0e9fe85e5b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5aeccfc4-46d0-4f3e-88f5-cfa6ff8efcdc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f0b48de4-dd3b-421d-8108-6ce51c694955"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7f6d0436-52b3-4ef1-805c-b13292fb3cec"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d6955e58-9a53-4b7c-9003-26addbf1f203"/>
    <rdfs:label>nefazodone-haloperidol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/83299b3f-4611-4536-9ac6-b19ee2c6cb86">
    <rdf:type rdf:resource="obo:MeSH_D003708"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7ab5c129-c949-4a93-8cb7-e1616cad395b"/>
    <rdfs:label>N-desmethyldiazepam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8f6c528a-8d0c-4e44-8227-cc7a426e5916">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0fdf05d8-670a-4fe1-a4e5-300dae2bb26f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/27e1289e-ccdf-48f4-8d39-1c5afc9597b8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/68e6effa-4569-41cb-a8b3-f8432f757cf3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8d78b15a-2c7a-4294-a615-59fd53c617f5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e4d8f5ef-87f4-4b29-9efe-c94904812c50"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c0aa30e0-ccc4-4710-86b6-0777641d0510"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ac5b6b15-0c2b-4108-88a8-83fb8da2b4c3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b93b97c2-3fe0-4877-a657-0cb1d8ba9e27"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/affb77c2-0d9a-4969-a2b7-a53f3c89c34a"/>
    <rdfs:label>Gemfibrozil-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1c96bc8f-634d-409c-ad65-66e4ad40a780">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/74d2fd6d-fce7-46a6-879d-ce962473173e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/e2de0afb-1d74-4519-a850-1fc3e37d29d9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/127f0240-4b7b-4cbc-b5fc-9ff1f5b2670d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8b8731b4-2531-43dc-9663-2940a8e06526">
    <rdfs:label>vildagliptin-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8fbd57b1-99ea-430a-9281-4eccdb885c29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/da2b489d-75c3-488f-81ef-baaaa19bb36c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/dedfac88-ce57-4e81-ab28-ecbe9d90ac34">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/754d67cd-3950-455b-9432-5756b41c1119">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f8a75b10-9e6a-4c2c-a606-4b4d43a98adf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/83c853d7-33d4-4fc6-83a9-da76743eb2a3">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/27d80099-9858-425e-9f31-f3a017d37ac8"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/1dea8d38-6dbb-4646-9710-8f9ac495d254"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/7b747600-35ce-4a8b-9583-f3af37610513">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/e315ee01-07bd-42ef-904d-a90413975a3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ef8212f0-8535-49c6-9b3c-f7d522e57e8c">
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3dbdb212-37e7-40fa-a490-52ec77d211d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/aaecc443-fd59-4b13-ae86-2524afdf6cf2">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/dfda5356-1fc3-426c-b5c3-f1e0e86f4168"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e71de17d-7258-42ba-be1e-bb1f64a91129">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/01434ea3-adaf-4fe4-8fed-8e7f70d22b35"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/90366e41-be33-4b29-b5c4-3cfadea4e9d0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b05da33a-31a0-4fbc-b825-4c44a79118af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/43637599-0968-4d2d-803f-466c0bc4bc3c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/2ae4ab71-55f7-4921-8ce0-a89a4161f0fd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/4f22fde0-3d7e-4832-b8a6-bb1340a12d58"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/d74679d9-cab1-48a1-8b2f-53dda1293541"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/771ac50b-38af-40f1-aefb-1b49aee3f42b">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/18f605fa-fde4-44f1-8611-5024057ff89f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/043703f0-ab96-49d9-8f88-b3dff2138778">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/cdd55da6-7347-4e31-bc13-c34784d6c1a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/44551efa-9262-4325-a058-16be39c4c233">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5ebafbc8-9f21-4fef-a95d-7b49923643c1"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/21e1270f-7796-4598-9519-2f89bc47a376"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ee8ba6be-43b6-4535-8cba-871e48a71c09">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7be89ebd-d2cf-4603-998e-4d37b5c19594"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7ec4f57b-e6de-4b8e-810f-608c0b1f5eb7">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/95258006-68bc-42f1-83d1-8db3a3ddf6fa">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/7daf676a-ef31-4a8c-9d22-59a30b5d2932"/>
    <rdfs:label>Edoxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e52bea32-0a71-4aa5-9a75-851cd5b2fe86">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7e4e3c55-0106-42d4-aad7-697eac9860e9">
    <rdfs:label>rifampin-pitavastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/939d6c53-f044-4e8d-9b12-543093ef4481">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c55b5cdc-2f43-4f41-8636-8fb2ab905f2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c7d77629-aaf9-494a-9204-6db41e5fba88">
    <obo:OBI_0001937>8.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9a1fc3ff-7da7-4294-8a86-21fcab56b9b4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/616dd07f-c6c2-4db4-ad0f-bfd04619e8d8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/4265d243-17e1-4607-b0d2-e60c28d62953"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/8d6011d5-4b06-49e9-aa4c-72f4e4a9a4fb">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0c8f2ab4-3713-4c61-ad7a-a0b91edb4ef1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/9b3c3207-228f-4128-be33-4ef306f60284">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/11f1fa4b-a20a-4761-8cf4-3891ca914630"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ee5c1891-79d5-4c9d-9a03-a6aa2b58481c">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/2562ec60-02b8-42f9-9b7f-a424af52d977"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/228ac81b-79d6-4cf6-a6da-c15d9b0a035d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/77335d5a-63c8-4b88-9fc9-7cd352e298f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/cb9abc51-96eb-4bfc-abfe-6d680071c41d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e12343e5-6a3e-45b6-895a-7e822e3462c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3499a189-d428-4aab-a82f-e868785fefd9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/694d6e05-da43-4b32-8aa2-82c168222f80">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0456d159-3a7e-4c71-8888-c36d706ddf3a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/8e96114f-ee16-4d15-a445-b86f3639c3cb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/3b8c8416-72e7-4d63-a683-cc8550450313">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c70b177b-f2b1-4151-a4d0-818260203c7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2c13d187-1687-4bb4-932c-e48fc03d82ed">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef6e2ce9-62a4-45ee-90c0-ae0a76ed70cc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5c923a35-3462-4254-a917-c543b8eb3ffe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ef1aafb3-4fe8-4d99-a3e3-0d98f754b6b1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/af35c2b0-bb7d-4565-83cd-e94dc307e9b5"/>
    <rdfs:label>paroxetine-pimozide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/919cd707-fdf0-4c03-9255-ef5dc654dbdc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/cf3e1d47-1b4f-423c-9f87-41c9ecef21f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a1a9509c-73cb-4800-80f3-2fc93e57e2ca">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/f747f5ac-1a4c-460f-acdc-5059b6941b4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/59fb8bb2-3ccc-4f57-875d-0455a81713f0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c290a788-a934-4338-9421-56114ac36c2e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/44467522-be5f-4172-997e-4339c24a46f7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f5092445-a3db-49a4-99af-828130d15e67">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/1617591a-46ae-42fa-b77e-573693978479"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/1ec40b2a-73b7-47ae-b465-5c49b35b60d5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/1a06fb17-33ae-4d97-b281-c808b90e7cc3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6a14bdf2-04d2-4a5a-85b0-834b1096c846">
    <rdf:type rdf:resource="obo:RxNorm_41127"/>
    <rdfs:label>Fluvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e1d0f2bb-fad8-497d-99a9-6884435f9349">
    <rdf:type rdf:resource="obo:MeSH_C102211"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/05d2c037-298f-45bf-965e-8c56ca46cf87"/>
    <rdfs:label>P88</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/04cf576b-fadc-4b3e-aaef-fb33d93a9489">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9df2b8b2-0b84-461c-b43a-79258a4d2b5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/072172bc-2fe9-4da2-b183-f3b7b459588f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/03f4391e-9a7c-48c7-9fe3-423558ce5d0f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/ea6fa8dc-9f11-47d9-9840-80d756f7c1a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/342d2937-70ab-4ffa-bb4e-92dd54865934">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/efd97c65-e190-49cf-8d20-c11eb6d9fb7a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/138ef4f4-9d8d-4820-8b26-f5175246296c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/8f8f77f5-402b-4aad-875d-484fb27c31bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4557b118-ec47-4dd3-8e8a-7d9c63f1c6bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/16cdfee2-1eef-4d27-9371-7e5869c90f14">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/d4ad157c-dd43-4409-8c2c-bfa88810de60"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c0f78156-383c-460f-be50-78c26c9a3867">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1528ee46-2eb3-4fcc-9dac-b799162800ab"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bbf720a6-4d8f-46ec-909e-da8ac8c63b71"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3cb18f86-5079-42f7-9af5-c35c868e9d3d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8b0129de-0b0c-42e4-bc27-b28a61f435b1"/>
    <rdfs:label>simvastatin-bosentan interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a99306c5-24f1-4e3d-ac10-252313ef9e5f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/83c848e5-820a-4ac0-a771-732f5f7fbd2a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/32672355-ffb2-4c28-aefd-d845d7f5bbc0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/d7b14074-2e56-4519-be83-40a5f57aaef4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0ddc3969-613a-4fbd-a7b9-2d6a071871d4">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/72623fbe-5ead-4084-adae-464dc8caff15"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/ca1d5cf2-40a3-4f10-a98d-7d20baf400af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6f15d58b-ea9c-464e-a20d-2cfe2745b166">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/2a964c5c-4d2c-4172-be71-ff0c3c62c018"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d2c46dea-f1b6-419f-96cc-f31d1d4d5e90">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/1eb86f08-a1f2-42da-8004-695c56056b18"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/d049f8ac-4cf6-48fc-aacf-dcea036ea40e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/67441125-357d-401e-8e29-96c33fd284f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/83dc5887-03cb-4084-94de-b2335357802b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/83f90777-f8ff-4659-bc10-9c29fb7aa2fa">
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3f429969-2a4e-4a82-a11d-f0ad2c9b75ef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/42f3303f-8b14-44fd-b28d-7205da03d8e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/272de90b-8170-4da4-8c56-65d8e068fdfd">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/919d020a-c61d-42c3-a8fd-e1bc58c52785">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/cd485d03-2b2c-4e59-a65b-2708225dfd42"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/52ba6ec0-2ecd-436e-a93a-b41081768631">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4f61214c-412b-4b0d-a11e-0d31e749547e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/88f8a6bf-5cde-444c-bb18-3b70d52411dc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/14a97214-d48b-4359-8787-29fcda9fedc2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/90f9746c-5ccc-4cd7-8316-072d3f751fbe">
    <rdfs:label>propranolol-m-chlorophenylpiperazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0000125">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/976223ef-4a64-4bf1-9c7b-6234f668a875">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/86a97769-b51b-4572-a2c1-b94234920d22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/addd3ded-8c24-4062-a387-c8e76fcc4ac1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/12ef826b-be6e-4d81-8db8-8d2dd9e7c46f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/8142ee63-d52a-4370-bff7-88f49358c9ad"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d39a4203-3f14-4f56-b824-dd4f18264694">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9a2032e8-287f-4412-8939-7f1a9f990550">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/aaab652c-96cf-40f0-9d81-d45e05e2d5cd"/>
    <rdfs:label>threohydrobupropion and erythrohydrobupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9ba60dea-1bff-4653-a7b2-8ecc0faaafaf">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3e3c4412-661f-4521-9f6c-f57bc774108f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/37624cbd-3a55-4646-b5fd-2e88f02b084c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ff7121fa-e85e-4e35-97c1-5fdd1a315ea9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/973e5d6e-0b86-4294-acb5-baebed794e35">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/cc28fe8b-9753-42d3-be8e-c52baf1fe5c7"/>
    <rdfs:label>nefazodone-triazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/bf66fd7f-112a-4d18-b1ef-d837dfacf4ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/432d3ecf-d605-4863-8174-a70f112c6303">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/fb6e47f3-b74d-4bb4-bdd2-e35ea9d7d086"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/93562201-825f-4578-a079-88a0301e324a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/7a475b66-97ca-497b-b943-00405fb85532"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6ea0743d-7095-4721-be27-d2214abcafda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/656a7c4d-525f-4928-bfe6-88d6c566ee89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5cc0acce-615c-44f0-bdf3-055791802e9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f0227d65-275a-4521-aaab-eca946e6ee51">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/a77592c1-b2fd-49ba-aa11-781150c37f10"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/03aa1ca6-6be8-4a88-bdb2-fe7ed25b010e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/84fc0c79-4908-40f4-8776-91ef18f1867b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/305ef049-b33e-4e8a-b6f4-c16ad4248a80">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7f294209-04e3-4f00-a76f-48fc395aee3e">
    <obo:OBI_0001937>85</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a181fc4e-c63f-4f99-b1e7-d2784f027d6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d3a1ec0c-50c9-4132-bd39-5a8bd509098b">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/6fb6332d-c204-4011-a0d2-ff687c4a263c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b2544471-e6fd-41b2-af74-ca93a89bf42e">
    <rdfs:label>fimasartan-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/c248a267-1702-4182-96e0-cbbb3c0e5d57">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0bc432bc-6c40-4c95-bbcf-bdaee64294d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2e1cce99-69f3-4033-a34c-ff7c85ce27fe">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b7b97734-3a11-4155-a204-080a00ed97c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ddd61976-f61f-4ef6-a858-9eef94b1f07e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/77335d5a-63c8-4b88-9fc9-7cd352e298f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6d531528-c9d7-4e01-8dd3-79ff36f88af9">
    <rdfs:label>nefazodone-simvastatin acid DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/67118646-5e4e-41b2-8e18-d10babd6f730">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9ccbbfee-0484-47f9-838f-31cfd8359a49"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/3e220779-3b10-4a46-bcf8-6b2ea1997695"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2c0650db-6d1d-4360-b493-544512cca91b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/de179a3c-82ff-49b8-bc2e-2dc999e173e6">
    <rdf:type rdf:resource="obo:RxNorm_1102261"/>
    <rdfs:label>telaprevir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ed2ed88e-fbf7-43ed-9416-cb0766290b30">
    <obo:OBI_0001937>24</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a5d29af0-936a-4457-953a-54754539ba33">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b614c831-2207-42cc-bccc-cb1258b35ae3"/>
    <rdfs:label>phenytoin-paroxetine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3b5a35b8-7b2d-4703-8911-7233e9f8d82b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/cc1aeb48-2afb-4812-81d5-2c2b1e03d84b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/212179a7-0433-42ce-9b42-0d4189a6070b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/f632f777-3f99-4bea-9c69-4216f1671f4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/19feb8c2-401c-4c2e-9f7a-9f37f0d03dcf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7c348e79-e686-4a0f-830c-e5bfdef79268"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/c243c723-607b-4060-b7dd-1947e2b95772"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c1e9f7f2-52a6-40ee-a299-eda5c15c5bcf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/44887abe-e507-4919-8cbe-204826448e81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/4ac375bd-de95-43fc-8e20-f12979b3291d">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6a9d9ad0-f5ec-4063-9026-3d87aa1937ba"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/760f6d49-ab2e-4134-b7a9-c19a1ca3e86e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/156d519d-6b45-47cc-8bd5-d116997232a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b63a9f90-d79c-41e5-ac04-3b35ffc45690">
    <obo:OBI_0001937>82</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/89b4cfe0-c4fb-47bd-86a5-1269ed9a916e">
    <obo:OBI_0001937>180</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b5ffd9f0-bb3e-4f65-8fe8-f99bcdf95837"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7d806e53-e38d-4de3-bc4b-c20e27f3f7fe">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/a746f03f-acbc-4db7-92ec-44fec9258d0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/d547af10-e068-4852-a717-7b1cdf0c76ee">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/8a9029ba-5bbd-4117-9284-a7ea829d6c79"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f3d2e73c-3ace-40c7-887a-51cab99f9d9b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f8e04e20-44e8-4b8c-8023-7885580da5d2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0cb4572f-1527-475d-8aed-eb240582137a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/65f40cc0-a7ab-4c40-a43b-9d804742a998"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/72577f38-71a5-4a77-b2c7-77c9ddbb574c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8720c63f-410f-42a7-9f11-7c526ec5c4ed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/50938b8e-d9fd-448a-b490-2b26d20c1fac"/>
    <rdfs:label>ketoconazole-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/8f780704-e55b-4ca7-a6cb-ca161ae0e78c">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/2a80a3cf-ace5-42d5-a017-d87b6d08b463"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0cb16428-c1a9-425f-81a9-a029d06ee8fc">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b2470394-5868-47a0-9371-76ae22a48fd8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/aadeb983-f009-475e-82b8-71a60be559c1">
    <obo:OBI_0001937>4.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7bbda2a1-26c9-44d8-842e-70edf7879316">
    <rdf:type rdf:resource="obo:RxNorm_61381"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/08094fcd-e5f9-410f-bbf8-8c38677fef48"/>
    <rdfs:label>olanzapine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/70094589-4e43-4d0b-a6e4-bb40721bb79c">
    <rdfs:label>Lexapro-metoprolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e2c840c8-6d0e-4675-af1e-cfe519bb7583">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1feb0bd8-c97d-4032-9cdc-628e83ac4f8e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/02b08dbf-085a-479a-8549-ad0b908b4d8f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/aff1c60f-ac50-4c54-bcbf-79da94ba2b7d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/67f42763-8b46-4059-bfcd-8bd207b7bea0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/be3e4233-c353-43db-8a20-2a3ee5b1900f"/>
    <rdfs:label>clopidogrel-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/011723e2-7547-4453-b80e-3749c6e8f53f">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/754d73af-17a5-423b-bb90-2c93f3d1de64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8a7bbee7-f0ec-4994-a368-f668ace3fcce">
    <rdfs:label>low-dose ASA-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e4c51b39-40a2-4357-bdd2-952aab5d61f3">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/be65f7b4-6539-42f6-852e-e3457ccb778c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3b808b40-c531-48c4-8c46-bfa51f84bbe1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4928a021-a47a-4dea-843a-ec8e58ad64ee">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6f924414-429c-41d2-9be3-25240f8b00b4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e75b54e7-8b9a-4107-b348-1f925357c948"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ff0dc922-97db-4161-ad49-95d17fbc5d66">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/55d9dc88-20e3-4494-8ef8-8fbae4b42f0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4711ecb1-9575-4bb5-89a6-a0305d2b035e">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/84283031-0e5e-4609-93c4-273e935cf38d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d1b21de5-5fb9-4de3-90d4-4e3508c61245">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/c10b6706-72fe-4bb1-95b2-1192488e2b3f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b55ef9ee-bf39-4eaf-b56d-ff1822d9902f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/f07e13c6-5404-4ae4-9168-6e6b4114986a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/38236ae8-3490-408a-8db4-e5083567a7b5">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/2bba3a03-ac7c-4845-8d09-a18d07738482"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5fe3293a-903c-4ba5-bccb-445a13f8e2e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0cb4572f-1527-475d-8aed-eb240582137a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a6bcbbfe-1e81-4d4b-801d-157ee15a9e59"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/e535b0c4-3b57-43af-a632-ee21ffd98a87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/0c72bd1e-3c18-4746-8ae3-12302c58d345">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/e66d246a-5924-48a0-b181-888e135e04e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/81ad0b47-3301-408c-8c19-29b3b34e0f68">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/cc0a332d-cdaf-4f24-9ec1-caa69c01cbda"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/b6939aa3-bb9e-4eb9-abbc-7d1a0f336447"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/c41fc23b-199e-4329-a9a8-db2987bbcac9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/29be924c-ec2c-4376-a134-54a0b5d4793f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1b31f14c-634d-4e43-8e87-969987c7d683"/>
    <rdfs:label>ambrisentan-warfarin drug package auc  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/24af9672-b957-4d22-8922-a374d03b129c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/aff1c60f-ac50-4c54-bcbf-79da94ba2b7d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5d87a0aa-c86c-4e36-a9a7-ac312676e7ad"/>
    <rdfs:label>clopidogrel-bupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a90c6df0-1910-4532-900e-87643cab8d8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/211e87cf-3e0a-41dc-ae5e-b4463b56acba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ee54986b-7d04-4bd4-9375-f56dda5a1792">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/297b74ef-4146-482a-8265-b479f83d09ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0fc8d811-5449-4708-84de-7b6e34732b16">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/eec84a6b-843c-47fa-8ca8-d805e145a329"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/aa957355-e185-468d-9b63-0da22213966d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/272c65a3-b91b-4513-8c65-413430c0e011">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a9de0538-05b6-4af6-a0ec-9a72d503b55a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ecca74fc-d594-4ab9-a54f-7e75dc3778ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ef2ba6ef-aa3b-4203-a1d9-4aa1e8552ba6">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/f632f777-3f99-4bea-9c69-4216f1671f4b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/db63c14a-4024-4759-8dc6-ac60ad850059"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d156072a-4b15-4a5b-af4c-9872033cf739"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b27f22bd-13be-4176-b17a-076be419e7f9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e4fcd024-a95b-4210-b1f1-af76cd4cc3a6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/fdc7a8f8-f7f7-4ba1-bbf8-ce3bc1073452"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/086e77bf-6281-4e99-9ed8-6cbe801c6d24">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/482adc86-5d1a-4f87-8fce-e69aa0f98498"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2bdd40a6-e061-41a1-b4a9-656d3137f22d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/365710ce-3abe-4afe-b6ee-7199b8916e24">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/c029db1f-e950-4f68-902e-022d1e9247ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9088d514-4cca-4d26-be4b-fd02e0435da9">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/cdab9130-a3e9-4b56-8ec1-f51b22c0e977"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/9201e88a-c7fd-4ca7-b1f3-ea08c6abdfee"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/a99b7888-ada4-47db-aea2-10d54b8ef8f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/4e7e9213-6381-445a-be4a-795c2a76d4a6">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a4477f23-c9cf-4c48-9411-b0b970f5592d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5a85db01-bee9-4266-9445-3f8aab910308">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8410ff5c-21ff-40c6-9167-4e7bac4dfbfc">
    <rdfs:label>fluvoxamine-mexiletine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bb3d4b96-2156-45c0-a27d-4f5adf708ca8">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/e1dcc20a-dce3-4447-a402-895b4ed6384b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8aace609-781e-4569-9cbc-209eb8b6fa7f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/7d96f3a4-6987-47c5-875d-34df2929262e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/fc95fac6-1193-4561-9306-7ef12eee5d79"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/88c88d8e-4d89-4a35-8cf2-b67eef9272a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/873e09a7-89d2-451c-812d-6695cf52024f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/9d82f13f-7c33-4a73-a0f2-3d0e18f41a13"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2e3650b2-4063-40de-b773-a307e339e204">
    <obo:OBI_0001937>27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/bc9837b6-8b89-4940-a48c-e46e10365ddf">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/4ba478e3-ef08-4841-971f-94236c0561c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e733764c-b527-413a-b686-2f155983c912">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/239f133d-b07b-4472-ae83-53dbb0a9a545"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/1f2b0477-2e61-43fc-bf8f-2bde356c4342">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b0a53278-20fc-4072-afaa-1b0e03c1e83d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/662ab7ea-fba5-4b6e-8cfc-7d7164227311"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/29f8ce49-c33b-4df4-a295-465e906d0c8b">
    <rdfs:label>bupropion-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/af27f440-b344-4907-943f-e43952007ced">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/36f76507-dc46-40d4-be14-ceccf4a16aaf"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/fc3c3895-a82f-4b57-b948-b1b3fcfadb19"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/3d7155cb-ba6f-4d93-b296-fe4977fb0487"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1cac2545-b462-4741-a6a8-47010caee63a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/96270bff-ac2a-42f3-9cc1-45e00d75e3d5">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/d3a54116-243d-419c-82b7-314d74107139"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/d55e3d03-4372-4d4f-a13a-38191a2276ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/34ee20ca-17bd-4765-a3cb-63318f517842">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/58b9856b-4077-42f6-90d2-2a767515ab1c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cd1b30d9-894c-4c2f-9289-e9b24d31d000">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a3f414bf-2e4b-475e-9601-93c7fe2074e9">
    <rdf:type rdf:resource="obo:RxNorm_596554"/>
    <rdfs:label>vildagliptin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/da26e33b-aa87-41d0-a67a-1ec122d3bbbd">
    <rdfs:label>Cimetidine-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8794751a-c9fa-4b32-a366-9eb3f6995fa5">
    <rdfs:label>Fluoxetine-olanzapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0da86ba8-7e8d-490f-bf75-61e413a818ac">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/0506b075-0604-48d1-9574-20d38c797c37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/84e00839-8e42-410b-92c5-8f178a4ce8e5">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/5a6d1598-fcd5-4a92-869b-6797881c686a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/7383c614-7025-4be1-8e5b-c1a43b16da9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/848b1722-2184-4834-ac23-415d81e7a73f">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
    <rdfs:label>digoxin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b7eed592-0875-464f-9d20-a71bc7c26d9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/88727bcd-991b-4ba9-bde5-a18c291ccad7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0eb8cdf6-2521-4dc5-89e9-f86173b918a2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/da26e33b-aa87-41d0-a67a-1ec122d3bbbd"/>
    <rdfs:label>Cimetidine-Atorvastatin drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ae231f99-322e-49c0-8b91-9a2f6330ac47"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3fb21f93-a70f-40de-9556-929b8d58158a">
    <obo:OBI_0001937>95</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4f1f02a6-bbdd-460f-ac92-2a4b2250c262">
    <obo:OBI_0001937>0.87</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cb88ff85-58e0-4e1b-a0c9-ddc7416f0c7c">
    <rdf:type rdf:resource="obo:RxNorm_352393"/>
    <rdfs:label>ABILIFY</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/de0e3152-d581-427e-9ed8-d72d4d17db30">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/cdd55da6-7347-4e31-bc13-c34784d6c1a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9d888302-b370-497d-856c-d5960acecdb8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1c5d01ce-df86-4791-b9b3-cb86289b5a23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/343bf2d3-bbe7-4090-bb14-2ed34d779e6b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/19f43838-ae5f-4d22-8748-12bf75158b31"/>
    <rdfs:label>ritonavir-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/8c5f3616-212e-49f5-89a9-096cda399c3b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/edf8411e-1667-4a2e-9d75-403fc894e5d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/630173ea-53c0-4e4b-9d7e-67bd6f3ac568">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/00142e37-3182-43e8-a466-2ebaa422e5b9">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/126e9897-18b5-4671-b21f-f63f6f26b307"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/13dea4f9-0d63-43e5-8864-03803092e0f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7c6852b7-e6d4-4dec-a058-7442c0efdcfa">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/4d9a1667-0f3d-4356-b35b-131906bd6136"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/453aa561-da55-4965-83de-2324ef3dc3fd">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b305faa1-9bfa-4534-8112-f7e985c95f4a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3c785bbe-d5f1-4462-8d80-e8892d28d367">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/97c15031-e508-4eaa-8d29-902b347f35ab"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/27acd8c9-27a8-4dd2-8908-13b36175ee78"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/41e18712-a7ca-4452-81c0-c29c0303129d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b3813376-a293-49eb-9f48-11696f1286b4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b5265e30-a552-48ec-9a34-4b205449e2e4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/8cd3de9c-9d08-4c37-8fff-3c025403fc83"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/73579387-ab3f-47d9-9941-774e83985d07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b63d3753-496c-415a-8e6c-37ec087977a2">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/a8b3353c-b1e0-44c4-bb33-cc450fe60d72"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/66b97f26-9239-4429-a99a-6d9ff63f9884"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/848b1722-2184-4834-ac23-415d81e7a73f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/39a62fdc-4f92-4716-94e0-5995e0175bde">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a4e43709-06f2-4ae7-ac95-e2fa4bea4771"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cb8c6c12-c1aa-4990-b191-6bdf29573f89">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b2d20151-4110-421e-8ef2-487445a3cd35"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/de7b757f-f9fd-4788-a0a8-4d994669f5b2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9debde91-c2c9-4ac9-9381-db6e04a2d022"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d7931892-b983-4b46-8b45-d3d052a4394c"/>
    <rdfs:label>iloperidone-dextromethorphan interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6847a043-2429-4903-8fff-21c11e4206c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/736b77d3-a308-4afc-936f-5585f68f3ffd">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/cc564b2e-9b1e-4ae3-8ac8-873260df5dc2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ecf9cded-fdd0-46dd-b4c5-481a7bdb86c6">
    <obo:OBI_0001937>102.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/6e656818-ae4e-4256-8cf4-eb4447154b90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/418ca3b4-7ee7-48ca-9370-0c224b82fe3d">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/9548ee35-54cc-4642-bf42-bb354564ab5c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/40b7d792-a95b-44d0-a973-bbbfd2cdd30e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/4fd8a44a-042c-4516-aa2d-6dff209a1d36">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/f67dd231-47ca-40d4-9a51-d1044becbce4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2a57ba9a-ceb1-43fa-a24a-895f890245b1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/ec571d62-666c-4306-8769-556509887311">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/cc83c9f7-690c-4091-ba80-e9f1ff18066e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/44301a1c-58ca-4070-b769-618857c80cb0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/47cbdf28-cb04-4aee-970e-5305ccb4d81d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/c7861393-b812-4e02-b74f-4cb4f521f6ac"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/257454db-3019-4529-85ac-abb346c865c1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/e3af2b19-e38b-4626-a201-f85d7033aa74"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/ee329f32-dac9-497f-be34-40391a208ee7">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b902a4ee-3414-4489-8004-e9136966453b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a597e8d5-a074-444f-b61f-e48bfb4d47b2">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/dcc0797b-e828-4eae-9c1c-40bd0150057b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/4cfd91de-7583-495f-8e42-c51664b39a91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6f7bf756-a358-49a3-8f91-6d2c46684844">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/699efb6f-2521-4f85-9cc8-3909a2792b76">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/47f463f1-2f5d-41ec-b9a8-a588c5d192a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/ec7f6823-c77f-4a3e-8ffe-72f9548b3bf7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e8addb28-3061-4ea6-bad2-d517cf33c736">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/e8293ff8-dab3-4e57-ba46-eacb0a69e83f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/738494d5-9c7c-4c40-bde5-7ee2cd2a6faa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/10e84f13-6403-46cf-a054-44e34a3c2351"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/7333c436-8c8e-444a-971b-d6a882671b82"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d896a107-cb01-4fd8-be4c-40171d75d851">
    <rdfs:label>phenytoin-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b08a9824-43ea-4da5-b9d3-b6fedc44fd03">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/0cb309ab-718b-4ab0-8718-a61b95112e6d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b0d2fe27-4554-41cf-adb2-abe2e4eb44a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/b40c7efb-3158-4ca5-8664-388ee2a343cd">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/c1eebefc-cfbe-4ae9-bcff-41d4e92ef13b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/502006a5-1bd1-4a01-ae6e-c566c54995fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/283449c6-cedf-4d2f-8fa4-853589ce4bdd">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/74b7d61a-acb1-441f-86e3-9067730a43f3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c6c247a6-274f-4d3a-b7d9-caf199effaec">
    <rdf:type rdf:resource="obo:MeSH_C015068"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/594b1264-112e-4b86-9ea9-8a9e93314d48"/>
    <rdfs:label>m-chlorophenylpiperazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/692c323e-fb26-429d-997a-dece5eff2b66">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3d2253f4-78fa-431d-be17-afac04fd0304"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/479bedaa-a712-4142-a00c-04adb4d059f4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/b05da33a-31a0-4fbc-b825-4c44a79118af"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/609d024e-c1e5-4ba5-89d3-074d10986a6f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/da52b3a9-d16b-44e0-bbfe-6dcf461dfa20"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1a49fa0f-5b47-482d-b56a-bc1df3d529d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/83993b05-73d5-4e11-adca-1c5686c5750b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a8fa911d-c3fa-4e75-983b-a128693929b4">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/3ea2113c-f66e-4bd3-a5df-147e24a52bb6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c040c03f-f099-4a9f-b71d-2cfca8425b68">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/80116197-8ea0-4414-b91f-106b1cb93194"/>
    <rdfs:label>ketoconazole-zolpidem drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/c4b5a395-5246-40ec-8ac1-16ff593f1bf5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f37a8977-0307-4b30-a778-b241b51dfc2b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8a7bbee7-f0ec-4994-a368-f668ace3fcce"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package auc UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ecf9cded-fdd0-46dd-b4c5-481a7bdb86c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1a235355-2e6a-4f06-aad6-8f1a125c27cb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c35f0e8b-7f71-44f4-b0a9-3e54af49a8ab"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/0099b479-867b-4367-976a-35be161200de"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/af04881e-f536-4a44-b0fa-f7bf58339c8b">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/062e60c2-6265-4c9d-b81c-98e8107d0642"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/a02485e2-9c41-4578-8e3e-d7ac40653c71"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d60d1bdc-e39d-4744-828c-85ca76ba7806"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/94358fba-4a61-47d5-a806-910b3258ea05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/768ddb65-9240-415e-a067-233fb946769b">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f94ca445-eebc-447c-a257-97ce17b8bc10">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b5f882a5-8400-45d3-9567-8bb3b2f96b38"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/4d029698-a8bd-4356-9dc8-c97c8894a6af"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/f29a21c8-baa3-433b-a81a-b99f7450e2cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c2aeae5b-fa14-426c-a4bc-6bf772f762ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e6f7a3fa-a495-4d16-b37b-cc352e34fcb0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b1d530f9-78c2-409d-b002-f3f4b38a417f">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0cbfb0bd-5f6f-4335-b71d-0cbcc9b21bd4">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/979f2ac7-3ddf-4456-b232-b5e4c30e01d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e9f198d4-d88e-4001-a131-186f1f27ab53">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/aa031e16-3b61-4580-ba03-bd59554e0cdf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/aa1acf8d-d2ae-4041-8f0e-57f4c3abf067">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/6fb6332d-c204-4011-a0d2-ff687c4a263c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d2fd4ebd-e9c2-41a8-a800-f6133024f7c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/605e1fed-86da-496c-a999-763ff0796775">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ab8dd3b9-2719-4eae-8fea-d83e657c33bc"/>
    <rdfs:label>ketoconazole-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/6bc78b47-81cd-4be8-8fde-5f8b6fef3767"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dc86f689-58ba-45c6-9326-7ca37e25a11f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/da171fb7-b711-48f8-9ad2-8df32e9f04eb">
    <rdfs:label>ritonavir-threohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ae426c77-969c-46bb-9511-dc5bb0902425">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/0264d459-5be3-4c7f-bbb8-632f9bf721e2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/1125b849-96a8-47d0-9f74-9f3414bf0763"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/da0954d3-87e6-484c-af13-2a479c7584c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/62d84e7f-9933-491b-b56b-216d2f43c974">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/10e84f13-6403-46cf-a054-44e34a3c2351">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/b97075e9-ac3e-4667-bc81-502081028e83"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/bc4d8075-bc06-43af-98d9-a8820fa88b61"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/b2a45c57-b931-4402-aa6b-7b74109aa137"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/3b146135-8360-452a-8972-51bf7bb983f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c8bab9c4-6441-4e56-b9d1-5b6bfa48d03a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/739aeb94-b19c-48a4-aef1-27b632e1d6f0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0c1982cc-8fd1-4af0-a9f8-1fa512070d88"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/0a46153e-6c6a-4ca1-9495-5d5eacfbf4ea"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fa74aa59-5b0a-4a51-8845-de1950785639">
    <rdfs:label>fluvoxamine-theophylline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5361d6c5-f78e-4cf0-93b0-af8e24d41f67">
    <obo:OBI_0001937>213</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/4b906e08-38e7-4686-9085-7ef2c0b83681">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d5744a31-624e-4922-b068-0bf47379b80d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/fcaa5b3d-eea3-4311-af56-7f1de088a367">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ab353f2b-6200-4284-8cce-61cd56782ccb"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/0c81295b-33d8-4b1f-998a-e461b622f6b9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/9f9418ae-fd5d-4c94-9781-cb5842506cf0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9b0377c1-c6fd-46fd-b540-46da2c2e03fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/35486bb6-ddd9-458e-8578-bbd7af42e6a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b4332f8e-8d54-40b6-8e38-7d5355acafa7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b38c66fd-f34b-44e6-9f43-6b5c3de59120">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
    <rdfs:label>Carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/49aaec22-ebc5-4396-820d-11d515594939">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/b08375a5-37bd-439c-9931-8b90d4770f4d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bbf0df82-8fba-445f-ae81-021c074447a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/03f4391e-9a7c-48c7-9fe3-423558ce5d0f">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/3e9353be-6549-4c1c-86b8-d3194e578a4c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/fe41e91e-537a-4e8a-8973-bc388cfa1813">
    <rdf:type rdf:resource="obo:MeSH_C092333"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/6e693a19-2a6a-46ca-98a2-980a3de8694f"/>
    <rdfs:label>HO-NEF</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d853bf18-810f-438f-9314-71e04b267777">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a59c5d5a-4ff2-4a5c-ae84-87ee667acb1f">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9713f4ef-a883-4946-8398-aaaa34ed4b2a"/>
    <rdfs:label>Atorvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f19966e2-8c39-4d16-92e4-0e8bdaa94247">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7f803a97-57c6-4ff9-8671-85304b2c39d5">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/bf60b148-de58-4866-96df-0cd68681f787"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/73579387-ab3f-47d9-9941-774e83985d07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2ce9d0c8-c896-4d94-9ae0-076b78cbfbb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e3572943-5a8f-424f-998e-cbb6ec520cf5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e3bf4399-72df-4a32-8059-c87b058849eb"/>
    <rdfs:label>mCPP-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/9302cddb-666d-4f6a-9cf6-5d2ab421ed24"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/23f34f31-0ca9-48ed-aac5-2ed94345f5e8">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/b3665c7d-5637-4bf8-b943-ce49d5830e27"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/584a8e66-0a18-4d24-8df1-d30ecf6170b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/310ecfcc-5d4b-4527-99a1-52b564ab7220">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/af9b0431-7c75-4b0d-b6b6-46350682019f"/>
    <rdfs:label>fluvoxamine-duloxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/95c9f562-f9df-45d1-9cc1-449bfde727f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f632f777-3f99-4bea-9c69-4216f1671f4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/4a62b9b1-2557-4f2e-97b9-75bce65ad27d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/648dd108-3faf-48a8-9a66-b6cb272ffae8">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/11eef13b-afad-47a0-bfbf-b16ad7e2f18f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/47c9921a-3fe8-4a55-bc88-b59bf127a277">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/39ba790c-a444-4b9d-996e-6ca6cbdf96e1"/>
    <rdfs:label>Amlodipine-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/b6221133-6c6a-465c-a339-105b2833fd20"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000001">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e7854d81-23c6-482b-bbdc-798baa36e8bc">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/78f824ba-0c8f-425a-8fdc-111d6e4b8112"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0dfcce0b-8f7c-49d5-b38b-dfc3c5f25be3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/03e8dbbb-0a2d-46ca-bdf5-71d8f548e643"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8b538190-dd33-49da-9ab7-6af1505cb527"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/335aca78-9ed2-4df9-b131-34bb04f8ed3e"/>
    <rdfs:label>ritonavir-threohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9335a340-21ca-4b48-901a-e8b97db9f6a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c87876bd-be57-497a-a85a-49da346a4060">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ad6ef1f5-26d9-423a-89b6-40b7cad663f8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/e1a2ed84-46ff-436e-9f2c-a2c429bb588d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c285221b-cdfc-414d-8183-1bc674a4b6f4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5b54ec5f-0c9d-4ff4-9e0a-300c03c4110c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/59d73727-992d-49ee-b8bb-5797b2b06513"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e8b1a712-a29d-4d2b-b415-6921c76787ea"/>
    <rdfs:label>sertraline-tolbutamide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/12a472d2-9755-4322-8451-0f56402eb9fc">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/ee06dc9b-8e76-4ce0-8118-5a0bbb3e724d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2534bfa1-8976-4715-ad76-75f05335874b">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/45f2041e-30ac-4700-8984-9f19f92a4a54">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/656a7c4d-525f-4928-bfe6-88d6c566ee89"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/4ce2400d-61cf-44b0-beec-7c391317b377"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/aaaf96b2-160c-4986-a93c-1ff5d4bd0047"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4e447fa4-9e30-4afa-92f2-877c0ecd1447">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/51e65a77-e7e7-4534-9958-f261386c9ce4">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/6f7bf756-a358-49a3-8f91-6d2c46684844"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f84a0da8-9b91-4a47-aedd-040283f0d24c"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/dbc3d1f2-a550-42d5-a95e-8284bc4cd46b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b2557a63-8862-4900-ad4c-db911a98abaf">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/362fc083-1254-440a-84fc-90c2e5377d4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6ceb5043-937b-4567-ab06-2a910284f683">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ec2e6abd-5d38-421b-97dc-071227beea58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/37305890-7376-407e-897f-013d6872ab30">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8bbad936-3e00-4e9c-94ae-e20659e84e4f">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/5a300901-3ce0-49ce-8dd6-c4d7ac486143"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2e23fc6a-abe9-4661-9e1b-f28cde72156d">
    <rdf:type rdf:resource="obo:RxNorm_32968"/>
    <rdfs:label>clopidogrel</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/f355d395-3d17-4512-8f3c-3717980f35ee">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/eb5387a7-9bab-4eb1-8a6e-33ee0767d6f1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/b3dd49aa-7300-48f6-8292-a177a1421baa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6830a000-91cf-44a7-8c74-b018c2be2b00">
    <rdfs:label>ABILIFY-paroxetine CR DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bb1c6bde-f19e-4359-afc1-fa0a7aea95dd">
    <obo:OBI_0001937>0.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e8d0fbd6-2c58-4d68-b7d7-5d1f9780c362">
    <rdfs:label>nefazodone-alprazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/16cc704d-38e1-4e76-8673-b42b665a4d7e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ad76f20d-85e9-430e-be82-5f80dfc14177"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/eec9a663-a1cc-4aa3-b076-fad5ad8bcf47"/>
    <rdfs:label>pravastatin-NFV interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0b27f32f-c6b5-441b-bf43-70529e1454d6">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/e49a039d-0a27-4a67-ad74-b7f9324b08e1"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/58a09a6b-07d0-4d75-a125-76405e5ce0d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1c69569c-836b-4036-823f-ab3aac10d4c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dc9407ee-71db-4c3c-a6fe-dc576b13fb94">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3a66734f-fc5a-4ea9-9b83-6c42e583f567"/>
    <rdfs:label>citalopram-ketoconazole drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a443a639-c392-4bc5-a841-69bdc8bd1d10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5ebafbc8-9f21-4fef-a95d-7b49923643c1">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/a19f531e-14fd-4704-9089-955d45b23a16"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/78753bb9-bc97-488b-9a8d-6a6647a8bbe6"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e45553d8-df82-4d15-9844-f61a1c15eaf9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/1c2279a9-f40c-4386-a5c6-1679d64649d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/7c4f786d-d9c7-423e-ac7b-ab07741d8589">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/74d8edf9-dcfa-4ee0-9111-22e67aef7ad2"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/99c27f7b-f381-4c93-993d-7fed9eb89890"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/767f57f1-16cb-459a-b77e-27739ecf7459">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/8dadae02-6d1f-47e8-8425-a8b4ef30f24b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2e2e40d8-c550-46d2-98cb-987b3e53708a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c6294d5a-b3a5-4585-815c-55e24c5b94f3">
    <rdfs:label>ketoconazole-rosuvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/dec78851-1738-4442-98f7-45b7db4d465a">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
    <rdfs:label>paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ac561c89-8d29-49e9-ade1-e2c883147548">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/9b3065dd-bb6f-4a20-be9a-b7da3ffc5a8f">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b2557a63-8862-4900-ad4c-db911a98abaf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/c394a05b-05f7-47d0-8aec-21701c447aef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f66094ee-13cb-4048-98e1-6e25d5ff2485">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3643556b-a437-4115-94f5-eb537c04f798">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ed9bd682-73bc-4499-b196-5a18cb4fed62"/>
    <rdfs:label>sitagliptin-simvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/ac87737a-4ce3-432b-a2c3-222b5ac86585"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c7e310fa-0193-472c-a248-98fb0af4b8a5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d41bfa32-c76f-4fb1-ae9e-cf41df05dafa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/de47029a-3fbe-4ccd-be30-4222a7714bf1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/3f0e5dc1-a3a1-47a8-a13c-44c2f94e4b0b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/b6fc6b41-617d-4a41-a7a4-e88cb0d47278"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f8e04e20-44e8-4b8c-8023-7885580da5d2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a6bcbbfe-1e81-4d4b-801d-157ee15a9e59"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/89e8d078-6cb1-43a0-8b6f-fd447aa540b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9e000256-86f1-488b-bf8c-49586a542f34">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/64dcb5f7-9499-459d-9115-f5304418972d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c595713f-dfaf-4a2b-b7e3-ef1b1d6bdc43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/ef99de22-336c-4cb0-a418-2f15bda7d39e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7668f141-e661-41d4-bc61-19a3d0934d47">
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2b59d69f-4be2-4d0d-b7ae-aa6f968268d6">
    <rdfs:label>atorvastatin-Nelfinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/66c4c46b-61fe-46d3-9575-14ba053a547e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/66fb6759-20c2-4f7c-83d4-53db9784e868"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/68293420-1d9e-43d6-9cf9-a9c7384fc476">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/686fd467-b511-4ac7-84d9-882be43bf017"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/a4cd9bae-3bfb-41a9-a242-813919afde24"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/0d27e922-05d1-4df5-8b07-3d634bb73b8e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d3563391-eb40-4023-ad0c-07a81f8fa7d9">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/7fe4d60b-56b4-4592-8500-9d691891de1c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ad3c0d25-cf1d-4fcd-9b2f-941b655314c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/51d474b5-58b2-4055-a2e7-83bd3eb54457">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3078e599-e2be-43cb-be11-dc5e3b09b85e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f527d6f2-817c-41a9-8a6e-7b8aefadb62e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e9923da1-297f-416c-9da5-ee6bf3e88f3d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/75c3e059-2360-4e86-bb6a-4c644fbe523b">
    <obo:OBI_0001937>27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d244c150-e345-4be2-80de-f98155264616">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2f8e6848-9faa-43ec-b712-07d92b1b6c31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/2013eba5-2e1a-45bc-a853-5e672ae47640">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/44028c09-3b11-431d-804b-bff84c772e79"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/c7593d57-53e7-4314-b64d-1de01081aac4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/97831ed4-583c-47c4-bf26-509df67a102c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0921f751-beb5-434c-aca7-47cdc2495474">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/db4130fd-214e-48f7-b837-6b77e603173e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/00ebb741-02f3-4cfe-985e-4b07a8d694ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b181ddf9-dda1-4ad5-b680-dd8ec6297df9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cfde3535-1041-43fe-95e3-e0429e78ab32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/bc4d8075-bc06-43af-98d9-a8820fa88b61">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/a349565e-99fb-4934-8377-da44dd3344f2">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/656a7c4d-525f-4928-bfe6-88d6c566ee89"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e4584037-ff70-45b1-945e-d51757975476"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/03e8dbbb-0a2d-46ca-bdf5-71d8f548e643">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/41cc2ffd-05aa-4956-b6cb-b9b660702fed"/>
    <rdfs:label>ritonavir-threohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/7668f141-e661-41d4-bc61-19a3d0934d47"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/496c46c2-368c-455a-b1b8-9f0bf4b59b8b">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/86a97769-b51b-4572-a2c1-b94234920d22"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/7dd60ee5-cdc9-4070-b1da-9d9a082b79b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0f138bb5-75c2-44f8-972d-10a4047a35e4">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/d15ddab5-fef3-4817-9b96-b0412651aa95"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8f2ce195-06bf-4c15-9b26-d94794b075c3">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f0840363-a8fb-44fb-a9a6-cea43a7e6a85"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3eb3385d-d064-41bc-9179-a536496ccda5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/88c9bf01-bfe7-4a75-9d00-50546dcd7b04">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a7df3001-d457-4711-862a-ba0917a6dce4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/c6ccabd9-a944-4140-8043-6e6b7264478c">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0f5607d5-e80a-45d6-9999-d8e7c1812b98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/42ed57c0-9e60-4ef6-b436-f5b1c20c01dc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3cb66b1c-fd9d-4a49-aebc-94733002b5b1"/>
    <rdfs:label>Gemfibrozil-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/844daebc-66ad-4598-aac0-cb5b5ee12a7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5f5e7cda-cb84-4035-ad21-825ac3d866e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/caf9b62a-c55d-4c98-9e02-dd4c560706f9">
    <rdfs:label>quinidine-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dc1184ea-4b92-434e-bc3b-f41ea18b35f2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bef98d8a-fbed-4991-9b69-e48ec6ce2830"/>
    <rdfs:label>paroxetine-procyclidine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/97df25f0-10a6-430c-b637-cfee3e8c4525"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/614887e0-aa56-42b8-a08d-14e3a4b0e077">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7e0a9709-3119-4f54-9172-7948cff7884f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/c83b9671-4585-4d0f-9721-533d1884b032">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/08e7425a-3134-4696-a6e6-5c4abd2ef86b">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b677c79e-ac49-4df5-a5ea-eec5533d6c0d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/df57fdd7-ed9d-49a9-9bb1-5a0713887f29"/>
    <rdfs:label>rosuvastatin-Lopinavir/Ritonavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/69fefe8b-ec4b-4d06-b547-6c40a60166a9">
    <rdfs:label>paroxetine-9-hydroxyrisperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/271d933d-8544-447f-aa03-71bdb7d09ede">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7c2e4d52-7a99-4a4c-87b6-6228f0ab3b15"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/4e89c636-8e92-44fa-8127-00b0fc28075e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2905a24e-04ab-4e97-aea9-11b4a14a9bd8">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/d7026c05-acee-4721-a6a7-103c7ec19edf"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/95258006-68bc-42f1-83d1-8db3a3ddf6fa"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/f8a36cb2-b1c5-4fad-af07-1cdb49c05d53"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2e181c53-55f1-4c2a-b3e5-2c4458eb6568">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/b4e45684-26ca-4c92-8de5-11c4c4b7cd47"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ace15ff9-cc32-470a-bd3c-07180f50744a">
    <obo:OBI_0001937>8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/49088242-9561-4d07-bb38-a87a5f891354">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/c94f88ef-699f-4f1e-beae-294b873b67f7"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/9c3cad5d-4b0b-486e-8f38-8a596bfb3dd3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7f0ef433-aafc-4e00-9457-5e6aef5f74a9">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7be89ebd-d2cf-4603-998e-4d37b5c19594">
    <obo:OBI_0001937>6.73</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/a979a1fb-1aed-462f-8a37-93f2353d3252">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e21a03be-6ad7-4e97-99fd-58c542c9cf97">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/59b74d35-17a6-4948-b3c0-919584bc782f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3b8bd4ff-5794-4704-a2e4-423819d5aecd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d0d86c31-3e20-46d7-9205-1a783f8795af">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/a5cebcac-40a4-4516-a868-be914d4f1dc5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/99a51f9b-5177-4574-a32b-d45b1556c06f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e71ee9e6-a59e-4cef-a6c8-81e3a26f7c32"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/9c726a2d-1726-4f17-890d-735071410b5d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/b3adb3ce-006c-45f9-9814-96216877428f">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/54251bef-7c90-435e-856d-648f063fe09b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/336faae2-2c34-4e4a-afa7-cf96214b9db5">
    <obo:OBI_0001937>135</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/eb3a5254-3a09-4117-bb11-2d3530ef6fa0">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1162fcb3-eee0-41e6-8c50-650175a7440f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/27993099-6f93-4ec6-8707-289e24fd2cdf"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fe04341a-a0a1-4792-a459-5e126637d775"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5ed7ce45-1410-4933-9e8c-f8630e82f6b8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/db3ddeb1-9b12-4f5e-815f-bc7265a426bf"/>
    <rdfs:label>lopinavir/ritonavir-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5ca5e412-45f7-4793-9bcd-cf39fe922f00">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c72cb449-f007-4766-ad99-da69862989e4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/3f4560ca-b7c2-4d6a-bbd6-4994f524c5ef"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/b7a79c73-24da-4419-a8f7-d4b1455f9034"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/bbedcc75-9175-4de6-b546-7da8bd87017f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/9c88087c-8ada-4f2f-803a-0d857ca8cc52">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/8e66b0db-bb09-4076-a863-39e5d11b2ca0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/95645cbe-744d-48b6-b255-23b419b01e9e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/29f8ce49-c33b-4df4-a295-465e906d0c8b"/>
    <rdfs:label>bupropion-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3e26a917-0f6b-4ed6-af16-828db27c6c5c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/af33769d-3535-4daf-a2ba-9bf2ff4f46fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a8f52966-6d50-444a-a1ab-0be0cfecce97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/61df763f-2449-43c3-b738-e9c29e72054a">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/21b04ab7-09d5-418e-aac7-96bfb8501ab3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/c21d5eeb-6b26-480c-9379-4ac3b49dfd11"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/1f3b77d8-0c8a-456c-a2dc-767a1b3aff00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b0ac7230-d335-4a40-80f1-4c1c168bee21">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/9c60f7e2-ead1-4bf1-b462-57a228723b8d"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/b3139efe-fdcd-488b-b605-1d2d91198986"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/682da0c8-77cf-4fed-9a97-11f51b497474">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/66f92631-6803-49a2-9e9e-f8c10e21b330"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/768955d9-9d1a-42f6-bb0a-b70324c4d2ab">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/afe1061a-2ac2-4a0a-b8b5-9201bb67fd85"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/f7e5c390-8dbc-4ffb-bbc5-0138ba57ea47"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/10f49f70-7e08-4fc4-9ae5-a1ddffeb38a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/c3953c13-a2f6-413b-8393-279f908ed777">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e878f2ed-fc38-40c5-94e3-c08c9dd211d0">
    <rdf:type rdf:resource="obo:RxNorm_203143"/>
    <rdfs:label>fluvoxamine maleate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2e387f65-c662-4cbe-a7d5-d8b32e763e53">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/62817ecc-fd90-4c87-9917-526c4734a3ff"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/fb946672-c887-457f-bcb4-331fd5a5d8f9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ee5bea21-b8fd-4897-bda1-2c7f8e5e58ce">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/4d4886f1-acf0-4772-97e2-30e414a97bf6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/eac477dd-7466-40f3-a753-df07092fdf4a">
    <rdf:type rdf:resource="obo:RxNorm_17767"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/015a545f-8da9-40c0-a6f4-cb6a96d40c62"/>
    <rdfs:label>amlodipine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f4daee1c-842e-4acc-ad43-e8a8d3bc3f5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ce1bcfbe-8e17-4108-a2f3-4d6e61da520e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/58efc232-6620-49e1-ba88-1d0d34bc99f7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/3795f5bb-facf-486c-9c71-ae7efe26188a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/98e12aab-943f-429d-a423-b6392f828906"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/71346028-1142-4cb0-b596-3a74927c5a2b">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7c37a933-96da-4b72-9f2f-15c33aa83b6f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/9369d712-9761-41bf-b07d-7ee335cb4f44"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/819b1748-1d4e-4233-b1b7-14013e238e44">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/71e30071-01b1-452f-a4f6-2e9c62d08cce">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f1192df4-04a7-45b9-a020-8884b6ab6b03"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/a59c5d5a-4ff2-4a5c-ae84-87ee667acb1f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/0dd1663e-0a0e-4649-a22e-09e894b0d941"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/06d4f329-4f23-4697-a0df-de94f6d73641">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/305ef049-b33e-4e8a-b6f4-c16ad4248a80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a2dd1aa5-520f-495e-b8d9-96f15d90836b">
    <obo:OBI_0001937>up to 20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/16e8e862-0d77-4f41-b8ca-07df46547a49">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/aebe7ae2-c4eb-4687-ab5b-8ec47914052b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/be5d47de-8217-495b-b2fa-ab6e9ebdf1dd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/263efd4b-eb2a-4c5a-abe5-a9a12769fa7b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/aa031e16-3b61-4580-ba03-bd59554e0cdf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cdaac0ed-ab50-4993-9c1c-dbe4c6126d4f">
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/557afcf6-bcb5-4edd-817c-52b49736a4be">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c133f023-69af-4418-8790-8ed4c331fde9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/ad63ad7c-3413-45b6-a3e5-51bb04710aea"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/4737110c-5607-4368-bad2-e06998eb1c58"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9d500e71-0135-4eca-a745-589efa9df0bc">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/c85e66cf-a312-4288-94fb-9210051ba9c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/35b5ad52-e398-4274-a574-e1b8ecddadce">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/fc0a8827-b547-419f-afef-8e0cfb7c96c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d827399f-2383-4a09-b6cd-eaa20babb079">
    <rdf:type rdf:resource="obo:MeSH_C406672"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/f02496d6-0156-4b6a-95c6-0ca44364113d"/>
    <rdfs:label>triazole-dione</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/37a5e77c-d390-4077-8782-f14fc5d0490e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/16bc845f-d2a8-409f-b1e5-49d73eb6b05f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fa81c822-d2f5-4a99-96d1-c3937a2ba7c2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fc2e07e6-2360-41cf-bb91-4909ea35c897"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/657697cc-699d-4aa8-95b4-1e518c7d1972"/>
    <rdfs:label>ticlopidine-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/df4c5346-b002-42e9-8929-f5508a3fded7">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/e98fb7fc-04e5-4d37-97c4-7591b8ef6255"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/d20fc3cf-5638-4330-8179-7e9be9fa2145">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/043703f0-ab96-49d9-8f88-b3dff2138778"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7b88cd94-085d-4063-a09f-738ce75a6a0e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e87ba6a1-36b5-4fbc-ae46-767ee795fe2f">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/8c1bf3d1-20f5-4285-a5e4-48d935edd346"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/aa067385-fa2c-4849-a93d-891cd7771dcd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d03627cc-628d-451f-b2d6-08885d585dd5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2fd32aea-8470-484d-9db8-c0bb9d5eed89">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/70094589-4e43-4d0b-a6e4-bb40721bb79c"/>
    <rdfs:label>Lexapro-metoprolol drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/37f04bd6-e17e-471f-b7d1-ee576ab35371"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d74679d9-cab1-48a1-8b2f-53dda1293541">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d8c4169f-faf9-484b-bdd1-0e6987d1cf23">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d503179d-fecf-4b4c-9faa-8c4b879b328e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/ef997962-301f-4814-8a7e-9e6f7f9b6d02">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/78ee8441-2f21-4f02-a89f-0c10064e9815"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/8f1ea85b-927a-479c-9a94-4c5a7ef4b1a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/eea79dbb-d264-40be-8fd3-f3fa5851de2b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/4baf166a-2b0b-4fda-b4ae-2e060bd8f339"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/74c35dd2-8cf4-4814-b28e-f6058409aa5e">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/cbb26c2f-0da2-4ebf-93c1-2d8bd63cb504"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/310f102b-bf10-4537-a327-cf3d81427882">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f27de024-518c-4daf-b7bf-fcff440e7d8a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8d0d498e-68c9-4702-a4f4-07cd14303e01"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/621ee676-a3f6-4b4f-891b-87b45d3f4d70"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/012b358e-ae6a-4a05-a6e6-3acc0027f613"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7f273737-169a-4af6-b148-8878cd3e2933"/>
    <rdfs:label>phenytoin-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c90de7a6-8e45-4ea2-92ee-7091aba29827">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0f168714-3741-4026-af78-681d315a80ea"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/84eac68a-2d96-4912-95c0-9cf355f8fb71"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e78e1e09-7677-4afc-9bdf-4bec20b17326"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6b0e0d15-74a3-421b-a706-f81d5dbbb688"/>
    <rdfs:label>Nelfinavir-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1dfa0477-d115-4a9b-81a1-0e462885c56a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/94f0db01-266e-4e81-8c8b-18237eb346b7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/aefece42-68ef-4309-aa94-05afa588f30b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9cf25550-4cfd-4809-8903-900da73f6039">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3d8462f2-02f5-49d3-9886-a9f37f2a7b2d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/18b94449-1b9a-429b-8c3c-d77f8139d433"/>
    <rdfs:label>ketoconazole-eszopiclone drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/2a24fdc3-d8cd-418e-9748-74b2edb97fb1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000100"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f03ddd80-b1d1-44d4-97d7-4fdc87232ab9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/011b6e8f-2bf7-44dd-907a-615d8bf44cb6">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/5c65a962-0f11-4641-8f46-157df71d01e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/0914b7f6-599d-416e-88a9-660176bb2282">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/3490d4a4-2a2f-4ad0-8b37-d02ff81a08a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7c2be797-47d2-472b-9c65-29b860abb29a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d38a6fee-673c-4d4d-9609-69c4cbf996e5">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/cdd19d03-db03-4c37-add8-576c0c0ef0fb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/51dcb979-afa1-42bc-8f4d-2cd8f097cc70"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/8846cd28-bc41-4151-9305-796d93361360"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/6c0acc73-f4b3-4269-99f9-d47ba96bdb44">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/8ec50a42-088d-49de-8b4d-8f0814cda1c9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/88cc3832-42a7-44e2-87c2-d2a852b829fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/126e9897-18b5-4671-b21f-f63f6f26b307">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/6dd6dcdf-54c5-4248-85d0-6bb6ceb5b8c1">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/f6291a43-a197-4aae-b31d-e6fe98b34578"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f21cad99-2bae-4da8-ac2f-355a3d8e3a72">
    <rdfs:label>Telaprevir-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/44b7822e-f43e-45a4-95bb-f77f1d2194ac">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3b836bc6-a02d-462f-abc5-ab16997af13b"/>
    <rdfs:label>cimetidine-zaleplon drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/d54f7613-301d-41a8-82ee-5803f94bead1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b618f65e-c58e-4db1-a085-73a879c567c7">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/6bdafaa0-30ee-481d-b028-f905d8150660"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/4e3dcb2b-1e50-4c3a-9391-9572d727bb02">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/a317cf42-42c9-4610-a326-d27e4a3f64bd"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/96c041eb-865a-4818-8a90-f37f50e6c039"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/abb820fd-b036-4eca-bddb-7d7c289e89f3">
    <rdfs:label>cimetidine-sertraline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d0f1dc5f-853e-4551-9e89-241ef4cb87be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3f4560ca-b7c2-4d6a-bbd6-4994f524c5ef">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/edf8411e-1667-4a2e-9d75-403fc894e5d7"/>
    <rdfs:label>desipramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/cc564b2e-9b1e-4ae3-8ac8-873260df5dc2">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/a14ef24c-1e57-45be-a4c2-1ecf6a3a96fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/38565de2-9447-411d-89c7-a3aeec8a0213">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/cfbf2cdd-d5d1-4a43-ba1e-d7f6c08cec5b">
    <rdf:type rdf:resource="obo:MeSH_D000661"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/c70b177b-f2b1-4151-a4d0-818260203c7d"/>
    <rdfs:label>L-amphetamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/55936487-dad7-405e-9828-9f7c6ad3ca0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/c8c5c4ba-deeb-4676-ad0a-316350e83993">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/579720b0-ef24-4ca9-8759-859662bd945c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8794751a-c9fa-4b32-a366-9eb3f6995fa5"/>
    <rdfs:label>Fluoxetine-olanzapine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f66094ee-13cb-4048-98e1-6e25d5ff2485"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/65327887-52eb-4935-953f-bb13638ffaf6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/96f03f69-24a5-440e-9341-40dcaea8d94e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/2de68fcc-9f7e-4ac4-b93a-402940ae5ebb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/88dce1ca-ecf1-4d44-a3f0-8b06fa3b1b67">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/47f78d43-5952-4205-bc5f-1ede08995031"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/265e7fee-18f0-4eb7-8744-96bff4ee2a75">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/50b8f37a-a7d5-4eb4-8ed8-7d598fcc6a94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/c0e6bb40-6d22-4b76-9866-71edb69ebb3f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/9a3c3c44-e078-4676-962d-7808fd13b2db"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/43aa88a4-c2b7-423f-9636-0787577e68c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2200b3d3-613d-432e-a5d9-140cdcd8b120">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/49493d85-360c-4d36-995d-417a5b3b4bef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ac78eb40-cfa8-4c24-bbfb-f56a0fe0ec1c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f10b9f51-0bd8-472a-b86f-32ca3792d192"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/04a34225-7830-4e64-955e-40e8965d9b55"/>
    <rdfs:label>paroxetine-9-hydroxyrisperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/bc82a57c-5d0f-46ae-acb1-bef388099d42">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/affe0619-1ecd-4574-912d-66be93eeedf8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/af35c2b0-bb7d-4565-83cd-e94dc307e9b5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/648f5e17-e2b4-4122-8a8d-b0413ae0e233"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/11420c0b-95cf-479b-8f26-0ee7a4509b42"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d28c129a-b36c-4f5f-a758-6dbbe07e274a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d1dc1925-17b7-46fa-8f56-4918b937dbc6"/>
    <rdfs:label>ketoconazole-P88 drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/83f90777-f8ff-4659-bc10-9c29fb7aa2fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e1abe6d5-2bd0-41e4-aea6-22602752e137">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/55af9046-9300-4bb5-8be6-fa08d4381415"/>
    <rdfs:label>fluoxetine-estazolam drug package auc UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/f8acfb11-63aa-4b6d-a581-0713c5eb60ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/aa957355-e185-468d-9b63-0da22213966d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/05cdd4ac-fec4-4b9c-a959-0e410eb09c32">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c16880cb-f7b8-4146-a162-193103571784">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c5dd151b-c549-4bae-a0de-a16fc6b0e8e3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e8b904b4-1daa-44c8-b240-81404c9f2036"/>
    <rdfs:label>simvastatin-Nelfinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9e3a0e1a-5149-49f6-b5f5-ec65bbdce2ed">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/8353a441-915b-4fe0-baa4-19647f8e15cc"/>
    <rdfs:label>simvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/582ee33f-261c-4e4e-9d97-297afc84c07a">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/5ef18917-0931-4a03-a963-2ff0a3ebd9ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/951f9e6e-fc91-49e7-a646-cda9bf5031a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/941bc456-e10a-4ca5-bbda-e75a1637f336">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7a58e018-0f2e-49fb-b3fd-6abcaa254099"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/94cf303c-0c30-49b2-b56a-0ddabe9e29ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ad531e75-b42b-4a19-8dfd-aaed7c9f4bed">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/9cd9f5de-6693-40b3-bdbc-3aeb4b7765fd"/>
    <rdfs:label>zolpidem</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/56ffa390-ffb6-4d78-b7db-c5028f30996e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/df758007-1616-405e-84ee-2185fea4cf20">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b5452931-4edf-478a-b1a8-fbb7e645ffdc">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/d23d089d-7d77-4dd0-a62c-0bc4c6f4a230"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/da6e3c99-462d-406b-9e65-0983ebbb6c61">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1c3755bd-5abf-46ab-813e-2955e75f0039">
    <rdf:type rdf:resource="obo:MeSH_D016572"/>
    <rdfs:label>ciclosporin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1a615024-1a0e-456c-a735-3ab4e404e2cf">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f1c7c1a8-5916-4207-8b0f-58fef7e37b87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/5ce306c6-8260-4a73-8ce1-5f933a231c5e">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6b3682fa-933e-493c-a3d4-a4f93eed4d9b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/2fc675db-a765-42ea-98c4-a5ef6918d992"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/20da7f1f-d885-400f-8101-a09b0ed87842">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/06600300-99e4-41da-bb8a-777ccda09c7a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/a89bcdc7-466a-4f9e-86fb-beceaae40e3c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/fcbd2788-9054-4be0-8ce9-764ecf6e7d73"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/df4c5346-b002-42e9-8929-f5508a3fded7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/df57fdd7-ed9d-49a9-9bb1-5a0713887f29">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/dc3eeafa-a449-4ec4-9601-8fdee673f1df"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/cf25c889-5c34-4e41-915f-bf2f75224d68"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e591bf70-e542-4edf-a5b0-70cd06156867">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fefb5e87-e056-49b9-8027-9de6b71d94ca">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/27d80099-9858-425e-9f31-f3a017d37ac8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/0a34f946-acd0-480b-9b6a-232933d82489"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/8090dad6-6e79-4199-afc6-4812eb92cdc3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/880cb54b-1feb-41e1-824d-a8c477cee5a6">
    <obo:OBI_0001937>68</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/c6247e60-a075-457c-8310-6c0397ce0c9b">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/1eb86f08-a1f2-42da-8004-695c56056b18"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/98056286-5a17-453e-be90-7f3513f536ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/26d71aa4-d2e0-44bf-9e7a-7fcf976764df">
    <rdfs:label>rifampicin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8f8f77f5-402b-4aad-875d-484fb27c31bb">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
    <rdfs:label>buspirone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/979f2ac7-3ddf-4456-b232-b5e4c30e01d9">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/49cae87f-eb68-49ec-a662-a3ce6d1e7a16"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/636d60ac-1847-4eb5-b036-4d5906d4c5bd">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/30b27cde-a7db-4d0b-ac79-2db4ed055976"/>
    <rdfs:label>Rosuvastatin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b290a6c3-b3d9-4a01-9738-6b1308f76afd">
    <rdf:type rdf:resource="obo:RxNorm_596"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/f80eeb2f-928b-462c-9764-59ae454f7da3"/>
    <rdfs:label>alprazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7e47319c-d61e-45dd-8dbd-d05f350c0abb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/900a34ef-5edc-4be9-b0f0-d174bedff34b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/dffbfd01-c3d5-468c-9e7a-45dc70d3a822"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1905039f-49a5-4f4f-acb1-d85ba7a552fe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3f39e2ee-3c21-4b57-b51b-10ed5f1af48e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/12246b4a-cf98-474e-89e7-dde0744ae83d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6d4fb606-8e58-400c-b698-e74b4715d8f6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/cada25c8-7816-45a5-bff0-ccd9f0c48779"/>
    <rdfs:label>ketoconazole-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/394f7269-9bf6-4b8e-baac-73562f992f16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e0ab6d9f-f595-40f0-9b66-8bdbea108406">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/e1f06ae3-47c0-4eb5-9102-a9b5ea61ae2f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/72d5340b-18da-4117-af2f-4ef3c071f26f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/d4b16ce6-27a6-4cda-a704-0bd44b928cf5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d066b5c9-7be1-4628-843a-24b86fc53217">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/dd532d32-91a4-4fa5-a139-d92297869d81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f35dc95a-75d0-48e7-95e9-fac53a9ce0c4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/29be924c-ec2c-4376-a134-54a0b5d4793f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a7c10dc2-cc67-4b45-a09c-4482178b1772"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7e47319c-d61e-45dd-8dbd-d05f350c0abb"/>
    <rdfs:label>ambrisentan-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cfafc593-664e-4a70-b91e-bc3a06af4172">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1dd4f6a4-e5f3-4d27-96af-e08b06f4732e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/752212a1-e53f-4cff-9ba9-27cc9add1105"/>
    <rdfs:label>atorvastatin-Nelfinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9b15f53a-e862-4d3b-ba3d-05886e1b3124">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/15385147-22e1-4bc3-973f-d25090691ea7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/e64ce42a-46a3-47d6-9a0d-72c5a4639cb1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/dec78851-1738-4442-98f7-45b7db4d465a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8f0fec97-b7b1-479e-b2ac-462976130a6d">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/df3b2879-6ef0-4833-973e-2af0ee4d0bc5"/>
    <rdfs:label>rivaroxaban</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9e42f17e-8c8f-4f68-ba3b-67eaa262946d">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/4cc71f9f-4183-4a07-a299-6aa4f1781c98"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/0bd50c1e-35a7-432b-8479-428e5cbb5a2a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d9546a13-0cd1-4c50-9df5-e099b84873a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0d7eb534-84c6-4f2f-8a5a-ab705e0c6752">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f21cad99-2bae-4da8-ac2f-355a3d8e3a72"/>
    <rdfs:label>Telaprevir-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/0698ad72-c83e-4eb1-8ec4-aa9386feac00"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3bb71cd9-8c0e-4b87-b34f-134604b80ebd">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/251c6393-bf3c-4d3f-892a-0b76387f265d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/67dbfa93-0950-4128-93b9-949df0141270">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/3be41fd1-6091-4e18-8d60-b44217acbe06"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/28b0649e-3771-4a45-899e-77bd5539c0a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/617d5c7b-74a0-4f88-bb7e-48e2963a8879">
    <rdfs:label>cimetidine-citalopram DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c6dbfe18-4c0f-4765-a966-f3607793f994">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a7a5d919-e8a6-43f1-be9c-61e8c93fda81"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ffc456c8-ac16-4100-8a0b-227002bbdefc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c21ffaed-b5f5-4078-b377-b88d3c182962">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/06008f41-984b-49e3-9d18-f660e59b938d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fc0ff910-1da8-499d-92bc-27719009f845"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/98e8d761-f16c-4947-852b-4055356db45c"/>
    <rdfs:label>fluoxetine-triazole-dione interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/43fa180b-bc54-444b-b7bd-bc939a6018cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c8ab28a2-8541-485a-879c-d48eae6dafc9">
    <rdf:type rdf:resource="obo:RxNorm_4053"/>
    <rdfs:label>Erythromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/279b69cf-198c-4846-b3f5-b859bbe28b73">
    <rdf:type rdf:resource="obo:RxNorm_17767"/>
    <rdfs:label>Amlodipine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/be5d47de-8217-495b-b2fa-ab6e9ebdf1dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dd6755fb-4378-4dbb-9f53-b412483aa00a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f667835c-4e11-4ba3-87d6-9a71402d3b46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ff1a493d-a9c9-43f9-870d-275b074f6420">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/cdaac0ed-ab50-4993-9c1c-dbe4c6126d4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bc997096-9e35-4684-bbb1-be93e69f3d93">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/cd0839e0-f141-41bd-a4e3-b2e2e793615d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/52bdccb9-9bbf-48ea-83f1-3ed4e974b934"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/93432714-23bb-4c31-bf79-aec7680ab26e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2e794354-4a52-4f30-9f60-89b878c458c0">
    <rdf:type rdf:resource="obo:RxNorm_4719"/>
    <rdfs:label>Gemfibrozil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/d29c4ec0-d986-44a7-afb1-ab6ab5885390">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a1a9509c-73cb-4800-80f3-2fc93e57e2ca"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/32462b2d-abe1-40ab-8823-9b058e80280e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/41bdd51e-53d5-4ee7-aad9-6c5459d93f02">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/976302ee-c5ee-4854-a75f-6ddd6c46f907"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/244c58ea-d05c-489e-9b22-a18fd942b23a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/4e29c59c-5c56-4920-8f7d-afe8e727a801">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e3a23e07-97fa-4ee5-9e8b-94291adce86c">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/ed3fad7a-09c9-4ef2-8e5e-11f4e7c3c78a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/7fad19a4-0656-48c4-a1da-0cd432cbb9f7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/3d43c31e-4f36-402a-b0f3-6d43d8b49258"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/97c09091-3e7f-41ee-8e38-9de6309869c7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9da95f79-a8bf-4ed3-9ab9-87744eee0c7a"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/f9305edf-c9e7-4ebf-84f5-a2b797de6113"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/11343533-ee02-419f-8667-386edd905154">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/bbd2f240-cd5c-4009-9ee4-287f3853f6a8"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/29b7c977-5e50-49b1-846e-60498cba2f34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c7861393-b812-4e02-b74f-4cb4f521f6ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/fd812fb7-08fd-4cc3-804b-ebf6653ef16c">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/a3c7be66-3cfc-4c4c-bd62-43067243eaa9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/60f6acfa-76aa-4bed-b00c-5f5fbe69ce41"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e25ff6f1-6490-421d-8235-5f65e7c84505">
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/59ca36c6-c912-4186-865a-239a549c8be6">
    <obo:OBI_0001937>517</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4b39124e-0ddc-42c3-b703-cd1bc7faa1c0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5fea5a92-acba-435f-8ce6-0704f7621fcc"/>
    <rdfs:label>fluvoxamine-ramelteon drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/3bb477a8-cb9b-4579-81a7-4dd07404917c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/5154b176-fba9-48e7-823e-2ab1f6d3dabb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9d585663-d621-4545-af15-da78a4b4f756">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b08862cf-0aa2-4f20-9ea4-28f971fdb16a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d399f4b8-33df-4ab5-8395-c746b9df8d19"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/008f8f1d-7ee2-4f5e-9582-e241017fb296"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a51eeecb-2576-42d2-a6f7-d339f32f6896"/>
    <rdfs:label>rifampicin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/8a6d1c8b-5df9-4c9f-85d5-b26fd3c9c282">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/9db4dad9-4889-49c6-ad4f-2fb4360fcc8c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/d945a0fe-d0e3-4f62-828f-c4d12003377e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ee44ccfe-2c29-44f6-a061-a87fde5be49f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f69d23b6-2b90-481f-8f87-3cf62ebb3fd4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4c363f07-4c76-4f46-974d-b99ae8b28db7"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/fc6cc211-7800-42eb-b82c-c680973f0824"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/0104adda-17ae-423a-a141-ffae08b01b9d">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/8c2c98cd-3b24-4bcb-ab7e-da0823cad540"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/e0cf3871-9195-42d8-a156-6c23cc62166c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/0f0c9e52-babb-4feb-a4c8-e96df80b87e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0fc5929f-cbb8-463e-b579-14edabd95916">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/a4b86277-6644-4c5d-965f-97204cf46a86">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/190df6d8-fc6f-4111-98bc-ca8df5416a3d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/ae06c72b-b870-4f1d-be08-263649a9dccf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b6daef22-5a77-4bcc-8911-4a6a7ba49183">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5f74e8c5-62e1-4841-8775-d11fad55dab1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/a5cebcac-40a4-4516-a868-be914d4f1dc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/9ae7ccc2-52d9-475c-b82d-7fe3c05efbae">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6911500d-2c87-41fb-8c23-709da13b575e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/cab19d37-b268-4147-b4e9-1d1a0ca18edf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/d6b062bf-43d9-4aef-adfe-6847797d43a6">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/0cf8e710-90b7-4501-bf39-7d662ebcfe2f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b8cdb992-477b-46dd-b6a8-d52c022dc7cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f96e07aa-9efe-49bd-b42f-b49a34e9e980">
    <rdfs:label>Carbamazepine-olanzapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cb994d00-a4be-474a-9a6c-65d1ad06ff13">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/67d9a513-2573-401e-932d-39cd55bb6c4f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0ff03303-c105-416f-83d3-8339969c1e74"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dd18e958-76b1-4320-bd0e-2354f6b55301"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/dcdd9f9e-23df-4162-be12-f0c04f67bd12"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/71eeca92-5727-43ee-8fbc-0d7518086210"/>
    <rdfs:label>digoxin-aliskiren interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/32462b2d-abe1-40ab-8823-9b058e80280e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ce44db78-5ae9-4ba9-860b-efbdbf91aa08">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/047e7784-c243-4d20-a5f4-2d9f0c8dbf7f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/6ea0743d-7095-4721-be27-d2214abcafda"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9f1c3fe8-5206-4e49-9996-3c61a7a20fa9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d84e8839-38d9-468e-a411-8d8d4fcb1021"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/b10f0c80-baeb-489a-b883-d40cd80cc2a6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/9d8cf3c6-6f32-49d8-8833-823621d4c6aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/50df314e-59b2-4390-ad82-b20f095b48c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4ad6f7e7-d790-4cc4-b2f6-5efb965f07b7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/27f71454-4319-4f05-b0fb-6f6eba2daf62"/>
    <rdfs:label>Erythromycin-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/a77f3611-fb00-4b60-8d37-ddbbba47e236"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/e45addfb-debb-4480-9b5e-fcd74eac8840">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/869783c9-e648-4b6e-899d-610196622e83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f0428cbe-3cae-48fe-9958-046362bde296">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/32ee39f7-0cd5-4669-8b8b-b831919ee09d"/>
    <rdfs:label>simvastatin-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/5f509aa6-d4da-45f5-90c6-35d37b3163bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5633510d-e175-4dd3-ba81-4228b56b1b20">
    <rdfs:label>simvastatin-ramipril DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8b0129de-0b0c-42e4-bc27-b28a61f435b1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/41bdf757-0934-42ee-a812-adcc0c01afb8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/49aaec22-ebc5-4396-820d-11d515594939"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c4787857-e8f3-4193-83b2-20324a2abcab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/dff95934-cb06-42ac-adc8-33c786e1aa91">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/6c547164-349c-4ca7-ad04-161baa4c2999"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/543fff0d-f78c-4fcc-85ed-966626c83b87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7d6acf9b-44e8-4d9a-bfbb-cad14ed84763">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/a8f52966-6d50-444a-a1ab-0be0cfecce97"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/a9d564db-5751-4a4e-959c-379bec66e194"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/0de4f891-0fe3-4d3b-b414-dcf0cd2f6f68"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/31a73510-4821-46ae-b63b-7f5100220bbe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1125b849-96a8-47d0-9f74-9f3414bf0763">
    <rdf:type rdf:resource="obo:RxNorm_596205"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/2c11d8e3-08de-4dbb-8700-e790f840eded"/>
    <rdfs:label>ramelteon</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/02be8092-7cac-4652-b498-757c8b5b8d18">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/0c532fed-e625-49b0-a08c-d71933af1180"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/68ac5bb5-aaab-4c8c-be0a-2f4c98686971">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/b6324cce-3413-46fb-a4d0-ee664c1e2374"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/018c45c6-a1d4-4fe3-8352-1679bf9fb46f">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/09105f3b-a225-45e3-b2a2-f50b632f6aa3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/d83a532c-8c83-4681-abdf-32e17e5db227">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b2571353-2142-4858-a184-40d947d4271f">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
    <rdfs:label>citalopram</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/27c70717-1aa0-4643-be8a-80b1cbedc344">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c808ef60-033d-4744-b62d-a0d85ca75ab6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/f196e823-9f67-49a7-8bbc-43a64d45e658">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/b6871b47-6754-4000-92c5-eb8596b6a4fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/36d1ad6e-e289-43e0-9618-52d8e01df573">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/60f6acfa-76aa-4bed-b00c-5f5fbe69ce41"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/9c2378bb-9344-4ece-a069-dea4db05bdd4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/d19de9ea-409e-4328-9f50-7fd4d84f93e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/798813e9-637e-43b9-ba30-49b9d977bb47">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/30ebd72e-a5d1-4750-a8fe-44b123c3fa56"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/adb80a4a-d257-469e-b937-835c95ea61f2">
    <rdfs:label>fluvoxamine-tacrine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/418eb9fc-88b4-43a0-bb41-649abe9fb86b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a99f0809-0b69-4650-9ae0-b15831188913"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7e12720e-5e97-4990-991b-db9d7be5ed60"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ad9b8300-e7fc-408b-aedc-ebf991386278"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/702bdcdb-b28c-4964-82e2-50cabc6c43f0"/>
    <rdfs:label>ketoconazole-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f799556e-3e2d-4743-87f0-92615e492d75">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/f1f8f444-f659-41fd-9d1b-ff658f3d545e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/04b06629-6b20-4e37-83ba-708341cd5c9d"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/8a1b6cae-9092-48bd-b77e-646b8f82ab9a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/aa22cd71-f93f-4b38-91d1-96ce59534d7a">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/5ae47ed6-165f-45ff-91a8-d34aff6653c8"/>
    <rdfs:label>bupropion</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/29b7c977-5e50-49b1-846e-60498cba2f34">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/fc3e6c1e-1a51-412b-bdaa-b1b46edaf616"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/64dcb5f7-9499-459d-9115-f5304418972d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f4d0b7ef-36cc-4237-8b6d-1ba3b90f924d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f369584f-68a6-453f-8180-14061b643be0"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/28e512af-4b20-44f1-ae51-9467f0499c7b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5e399782-c1c3-44f9-94d9-5a6cd7c86f8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/75110f16-c72f-4690-929c-eae94e77625a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/dd31fe64-8f85-4a2e-8159-0096522c7800">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/e8976942-a378-44be-bebe-7befd7f5d979"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/20799405-5c0e-454c-b245-dc0391238e63"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/e6f83fb2-8b8f-486a-ba96-ae81cbf7a6bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/26e2d7f6-d4e8-408e-a2af-a40ba81af7f8">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/ab5ccb45-5947-472c-81cd-e21adcc9f70f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/18cba3cf-cc96-4e53-919f-4022d8ef8a44"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a9ad2929-5121-4c15-973f-b602aa7dafdf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/81ad0b47-3301-408c-8c19-29b3b34e0f68"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/4be60b54-418a-41fb-8803-e5c0fd3f3a4e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f31a1940-36a3-4b1e-b3c7-f637d6545b85">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/384ae7ad-7920-4040-b96b-1fd154d1ba13"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/99b94fbc-57cc-4e0d-ab99-fbfe0f119018"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/dbb2f0c1-1e1c-4a31-9caa-b23e9f53f037"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0fafe663-f0cb-4886-9324-8077ba9efef0">
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/c33e1658-4013-4c2a-896c-13fd93746f79"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/9e3a0e1a-5149-49f6-b5f5-ec65bbdce2ed"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/13419dbe-ad01-4eae-bd24-e9a45cf6a69e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/206f6e7b-7a08-4963-8da3-862161a20d5a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/b59166e3-a2c0-4485-b4ab-143dab918c6a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/88eb7c74-e75c-46c8-af6e-8a8239211688"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/c9eff0e0-a204-408b-973f-a66ee4192c05">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/ff0dc922-97db-4161-ad49-95d17fbc5d66"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/06158a46-c8be-4358-aaee-37de7f09d073"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dd2c9b00-33ae-4ec0-be27-5f4931eaaa5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c0aa30e0-ccc4-4710-86b6-0777641d0510">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fe3b3c48-d8d2-470b-ae9e-23a7a5197d93"/>
    <rdfs:label>Gemfibrozil-atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/data-ratio-type/695a5483-102d-45e0-8ee5-0f5c38f63bb0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/0a5e84c1-e101-480d-b043-ea1ac83f9f14">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/f071db17-11ee-43ba-bc28-7057d43f887a">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/70d1854a-4d7c-4868-bd8f-ede3e99ce837"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/94f11835-77dd-4a59-8e55-17761800b675"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/efd97c65-e190-49cf-8d20-c11eb6d9fb7a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5a1bf7dd-33df-4d41-8763-738e99c48934">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5cb8625f-5183-4fd8-837e-7f829d7d5f27">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/72623fbe-5ead-4084-adae-464dc8caff15">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/051d7153-e715-4244-a9ed-d598a6967080"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/98b2d0f7-0b37-46dc-b920-36fb4bc06d0e">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/9653f3ab-c26e-475b-ab0e-35244fa11e39"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f9d2570f-6c18-4236-a7c4-be53dab350ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/7819ab85-350d-4bfb-a81b-928cd498e0c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/06fcd968-2c44-413c-ba3b-f108e1f03a1f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b9a918d2-cdb1-41eb-808d-bcce1bc305a8"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/ffe57c4e-19fc-475f-b7f5-f9e73653c933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/3bffee20-9f2e-4abd-a9d8-70d3f44d30b0">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/c43f621a-bac6-4a38-9f47-1da001e592b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c3798e4d-0c9a-43e6-8bec-e7fc38dbf5e8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/db7cf377-5800-4fe4-940d-526b2686c82f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/ae4c62c7-0966-4c41-a5f7-252ab24cd003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2f7ff75b-f4c8-494b-9977-5a8a9d63ceff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b110f347-f4c5-48ba-a6e8-d1b0a95116cb">
    <rdfs:label>efavirenz-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8a92762a-a595-4b59-a998-3737fce7e6bb">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
    <rdfs:label>Nelfinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0dfcd18f-ba59-4f54-aa3c-144ce3cc8c3d">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0eca4c7d-b2e5-474a-8781-042f9586651c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c94e3da0-8a1b-4266-b4c5-a69db0a20d43">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5ca5e412-45f7-4793-9bcd-cf39fe922f00"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/75110f16-c72f-4690-929c-eae94e77625a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/40bb24bd-421d-4e0a-aba0-309be380d193">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f791d686-76be-4bd7-b3d5-5d1ec8dec7c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/052e13ae-eed5-4fed-a95d-dbeccfe64648">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/d8e48151-4fdc-4b84-b6d4-3331a221ed18">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/64078e13-ee47-411c-a0ae-15a6a0b7c342"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/fbf101fe-858e-4330-a7ed-fc054b7ec19e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ba87e8db-854a-4334-bade-05b42ca6d706">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/cab19d37-b268-4147-b4e9-1d1a0ca18edf"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/abbb097f-ada8-489c-9056-bfbaddddcfef"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/precipitant-drug/9ecb62e5-485b-49ca-8aba-dd816453c61b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9b8b6048-b919-4c79-93e3-b5951280b4ce">
    <obo:OBI_0001937>3.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/97b4c405-4eaf-49c6-b043-b34244173fd3">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
    <rdfs:label>Fluvoxamine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8f37b14e-3d9c-416a-a490-4ebf5b2d7a09">
    <obo:OBI_0001937>573.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000127"/>
  </rdf:Description>
</rdf:RDF>
